<SEC-DOCUMENT>0001493152-23-019787.txt : 20230601
<SEC-HEADER>0001493152-23-019787.hdr.sgml : 20230601
<ACCEPTANCE-DATETIME>20230601144901
ACCESSION NUMBER:		0001493152-23-019787
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		37
FILED AS OF DATE:		20230601
DATE AS OF CHANGE:		20230601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neuraxis, INC
		CENTRAL INDEX KEY:			0001933567
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				455079684
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-269179
		FILM NUMBER:		23984281

	BUSINESS ADDRESS:	
		STREET 1:		11550 N. MERIDIAN STREET
		STREET 2:		SUITE 325
		CITY:			CARMEL
		STATE:			IN
		ZIP:			46032
		BUSINESS PHONE:		(812) 689-0791

	MAIL ADDRESS:	
		STREET 1:		11550 N. MERIDIAN STREET
		STREET 2:		SUITE 325
		CITY:			CARMEL
		STATE:			IN
		ZIP:			46032
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">As filed with the U.S. Securities and Exchange Commission
on June 1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
No. 333-269179</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>AMENDMENT NO. 5 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 14pt">TO</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT UNDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES ACT OF 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>NEURAXIS,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Exact
name of registrant as specified in its charter)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3845</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>45-5079684</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State
    or other jurisdiction of</I></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>incorporation
    or organization)</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary
    Standard Industrial</I></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Classification
    Code Number)</I></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(I.R.S.
    Employer</I></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Identification
    Number)</I></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11550
N. Meridian Street, Suite 325</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carmel,
IN 46032</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone:
(812) 689-0791</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code and telephone number, including area code, of registrant&rsquo;s principal executive offices)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brian
Carrico</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief
Executive Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11550
N. Meridian Street, Suite 325</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carmel,
IN 46032</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone:
(812) 689-0791</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
address, including zip code and telephone number, including area code, of agent for service)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Copies
of all communications, including communications sent to agent for service, should be sent to:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Joseph
    M. Lucosky, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lahdan
S. Rahmati, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lucosky
    Brookman LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>101
    Wood Avenue South, 5th Floor</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Woodbridge,
    NJ 08830</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(732)
    395-4496</B></FONT></P></TD>
    <TD STYLE="text-align: center; width: 2%"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>
                          <P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 49%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ross
    D. Carmel, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Barry
    P. Biggar, Esq.</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carmel,
    Milazzo &amp; Feil LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>55
    West 39th Street, 4th Floor</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
    York, NY 10018</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(212)
    658-0458</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
date of commencement of proposed sale to the public:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
soon as practicable after the effective date of this registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo;
&ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer &#9746;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company &#9746;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company &#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date
as the Commission, acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this preliminary prospectus is not complete and may be changed. These securities included in this Registration Statement,
of which this prospectus, are subject to an effective Registration Statement. This preliminary prospectus is not an offer to sell these
securities and we are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">SUBJECT
TO COMPLETION, DATED [&#9679;], 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">PRELIMINARY
PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_001.jpg" ALT="" STYLE="height: 72.75pt; width: 194.25pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>NEURAXIS,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-size: 12pt"><B>[&#9679;]</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Shares
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering [&#9679;] shares of common stock, par value $0.001 per share, of Neuraxis, Inc., at an estimated initial public offering
price at $[&#9679;] per share. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, the selling stockholders identified
herein (the &ldquo;Selling Stockholders&rdquo;) are offering an aggregate of [&#9679;] shares of common stock, registered for
resale hereby. The [&#9679;] shares of common stock offered by the Selling Stockholders are defined herein as the &ldquo;Selling
Stockholder Shares.&rdquo;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has been no public market for our common stock. We have applied to have our common stock listed on the Nasdaq
Capital Market (&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;NRXS&rdquo;. We will not proceed with this offering in the event the common
stock is not approved for listing on Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company&rdquo; under applicable Securities and Exchange Commission rules and will be subject to reduced
public company reporting requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves a high degree of risk. See &ldquo;<I>Risk Factors</I>&rdquo; beginning on page 12 of this prospectus. You
should carefully consider these risk factors, as well as the information contained in this prospectus, before purchasing any of the securities
offered by this prospectus.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><B>Per Share</B></P>
<P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><B>Total</B></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><B>&nbsp;</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%">Public offering price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Underwriting discounts and commissions (1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Proceeds to us, before expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Proceeds to Selling Stockholders, before expenses (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
We have agreed to pay Alexander Capital L.P., as the representative of the underwriters named in this prospectus (the &ldquo;Underwriter&rdquo;),
an underwriting discount of seven percent (7%) of the amount raised in the offering. In addition, we have also agreed to pay to the underwriters
a non-accountable expense allowance in the amount of 1% of the gross offering amount (including shares purchased upon exercise of the
over-allotment option). We have also agreed to issue to the Underwriter, on the closing date of this offering, warrants in an amount
equal to six percent (6%) of the aggregate number of shares of common stock sold by us in this offering and exercisable at a price
per share equal to one hundred and twenty percent (120%) of the public offering price (the &ldquo;Underwriter&rsquo;s Warrants&rdquo;).
For a description of compensation to be received by the Underwriter, see &ldquo;<I>Underwriting</I>&rdquo; for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(2) The amount of offering proceeds to us presented
in this table does not give effect to the sale of the Selling Stockholder Shares as we will receive no proceeds from any such sales.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the Underwriter an option, exercisable for up to 45 days from the date of this prospectus, to purchase a maximum of [&#9679;]
shares of common stock (equal to fifteen percent (15%) of the aggregate number of shares of common stock sold in this offering)
on the same terms as the other shares of common stock being purchased by the Underwriter from us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
offering is being conducted on a firm commitment basis. The Underwriter is obligated to take and purchase all of the shares of common
stock offered under this prospectus if any such shares are taken.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter expects to deliver the securities to purchasers in the offering on or about [&#9679;], 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sole
Book Running Manager</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALEXANDER
CAPITAL L.P.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus
dated [&#9679;], 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TABLE
OF CONTENTS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#A1_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#A1_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#A1_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF THE OFFERING</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#A1_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#eds_008">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#M_001">DIVIDEND POLICY</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#M_002">CAPITALIZATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#M_003">DILUTION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#M_004">MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#M_005">BUSINESS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_001">MANAGEMENT</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_002">EXECUTIVE
    OFFICER AND DIRECTOR COMPENSATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_003">PRINCIPAL STOCKHOLDERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_004">CERTAIN
    RELATIONSHIPS AND RELATED PERSONS TRANSACTIONS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#se_001">SELLING STOCKHOLDERS</A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">98</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_005">DESCRIPTION OF OUR SECURITIES</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">101</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_006">SHARES ELIGIBLE FOR FUTURE SALE</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_007">MATERIAL UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_008">UNDERWRITING</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_009">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><A HREF="#z_001">INTERESTS
                                            OF NAMED EXPERTS AND COUNSEL</A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">114</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_010">EXPERTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ka_011">WHERE YOU CAN FIND MORE INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#index_001">INDEX TO FINANCIAL STATEMENTS</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>You
should rely only on the information contained in this prospectus. We have not authorized anyone to provide any information or to make
any representations other than those contained in this prospectus we have prepared. We take no responsibility for and can provide no
assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the securities
offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus
is current only as of its date. You should also read this prospectus together with the additional information described under &ldquo;Additional
Information.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="A1_001"></A>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains &ldquo;forward-looking statements&rdquo;. Forward-looking statements discuss matters that are not historical facts.
Because they discuss future events or conditions, forward-looking statements may include words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;could,&rdquo; &ldquo;should,&rdquo; &ldquo;would,&rdquo; &ldquo;may,&rdquo; &ldquo;seek,&rdquo;
&ldquo;plan,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo;
&ldquo;forecast,&rdquo; &ldquo;potential,&rdquo; and &ldquo;continue&rdquo; or the negatives thereof or similar expressions. Forward-looking
statements speak only as of the date they are made, are based on various underlying assumptions and current expectations about the future
and are not guarantees of future performance. Such statements involve known and unknown risks, uncertainties and other factors that may
cause our actual results, level of activity, performance or achievement to be materially different from the results of operations or
plans expressed or implied by such forward-looking statements. You are cautioned to not place undue reliance on these forward-looking
statements, which speak only as of their dates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot predict all the risks and uncertainties that may impact our business, financial condition, or results of operations. Accordingly,
the forward-looking statements in this prospectus should not be regarded as representations that the results or conditions described
in such statements will occur or that our objectives and plans will be achieved. These forward-looking statements are found at various
places throughout this prospectus and include information concerning possible or projected future results of our operations, including
statements about potential acquisition or merger targets, strategies or plans; business strategies; prospects; future cash flows; financing
plans; plans and objectives of management; any other statements regarding future cash needs, future operations, business plans and future
financial results; and any other statements that are not historical facts. <FONT STYLE="background-color: white">We qualify all of the
forward-looking statements in this prospectus by this cautionary note.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject
to a variety of factors and risks, including, but not limited to, those set forth under &ldquo;<I>Risk Factors</I>&rdquo; starting page
12 of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of those risk factors are outside of our control and could cause actual results to differ materially from the results expressed or implied
by those forward-looking statements. Considering these risks, uncertainties and assumptions, the events described in the forward-looking
statements might not occur or might occur to a different extent or at a different time than we have described. All subsequent written
and oral forward-looking statements concerning other matters addressed in this prospectus and attributable to us or any person acting
on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of
new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MARKET
AND INDUSTRY DATA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains statistical data, estimates and forecasts that are based on independent industry publications or other publicly available
information, as well as other information based on our internal sources. While we believe the industry and market data included in this
prospectus are reliable and are based on reasonable assumptions, these data involve many assumptions and limitations, and you are cautioned
not to give undue weight to these estimates. The industry in which we operate is subject to a high degree of uncertainty and risk due
to a variety of factors, including those described in the sections titled &ldquo;Cautionary Note Regarding Forward-Looking Statements&rdquo;
and &ldquo;Risk Factors&rdquo; included in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRADEMARKS
AND TRADE NAMES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own or have rights to various trademarks, service marks and trade names that we use in connection with the operation of our business.
This prospectus may also contain trademarks, service marks and trade names of third parties, which are the property of their respective
owners. Our use or display of third parties&rsquo; trademarks, service marks, trade names or products in this prospectus is not intended
to, and does not imply a relationship with, or endorsement or sponsorship by us. Solely for convenience, the trademarks, service marks
and trade names referred to in this prospectus may appear without the <SUP>&reg;</SUP>, TM or SM symbols, but such references are not
intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the
applicable licensor to these trademarks, service marks and trade names.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLOSSARY
OF CERTAIN TERMS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a neuromodulation therapy device company, describing our business involves several technical terms and acronyms. We are providing the
following glossary to assist readers with certain technical terms and acronyms and to also define certain frequently used terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;AAP&rdquo;
means the American Academy of Pediatrics, the largest professional association of pediatricians in the U.S.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ACA&rdquo;
means the Affordable Care Act, a comprehensive reform law which increases health insurance coverage for the uninsured and implements
reforms to the health insurance market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CBT&rdquo;
means cognitive behavioral therapy, a form of psychological treatment that has been demonstrated to be effective for a range of problems
including depression, anxiety disorders, alcohol and drug use problems, marital problems, eating disorders, and severe mental illness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CCPA&rdquo;
means the California Consumer Privacy Act, a state statute intended to enhance privacy rights and consumer protection for residents of
California.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CE&rdquo;
means that the manufacturer or importer of a commercial product affirms the product&rsquo;s conformity with European health, safety and
environmental safety standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CE
Certificate&rdquo; means the CE mark that is placed on the backside of certain products sold in the European Economic Area and the European
Union.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;cGCPs&rdquo;
means current Good Clinical Practices, which is an international ethical and scientific quality standard for designing, conducting, recording
and reporting trials that involve the participation of human subjects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CMS&rdquo;
means Centers for Medicare and Medicaid Services, a federal agency within the United States Department of Health and Human Services that
administers the Medicare program and works in partnership with state governments to administer Medicaid, the Children&rsquo;s Health
Insurance Program, and health insurance portability standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CPRA&rdquo;
means the California Privacy Rights Act of 2020,  a California ballot proposition that expands California&rsquo;s consumer privacy
law and builds upon the California Consumer Privacy Act of 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;CPT
codes&rdquo; means the Common Procedural Terminology codes, a medical code set that is used to report medical, surgical, and diagnostic
procedures and services to entities such as physicians, health insurance companies and accreditation organizations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;DHS&rdquo;
means designated health services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;EEA&rdquo;
means the European Economic Area.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;EU&rdquo;
means the European Union.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FATCA&rdquo;
means the Foreign Account Tax Compliance Act, which requires all non-U.S. foreign financial institutions to search their records for
customers with indicia of a connection to the U.S., including indications in records of birth or prior residency in the U.S., or the
like, and to report the assets and identities of such persons to the U.S. Department of the Treasury.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FDA&rdquo;
means the U.S. Food and Drug Administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FDCA&rdquo;
means the Federal Food, Drug, and Cosmetic Act, a set of laws giving authority to the U.S. Food and Drug Administration to oversee the
safety of food, drugs, medical devices, and cosmetics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FSCA&rdquo;
means Field Safety Corrective Action, which is an action taken by a manufacturer to reduce a risk of death or serious deterioration in
the state of health associated with the use of a medical device that is already placed on the market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FTC&rdquo;
means Federal Trade Commission, an independent agency of the United States government whose principal mission is the enforcement of civil
U.S. antitrust law and the promotion of consumer protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FAPD&rdquo;
means functional abdominal pain disorder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 4 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;GDPR&rdquo;
means General Data Protection Regulation, a regulation in EU law on data protection and privacy in the EU and the EEA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;HDE&rdquo;
means Humanitarian Device Exemption, a regulatory pathway for products intended for diseases or conditions that affect small, rare populations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;HIPAA&rdquo;
means Health Insurance Portability and Accountability Act, which is a US law designed to provide privacy standards to protect patients&rsquo;
medical records and other health information provided to health plans, doctors, hospitals and other health care providers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;IBS&rdquo;
means irritable bowel syndrome, a group of symptoms that occur together, including repeated pain in abdomen and changes in bowel movements,
which may be diarrhea, constipation, or both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;IRB&rdquo;
means Institutional Review Board, which is any group that has been formally designated to review and monitor biomedical research involving
human subjects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;JOBS
Act&rdquo; means the Jumpstart Our Business Startups Act of 2012, as amended, which is a law intended to encourage funding of small businesses
in the U.S. by permitting specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Masimo&rdquo;
means Masimo Corporation, a global medical technology company that develops, manufactures, and markets a variety of noninvasive patient
monitoring technologies, hospital automation solutions, home monitoring devices, ventilation solutions, and consumer products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;MACs&rdquo;
means Medicare Administrative Contractors, which is a private health care insurer that has been awarded a geographic jurisdiction to
process Medicare Part A and Part B medical claims or Durable Medical Equipment claims for Medicare Fee-For-Service beneficiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;MDR&rdquo;
means the medical device reporting, one of the post-market surveillance tools the FDA uses to monitor device performance, detect potential
device-related safety issues, and contribute to benefit-risk assessments of these products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;MHLW&rdquo;
means Ministry of Health, Labour and Welfare of Japan, a cabinet level ministry of the Japanese government that provides services on
health, labor and welfare.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;NASPGHAN&rdquo;
means the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;PENFS&rdquo;
means Percutaneous Electrical Nerve Field Stimulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;PMA&rdquo;
means the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;QSR&rdquo;
means quality system regulations maintained by the FDA that must be followed by all medical device manufacturers who wish to sell devices
in the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;RCT&rdquo;
means Randomized Controlled Trial, which is a study in which people are allocated at random (by chance alone) to receive one of several
clinical interventions, including a standard of comparison or control in for the form of a placebo (e.g., a sugar pill) or no intervention
at all.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SSRI&rdquo;
is a type of antidepressant drug that inhibits the reabsorption of serotonin by neurons and increases the availability
of serotonin as a neurotransmitter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;TCA&rdquo;
means the EU-UK Trade and Cooperation Agreement, a free trade agreement signed on December 30, 2020, between the EU, the European Atomic
Energy Community, and the United Kingdom that provides for free trade in goods and limited mutual market access in services, as well
as for cooperation mechanisms in a range of policy areas, transitional provisions about EU access to UK fisheries, and UK participation
in some EU programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;TKBMN&rdquo;
means TKBMN, LLC, an Indiana company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;UKCA&rdquo;
means UK conformity assessment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;UKCA
Marking&rdquo; means a certification mark that indicates conformity with the applicable requirements for products sold within Great Britain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;USPTO&rdquo;
means United States Patent and Trademark Office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 4 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 0pt; margin-bottom: 0pt; margin-right: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="A1_002"></A>PROSPECTUS
SUMMARY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>This
prospectus summary contains an overview of the information from this prospectus but may not contain all of the information that is important
to you. This prospectus includes specific terms of the offering of our securities, information about our business, and financial data.
We encourage you to read this prospectus, including the &ldquo;Risk Factors&rdquo; section beginning on page 12 and the financial statements
and the notes thereto, in its entirety before making an investing decision. As used in this prospectus, the terms &ldquo;we,&rdquo; &ldquo;us,&rdquo;,
&ldquo;the Company&rdquo;, &ldquo;our,&rdquo; and &ldquo;Neuraxis&rdquo; refer to Neuraxis, Inc., a corporation organized under the laws
of Delaware, including our subsidiaries, unless the context indicates a different meaning.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children.
We are dedicated to advancing science with our proprietary PENFS technology, which we developed. We believe that superior science and
evidence-based research are necessary for adoption by the medical and scientific community. With one FDA indication&mdash;functional
abdominal pain associated with IBS in adolescents 11-18 years old&mdash;on the market, additional clinical trials of PENFS in multiple
pediatric conditions are underway focused on unmet healthcare needs in children, see &ldquo;<I>&mdash;Our Pipeline</I>&rdquo; for more
information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have incurred significant operating losses. Our net loss was $2.2 million and $0.5 million for the three months
ended March 31, 2023 and 2022, respectively, and $4.8 million and $3 million for the years ended December 31, 2022, and 2021, respectively.
We had an accumulated deficit of $36.1 million and $33.9 million as of March 31, 2023 and December 31, 2022, respectively.  Our
auditors have expressed substantial doubt about our ability to continue as a going concern paragraph in their audit opinion. We expect
to incur significant expenses and operating losses for the foreseeable future as we continue to pursue widespread insurance coverage
of our IB-Stim device and seek FDA clearance of our device for other indications. There are a number of milestones and conditions that
we must satisfy before we will be able to generate sufficient revenue to fund our operations, including FDA clearance of our IB-Stim
device to treat future indications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Mission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to provide solutions that create value and provide better and safer patient outcomes. We believe in improving lives and minimizing
suffering, particularly in the pediatric population, where research and therapeutics are usually lacking. The FDA has already
cleared our IB-Stim therapy for functional abdominal pain, associated with IBS, in children. Through innovation and research, we are
reimagining the future of patient care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Pipeline</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IB-Stim device is to be used for the indication of functional abdominal pain associated with IBS and functional nausea in children. The
same underlying technology will be used for the remaining pipeline indications, but we may use a name other than &ldquo;IB-Stim&rdquo;
for marketing and commercialization purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
one FDA indication&mdash;functional abdominal pain associated with IBS in adolescents 11-18 years old&mdash;on the market, additional
clinical trials of PENFS in multiple pediatric conditions are underway focused on unmet healthcare needs in children. These indications
consist of chronic nausea, post-concussion syndrome, chemotherapy-induced nausea and vomiting, and cyclic vomiting syndrome.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chart below shows our status in the FDA review process for IB-Stim and each of the following pediatric indications:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<I>Chronic nausea:</I>  RCT completed, and data being analyzed, see ClinicalTrials.gov Identifier: NCT03675321.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<I>Post-concussion syndrome:</I>  RCT currently enrolling patients, see ClinicalTrials.gov Identifier: NCT04978571.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<I>Chemotherapy-induced nausea and vomiting:</I>  RCT is currently enrolling patients, see ClinicalTrials.gov Identifier:
NCT05143554.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<I>Cyclic vomiting syndrome:</I> Pilot study completed, see ClinicalTrials.gov Identifier: NCT03434652. Multicenter
RCT is anticipated to begin enrolling patients in the second half of 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
step in the FDA review process differs in duration and cannot be predicted with accuracy. Timing of FDA review and approval, if
ever received, cannot be assured and the process and any approval is within the sole control and discretion of the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_002.jpg" ALT="" STYLE="height: 351px; width: 624px">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Product</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IB-Stim is a PENFS system intended to be used in patients 11-18 years of age with functional abdominal pain associated with IBS. IB-Stim
already has market clearance from the FDA for functional abdominal pain associated with IBS in children. FDA has classified the non-implanted
nerve stimulator for functional abdominal pain relief as Class II devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IB-Stim is intended to be used for 120 hours per week for three (3) consecutive weeks, and not to exceed four (4) consecutive
weeks, through application to branches of Cranial Nerves V, VII, IX and X, and the occipital nerves identified by transillumination,
as an aid in the reduction of pain when combined with other therapies for IBS (DEN180057, 2019). In published studies, patients treated
with IB-Stim demonstrated significant improvement in pain, disability and global symptoms with no serious adverse events, and minimal
to no side effects, including localized skin irritation. See <I>Neurostimulation for abdominal pain-related functional gastrointestinal
disorders in adolescents: a randomized, double-blind, sham-controlled trial</I>, Kovacic K, et.al., Lancet Gastroenterol Hepatol. 2017;2:727-737;
<I>Efficacy of Auricular Neurostimulation in Adolescents With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial</I>, Krasaelap
A et.al., Clin Gastroenterol Hepatol. 2020;18:1987-1994; <I>Effect of percutaneous electrical nerve field stimulation on mechanosensitivity,
sleep, and psychological comorbidities in adolescents with functional abdominal pain disorders</I>, Santucci et.al., Neurogastroenterol
Motil. 2022;34:e14358.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the IB-Stim to produce systemic effects by modulating the central nervous system has been demonstrated in a pre-clinical animal
model of IBS (see &ldquo;<I>Business</I>&mdash;<I>Pre-Clinical Data</I>&rdquo;). In patients with IBS, the largest effect on all pain
measures, including composite pain scores, worst pain, disability and global symptoms, was seen after completing three consecutive weeks
of treatment (see &ldquo;<I>Business</I>&mdash;<I>Clinical Data</I>&rdquo;). A fourth consecutive week of treatment was included in clinical
testing; no safety concerns were identified with this extra consecutive week of treatment. In the trial of 115 subjects, 10 patients
reported side-effects and only three discontinued the study because of side-effects. Of such 10 patients, six patients experienced
ear discomfort (three patients in the PENFS group, three patients in the sham group), three patients experienced
adhesive allergy (one patient in the PENFS group, two (2) patients in the sham group), and one patient experienced
syncope due to needle phobia (in the sham group). There were no serious adverse events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
providers are trained to place the IB-Stim through IB-Stim Training and Certification. Once the provider is trained, the device can
be placed in the outpatient clinic and can be removed by the provider in the clinic or the patient at home. IB-Stim stays on for a
total of five (5) days to allow delivery of gentle electrical pulses to nerves below the skin that access the central nervous
system. A study in adolescents showed greater improvement in functional abdominal pain and global symptom improvement with every
week of treatment (up to four weeks). At the end of the four-week study, 95% of adolescents stated they would recommend the
treatment to family or friends. Safety of percutaneous electrical nerve field stimulation has also been reported in a separate study
of over 1200 adult patients with no serious adverse events and minimal to no side-effects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
wearing our IB-Stim device, patients can still attend school and extracurricular activities, exercise or play non-contact sports, shower,
wear ear buds or headphones, and travel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
IB-Stim device costs $1,195 per device, and each patient will use three to four devices. Potential patients with other indications are
expected to use six or more devices per patient.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pediatrics
Industry Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pediatric
providers, as a whole, had expressed concern about the lack of attention given to children with functional abdominal pain disorders (including
IBS) and the limited treatment options available for a population that suffers from significant disabilities. With 20% of the United
States population under age 18, our Company focus is on opportunities in pediatrics industry. The pediatrics industry has multi-billion-dollar
market opportunities. The following points clearly outline the unmet need in children:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Functional
    abdominal pain in children is one of the most common conditions seen by pediatricians and pediatric gastroenterologists.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Children
    with functional abdominal pain report lower quality of life compared with their healthy peers and equal to those with inflammatory
    bowel disease.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
    35-45% of children with functional abdominal pain disorders continue to have symptoms into adulthood, which impacts quality of life
    and healthcare spending.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    study published in 2021 demonstrates insufficient evidence for the use of medications in pediatric functional abdominal pain disorders.
    This lack of evidence for drugs has been supported in by the American Academy of Pediatrics and NASPGHAN.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IB-Stim
    is the only therapy that has shown to improve pain, global symptoms, and functional disability in children with FAP and IBS.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IB-Stim
    is the only currently used drug or device therapy that is better than placebo in a randomized controlled trial and received
    FDA clearance for pediatric IBS.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Opportunity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total addressable market (&ldquo;TAM&rdquo;) for our target pediatric indications is $9 billion. The TAM is calculated by the total number
of patients we target to treat multiplied by the revenue potential from each patient. This aggregate target TAM is broken down into five
(5) pipeline indications. The first pipeline indication is functional abdominal pain associated with irritable bowel syndrome which has
a TAM of $1.48 billion, followed by functional nausea in children which has a TAM of $2.26 billion, cyclic vomiting syndrome which has
a TAM of $2.8 billion, followed by post-concussion syndrome which has a TAM of $1.9 billion, and finally chemo-therapy induced nausea
and vomiting in children which has a TAM of $0.72 billion.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
years, physicians and qualified healthcare professionals have resorted to the use of off-label medications without proper evidence
of efficacy or safety. This is despite a technical report from the American Academy of Pediatrics and NASPGHAN which found very little
evidence to endorse the use of any drugs in the treatment of FAPDs in children. Medications including tricyclic antidepressants, SSRIs
and gabapentinoids continue to be used off-label despite lack of evidence to support efficacy or safety. Not only have the most commonly
used medications (amitriptyline and SSRIs) failed to beat placebos in clinical trials, but new studies also suggest significant risks
with the potential for serious side effects with these drugs. For example, significant risk of TCA side effects in children include increased
risk of suicidal ideation, mood changes, EKG disturbance, and long-term risk of dementia. Other side effects of pharmaceuticals given
are depression and weight gain. The absence of conclusive data to support treatments based on scientific evidence, and the fact no drug
therapies have been approved by the FDA for the treatment of FAPDs or IBS in children, presents a unique market opportunity for Neuraxis.
Below are the current standard treatments in children with functional abdominal pain and IBS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_004.jpg" ALT="" STYLE="height: 169.5pt; width: 6in"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Solutions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered the pediatric market with clinical evidence, coverage and payment, and key opinion leaders and society endorsement, including
a signed letter from the American Academy of Pediatrics and NASPGHAN supporting our request for insurers to pay for our IB-Stim device.
Our IB-Stim is a non-drug alternative to reduce functional abdominal pain in patients with IBS. In June 2019, the FDA cleared IB-Stim,
a non-surgical, neuromodulation device for children and adolescents who suffer from IBS, through a de novo process (DEN180057, 2019).
The FDA created a new classification of PENFS for the IB-Stim device. This is based on pre-clinical and clinical studies demonstrating
the mechanism of action and efficacy. Based on this new class of devices, the IB-Stim falls under 21 CFR Part 876, Subpart F &ndash;
Therapeutic Devices, 876.5340, Product Code QHH. As a PENFS device, it is non-implantable and provides field stimulation to cranial nerves
V, VII, IX and X in the ear to access the CNS. It stimulates remotely from the source of pain to modulate central pain regions, such
as the limbic system, and relieve functional abdominal pain associated with IBS. Studies have demonstrated long-term benefits in functional
disability, psychological co-morbidities, and pain. For more information, see &ldquo;<I>Business&mdash;Our Solutions</I>.&rdquo; We have
only submitted one FDA De Novo request and have not submitted any additional 510(k) premarket notifications for our pipeline indications
to date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
with treatment so far has been outstanding with the four weeks of therapy required to sustain long-term benefits. Compliance has been
an issue with non-pharmacological treatment for children, particularly with some of the psychological approaches such as cognitive behavioral
therapy or guided imagery, which sometimes requires 8-12 weeks of treatment. In fact, 95% of adolescents who used IB-Stim said that they
would recommend this treatment to family and friends. Many children&rsquo;s hospitals across the country are already treating children
with IB-Stim successfully, since it provides a better alternative for therapy in children with IBS and disability and allows them to
treat them safely and effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have concentrated our marketing focus on 260 children&rsquo;s hospitals. To date, we have sold our IB-Stim product to approximately 50
children&rsquo;s hospitals within our target market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
competitive landscape for therapies includes off-label drugs and drugs with FDA approved only for adults with IBS. There is no FDA indicated
treatments for patients 11-18 years of age with functional abdominal pain associated with IBS and prescriptions often contain
FDA black box labels. Current treatments treat locally and peripherally whereas IB-Stim treats at the level of the brain gut axis.
Current treatments also include devices that could theoretically be used, but do not have supporting data or FDA clearance
for functional bowel disorders or IBS. Our method patents also limit other devices from targeting IBS through stimulation of cranial
nerve branches in the ear.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
drugs for adults with IBS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rifaximin:
    an intraluminal antibiotic approved for IBS-diarrhea</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amitiza:
    a drug that stimulates fluid secretion from the intestine, approved for IBS-diarrhea</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linzess:
    a drug that stimulates fluid secretion from the intestine, approved for IBS-constipation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plecanatide:
    a drug that stimulates fluid secretion from the intestine, approved IBS-constipation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eluxadoline:
    a schedule IV-controlled substance that is a mixed opioid receptor agonist/antagonist in the intestine approved for IBS-diarrhea</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Devices:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gammaCore:
    a transcutaneous, cervical vagal nerve stimulator cleared for cluster and migraine headaches. Recent studies using this device for
    adults with gastroparesis.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transcranial
    Magnetic Stimulation: Multiple devices cleared to treat major depressive disorder and obsessive-compulsive disorder. To date, no
    known gastrointestinal indications.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roo
    System and Sparrow therapy system: Transcutaneous auricular stimulation devices-cleared for neonatal and adult opioid withdrawal.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
neurostimulation market is predominantly comprised of surgically implanted, invasive technologies that are not directly competitive with
our technology. Several neurostimulation companies are large, publicly-traded companies that have a history in the market, have significantly
easier access to capital and other resources and have an established product pipeline. The combined clinical research and product development
done by the industry, including by us and all of our competitors, is uncovering the beneficial effects of neurostimulation which now
establishes neuromodulation as a valid and scientifically supported approach to the treatment of neurological conditions, and accordingly,
we expect for competition in the non-implanted space to grow in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
many companies have joined the neuromodulation space, there are no companies targeting the CNS or the brain-gut axis through auricular
nerves for functional bowel disorders or IBS. Currently, the Neuraxis method patents protect access to the brain, particularly the limbic
systems through branches of cranial nerves in the ear.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Competitive Strengths</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the following competitive strengths will enable us to compete effectively:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    to market</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    portfolio of device and method patents</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    market opportunities</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    pediatric pipeline </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Academic
    Society Support</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lower
    capital expenditures in nurse, trainers, and representatives for first line therapy</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    clinical data carried out in leading academic institutions in the U.S. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Growth Strategies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
    price of our product is $1,195 per device and $4,780 per patient </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    gross margin</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct
    sales force</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target
    customers are children&rsquo;s hospitals and pediatric clinics</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
Development</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc. was established in 2011 and incorporated in the state of Indiana on April 17, 2012, under the name of Innovative Health Solutions,
Inc. The name was changed to Neuraxis, Inc. in March of 2022. Additionally, the Company filed a Certificate of Conversion to become a
Delaware corporation on June 23, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 7, 2021, the Company&rsquo;s board of directors authorized a 4-for-1 stock split and increased the number of authorized common
stock shares from 2,700,000 to 10,800,000. On September 9, 2021, the board authorized another increase of authorized shares of common
stock from 10,800,000 to 13,400,000 in anticipation of this offering. All share and per share amounts for our common stock in this prospectus,
including the financial statements, have been retroactively restated to give effect to the split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the conversion to a Delaware corporation, the total number of shares of all classes of stock which we have authority to issue
was set at 101,120,000 shares, consisting of (1) 100,000,000 shares of common stock, par value $0.001 per share and (ii) 1,120,000 shares
of preferred stock, par value $0.001 per share 1,000,000 of which was designated as &ldquo;Series A Preferred Stock&rdquo; and 120,000
of which was designated as &ldquo;Series Seed Preferred Stock&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
March through May 2023, we entered into Securities Purchase Agreements (the &ldquo;SPAs&rdquo;) which provide for advances of up to $6
million in proceeds to us, subject to our satisfaction of certain conditions (the &ldquo;2023 Private Placement&rdquo;). Pursuant to
the SPAs, from March through May of 2023, we issued Senior Secured Convertible Promissory Notes (&ldquo;Notes&rdquo;) with an aggregate
principal amount of $4,733,333, which amount included an original issue discount (&ldquo;OID&rdquo;) of $473,333, and underwriter fees
of $338,250, resulting in advance proceeds to us of $3.9 million. The notes automatically convert into Common Stock at IPO on primary
exchange. Conversion Price will be set at a 30% discount to the IPO price or $[&#9679;] per share. As a result, the notes will convert into
[&#9679;] shares of common stock at IPO. In connection with the issuance of the Notes, we also issued five-year warrants exercisable for
an aggregate of [&#9679;] shares of common stock with a strike price at a 25% premium to the Conversion Price or $[&#9679;] per share subject
to anti-dilution, issuable on a pro rata basis at each funding. For more information regarding the warrants issued under the SPAs, see
&ldquo;<I>Description of Our Securities&mdash;Warrants</I>.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes were issued with OID of 10% of the principal amount and bear interest at 12%. The Notes will mature in six (6) months from
their respective issue dates or a successful IPO on a primary exchange in the U.S. (whichever comes sooner). If the IPO is not
completed or the Note is not repaid by the maturity date the following will ensue: a) principal amount of the note will be
automatically increased by 20%; b) the warrant coverage will be increased to 75%; c) the default interest rate will begin to accrue
at 20% per annum until the default is cured (default interest will be repaid in cash monthly); d) noteholder will be paid 30% of
gross revenues in cash on a monthly basis until the default is cured or the note is repaid in full. Interest accrues on the
aggregate principal amount (which includes OID) and is payable monthly, at the Company&rsquo;s election, in cash or
in-kind.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company used $2.65 million of the cash received from the 2023 Private Placement to pay the principal portion of some of the
2022 Senior Secured Convertible Promissory Notes (as defined below) from Leonite Fund I, LP, Bigger Capital Fund, LP, and District 2
Capital Fund, LP reducing the amount due to the original issue discount or an aggregate principal amount of $294,444. This balance
will automatically convert into shares of common stock at the terms described below of the lower of (a) $9.44 per share, or (b) a
discount of 30% to the price per share in any subsequent offering.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 12, 2023, we filed a certificate of amendment to our certificate of incorporation with the Secretary of State of the State of
Delaware and effectuated a reverse stock split of our common stock at a ratio of 1-for-2. All share information in this prospectus, including
historical share information in our financial statements, has been adjusted for this reverse stock split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
June through November of 2022, we entered into Securities Purchase Agreements (the &ldquo;2022 SPAs&rdquo;) with Leonite Fund
I, <FONT STYLE="background-color: white">LP, Emmis Capital II</FONT>, LLC, Bigger Capital Fund, LP, District 2 Capital Fund, LP, and
Exchange Listing, LLC, which provide for advances of up to $3 million in proceeds to us, subject to our satisfaction of certain
conditions. Pursuant to the SPAs, from June 2022 through November of 2022, we issued Senior Secured Convertible Promissory Notes (&ldquo;2022
Senior Secured Convertible Promissory Notes&rdquo;) with an aggregate principal amount of $3,333,333, which amount included an
original issue discount (&ldquo;OID&rdquo;) of $333,333, and legal fees for $130,000, resulting in advance proceeds to us of $3
million. In connection with the issuance of 2022 Senior Secured Convertible Promissory Notes, we also issued five-year
warrants exercisable for an aggregate of 353,111 shares of common stock with an exercise price of the lower of (a) $11.80 and (b) a
12% discount to the price per share in any subsequent offering by the Company, and we entered into a Pledge and Security Agreement
with Leonite Fund I, LP, dated June 3, 2022. Pursuant to the Pledge and Security Agreement, the Company granted a security interest
in all of its assets in favor of Leonite Fund I, LP, in its capacity as collateral agent for the purchaser parties under the SPAs.
For more information regarding the warrants issued under the SPAs, see &ldquo;<I>Description of Our Securities&mdash;Warrants</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Senior Secured Convertible Promissory Notes were issued with OID of 10% of the principal amount and bear interest at the
greater of (a) the prime rate of interest, as published by the Wall Street Journal, plus 8.5% per annum, or (b) 12%. The 2022 Senior
Secured Convertible Promissory Notes will mature in twelve (12) months from their respective issue dates. Any amount of principal,
interest, other amounts due hereunder or penalties on 2022 Senior Secured Convertible Promissory Notes, which is not paid by maturity
date, shall bear interest at the lesser of the rate of twenty four percent (24%) per annum or the maximum legal amount permitted by law,
from the due date thereof until the same is paid in full, including following the entry of a judgment in favor of the Noteholder. The
2022 Senior Secured Convertible Promissory Notes are convertible at the option of the holder into shares of common stock at the
lower of (a) $9.44 per share, or (b) a discount of 30% to the price per share in any subsequent offering, subject to adjustment in the
event of common stock distribution, stock splits, fundamental transactions, dilutive issuances or similar events affecting our common
stock and the conversion price. Interest accrues on the aggregate principal amount (which includes OID) and is payable monthly, at the
Company&rsquo;s election, in cash or in-kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the advance of the consideration under the 2022 SPAs, the Company is required to issue to the noteholders a number of shares of
common stock, calculated based on the value of 10% of the principal amount of the Notes issued in such advance, at a value per share
equal to the conversion price of the 2022 Senior Secured Convertible Promissory Notes at the date of such advance (the &ldquo;Commitment
Shares&rdquo;). Accordingly, in connection with the initial advance and issuance of Notes, assuming a conversion price of $9.44 per share,
we will be issuing 35,317 Commitment Shares to the Noteholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;<I>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&mdash;Recent Developments</I>&rdquo;
for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
December 2022 through January 2023, the Company issued unsecured convertible promissory notes to three existing investors, Todd Maxwell,
Rogan O&rsquo;Donnell and Michael &amp; Michele Robuck, with an aggregate principal amount of $222,222, which amount included an OID
of $22,222, resulting in advance proceeds to us of $200,000. The notes carry an OID of 10% of the principal amount and have an interest
rate of 12% per annum. The notes will mature at the earlier of (i) twelve (12) months from the issue date or (ii) the date upon which
the Company completes a registered public offering of shares of the Company, which encompasses the closing of this offering. The notes
are convertible into shares of common stock at the higher of (i) $9.44 per share, or (ii) the price per share of common stock issued
pursuant to the next registered public offering of shares of the Company made prior to the conversion of any portion of the note. Interest
accrues on the aggregate principal amount (which includes OID) and is payable on the maturity date, at the Company&rsquo;s election,
in cash or in-kind. The holders of the notes are entitled to piggyback registration rights on any registration statement filed by the
Company, other than the registration statement of which this prospectus forms a part and any registration filed on Form S-4 or Form S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a party to three advisory agreements with Exchange Listing, LLC, a consultant engaged in connection with listing our common stock
for trading on Nasdaq. Pursuant to the first advisory agreement with Exchange Listing, dated March 3, 2022, and amended February 10,
2023, we have agreed to pay Exchange Listing a monthly consulting fee of $5,000 and a final payment of $50,000 upon a successful Nasdaq
listing, and, also upon such listing, to issue Exchange Listing 125,000 shares of our common stock and to issue Exchange Listing five-year
warrants to purchase [&#9679;] shares of our common stock (representing 2.0% of our outstanding shares after giving effect to
this offering on a fully-diluted basis, as presented in the pro forma as adjusted column under &ldquo;Capitalization&rdquo;) with an
exercise price of $[&#9679;] per share (representing the assumed public offering price set forth on the cover page of this prospectus).
Pursuant to the second advisory agreement with Exchange Listing, dated June 20, 2022, as amended on December 20, 2022 and February 10, 2023, we have agreed to pay Exchange Listing fees in the aggregate of up to $136,166 for advice in connection
with communication and other related matters leading up to this offering. Pursuant to the third advisory agreement with Exchange Listing,
dated February 10, 2023, we have agreed to issue Exchange Listing 125,000 shares of our common stock as pre-payment for future services.
We have agreed to piggyback registration rights with respect to the shares issuable upon exercise of the warrants.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being a Smaller Reporting Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;smaller reporting company&rdquo; as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage
of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We
will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our shares held by non-affiliates
equals or exceeds $250 million as of the prior June 30<SUP>th</SUP>, or (2) our annual revenues equaled or exceeded $100 million during
such completed fiscal year and the market value of our shares held by non-affiliates equals or exceeds $700 million as of the prior June
30<SUP>th</SUP>. Such reduced disclosure and corporate governance obligations may make it more challenging for investors to analyze our
results of operations and financial prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
additional information, see &ldquo;<I>Risk Factors -&thinsp;Because the Company is a &lsquo;smaller reporting company,&rsquo; we may
take advantage of certain scaled disclosures available to us, resulting in holders of our securities receiving less Company information
than they would receive from a public company that is not a smaller reporting company&rdquo; and &ldquo;As a &lsquo;smaller reporting
company&rsquo;, we may at some time in the future choose to exempt our company from certain corporate governance requirements that could
have an adverse effect on our public stockholders.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being an Emerging Growth Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company&rdquo; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (the &ldquo;JOBS
Act&rdquo;). We will remain an emerging growth company until the earlier of (1) December 31, 2024, (2) the last day of the fiscal year
in which we have total annual gross revenue of at least $1.235 billion, (3) the last day of the fiscal year in which we are deemed to
be a &ldquo;large accelerated filer&rdquo; as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), which would occur on the date on which we have issued more than $1.0 billion in non-convertible debt securities during the
prior three-year period. An emerging growth company may take advantage of specified reduced reporting requirements and is relieved of
certain other significant requirements that are otherwise generally applicable to public companies. As an emerging growth company, we
may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">present
    only two years of audited financial statements, plus unaudited condensed financial statements for any interim period, and related
    management&rsquo;s discussion and analysis of financial condition and results of operations in this prospectus;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">avail
    ourselves of the exemption from the requirement to obtain an attestation and report from our auditors on the assessment of our internal
    control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002 (the &ldquo;Sarbanes-Oxley Act&rdquo;);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reduced disclosure about our executive compensation arrangements; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    require stockholder non-binding advisory votes on executive compensation or golden parachute arrangements;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">defer
    complying with certain changes in accounting standards; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    comply with requirements of PCAOB regarding communications of critical audit matters (CAMS) in the auditor&rsquo;s report on the
    financial statements.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an emerging growth company, and under the JOBS Act, an emerging growth company can delay the adoption of certain accounting standards
until those standards would otherwise apply to private companies. We have elected not to take advantage of the extended transition period
for complying with new or revised accounting standards provided to emerging growth companies under the JOBS Act. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
                                            Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incorporated in Indiana on April 17, 2012, under the name Innovative Health Solutions, Inc. On March 11, 2022, we amended our Articles
of Incorporation to change our name to Neuraxis, Inc. On June 23, 2022, we changed our state of incorporation from Indiana to Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 11550 N. Meridian Street, Suite 325, Carmel, IN 46032, and our telephone number is (812) 689-0791.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="A1_003"></A>SUMMARY
OF THE OFFERING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
    Offered:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
shares of common stock,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> at an estimated public offering
price of $[&#9679;] per share. </FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-allotment
    option:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have granted the Underwriter a 45-day option to purchase up to a total of [&#9679;] shares of common stock (equal to fifteen
    percent (15%) of the aggregate number of shares of common stock sold in this offering) at the public offering price per share
    in this offering, less the underwriting discounts payable by us, solely to cover over-allotments, if any. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriter&rsquo;s
    warrants:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have agreed to issue&nbsp;Alexander Capital L.P., as the Underwriter, the Underwriter&rsquo;s Warrants to purchase a number of shares
    of common stock equal in the aggregate to six percent (6%) of the total number of shares of common stock issued in this offering.
    The Underwriter&rsquo;s Warrants will be exercisable at a per share exercise price equal to one hundred and twenty percent (120%)
    of the public offering price per share sold in this offering. The registration statement also registers the shares of common
    stock issuable upon exercise of the Underwriter&rsquo;s Warrants. The Underwriter&rsquo;s Warrants have been deemed compensation
    by the Financial Industry Regulatory Authority (&ldquo;FINRA&rdquo;) and are therefore also subject to a 180-day lock-up pursuant
    to FINRA Rule 5110. Except as permitted by Rule 5110, the Underwriter (or permitted assignees under the Rule) will not sell, transfer,
    assign, pledge, or hypothecate the Underwriter&rsquo;s Warrants or the securities underlying the Underwriter&rsquo;s Warrants, nor
    will any of them engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic
    disposition of the option or the underlying securities for a period of 180 days from the commencement of sales under this prospectus.
    See &ldquo;<I>Underwriting</I>&rdquo; for more information.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    stock Offered by Selling Stockholders</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Selling Stockholders are offering an aggregate of [&#9679;] shares of common stock issued and outstanding as of [&#9679;]. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    stock issued and outstanding immediately before this offering (1):</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,963,322
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
    stock issued and outstanding after the offering (2):</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
    of proceeds:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            estimate that the net proceeds to us from this offering will be approximately $[&#9679;]
                                            million, or approximately $[&#9679;] million if the Underwriter exercises its
                                            over-allotment option in full, assuming an offering price of $[&#9679;] per share,
                                            after deducting underwriting discounts and commissions and estimated offering expenses
                                            payable by us. We will not receive any proceeds from the sale of the Selling Stockholder
                                            Shares.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    intend to use the net proceeds of this offering primarily for sales and marketing activities, research and development,  certain payments to our executive officers pursuant to their respective employment agreements, and general
    corporate purposes. See &ldquo;<I>Use of Proceeds</I>&rdquo; for additional information.</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed
    Nasdaq Capital Market Trading Symbol and Listing:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have applied to list our common stock on the Nasdaq Capital Market under the symbol &ldquo;NRXS&rdquo;. We believe that upon the
    effective date of the registration statement of which this prospectus forms a part, we will meet the standards for listing on Nasdaq.
    The closing of this offering is contingent upon the successful listing of our common stock on the Nasdaq Capital Market.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    Factors:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
    &ldquo;<I>Risk Factors</I>&rdquo; beginning on page 12 and the other information contained in this prospectus for a discussion of
    factors you should carefully consider before investing in our securities.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-up:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 68%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
    our directors, executive officers, and certain stockholders who own five percent (5%) or more of our outstanding common stock have
    agreed with the Underwriter not to offer for sale, issue, sell, contract to sell, sell any option or contract to purchase, purchase
    any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly
    or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares
    of capital stock of the Company, in the case of the Company for a period of 180 days after the date of this prospectus, and in the
    case of our directors and executive officers and our five percent (5%) and greater stockholders for a period of 180 days after the
    date of this prospectus, without the prior written consent of the Underwriter. See &ldquo;<I>Underwriting</I>&rdquo; for additional
    information.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    total number of shares of common stock that will be outstanding after this offering is based on 1,963,322 shares of common
    stock outstanding as of March 31, 2023 and includes 250,000 shares of common stock to be issued to Exchange Listing
    LLC in connection with the closing of this offering, 50,000 shares of common stock to be issued to Lucosky Brookman LLP in connection
    with the closing of this offering, an additional 230,954 and 1,013,274 shares of common stock upon the conversion of the Series Seed
    Preferred Stock and the Series A Preferred Stock, respectively, and an additional [&#9679;] shares of common stock upon conversion
    of the convertible notes in connection with the closing of this offering. Unless otherwise indicated, the shares outstanding
    after this offering excludes the following: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,779
                                            shares of our common stock issuable upon exercise of warrants to purchase shares of Series
                                            A Preferred Stock converting to warrants to purchase shares of common stock. (see &ldquo;<I>Description
                                            of Our Securities&mdash;Warrants</I>&rdquo; for more information);</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">770,284
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock issuable upon exercise
    of warrants to purchase common stock (see &ldquo;<I>Description of Our Securities&mdash;Warrants</I>&rdquo; for
    more information);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of our common stock issuable upon exercise of the Underwriter&rsquo;s Warrants to purchase common stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
                                            </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuable
                                            upon exercise of warrants issuable to Exchange Listing, LLC upon the listing of our common
                                            stock on Nasdaq (see &ldquo;<I>Prospectus Summary&mdash;Recent Developments</I>&rdquo; for
                                            more information); and </FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,319,394
    shares of our common stock issuable upon exercise of options to purchase common stock; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, this prospectus reflects and assumes no exercise by the Underwriter of its over-allotment option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUMMARY
OF RISK FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to a number of risks and uncertainties of which you should be aware before making an investment decision. You should
consider all of the information set forth in this prospectus and, in particular, the specific factors set forth under &ldquo;<I>Risk
Factors</I>&rdquo; in deciding whether to invest in our securities. These risks include, without limitation, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating to Our Business and Our Product</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    business and prospects depend entirely on our current product, IB-Stim. Even though we have received FDA clearance for our product,
    it will remain subject to ongoing regulatory review. If we are unable to maintain regulatory clearance and commercialize our product
    or are significantly delayed or limited in our commercialization efforts, our business and prospects will be materially harmed.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    date, we have not generated any operating profits, and due to our long-term research and development efforts, we have a history of
    incurring substantial operating losses.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
    the Company believes in the viability of its strategy to further implement its business plan and generate sufficient revenues and
    in its ability to raise additional funds by way of a public or private offering of its debt or equity securities, there can be no
    assurance that it will be able to do so on reasonable terms, or at all. The ability of the Company to continue as a going concern
    is dependent upon its ability to further implement its business plan and generate sufficient revenues and its ability to raise additional
    funds by way of a public or private offering. Neither future cash generated from operating activities, nor management&rsquo;s contingency
    plans to mitigate the risk and extend cash resources through the evaluation period, are considered probable, and therefore substantial
    doubt is deemed to exist about the Company&rsquo;s ability to continue as a going concern.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    clinical studies could be delayed or otherwise adversely affected by many factors, including difficulties in enrolling patients.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    we are unable to develop an adequate sales and marketing organization or contract with third parties to assist us, we may not be
    able to successfully commercialize our products for current and future indications.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be successful in achieving market acceptance of our products by healthcare professionals, patients and/or third-party payers
    in the timeframes we anticipate, or at all, which could have a material adverse effect on our business, prospects, financial condition
    and results of operations.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Failure
    to secure and maintain adequate coverage and reimbursement from third-party payers could adversely affect acceptance of our products
    and reduce our revenues.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be successful in maintaining reimbursement codes necessary to facilitate accurate and timely billing for our products or
    physician services attendant to our products.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may depend on single-source suppliers for some of our components. The loss of these suppliers could prevent or delay shipments of
    our products, delay our clinical studies or otherwise adversely affect our business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quality
    control problems with respect to devices and components supplied by third-party suppliers could have a material adverse effect on
    our reputation, our clinical studies or the commercialization of our products and, as a result, a material adverse effect on our
    business, prospects, financial condition and results of operations.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
    testing of our products may not yield successful results and could reveal currently unknown aspects or safety hazards associated
    with our products.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    size and expected growth of our available market has not been established with precision and may be smaller than we estimate.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    physicians and patients do not accept our current and future products or if the market for indications for which any product candidate
    is approved is smaller than expected, we may be unable to generate significant revenue, if any.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
    of the specialized nature of our business, the termination of relationships with our key employees, consultants and advisors may
    prevent us from successfully operating our business, including developing our products, conducting clinical studies, commercializing
    our products and obtaining any necessary financing.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    or third-party complaints or negative reviews or publicity about our company or our products could harm our reputation and brand.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developing
    medical technology entails significant technical, regulatory and business risks.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to compete with treatments now being marketed and developed, or which may be developed and marketed in the future
    by other companies.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Legal and Regulatory Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
    liability suits, whether or not meritorious, could be brought against us due to alleged defective devices or for the misuse of our
    products, which could result in expensive and time-consuming litigation, payment of substantial damages and/or expenses and an increase
    in our insurance rates.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are subject to consumer protection laws that regulate our marketing practices and prohibit unfair or deceptive acts or practices.
    Our actual or perceived failure to comply with such obligations could harm our business, and changes in such regulations or laws
    could require us to modify our products or marketing or advertising efforts.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are increasingly dependent on information technology systems and are subject to privacy and security laws. Our products and our systems
    and infrastructure face certain risks, including from cyber security breaches and data leakage.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may choose to, or may be required to, suspend, repeat or terminate our clinical studies if they are not conducted in accordance with
    regulatory requirements, the results are negative or inconclusive or the studies are not well designed.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legislative
    and regulatory changes in the U.S. and in other countries regarding healthcare insurance and government-sponsored reimbursement programs
    (such as Medicare in the United States) may adversely affect our business and financial results.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    are subject to extensive post-marketing regulation by the FDA and comparable authorities in other jurisdictions, which could impact
    the sales and marketing of our products and could cause us to incur significant costs to maintain compliance. In addition, we may
    become subject to additional regulation in other jurisdictions if we market and sell our products outside of the U.S.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    addition to FDA requirements, we will spend considerable time and money complying with other federal, state, local and foreign rules,
    regulations and guidance and, if we are unable to fully comply with such rules, regulations and guidance, we could face substantial
    penalties.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    products may in the future be subject to recalls that could harm our reputation, business and financial results.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    our products cause or contribute to a death or a serious injury, or malfunction in certain ways, we will be subject to medical device
    reporting regulations, which can result in voluntary corrective actions or agency enforcement actions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may be subject to fines, penalties or injunctions if we are determined to be promoting the use of our products for unapproved or
    off-label uses.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    pediatrics and medical device industries are characterized by patent and other intellectual property litigation and disputes, and
    any litigation, dispute or claim against us may cause us to incur substantial costs, could place a significant strain on our financial
    resources, divert the attention of management from our business, harm our reputation and require us to remove certain devices from
    the market.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="border: Black 1.5pt solid; margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in; margin-right: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our devices.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual
    property litigation and infringement claims could cause us to incur significant expenses or prevent us from selling certain of our
    products.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    depend extensively on our patents and proprietary technology and the patents, and we must protect those assets in order to preserve
    our business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to legal and factual uncertainties regarding the scope and protection afforded by patents and other proprietary rights, we may not
    have meaningful protection from competition.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    the third parties on which we rely for the conduct of our clinical trials and results do not perform our clinical trial activities
    in accordance with good clinical practices and related regulatory requirements, we may be unable to obtain regulatory approval for
    or commercialize our product candidates.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Common Stock and This Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
    has been no public market for our common stock prior to this offering, and an active market in which investors can resell their shares
    of our common stock may not develop.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    market price of our common stock may fluctuate, and you could lose all or part of your investment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    may not be able to satisfy listing requirements of Nasdaq or maintain a listing of our common stock on Nasdaq.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have considerable discretion as to the use of the net proceeds from this offering and we may use these proceeds in ways with which
    you may not agree.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    will experience immediate and substantial dilution as a result of this offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    do not expect to declare or pay dividends in the foreseeable future.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    securities industry analysts do not publish research reports on us, or publish unfavorable reports on us, then the market price and
    market trading volume of our common stock could be negatively affected.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
    issuances of our common stock or securities convertible into, or exercisable or exchangeable for, our common stock, or the expiration
    of lock-up agreements that restrict the issuance of new common stock or the trading of outstanding common stock, could cause the
    market price of our common stock to decline and would result in the dilution of your holdings.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    our shares of common stock become subject to the penny stock rules, it would become more difficult to trade our shares.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will be subject to ongoing public reporting requirements that are less rigorous than Exchange Act rules for companies that are not
    emerging growth companies and our stockholders could receive less information than they might expect to receive from more mature
    public companies.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
    the Company is a &ldquo;smaller reporting company,&rdquo; we may take advantage of certain scaled disclosures available to us, resulting
    in holders of our securities receiving less Company information than they would receive from a public company that is not a smaller
    reporting company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="A1_004"></A>RISK
FACTORS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
in our securities involves a high degree of risk. You should carefully consider and evaluate all of the information contained in this
prospectus before you decide to purchase our common stock. The risks and uncertainties described in this prospectus are not the only
ones we may face. Additional risks and uncertainties that we do not presently know about or that we currently believe are not material
may also adversely affect our business, business prospects, results of operations or financial condition. Any of the risks and uncertainties
set forth herein, could materially and adversely affect our business, results of operations and financial condition. This could cause
the market price of our common stock to decline, perhaps significantly, and you may lose part or all of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating to Our Business and Our Product</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business and prospects depend entirely on our current product, IB-Stim. Even though we have received FDA clearance for our product, it
will remain subject to ongoing regulatory review. If we are unable to maintain regulatory clearance and commercialize our product or
are significantly delayed or limited in our commercialization efforts, our business and prospects will be materially harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Almost
all of our revenues have been derived from sales and royalties from sales of IB-Stim, and we expect to develop, market, and sell other
neuromodulation therapy devices for the treatment of chronic and debilitating conditions in children. The commercial success of our products
and our ability to generate and maintain revenues from the sale of our products will depend on a number of factors, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to develop and obtain additional regulatory clearances and further commercialize our products for additional indications;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to expand into new markets and future indications;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    acceptance of our products by patients and the healthcare community, including physicians and third-party payers (both private and
    governmental), as therapeutically effective and safe;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    accomplishment of various scientific, engineering, clinical, regulatory and other goals, which we sometimes refer to as milestones,
    on our anticipated timeline;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    relative cost, safety and efficacy of alternative therapies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to obtain and maintain sufficient coverage or reimbursement by private and governmental third-party payers and to comply
    with applicable health care laws and regulations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability of our third-party manufacturers to manufacture our products in sufficient quantities with acceptable quality;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to provide marketing, distribution and customer support for our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential presence of competitive products in our active indications;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">results
    of future clinical studies relating to our products or other competitor products for similar indications;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance
    with applicable laws and regulatory requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    maintenance of our existing regulatory clearance; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    consequences of any reportable adverse events involving our products.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the promotion of our products is limited to approved indications, which vary by geography. The labelling for our device in
the U.S. is limited in certain respects, which may limit the number of patients to whom it is prescribed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to generate future revenues will also depend on achieving regulatory approval of, and eventual commercialization of, our products
for additional indications and in additional geographies, which is not guaranteed. Our near-term prospects are substantially dependent
on our ability to obtain regulatory approvals on the timetable we have anticipated, and thereafter to further successfully commercialize
our products for additional indications. Regulatory changes or actions in areas in which we operate or propose to operate may further
affect our ability to obtain regulatory clearances on our anticipated timetable. If we are not able to receive such approvals, meet other
anticipated milestones, or further commercialize our products, or are significantly delayed or limited in doing so, our business and
prospects will be materially harmed and we may need to reduce expenses by delaying, reducing or curtailing the development of our products
and we may need to raise additional capital to fund our operations, which we may not be able to obtain on favorable terms, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>To
date, we have not generated any operating profits, and due to our long-term research and development efforts, we have a history of incurring
substantial operating losses.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were founded in 2011 and have a history of incurring substantial operating losses. We anticipate continuing to incur significant costs
associated with developing and commercializing our products for approved indications including signal development, device hardware and
software development, product sales, marketing, manufacturing, and distribution expenses. We expect our research, development, and clinical
study expenses to increase in connection with our ongoing activities and as additional indications enter clinical development and as
we advance our product development. Our expenses could increase beyond expectations if, for example, we are required by the FDA, or other
regulatory agencies or similar governing bodies, to change manufacturing processes for our products or to perform clinical, nonclinical
or other types of studies in addition to those that we currently anticipate. Our revenues are dependent, in part, upon the size of the
markets in the jurisdictions in which we receive regulatory approval, the accepted price for our products and the ability to obtain reimbursement
at the accepted applicable price. If the number of addressable patients is not as significant as we or our strategic partners and licensees
estimate, the indications approved by regulatory authorities are narrower than we expect or the eligible population for treatment is
narrowed by competition, regulatory approvals, physician choice or treatment guidelines, we may not generate significant revenues. If
we are not able to generate significant revenues, we may never be sustainably profitable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
clinical studies could be delayed or otherwise adversely affected by many factors, including difficulties in enrolling patients.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
testing can be costly and take many years, and the outcome is uncertain and susceptible to varying interpretations. Moreover, success
in pre-clinical and early clinical studies does not ensure that large-scale studies will be successful or predict final results. Acceptable
results in early studies may not be replicable in later studies. A number of companies in therapeutics industries have suffered significant
setbacks in advanced clinical studies, even after promising results in earlier studies. Negative or inconclusive results or adverse events
or incidents during a clinical study could cause the clinical study to be redone or terminated. In addition, failure to appropriately
construct clinical studies could result in high rates of adverse events or incidents, which could cause a clinical study to be suspended,
redone or terminated. Our failure or the failure of third-party participants in our studies to comply with their obligations to follow
protocols and/or legal requirements may also result in our inability to use the affected data in our submissions to regulatory authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
timely completion of clinical studies depends, among other things, on our ability to enroll a sufficient number of patients who remain
in the study until its conclusion. We may experience difficulties in patient enrollment in our clinical studies for a variety of reasons,
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    severity of the disease under investigation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    limited size and nature of the patient population;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    patient eligibility criteria defined in our protocol and other clinical study protocols;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    nature of the study protocol, including the attractiveness of, or the discomforts and risks associated with, the treatments received
    by enrolled subjects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    and delays in clinical studies that may occur as a result of the COVID-19 pandemic;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to obtain IRB approval at clinical study locations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">clinicians&rsquo;
    and patients&rsquo; perceptions as to the potential advantages, disadvantages and side effects of our products in relation to other
    available therapies, including any new drugs or treatments that may be approved for the indications we are pursuing;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">availability
    of other clinical studies that exclude use of our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    possibility or perception that enrolling in a product&rsquo;s clinical study may limit the patient&rsquo;s ability to enroll in future
    clinical studies for other therapies due to protocol restrictions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    possibility or perception that our software is not secure enough to maintain patient privacy;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patient
    referral practices of physicians;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to monitor patients adequately during and after treatment;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    availability of appropriate clinical study investigators, support staff, drugs and other therapeutic supplies and proximity of patients
    to clinical sites;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">physicians&rsquo;
    or our ability to obtain and maintain patient consents; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    risk that when we collaborate with a third-party for research of a product in a particular institution, we can expect to relinquish
    some or all of the control over the future success of that study to the third-party.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we have difficulty enrolling and retaining a sufficient number or diversity of patients to conduct our clinical studies as planned, or
encounter other difficulties, we may need to delay, terminate or modify ongoing or planned clinical studies, any of which would have
an adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we are unable to develop an adequate sales and marketing organization or contract with third parties to assist us, we may not be able
to successfully commercialize our products for current and future indications.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
achieve commercial success for our products, we must compliantly develop and grow our sales and marketing organization and, as necessary,
enter into sales and distribution relationships with third parties to market and sell our products. Developing and managing a sales and
marketing organization is a difficult, expensive and time consuming process. We may not be able to successfully develop adequate sales
and marketing capabilities to achieve our growth objectives. We compete with other medical device, pharmaceutical and life sciences companies
to recruit, hire, train and retain the sales and marketing personnel that we anticipate we will need, and the nature of our products
may make it more difficult to compete for sales and marketing personnel. In addition, because our current products require, and we anticipate
our future products will require, physician training and education, our sales and marketing organization may need to grow substantially
as we expand our approved indications and markets. As a consequence, our expenses associated with building up and maintaining our sales
force and marketing capabilities may be disproportionate to the revenues we may be able to generate on sales of our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to establish adequate sales and marketing capabilities or successful sales and distribution relationships, we may fail
to realize the full revenue potential of our products for current and future indications, and we may not be able to achieve the necessary
growth in a cost-effective manner or realize a positive return on our investment. In our future sales and distribution agreements with
other companies, we generally may not have control over the resources or degree of effort that any of these third parties may devote
to our products, and if they fail to devote sufficient time and resources to the marketing of our products, or if their performance is
substandard, our revenues may be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
success of our business may be dependent on the actions of our collaborative partners.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business strategy includes, in part, the consummation of collaborative arrangements with companies who will support the development and
commercialization of our products and technology. We may also enter into clinical collaborations with third parties to test our products
and technology together with other products and technologies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
we collaborate with a third party for commercialization of a product in a particular territory, we can expect to relinquish some or all
of the control over the future success of that product to the third party in that territory. In addition, our collaborative partners
may have the right to terminate applicable agreements, including payment obligations, prior to or upon the expiration of the agreed-upon
terms. We may not be successful in establishing or maintaining collaborative arrangements on acceptable terms or at all, collaborative
partners may terminate funding before completion of projects, our products may not achieve the criteria for milestone payments, our collaborative
arrangements may not result in successful product commercialization, our products may not receive acceptable pricing and we may not derive
any revenue from such arrangements. Additionally, our collaborators may not perform their obligations as expected or in compliance with
study protocols or applicable laws. Acts or omissions by collaborators may disqualify study data for use in regulatory submissions and/or
create liability for us in the jurisdictions in which we operate. Any disagreements with collaborators, including disagreements over
proprietary rights, contract interpretation or the preferred course of commercialization, might cause delays or termination of the commercialization
of products, might lead to additional responsibilities for us with respect to commercializing products, or might result in litigation
or arbitration, any of which would be time-consuming and expensive. To the extent that we are not able to develop and maintain collaborative
arrangements, we would need to devote substantial capital to undertake commercialization activities on our own in order to further expand
our reach, and we may be forced to limit the territories in which we commercialize our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be successful in achieving market acceptance of our products by healthcare professionals, patients and/or third-party payers
in the timeframes we anticipate, or at all, which could have a material adverse effect on our business, prospects, financial condition
and results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not achieve market acceptance of our products for current or future indications within the timeframes we have anticipated, or at
all, for a number of different reasons, including the following factors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    may be difficult to gain broad acceptance of our products because they are new technologies and involve a novel or derivative mechanism
    of action and, as such, physicians may be reluctant to prescribe our products without prior experience or additional data or training;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">physicians
    may be reluctant to prescribe our products due to their perception that the supporting clinical study designs have limitations, as
    they are, for example, unblinded;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">physicians
    at large academic universities and medical centers may prefer to enroll patients into clinical studies instead of prescribing our
    products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
    may be difficult to gain broad acceptance at community hospitals where the number of patients seeking treatment may be more limited
    than at larger medical centers, and such community hospitals may not be willing to invest in the resources necessary for their physicians
    to become trained to use our products, which could lead to reluctance to prescribe our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patients
    may be reluctant to use our products for various reasons, including a perception that the treatment is untested or difficult to use
    or a perception that our software is not secure;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    products may have side effects and our products cannot be worn in all circumstances; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    patient will use more than one device and therefore, as the duration of the treatment course increases, the overall price will increase
    correspondingly and, when used in combination with other treatments, the overall cost of treatment will be greater than using a single
    type of treatment.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, our products may not achieve market acceptance for current or future indications because of the following additional factors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">achieving
    patient acceptance could be difficult because not all patients are willing to comply with requirements of treatment with our products,
    and other patients may forego our products for financial, privacy, cosmetic, visibility or mobility reasons;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">achieving
    patient compliance may be difficult because the recommended use of our products is 120 hours per week for three (3) consecutive weeks,
    and not to exceed four (4) weeks, which to some extent restricts physical mobility because our products cannot be worn in all circumstances,
    and the patient or a caregiver must ensure that it remains continuously operable and this may also impact the pool of patients to
    whom physicians may be willing to prescribe our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
    may be certain perceived limitations to our study designs or data obtained from our clinical studies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">efficacy
    may also be limited in instances where patients take a break from the device when experiencing skin rashes, or while bathing or swimming
    (because our products should not be immersed in water); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patients
    may decline therapy or prescribers may be unwilling to prescribe our products due to certain adverse events attributable to the device
    reported in clinical studies by patients treated with our products.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, even if we are successful in achieving market acceptance of our products for IBS or other indications, we may be unsuccessful
in achieving market acceptance of our products for other indications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
may be other factors that are presently unknown to us that also may negatively impact our ability to achieve market acceptance of our
products. If we do not achieve market acceptance of our products in the timeframes we anticipate, or are unable to achieve market acceptance
at all, our business, prospects, financial condition and results of operations could be materially adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to secure and maintain adequate coverage and reimbursement from third-party payers could adversely affect acceptance of our products
and reduce our revenues.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that the majority of our revenues will come from third-party payers, primarily children&rsquo;s hospitals, either directly to
us in markets where we provide our products or plan to provide our device candidates to patients or indirectly via payments made to hospitals
or other entities providing our products or which may in the future provide our device candidates to patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S., private payers cover the largest segment of the population, with the remainder either uninsured or covered by governmental
payers. The majority of the third-party payers outside the U.S. are government agencies, government sponsored entities or other payers
operating under significant regulatory requirements from national or regional governments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third-party
payers may decline to cover and reimburse certain procedures, supplies or services. Additionally, some third-party payers may decline
to cover and reimburse our products for a particular patient even if the payer has a favorable coverage policy addressing our products
or previously approved reimbursement for our products. Additionally, private and government payers may consider the cost of a treatment
in approving coverage or in setting reimbursement for the treatment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
and government payers are increasingly challenging the prices charged for medical products and services. Additionally, the containment
of healthcare costs has become a priority of governments. Adoption of additional price controls and cost-containment measures, and adoption
of more restrictive policies in jurisdictions with existing controls and measures, could further limit our revenues and operating results.
If third-party payers do not consider our products or the combination of our products with additional treatments to be cost-justified
under a required cost-testing model, they may not cover our products for their populations or, if they do, the level of reimbursement
may not be sufficient to allow us to sell our products on a profitable basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursement
for the treatment of patients with medical devices is governed by complex mechanisms. These mechanisms vary widely among countries, can
be informal, somewhat unpredictable, and evolve constantly, reflecting the efforts of these countries to reduce public spending on healthcare.
As a result, obtaining and maintaining reimbursement for the treatment of patients with medical devices has become more challenging.
We cannot guarantee that the use of our products will receive reimbursement approvals and cannot guarantee that our existing reimbursement
approvals will be maintained in any country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
failure to secure or maintain adequate coverage or reimbursement for our products by third-party payers in the U.S. or in the other jurisdictions
in which we market our products could have a material adverse effect on our business, revenues and results of operations and cause our
stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be successful in maintaining reimbursement codes necessary to facilitate accurate and timely billing for our products or physician
services attendant to our products</I>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third-party
payers, healthcare systems, government agencies or other groups often issue reimbursement codes to facilitate billing for products and
physician services used in the delivery of healthcare. Our technology specific CAT III CPT Code (0720T) was published on December 30,
2021 and effective on July 1, 2022. We may not be able to maintain the CPT code for physician services related to our products. Our future
revenues and results may be affected by the absence of CPT codes, as physicians may be less likely to prescribe the therapy when there
is no certainty that adequate reimbursement will be available for the time, effort, skill, practice expense and malpractice costs required
to provide the therapy to patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outside
the U.S., we have not secured codes to describe our products or to document physician services related to the delivery of therapy using
our products. The failure to obtain and maintain these codes could affect the future growth of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may depend on single-source suppliers for some of our components. The loss of these suppliers could prevent or delay shipments of our
products, delay our clinical studies or otherwise adversely affect our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
certain jurisdictions, we may source some of the components of our products from only a single vendor. If any one of these single-source
suppliers were to fail to continue to provide components to us on a timely basis, or at all, our business and reputation could be harmed.
We will seek and maintain second-source suppliers, but we can provide no assurance that we will secure or maintain such suppliers. We
have developed or are in the process of developing and obtaining regulatory approval for second sources for components in all jurisdictions.
Various steps must be taken before securing these suppliers, including qualifying these suppliers in accordance with regulatory requirements,
but we may never receive such approvals. The risks associated with the failure of our suppliers to comply with strictly enforced regulatory
requirements as described below are exacerbated by our dependence on single-source suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we experience any deficiency in the quality of, delay in or loss of availability of any components supplied to us by third-party suppliers,
or if we switch suppliers or components, we may face additional regulatory delays and the manufacture and delivery of our products would
be interrupted for an extended period of time, which could materially adversely affect our business, prospects, financial condition and
results of operations. If we are required to obtain prior regulatory approval from the FDA or regulatory authorities or similar governing
bodies in other jurisdictions or to conduct a new conformity assessment procedure for our products, regulatory approval for our products
may not be received on a timely basis, or at all, which would have a material adverse effect on our business, prospects, financial condition
and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Quality
control problems with respect to devices and components supplied by third-party suppliers could have a material adverse effect on our
reputation, our clinical studies or the commercialization of our products and, as a result, a material adverse effect on our business,
prospects, financial condition and results of operations</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products, which are manufactured by third parties, are highly technical and are required to meet exacting specifications. Any quality
control problems that we experience with respect to the devices and components supplied by third-party suppliers could have a material
adverse effect on our reputation, our attempts to complete our clinical studies, our operating expenses or the commercialization of our
products. The failure of our suppliers to comply with strictly enforced regulatory requirements could expose us to regulatory action,
including warning letters, product recalls, suspension or termination of distribution, product seizures or civil penalties. If we experience
any delay in the receipt or deficiency in the quality of products supplied to us by third-party suppliers, or if we have to switch to
replacement suppliers, we may face additional regulatory delays and the manufacture and delivery of our products would be interrupted
for an extended period of time, which would materially adversely affect our business, prospects, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
currently do not own a manufacturing facility and rely on a sole manufacturer for the production of our product</I></B>. <B><I>Any significant
disruption to the sole manufacturer&rsquo;s operations or facilities could have a material adverse effect on our business, financial
condition and results of operations</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on a sole manufacturer for the production of our products. We do not have control over the operations of the facilities of the third-party
manufacturer that we use. A significant disruption to our manufacturer could have a material adverse effect on our business, financial
condition and results of operations. Our reliance on our manufacturer poses a number of risks, including lack of control over the manufacturing
process and ultimately over the quality and timing of delivery of our product. A change in our relationship with our manufacturer could
result in a material adverse effect on our business, financial condition and results of operations. A decision to change manufacturers
would result in longer times for design and production as we secure any necessary licenses or clearances, develop quality control measures,
and implement manufacturing processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Continued
testing of our products may not yield successful results and could reveal currently unknown aspects or safety hazards associated with
our products</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development programs are designed to test the safety and efficacy of our products through extensive pre-clinical and clinical
testing. Even if our ongoing and future pre-clinical and clinical studies are completed as planned, we cannot be certain that their results
will support our claims or that the FDA and other regulatory authorities will agree with our conclusions. Success in pre-clinical studies
and early clinical studies does not ensure that later clinical studies will be successful, and we cannot be sure that the later studies
will replicate the results of prior studies and pre-clinical studies. The clinical study process may fail to demonstrate that our device
candidates are safe and effective for the proposed indicated uses, which could cause us to abandon a device candidate and may delay development
of others. It is also possible that patients enrolled in clinical studies will experience adverse side effects that have not been previously
observed. In addition, our pre-clinical and clinical studies for our device candidates involve a relatively small patient population
and, as a result, these studies may not be indicative of future results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may experience numerous unforeseen events during, or as a result of, the testing process that could delay or prevent further commercialization
of our products, including the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-clinical
    and clinical testing for our products may not produce the desired effect, may be inconclusive or may not be predictive of safety
    or efficacy results obtained in future clinical studies, following long-term use or in much larger populations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
    adverse events or other side effects that are not currently known may occur during our clinical studies that may preclude additional
    regulatory approval or result in additional limitations to commercial use if approved; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    data collected from our clinical studies may not reach statistical significance or otherwise not be sufficient to support FDA or
    other regulatory approval.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
unacceptable side effects arise in the development of our products for future indications, we could suspend or terminate our clinical
studies or the FDA or other regulatory authorities could order us to cease clinical studies or deny approval of our device candidates
for any or all targeted indications, narrow the approved indications for use or otherwise require restrictive product labeling or marketing
or require further clinical studies, which may be time-consuming and expensive and may not produce results supporting FDA or other regulatory
approval of our products in a specific indication. Treatment-related side effects could also affect patient recruitment or the ability
of enrolled patients to complete the study or result in potential product liability claims. In addition, these side effects may not be
appropriately recognized or managed by the treating medical staff. We expect to have a need to train medical personnel using our devices
for clinical studies and upon any commercialization of our products for future indications. Inadequate training in recognizing or managing
the potential side effects of our products could result in patient injury or death. Any of these occurrences may harm our business, prospects
and financial condition significantly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
delay or termination of our clinical studies will delay the filing of submissions for regulatory approvals of our products and ultimately
our ability to commercialize our products and generate revenues. Furthermore, we may abandon our products for indications that we previously
believed to be promising. Any of these events could have a material adverse effect on our business, prospects, financial condition and
results of operations and cause our stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
we expand, we may experience difficulties managing our growth</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
anticipated growth will place a significant strain on our management and on our operational and financial resources and systems. We could
face challenges inherent in efficiently managing a more complex business with an increased number of employees over large geographic
distances, including the need to implement appropriate systems, policies, benefits and compliance programs. Failure to manage our growth
effectively could materially adversely affect our business. Additionally, our anticipated growth will increase the demands placed on
our third-party suppliers, resulting in an increased need to carefully monitor the available supply of components and services and to
scale up our quality assurance programs. There is no guarantee that our suppliers will be able to support our anticipated growth. Any
failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and commercialization
goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
size and expected growth of our available market has not been established with precision and may be smaller than we estimate.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
data on the available market for our current products and future products is based on a number of internal and third-party research reports,
estimates and assumptions. While we believe that such research, our assumptions and the data underlying our estimates are reasonable,
these assumptions and estimates may not be correct. In addition, the statements in this prospectus relating to, among other things, the
expected growth in the market for our IB-Stim are based on a number of internal and third-party data, estimates and assumptions, and
may prove to be inaccurate. If the actual number of consumers who would benefit from our products, the price at which we can sell future
products or the available market for our products is smaller than we estimate, it could have a material adverse effect on our business,
financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
physicians and patients do not accept our current and future products or if the market for indications for which any product candidate
is approved is smaller than expected, we may be unable to generate significant revenue, if any.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
when any of our product candidates obtain regulatory approval, they may not gain market acceptance among physicians, patients, and third-party
payers. Physicians may decide not to recommend our treatments for a variety of reasons including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">timing
    of market introduction of competitive products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">demonstration
    of clinical safety and efficacy compared to other products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cost-effectiveness;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limited
    or no coverage by third-party payers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">convenience
    and ease of administration;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prevalence
    and severity of adverse side effects;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    in the label of the device;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    potential advantages of alternative treatment methods; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ineffective
    marketing and distribution support of its products.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of our product candidates is approved but fails to achieve market acceptance or such market is smaller than anticipated, we may not
be able to generate significant revenue and our business would suffer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
of the specialized nature of our business, the termination of relationships with our key employees, consultants and advisors may prevent
us from successfully operating our business, including developing our products, conducting clinical studies, commercializing our products
and obtaining any necessary financing</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are highly dependent on the members of our executive team, the loss of whose services may adversely impact the achievement of our objectives.
While we have entered into employment agreements with each of our key executives, any of them could leave our employment at any time.
We do not have &ldquo;key person&rdquo; insurance on any of our employees. The loss of the services of one or more of our current employees
might impede the achievement of our business objectives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
competition for qualified personnel in the medical device fields is intense, and we rely heavily on our ability to attract and retain
qualified scientific, technical and managerial personnel. Our future success depends upon our ability to attract, retain and motivate
highly skilled employees. In order to commercialize our products successfully, we will be required to expand our workforce, particularly
in the areas of research and development and clinical studies, sales and marketing and supply chain management. These activities will
require the addition of new personnel and the development of additional expertise by existing management personnel. We face intense competition
for qualified individuals from numerous pharmaceutical, biopharmaceutical and biotechnology companies, as well as academic and other
research institutions. We may not be able to attract and retain these individuals on acceptable terms or at all. Failure to do so could
materially harm our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Customer
or third-party complaints or negative reviews or publicity about our company or our products could harm our reputation and brand.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are heavily dependent on customers who use our IB-Stim device to provide good reviews and word-of-mouth recommendations to contribute
to our growth. Customers who are dissatisfied with their experiences with our products or services may post negative reviews. We may
also be the subject of blog, forum or other media postings that include inaccurate statements and/or create negative publicity. In addition,
any negative news regarding similar products may adversely impact our business. Any negative reviews or publicity, whether real or perceived,
disseminated by word-of-mouth, by the general media, by electronic or social networking means or by other methods, could harm our reputation
and brand and could severely diminish consumer confidence in our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Adverse
global economic conditions could have a negative effect on our business, results of operations and financial condition and liquidity.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
general slowdown in the global economy, including a recession, or in a particular region or industry, an increase in trade tensions with
U.S. trading partners, inflation or a tightening of the credit markets could negatively impact our business, financial condition and
liquidity. Adverse global economic conditions have from time to time caused or exacerbated significant slowdowns in the industries and
markets in which we operate, which have adversely affected our business and results of operations. Macroeconomic weakness and uncertainty
also make it more difficult for us to accurately forecast revenue, gross profit and expenses, and may make it more difficult to raise
or refinance debt. Sustained uncertainty about, or worsening of, current global economic conditions and further escalation of trade tensions
between the U.S. and its trading partners, could result in a global economic slowdown and long-term changes to global trade. Such events
may also (i) cause our customers and consumers to reduce, delay or forgo spending, (ii) result in customers sourcing products from other
suppliers not subject to such restrictions or tariffs, (iii) lead to the insolvency or consolidation of key suppliers and customers,
and (iv) intensify pricing pressures. Any or all of these factors could negatively affect demand for our products and our business, financial
condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
economic conditions in certain regions may also be affected by natural disasters and public health emergencies, such as extreme weather
events, and could have a significant adverse effect on our business, including interruption of our commercial and clinical operations,
supply chain disruption, endangerment of our personnel, fewer patient visits, increased patient drop-out rates, delays in recruitment
of new patients, and other delays or losses of materials and results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
COVID-19 pandemic could materially adversely impact our business</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the COVID-19 pandemic continues around the globe, we have experienced and will likely continue to experience disruptions that could severely
impact our business and clinical studies, which could include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    and/or difficulties in onboarding active patients and enrolling patients in our clinical studies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    and/or difficulties in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site
    staff;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">declines
    in prescriptions written due to a perception that our products are difficult to administer remotely or if patients are unwilling
    to travel to treatment sites or receive in-home treatment assistance from us or other caregivers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reductions
    in third-party reimbursements, which could materially affect our revenue, as most of our patients rely on third-party payers to cover
    the cost of our products and a material number of our patients could lose access to their private health insurance plan if they or
    someone in their family lose their job;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
    of healthcare resources away from conducting clinical studies, including the diversion of hospitals serving as our clinical study
    sites and hospital staff supporting the conduct of our clinical studies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
    of key clinical study activities, such as clinical study site monitoring, due to limitations on travel imposed or recommended by
    federal or state governments, employers and others;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">staff
    disruptions and turnover internally and at treatment sites and third-party providers who provide support, either directly as a result
    of illness or indirectly as a result of vaccine mandates and other changes in terms of employment;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in receiving approval from local regulatory authorities or IRBs to initiate our planned clinical studies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in clinical sites receiving the supplies and materials needed to conduct our clinical studies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interruption
    in shipping that may affect the transport of active patient and clinical study materials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in local regulations as part of a response to the COVID-19 outbreak that may require us to change the ways in which our clinical
    studies are conducted, which may result in unexpected costs, or to discontinue the clinical studies altogether;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations
    in employee resources or forced furlough of government employees;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption
    of our supply chain as our suppliers and common carriers are unable to meet our requirements to provide us the materials we need
    for clinical study and active patient care needs;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">indirect
    consequences of the COVID-19 pandemic on the economy in general, such as an increase in bankruptcies of our key suppliers, or the
    inability of our third-party payers to meet their obligations reimburse us in a timely fashion or at all;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">postponements
    and cancellations of key conferences and meetings and travel restrictions could interfere with our ability to interact with key thought
    leaders in the field, leading to a disruption in the rate of adoption of our technology;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">access
    restrictions at offices, hospitals, and treatment centers, and stakeholder illness could interfere with the ability of our sales
    force to engage in face-to-face visits with providers, leading to a disruption in the rate of adoption of our technology;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases
    in expenditures for technology and other tools necessary to provide patient care in an environment where both patient and care-giver
    travel is restricted and access to in-person interaction is limited;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    of the FDA to accept data from clinical studies in affected geographies outside the United States; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patient
    delays in seeking or receiving treatment, either due to fear of infection or lack of access to treatment and study sites, leading
    to fewer diagnoses of the indications our products are approved to treat or more advanced procession of the disease, which may contraindicate
    the use of our products or disqualify the patient from participating in a given study.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global status of the COVID-19 pandemic continues to rapidly evolve. The extent to which the pandemic may impact our business and clinical
studies will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate
geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing guidelines, business closures
or business disruptions and the effectiveness of actions taken to contain and treat the disease. The response to the pandemic may result
in permanent changes to the environment in which we operate as described above in ways we are unable to predict. The COVID-19 pandemic
may also have the effect of heightening many of the other risks described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Developing
medical technology entails significant technical, regulatory and business risks</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may fail to adapt our technology to user requirements or emerging treatment standards. Neuromodulation therapies are not currently considered
standard of care for IBS and may not ever be considered standard of care. Treatment standards may not evolve to incorporate our product.
New industry standards for the development, manufacture and marketing of medical devices may evolve and we may not be able to conform
to the changes, meet new standards in a timely fashion or maintain a competitive position in the market. In particular, regulatory standards
for electrical treatments of medical conditions are evolving. If we face material delays in introducing our products and new technology,
we may fail to attract new customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Company has an evolving business strategy and investors must be willing to accept a substantial degree of uncertainty.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s strategic focus is on the development of developing neuromodulation therapies to address chronic and debilitating conditions
in children. The Company may engage in ongoing discussions with potential licensees, other strategic partners and institutional or private
financing sources, the result of which could add to or alter its current strategic focus, cash needs or ownership structure. Investors
must be willing to accept a substantial degree of uncertainty and must be willing to rely upon the Company&rsquo;s board of directors
and management to complete an appropriate business strategy to commercially exploit targeted business opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to compete with treatments now being marketed and developed, or which may be developed and marketed in the future by
other companies.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products will compete with existing and new therapies and treatments for chronic and debilitating conditions in children. We are aware
of a number of companies currently seeking to develop alternative therapies or treatment for such diseases and conditions at least in
part. Numerous pharmaceutical, biotechnology, drug delivery and medical device companies, hospitals, research organizations, individual
scientists, and nonprofit organizations are engaged in the development of alternatives to our technology. Some of these companies have
greater research and development capabilities, experience, manufacturing, marketing, financial, and managerial resources than we do.
Collaborations or mergers between large pharmaceutical or biotechnology companies with competing treatment technologies could enhance
our competitors&rsquo; financial, marketing, and other resources. Developments by other medical device companies could make our products
or technologies uncompetitive or obsolete. Accordingly, our competitors may succeed in developing competing technologies, obtaining FDA
clearances and/or approval for products or gaining market acceptance more rapidly than we can.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Due
in part to our limited financial resources, we may fail to select or capitalize on the most scientifically, clinically or commercially
promising or profitable indications or therapeutic areas for our product candidates, and/or we may be unable to pursue the clinical trials
that we would like to pursue.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited technical, managerial, and financial resources to determine the indications on which we should focus the development efforts
related to our product candidates. Due to our limited available financial resources, we may have curtailed clinical development programs
and activities that might otherwise have led to more rapid progress of our product candidates through the regulatory and development
processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may make incorrect determinations with regard to the indications and clinical trials on which to focus the available resources that we
do have. Furthermore, we cannot assure you that we will be able to retain adequate staffing levels to run our operations and/or to accomplish
all of the objectives that we otherwise would seek to accomplish. Our decisions to allocate our research, management, and financial resources
toward particular indications or therapeutic areas for our product candidates may not lead to the development of viable commercial products
and may divert resources from better opportunities. Similarly, our decisions to delay or terminate product development programs may also
cause us to miss valuable opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have material weaknesses in our internal control over financing reporting. If we fail to establish and maintain proper and effective
internal control over financial reporting, our operating results and our ability to operate our business could be harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensuring
that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements
on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Our internal control over financial
reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements in accordance with generally accepted accounting principles. Prior to this offering, due to accounting resource
constraints, we have had limited review controls. These constraints have resulted in (1) a lack of segregation of duties, since we have
a limited administrative staff, and (2) lack of internal controls structure review. As a result of these constraints, we have a material
weakness in our internal control over financing reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is composed of a small number of individuals resulting in a situation where limitations on segregation of duties exist. All
responsibility for accounting entries and the creation of financial statements is held by a single person, though the Company engages
multiple accounting consultants for accounting, tax and audit support. To remedy this situation, we would need to hire additional staff
or financial consultant support. Currently, we are unable to hire additional staff to facilitate greater segregation of duties but will
reassess our capabilities after completion of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, we intend to begin the process of documenting, reviewing and improving our internal controls and procedures
for compliance with Section 404 of the Sarbanes-Oxley Act, which will require annual management assessment of the effectiveness of our
internal control over financial reporting. To comply with the requirements of being a public company, the Company has undertaken various
actions, and will take additional actions, such as remediating the material weaknesses described above, implementing additional internal
controls and procedures and hiring internal audit staff or financial consultants. Testing and maintaining internal controls can divert
our management&rsquo;s attention from other matters that are important to the operation of our business. Additionally, when evaluating
internal controls over financial reporting, the Company may identify additional material weaknesses that it may not be able to remediate
in time to meet the applicable deadline imposed upon us for compliance with the requirements of Section 404 of the Sarbanes-Oxley Act.
If the Company identifies any additional material weaknesses in its internal control over financial reporting or is unable to remediate
the material weakness described above or comply with the requirements of Section 404 of the Sarbanes-Oxley Act in a timely manner or
if the Company&rsquo;s independent registered public accounting firm is unable to express an unqualified opinion as to the effectiveness
of our internal control over financial reporting once it is no longer an emerging growth company, or if the Company is unable to conclude
in our quarterly and annual reports that our disclosure controls and procedures are effective, investors may lose confidence in the accuracy
and completeness of the Company&rsquo;s financial reports and the market price of our common stock could be negatively affected, and
the Company could become subject to investigations by the stock exchange on which our securities are listed, the SEC or other regulatory
authorities, which could require additional financial and management resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if the Company fails to remediate any material weakness, including the material weaknesses described above, our financial statements
could be inaccurate and the Company could face restricted access to capital markets. Our small size and internal control deficiencies
may adversely affect our financial condition, results of operation and access to capital. <FONT STYLE="background-color: white">Moreover,
our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well
designed and operated, can provide only reasonable, not absolute, assurance that the control system&rsquo;s objectives will be met. Because
of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to
error or fraud will not occur or that all control issues and instances of fraud will be detected.</FONT> If we cannot provide reliable
financial reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment
existed, and our business and reputation with investors may be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
restated our previously issued financial statements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determined that a restatement of our December 31, 2021 audited financial statements was required after discussions among management and
our independent registered public account firm, Rosenberg Rich Baker Berman, P.A., for certain disclosures that have been expanded or
have added clarifications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
should consult with a tax expert before investing in our Company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should consult with your own tax advisor about the tax consequences of investing in the Company through the purchase of its securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Legal and Regulatory Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Product
liability suits, whether or not meritorious, could be brought against us due to alleged defective devices or for the misuse of our products,
which could result in expensive and time-consuming litigation, payment of substantial damages and/or expenses and an increase in our
insurance rates</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our current or future devices are defectively designed or manufactured, contain defective components or are misused, or if someone claims
any of the foregoing, whether or not meritorious, we may become subject to substantial and costly litigation. For example, we may be
sued if our products cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical testing, manufacturing,
marketing or sale. This may occur if our products are misused or damaged, have a sudden failure or malfunction (including with respect
to safety features) or are otherwise impaired due to wear and tear. Even absent a product liability suit, malfunctions of our products
or misuse by physicians or patients would need to be remedied swiftly in order to maintain continuous use and ensure efficacy of our
products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent
in the device, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection
acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required
to limit commercialization of our products. Even successful defense may require significant financial and management resources. Regardless
of the merits or eventual outcome, liability claims may result in:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">decreased
    demand for our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injury
    to our reputation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">withdrawal
    of clinical study participants and inability to continue clinical studies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">initiation
    of investigations by regulators;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">costs
    to prepare for and defend the related litigation;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    diversion of management&rsquo;s time and our resources;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">substantial
    monetary awards to study participants or patients;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    recalls, withdrawals or labeling, marketing or promotional restrictions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">loss
    of revenues;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">exhaustion
    of any available insurance and our capital resources;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inability to commercialize any device candidate; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    decline in our share price.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
liability claims could divert management&rsquo;s attention from our core business, be expensive to defend and result in sizable damage
awards against us. We may not have sufficient insurance coverage for all claims. Any product liability claims brought against us, with
or without merit, could increase our product liability insurance rates or prevent us from securing continuing coverage, could harm our
reputation in the industry and could reduce revenues. Product liability claims in excess of our insurance coverage would be paid out
of cash reserves, if any, which could have a material adverse effect on our business, prospects, financial condition and results of operations
and cause our stock price to decline. Even if our agreements with our third-party manufacturers and suppliers entitle us to indemnification
against losses, such indemnification may not be available or adequate should any claim arise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
future litigation and regulatory actions could have a material adverse impact on the Company</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may be subject to litigation and other legal and regulatory proceedings relating to our business or investigations or
other actions by governmental agencies. No assurances can be given that the results of these or new matters will be favorable to us.
An adverse resolution of lawsuits, arbitrations, investigations or other proceedings or actions could have a material adverse effect
on our financial condition and results of operations, including as a result of non-monetary remedies. Defending ourselves in these matters
may be time-consuming, expensive and disruptive to normal business operations and may result in significant expense and a diversion of
management&rsquo;s time and attention from the operation of our business, which could impede our ability to achieve our business objectives.
Additionally, any amount that we may be required to pay to satisfy a judgment, settlement, fine or penalty may not be covered by insurance.
Subject to the Delaware General Corporation Law, our certificate of incorporation permit us to indemnify any director against any liability,
to purchase and maintain insurance against any liability for any director and to provide any director with funds (whether by loan or
otherwise) to meet expenditures incurred or to be incurred by such director in defending any criminal, regulatory or civil proceedings
or in connection with an application for relief (or to enable any such director to avoid incurring such expenditure). In addition, under
our Articles of Incorporation and bylaws (the &ldquo;Bylaws&rdquo;) we are obligated to indemnify each of our directors and officers
against certain liabilities and expenses arising from their being a director or officer to the maximum extent permitted by Delaware law.
In the event we are required to make such payments to our directors and officers, there can be no assurance that any of these payments
will not be material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to consumer protection laws that regulate our marketing practices and prohibit unfair or deceptive acts or practices. Our
actual or perceived failure to comply with such obligations could harm our business, and changes in such regulations or laws could require
us to modify our products or marketing or advertising efforts.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the marketing or advertisement of our products, we could be the target of claims relating to false, misleading, deceptive
or otherwise noncompliant advertising or marketing practices, including under the auspices of the FTC and state consumer protection statutes.
If we rely on third parties to provide any marketing and advertising of our products, we could be liable for, or face reputational harm
as a result of, their marketing practices if, for example, they fail to comply with applicable statutory and regulatory requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are found to have breached any consumer protection, advertising, unfair competition or other laws or regulations, we may be subject
to enforcement actions that require us to change our marketing and business practices in a manner that may negatively impact us. This
could also result in litigation, fines, penalties and adverse publicity that could cause reputational harm and loss of customer trust,
which could have a material adverse effect on our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are increasingly dependent on information technology systems and are subject to privacy and security laws. Our products and our systems
and infrastructure face certain risks, including from cyber security breaches and data leakage</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
increasingly rely upon technology systems and infrastructure. Our technology systems, including our products, are potentially vulnerable
to breakdown or other interruption by fire, power loss, system malfunction, unauthorized access and other events. Likewise, data privacy
breaches by employees and others with both permitted and unauthorized access to our products and our systems may pose a risk that protected
patient information (&ldquo;PI&rdquo;) may be exposed to unauthorized persons or to the public, or may be permanently lost. The increasing
use and evolution of technology, including cloud-based computing, creates additional opportunities for the unintentional dissemination
of information, intentional destruction of confidential information stored in our systems or in non-encrypted portable media or storage
devices. We could also experience a business interruption, information theft of confidential information, or reputational damage from
industrial espionage attacks, malware or other cyber incidents, which may compromise our system infrastructure or lead to data leakage,
either internally or at our third-party service providers or other business partners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
size and complexity of our computer systems, and scope of our geographic reach, make us potentially vulnerable to information technology
system breakdowns, internal and external malicious intrusion, cyberattacks and computer viruses. Because the techniques used to obtain
unauthorized access, or to sabotage systems, change frequently and generally are not recognized until launched against a target, we may
be unable to anticipate these techniques or to implement adequate preventative measures. If we do not allocate and effectively manage
the resources necessary to build and sustain the proper technology infrastructure or properly manage third-party contractors who perform
data management services on our behalf, then a security breach could subject us to, among other things, transaction errors, business
process inefficiencies, the loss of customers, damage to our reputation, business disruptions or the loss of or damage to intellectual
property. Such security breaches could expose us to a risk of loss of information, litigation, penalties, remediation costs and potentially
significant liability to customers, employees, business partners and regulatory authorities, including, for example, under the Health
Insurance Portability and Accountability Act of 1996 (&ldquo;HIPAA&rdquo;) in the United States and Regulation 2016/679 on the protection
of natural persons with regard to the processing of personal data and on the free movement of such data under GDPR in the EU. If our
data management systems (including third party data management systems) do not effectively collect, secure, store, process and report
relevant data for the operation of our business, whether due to equipment malfunction or constraints, software deficiencies, or human
error, our ability to effectively plan, forecast and execute our business plan and comply with applicable laws and regulations will be
impaired. Any such impairment could materially and adversely affect our financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we have invested heavily in the protection of data and information technology and in related training, there can be no assurance that
our efforts will prevent significant breakdowns, breaches in our systems or other cyber incidents or ensure compliance with all applicable
security and privacy laws, regulations, and standards, including with respect to third-party service providers that utilize sensitive
personal information, including PI, on our behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
security breach, whether of our products, systems or third-party hosting services we utilize, could disrupt treatments being provided
by our products, disrupt access to our customers&rsquo; stored information, such as patient treatment data and health information, and
could lead to the loss of, damage to or public disclosure of such data and information, including patient health information. Such an
event could have serious negative consequences, including possible patient injury, regulatory action, fines, penalties and damages, reduced
demand for our products, an unwillingness of customers to use our products, harm to our reputation and brand and time-consuming and expensive
litigation, any of which could have a material adverse effect on our financial results. We currently carry cyber and privacy liability
insurance with an aggregate limit of $1,000,000, but the amount of insurance coverage that we purchased and may purchase in the future
may be inadequate. In the future, our insurance coverage may be expensive or not be available on acceptable terms or in sufficient amounts,
if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may choose to, or may be required to, suspend, repeat or terminate our clinical studies if they are not conducted in accordance with
regulatory requirements, the results are negative or inconclusive or the studies are not well designed</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
studies must be conducted in accordance with the FDA&rsquo;s cGCPs and the equivalent laws and regulations applicable in other jurisdictions
in which the clinical studies are conducted. The clinical studies are subject to oversight by the FDA, regulatory agencies in other jurisdictions,
ethics committees and institutional review boards at the medical institutions where the clinical studies are conducted. In addition,
clinical studies must be conducted with device candidates produced under the FDA&rsquo;s QSR and in accordance with the applicable regulatory
requirements in the other jurisdictions in which the clinical studies are conducted. The conduct of clinical studies may require large
numbers of test patients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA or regulatory agencies in other jurisdictions might delay or terminate our clinical studies of a device candidate for various reasons,
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    device candidate may have unforeseen adverse side effects or may not appear to be more effective than current therapies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    may not agree with the FDA, a regulatory authority in another jurisdiction or an ethics committee regarding the protocol for the
    conduct of a clinical study;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">new
    therapies may become the standard of care while we are conducting our clinical studies, which may require us to revise or amend our
    clinical study protocols or terminate a clinical study; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fatalities
    may occur during a clinical study due to medical problems that may or may not be related to clinical study treatments.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
the process of obtaining and maintaining regulatory approvals in the U.S. and other jurisdictions is lengthy, expensive and uncertain.
It can vary substantially, based on the type, complexity and novelty of the product involved. Accordingly, any of our device candidates
could take a significantly longer time than we expect to, or may never, gain regulatory approval, which could have a material adverse
effect on our business, prospects, financial condition and results of operations and cause our stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Legislative
and regulatory changes in the U.S. and in other countries regarding healthcare insurance and government-sponsored reimbursement programs
(such as Medicare in the United States) may adversely affect our business and financial results</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely to a material degree on highly regulated private and government-run health insurance programs for our revenue in most of the countries
in which we operate. The laws and regulations regarding health care programs, both public and private, are driven by public policy considerations
that may be unrelated to the direct provision of patient care, such as lowering costs or requiring or limiting access to healthcare options.
These laws and regulations are very complicated and there are many requirements we must satisfy in order for our products to become and
remain eligible for reimbursement under these programs. In many cases we may have limited negotiating power when negotiating reimbursement
rates for our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, lawmakers and regulators could also pass additional healthcare laws and implement other regulatory changes at both the national
and local levels. These laws and regulations could potentially affect coverage and reimbursement for our products. However, we cannot
predict the ultimate content, timing or effect of any future healthcare initiatives or the impact any future legislation or regulation
will have on us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to countries outside the U.S., the national competent authorities in the EU member states, the UK, Switzerland, Israel, Japan,
and other jurisdictions are also increasingly active in their goal of reducing public spending on healthcare. We cannot, therefore, guarantee
that the treatment of patients with our products would be reimbursed in any particular country or, if successfully included on reimbursement
lists, whether we will remain on such lists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to extensive post-marketing regulation by the FDA and comparable authorities in other jurisdictions, which could impact the
sales and marketing of our products and could cause us to incur significant costs to maintain compliance. In addition, we may become
subject to additional regulation in other jurisdictions if we market and sell our products outside of the U.S</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
market and sell our products subject to extensive regulation by the FDA and numerous other federal, state and governmental authorities
in other jurisdictions. These regulations are broad and relate to, among other things, the conduct of pre-clinical and clinical studies,
product design, development, manufacturing, labeling, testing, product storage and shipping, premarket clearance and approval, conformity
assessment procedures, premarket clearance and approval of modifications introduced in marketed products, post-market surveillance and
monitoring, reporting of adverse events and incidents, pricing and reimbursement, interactions with healthcare professionals, interactions
with patients, information security, advertising and promotion and product sales and distribution. Although IB-Stim already has market
clearance from FDA for functional abdominal pain associated with IBS in children, we will require additional FDA clearances to market
our products for treating other indications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, before our products can be marketed in the EU, our products must obtain a CE Certificate from a notified body. New intended
uses of CE marked medical devices falling outside the scope of the current CE Certificate require a completely new conformity assessment
before the device can be CE marked and marketed in the EU for the new intended use. The process required to gather necessary information
and draw up documentation in order to obtain CE Certification of a medical device in the EU can be expensive and lengthy and its outcome
can be uncertain. We may make modifications to our products in the future that we believe do not or will not require notifications to
our notified body or new conformity assessments to permit the maintenance of our current CE Certificate. If the competent authorities
of the EU member states or our notified body disagree and require the conduct of a new conformity assessment, the modification of the
existing CE Certificate or the issuance of a new CE Certificate, we may be required to recall or suspend the marketing of the modified
versions of our products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Japan, new medical devices or new therapeutic uses of medical devices falling outside the scope of the existing approval by the MHLW
require a new assessment and approval for each such new device or use. Accordingly, we may be required to obtain a new approval from
MHLW before we launch a modified version of our products or the use of our products for additional indications. Approval time frames
from the MHLW vary from simple notifications to review periods of one or more years, depending on the complexity and risk level of the
device. In addition, importation into Japan of medical devices is subject to &ldquo;Quality Management System (QMS) Ordinance,&rdquo;
which includes the equivalent of &ldquo;Good Import&rdquo; regulations in the U.S. As with any highly regulated market, significant changes
in the regulatory environment could adversely affect our ability to commercialize our products in Japan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the U.S. and other jurisdictions, we also are subject to numerous post-marketing regulatory requirements, which include regulations under
the QSR related to the manufacturing of our products, labeling regulations and medical device reporting regulations, which require us
to report to the FDA or comparable regulatory authorities in other jurisdictions and our notified body if our products cause or contributes
to a death or serious injury, or malfunction in a way that would likely cause or contribute to a death or serious injury. In addition,
these regulatory requirements may in the future change in a way that adversely affects us. If we fail to comply with present or future
regulatory requirements that are applicable to us, we may be subject to enforcement action by the FDA or comparable regulatory authorities
in other jurisdictions and notified bodies, which may include any of the following sanctions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">untitled
    letters, warning letters, fines, injunctions, consent decrees and civil penalties;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
    expenditures to address or defend such actions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">patient
    notification, or orders for repair, replacement or refunds;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">voluntary
    or mandatory recall, withdrawal or seizure of our current or future devices;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">administrative
    detention by the FDA or other regulatory authority in another jurisdiction of medical devices believed to be adulterated or misbranded;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
    restrictions, suspension or shutdown of production;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    or delay of our requests for approval for new intended uses for or modifications to our products or for approval of new devices;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    or delay in obtaining CE Certificates for new intended uses for or modifications to our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension,
    variation or withdrawal of the CE Certificates granted by our notified body in the EU;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prohibition
    or restriction of products being placed on the market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
    restrictions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
    or withdrawal of approvals that have already been granted;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    to grant export approval for our products or any device candidates; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">criminal
    prosecution.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
occurrence of any of these events could have a material adverse effect on our business, prospects, financial condition and results of
operations and cause our stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Over
time, we expect to make modifications to our products that are designed to improve efficacy, reduce side effects, enhance the user experience
or for other purposes. Modifications to our products may require approvals, modified or new CE Certificates and analogous regulatory
approvals in other jurisdictions or even require us to cease promoting or to recall the modified versions of our products until such
clearances, approvals or modified or new CE Certificates are obtained, and the FDA, comparable regulatory authorities in other jurisdictions
or our notified body may not agree with our conclusions regarding whether new approvals are required</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any substantial change introduced to a medical device or to the quality system certified by our notified body requires a new
conformity assessment of the device and can lead to changes to the CE Certificates or the preparation of a new CE Certificate of Conformity.
Substantial changes may include, among others, the introduction of a new intended use of the device, a change in its design or a change
in the Company&rsquo;s suppliers. Responsibility for determination that a modification constitutes a substantial change lies with the
manufacturer of the medical device. We must inform the notified body that conducted the conformity assessment of the products we market
or sell in the EU of any planned substantial changes to our quality system or changes to our products that could, among other things,
affect compliance with the MDR or the devices&rsquo; intended use. The notified body will then assess the changes and verify whether
they affect the product&rsquo;s conformity with the Essential Requirements laid down in Annex I to the MDD or the conditions for the
use of the device. If the assessment is favorable, the notified body will issue a new CE Certificate or an addendum to the existing CE
Certificate attesting compliance with the Essential Requirements laid down in Annex I to the MDD. There is a risk that the competent
authorities of the EU member states or our notified body may disagree with our assessment of the changes introduced to our products.
The competent authorities of the EU member states or our notified body also may come to a different conclusion than the FDA on any given
product modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, medical devices that have obtained a CE Certification under the MDD may in principle continue to be marketed under such CE
Certificate until the CE Certificate expires and at the latest until May 27, 2024, provided that the manufacturer complies with the MDR&rsquo;s
additional requirements related to post-marketing surveillance, market surveillance, vigilance, and registration of economic operators
and of devices. However, if such medical devices undergo a significant change in their design or intended use, we would need to obtain
a new CE Certificate under the MDR for these devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the FDA disagrees with us and requires us to submit a new application for then-existing modifications and/or the competent authorities
of the EU member states or our notified body disagree with our assessment of the change introduced in a product, its design or its intended
use, we may be required to cease promoting or to recall the modified product until we obtain approval and/or until a new conformity assessment
has been conducted in relation to the product, as applicable. In addition, we could be subject to significant regulatory fines or other
penalties. Furthermore, our products could be subject to recall if the FDA, comparable regulatory authorities in other jurisdictions,
or our notified body determine, for any reason, that our products are not safe or effective or that appropriate regulatory submissions
were not made. Any recall or requirement that we seek additional approvals or clearances could result in significant delays, fines, increased
costs associated with modification of a product, loss of revenues and potential operating restrictions imposed by the FDA, comparable
foreign regulatory authorities in other jurisdictions, or our notified body. Delays in receipt or failure to receive approvals/certification,
or the failure to comply with any other existing or future regulatory requirements, could reduce our sales, profitability and future
growth prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>In
addition to FDA requirements, we will spend considerable time and money complying with other federal, state, local and foreign rules,
regulations and guidance and, if we are unable to fully comply with such rules, regulations and guidance, we could face substantial penalties</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to extensive regulation by the U.S. federal government and the states and other countries in which we conduct our business.
U.S. federal government healthcare laws apply when we submit a claim on behalf of a U.S. federal healthcare program beneficiary, or when
a customer submits a claim for an item or service that is reimbursed under a U.S. federal government-funded healthcare program, such
as Medicare or Medicaid. The laws that affect our ability to operate our business in addition to the Federal Food, Drug, and Cosmetic
Act and FDA regulations include, but are not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    U.S. federal Anti-Kickback Statute, an intent-based federal criminal statute which prohibits knowingly and willfully offering, providing,
    soliciting or receiving remuneration of any kind to induce or reward, or in return for, referrals or the purchase, lease, order or
    recommendation or arranging of any items or services reimbursable by a federal healthcare program;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Federal Civil False Claims Act, which imposes civil penalties, including through civil whistleblower or &ldquo;qui tam&rdquo; actions,
    for knowingly submitting or causing the submission of false or fraudulent claims of payment to the federal government, knowingly
    making, using or causing to be made or used a false statement or record material to payment of a false claim or avoiding, decreasing
    or concealing an obligation to pay money to the federal government;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Federal Criminal False Claims Act, which is similar to the Federal Civil False Claims Act and imposes criminal liability on those
    that make or present a false, fictitious or fraudulent claim to the federal government;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medicare
    laws and regulations that prescribe requirements for coverage and reimbursement, and laws prohibiting false claims or unduly influencing
    selection of products for reimbursement under Medicare and Medicaid;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">healthcare
    fraud statutes that prohibit false statements and improper claims to any third-party payer;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Federal Physician Self-Referral Law, commonly known as the Stark law, which, absent an applicable exception, prohibits physicians
    from referring Medicare and Medicaid patients to an entity for the provision of certain designated health services (&ldquo;DHS&rdquo;),
    if the physician (or a member of the physician&rsquo;s immediate family) has an impermissible financial relationship with that entity
    and prohibits the DHS entity from billing for such improperly referred services;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Federal Beneficiary Anti-Inducement Statute, which prohibits the offering of any remuneration to a beneficiary of Medicare or Medicaid
    that is likely to influence that beneficiary&rsquo;s choice of provider or supplier. This can include, but is not limited to, inappropriate
    provision of patient services including financial assistance. Recent government investigations have focused on this particular prohibition.
    There are established exceptions from liability, but we cannot guarantee that all of our practices will fall squarely within those
    exceptions;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    U.S. Foreign Corrupt Practices Act, which can be used to prosecute companies in the U.S. for arrangements with physicians or other
    parties outside the U.S. if the physician or party is a government official of another country and the arrangement violates the law
    of that country;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Federal Trade Commission Act, the Lanham Act and similar federal and state laws regulating truthfulness in advertising and consumer
    protection; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Federal Physician Payments Sunshine Act, the French Sunshine Act and similar state and foreign laws, which require periodic reporting
    of payments and other transfers of value made to U.S. and French-licensed physicians, teaching hospitals, and in the U.S., physician
    assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, and certified nurse-midwives.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Similar
laws exist in the EU, individual EU member states and other countries. These laws are complemented by EU or national professional codes
of practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HIPAA
provides data privacy and security provisions for safeguarding medical information. Additionally, states in the U.S. are enacting local
privacy laws (e.g., California). In the EU, the GDPR harmonizes data privacy laws and rules on the processing of personal data, including
patient and employee data, across the EU. The GDPR has a number of strict data protection and security requirements for companies processing
data of EU residents, including when such data is transferred outside of the EU. Additionally, we need to comply with analogous privacy
laws in other jurisdictions in which we operate, such as the Israeli Privacy Protection Law, the Asia Pacific Economic Cooperation Privacy
Framework, and Japan&rsquo;s Act on the Protection of Personal Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws and codes of practices applicable to us are subject to evolving interpretations. Moreover, certain U.S. federal and state laws regarding
healthcare fraud and abuse and certain laws in other jurisdictions regarding interactions with healthcare professionals and patients
are broad and we may be required to restrict certain of our practices to be in compliance with these laws. Healthcare fraud and abuse
laws also are complex and even minor, inadvertent irregularities, or even the perception of impropriety, can potentially give rise to
claims that a statute has been violated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
violation of these laws could have a material adverse effect on our business, prospects, financial condition and results of operations
and cause our stock price to decline. Similarly, if there is a change in law, regulation or administrative or judicial interpretations,
we may have to change our business practices or our existing business practices could be challenged as unlawful, which likewise could
have a material adverse effect on our business, prospects, financial condition and results of operations and cause our stock price to
decline. Fines and penalties for violations of these laws and regulations could include severe criminal and civil penalties, including,
for example, significant monetary damages, exclusion from participation in the federal healthcare programs and permanent disbarment of
key employees. Any penalties, damages, fines, curtailment or restructuring of our operations would adversely affect our ability to operate
our business, our prospects and our financial results. In addition, any action against us for violation of these laws, even if we successfully
defend against it, could cause us to incur significant legal expenses, divert our management&rsquo;s attention from the operation of
our business and damage our reputation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, although we believe that we have the required licenses, permits and accreditation to dispense our products in the future, a
regulator could find that we need to obtain additional licenses or permits. We also may be subject to mandatory reaccreditation and other
requirements in order to maintain our billing privileges. Failure to satisfy those requirements could cause us to lose our privileges
to bill governmental and private payers. If we are required to obtain permits or licenses that we do not already possess, we also may
become subject to substantial additional regulation or incur significant expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
ensure compliance with Medicare, Medicaid and other regulations, federal and state governmental agencies and their agents, including
MACs, may conduct audits of our operations to support our claims submitted for reimbursement of items furnished to beneficiaries and
health care providers. Depending on the nature of the conduct found in such audits and whether the underlying conduct could be considered
systemic, the resolution of these audits could adversely impact our revenue, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we, our collaborative partners, our contract manufacturers or our component suppliers fail to comply with the FDA&rsquo;s QSR or equivalent
regulations established in other countries, the manufacturing and distribution of our products could be interrupted, and our product
sales and results of operations could suffer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We,
our collaborative partners, our contract manufacturers and our component suppliers are required to comply with the FDA&rsquo;s QSR
and the equivalent quality system requirements imposed by the laws and regulations in other jurisdictions, which are a complex
regulatory framework that covers the procedures and documentation of the design, testing, production, control, quality assurance,
labeling, packaging, sterilization, storage and shipping of our products. We cannot assure you that our facilities or our contract
manufacturers&rsquo; or component suppliers&rsquo; facilities would pass any future quality system inspection. If our or any of our
contract manufacturers&rsquo; or component suppliers&rsquo; facilities fails a quality system inspection, the manufacturing or
distribution of our products could be interrupted  and our operations disrupted. Failure to take adequate and timely
corrective action in response to an adverse quality system inspection could force a suspension or shutdown of our packaging and
labeling operations or the manufacturing operations of our contract manufacturers, and lead to suspension, variation or withdrawal
of our regulatory approvals or a recall of our products. If any of these events occurs, we may not be able to provide our customers
with our products on a timely basis, our reputation could be harmed and we could lose customers, any or all of which could have a
material adverse effect on our business, prospects, financial condition and results of operations and cause our stock price to
decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
products may in the future be subject to recalls that could harm our reputation, business and financial results</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA and similar governmental authorities in other jurisdictions have the authority to require the recall of commercialized products in
the event of material deficiencies or defects in design or manufacture. In the case of the FDA, the authority to require a recall must
be based on an FDA finding that there is a reasonable probability that the device would cause serious injury or death. In addition, governmental
bodies in other jurisdictions have the authority to require the recall of our products in the event of material deficiencies or defects
in design or manufacture. Distributors and manufacturers may, under their own initiative, recall a product if any material deficiency
in a device is found. A government-mandated or voluntary recall by us or one of our manufacturers could occur as a result of component
failures, manufacturing errors, design or labeling defects or other deficiencies and issues. The FDA requires that certain classifications
of recalls be reported to the FDA within ten working days after the recall is initiated. Requirements for the reporting of product recalls
to the competent authorities are imposed in other jurisdictions in which our products are or would be marketed in the future. Companies
are required to maintain certain records of recalls, even if they are not reportable to the FDA or to the competent authorities of other
countries. In the future, we may initiate voluntary recalls involving our products that we determine do not require notification of the
FDA or to other equivalent non-U.S. authorities. If the FDA or the equivalent non-U.S. authorities disagree with our determinations,
they could require us to report those actions as recalls. A future recall announcement could harm our reputation with customers and negatively
affect our sales. In addition, the FDA and the equivalent non-U.S. authorities could take enforcement action if we fail to report the
recalls when they were conducted. Recalls of our products would divert managerial and financial resources and could have a material adverse
effect on our business, prospects, financial condition and results of operations and cause our stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our products cause or contribute to a death or a serious injury, or malfunction in certain ways, we will be subject to medical device
reporting regulations, which can result in voluntary corrective actions or agency enforcement actions</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the FDA Medical Device Reporting regulations and the equivalent regulations applicable in other jurisdictions in which our products are
or may be marketed in the future, medical device manufacturers are required to report to the FDA and to the equivalent non-U.S. authorities
information that a device has or may have caused or contributed to a death or serious injury or has malfunctioned in a way that would
likely cause or contribute to death or serious injury if the malfunction of the device or one of our similar devices were to recur. If
we fail to report these events to the FDA or to the equivalent authorities in other jurisdictions within the required time frames, or
at all, the FDA or the equivalent authorities in other jurisdictions could take enforcement action against us. Any such adverse event
involving our products also could result in future voluntary corrective actions, such as recalls or customer notifications, or agency
action, such as inspection or enforcement action. Any corrective action, whether voluntary or involuntary, as well as defending ourselves
in a lawsuit, will require the dedication of our time and capital, distract management from operating our business, and may harm our
reputation and financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to fines, penalties or injunctions if we are determined to be promoting the use of our products for unapproved or off-label
uses</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
devices may be marketed only for the indications for which they are approved. Our promotional materials and training materials must comply
with FDA regulations and other applicable laws and regulations governing the promotion of our products in the U.S. and other jurisdictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the FDA or the competent authorities in other jurisdictions determine that our promotional materials or training constitutes promotion
of an unapproved use, they could request that we modify our training or promotional materials or subject us to regulatory or enforcement
actions, including the issuance of an untitled or warning letter, an injunction, seizure, civil fines and criminal penalties. It is also
possible that authorities in other federal, state or national enforcement in other jurisdictions might take action if they consider our
promotional or training materials to constitute promotion of an unapproved use, which could result in significant fines or penalties
under other statutory authorities, such as laws prohibiting false claims for reimbursement. In that event, our reputation could be damaged
and the commercialization of our products could be impaired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are affected by and subject to environmental laws and regulations that could be costly to comply with or that may result in costly liabilities</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to environmental laws and regulations, including those that impose various environmental controls on the manufacturing, transportation,
storage, use and disposal of hazardous chemicals and other materials used in, and hazardous waste produced by, the manufacturing of our
products. We incur and expect to continue to incur costs to comply with these environmental laws and regulations. Additional or modified
environmental laws and regulations, including those relating to the manufacture, transportation, storage, use and disposal of materials
used to manufacture our products or restricting disposal or transportation of batteries, may be imposed that may result in higher costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we cannot predict the effect that additional or modified environmental laws and regulations may have on us, our third-party
suppliers of equipment and our products or our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
pediatrics and medical device industries are characterized by patent and other intellectual property litigation and disputes, and any
litigation, dispute or claim against us may cause us to incur substantial costs, could place a significant strain on our financial resources,
divert the attention of management from our business, harm our reputation and require us to remove certain devices from the market</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether
a product infringes a patent or violates other intellectual property rights involves complex legal and factual issues, the determination
of which is often uncertain. Any intellectual property dispute, even a meritless or unsuccessful one, would be time consuming and expensive
to defend and could result in the diversion of our management&rsquo;s attention from our business and result in adverse publicity, the
disruption of research and development and marketing efforts, injury to our reputation and loss of revenues. Any of these events could
negatively affect our business, prospects, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
parties may assert that our products, the methods employed in the use of our products or other activities infringe on their patents.
Such claims may be made by competitors seeking to obtain a competitive advantage or by other parties, many of whom have significantly
larger intellectual property portfolios than we have. Additionally, in recent years, individuals and groups have begun purchasing intellectual
property assets for the purpose of making claims of infringement and attempting to extract settlements from companies like ours. With
respect to our current products, the risk of infringement claims is exacerbated by the fact that there are numerous issued and pending
patents relating to the treatment of cancer. Because patent applications can take many years to issue, and in many cases remain unpublished
for many months after filing, there may be applications now pending of which we are unaware that may later result in issued patents that
our products may infringe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
could also be existing patents that one or more components of our products or other device candidates may inadvertently infringe. As
the number of competitors in the market or other device candidates grows, the possibility of inadvertent patent infringement by us or
a patent infringement claim against us increases. To the extent we gain greater market visibility, our risk of being subject to such
claims is also likely to increase. If a third party&rsquo;s patent was upheld as valid and enforceable and we were found to be infringing,
we could be prevented from making, using, selling, offering to sell or importing our products or other device candidates, unless we were
able to obtain a license under that patent or to redesign our systems to avoid infringement. A license may not be available at all or
on terms acceptable to us, and we may not be able to redesign our products to avoid any infringement. Modification of our products or
development of device candidates to avoid infringement could require us to conduct additional clinical studies and to revise our filings
with the FDA and other regulatory bodies, which would be time-consuming and expensive. If we are not successful in obtaining a license
or redesigning our devices, we may be unable to make, use, sell, offer to sell or import our devices and our business could suffer. We
may also be required to pay substantial damages and undertake remedial activities, which could cause our business to suffer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also be subject to claims alleging that we infringe or violate other intellectual property rights, such as copyrights or trademarks,
may have to defend against allegations that we misappropriated trade secrets, and may face claims based on competing claims of ownership
of our intellectual property. The confidentiality and assignment of inventions agreements that our employees, consultants and other third
parties sign may not in all cases be enforceable or sufficient to protect our intellectual property rights. In addition, we may face
claims from third parties based on competing claims to ownership of our intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may employ individuals who were previously employed at other medical device companies, and as such we may be subject to claims that such
employees have inadvertently or otherwise used or disclosed the alleged trade secrets or other proprietary information of their former
employers. Any such litigation, dispute or claim could be costly to defend and could subject us to substantial damages, injunctions or
other remedies, which could have a material adverse effect on our business, prospects, financial condition and results of operations
and cause our stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changes
in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our devices</I></B><I>.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
is the case with other medical device companies, our success is heavily dependent on our intellectual property rights, and particularly
on our patent rights. Obtaining and enforcing patents in the medical device industry involves both technological and legal complexity,
and is therefore costly, time consuming and inherently uncertain. In addition, the U.S. has recently enacted and is currently implementing
wide-ranging patent reform legislation. Certain U.S. Supreme Court rulings have narrowed the scope of patent protection available in
certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard
to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents
once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents
could change in unpredictable ways that could further negatively impact the value of our patents, narrow the scope of available patent
protection or weaken the rights of patent owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Future
regulatory action remains uncertain.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate in a highly regulated and evolving environment with rigorous regulatory enforcement. Any legal or regulatory action could be
time-consuming and costly. If we or the manufacturers or distributors that supply our products fail to comply with all applicable laws,
standards, and regulations, action by the FDA or other regulatory agencies could result in significant restrictions, including restrictions
on the marketing or use of the products we sell or the withdrawal of the products we sell from the market. Any such restrictions or withdrawals
could materially affect our reputation, business and operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
product candidates will remain subject to ongoing regulatory review even after they receive marketing clearances, and if we fail to comply
with continuing regulations, we could lose these clearances and the sale of any of our approved commercial products could be suspended.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
as we received regulatory clearance to market the IB-Stim, the manufacturing, labeling, packaging, adverse event reporting, storage,
advertising, promotion, and record keeping related to IB-Stim will remain subject to extensive regulatory requirements. If we fail to
comply with the regulatory requirements of the FDA and other applicable domestic and foreign regulatory authorities or discover any previously
unknown problems with any approved product, manufacturer, or manufacturing process, we could be subject to administrative or judicially
imposed sanctions, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">restrictions
    on the products, manufacturers, or manufacturing processes;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">warning
    letters;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">civil
    or criminal penalties;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fines;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">injunctions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">product
    seizures or detentions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pressure
    to initiate voluntary product recalls;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">suspension
    or withdrawal of regulatory clearances and/or approvals; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">refusal
    to approve pending applications for marketing clearances and/or approval of new products or supplements to approved applications.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Intellectual
property litigation and infringement claims could cause us to incur significant expenses or prevent us from selling certain of our products.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
therapeutic medical device and pharmaceutical industries are characterized by extensive intellectual property litigation and, from time
to time, we may become the subject of claims of infringement or misappropriation. Regardless of outcome, such claims are expensive to
defend and divert management and operating personnel from other business issues. A successful claim or claims of patent or other intellectual
property infringement against us could result in payment of significant monetary damages and/or royalty payments or negatively impact
our ability to sell current or future products in the affected category.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
depend extensively on our patents and proprietary technology and the patents, and we must protect those assets in order to preserve our
business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we expect to seek patent protection for any devices, <I>in silico</I> products (if any), systems, and processes we discover and/or for
any specific use we discover for new or previously known compounds, devices, biologics, products, systems, or processes, any or all of
these may not be subject to effective patent protection. In addition, our issued patents may be declared invalid or our competitors may
find ways to avoid the claims in the patents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success will depend, in part, on our ability to obtain patents, protect our trade secrets and proprietary knowledge and operate without
infringing on the proprietary rights of others. We are the sole assignee of numerous granted United States patents, pending United States
patent applications and international patents. The patent position of pharmaceutical and biotechnology firms like us are generally highly
uncertain and involves complex legal and factual questions, resulting in both an apparent inconsistency regarding the breadth of claims
allowed in United States patents and general uncertainty as to their legal interpretation and enforceability. Accordingly, patent applications
assigned to us may not result in patents being issued, any issued patents assigned to us may not provide us with competitive protection
or may be challenged by others, and the current or future granted patents of others may have an adverse effect on our ability to do business
and achieve profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
others may independently develop similar products, may duplicate our products, or may design around our patent rights. In addition, as
a result of the assertion of rights by a third-party or otherwise, we may be required to obtain licenses to patents or other proprietary
rights of others in or outside of the United States. Any licenses required under any such patents or proprietary rights may not be made
available on terms acceptable to us, if at all. If we do not obtain such licenses, we could encounter delays in product market introductions
during our attempts to design around such patents or could find that the development, manufacture or sale of products requiring such
licenses is foreclosed. In addition, we could incur substantial costs in defending suits brought against us or in connection with patents
to which we hold licenses or in bringing suit to protect our own patents against infringement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Due
to legal and factual uncertainties regarding the scope and protection afforded by patents and other proprietary rights, we may not have
meaningful protection from competition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
long-term success will substantially depend upon our ability to protect our proprietary technologies from infringement, misappropriation,
discovery and duplication, and avoid infringing the proprietary rights of others. Our patent rights and the patent rights of biotechnology
and pharmaceutical companies in general, are highly uncertain and include complex legal and factual issues. Because of this, our pending
patent applications may not be granted. These uncertainties also mean that any patents that we own or will obtain in the future could
be subject to challenge, and even if not challenged, may not provide us with meaningful protection from competition. Due to our financial
uncertainties, we may not possess the financial resources necessary to enforce our patents. Patents already issued to us or our pending
applications may become subject to dispute, and any dispute could be resolved against us. Because a substantial number of patents have
been issued in the field of neuromodulation therapy and because patent positions can be highly uncertain and frequently involve complex
legal and factual questions, the breadth of claims obtained in any application or the enforceability of our patents cannot be predicted.
Consequently, we do not know whether any of our pending or future patent applications will result in the issuance of patents or, to the
extent patents have been issued or will be issued, whether these patents will be subject to further proceedings limiting their scope,
will provide significant proprietary protection or competitive advantage, or will be circumvented or invalidated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
because of these legal and factual uncertainties, and because pending patent applications are held in secrecy for varying periods in
the United States and other countries, even after reasonable investigation, we may not know with certainty whether any products that
we (or a licensee) may develop will infringe upon any patent or other intellectual property right of a third party. We believe that the
patents that we own or have applied for do not infringe any third-party patents; however, we cannot know for certain whether we could
successfully defend our position, if challenged. We may incur substantial costs if we are required to defend our intellectual property
in patent suits brought by third parties. These legal actions could seek damages and seek to enjoin testing, manufacturing and marketing
of the accused product or process. In addition to potential liability for significant damages, we could be required to obtain a license
to continue to manufacture or market the accused product or process.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the third parties on which we rely for the conduct of our clinical trials and results do not perform our clinical trial activities in
accordance with good clinical practices and related regulatory requirements, we may be unable to obtain regulatory approval for or commercialize
our product candidates.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may use independent clinical investigators and other third-party service providers to conduct and/or oversee the clinical trials of our
product candidates for the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA requires us and our clinical investigators to comply with regulations and standards, commonly referred to as good clinical practices,
for conducting, recording, and reporting the results of clinical trials to assure that data and reported results are credible and accurate,
and that the trial participants are adequately protected. Our reliance on third parties that we do not control does not relieve us of
these responsibilities and requirements. Third parties may not complete activities on schedule or may not conduct our clinical trials
in accordance with regulatory requirements or the respective trial plans and protocols. The failure of these third parties to carry out
their obligations could delay or prevent the development, approval, and commercialization of our product candidates or result in enforcement
action against us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Common Stock and this Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
has been no public market for our common stock prior to this offering, and an active market in which investors can resell their shares
of our common stock may not develop.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has been no public market for our common stock. We have applied to list our common stock on Nasdaq under the
symbol &ldquo;NRXS.&rdquo; The closing of this offering is contingent upon the successful listing of our common stock on the Nasdaq Capital
Market. There is no guarantee that Nasdaq, or any other exchange or quotation system, will permit our common stock to be listed and traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
if our common stock is approved for listing on Nasdaq, a liquid public market for our common stock may not develop. The initial public
offering price for our common stock has been determined by negotiation between us and the Underwriter based upon several factors, including
prevailing market conditions, our historical performance, estimates of our business potential and earnings prospects, and the market
valuations of similar companies. The price at which the common stock is traded after this offering may decline below the initial public
offering price, meaning that you may experience a decrease in the value of your common stock regardless of our operating performance
or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Volatility
in the market price of our common stock may prevent investors from being able to sell their common stock at or above the initial public
offering price.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
this offering, the market price for our common stock is likely to be volatile, in part because our shares have not been traded publicly.
In addition, the market price of our common stock may fluctuate significantly in response to several factors, most of which we cannot
control, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated variations in our periodic operating results;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated changes in our growth rate relative to our competitors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increases
    in market interest rates that lead investors of our common stock to demand a higher investment return;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in earnings estimates;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in market valuations of similar companies;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
    or announcements by our competitors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    market reaction to any increased indebtedness we may incur in the future;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    of our common stock by our officers, directors, or significant stockholders;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions
    or departures of key personnel;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    progress toward developing our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    commencement, enrollment and results of our future clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    results from, delays in or termination of our clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    regulatory decisions, including failure to receive regulatory approval;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">publication
    of research reports about us or our industry or positive or negative recommendations or withdrawal of research coverage by securities
    analysts, if any;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">perceptions
    about the market acceptance of our products and the recognition of our brand;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">threatened
    or actual litigation and governmental investigations;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions
    by stockholders;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">speculation
    in the media, online forums, or investment community; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    intentions and ability to list our common stock on Nasdaq and our subsequent ability to maintain such listing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
public offering price of our common stock has been determined by negotiations between us and the underwriter based upon many factors
and may not be indicative of prices that will prevail following the closing of this offering. In addition, the stock market in general,
and the stock of early-stage companies like ours in particular, has experienced extreme price and volume fluctuations that have often
been unrelated or disproportionate to the operating performance of these companies. Such rapid and substantial price volatility, including
any stock run-up, may be unrelated to our actual or expected operating performance, financial condition or prospects, making it difficult
for investors to assess the rapidly changing value of our stock. Volatility in the market price of our common stock may prevent investors
from being able to sell their common stock at or above the initial public offering price. As a result, you may suffer a loss on your
investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Certain
recent initial public offerings of companies with relatively small public floats comparable to our anticipated&nbsp;public&nbsp;float&nbsp;have
experienced extreme volatility that was seemingly unrelated to the underlying performance of the respective company. Our common stock
may potentially experience rapid and substantial price volatility, which may make it difficult for prospective investors to assess the
value of our common stock.</I></B>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the risks addressed above under &ldquo;<I>Volatility in the market price of our common stock may prevent investors from being
able to sell their common stock at or above the initial public offering price</I>,&rdquo; our common stock may be subject to rapid and
substantial price volatility. We may experience extreme stock price volatility unrelated to our actual or expected operating performance,
financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our common shares.
Recently, there have been instances of extreme stock price run-ups followed by rapid price declines and strong stock price volatility
with a number of recent initial public offerings, especially among companies with relatively smaller public floats. As a relatively small-capitalization
company with relatively small&nbsp;public&nbsp;float, we may experience greater stock price volatility, extreme price run-ups, lower
trading volume and less liquidity than large-capitalization companies. In particular, our common stock may be subject to rapid and substantial
price volatility, low volumes of trades and large spreads in bid and ask prices. Such volatility, including any stock-run up, may be
unrelated to our actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors
to assess the rapidly changing value of our common stock. Because of the&nbsp;low&nbsp;public&nbsp;float&nbsp;and the absence of any
significant trading volume, the reported prices may not reflect the price at which you would be able to sell shares if you want to sell
any shares you own or buy shares if you wish to buy share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if the trading volumes of our shares of common stock are low, persons buying or selling in relatively small quantities may
easily influence prices of our shares of common stock. This low volume of trades could also cause the price of our common stock to fluctuate
greatly, with large percentage changes in price occurring in any trading day session. Holders of our common stock may also not be able
to readily liquidate their investment or may be forced to sell at depressed prices due to low volume trading. Broad market fluctuations
and general economic and political conditions may also adversely affect the market price of our common stock. As a result of this volatility,
investors may experience losses on their investment in our common stock. A decline in the market price of our common stock also could
adversely affect our ability to issue additional shares of common stock or other securities and our ability to obtain additional financing
in the future. No assurance can be given that an active market in our common stock will develop or be sustained. If an active market
does not develop, holders of our common stock may be unable to readily sell the shares they hold or may not be able to sell their shares
at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may not be able to satisfy listing requirements of Nasdaq or maintain a listing of our common stock on Nasdaq.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our common stock is listed on Nasdaq, we must meet certain financial and liquidity criteria to maintain such listing. If we violate Nasdaq&rsquo;s
listing requirements, or if we fail to meet any of Nasdaq&rsquo;s listing standards, our common stock may be delisted. In addition, our
board of directors may determine that the cost of maintaining our listing on a national securities exchange outweighs the benefits of
such listing. A delisting of our common stock from Nasdaq may materially impair our stockholders&rsquo; ability to buy and sell our common
stock and could have an adverse effect on the market price of, and the efficiency of the trading market for, our common stock. The delisting
of our common stock could significantly impair our ability to raise capital and the value of your investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have considerable discretion as to the use of the net proceeds from this offering and we may use these proceeds in ways with which you
may not agree.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use the proceeds from this offering for working capital, sales and marketing activities, research and development, and repayment
of our convertible notes. However, we have considerable discretion in the application of the proceeds. Because of the number and variability
of factors that will determine our use of our net proceeds from this offering, their ultimate use may vary substantially from their currently
intended use. You will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately.
You must rely on the judgment of our management regarding the application of the net proceeds of this offering. The net proceeds may
be used for corporate or other purposes with which you do not agree or that do not improve our profitability or increase our share price.
The net proceeds from this offering may also be placed in investments that do not produce income or that lose value. Please see &ldquo;<I>Use
of Proceeds</I>&rdquo; below for more information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
will experience immediate and substantial dilution as a result of this offering.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023, our net tangible book value was approximately $(8.7) million, or approximately $(4.36)
per share. Since the effective price per share of our common stock being offered in this offering is substantially higher than the
net tangible book value per share of our common stock, you will suffer substantial dilution with respect to the net tangible book
value of the common stock you purchase in this offering. Based on the assumed public offering price of $[&#9679;] per share
of common stock being sold in this offering and our net tangible book value per share as of March 31, 2023, if you
purchase shares of common stock in this offering, you will suffer immediate and substantial dilution of $[&#9679;] per share
(or $[&#9679;] per share if the Underwriter exercises the over-allotment option in full) with respect to the net tangible
book value of the common stock. See the section titled &ldquo;<I>Dilution</I>&rdquo; for a more detailed discussion of the dilution
you will incur if you purchase securities in this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not expect to declare or pay dividends in the foreseeable future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect to declare or pay dividends in the foreseeable future, as we anticipate that we will invest future earnings in the development
and growth of our business. Therefore, holders of our common stock will not receive any return on their investment unless they sell their
securities, and holders may be unable to sell their securities on favorable terms or at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
securities industry analysts do not publish research reports on us, or publish unfavorable reports on us, then the market price and market
trading volume of our common stock could be negatively affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
trading market for our common stock may be influenced in part by any research reports that securities industry analysts publish about
us. We do not currently have and may never obtain research coverage by securities industry analysts. If no securities industry analysts
commence coverage of us, the market price and market trading volume of our common stock could be negatively affected. In the event we
are covered by analysts, and one or more of such analysts downgrade our securities, or otherwise reports on us unfavorably, or discontinues
coverage of us, the market price and market trading volume of our common stock could be negatively affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Future
issuances of our common stock or securities convertible into, or exercisable or exchangeable for, our common stock, or the expiration
of lock-up agreements that restrict the issuance of new common stock or the trading of outstanding common stock, could cause the market
price of our common stock to decline and would result in the dilution of your holdings.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
issuances of our common stock or securities convertible into, or exercisable or exchangeable for, our common stock, or the expiration
of lock-up agreements that restrict the issuance of new common stock or the trading of outstanding common stock, could cause the market
price of our common stock to decline. We cannot predict the effect, if any, of future issuances of our securities, or the future expirations
of lock-up agreements, on the price of our common stock. In all events, future issuances of our common stock would result in the dilution
of your holdings. In addition, the perception that new issuances of our securities could occur, or the perception that locked-up parties
will sell their securities when the lock-ups expire, could adversely affect the market price of our common stock. In connection with
this offering, we will enter into a lock-up agreement that prevents us, subject to certain exceptions, from offering additional shares
of capital stock for up to six months after the closing of this offering, as further described in the section titled &ldquo;<I>Underwriting</I>.&rdquo;
In addition to any adverse effects that may arise upon the expiration of these lock-up agreements, the lock-up provisions in these agreements
may be waived, at any time and without notice. If the restrictions under the lock-up agreements are waived, our common stock may become
available for resale, subject to applicable law, including without notice, which could reduce the market price for our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Future
issuances of debt securities, which would rank senior to our common stock upon our bankruptcy or liquidation, and future issuances of
preferred stock, which could rank senior to our common stock for the purposes of dividends and liquidating distributions, may adversely
affect the level of return you may be able to achieve from an investment in our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the future, we may attempt to increase our capital resources by offering debt securities. Upon bankruptcy or liquidation, holders of
our debt securities, and lenders with respect to other borrowings we may make, would receive distributions of our available assets prior
to any distributions being made to holders of our common stock. Moreover, if we issue preferred stock, the holders of such preferred
stock could be entitled to preferences over holders of common stock in respect of the payment of dividends and the payment of liquidating
distributions. Because our decision to issue debt or preferred stock in any future offering, or borrow money from lenders, will depend
in part on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of any
such future offerings or borrowings. Holders of our common stock must bear the risk that any future offerings we conduct or borrowings
we make may adversely affect the level of return, if any, they may be able to achieve from an investment in our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
our shares of common stock become subject to the penny stock rules, it would become more difficult to trade our shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally
equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized
for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions
in such securities is provided by the exchange or system. If we do not retain a listing on Nasdaq or another national securities exchange
and if the price of our common stock is less than $5.00, our common stock could be deemed a penny stock. The penny stock rules require
a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure
document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny
stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable
investment for the purchaser and receive (i) the purchaser&rsquo;s written acknowledgment of the receipt of a risk disclosure statement;
(ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement.
These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our common stock, and
therefore stockholders may have difficulty selling their shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will be subject to ongoing public reporting requirements that are less rigorous than Exchange Act rules for companies that are not emerging
growth companies, and our stockholders could receive less information than they might expect to receive from more mature public companies.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the completion of this offering, we will be required to publicly report on an ongoing basis as an &ldquo;emerging growth company&rdquo;
(as defined in the JOBS Act) under the reporting rules set forth under the Exchange Act. For so long as we remain an emerging growth
company, we may take advantage of certain exemptions from various reporting requirements that are applicable to other Exchange Act reporting
companies that are not emerging growth companies, including but not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    permitted to comply with reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
    exempt from the requirement to hold a non-binding advisory vote on executive compensation and stockholder approval of any golden
    parachute payments not previously approved.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to take advantage of these reporting exemptions until we are no longer an emerging growth company. We would remain an emerging
growth company for up to five years, although if the market value of our common stock that is held by non-affiliates exceeds $700 million
as of any June 30 before that time, we would cease to be an emerging growth company as of the following December 31.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we will be subject to ongoing public reporting requirements that are less rigorous than Exchange Act rules for companies that are not
emerging growth companies, our stockholders could receive less information than they might expect to receive from more mature public
companies. We cannot predict if investors will find our common stock less attractive if we elect to rely on these exemptions, or if taking
advantage of these exemptions would result in less active trading or more volatility in the price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
the Company is a &ldquo;smaller reporting company,&rdquo; we may take advantage of certain scaled disclosures available to us, resulting
in holders of our securities receiving less Company information than they would receive from a public company that is not a smaller reporting
company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;smaller reporting company&rdquo; as defined in the Exchange Act. As a smaller reporting company, we may take advantage of
certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures
for so long as (i) our common stock held by non-affiliates is less than $250 million measured on the last business day of our second
fiscal quarter, or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and our common stock
held by non-affiliates is less than $700 million measured on the last business day of our second fiscal quarter. To the extent we take
advantage of any reduced disclosure obligations, it may make it harder for investors to analyze the Company&rsquo;s results of operations
and financial prospectus in comparison with other public companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a smaller reporting company, we are permitted to comply with scaled-back disclosure obligations in our SEC filings compared to other
issuers, including with respect to disclosure obligations regarding executive compensation in our periodic reports and proxy statements.
We have elected to adopt the accommodations available to smaller reporting companies. Until we cease to be a smaller reporting company,
the scaled-back disclosure in our SEC filings will result in less information about our company being available than for other public
companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
investors consider our common stock less attractive as a result of our election to use the scaled-back disclosure permitted for smaller
reporting companies, there may be a less active trading market for our common stock and our share price may be more volatile.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
a &ldquo;smaller reporting company,&rdquo; we may at some time in the future choose to exempt our Company from certain corporate governance
requirements that could have an adverse effect on our public shareholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq rules, a &ldquo;smaller reporting company,&rdquo; as defined in Rule 12b-2 under the Exchange Act, is not subject to certain corporate
governance requirements otherwise applicable to companies listed on Nasdaq. For example, a smaller reporting company is exempt from the
requirement of having a compensation committee composed solely of directors meeting certain enhanced independence standards, as long
as the compensation committee has at least two members who do meet such standards. Although we have determined not to avail ourselves
of this or other exemptions from Nasdaq requirements that are or may be afforded to smaller reporting companies while we will seek to
maintain our shares on Nasdaq, in the future we may elect to rely on any or all of these exemptions. By electing to utilize any such
exemptions, our Company may be subject to greater risks of poor corporate governance, poorer management decision-making processes, and
reduced results of operations from problems in our corporate organization. Consequently, if we were to avail ourselves of these exemptions,
our stock price might suffer, and there is no assurance that we would be able to continue to meet all continuing listing requirements
of Nasdaq from which we would not be exempt, including minimum stock price requirements.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="eds_008"></A>USE
OF PROCEEDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon an assumed public offering price of $[&#9679;] per share, we estimate that we will receive net proceeds from this
offering, after deducting the underwriting discounts and the estimated offering expenses payable by us, of approximately $[&#9679;]
million assuming the Underwriter does not exercise its over-allotment option. We will not receive any of the proceeds from the sale
of common stock in this offering by the Selling Stockholders identified in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to use the net proceeds we receive from this offering for the following purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
    of Net Proceeds</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
    and Marketing</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and Development<SUP>(1)</SUP></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Officer Contract Payments<SUP>(2)</SUP> </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Corporate Purposes<SUP>(3)</SUP> </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    all funding of our IB-Stim device through the 510(k) De Novo FDA review for functional abdominal pain and IBS in children, as well
    as anticipated funding needed to achieve the regulatory milestones for our technology in respect of other indications identified
    in the chart captioned &ldquo;FDA Pipeline Indications&rdquo; under &ldquo;<I>Prospectus Summary&mdash;Our Pipeline</I>.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    payments to our executive officers pursuant to their respective employment agreements. For more information, see &ldquo;<I>Executive
    Officer and Director Compensation &mdash;Employment Agreements</I>.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            $50,000 payable to Exchange Listing upon the listing of our common stock on Nasdaq and approximately
                                            $60,000 to repay the balance of two loans payable to a member of our board of directors.
                                            See &ldquo;<I>Prospectus Summary&mdash;Recent Developments</I>&rdquo; and &ldquo;<I>Certain
                                            Relationships and Related Persons Transactions,</I>&rdquo; respectively, for more information.</FONT></P>


</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our existing cash and cash equivalents, together with proceeds from this offering, will be sufficient to fund our operating
expenses and capital expenditure requirements through at least the next 12 months. The foregoing represents our current intentions based
upon our present plans and business conditions to use and allocate the net proceeds of this offering. However, the nature, amounts and
timing of our actual expenditures may vary significantly depending on numerous factors. As a result, our management has and will retain
broad discretion over the allocation of the net proceeds from this offering. We may find it necessary or advisable to use the net proceeds
from this offering for other purposes, and we will have broad discretion in the application of net proceeds from this offering. To the
extent that the net proceeds we receive from this offering are not immediately used for the above purposes, we intend to invest our net
proceeds in short-term, interest-bearing bank deposits or debt instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="M_001"></A>DIVIDEND
POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not declared or paid any cash dividend on its common stock, and it currently intends to retain future earnings, if any, to
finance the expansion of its business, and the Company does not expect to pay any cash dividends in the foreseeable future. The decision
whether to pay cash dividends on its common stock will be made by its board of directors, in their discretion, and will depend on the
Company&rsquo;s financial condition, results of operations, capital requirements and other factors that its board of directors considers
significant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="M_002"></A>CAPITALIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is our capitalization as of March 31, 2023: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma basis to reflect conversion of the Series A and Series Seed Preferred Stock in connection with this offering, and issuance
    of 125,000 shares of common stock to Exchange Listing, LLC for services in connection with the offering and 125,000 shares of common
    stock to Exchange Listing, LLC for future services in connection with the latest advisory agreement, 50,000 shares of common stock
    issued to Lucosky Brookman LLP in partial settlement of accounts payable in connection with the closing of this offering; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    a pro forma as adjusted basis to reflect the issuance and sale of the shares by us in this offering at the assumed public
    offering price of $[&#9679;] per shares, after deducting the estimated underwriting discounts and the estimated offering
    expenses payable by us and the elimination of the derivative liability of $1,947,630 and warrant liability of $3,541,532
    valued at March 31, 2023, the conversion of $5,222,222 of the convertible notes into common stock, the repayment of the remaining
    convertible note balance of $416,667, the repayment of the $52,600 promissory note from Exchange Listing, LLC, and the repayment
    of the approximately $60,000 balance of two loans payable to a member of our board of directors. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
as adjusted information below is illustrative only, and our capitalization following the completion of this offering will be adjusted
based on the actual public offering price and other terms of this offering determined at pricing. You should consider this table in conjunction
with &ldquo;<I>Use of Proceeds</I>&rdquo; above as well as our &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition
and Results of Operations of the Company,&rdquo; and our audited and unaudited financial statements and the notes to those financial
statements included elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of March 31, 2023 </FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual</FONT></P>
                                                                                <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></P></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    Forma (Unaudited)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    Forma As Adjusted (Unaudited)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><P STYLE="margin: 0; text-indent: 0.5in"> 45,463 </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><P STYLE="margin: 0; text-indent: 0.5in"> [&#9679;] </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><P STYLE="margin: 0"> [&#9679;] </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 9,325,388 </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    stockholders&rsquo; equity:</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, par value $0.001 per share, 100,000,000 shares authorized, 1,963,322 shares issued and outstanding on an actual basis, [&#9679;]
    shares issued and outstanding on a pro forma basis, and [&#9679;] shares issued and outstanding on a pro forma as adjusted
    basis as of March 31, 2023; </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,963</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Series A Preferred Stock, par value $0.001 per share, 1,000,000 shares authorized, 506,635 shares issued and outstanding on
    an actual basis, 0 shares issued and outstanding on a pro forma basis, and 0 shares issued and outstanding on a pro forma as
    adjusted basis as of March 31, 2023; </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">507</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Series Seed Preferred Stock, par value $0.001 per share, 120,000 shares authorized, 115,477 shares issued and outstanding
    on an actual basis, 0 shares issued and outstanding on a pro forma basis, and 0 shares issued and outstanding on a pro forma as
    adjusted basis as of March 31, 2023; </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid in capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,355,230</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    (deficit)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36,104,838</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    stockholders&rsquo; (deficit) equity</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,747,023</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> $ </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> 1,578,365 </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> [&#9679;] </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&ldquo;Actual&rdquo; column in the table above is based on 1,963,322 shares of common stock outstanding as of March 31,
2023, the &ldquo;Pro Forma&rdquo; column includes an additional 230,954 and 1,013,274 shares of common stock upon the conversion
of the Series Seed Preferred Stock and the Series A Preferred Stock, respectively, and issuance of 125,000 shares of common stock to
Exchange Listing, LLC for services in connection with the offering and 125,000 shares of common stock to Exchange Listing, LLC for future
services in connection with the latest advisory agreement, 50,000 shares of common stock issued to Lucosky Brookman LLP in partial settlement
of accounts payable in connection with the closing of this offering, and the &ldquo;Pro Forma As Adjusted&rdquo; column includes an additional
[&#9679;] shares of common in connection with the offering, [&#9679;] shares of common stock in connection with the convertible
notes, and in all cases excludes, as of such date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,779
                                            shares of our common stock issuable upon exercise of warrants to purchase shares of Series
                                            A Preferred Stock converting to warrants to purchase shares of common stock. (See &ldquo;<I>Description
                                            of Our Securities&mdash;Warrants</I>&rdquo; for more information);</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">770,284
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock issuable upon exercise
    of warrants to purchase common stock (see &ldquo;<I>Description of Our Securities&mdash;Warrants</I>&rdquo; for
    more information);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of our common stock issuable upon exercise of the Underwriter&rsquo;s Warrants to purchase common stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares issuable upon exercise of warrants issuable
    to Exchange Listing, LLC upon the listing of our common stock on Nasdaq (see &ldquo;<I>Prospectus Summary&mdash;Recent Developments</I>&rdquo;
    for more information); and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,319,394
    shares of our common stock issuable upon exercise of options to purchase common stock. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="M_003"></A>DILUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our common stock, your ownership interest will be diluted to the extent of the difference between the offering price
per share of our common stock and the as-adjusted net tangible book value per share of our common stock immediately after the
offering. Historical net tangible book value per share represents the amount of the Company&rsquo;s total tangible assets less total
liabilities, divided by the number of shares of its common stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
historical net tangible book value (deficit) of our common stock as of March 31, 2023, was approximately $(8.7) million
or $(4.36) per share based upon shares of common stock outstanding on such date. Historical net tangible book value (deficit)
per share represents the amount of its total tangible assets reduced by the amount of its total liabilities, divided by the total number
of shares of common stock outstanding. The effect of the conversion of the Series A, Series Seed, and issuance of shares
pursuant to consulting agreements to the historical net tangible book value (deficit) is $[&#9679;] per share based upon shares
of common stock outstanding as of March 31, 2023. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving effect to the Company&rsquo;s sale of all of the [&#9679;] shares of common stock offered in this offering at a public
offering price of $[&#9679;] per share, issuance of shares of common stock from convertible notes, after deducting estimated
underwriting discounts and commissions and the Company&rsquo;s estimated offering expenses, and paying the remainder of the convertible
notes, the Company&rsquo;s pro forma as adjusted net tangible book value as of March 31, 2023 would have been $[&#9679;]
million or $[&#9679;] per share. This represents an immediate increase in net tangible book value of $[&#9679;] per
share to the Company&rsquo;s existing stockholders, and an immediate dilution in net tangible book value of $[&#9679;] per share
to new investors. The following table illustrates this per share dilution:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 84%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    public offering price per share</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </P></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historical
    net tangible value (deficit) per share as of March 31, 2023 </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4.36</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    per share attributable to the conversion of preferred stock and stock issuances</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
    forma deficiency in net tangible book value per share as of March 31, 2023, before giving effect to this offering</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    attributable to new investors in this offering</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    adjusted, net tangible book value per share after the offering</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
    per share to new investors in this offering</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information discussed above is illustrative only, and the dilution information following this offering will be adjusted based on the
actual public offering price and other terms of this offering determined at pricing. A $1.00 increase (decrease) in the assumed public
offering price of $[&#9679;] per share would increase (decrease) the pro forma as adjusted net tangible book value by $[&#9679;],
$([&#9679;]) per share and increase the dilution to new investors by $[&#9679;] per share and decrease the dilution to new
investors by $[&#9679;] per share, assuming the number of shares offered by the Company, as set forth on the cover page of this
prospectus, remains the same, and after deducting the estimated underwriting discounts and commissions and estimated expenses payable
by the Company. The Company may also increase or decrease the number of shares it is offering. An increase of 100,000 shares offered
by it would increase the pro forma as adjusted net tangible book value by $[&#9679;] per share and decrease the dilution to new
investors by $[&#9679;] per share, assuming the assumed public offering price of $[&#9679;] per share remains the
same and after deducting the estimated underwriting discounts and commissions and estimated expenses payable by the Company. Similarly,
a decrease of 100,000 shares offered by the Company would decrease the pro forma as adjusted net tangible book value by $[&#9679;]
per share and increase the dilution to new investors by $[&#9679;] per share, assuming the assumed public offering price of
$[&#9679;] per share remains the same and after deducting the estimated underwriting discounts and commissions and estimated
expenses payable by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Underwriter&rsquo;s over-allotment option to purchase additional shares and/or warrants from the Company is exercised in full, and
based on the assumed public offering price of $[&#9679;] per share, the pro forma as adjusted net tangible book value per
share after this offering would be $[&#9679;] per share, the increase in as adjusted net tangible book value per share to existing
stockholders would be $[&#9679;] per share and the dilution to new investors purchasing shares in this offering would be
$[&#9679;] per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of common stock outstanding is based on 1,963,322 shares of common stock issued and outstanding as of March 31, 2023, and excludes the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">289,779
    shares of our common stock issuable upon exercise of warrants to purchase shares of Series A Preferred Stock converting to warrants
    to purchase shares of common stock. (See &ldquo;<I>Description of Our Securities&mdash;Warrants</I>&rdquo; for
    more information);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">770,284
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock issuable upon exercise
    of warrants to purchase common stock (see &ldquo;<I>Description of Our Securities&mdash;Warrants</I>&rdquo; for
    more information);</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;] </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of our common stock issuable upon exercise of the Underwriter&rsquo;s Warrants to purchase common stock;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuable upon exercise of warrants issuable
    to Exchange Listing, LLC upon the listing of our common stock on Nasdaq (see &ldquo;<I>Prospectus Summary&mdash;Recent Developments</I>&rdquo;
    for more information); and </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,319,394
    shares of our common stock issuable upon exercise of options to purchase common stock</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated herein, all information in this prospectus assumes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise of the outstanding options or warrants, described above; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise of the Underwriter&rsquo;s option to purchase up to an additional [&#9679;] shares of common stock to cover
    over-allotments, if any, or any warrants issued to the Underwriter as compensation.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="M_004"></A>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>You
should read the following discussion and analysis of our financial condition and results of operations together with our financial statements
and the related notes appearing at the end of this prospectus. Some of the information contained in this discussion and analysis or set
forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business and related financing,
includes forward-looking statements that involve risks, uncertainties, and assumptions. You should read the &ldquo;Certain Note Regarding
Forward-Looking Statements&rdquo; and &ldquo;Risk Factors&rdquo; sections of this prospectus for a discussion of important factors that
could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained
in the following discussion and analysis.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children.
Our mission is to provide solutions that create value and provide better and safer patient outcomes. Our IB-Stim device is a PENFS system
intended to be used in patients 11-18 years of age with functional abdominal pain associated with IBS. Our device already has market
clearance from FDA for functional abdominal pain associated with IBS in children. Other indications in our pipeline are comprised of
functional nausea in children, post-concussion syndrome in children, and cyclic vomiting syndrome in children. For more information,
see &ldquo;<I>Business&mdash;Our Pipeline</I>&rdquo; and <I>&ldquo;&mdash;Products</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have incurred significant operating losses. Our net loss was $2.2 million and $0.5 million for the three
months ended March 31, 2023 and 2022, respectively, and $4.8 million and $3 million for the years ended December
31, 2022, and 2021, respectively. As of March 31, 2023, we had an accumulated deficit of $36.1 million. Our
auditors have expressed substantial doubt about our ability to continue as a going concern paragraph in their audit opinion. We expect
to incur significant expenses and operating losses for the foreseeable future as we continue to pursue widespread insurance coverage
of our IB-Stim device and seek FDA clearance of our device for other indications. There are a number of milestones and conditions that
we must satisfy before we will be able to generate sufficient revenue to fund our operations, including FDA clearance of our IB-Stim
device to treat future indications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Factors
Affecting our Business and Results of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue is derived from the sale of our IB-Stim device to healthcare companies, primarily hospitals and clinics. Sales generally are
not seasonal and only mildly correlated with economic cycles. Our IB-Stim device costs $1,195 per device, and each child being treated
for functional abdominal pain associated with IBS will use three to four devices. Potential patients with future indications are expected
to use six or more devices per patient.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales typically are made on a purchase order basis rather than through long-term purchase commitments. We enter into sales
agreements with customers for IB-Stim devices based on purchase orders and standard terms, which vary slightly based on the
customer&rsquo;s form, and conditions of sale. Standard payment terms generally are that payment is due within 30 to 90 days. Our
largest sales were to three hospitals representing approximately 45% and 56% of total sales for the three months ended March 31,
2023 and 2022, respectively, and to four hospitals representing approximately 58% and 57% of total sales for the years ended
December 31, 2022 and 2021, respectively. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inflation
did not have a material impact on our operations for any applicable period, and we do not expect inflation to have a material impact
on our operations for the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have four categories of expenses: cost of goods sold, selling expenses, research and development (&ldquo;R&amp;D&rdquo;), and general
and administrative (&ldquo;G&amp;A&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
of goods sold consist of costs paid for the IB-Stim device to our contract manufacturer along with periodic inventory adjustments
and expired inventory write-offs. We ramped up production in 2018 and 2019 to meet expected demand and avoid any inventory
shortages. This resulted in some excess inventory that did expire. We had no costs for expired inventory for the three months
ended March 31, 2023 and 2022. The costs of expired inventory were $10k and $48k for the years ended December 31, 2022 and 2021,
respectively, representing 3.4% and 10.4% of our costs of goods sold, respectively. Expired inventory expense is related to our
FDA clearance for our device in the treatment of functional abdominal pain associated with IBS in children. Specifically, a certain
component of our IB-Stim device is cleared for a two-year period after the date the device is manufactured, and if the device is not
sold in such period, we must take the device out of inventory and write it off. We had no expired inventory for the three
months ended March 31, 2023 and 2022. Accordingly, expired inventory has not been material to our results, averaging less
than 1% of revenue over the past four years. We have a fixed-price contract with the manufacturer of our IB-Stim
device to produce the device. We expect production costs to remain relatively constant and only nominal inventory expirations in the
foreseeable future.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
core selling expenses primarily consist of commissions and shipping costs. These expense items are generally correlated with sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R&amp;D
expense is attributable to our clinical trials and related efforts to have our IB-Stim device cleared by the FDA for other indications.
We expect to spend approximately $0.3 million for research and development in 2023 for clinical trials for cyclic vomiting syndrome
in children, and we anticipate that these costs will decrease in 2024 as a majority of the clinical trials will
be completed. </FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G&amp;A
expense consists of payroll and professional fees and is our most significant expense category. Payroll and professional fees account
for approximately 89.6% of our G&amp;A expenses. The balance of the expenses are normal operating expenses for facility expenses,
utilities, travel, etc. We expect G&amp;A expenses to increase during the remainder of 2023 as we transition to operating as a public company, but we expect
G&amp;A expense to stabilize within two years of completion of this offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gross
Profit and Gross Margin</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management uses gross profit and gross margin to evaluate the efficiency of operations and as a key component to determining the effectiveness
and allocation of resources. We calculate gross profit as revenue less cost of goods sold, and gross margin as gross profit divided by
revenue. Our gross margin has been and will continue to be affected by a variety of factors, primarily the average selling price of our
IB-Stim device, production volume, order flows, change in mix of customers, third-party manufacturing costs related to components of
our IB-Stim device, and cost-reduction strategies. We expect our gross profit to increase for the foreseeable future as our revenue grows,
both through broader insurer acceptance of our IB-Stim device in the near term and approval of our technology for the treatment of other
indications over the longer term. Our gross margin may fluctuate from quarter to quarter due to changes in average selling prices, particularly
as we introduce enhancements to our IB-Stim device and new products to address other indications, and as we adopt new manufacturing processes
and technologies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
of Three Months Ended March 31, 2023 and 2022 </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ended March 31,</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    sales</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">805,110</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">770,267</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
    of goods sold</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,900</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75,200</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    profit</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">709,210</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">695,067</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
    expenses</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,932</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">135,880</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,797</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,398</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and administrative</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,480,755</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,028,096</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(896,274</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(513,307</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    income (expense):</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
    charges</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,772</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    expense </FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(161,689</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(26,100</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of warrant liability</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">234,807</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of derivative financial instruments</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">191,297</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of debt discount and issuance cost</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,662,655</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extinguishment
    of derivative liabilities</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,129,498</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Income</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,550</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><P STYLE="margin: 0">Other expense</P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><P STYLE="margin: 0"> (7,172 </P></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"> ) </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> 257 </TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other income (expense)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,277,136</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,833</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,173,410</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(539,140</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Sales</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Net sales increased approximately $35 thousand, or 4.5%, from $770 thousand
for the three months ended March 31, 2022, to $805 thousand for the three months ended March 31, 2023. The increase was primarily due
to ordering patterns of our major customers. We believe net sales will increase as we ramp up our marketing efforts and as our IB-Stim
device is cleared by the FDA for other indications, such as functional nausea, post-concussion syndrome and cyclic vomiting syndrome in
children. For more information, see &ldquo;<I>Business&mdash;Our Pipeline</I>.&rdquo; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Costs
of Goods Sold</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Costs of goods sold increased approximately 27.5% in the three months ended
March 31, 2023, as compared to the three months ended March 31, 2022, mainly because of increased product sales discussed above.
We expect costs of goods sold to remain relatively constant as we grow, primarily due to our current pricing with our contract manufacturer. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gross
Profit</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Gross profit increased
approximately $14 thousand, from $695 thousand for the three months ended March 31, 2022, to $709 thousand for the three months
ended March 31, 2023, representing 88.1% of revenue in the 2023 period and 90.2% of revenue in the 2022 period. The increase was
primarily due to increased sales in 2023. We believe gross profit will continue to grow as sales increase, which, in turn, is tied
to broader insurance coverage. </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gross
Margin</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Gross margin decreased approximately 2.3%, from 88.1% for the three months
ended March 31, 2023, to 90.2% for the three months ended March 31, 2022. The decrease was primarily due to slightly higher cost of sales
due to increased purchases to replenish inventory. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Selling
Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
expenses were down 20.6% in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. This was
primarily due to lower commission costs in 2023. The commission costs were directly attributable to the decrease in commission rate from
15.0% in 2022 to 12.0% in 2023.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Research
and Development</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R&amp;D
expense decreased 62.2% in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, and this decrease
was due to more studies and clinical trials expense in the 2022 period. R&amp;D costs are expected to increase during the remainder of
2023.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
and Administrative</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G&amp;A
expense increased approximately 44.0% in the three months ended March 31, 2023, as compared to the three months ended March 31, 2022.
This increase was due primarily to wages and professional fees related to the initial public offering. We expect G&amp;A expense to
decrease in 2024 primarily because of reduced costs after the offering.&nbsp;</FONT> </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Loss</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating loss increased $383 thousand, or 74.6%, for the three months ended March 31, 2023, as compared to the three months ended March
31, 2022, primarily due to increased wages and professional fees.&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Income (Expense)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense increased $1.3 million for the three months ended March 31, 2023 and was primarily attributable to an increase in interest expense,
financing charges, and amortization of the debt discount. These losses were primarily offset by extinguishment of derivative liability
due to repayment of some of the convertible notes, and favorable changes in the fair value of the derivative and warrant liabilities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: SP_001 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Loss</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Our net loss increased
approximately $1.6 million, or 303.1%, in the three months ended March 31, 2023, as compared to the three months ended March 31,
2022. The change was attributable to the increase in G&amp;A expenses, and the other income (expense) section discussed above. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
of Year Ended December 31, 2022, and Year Ended December 31, 2021</I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> Years Ended December 31, </TD><TD STYLE="font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022 </TD><TD STYLE="font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2021 </TD><TD STYLE="font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2"> &nbsp; </TD><TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; font-weight: bold; text-align: left"> Net sales </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 16%; text-align: right"> 2,684,735 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 16%; text-align: right"> 2,721,286 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Costs of goods sold </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 297,060 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 467,656 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> Gross profit </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2,387,675 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2,253,630 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Selling expenses </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 410,883 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 455,879 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Research and development </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 225,610 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 203,414 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> General and administrative </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 5,123,420 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 4,564,371 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> Operating loss </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> (3,372,238 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> (2,970,034 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> Other income (expense): </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Financing charges </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (2,322,216 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Interest expense </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (318,666 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (36,928 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Change in fair value of warrant liability </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 606,049 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (29,342 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Change in fair value of derivative financial instruments </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 713,989 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Amortization of debt discount and issuance cost </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (98,935 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Other income </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 11,956 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 8,272 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Total other income (expense) </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> (1,407,823 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> (57,998 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"> Net loss </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> (4,780,061 </TD><TD STYLE="font-weight: bold; text-align: left"> ) </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"> (3,028,032 </TD><TD STYLE="font-weight: bold; text-align: left"> ) </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Sales</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
sales remained flat at $2.7 million for the years ended December 31, 2022 and 2021. This was primarily due to the Company&rsquo;s focus
on gaining further insurance coverage for our products, funding, and the initial public offering.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Costs
of Goods Sold</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
of goods sold decreased approximately 36%, in the year ended December 31, 2022, as compared to the year ended December 31, 2021, primarily
due to a reduction in promotional sales orders. In 2021, the Company sold some devices at a discounted price or gave them away to stimulate demand and gain new customers.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gross
Profit</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit increased approximately $0.1 million, from $2.3 million for the year ended December 31, 2021, to $2.4 million for the year ended
December 31, 2022, representing 88.9% of revenue in 2022 and 82.8% of revenue in 2021. The increase was primarily due to the decrease
in cost of goods sold combined with flat sales in 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gross
Margin</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
margin increased approximately 7.4%, from 82.8% for the year ended December 31, 2021, to 88.9% for the year ended December 31, 2022.
The increase was primarily due to the decrease in cost of goods sold combined with flat sales in 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Selling
Expenses</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
expenses were down 9.9% in the year ended December 31, 2022, as compared to the year ended December 31, 2021. This was primarily due
a decrease in commission expense of $47 thousand. This was attributable to a slight decrease in sales and a decrease in the commission rate from 15% to 12% mid-year of 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Research
and Development</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">R&amp;D
expense increased 10.9% in the year ended December 31, 2022, as compared to the year ended December 31, 2021, and this increase was due
to our support and expansion of clinical trials to get our IB-Stim device cleared for other indications. R&amp;D costs represented 8.4%
of net sales and 7.5% of net sales in 2022 and 2021, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General
and Administrative</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expense increased approximately 12.3% in the year ended December 31, 2022, as compared to the year ended December
31, 2021. This was due primarily to increased costs associated with the public offering including investor relations, professional fees,
payroll, insurance, and travel.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Loss</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating loss increased $0.4 million, or 13.5%, for the year ended December 31, 2022, as compared to the year ended December 31, 2021,
primarily due to flat sales and increased general and administrative expenses.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Income (Expense)</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense increased 1.3 million for the year ended December 31, 2022 and was primarily attributable to an increase in interest expense, financing charges, and amortization
of the debt discount. These losses were primarily offset by favorable changes in the fair value of the derivative and warrant liabilities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Loss</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net loss increased approximately $1.8 million, or 57.9%, in the year ended December 31, 2022, as compared to the year ended December
31, 2021. The change was attributable to the increase in G&amp;A, and the other income (expense) section discussed above.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> We had cash on hand of approximately
$45 thousand at March 31, 2023, as compared to cash-on-hand of approximately $86 thousand at March 31, 2022. Working capital for March
31, 2023 was $(8.8) million, as compared to working capital of $(1.5) million at March 31, 2022. The decrease in working capital was
due to liabilities assumed in connection with issuance of the Notes. See &ldquo;&mdash;<I>Recent Development</I>s.&rdquo; </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had cash on hand of approximately $0.3 million at December 31, 2022, as compared to cash-on-hand of approximately
$0.3 million at December 31, 2021. Working capital at December 30, 2022 was $(6.5) million, as compared
to working capital of $(0.9) million at December 31, 2021. The decrease in working capital was due to cash used by operating activities of $2.9 million, and liabilities assumed
in connection with the issuance of convertible notes. See &ldquo;&mdash;<I>Recent Developments</I>.&rdquo; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> We have incurred losses since inception and have
funded our operations primarily with a combination of sales, debt, and the sale of capital stock. As of March 31, 2023, we had an stockholders&rsquo;
deficit of approximately $7.7 million. At March 31, 2023, we had short-term outstanding borrowings of approximately $581 thousand, net
of discounts of $4,481,355. As of March 31, 2023, we had cash of approximately $45 thousand and a working capital deficit of approximately
$8.8 million. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> &nbsp; </P>

<P STYLE="margin: 0pt; text-align: justify"> Our future capital requirements will depend upon many factors, including progress with developing,
manufacturing, and marketing our technologies, the time and costs involved in preparing, filing, prosecuting, maintaining, and enforcing
patent claims and other proprietary rights, our ability to establish collaborative arrangements, marketing activities and competing technological
and market developments, including regulatory changes and overall economic conditions in our target markets. Our ability to generate
revenue and achieve profitability requires us to successfully market and secure purchase orders for our products from customers currently
identified in our sales pipeline and to new customers as well. The primary activity that will drive all customers and revenues is the
adoption of insurance coverage by commercial insurance carriers nationally, so this is a top priority of the Company. These activities,
including our planned research and development efforts, will require significant uses of working capital through the rest of 2023 and
beyond. Based on our current operating plans, we believe that our existing cash at the time of this filing will only be sufficient to
meet our anticipated operating needs through July 2023. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
anticipate our sales over the next 12 months to be approximately $5 million, assuming our expectations with respect to
acceptance by insurance providers are generally correct, and we anticipate our liquidity needs over this period to be approximately $7
million. We expect proceeds from this offering to fund our capital needs for the following 12 months.</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
we will have to meet all the financial disclosure and reporting requirements associated with being a publicly reporting company. Our
management will have to spend additional time on policies and procedures to make sure it is compliant with various regulatory requirements,
especially that of Section 404 of the Sarbanes-Oxley Act. This additional corporate governance time required of management could limit
the amount of time our management has to implement our business plan and may delay our anticipated growth plans. We anticipate over the
next 12 months the cost of being a reporting public company will be approximately $0.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our cash flows from operating, investing, and financing activities for the three months ended March
31, 2023 and 2022: </FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
    Months </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ended March 31,</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT> </TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in operating activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(622,912</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(193,913</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net cash
    used by investing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,608</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash provided by (used in) financing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,284</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41,440</FONT> </TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Activities</I> &ndash; Cash used in operating activities primarily consisted of general and administrative
expense resulting in a net loss for the year. The net loss was partially offset by favorable changes in
accounts payable in the 2023 period, and the net loss was negatively impacted with changes in accounts receivable, inventory, and other current assets. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
Activities</I> &ndash; Net cash provided by investing activities primarily consisted of equipment
additions. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Financing
Activities </I> - Net cash provided by financing activities in the three months ended March 31, 2023, primarily consisted of proceeds
from new convertible debt. Net cash used by financing activities in the three months ended March 31, 2022, primarily consisted of principal
payments on notes payable. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our cash flows from operating, investing, and financing activities for the years ended December 31, 2022 and
2021:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> Years Ended December 31, </TD><TD STYLE="font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2022 </TD><TD STYLE="font-weight: bold"> &nbsp; </TD><TD STYLE="font-weight: bold"> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> 2021 </TD><TD STYLE="font-weight: bold"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right"> &nbsp; </TD><TD> &nbsp; </TD><TD> &nbsp; </TD>
    <TD COLSPAN="2" STYLE="text-align: right"> &nbsp; </TD><TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"> Net cash used in operating activities </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 16%; text-align: right"> (2,298,004 </TD><TD STYLE="width: 1%; text-align: left"> ) </TD><TD STYLE="width: 2%"> &nbsp; </TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 16%; text-align: right"> (2,234,326 </TD><TD STYLE="width: 1%; text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> Net cash used by investing activities </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (61,205 </TD><TD STYLE="text-align: left"> ) </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> (1,390 </TD><TD STYLE="text-align: left"> ) </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> Net cash provided by financing activities </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 2,292,050 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD> &nbsp; </TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 661,099 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Activities</I> &ndash; Cash used in operating activities primarily consisted of general and administrative expense that more than offset
sales, resulting in a net loss for the year. The net loss was partially offset by favorable changes in warrant liabilities and accounts
payable in 2022, and net loss was partially offset by favorable changes in accounts receivable and accounts payable in 2021.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
Activities</I> &ndash; Net cash used in investing activities primarily consisted of equipment additions.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Financing
Activities </I>- Net cash provided by financing activities in 2022 primarily consisted of proceeds from convertible notes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities in 2021 primarily consisted of proceeds from the sale of preferred stock. We also borrowed $250,000
from a third party in December 2021.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 23, 2022, the Company filed a Certificate of Conversion to become a Delaware corporation.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
March through May 2023, we entered into Securities Purchase Agreements (the &ldquo;SPAs&rdquo;) which provide for advances of up to
$6 million in proceeds to us, subject to our satisfaction of certain conditions (&ldquo;2023 Private Placement&rdquo;). Pursuant to
the SPAs, from March through May of 2023, we issued Senior Secured Convertible Promissory Notes (&ldquo;Notes&rdquo;) with an aggregate
principal amount of $4,733,333, which amount included an original issue discount (&ldquo;OID&rdquo;) of $473,333, and underwriter fees
for $338,250, resulting in advance proceeds to us of $3.9 million. The notes automatically convert into Common Stock at IPO on primary
exchange. Conversion Price will be set at a 30% discount to the IPO price or $[&#9679;] per share. As a result, the notes will convert into
[&#9679;] shares of common stock at IPO. In connection with the issuance of the Notes, we also issued five-year warrants exercisable for
an aggregate of [&#9679;] shares of common stock with a strike price at a 25% premium to the Conversion Price or $[&#9679;] per share subject
to anti-dilution, issuable on a pro rata basis at each funding. For more information regarding the warrants issued under the SPAs, see
&ldquo;<I>Description of Our Securities&mdash;Warrants</I>.&rdquo; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes were issued with OID of 10% of the principal amount and bear interest at 12%. The Notes will mature in six (6) months from their
respective issue dates or a successful IPO on primary exchange in the U.S. (whichever comes sooner). If the IPO is not completed or the
Note is not repaid by the maturity date the following will ensue: a) principal amount of the note will be automatically increased by
20%; b) the warrant coverage will be increased to 75%; c) the default interest rate will begin to accrue at 20% per annum until the default
is cured (default interest will be repaid in cash monthly); d) noteholder will be paid 30% of gross revenues in cash on a monthly basis
until the default is cured or the note is repaid in full. Interest accrues on the aggregate principal amount (which includes OID) and
is payable monthly, at the Company&rsquo;s election, in cash or in-kind.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company used $2.65 million of the cash received from the 2023 Private Placement pay the principal portion of some of the
2022 Senior Secured Convertible Promissory Notes from Leonite Fund I, LP, Bigger Capital Fund, LP, and District 2 Capital Fund, LP
reducing the amount due to the original issue discount or an aggregate principal amount of $294,444. This balance will automatically
convert into shares of common stock at the terms described below of the lower of (a) $9.44 per share, or (b) a discount of 30% to
the price per share in any subsequent offering.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 12, 2023, we filed a certificate of amendment to our certificate of incorporation with the Secretary of State of the State of
Delaware and effectuated a reverse stock split of our common stock at a ratio of 1-for-2. All share information in this prospectus,
including historical share information in our financial statements, has been adjusted for this reverse stock split.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
June through November of 2022, we entered into Securities Purchase Agreements (the &ldquo;SPAs&rdquo;) with Leonite Fund I, LP, <FONT STYLE="background-color: white">Emmis
Capital II</FONT>, LLC, Bigger Capital Fund, LP, District 2 Capital Fund, LP, and Exchange Listing, LLC, which provide for advances of
up to $3 million in proceeds to us, subject to our satisfaction of certain conditions. Pursuant to the SPAs, from June through November
of 2022, we issued Senior Secured Convertible Promissory Notes (&ldquo;2022 Senior Secured Convertible Promissory Notes&rdquo;)
with an aggregate principal amount of $3,333,333, which amount included an original issue discount (&ldquo;OID&rdquo;) of $333,333, and
legal fees for $130,000, resulting in advance proceeds to us of $3 million. In connection with the issuance of the 2022 Senior Secured
Convertible Promissory Notes, we also issued five-year warrants exercisable for an aggregate of 353,111 shares of common stock with
an exercise price of the lower of (a) $11.80 and (b) a 12% discount to the price per share in any subsequent offering by the Company,
and we entered into a Pledge and Security Agreement with Leonite Fund I, LP, dated June 3, 2022. Pursuant to the Pledge and Security
Agreement, the Company granted a security interest in all of its assets in favor of Leonite Fund I, LP, in its capacity as collateral
agent for the purchaser parties under the SPAs. For more information regarding the warrants issued under the SPAs, see &ldquo;<I>Description
of Our Securities&mdash;Warrants</I>.&rdquo; </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The 2022 Senior Secured Convertible
Promissory Notes were issued with OID of 10% of the principal amount and bear interest at the greater of (a) the prime rate of interest,
as published by the Wall Street Journal, plus 8.5% per annum, or (b) 12%. The 2022 Senior Secured Convertible Promissory Notes
will mature in twelve (12) months from their respective issue dates. Any amount of principal, interest, other amounts due hereunder or
penalties on the 2022 Senior Secured Convertible Promissory Notes, which is not paid by maturity date, shall bear interest at
the lesser of the rate of twenty four percent (24%) per annum or the maximum legal amount permitted by law, from the due date thereof
until the same is paid in full, including following the entry of a judgment in favor of Noteholder. The 2022 Senior Secured Convertible
Promissory Notes are convertible into shares of common stock at the lower of (a) $9.44 per share, or (b) a discount of 30% to the
price per share in any subsequent offering, subject to adjustment in the event of common stock distribution, stock splits, fundamental
transactions, dilutive issuances or similar events affecting our common stock and the conversion price. Interest accrues on the aggregate
principal amount (which includes OID) and is payable monthly, at the Company&rsquo;s election, in cash or in-kind.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the advance of the consideration under the SPAs, the Company is required to issue to the noteholders a number of shares of common stock,
calculated based on the value of 10% of the principal amount of the Notes issued in such advance, at a value per share equal to the conversion
price of the 2022 Senior Secured Convertible Promissory Notes at the date of such advance (the &ldquo;Commitment Shares&rdquo;).
Accordingly, in connection with the initial advance and issuance of 2022 Senior Secured Convertible Promissory Notes, assuming
a conversion price of $9.44 per share, we will be issuing 35,317 Commitment Shares to the Noteholders.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Senior Secured Convertible Promissory Notes have certain restrictions on the Company&rsquo;s issuance of securities, including,
among other restrictions, (i) the Company shall not without the Noteholder&rsquo;s written consent (a) pay, declare or set apart for
such payment, any dividend or other distribution (whether in cash, property or other securities) on the common stock of the Company other
than dividends on common stock solely in the form of additional common stock, or (b) directly or indirectly or through any subsidiary
make any other payment or distribution in respect of common stock or equivalents, (ii) unless approved by the Noteholders in writing,
the Company shall not enter into an agreement or amend an existing agreement to effect any sale of securities involving, or convert any
securities previously issued under, a variable rate transaction, which means a transaction in which the Company (A) issues or sells any
convertible securities either (x) at a conversion, exercise or exchange rate or other price that is based upon and/or varies with the
trading prices of, or quotations for, the common stock, or (y) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such convertible securities or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company, or the market for the common stock, or (B) enters into any agreement
whereby the Company may sell securities at a future determined price (other than standard and customary &ldquo;preemptive&rdquo; or &ldquo;participation&rdquo;
rights), (iii) the Noteholders have the right, but not the obligation, to participate in the purchase of the securities being offered
up to an amount equal to thirty percent (30%) of the principal amount of 2022 Senior Secured Convertible Promissory Notes (the
&ldquo; Participation Right&rdquo;) when the Company or its subsidiary proposes to offer and sell its securities, whether in the form
of debt, equity financing, or any other financing transaction (each a &ldquo;Future Offering&rdquo;); provided that, the Participation
Right shall not exceed the lesser of (i) one-third of the aggregate amount of the Future Offering, and (ii) an amount equal to the principal
amount (allocated to the Noteholder&rsquo;s pro-rata to their portion of the principal amount), and (iv) if the Company has a bona fide
offer of capital or financing from any third party that the Company intends to act upon, other than an underwritten initial public offering
of the Company&rsquo;s common shares, then the Company must first offer such opportunity to the Noteholders to provide such capital or
financing to the Company on the same terms. The 2022 Senior Secured Convertible Promissory Notes holders waived their Participation
Right to participate in the December 2022 and January 2023 convertible note issuances described below.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to pay to the Noteholders any outstanding principal amount of 2022 Senior Secured Convertible Promissory Notes, all
accrued and unpaid interest, and fees and penalties, if any, from any future financing proceeds (which includes proceeds to us from this
offering) and other future receipts, at the Noteholder&rsquo;s discretion, except for the right of the Company to make bona fide payments
to vendors with common stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"> The
Company used $2.65 million of the cash received from the 2023 Private Placement to pay the principal portion of some of the
2022 Senior Secured Convertible Promissory Notes from Leonite Fund I, LP, Bigger Capital Fund, LP, and District 2 Capital Fund, LP
reducing the amount due to the original issue discount or an aggregate principal amount of $294,444. This balance will automatically
convert into shares of common stock at the terms described below of the lower of (a) $9.44 per share, or (b) a discount of 30% to
the price per share in any subsequent offering. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
December 2022 through January 2023, the Company issued unsecured convertible promissory notes to three existing investors, Todd Maxwell,
Rogan O&rsquo;Donnell and Michael &amp; Michele Robuck, with an aggregate principal amount of $222,222, which amount included an OID
of $22,222, resulting in advance proceeds to us of $200,000. The notes carry an OID of 10% of the principal amount and have an interest
rate of 12% per annum. The notes will mature at the earlier of (i) twelve (12) months from the issue date or (ii) the date upon which
the Company completes a registered public offering of shares of the Company, which encompasses the closing of this offering. The notes
are convertible into shares of common stock at the higher of (i) $9.44 per share, or (ii) the price per share of common stock
issued pursuant to the next registered public offering of shares of the Company made prior to the conversion of any portion of the note.
Interest accrues on the aggregate principal amount (which includes OID) and is payable on the maturity date, at the Company&rsquo;s election,
in cash or in-kind. The holders of the notes are entitled to piggyback registration rights on any registration statement filed by the
Company, other than the registration statement of which this prospectus forms a part and any registration filed on Form S-4 or Form S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a party to three advisory agreements with Exchange Listing, LLC, a consultant engaged in connection with listing our common stock
for trading on Nasdaq. Pursuant to the first advisory agreement with Exchange Listing, dated March 3, 2022, and amended February 10,
2023, we have agreed to pay Exchange Listing a monthly consulting fee of $5,000 and a final payment of $50,000 upon a successful Nasdaq
listing, and, also upon such listing, to issue Exchange Listing 125,000 shares of our common stock and to issue Exchange Listing five-year
warrants to purchase [&#9679;]  shares of our common stock (representing 2.0% of our outstanding shares after giving effect to this
offering on a fully-diluted basis, as presented in the pro forma as adjusted column under &ldquo;Capitalization&rdquo;) with an exercise
price of $[&#9679;] per share (representing the assumed public offering price set forth on the cover page of this prospectus).
Pursuant to the second advisory agreement with Exchange Listing, dated June 20, 2022, and amended December 20, 2022, and amended February
10, 2023, we have agreed to pay Exchange Listing fees in the aggregate of up to $136,166 for advice in connection with communication
and other related matters leading up to this offering. Pursuant to the third advisory agreement with Exchange Listing, dated February
10, 2023, we have agreed to issue Exchange Listing 125,000 shares of our common stock as pre-payment for future services. We have agreed
to piggyback registration rights with respect to the shares issuable upon exercise of the warrants.</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quantitative
and Qualitative Disclosures About Market Risk</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not utilized any derivative financial instruments such as futures contracts, options and swaps, forward foreign exchange contracts
or interest rate swaps and futures. We believe that adequate controls are in place to monitor any hedging activities. We do not intend
to hedge any existing or future borrowings and, consequently, we do not expect to be affected by changes in market interest rates. We
do not currently have any sales or own assets and operate facilities in countries outside the United States and, consequently, we are
not affected by foreign currency fluctuations or exchange rate changes. Overall, we believe that our exposure to interest rate risk and
foreign currency exchange rate changes is not material to our financial condition or results of operations.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have any off-balance sheet arrangements.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Policies</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
prepare our financial statements in conformity with accounting principles generally accepted in the United States (&ldquo;U.S. GAAP&rdquo;),
which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent
assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the financial
reporting period. We continually evaluate these estimates and assumptions based on the most recently available information, our own historical
experience and on various other assumptions that we believe to be reasonable under the circumstances. Since the use of estimates is an
integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies
require higher degrees of judgment than others in their application. We consider the policies discussed below to be critical to an understanding
of our financial statements.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC defines critical accounting policies as those that are, in management&rsquo;s view, most important to the portrayal of our financial
condition and results of operations and those that require significant judgments and estimates.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting principles we utilized in preparing our financial statements conform in all material respects to U.S GAAP.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inventories</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are valued at the lower of cost or net realizable value. Our inventory is comprised of finished medical devices on hand. Certain components
within the devices have an expiration date and are removed from current inventory and expensed at the date of expiration.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Leases</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
account for our leases under Accounting Standards Update No. 2016-02, <I>Leases</I>. We do not record an operating lease right of use
(&ldquo;ROU&rdquo;) asset and corresponding lease liability for leases with an expected term of 12 months or less and recognize lease
expense for these leases as incurred over the lease term. Operating lease ROU assets and operating lease liabilities for leases with
an expected term of more than 12 months are recognized based on the present value of lease payments over the lease term. For lease present
value calculations, absent a rate implicit in the lease, we determine a comparable incremental borrowing rate. The present value is then
recognized as lease expense on a straight-line basis over the lease term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Derivative
Financial Instruments</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
evaluate our financial instruments and other contracts to determine if those contracts or embedded components of those contracts qualify
as derivatives to be separately accounted for in accordance with Accounting Standards Codification 815, <I>Derivatives and Hedging </I>(&ldquo;ASC
815&rdquo;). The result of this accounting treatment is that the fair value of the derivative is re-measured at each balance sheet date
and recorded as a liability or asset and the change in fair value is recorded in the statements of operations and comprehensive loss.
As of December 31, 2020, our derivative financial instruments were comprised of warrants issued in connection with capital raising transactions.
Upon settlement of a derivative financial instrument, the instrument is re-measured at the settlement date and the fair value of the
underlying instrument is reclassified to equity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative financial instruments, including whether such instruments should be recorded as liabilities/assets or as
equity, is reassessed at the end of each reporting period. Derivative financial instruments that become subject to reclassification are
reclassified at the fair value of the instrument on the reclassification date. Derivative financial instruments will be classified in
the balance sheet as current if the right to exercise or settle the derivative financial instrument lies with the holder.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue
Recognition</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
is recognized in one major product segment &ndash; commercial products. The timing of revenue recognition for this product segment occurs
as goods are transferred at a point in time.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate credit losses on accounts receivable by estimating expected credit losses over the contractual term of the receivable using
a discounted cash flow method. When developing this estimate of expected credit losses, we consider all available information (past,
current, and future) relevant to assessing the collectability of cash flows. The Company has concluded that realization losses on balances
outstanding at year-end will be immaterial.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Accounting Pronouncements</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There are several recently issued accounting pronouncements that have been reviewed and adopted. The pronouncements regarding leases had a material impact on our financial statements. There are no other recently issued accounting pronouncements that we have not yet adopted that we believe are applicable or would have a material impact on our financial statements. For more information regarding recent accounting pronouncements, refer to Note 1 to our audited financial statements contained elsewhere in this prospectus. </FONT> </P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an emerging growth company, and under the JOBS Act, an emerging growth company can delay the adoption of certain accounting standards
until those standards would otherwise apply to private companies. We have elected not to take advantage of the extended transition period
for complying with new or revised accounting standards provided to emerging growth companies under the JOBS Act.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="M_005"></A>BUSINESS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children.
We are dedicated to advancing science with our proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology,
which was developed internally by the Company. We believe that superior science and evidence-based research, are necessary
for adoption by the medical and scientific community. With one FDA indication (functional abdominal pain associated with IBS in adolescents
11-18 years old) on the market, additional clinical trials of PENFS in multiple pediatric conditions are underway focused
on unmet healthcare needs in children, see &ldquo;&mdash;<I>Our Pipeline</I>&rdquo; for more information.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
first product, IB-Stim, is a PENFS system intended to be used in patients 11-18 years of age with functional abdominal pain associated
with IBS. IB-Stim is a US FDA Class II medical device that has received one regulatory clearance: IB-Stim (DEN180057, 2019), under the regulation
name of &ldquo;non-implanted nerve stimulator for functional abdominal pain relief.&rdquo;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Mission</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to provide solutions that create value and provide better and safer patient outcomes. We believe in improving lives and minimizing
suffering; particularly in the pediatric population, where research and therapeutics are usually lacking. The Company already has market
clearance for its IB-Stim &reg; that targets functional abdominal pain associated with IBS, in children, with a total addressable
market of up to 6 million children. Through innovation and research, we are reimagining the future of patient care.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Corporate History</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc.  was established in 2011 and incorporated
in the state of Indiana on April 17, 2012, under the name of Innovative Health Solutions, Inc. The name was changed to Neuraxis, Inc.
in March of 2022. Additionally, the Company filed a Certificate of Conversion to become a Delaware corporation on June 23, 2022. The
authorized shares were increased, and a par value established. On September 7, 2021, the Company&rsquo;s board of directors authorized
a 4-for-1 stock split. They also increased the number of authorized common stock shares from 2,700,000 to 10,800,000. Furthermore, on
September 9, 2021, the board authorized and increase of authorized shares of common stock from 10,800,000 to 13,400,000 in anticipation
of a capital offering.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As part of the conversion
to a Delaware corporation, the total number of shares of all classes of stock which the Corporation shall have authority to issue is
101,120,000 share, consisting of (1) 100,000,000 shares of common stock, par value $0.001 per share, and (ii) 1,120,000 shares of Preferred Stock, par value $0.001 per share (&ldquo;Preferred Stock&rdquo;), 1,000,000 of which is designated
as &ldquo;Series A Preferred Stock&rdquo; and 120,000 of which is designated as &ldquo;Series Seed Preferred Stock&rdquo;.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Furthermore, on January
10, 2023, the Company&rsquo;s board of directors authorized a 1-for-2 reverse stock split. All per share information has been adjusted
for this reverse stock split. The reverse split became effective on January 12, 2023.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed three FDA cleared products, the IB-Stim (DEN180057, 2019), the NSS-2 Bridge (DEN170018, 2017), and the original 510(K)
clearance (K140530, 2014), all of which were developed internally by the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    IB-Stim is a PENFS device that is indicated in patients 11-18 years of age with functional abdominal pain associated with irritable
    bowel syndrome. The IB-Stim currently is the only product marketed and sold by the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NSS-2 Bridge is a percutaneous nerve field stimulator, or PNFS, device indicated for use in the reduction of the symptoms of opioid
    withdrawal. The NSS-2 Bridge device was licensed to Masimo in April 2020, and we received a one-time licensing fee of $250,000 from
    Masimo. Masimo markets and sells this product as its <I>Masimo Bridge</I>, and we will not receive any further licensing payments
    or other revenue from this product.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    original 510(K) device was the electroacupuncture device (&ldquo;EAD&rdquo;), now called <I>NeuroStim</I>. The EAD is no longer being
    manufactured, sold or distributed but reserved only for research purposes.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pediatrics
Industry Overview</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pediatric
providers, as a whole, had expressed concern about the lack of attention given to children with functional abdominal pain disorders (including
IBS) and the limited treatment options available for a population that suffers from significant disabilities. With 20% of the
United States population under age 18, our Company focus is on opportunities in pediatrics industry. The pediatrics industry
has multi-billion-dollar market opportunities. The following points clearly outline the unmet need in children:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Functional
    abdominal pain in children is one of the most common conditions seen by pediatricians and pediatric gastroenterologists.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Children
    with functional abdominal pain report lower quality of life compared with their healthy peers and equal to those with inflammatory
    bowel disease.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
    35-45% of children with functional abdominal pain disorders continue to have symptoms into adulthood, which impacts quality of life
    and healthcare spending.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    study published in 2021 demonstrates insufficient evidence for the use of medications in pediatric functional abdominal pain disorders.
    This lack of evidence for drugs has been supported in by the American Academy of Pediatrics and NASPGHAN.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IB-Stim
    is the only therapy that has shown to improve pain, global symptoms, and functional disability in children with FAP and IBS.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IB-Stim
    is the only currently used therapy that is better than placebo in a randomized controlled trial and received FDA clearance for pediatric
    IBS.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Opportunity</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
years, physicians and qualified healthcare professionals have resorted to the use of off-label medications without proper evidence
of efficacy or safety. This is despite a technical report from the American Academy of Pediatrics and NASPGHAN which found very little
evidence to endorse the use of any drugs in the treatment of FAPDs in children. Medications including tricyclic antidepressants, SSRIs
and gabapentinoids continue to be used off-label despite lack of evidence to support efficacy or safety. Not only have the most commonly
used medications (amitriptyline and SSRIs) failed to beat placebo in clinical trials, but new studies also suggest significant risks
with the potential for serious side effects with these drugs. The absence of conclusive data to support treatments based on scientific
evidence, and the fact no drug therapies have been approved by the FDA for the treatment of FAPDs or IBS in children, presents a unique
market opportunity  for Neuraxis. Below are the current standard treatments in children with functional abdominal pain and IBS.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_005.jpg" ALT=""></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Solutions</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into the pediatric market with clinical evidence, coverage and payment, and key opinion leaders and society endorsement, including
a signed letter from the American Academy of Pediatrics and NASPGHAN supporting our request for insurers to pay for our IB-Stim device.
Our IB-Stim&reg; is a non-drug alternative to reduce functional abdominal pain in patients with IBS. In June 2019, the FDA cleared IB-Stim,
a non-surgical, neuromodulation device for children and adolescents who suffer from IBS, through a de novo process (DEN180057, 2019).
The FDA created a new classification of PENFS for the IB-Stim device. This is based on pre-clinical and clinical studies demonstrating
the mechanism of action and efficacy. Based on this new class of devices, the IB-Stim falls under 21 CFR Part 876, Subpart F &ndash;
Therapeutic Devices, 876.5340, Product Code QHH. As a PENFS device, it is non-implantable and provides field stimulation to cranial nerves
V, VII, IX and X in the ear to access the CNS. It stimulates remotely from the source of pain to modulate central pain regions, such
as the limbic system, and relieve functional abdominal pain associated with IBS. Studies have demonstrated long-term benefits in functional
disability, psychological co-morbidities and pain. For example, the table below is from a recently published study of IB-Stim in a population
of patients with chronic functional abdominal pain. The follow-up was done at 6-12 months post-treatment and shows improvements in validated
questionnaires compared to baseline (API), functional disability index (FDI), pain catastrophizing scale (PCS), Screen for Childhood
Anxiety Related Disorders (SCARED) and the Promis Anxiety.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santucci
NR, King C, El-Chammas KI, Wongteerasut A, Damrongmanee A, Graham K, Fei L, Sahay R, Jones C, Cunningham NR, Coghill RC. <I>Effect of
percutaneous electrical nerve field stimulation on mechanosensitivity, sleep, and psychological comorbidities in adolescents with functional
abdominal pain disorders.</I> Neurogastroenterol Motil. 2022;34:e14358.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="forms-1a_021.jpg" ALT="" STYLE="height: 307px; width: 625px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have only submitted one FDA De Novo request and have not submitted any additional 510(k) premarket notifications for our pipeline indications
to date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
with treatment so far has been outstanding with the four weeks of therapy required to sustain long-term benefits. Compliance has been
an issue with non-pharmacological treatment for children, particularly with some of the psychological approaches such as cognitive behavioral
therapy or guided imagery, which sometimes requires 8-12 weeks of treatment. In fact, 95% of adolescents who used IB-Stim said that they
would recommend this treatment to family and friends. Many children&rsquo;s hospitals across the country are already treating children
with IB-Stim successfully since it provides a better alternative for therapy in children with IBS and disability and allows them to treat
them safely and effectively.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have concentrated our marketing focus on the 260 children&rsquo;s hospitals. To date, we have sold our IB-Stim product to approximately
57 children&rsquo;s hospitals within our target market including 9 new accounts in Q1 2023. Additionally, we have sold into
28 different states. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="forms-1a_014.jpg" ALT="" STYLE="height: 261px; width: 625px"></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> In the next 12 months, we intend to use artificial intelligence (machine learning) to analyze large datasets as an
input to identify patterns of interaction among variables, allowing for the diagnosis of Functional Abdominal Pain Disorders in the primary
care setting using symptom-based criteria. We believe that automated diagnosis with electronic medical record (EMR) integration will be
the new standard of care for conditions like FAPDs in the next 3 years. The current barrier for primary care pediatric providers to treating
children with FAPD is the lack of confidence in making the &ldquo;symptoms-based diagnosis&rdquo;. Through AI (machine learning), it will
be possible to not only make a diagnosis of FAPDs based on clinical history but also to predict response to treatment. AI will allow the
collection of complex and nuanced clinical data from the EMR and select patients with a higher likelihood of response to neuromodulation
with IB-Stim. Automated diagnosis through AI would obviate the need for referral to pediatric subspecialists for those children predicted
to have a FAPD. Making the diagnosis of FAPD in the general pediatrician&rsquo;s offices and predicting response to treatment with IB-Stim
will improve health outcomes. help decrease healthcare costs, and bring access and treatment to exponentially more patients. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
competitive landscape for therapies includes off-label drugs and drugs with FDA approved only for adults with IBS while there is no FDA
indicated treatments for patients 11-18 years of age with functional abdominal pain associated with IBS and prescriptions often contain FDA
black box labels. It also includes devices that could theoretically be used, but do not have supporting data or FDA clearance for functional
bowel disorders or IBS. Our method patents also limit other devices from targeting IBS through stimulation of cranial nerve branches
in the ear.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="forms-1a_025.jpg" ALT=""></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Approved
drugs for Adults with IBS</U></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rifaximin:
    an intraluminal antibiotic approved for IBS-diarrhea</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amitiza:
    a drug that stimulates fluid secretion from the intestine, approved for IBS-diarrhea</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linzess<B>:
    </B>a drug that stimulates fluid secretion from the intestine, approved for IBS-constipation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plecanatide:
    a drug that stimulates fluid secretion from the intestine, approved IBS-constipation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eluxadoline:
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a schedule IV-controlled substance that is a
    mixed opioid receptor agonist/antagonist in the intestine approved for IBS-diarrhea</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Devices</U></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gammaCore:
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a transcutaneous, cervical vagal nerve stimulator
    cleared for cluster and migraine headaches. Recent studies using this device for adults with gastroparesis.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transcranial
    Magnetic Stimulation: Multiple devices cleared to treat major depressive disorder and obsessive-compulsive disorder. To date,
    no known gastrointestinal indications.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roo
    System and Sparrow therapy system: Transcutaneous auricular stimulation devices-cleared for neonatal and adult opioid withdrawal.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
neurostimulation market is predominantly comprised of surgically implanted, invasive technologies that are not directly competitive
with our technology. Several neurostimulation companies are large, publicly traded companies that have a history in the market, have
significantly easier access to capital and other resources and have an established product pipeline. The combined clinical research
and product development done by the industry, including by us and all of our competitors, is uncovering the beneficial effects of
neurostimulation which now establishes neuromodulation as a valid and scientifically supported approach to the treatment of
neurological conditions, and accordingly, we expect for competition in the non-implanted space to grow in the future.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
many companies have joined the neuromodulation space, there are no companies targeting the CNS or the brain-gut axis through auricular
nerves for functional bowel disorders or IBS. Currently, the Neuraxis method patents protect access to the brain, particularly the limbic
systems through branches of cranial nerves in the ear.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Competitive Strengths</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that the following competitive strengths will enable us to compete effectively:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    to market</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    portfolio of device and method patents</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    Market Opportunities</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    pediatric pipeline </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Academic
    Society Support</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lower
    capital expenditures in nurse, trainers, and representatives for first line therapy</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    clinical data carried out in leading academic institutions in the U.S.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Growth Strategies</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List
    price of our product is $1,195 per device and $4,780 per patient </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strong
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">gross margin</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct
    sales force</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Target
    customers are children&rsquo;s hospitals and pediatric clinics</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Pipeline</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IB-Stim device is to be used for the indication</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
of functional abdominal pain associated with IBS and functional nausea in children. The same underlying technology will be
used for the remaining pipeline indications, but we may use a name other than &ldquo;IB-Stim&rdquo; for marketing and commercialization
purposes.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
one FDA indication&mdash;functional abdominal pain associated with IBS in adolescents 11-18 years old&mdash;on the market, additional
clinical trials of PENFS in multiple pediatric conditions are underway focused on unmet healthcare needs in children. These indications
consist of chronic nausea, post-concussion syndrome, chemotherapy-induced nausea and vomiting, cyclic vomiting syndrome.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chart below shows our status in the FDA review process for IB-Stim and each of the following pediatric indications:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <I>Chronic
nausea: </I> RCT completed, and data being analyzed. ClinicalTrials.gov Identifier: NCT03675321, <I>Defining Adolescent Nausea
Through Brain-Gut Physiology and Non-Invasive Neurostimulation Response.</I> A randomized, double blind, placebo-controlled trial to
evaluate the efficacy of IB-Stim in children with functional nausea. The primary endpoint was to measure improvements in nausea
using the Nausea Severity Scale after IB-Stim therapy compared to a placebo device. The study enrolled 110 participants and was
conducted at Children&rsquo;s Wisconsin/Medical College of Wisconsin.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <I>Post-concussion
syndrome:</I> RCT currently enrolling patients. ClinicalTrials.gov Identifier: NCT04978571, <I>A Prospective Study on the Effect
of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients with Post-Concussion Syndrome (PCS). </I>A
randomized, double blind, placebo-controlled trial to evaluate the efficacy of IB-Stim in children with post-concussion symptoms.
The primary endpoint will be to measure improvements in validated measures, including the Immediate Post-Concussion Assessment,
Post-Concussion Symptom Scale, and Balance Error Scoring Symptom compared to placebo. The study will enroll 100 participants and is
being conducted at Children&rsquo;s Hospital of Orange County.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <I>Chemotherapy-induced
nausea and vomiting:</I> RCT currently enrolling patients. ClinicalTrials.gov Identifier: NCT05143554, <I>Efficacy of Auricular
Neurostimulation for Children Adolescents and Young Adults with Chemotherapy Induced Nausea and Vomiting.</I> Subject will be
randomized to five days of active vs placebo device during administered chemotherapy known to cause moderate to severe
nausea/vomiting. With the next scheduled identical chemotherapy cycle, each subject will cross over to the other device (active vs
placebo). The primary endpoint will be to measure improvements in validated measures of nausea and vomiting including the Baxter
Retching Faces Scale, Rhodes Index of Nausea, Vomiting and Retching, and also assessment of rescue medication. The study will enroll
50 participants and is being conducted at Children&rsquo;s Wisconsin/Medical College of Wisconsin.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<I>Cyclic vomiting syndrome:</I> Pilot study completed, see ClinicalTrials.gov Identifier: NCT03434652. <I>Auricular Neurostimulation
for Children with Cyclic Vomiting Syndrome: A randomized, placebo-controlled trial.</I> RCT anticipated to begin enrolling patients in
the second half of 2023. This will be a multi-center, randomized, double blind, placebo-controlled trial to evaluate efficacy
of IB-Stim in pediatric patients with cyclic vomiting syndrome. The primary endpoint will be to measure decreases in the frequency and
severity of cyclic vomiting episodes compared to a placebo device. The study will include a minimum of 120 patients and the 3 sites are
yet to be finalized.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
step in the FDA review process differs in duration and cannot be predicted with accuracy. Timing of FDA review and approval, if ever
received, cannot be assured and the process and any approval is within the sole control and discretion of the FDA.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="forms-1a_002.jpg" ALT="" STYLE="height: 351px; width: 624px"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Products</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IB-Stim is a percutaneous PENFS system intended to be used in patients 11-18 years of age with functional
abdominal pain associated with IBS. IB-Stim already has market clearance from FDA for functional abdominal pain associated with IBS in
children. FDA has classified the non-implanted nerve stimulator for functional abdominal pain relief as Class II devices.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IB-Stim is intended to be used for 120 hours per week for three (3) consecutive weeks, and not to exceed four (4) weeks, through application
to branches of Cranial Nerves V, VII, IX and X, and the occipital nerves identified by transillumination, as an aid in the reduction
of pain when combined with other therapies for IBS (DEN180057, 2019). In published studies, patients treated with IB-Stim demonstrated
significant improvement in pain, disability and global symptoms with no serious adverse events, and minimal to no side effects, including
localized skin irritation. See <I>Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a
randomized, double-blind, sham-controlled trial</I>, Kovacic K, et.al., Lancet Gastroenterol Hepatol. 2017;2:727-737; <I>Efficacy of
Auricular Neurostimulation in Adolescents With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial</I>, Krasaelap A et.al.,
Clin Gastroenterol Hepatol. 2020;18:1987-1994; <I>Effect of percutaneous electrical nerve field stimulation on mechanosensitivity, sleep,
and psychological comorbidities in adolescents with functional abdominal pain disorders</I>, Santucci et.al., Neurogastroenterol Motil.
2022;34:e14358.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the IB-Stim to produce systemic effects by modulating the central nervous system has been demonstrated in a pre-clinical animal
model of IBS (see Business&mdash;<I>Pre-Clinical Data</I>). In patients with IBS, the largest effect on all pain measures, including
composite pain scores, worst pain, disability and global symptoms, was seen after completing three consecutive weeks of treatment (see
Business&mdash;<I>Clinical Data</I>). A fourth consecutive week of treatment was included in clinical testing; no safety concerns
were identified with this extra consecutive week of treatment. In the trial of 115 subjects, 10 patients reported side-effects and only
three discontinued the study because of side-effects. Of such 10 patients, six experienced ear discomfort (three in the PENFS group,
three in the sham group), three experienced adhesive allergies (one in the PENFS group, 2 in the sham group), and one experienced
syncope due to needle phobia (in the sham group). There were no serious adverse events.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
providers are trained to place the IB-Stim through IB-Stim Training and Certification. Once the provider is trained, the device can be
placed in the outpatient clinic and can be removed by the provider in the clinic or the patient at home. IB-Stim stays on for a total
of five-days to allow delivery of gentle electrical pulses to nerves below the skin that access the central nervous system. A study in
adolescents showed greater improvement in functional abdominal pain and global symptom improvement with every week of treatment (up to
four weeks). At the end of the four-week study, 95% of adolescents stated they would recommend the treatment to family or friends. Safety
of percutaneous electrical nerve field stimulation has also been reported in a separate study of over 1200 adult patients with no serious
adverse events and minimal to no side-effects.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
wearing our IB-Stim device and following an easy-to-learn and efficient procedure, patients can still attend school and extracurricular
activities, exercise or play non-contact sports, shower, wear ear buds or headphones, and travel.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
IB-Stim device costs $1,195 per device, and each patient will use four (4) devices. Potential patients with other indications are expected
to use six (6) or more devices per patient.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Technology</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
maladaptive central nervous system can process pain and emotions differently. This often occurs in children following a traumatic event,
viral infections, inflammation or trauma. Changes in brain pathways are known to be involved in the pathophysiology of functional bowel
disorders and IBS. The IB-Stim works by sending gentle electrical impulses into cranial nerve bundles located in the ear. This stimulation
targets brain areas that process pain and helps reduce functional abdominal pain associated with IBS. An animal model of IBS demonstrated
that the firing of neurons in the amygdala could be reduced by more than 50% in just 15 minutes of stimulation with the IB-Stim
technology. A recent human study in adults with pain related to fibromyalgia suggested that the IB-Stim technology exerts its effect
by modulating emotional and executive control centers related to pain processing, see <I>Feasibility of Auricular Field Stimulation
in Fibromyalgia: Evaluation by Functional Magnetic Resonance Imaging, Randomized Trial</I>, Woodbury et.al.<I>,</I> Pain Med. 2021;22:715-726.
The field of art pertains to an electrical stimulation device, including a stimulator containing a generator to deliver electrical
pulses with defined parameters, and a power supply for supplying the electrical energy through four separate needles, and at least one
of which is a needle array.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="forms-1a_008.jpg" ALT="" STYLE="height: 476px; width: 550px"></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-Clinical
</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Data</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
an animal model of IBS, extracellular, electrophysiologic recordings were performed from neurons in the rat amygdala before and 15 minutes
after PENFS treatment. There was a 65% decrease in the spontaneous firing of these neurons after 15 minutes of PENFS.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
This dampening of neurons in the CNS likely accounts for the modulation of pain responses in a model of post-inflammatory visceral and
somatic hyperalgesia.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_015.jpg" ALT="" STYLE="height: 258px; width: 150px"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Clinical
Data</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
goal is to have over 700 published patients specific to our first FDA indication which is functional abdominal pain associated with irritable
bowel syndrome in patients 11-18 years of age by July 1, 2023. A published patient is defined as a patient who went through a study and
the study was analyzed and now the study has been published in a peer-reviewed journal.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
randomized, controlled study in children 11-18 year of age used primary endpoint of improvements in abdominal pain. The Pain Frequency-Severity-Duration
(&ldquo;PFSD&rdquo;) questionnaires was completed at baseline by all subjects and after each week of treatment (weeks 1&ndash;3), as
well as at extended follow-up occurring in the 8&ndash;12 weeks following the end of treatment. The PFSD scale incorporates multiple
aspects of the pain experience and was administered weekly during treatment and at extended follow-up appointments. The PFSD scale validated
for chronic pain in children (aged 8&ndash;18 years). The PFSD was also used to rate weekly worst abdominal pain on a numerical rating
scale (0 for no pain, 10 for worst pain). Patients were followed up for a median of 9.2 weeks from the last week of treatment.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the active PENFS group, median worst pain at follow-up remained lower (baseline: 8.0 vs. follow-up: 6.0), whereas there was no difference
at follow-up in the control group (baseline: 7.5 vs. follow-up: 7.0). The between-group differences in worst pain ratings after 3 weeks
of treatment showed that the PENFS group improved to a greater extent, with the control group reporting significantly higher worst pain
(median 7.0) than the PENFS group (median 5.0).</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
long-term follow-up, median PFSD composite scores were 12.6 (IQR 3.6&ndash;22.5) in the PENFS group and 16.8 (4.8&ndash;33.6) in the
control group. A comparison of changes in PFSD composite scores (baseline to follow-up) showed that patients in the PENFS group reported
significantly greater improvement in pain (median &ndash;8.4) than those in the control group (median 0.0). This study was published
in the Lancet Gastroenterology Hepatology, (Kovacic K, et.al. Lancet Gastroenterol Hepatol. 2017;2:727-737).</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><IMG SRC="forms-1a_010.jpg" ALT=""></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
secondary endpoint in the same study used the</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> functional
disability index (FDI) to assess functional disability in those treated with PENFS and compared to sham treatment. Those treated with
PENFS changed from moderate disability to minimal at the 2&ndash;3-month follow-up while the sham device group had
no change.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="forms-1a_016.jpg" ALT=""></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">A separate published paper looked at 51
pediatric patients with IBS and used the symptoms response scale (SRS) to assess global symptoms improvement following PENFS
treatment compared to sham. Global symptom improvement was assessed with a validated pediatric questionnaire, Symptom Response Scale
(SRS). Symptoms were recorded as better, worse, or no change based on a 15-point scale across individual domains for both
improvement and deterioration of overall symptoms. Findings from several studies that used the SRS have shown that using 7-point
scale response options in disease-specific measures, a change score of 0.5 represents the minimal clinically important difference
(Juniper et.al. J Clin Epidemiol 1994; 47: 81&ndash;87 and Guyatt GH et.al.1987; 42: 773&ndash;78). As previously noted, a minimum
change in score of &ge; 2 was chosen for this study as a more stringent criterion for
global improvement before and after PENFS treatment and to compare between groups. Patients and providers were blinded in terms of
those who received active PENFS or sham. At the end 3 weeks of therapy using the change of &ge; 2,
81% of the PENFS group compared with 26% of the sham group (*p&le; 0.001, #p=0.002)
reported overall symptom improvement. When applying an even more stringent criteria with a change &ge; 3
on the SRS, 67% of the PENFS group compared with 22% of the sham group reported symptoms improvement (p=0.002) (Krasaelap A et.al.
Efficacy of Auricular Neurostimulation in Adolescents With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial. Clin
Gastroenterol Hepatol. 2020;18:1987-1994).</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_017.jpg" ALT="" STYLE="height: 215px; width: 200px"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
more recent open-label study of 20 patients treated with PENFS in a &ldquo;real-world&rdquo; clinical setting at Cincinnati Children&rsquo;s
Hospital demonstrated that after PENFS, abdominal pain (p &lt; 0.0001), nausea (p=0.001), pain catastrophizing (p = 0.001), functional
disability (p&lt;0.0001), and anxiety (p = 0.03) exhibited significant improvements, and were sustained 6-12 months after treatment (Santucci
et.al. Effect of percutaneous electrical nerve field stimulation on mechanosensitivity, sleep, and psychological comorbidities in adolescents
with functional abdominal pain disorders. Neurogastroenterol Motil. 2022;34:e14358). Validated questionnaires</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
included the abdominal pain index (API), nausea severity scale (NSS), functional disability index (FDI), as well as psychological measures
of catastrophizing (PCS-C) and anxiety (SCARED). The table below summarizes the results pre, during and post PENFS results at long-term
follow-up (Santucci et.al. Effect of percutaneous electrical nerve field stimulation on mechanosensitivity, sleep, and psychological
comorbidities in adolescents with functional abdominal pain disorders. Neurogastroenterol Motil. 2022;34:e14358).</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_012.jpg" ALT="" STYLE="height: 295px; width: 625px"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
clinically meaningful endpoint is the number needed to treat (NNT) used in treatment for abdominal pain-related functional gastrointestinal
disorders in adolescents. NNT means the number of patients that need to be treated for one patient to get the targeted improvement (</FONT>&ge;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%
improvement).</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reimbursement</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
technology specific CAT III CPT Code (0720T) was published on December 30, 2021 and effective on July 1, 2022. A CAT III CPT code is
viewed as a temporary CPT code, and we expect to engage with AAP and NASPGHAN to submit for our permanent CAT I CPT code in 2023 and
receive approval in early 2024 - 2025. To expand our coverage, we launched internal prior authorization team to remove the barrier
for children&rsquo;s hospitals who do not have the time to do prior authorizations for patients in need of IB-Stim. As of the date
of this prospectus, there are four (4) commercial written insurance coverage policies that cover our CPT Code, including BCBS
Nebraska, which covers approximately 700,000 lives, BCBS Massachusetts, which covers approximately 3 million lives, BCBS South Carolina,
which covers 750,000 lives, and Quartz Wisconsin, which covers approximately 300,000 lives. </FONT>A total of approximately 4.75
million lives are now covered by the four (4) commercial written insurance coverage policies that cover our CPT Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0">Moreover, we are actively leveraging publications to expand the coverage.
We are expecting position paper from the academic society and guideline changes that support IB-Stim as standard of care.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Marketing</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
market our products through search engine optimization, or SEO, internet channels and to physicians via the academic society. We plan
to extensively ramp-up our marketing efforts to patients and physicians as we gain additional indications.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patients/Customers</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current patient base is children 11-18 years of age and suffering from functional abdominal pain. Our customers are primarily
children&rsquo;s hospitals who serve these children.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="forms-1a_018.jpg" ALT="" STYLE="height: 302px; width: 625px"></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property consists of patents, trademarks, and trade secrets. Our trade secrets consist of product formulas, research,
and development, and unpatentable know-how, all of which we seek to protect, in part, by confidentiality agreements. To protect our
intellectual property, we rely on a combination of laws and regulations, as well as contractual restrictions. Federal trademark law protects
our registered trademarks. We also rely on the protection of laws regarding unregistered copyrights for certain content we create and
trade secret laws to protect our proprietary technology. To further protect our intellectual property, we enter into confidentiality
agreements with our executive officers and directors.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trademarks</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has 10 registered trademarks, eight (8) of which are being used in commerce:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Country</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 14%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Trademark</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 9%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Reg. No.</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Reg. Date</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 41%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Class/Goods</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Status</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">NEURO-STIM and Design</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5105257&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">20-Dec-2016&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. nerve stimulator apparatus</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Registered</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">NSS THE NEUROSTIM SYSTEM and Design</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">4905470</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">23-Feb-2016&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. nerve stimulator apparatus </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Registered</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">THE NEURO-STIM SYSTEM and Design</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5105258&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">20-Dec-2016&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. nerve stimulator apparatus </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Registered</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">NSS</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">4852008&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10-Nov-2015&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. Medical apparatus, namely, electrical nerve stimulators;
    medical device, namely, a non- implantable neurological pain management generator, with percutaneously-implantable needle arrays;
    medical system and apparatus consisting of a non-implantable modulating frequency generator, providing neuromodulation therapy to
    cranial and peripheral nerves; medical system and apparatus consisting of implantable arrays for transmitting current into auricular
    and peri-auricular tissue; medical device for peripheral nerve and nerve field stimulation; medical system and apparatus consisting
    of a non-implantable modulating frequency generator and implantable needle arrays for transmitting current into auricular and peri-auricular
    tissue for use in pain management, namely, patient stimulators for auricular and peri-auricular peripheral nerve field neuromodulation
    therapy; medical apparatus, appliances and instruments for peripheral nerve field stimulation in cranial and peripheral nerves and
    occipital nerve branches, for pain control, headache control, control of phantom limb pain, stump pain, reflex sympathetic dystrophy
    (RSD), peripheral neuropathies and other types of sympathetically mediated pain </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Registered</FONT></TD></TR>
</TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; width: 8%"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 14%"><FONT STYLE="font-size: 10pt">IB-STIM</FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-size: 10pt">5926831&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 10%"><FONT STYLE="font-size: 10pt">03-Dec-2019&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 41%"><FONT STYLE="font-size: 10pt">10 Int. medical apparatus, namely, electrical nerve
    stimulators; medical device, namely, a non- implantable modulating frequency generator, providing neuromodulation therapy to cranial
    and peripheral nerves; medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular
    and peri-auricular tissue; medical device for peripheral nerve and nerve field stimulation; medical device consisting of a non-implantable
    modulating frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular
    tissue for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and
    peri-auricular peripheral nerve field neuromodulation therapy; medical apparatus, for peripheral nerve field stimulation in cranial
    and peripheral nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal
    pain, nausea, functional nausea, abdominal migraine, Crohn&rsquo;s Disease, visceral hypersensitivity, chronic inflammatory bowel
    disease, changes in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes
    in autonomic nervous system and other types of sympathetically mediated pain </FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 8%"><FONT STYLE="font-size: 10pt">Registered </FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">IB-STIM and Design</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5926832</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">03-Dec-2019</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. medical apparatus, namely, electrical nerve stimulators;
    medical device, namely, a non- implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral
    nerves; medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular and peri-auricular
    tissue; medical device for peripheral nerve and nerve field stimulation; medical device consisting of a non-implantable modulating
    frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular tissue
    for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and peri-auricular
    peripheral nerve field neuromodulation therapy; Medical apparatus, for peripheral nerve field stimulation in cranial and peripheral
    nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea,
    functional nausea, abdominal migraine, Crohn&rsquo;s Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes
    in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes in autonomic
    nervous system and other types of sympathetically mediated pain </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Registered</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">IB-STIM AURICULAR STIMULATOR</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">5978411&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">04-Feb-2020&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. medical apparatus, namely, electrical nerve stimulators;
    Medical device, namely, a non- implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral
    nerves; Medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular and peri-auricular
    tissue; Medical device for peripheral nerve and nerve field stimulation; Medical device consisting of a non-implantable modulating
    frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular tissue
    for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and peri-auricular
    peripheral nerve field neuromodulation therapy; Medical apparatus, for peripheral nerve field stimulation in cranial and peripheral
    nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea,
    functional nausea, abdominal migraine, Crohn&rsquo;s Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes
    in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes in autonomic
    nervous system and other types of sympathetically mediated pain </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Registered</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">IB-STIM AURICULAR STIMULATOR and Design</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;5978412</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">04-Feb-2020&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. medical apparatus, namely, electrical nerve stimulators;
    medical device, namely, a non- implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral
    nerves; medical apparatus consisting of percutaneously implantable arrays for transmitting current into auricular and peri-auricular
    tissue; medical device for peripheral nerve and nerve field stimulation; medical device consisting of a non-implantable modulating
    frequency generator and percutaneously implantable needle arrays for transmitting current into auricular and peri-auricular tissue
    for use in pain management and FGID (functional gastrointestinal disorders), namely, patient stimulator for auricular and peri-auricular
    peripheral nerve field neuromodulation therapy; medical apparatus, for peripheral nerve field stimulation in cranial and peripheral
    nerves and occipital nerve branches, for pain control, FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea,
    functional nausea, abdominal migraine, Crohn&rsquo;s Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes
    in FGID co-morbidities, sleep disturbances, psychological disorders, including mood and anxiety, satiety and changes in autonomic
    nervous system and other types of sympathetically mediated pain </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Registered</FONT></TD></TR>
</TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center; width: 8%"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 14%"><FONT STYLE="font-size: 10pt">NEURAXIS</FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 10%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 41%"><FONT STYLE="font-size: 10pt">10 Int. Nerve stimulator apparatus; nerve stimulator
    apparatus for FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine,
    Crohn&rsquo;s Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co- morbidities, sleep disturbances,
    psychological disorders, including mood, anxiety, and satiety, pain control, headache control, control of phantom limb pain, stump
    pain, reflex sympathetic dystrophy (RSD), peripheral neuropathies and other types of sympathetically mediated pain </FONT></TD>
    <TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 8%"><FONT STYLE="font-size: 10pt">Filed</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">US</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">NEURAXIS (STYLIZED)</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">10 Int. Nerve stimulator apparatus; nerve stimulator apparatus for
    FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine, Crohn&rsquo;s
    Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co- morbidities, sleep disturbances, psychological
    disorders, including mood, anxiety, and satiety, pain control, headache control, control of phantom limb pain, stump pain, reflex
    sympathetic dystrophy (RSD), peripheral neuropathies and other types of sympathetically mediated pain </FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Filed</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no unregistered trademarks.</FONT></P>


<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Patents</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has eight (8) granted patents and nine (9) applied for patent applications in the United States and nine (9) applied
for foreign patent applications.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Country</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owner</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Serial
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Actual
    Filing Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Patent
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue
    Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anticipated
    Expiration Date</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 18%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: bottom; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Application
    Status</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 1%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Licensing
    Status</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3096494</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Apr-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CN</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">201980027574.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Apr-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19850021.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Apr-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-509961</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23-Oct-2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KR</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-2020-7034010</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Apr-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/040766</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23-Sep-2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11369791</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28-Jun-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21-Jun-2039</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/715121</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07-Apr-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63/314028</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25-Feb-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE AND METHODS FOR USING THE SAME &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63/315371</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01-Mar-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    NERVE FIELD STIMULATION DEVICE AND METHODS FOR USING THE SAME &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16/014169</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21-Jun-2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10322062</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18-Jun-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-May-2034</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    PERIPHERAL NERVE FIELD STIMULATOR AND METHOD OF OPERATING SAME &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Out-licensed</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16/408004</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09-May-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11077019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03-Aug-2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-May-2034</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    PERIPHERAL NERVE FIELD STIMULATOR AND METHOD OF OPERATING SAME</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Out-licensed</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/363620</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-Jun-2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AURICULAR
    PERIPHERAL NERVE FIELD STIMULATOR AND METHOD OF OPERATING SAME </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/830411</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02-Jun-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEVICE
    AND METHOD FOR ERADICATING PATHOGENS IN NASAL PASSAGES &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 11%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/589082</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31-Jan-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTERNAL
    AUDITORY CANAL PHOTOBIOMODULATION AND AUDIO THERAPY DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/861646</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-Jul-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTERNAL
    AUDITORY CANAL THERAPY DEVICE</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CA</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3143304</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Dec-2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTERNAL
    AUDITORY CANAL PHOTOBIOMODULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CN</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">202080060202.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23-Jun-2020</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTERNAL
    AUDITORY CANAL PHOTOBIOMODULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20830917.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Dec-2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTERNAL
    AUDITORY CANAL PHOTOBIOMODULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">JP</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021-576915</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24-Dec-2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTERNAL
    AUDITORY CANAL PHOTOBIOMODULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17/617364</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08-Dec-2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXTERNAL
    AUDITORY CANAL PHOTOBIOMODULATION DEVICE &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">applied
    for</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15/488416</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-Apr-2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10413719</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17-Sep-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-April-2037</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">METHODS
    OF TREATING DISEASE USING AURICULAR PERIPHERAL NERVE FIELD STIMULATION &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Out-licensed</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16/534159</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07-Aug-2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11331473</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17-May-2022</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-April-2037</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">METHODS
    OF TREATING DISEASE USING AURICULAR PERIPHERAL NERVE FIELD STIMULATION &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15/595185</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15-May-2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9839577</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12-Dec-2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-May-2034</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SYSTEM
    AND METHOD FOR AURICULAR PERIPHERAL NERVE FIELD STIMULATION &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Out-licensed</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15/811278</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13-Nov-2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10010479</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03-Jul-2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-May-2034</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SYSTEM
    AND METHOD FOR AURICULAR PERIPHERAL NERVE FIELD STIMULATION &nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Out-licensed</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">US</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14/277158</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-May-2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9662269</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-May-2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14-May-2034</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SYSTEMS
    AND METHODS FOR AURICULAR PERIPHERAL NERVE FIELD STIMULATION</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">granted</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Out-licensed</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> US </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Neuraxis, Inc. </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 17/725,761 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 21-Apr-2022 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> AURICULAR NERVE FIELD STIMULATION DEVICE AND METHODS
    FOR USING THE SAME </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> Pending </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> &nbsp; </TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>License
Agreements</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>TKBMN
Exclusive License Agreement</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 7, 2020, the Company entered into an exclusive license agreement with TKBMN, LLC to obtain an exclusive license under certain patent
rights (the &ldquo;Patent Rights&rdquo;) owned by TKBMN. Dr. Thomas Carrico, our Chief Regulatory Officer, is the manager of TKBMN.
Brian Carrico, our Chief Executive Officer, and Matt Carrico, our National Sales Director, are members of TKBMN. TKBMN owns the rights
to &ldquo;Systems and Methods for Electro-Therapy Treatment,&rdquo; US Patent No. 10,792,500 (the &ldquo;TKBMN Patent&rdquo;). The expiration
date of the TKBMN Patent is Oct 18, 2037, if all maintenance fees remain paid. Thomas Carrico is the author and inventor of the TKBMN
Patent and has assigned the auricular portion of the TKBMN Patent to the Company.</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the exclusive license agreement, TKBMN agreed to grant an exclusive, worldwide, non-transferable, royalty-free license under Patent
Rights, which including three patents applications filed by TKBMN in connection with systems and methods for elector-therapy treatment,
to the Company to develop, market, and sell licensed products, in the field of electro-therapy treatment by stimulation of cranial nerves,
cranial nerve branches, auricular nerves, auricular nerve branches, auricular nerve bundles, and/or auricular anatomical structures in
human patients (the &ldquo;Field&rdquo;), in consideration of a one-time license fee of $1.00. The Company has the right to grant sublicenses
to the Patents Rights in the Field. The exclusive license agreement expires upon the expiration of the last to expire valid claim within
the Patent Rights and may be terminated by the Company upon 60 days prior written notice. Upon expiration or termination of the exclusive
license agreement, all rights in the Patent Rights will revert to TKBMN. There are no royalties or any other form of committed revenue
to TKBMN or any of its members, Under the agreement, the Company has agreed to cover fees and expenses associated with maintenance, prosecution,
and additional associated/continuation patent filings for the TKBMN Patent.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Masimo
License and Collaboration Agreement</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2020, the Company entered into a license and collaboration agreement with Masimo. As consideration, in part, Masimo entered
into a Series A Preferred Stock purchase agreement with the Company. Under the license and collaboration agreement, the Company
grants an exclusive, fully paid-up, royalty-free license to specifically identified patents and trademarks in a limited Field
of use. At all times, the Company remains the owner of all licensed intellectual property rights, and there is a possibility
of joint ownership of collaboratively developed products and methods. The licensed patents are generally directed to a device
and the treatment of opioid withdrawal symptoms. The licensed trademarks are generally directed to the NSS-2 Bridge mark.
The license agreement includes a collaboration component to efficiently develop, obtain regulatory approval, and commercialize
products for the limited field of use. The term of the agreement is in effect until the expiration or lapse of the last intellectual
property rights. Masimo paid a one-time fee of $250,000. The license and collaboration agreement may not be terminated by the Company
for any reason, and the sole remedy for any breach or default by Masimo shall be to seek monetary damages and equitable remedies. The
license and collaboration agreement may be terminated by Masimo if there is material breach by the Company that remain uncured for thirty
(30) days or without cause by providing thirty (30) days prior written notice. See <I>&ldquo;&mdash;Our Corporate History</I>&rdquo;
for more information.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being a Smaller Reporting Company</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a &ldquo;smaller reporting company&rdquo; as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage
of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We
will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our shares held by non-affiliates
equals or exceeds $250 million as of the prior June 30<SUP>th</SUP>, or (2) our annual revenues equaled or exceeded $100 million during
such completed fiscal year and the market value of our shares held by non-affiliates equals or exceeds $700 million as of the prior June
30<SUP>th</SUP>. Such reduced disclosure and corporate governance obligations may make it more challenging for investors to analyze our
results of operations and financial prospects.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
additional information, see &ldquo;<I>Risk Factors &ndash; Because the Company is a &lsquo;smaller reporting company,&rsquo; we may take
advantage of certain scaled disclosures available to us, resulting in holders of our securities receiving less Company information than
they would receive from a public company that is not a smaller reporting company&rdquo; and &ldquo;As a smaller reporting company,&rdquo;
we may at some time in the future choose to exempt our Company from certain corporate governance requirements that could have
an adverse effect on our public stockholders.&rdquo;</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being an Emerging Growth Company</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;emerging growth company&rdquo; as defined in the JOBS Act. We will remain an emerging growth company until the earlier
of (1) December 31, 2024, (2) the last day of the fiscal year in which we have total annual gross revenue of at least $1.235 billion,
(3) the last day of the fiscal year in which we are deemed to be a &ldquo;large accelerated filer&rdquo; as defined in Rule 12b-2 under
the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur on the date on which we have issued more than
$1.0 billion in non-convertible debt securities during the prior three-year period. An emerging growth company may take advantage of
specified reduced reporting requirements and is relieved of certain other significant requirements that are otherwise generally applicable
to public companies. As an emerging growth company, we may:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">present
    only two years of audited financial statements, plus unaudited condensed financial statements for any interim period, and related
    management&rsquo;s discussion and analysis of financial condition and results of operations in this prospectus;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">avail
    ourselves of the exemption from the requirement to obtain an attestation and report from our auditors on the assessment of our internal
    control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reduced disclosure about our executive compensation arrangements; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
    require stockholder non-binding advisory votes on executive compensation or golden parachute arrangements.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the JOBS Act, an emerging growth company can delay the adoption of certain accounting standards until those standards
would otherwise apply to private companies. We have elected not to take advantage of the extended transition period
for complying with new or revised accounting standards provided to emerging growth companies under the JOBS Act.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Regulation</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products and our operations are subject to extensive regulation by the U.S. Food and Drug Administration, or FDA, and other federal,
state, and local authorities in the United States, as well as comparable authorities in foreign jurisdictions. Our products are subject
to regulation as medical devices in the United States under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
States Regulation</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA regulates, among other things, the development, design, non-clinical and clinical testing, manufacturing, safety, effectiveness,
labeling, packaging, storage, installation, servicing, recordkeeping, premarket clearance or approval, adverse event reporting, advertising,
promotion, marketing and distribution, and import and export and post-marketing surveillance of medical devices in the United States
to ensure that medical devices distributed domestically are safe and effective for their intended uses and otherwise meet the requirements
of the FDCA.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>FDA
Premarket Clearance and Approval Requirements</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
an exemption applies, each new or significantly modified medical device commercially distributed in the United States requires FDA clearance
of a 510(k) premarket notification. The 510(k) clearance can be resource intensive, expensive, and lengthy.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the FDCA, medical devices are classified into one of three classes&mdash;Class I, Class II or Class III&mdash;depending on the degree
of risk associated with each medical device and the extent of manufacturer and regulatory control needed to ensure its safety and effectiveness.
Class I devices are those for which safety and effectiveness can be assured by adherence to the FDA&rsquo;s general controls for medical
devices, which include compliance with the applicable portions of FDA&rsquo;s current good manufacturing practices for devices, as reflected
in the Quality System Regulation, or QSR, establishment registration and device listing, reporting of adverse medical events, and truthful
and non-misleading labeling, advertising, and promotional materials. Some Class I devices, also called Class I reserved devices, also
require premarket clearance by the FDA through the 510(k) premarket notification process described below. Most Class I devices are exempt
from the premarket notification requirements.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
II devices are subject to the FDA&rsquo;s general controls, and any other special controls deemed necessary by the FDA to ensure the
safety and effectiveness of the device. These special controls can include performance standards, special labeling requirements, post-market
surveillance, patient registries and FDA guidance documents.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
Class II devices are required to submit to the FDA a premarket notification under Section 510(k) of the FDCA requesting permission to
commercially distribute the device. The FDA&rsquo;s permission to commercially distribute a device subject to a 510(k) premarket notification
is generally known as 510(k) clearance.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a new medical device does not qualify for the 510(k) premarket notification process because no predicate device to which it is substantially
equivalent can be identified, the device is automatically classified into Class III. The Food and Drug Administration Modernization Act
of 1997 established a new route to market for low to moderate risk medical devices that are automatically placed into Class III due to
the absence of a predicate device, called the &ldquo;Request for Evaluation of Automatic Class III Designation,&rdquo; or the de novo
classification process. This process allows a manufacturer whose novel device is automatically classified into Class III to request down-classification
of its medical device into Class I or Class II on the basis that the device presents low or moderate risk. If the manufacturer seeks
reclassification into Class II, the manufacturer must include a draft proposal for special controls that are necessary to provide a reasonable
assurance of the safety and effectiveness of the medical device. The FDA may reject the reclassification petition if it identifies a
legally marketed predicate device that would be appropriate for a 510(k) or that general controls would be inadequate to control the
risks and special controls cannot be developed.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obtaining
FDA marketing authorization, de novo down-classification, or approval for medical devices is expensive and uncertain, and may take several
years, and generally requires significant scientific and clinical data.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
pre-amendment devices are unclassified, but are subject to FDA&rsquo;s premarket notification and clearance process in order to be commercially
distributed.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investigational
Device Process</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
trials are sometimes required to support a 510(k) submission. In the United States, absent certain limited exceptions, human clinical
trials intended to support medical device clearance or approval or to determine safety and effectiveness of a device for an investigational
use must be conducted in accordance with the FDA&rsquo;s investigational device exemption, or IDE, regulations which govern investigational
device labeling, prohibit promotion of the investigational device, and specify an array of recordkeeping, reporting and monitoring responsibilities
of study sponsors and study investigators. If the device presents a &ldquo;significant risk,&rdquo; to human health, as defined by the
FDA, the FDA requires the device sponsor to submit an IDE application to the FDA, which must become effective prior to commencing human
clinical trials. The IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing that
it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE application must be approved in
advance by the FDA for a specified number of subjects. Generally, clinical trials for a significant risk device may begin once the IDE
application is approved by the FDA and the study protocol and informed consent are approved by appropriate institutional review boards
at the clinical trial sites. There can be no assurance that submission of an IDE will result in the ability to commence clinical trials,
and although the FDA&rsquo;s approval of an IDE allows clinical testing to go forward for a specified number of subjects, it does not
bind the FDA to accept the results of the trial as sufficient to prove the product&rsquo;s safety and effectiveness, even if the trial
meets its intended success criteria.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the device under evaluation does not present a significant risk to human health, then the device sponsor is not required to submit an
IDE application to the FDA before initiating human clinical trials, but must still comply with abbreviated IDE requirements when conducting
such trials. A significant risk device is one that presents a potential for serious risk to the health, safety or welfare of a patient
and either is implanted, used in supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating
disease or otherwise preventing impairment of human health, or otherwise presents a potential for serious risk to a subject. An IDE application
must be supported by appropriate data, such as animal and laboratory test results, showing that it is safe to test the device in humans
and that the testing protocol is scientifically sound. The IDE will automatically become effective thirty (30) days after receipt by
the FDA unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or
other concerns with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regardless
of the degree of risk presented by the medical device, clinical studies must be approved by, and conducted under the oversight of, an
Institutional Review Board, or IRB, for each clinical site. The IRB is responsible for the initial and continuing review of the IDE,
and may pose additional requirements for the conduct of the study. If an IDE application is approved by the FDA and one or more IRBs,
human clinical trials may begin at a specific number of investigational sites with a specific number of patients, as approved by the
FDA. If the device presents a non-significant risk to the patient, a sponsor may begin the clinical trial after obtaining approval for
the trial by one or more IRBs without separate approval from the FDA, but must still follow abbreviated IDE requirements, such as monitoring
the investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping requirements. Acceptance
of an IDE application for review does not guarantee that the FDA will allow the IDE to become effective and, if it does become effective,
the FDA may or may not determine that the data derived from the trials support the safety and effectiveness of the device or warrant
the continuation of clinical trials. An IDE supplement must be submitted to, and approved by, the FDA before a sponsor or investigator
may make a change to the investigational plan that may affect its scientific soundness, study plan or the rights, safety or welfare of
human subjects.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
a study, the sponsor is required to comply with the applicable FDA requirements, including, for example, trial monitoring, selecting
clinical investigators and providing them with the investigational plan, ensuring IRB review, adverse event reporting, record keeping
and prohibitions on the promotion of investigational devices or on making safety or effectiveness claims for them. The clinical investigators
in the clinical study are also subject to FDA&rsquo;s regulations and must obtain patient informed consent, rigorously follow the investigational
plan and study protocol, control the disposition of the investigational device, and comply with all reporting and recordkeeping requirements.
Additionally, after a trial begins, we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons,
including the following:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    FDA or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patients
    do not enroll in clinical trials at the rate expected;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patients
    do not comply with trial protocols;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patient
    follow-up is not at the rate expected;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patients
    experience serious adverse events;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patients
    die during a clinical trial, even though their death may not be related to the products that are part of the trial;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Device
    malfunctions occur with unexpected frequency or potential adverse consequences;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Side
    effects or device malfunctions of similar products already in the market that change the FDA&rsquo;s view toward approval of result
    in the imposition of new requirements or testing;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Institutional
    review boards and third-party clinical investigators may delay or reject the trial protocol;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third-party
    clinical investigators decline to participate in a trial or do not perform a trial on the anticipated schedule or consistent with
    the clinical trial protocol, investigator agreement, investigational plan, good clinical practices, the IDE regulations, or other
    FDA or IRB requirements;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third-party
    investigators are disqualified by the FDA;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    or third-party organizations do not perform data collection, monitoring and analysis in a timely or accurate manner or consistent
    with the clinical trial protocol or investigational or statistical plans, or otherwise fail to comply with the IDE regulations governing
    responsibilities, records, and reports of sponsors of clinical investigations;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third-party
    clinical investigators have significant financial interests related to us or our study such that the FDA deems the study results
    unreliable, or the company or investigators fail to disclose such interests;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
    inspections of our clinical trials or manufacturing facilities, which may, among other things, require us to undertake corrective
    action or suspend or terminate our clinical trials;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in government regulations or administrative actions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    interim or final results of the clinical trial are inconclusive or unfavorable as to safety or effectiveness; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    FDA concludes that our trial design is unreliable or inadequate to demonstrate safety and effectiveness.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>510(k)
Clearance Process</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 510(k) process, the manufacturer must submit to the FDA a premarket notification submission demonstrating that the proposed device
is &ldquo;substantially equivalent,&rdquo; as defined in the FDCA, to a legally marketed predicate device.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
predicate device is a legally marketed device that is not subject to premarket approval, i.e., a device that was legally marketed prior
to May 28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been reclassified from Class III to Class
II or I, or a device that was found substantially equivalent through the 510(k) process. A device is considered to be substantially equivalent
if, with respect to the predicate device, it has the same intended use and has either (i) the same technological characteristics; or
(ii) different technological characteristics, but the information provided in the 510(k) submission demonstrates that the device does
not raise different questions of safety or effectiveness than the predicate device.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
the FDA will accept a 510(k) premarket notification for substantive review, the FDA will first assess whether the submission satisfies
a minimum threshold of acceptability. If the FDA determines that the 510(k) submission lacks necessary information for substantive review,
the FDA will issue a &ldquo;Refuse to Accept&rdquo; letter which generally outlines the information the FDA believes is necessary to
permit a substantive review and to reach a determination regarding substantial equivalence. An applicant must submit the requested information
before the FDA will proceed with additional review of the submission. If a 510(k) submission is accepted for substantive review, the
Medical Device User Fee Amendments sets a performance goal of 90 days for FDA review of a 510(k) submission, but the review time can
be delayed if FDA raises questions or requests additional information during the review process. As a practical matter, clearance often
takes longer, and clearance is never assured. Thus, as a practical matter, clearance often takes longer than 90 days. Although many 510(k)
premarket notifications are cleared without clinical data, the FDA may require further information, including clinical data, to make
a determination regarding substantial equivalence, which may significantly prolong the review process. If the FDA agrees that the device
is substantially equivalent, it will grant clearance to commercially market the device.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the FDA determines that the device is substantially equivalent to a predicate device, it will grant 510(k) clearance to commercially
market the device. If the FDA determines that the device is &ldquo;not substantially equivalent&rdquo; to a previously cleared device,
the device is automatically designated as a Class III device. The device sponsor must then fulfill more rigorous requirements of the
PMA approval process, or can request a risk-based classification determination for the device in accordance with the &ldquo;<I>de novo</I>&rdquo;
process, which is a route to market for certain novel medical devices that are low to moderate risk and are not substantially equivalent
to a predicate device.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
devices can only be marketed for the indications for use for which they are cleared or approved. After a device receives 510(k) clearance,
any modification that could significantly affect its safety or effectiveness, or that would constitute a major change or modification
in its intended use, will require a new 510(k) clearance or, depending on the modification, PMA approval or <I>de novo </I>reclassification.
The FDA requires each manufacturer to determine whether the proposed change requires submission of a 510(k), <I>de novo </I>request or
a PMA in the first instance, but the FDA may review this determination to evaluate the regulatory status of the modified product at any
time and may require the manufacturer to cease marketing and/or request the recall of the modified device until 510(k) marketing clearance
or PMA approval is obtained or a <I>de novo </I>request is granted. Also, in these circumstances, the manufacturer may be subject to
significant regulatory fines or penalties.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements
for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process
for their products. For example, in November 2018, FDA officials announced steps that the FDA intended to take to modernize the premarket
notification pathway under Section 510(k) of the FDCA. Among other things, the FDA announced that it planned to develop proposals to
drive manufacturers utilizing the 510(k) pathway toward the use of newer predicates. These proposals included plans to potentially sunset
certain older devices that were used as predicates under the 510(k) clearance pathway, and to potentially publish a list of devices that
have been cleared on the basis of demonstrated substantial equivalence to predicate devices that are more than 10 years old. These proposals
have not yet been finalized or adopted, although the FDA may work with Congress to implement such proposals through legislation.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">More
recently, in September 2019, the FDA issued revised final guidance describing an optional &ldquo;safety and performance based&rdquo;
premarket review pathway for manufacturers of &ldquo;certain, well-understood device types&rdquo; to demonstrate substantial equivalence
under the 510(k) clearance pathway by showing that such device meets objective safety and performance criteria established by the FDA,
thereby obviating the need for manufacturers to compare the safety and performance of their medical devices to specific predicate devices
in the clearance process. The FDA has developed and maintains a list device types appropriate for the &ldquo;safety and performance based&rdquo;
pathway and continues to develop product-specific guidance documents that identify the performance criteria for each such device type,
as well as recommended testing methods, where feasible.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>PMA
Approval Process</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class
III devices require PMA approval before they can be marketed, although some pre-amendment Class III devices for which FDA has not yet
required a PMA are cleared through the 510(k) process. The PMA process is more demanding than the 510(k) premarket notification process.
In a PMA, the manufacturer must demonstrate that the device is safe and effective for its intended use, and the PMA must be supported
by extensive data, including data from preclinical studies and human clinical trials. The PMA must also contain a full description of
the device and its components, a full description of the methods, facilities, and controls used for manufacturing, and proposed labeling.
Following receipt of a PMA, the FDA conducts an administrative review to determine whether the application is sufficiently complete to
permit a substantive review. If it is not, the agency will refuse to file the PMA. If FDA accepts the application for substantive review,
it has 180 days under the FDCA to complete its review of a filed PMA application, although in practice, the FDA&rsquo;s review often
takes significantly longer, and can take up to several years. During this review period, the FDA may request additional information or
clarification of information already provided, and the FDA may issue a major deficiency letter to the applicant, requesting the applicant&rsquo;s
response to deficiencies communicated by the FDA. The FDA considers a PMA or PMA supplement to have been voluntarily withdrawn if an
applicant fails to respond to an FDA request for information (e.g., major deficiency letter) within a total of 360 days. Before approving
or denying a PMA application, an advisory panel of experts from outside the FDA may be convened to review and evaluate the application
and provide recommendations to the FDA as to whether the FDA should approve the submission, approve it with specific conditions, or not
approve it. The FDA may or may not accept the panel&rsquo;s recommendation. Prior to approval of a PMA, the FDA may conduct inspections
of the clinical trial data and clinical trial sites, as well as conduct inspections of the applicant or its third-party manufacturers&rsquo;
or suppliers&rsquo; manufacturing facility or facilities to, among other things, ensure compliance with the QSR. PMA applications are
also subject to the payment of user fees, which for fiscal year 2021 includes a standard application fee of $365,657.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
    the FDA review of a PMA application generally takes between one and three years, but may take significantly longer. The FDA can delay,
    limit or deny approval of a PMA application for many reasons, including:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    device may not be shown safe or effective to the FDA&rsquo;s satisfaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    data from pre-clinical studies and/or clinical trials may be found unreliable or insufficient to support approval;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    manufacturing process or facilities may not meet applicable requirements; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in FDA approval policies or adoption of new regulations may require additional data.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the FDA evaluation of a PMA is favorable, the FDA will issue either an approval letter, or an approvable letter, the latter of which
usually contains a number of conditions that must be met in order to secure final approval of the PMA. When and if those conditions have
been fulfilled to the satisfaction of the FDA, the agency will issue a PMA approval letter authorizing commercial marketing of the device,
subject to the conditions of approval and the limitations established in the approval letter. The FDA may approve a PMA with post-approval
conditions intended to ensure the safety and effectiveness of the device, including, among other things, restrictions on labeling, promotion,
sale and distribution, and collection of long-term follow-up data from patients in the clinical study that supported PMA approval or
requirements to conduct additional clinical studies post-approval. The FDA may condition PMA approval on some form of post-market surveillance
when deemed necessary to protect the public health or to provide additional safety and effectiveness data for the device in a larger
population or for a longer period of use. In such cases, the manufacturer might be required to follow certain patient groups for a number
of years and to make periodic reports to the FDA on the clinical status of those patients. Failure to comply with the conditions of approval
can result in material adverse enforcement action, including withdrawal of the approval. If the FDA&rsquo;s evaluation of a PMA application
or manufacturing facilities is not favorable, the FDA will deny approval of the PMA or issue a not approvable letter. The FDA also may
determine that additional tests or clinical trials are necessary, in which case the PMA approval may be delayed for several months or
years while the trials are conducted and data is submitted in an amendment to the PMA, or the PMA is withdrawn and resubmitted when the
data are available. The PMA process can be expensive, uncertain and lengthy and a number of devices for which the FDA approval has been
sought by other companies have never been approved by the FDA for marketing.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
changes to an approved medical device, such as changes in manufacturing facilities, methods, quality control procedures, sterilization
(if applicable), packaging, expiration date, labeling, device specifications, materials, or design of a device, or other changes which
affect the safety or effectiveness of the device that has been approved through the PMA process require submission of a new PMA or PMA
supplement. PMA supplements often require submission of the same type of information as a PMA, except that the supplement is limited
to information needed to support any changes from the device covered by the original, approved PMA and may not require as extensive clinical
data or the convening of an advisory panel, depending on the nature of the proposed change. Certain other changes to an approved device
require the submission of a new PMA, such as when the design change causes a different intended use, mode of operation, and technical
basis of operation, or when the design change is so significant that a new generation of the device will be developed, and the data that
were submitted with the original PMA are not applicable for the change in demonstrating a reasonable assurance of safety and effectiveness.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Ongoing
Regulation by the FDA</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even
after the FDA permits a device to be marketed, numerous and pervasive regulatory requirements continue to apply. These include:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishment
    registration and device listing with the FDA;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QSR
    requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, supplier/contractor
    selection, compliant handling, documentation and other quality assurance procedures during all aspects of the design and manufacturing
    process;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labeling
    regulations, advertising and promotion requirements, restrictions on sale, distribution or sale of a device, each including the FDA
    prohibition against the promotion of products for any uses other than those authorized by the FDA, which are commonly known as &ldquo;off-label&rdquo;
    uses;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Medical Device Reporting, or MDR, regulations, which require that a manufacturer report to the FDA if a device it markets may have
    caused or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would
    be likely to cause or contribute to a death or serious injury, if the malfunction were to recur;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
    device correction and removal reporting regulations, which require that manufacturers report to the FDA field corrections or removals
    if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recall
    requirements, including a mandatory recall if there is a reasonable probability that the device would cause serious adverse health
    consequences or death;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
    order of repair, replacement, or refund;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Device
    tracking requirements; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-market
    study and surveillance requirements.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute
a major change in its intended use, will require a new 510(k). The FDA requires each manufacturer to make this determination initially,
but the FDA can review any such decision and can disagree with a manufacturer&rsquo;s determination. If the FDA disagrees with a manufacturer&rsquo;s
determination not to seek a new 510(k) clearance, the FDA may retroactively require it to seek 510(k) clearance. The FDA could also require
the manufacturer to cease marketing and distribution and/or recall the modified device until 510(k) clearance is obtained. Also, in these
circumstances, the manufacturer may be subject to significant regulatory fines and penalties.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
regulations require us to register as a medical device manufacturer with the FDA. Additionally, some states also require medical device
manufacturers and/or distributors doing business within the state to register with the state or apply for a state license, which could
subject our facility to state inspection as well as FDA inspection on a routine basis for compliance with the QSR and any applicable
state requirements. These regulations require that we manufacture our products and maintain related documentation in a prescribed manner
with respect to manufacturing, testing and control activities.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing
processes for medical devices are required to comply with the applicable portions of the QSR, which cover the methods and the facilities
and controls for the design, manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution,
installation and servicing of finished devices intended for human use. The QSR also requires, among other things, maintenance of a device
master file, device history file, and complaint files. As a manufacturer, we are subject to periodic scheduled or unscheduled inspections
by the FDA. Failure to maintain compliance with the QSR requirements could result in the shutdown of, or restrictions on, manufacturing
operations and the recall or seizure of marketed products, which would have a material adverse effect on our business. The discovery
of previously unknown problems with any of our products, including unanticipated adverse events or adverse events of increasing severity
or frequency, whether resulting from the use of the device within the scope of its clearance or off-label by a physician in the practice
of medicine, could result in restrictions on the device, including the removal of the product from the market or voluntary or mandatory
device recalls.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
FDA has broad regulatory compliance and enforcement powers. If the FDA determines that a manufacturer has failed to comply with applicable
regulatory requirements, it can take a variety of compliance or enforcement actions, which may result in any of the following sanctions:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warning
    letters, untitled letters, fines, injunctions, consent decrees and civil penalties;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recalls,
    withdrawals, or administrative detention or seizure of our products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    restrictions or partial suspension or total shutdown of production;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refusing
    or delays in processing, clearing, or approving submissions or applications for new products or modifications to existing products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suspension
    or withdrawal of 510(k) clearances or PMA approvals that have already been granted;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FDA
    refusal to issue certification to foreign governments needed to export our products for sale in other countries; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Criminal
    prosecution.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
facilities, records and manufacturing processes are subject to periodic unscheduled inspections by the FDA. Failure to comply with the
applicable United States medical device regulatory requirements could result in, among other things, warning letters, untitled letters,
fines, injunctions, consent decrees, civil penalties, unanticipated expenditures, repairs, replacements, refunds, recalls or seizures
of products, operating restrictions, total or partial suspension of production, the FDA&rsquo;s refusal to issue certificates to foreign
governments needed to export products for sale in other countries, the FDA&rsquo;s refusal to grant future premarket clearances or approvals,
withdrawals or suspensions of current product clearances or approvals and criminal prosecution.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Regulation
of Medical Devices in the European Union</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
European Union, or EU, has adopted specific directives regulating the design, manufacture, clinical investigations, conformity assessment,
labeling and adverse event reporting for medical devices. EU directives must be implemented into the national laws of the EU member states
and national laws may vary from one member state to another.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the EU, there is currently no premarket government review of medical devices. However, the EU requires that all medical devices placed
on the market in the EU must meet the relevant essential requirements laid down in the Council Directive 93/42/EEC, or the Medical Devices
Directive, and the Council Directive 90/385/EEC, or the Active Implantable Medical Devices Directive. The most fundamental essential
requirement is that a medical device must be designed and manufactured in such a way that it will not compromise the clinical condition
or safety of patients, or the safety and health of users and others. In addition, the device must achieve the performances intended by
the manufacturer and be designed, manufactured, and packaged in a suitable manner. The European Commission has adopted various standards
applicable to medical devices. These include standards governing common requirements, such as sterilization and safety of medical electrical
equipment and product standards for certain types of medical devices. There are also harmonized standards relating to design and manufacture.
While not mandatory, compliance with these standards is viewed as the easiest way to satisfy the essential requirements as a practical
matter. Compliance with a standard developed to implement an essential requirement also creates a rebuttable presumption that the device
satisfies that essential requirement.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
demonstrate compliance with the essential requirements laid down in Annex I to the Medical Devices Directive, medical device manufacturers
must undergo a conformity assessment procedure, which varies according to the type of medical device and its (risk) classification. Conformity
assessment procedures require an assessment of available clinical evidence, literature data for the product, and post-market experience
in respect of similar products already marketed. Except for low-risk medical devices (Class I non-sterile, non-measuring devices), where
the manufacturer can self-declare the conformity of its products with the essential requirements (except for any parts which relate to
sterility or metrology), a conformity assessment procedure requires the intervention of a Notified Body. Notified Bodies are independent
organizations designated by EU countries to assess the conformity of devices before being placed on the market. A Notified Body would
typically audit and examine a product&rsquo;s technical dossiers and the manufacturers&rsquo; quality system (which must, in particular,
comply with ISO 13485:2016 related to Medical Devices Quality Management Systems). If satisfied that the relevant product conforms to
the relevant essential requirements, the Notified Body issues a certificate of conformity, which the manufacturer uses as a basis for
its own declaration of conformity. The manufacturer may then apply the CE Mark to the device, which allows the device to be placed on
the market throughout the EU.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notified
Body certificates of conformity are valid for a fixed duration (which shall not exceed five years). Throughout the term of the certificate,
the manufacturer will be subject to periodic surveillance audits to verify continued compliance with the applicable requirements. In
particular, there will be a new audit by the Notified Body before it will renew the relevant certificate(s).</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a general rule, demonstration of conformity of medical devices and their manufacturers with the essential requirements must be based,
among other things, on the evaluation of clinical data supporting the safety and performance of the products during normal conditions
of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use,
that the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed against the benefits of its intended
performance, and that any claims made about the performance and safety of the device are supported by suitable evidence. All manufacturers
placing medical devices into the market in the EU must comply with the EU medical device vigilance system. Under this system, incidents
must be reported to the relevant authorities of the EU member states, and manufacturers are required to take Field Safety Corrective
Actions, or FSCAs, to reduce a risk of death or serious deterioration in the state of health associated with the use of a medical device
that is already placed on the market. An incident is defined as any malfunction or deterioration in the characteristics and/or performance
of a device, as well as any inadequacy in the labeling or the instructions for use which, directly or indirectly, might lead to or might
have led to the death of a patient or user or of other persons or to a serious deterioration in their state of health. An FSCA may include
the recall, modification, exchange, destruction or retrofitting of the device. FSCAs must be communicated by the manufacturer or its
legal representative to its customers and/or to the end users of the device through Field Safety Notices.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
advertising and promotion of medical devices is subject to some general principles set forth by EU directives. According to the Medical
Devices Directive, only devices that are CE-marked may be marketed and advertised in the EU in accordance with their intended purpose.
Directive 2006/114/EC concerning misleading and comparative advertising and Directive 2005/29/EC on unfair commercial practices, while
not specific to the advertising of medical devices, also apply to the advertising thereof and contain general rules, for example requiring
that advertisements are evidenced, balanced and not misleading. Specific requirements are defined at national level. EU member states
laws related to the advertising and promotion of medical devices, which vary between jurisdictions, may limit or restrict the advertising
and promotion of products to the general public and may impose limitations on promotional activities with healthcare professionals.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
EU member states have adopted specific anti-gift statutes that further limit commercial practices for medical devices, in particular
vis-&agrave; -vis healthcare professionals and organizations. Additionally, there has been a recent trend of increased regulation of
payments and transfers of value provided to healthcare professionals or entities. In addition, many EU member states have adopted national
&ldquo;Sunshine Acts&rdquo; which impose reporting and transparency requirements (often on an annual basis), similar to the requirements
in the United States, on medical device manufacturers. Certain countries also mandate implementation of commercial compliance programs.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 25, 2017, Regulation 2017/745, or the EU Medical Devices Regulation, entered into force, which repeals and replaces the Medical Devices
Directive and the Active Implantable Medical Devices Directive. Unlike directives, which must be implemented into the national laws of
the EU member states, regulations are directly applicable, without the need for adoption of EU member state laws implementing them, in
all EU member states and are intended to eliminate current differences in the regulation of medical devices among EU member states. The
Medical Devices Regulation, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory
framework across the EU for medical devices and ensure a high level of safety and health while supporting innovation.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Medical Devices Regulation was originally intended to become applicable three years after publication, but in April 2020 the transition
period was extended by the European Parliament and the Council of the EU by an additional year &ndash; until May 26, 2021. Devices lawfully
placed on the market pursuant to the Medical Devices Directive and the Active Implantable Medical Devices Directive prior to May 26,
2021 may generally continue to be made available on the market or put into service until May 26, 2025. Once applicable, the new regulations
will among other things:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strengthen
    the rules on placing devices on the market and reinforce surveillance once they are available;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
    explicit provisions on manufacturers&rsquo; responsibilities for the follow-up of the quality, performance and safety of devices
    placed on the market;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improve
    the traceability of medical devices throughout the supply chain to the end-user or patient through a unique identification number;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
    up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available
    in the European Union, or EU; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strengthen
    the rules for the assessment of certain high-risk devices, which may have to undergo an additional check by experts before they are
    placed on the market.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aforementioned EU rules are generally applicable in the European Economic Area, or EEA, which consists of the 27 EU member states plus
Norway, Liechtenstein and Iceland. Other countries, such as Switzerland, have entered into Mutual Recognition Agreements and allow the
marketing of medical devices that meet EU requirements.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
EU-UK Trade and Cooperation Agreement, or TCA, came into effect on January 1, 2021. The TCA does not specifically refer to medical devices.
However, as a result of Brexit, the Medical Devices Regulation will not be implemented in the UK, and previous legislation that mirrored
the Medical Devices Regulation in the UK law has been revoked. The regulatory regime for medical devices in the UK will continue to be
based on the requirements derived from current EU legislation, and the UK may choose to retain regulatory flexibility or align with the
Medical Devices Regulation going forward. CE markings will continue to be recognized in the UK, and certificates issued by EU recognized
Notified Bodies will be valid in the UK, until June 30, 2023. For medical devices placed on the UK market after this period, the UK Conformity
Assessment, or UKCA, marking will be mandatory. In contrast, UKCA marking and certificates issued by UK Notified Bodies will not be recognized
on the EU market. The TCA does provide for cooperation and exchange of information in the area of product safety and compliance, including
market surveillance, enforcement activities and measures, standardization related activities, exchanges of officials, and coordinated
product recalls (or other similar actions). For medical devices that are locally manufactured but use components from other countries,
the &ldquo;rules of origin&rdquo; criteria will need to be reviewed. Depending on which countries products will ultimately be sold in,
manufacturers may start seeking alternative sources for components if this would allow them to benefit from no tariffs. The rules for
placing medical devices on the Northern Ireland market will differ from those in the UK.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Healthcare
Fraud and Abuse Laws</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, we are subject to a number of federal and state healthcare regulatory laws that restrict business practices in the
healthcare industry. These laws include, but are not limited to, federal and state anti-kickback, false claims, transparency and other
healthcare fraud and abuse laws.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal Anti-Kickback Statute prohibits, among other things, any person or entity from knowingly and willfully offering, paying,
soliciting, receiving or providing any remuneration, directly or indirectly, overtly or covertly, to induce or in return for purchasing,
leasing, ordering, or arranging for or recommending the purchase, lease, or order of any good, facility, item or service reimbursable,
in whole or in part, under Medicare, Medicaid or other federal healthcare programs. The term &ldquo;remuneration&rdquo; has been broadly
interpreted to include anything of value, including cash, improper discounts, and free or reduced-price items and services. Among
other things, the Anti-Kickback Statute has been interpreted to apply to arrangements between medical device manufacturers on the one
hand and prescribers and purchasers on the other. Although there are a number of statutory exceptions and regulatory safe harbors protecting
some common activities from prosecution, the exceptions and safe harbors are drawn narrowly. The government can exercise enforcement
discretion in taking action against unprotected activities. Further, a person or entity does not need to have actual knowledge of the
statute or specific intent to violate it in order to have committed a violation. The majority of states also have anti-kickback laws,
which establish similar prohibitions, and in some cases may apply to items or services reimbursed by any third-party payor, including
commercial insurers and self-pay patients.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
federal false claims, including the civil False Claims Act, prohibit, among other things, any person or entity from knowingly presenting,
or causing to be presented, a false, fictitious or fraudulent claim for payment to, or approval by, the federal government, knowingly
making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government,
or knowingly making a false statement to avoid, decrease or conceal an obligation to pay money to the U.S. federal government. A claim
includes &ldquo;any request or demand&rdquo; for money or property presented to the U.S. government. Actions under the civil False Claims
Act may be brought by the Attorney General or as a qui tam action by a private individual in the name of the government. Moreover, a
claim including items or services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent
claim for purposes of the federal civil False Claims Act. In addition, various states have enacted false claim laws analogous to the
federal False Claims Act, although many of these state laws apply where a claim is submitted to any third-party payor and not merely
a federal healthcare program.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
federal Health Insurance Portability and Accountability Act of 1996 created additional federal criminal statutes that prohibit, among
other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including
private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a
criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or
making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits,
items or services. Similar to the U.S. federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the
statute or specific intent to violate it in order to have committed a violation.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment
is available under Medicare, Medicaid or the Children&rsquo;s Health Insurance Program, with specific exceptions, to report annually
to CMS, information related to payments or other transfers of value made to physicians
(defined to include doctors, dentists, optometrists, podiatrists and chiropractors), and teaching hospitals, and applicable manufacturers
and applicable group purchasing organizations to report annually to CMS ownership and investment interests held by physicians and their
immediate family members. Beginning in 2022, such obligations will include payments and other transfers of value provided in the previous
year to additional healthcare professionals, including physician assistants, nurse practitioners, clinical nurse specialists, certified
nurse anesthetists, anesthesiologist assistants and certified nurse midwives.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Violations
of fraud and abuse laws, including federal and state anti-kickback and false claims laws, may be punishable by criminal and civil sanctions,
including fines and civil monetary penalties, the possibility of exclusion from federal healthcare programs (including Medicare and Medicaid),
disgorgement and corporate integrity agreements, which impose, among other things, rigorous operational and monitoring requirements on
companies. Similar sanctions and penalties, as well as imprisonment, also can be imposed upon executive officers and employees of such
companies.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Coverage
and Reimbursement</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United States, our currently cleared products are not separately reimbursed by any third-party payors and if covered, are paid for
as part of the procedure in which the product is used. Outside of the United States, there are many reimbursement programs through private
payors as well as government programs. In some countries, government reimbursement is the predominant program available to patients and
hospitals. Our commercial success depends in part on the extent to which governmental authorities, private health insurers and other
third-party payors provide coverage for and establish adequate reimbursement levels for the procedures in which our products are used.
Failure by physicians, hospitals, ambulatory surgery centers and other users of our products to obtain coverage and adequate reimbursement
from third-party payors for procedures in which our products are used, or adverse changes in government and private third-party payors&rsquo;
coverage and reimbursement policies, may adversely impact demand for our products.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on our experience to date, third-party payors generally reimburse for the procedures in which our products are used if medical necessity
is met and a prior approval is completed with a favorable response. Some payors are moving toward a managed care system and control
their healthcare costs by establishing coverage policies that categorically restrict coverage of certain procedures, or by limiting authorization
for procedures, including elective procedures using our devices. No uniform policy of coverage and reimbursement among payors in the
United States exists and coverage and reimbursement for procedures can differ significantly from payor to payor. Third-party payors are
increasingly auditing and challenging the prices charged for medical products and services with concern for upcoding, miscoding, using
inappropriate modifiers, or billing for inappropriate care settings. Some third-party payors must approve coverage for new or innovative
devices or procedures before they will reimburse healthcare providers who use the products or therapies. Even though a new product may
have been cleared for commercial distribution by the FDA, we may find limited demand for our product unless reimbursement approval can
be obtained and/or maintained from governmental and private third-party payors.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to uncertainties surrounding coverage policies, there are periodic changes to reimbursement levels. Third-party payors regularly
update reimbursement amounts and also from time to time revise the methodologies used to determine reimbursement amounts. This includes
routine updates to payments to physicians, hospitals and ambulatory surgery centers for procedures during which our products are used.
These updates could directly impact the demand for our products.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the overall escalating cost of medical products and services being paid for by the government and private health insurance has
led to, and will continue to lead to, increased pressures on the healthcare and medical device industry to reduce the costs of products
and services. Third-party payors are developing increasingly sophisticated methods of controlling healthcare costs through prospective
reimbursement and capitation programs, group purchasing, redesign of benefits, and exploration of more cost-effective methods of delivering
healthcare. In the United States, some insured individuals enroll in managed care programs, which monitor and often require pre-approval
of the services that a member will receive. Some managed care programs pay their providers on a per capita (patient) basis, which puts
the providers at financial risk for the services provided to their patients by paying these providers a predetermined payment per member
per month and, consequently, may limit the willingness of these providers to use our products.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
international markets, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted
price ceilings on specific product lines and procedures. In the European Union, member states are facing increased pressure to limit
public healthcare spending. There can be no assurance that procedures using our products will be covered for a specific indication, that
our products will be considered cost-effective by third-party payors, that an adequate level of reimbursement will be available or that
the third-party payors&rsquo; reimbursement policies will not adversely affect our ability to sell our products profitably. More and
more, local, product specific reimbursement law is applied as an overlay to medical device regulation, which has provided an additional
layer of clearance requirement.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Healthcare
Reform</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
United States and some foreign jurisdictions are considering or have enacted a number of legislative and regulatory proposals to change
the healthcare system in ways that could affect our ability to sell our products profitably. Among policy makers and payors in the United
States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare
costs, improving quality or expanding access. Current and future legislative proposals to further reform healthcare or reduce healthcare
costs may limit coverage of or lower reimbursement for the procedures associated with the use of our products. The cost containment measures
that payors and providers are instituting and the effect of any healthcare reform initiative implemented in the future could impact our
revenue from the sale of our products.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
implementation of the Affordable Care Act (the &ldquo;ACA&rdquo;) in the United States, for example, has changed healthcare financing
and delivery by both governmental and private insurers substantially, and affected medical device manufacturers significantly. The ACA,
among other things, provided incentives to programs that increase the federal government&rsquo;s comparative effectiveness research,
and implemented payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and
other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models. Additionally,
the ACA expanded eligibility criteria for Medicaid programs and created a new Patient-Centered Outcomes Research Institute to oversee,
identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research. Since its enactment,
there have been judicial, executive and political challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court
dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality
of the ACA. It is unclear how healthcare reform measures of the Biden administration or other efforts, if any, to challenge, repeal or
replace the ACA will impact the law or our business.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, other legislative changes have been proposed and adopted since the ACA was enacted. For example, the Budget Control Act of
2011, among other things, reduced Medicare payments to providers by 2% per fiscal year, effective on April 1, 2013 and, due to subsequent
legislative amendments to the statute, will remain in effect through 2030, with the exception of a temporary suspension from May 1, 2020
through March 31, 2021, unless additional Congressional action is taken. Additionally, the American Taxpayer Relief Act of 2012, among
other things, further reduced Medicare payments to several providers, including hospitals, and increased the statute of limitations period
for the government to recover overpayments to providers from three to five years. The Medicare Access and CHIP Reauthorization Act of
2015 repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed
annual updates and a new system of incentive payments that began in 2019 that are based on various performance measures and physicians&rsquo;
participation in alternative payment models, such as accountable care organizations.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect additional state and federal healthcare reform measures to be adopted in the future, any of which could limit the amounts that
federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products or
additional pricing pressure.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Data
Privacy and Security Laws</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerous
state, federal and foreign laws, including consumer protection laws and regulations, govern the collection, dissemination, use, access
to, confidentiality and security of personal information, including health-related information. In the United States, numerous federal
and state laws and regulations, including data breach notification laws, health information privacy and security laws, including HIPAA,
and federal and state consumer protection laws and regulations (e.g., Section 5 of the FTC Act), that govern the collection, use, disclosure,
and protection of health-related and other personal information could apply to our operations or the operations of our partners. In addition,
certain state and non-U.S. laws, such as the CCPA, the CPRA and the GDPR, govern the privacy and security of personal information, including
health-related information in certain circumstances, some of which are more stringent than HIPAA and many of which differ from each other
in significant ways and may not have the same effect, thus complicating compliance efforts. Failure to comply with these laws, where
applicable, can result in the imposition of significant civil and/or criminal penalties and private litigation. Privacy and security
laws, regulations, and other obligations are constantly evolving, may conflict with each other to complicate compliance efforts, and
can result in investigations, proceedings, or actions that lead to significant civil and/or criminal penalties and restrictions on data
processing.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Europe, the GDPR went into effect on May 25, 2018 and introduces strict requirements for processing the personal data of European Union
data subjects. Companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory
enforcement of data protection requirements and potential fines for noncompliance of up to &euro;20 million or 4% of the annual global
revenues of the preceding financial year of the noncompliant company, whichever is greater.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
other requirements, the GDPR regulates transfers of personal data subject to the GDPR to third countries that have not been found to
provide adequate protection to such personal data, including the United States, and the efficacy and longevity of current transfer mechanisms
between the EU and the United States remains uncertain. For example, in 2016, the EU and United States agreed to a transfer framework
for data transferred from the EU to the United States, called the Privacy Shield, but the Privacy Shield was invalidated in July 2020
by the Court of Justice of the European Union.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
from January 1, 2021, companies have to comply with the GDPR and also the United Kingdom General Data Protection Regulation, or the UK
GDPR, which, together with the amended UK Data Protection Act 2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines
under the GDPR, i.e., fines up to the greater of &euro;20 million (&pound;17.5 million) or 4% of global turnover. The relationship between
the United Kingdom and the European Union in relation to certain aspects of data protection law remains unclear, and it is also unclear
how United Kingdom data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from
the United Kingdom will be regulated in the long term. Currently there is a four- to six-month grace period agreed in the EU and United
Kingdom Trade and Cooperation Agreement, ending June 30, 2021 at the latest, while the parties discuss an adequacy decision. The European
Commission published a draft adequacy decision on February 19, 2021. If adopted, the decision will enable data transfers from EU member
states to the United Kingdom for a four-year period, subject to subsequent extensions.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Environmental
Matters</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on our current operations, environmental protection requirements do not have a significant financial and operational effect on the capital
expenditures, earnings and competitive position of our Company in the current financial year and are not expected to have a significant
effect in the reasonably foreseeable future.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Manufacturing Services Agreement</B></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On August 21, 2020, the Company entered into a
Manufacturing Services Agreement with GMI Corporation (&ldquo;GMI&rdquo;), dated as of August 21, 2020 (&ldquo;MSA&rdquo;), for the manufacture
and supply of the Company&rsquo;s IB-STIM device based upon the Company&rsquo;s product specifications as set forth in the MSA.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company provides the necessary equipment to
GMI and retains ownership. GMI bears the risk of loss of and damage to the equipment and consigned materials. Performance under the MSA
is initiated by orders issued by the Company and accepted by GMI.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The initial term of the MSA was 24 months and
automatically renews for terms of twelve months unless either party provides a written termination notice to the other party within 180
days prior to the end of the then-current term.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">GMI was established in
1990 and manufactures our IB-Stim device in its 69,000 square foot facility that including offices, factory, environmentally
controlled room, warehouse, parts processing, assembly, quality control, of which approximately 1,000 square feet is dedicated to
producing our product, located in Indiana.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">With controlled, repeatable, monitored production
process, GMI has kit production capacity that is sufficient for all our projected needs. There is a new, dedicated, environmentally controlled
build room built in 2022 for our equipment and production. All of our material are now maintained in this room.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">GMI has a quality management system that is ISO
13485:2016 certified, FDA registered, and ITAR registered.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In connection with the MSA, the Company entered
into a quality agreement with GMI, dated as of August 24, 2020, for GMI to test product provided by the Company and perform quality assurance
services.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of March 31, 2023, we had 17 full-time
employees and 1 part-time employee.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Facilities</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">Our
corporate headquarter is located in Carmel, Indiana, where we leased an office space for employees, <FONT STYLE="background-color: white">pursuant
to a lease agreement with SEPRO DEVELOPMENT COMPANY II, LLC. The three-year term of this lease commenced March 1, 2021 and is scheduled
to end on February 28, 2024. Over the term of this lease, base rent is $1,675.88 through March 2023, and $1,716.75 thereafter.
The lease may be extended for one year with an annual base rent of $21.50 per rentable square foot.</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="background-color: white"></FONT></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
also lease </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">981 rentable <FONT STYLE="background-color: white">square
feet of space in </FONT>Versailles<FONT STYLE="background-color: white">, Indiana, where we lease </FONT>a total of 3,825 rentable <FONT STYLE="background-color: white">square
feet of office space pursuant to two lease agreements with Hashbo Properties, LLC. The lease term of each lease agreement commenced January
1, 2022 and is scheduled to end December 31, 2023, with an automatic one year renewal. Rents are payable monthly at a rate of $1,664
and $469.85, respectively.</FONT></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may be involved in litigation relating to claims arising out of operations in the normal course of business.
As of March 31, 2023, other than those described below, there were no pending or threatened legal proceedings that could reasonably
be expected to have a material effect on the results of the Company&rsquo;s operations. There are also no proceedings in which any of
the Company&rsquo;s directors, officers or affiliates is an adverse party to the Company or has a material interest adverse to the Company&rsquo;s
interest.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2019, plaintiff Ritu Bhambhani, M.D., initiated a lawsuit against Innovative Health Solutions, Inc. and others in the
United States District Court for the District of Maryland. Plaintiffs Bhambhani and Sudhir Rao subsequently amended the complaint, with
the Third Amended Complaint (&ldquo;Complaint&rdquo;) containing the most recent set of allegations. The Complaint asserted claims under
the RICO Act, as well as of fraudulent misrepresentation, intentional misrepresentation by concealment, and civil conspiracy and sought
compensatory damages in excess of $5 million, pre-judgment interest, punitive damages, attorney&rsquo;s fees, court costs and designation
of the case as a class action. The Complaint states that the Company, distributors of the Company&rsquo;s product, and medical billing
and coding consultants allegedly made misrepresentations to the plaintiffs that the Company&rsquo;s NeuroStim device and related procedures
could be billed to, and reimbursed by, Medicare and other insurance payors as a surgically implantable neurostimulator. Plaintiffs claim
to have suffered damages when Medicare administrative contractors declined to pay plaintiffs for their use of the device.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 11, 2022, the Company filed a motion for summary judgment based upon the plaintiffs not being proper parties to assert claims
against the Company. On June 14, 2022, the Court granted the Company&rsquo;s motion for summary judgment and dismissed the
Complaint.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2022, plaintiffs Ritu Bhambhani and Sudhir Rao filed a notice of appeal with the Fourth Circuit Court of Appeals. The Company
filed a motion to dismiss. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">On January 4, 2023, the
Court issued an order that stated it was deferring a ruling on the motion to dismiss the appeal and that </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">it
would address those arguments at the same time that it addressed the substantive merits of the case. &nbsp;The parties&rsquo; appellate
briefing is scheduled to be concluded in early April 2023.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
While it is too early to predict the ultimate outcome of this matter, we continue to believe we have meritorious defenses, that the dismissal
of the Complaint should be upheld, and intend to continue to defend this matter vigorously.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2022, plaintiffs Ritu Bhambhani, LLC; Box Hill Surgery Center, LLC; Pain and Spine Specialists of Maryland, LLC; and
SimCare ASC, LLC initiated a lawsuit against the Company and others in the United States District Court for the District of Maryland.
The plaintiffs in this lawsuit are business entities owned or partially owned by the plaintiffs that initiated the litigation described
above. The Complaint asserted claims under the RICO Act, as well as fraudulent misrepresentation, intentional misrepresentation by
concealment, and civil conspiracy and seeks compensatory damages in excess of $75,000, pre-judgment interest, punitive damages, attorney&rsquo;s
fees, and court costs. The Complaint states that the Company, distributors of the Company&rsquo;s product, and medical billing and
coding consultants allegedly made misrepresentations to the plaintiffs that the Company&rsquo;s NeuroStim device and related procedures
could be billed to, and reimbursed by, Medicare and other insurance payors as a surgically implantable neurostimulator. Plaintiffs claim
to have suffered damages when Medicare administrative contractors declined to pay plaintiffs for their use of the device.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> On
May 26, 2023, we received notice from the Court that it had entered an Order and a Memorandum Opinion to rule upon the Company&rsquo;s motion
to dismiss. The Order and Memorandum Opinion are dated May 25, 2023. Substantively, the Order and Memorandum Opinion dismiss, with prejudice,
the plaintiffs&rsquo; attempt to assert Racketeering Influenced and Corrupt Organizations statutory claims. The Court further ruled that the
remaining claims are permitted to proceed. No trial date or other pretrial deadlines have been scheduled for this case. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
it is too early to predict the ultimate outcome of this matter, we believe we have meritorious defenses and intend to defend this matter
vigorously.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_001"></A>MANAGEMENT</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors were elected to serve until the next annual meeting of stockholders and until their respective successors will have been elected
and will and will have qualified. The following table sets forth the name, age, and position held with respect to our present executive
officers and directors and our director nominees.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directors
and Executive Officers</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to our directors and executive officers:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President,
    Chief Executive Officer, and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Seale</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
    Clarence*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
    Miranda*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Medical Officer, Senior Vice President of Science and Technology</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrico*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Regulatory Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Robin Brown</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    of Innovation and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Peterson*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    of Design and Engineering and Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
    Henrichs**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bradley
    Mitch Watkins**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beth
    Keyser**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Dan
Clarence, Adrian Miranda, Thomas Carrico, and Gary Peterson are current members of
our board of directors and have effectively resigned from the board of directors immediately upon the effectiveness of the registration
statement of which this prospectus forms a part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**Timothy
Henrichs, Bradley Mitch Watkins, and Beth Keyser have accepted nomination to our board of directors and will become members of our board
of directors immediately upon the effectiveness of the registration statement of which this prospectus forms a part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Brian
Carrico, President, Chief Executive Officer and Director</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
Carrico joined the Company in 2012. During his tenure, Mr. Carrico has held multiple leadership positions of increasing responsibility,
including Vice President of Sales and President before becoming CEO on January 1, 2018. As an early employee in the Company&rsquo;s life
cycle, Mr. Carrico was instrumental in setting the strategic agenda for the Company, raising start-up capital, championing new product
development, and bringing the Company&rsquo;s technology to market. Prior to joining Neuraxis, Mr. Carrico worked selling in the operating
room at Bard Medical and in the Cath lab at St. Jude Medical. He attended Indiana State University and holds a Bachelor of Science in
Business Marketing.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>John
Seale, Chief Financial Officer</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: #FEFEFE">John
Seale</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">is a certified public accountant and a certified
information technology professional. He has served as our Chief Financial Officer since August 2022 and is also the managing partner
of RBSK Partners PC (&ldquo;RBSK&rdquo;), a CPA firm that offers a blend of accounting, audit, tax and specialized advisory services
to individuals and business clients and has been with RBSK since 1984. Mr. Seale, through RBSK, has prepared the Company&rsquo;s
financial statements since 2017. Mr. <FONT STYLE="background-color: #FEFEFE">Seale</FONT> specializes in delivering services to
clients in a variety of industries, including health care, manufacturing, professional services, agriculture, warehousing, real estate
and not-for-profits. Mr. <FONT STYLE="background-color: #FEFEFE">Seale</FONT> is also  qualified to perform peer reviews of CPA firms
in accordance with standards established by the Peer Review Board of the AICPA.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
<FONT STYLE="background-color: #FEFEFE">Seale</FONT> is a member of the American Institute of CPAs (AICPA), the Indiana CPA Society,
the Ohio CPA Society and the Association of Certified Fraud Examiners. He formerly served on the Indiana Society&rsquo;s Peer Review
Committee and the Review Acceptance Board, is a former member of the AICPA Information Technology Executive Committee and was the designated
audit committee financial expert on the board of directors of MainSource Financial Group.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Dan
Clarence, Chief Operating Officer</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
Clarence, a proven senior executive with results oriented general management skills and a consistent track record of successful sales
and marketing initiatives over his career of thirty plus years, has served as our COO since 2018. Mr. Clarence attained a bachelor&rsquo;s
degree from Central Michigan University, followed by Graduate Studies at the University of Chicago MBA program.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
his role as VP of Sales and Senior Director of Sales at Euro-Pro/Shark Ninja, a multi-Billion dollar privately held corporation, from
2011 to 2018, Mr. Clarence was responsible for pioneering the Wal-Mart/Sam&rsquo;s Club business.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Adrian
Miranda, Chief Medical Officer, Senior Vice President of Science and Technology</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
Miranda has served as our Chief Medical Officer since 2018 and brings a unique background of research and clinical expertise to
his role. Prior to joining Neuraxis, Dr Miranda was an Assistant professor at the Medical College of Wisconsin. He is a board-certified
pediatric gastroenterologist. He obtained his undergraduate degree in Biology from San Diego State University and obtained his medical
degree from the Medical College of Wisconsin. He completed his residency and subspecialty training in pediatric gastroenterology at Children&rsquo;s
Hospital of Wisconsin.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a physician scientist, he has spent the past 20 years of his career investigating the pathophysiology of visceral and somatic pain, as
well as exploring new therapeutic options. His focus has been on studying the effects of adverse early life events, neuroplasticity and
the development of chronic pain. He has an extensive publication record and has lectured nationally and internationally.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Thomas
</I></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Carrico, Chief Regulatory Officer</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrico has served as our Chief Regulatory Officer
since November 2017. He joined the Company in February 2012 as Director of Regulatory Affairs. Prior to and during his early years with
Neuraxis, he was President &amp; Clinic Director at Spine and Neuromuscular Associates in Lawrenceburg, Indiana from January 2002 to
December 2018. He has over 40 years of experience in the healthcare field and has been involved in the study and application of techniques
and treatments that directly affect the autonomic nervous system, especially regarding homeostasis and balance of the parasympathetic
and the sympathetic nervous system. Dr. Carrico has a history of working with attorneys while serving on state and national boards, which
has positioned him to integrate into regulatory responsibilities at the Company. Dr. Carrico received his undergraduate education from
Indiana University and his Doctorate from Palmer College of Chiropractic.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Christopher
Robin Brown, Director of Innovation, Founder and Director</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Brown is a co-founder of the Company. He developed clinical protocol, initial practice guidelines, designed and implemented the practitioner
certification program, initiated the company 401K, and personally financed the first two years of the Company. After developing the technique
of transillumination to isolate auricular neurovascular bundles, he authored and designed the initial studies establishing neurovascular
and tissue energy transfer theories upon which the devices&rsquo; use are based. Dr. Brown established initial communications
with Dr. Thomas Carrico (Chief Regulatory Officer), Dr. Adrian Miranda (Chief Medical Officer), John Seale (Accountant &amp; CFO) and
our IP attorneys at Barnes and Thornburg. Dr. Brown is listed as the sole or principal inventor on all Neuraxis patents and is currently
active in further device development working closely with compliance, product design and engineering.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
graduation from the Indiana University School of Dentistry in 1982, while serving as clinic chief in the United States Army Reserve (USAR)
dental corps at Fort Benjamin Harrison in Indianapolis, Indiana, Dr. Brown started a private practice (current) concentrating in head,
neck, and facial pain developing the first hospital based facial pain clinic in Indiana. He received his master&rsquo;s degree in Biomechanical
Trauma in 1996 from Lynn University, one of only 12 dentists in the United States to hold the combination of DDS and MPS degrees. Dr.
Brown has authored several textbook chapters, published peer reviewed articles on the physics of soft tissue trauma, pain, financial
management, was regional editor for a national facial pain management Journal, and has lectured extensively nationally and internationally.
He served on the Board of Directors of the American Academy of Pain Management for 15 years, helping grow the organization from 800 members
to over 5000. Throughout his tenure, he developed educational tracks, served as Industry liaison, one term as treasurer and one term
as President. He served on the national board of The Alliance of TMD practitioners, serving one term as president.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Throughout
his career, Dr. Brown has been active in the purchasing and management of several destressed clinics, re-structuring them into profitable
enterprises. He has performed extensive volunteer work overseas providing surgical care in the Dominican Republic, local dental clinics
serving the underprivileged, and recently provided dental screenings for the deployment of soldiers in the USAR and National Guard.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Gary
Peterson, Director of Design and Engineering</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
Peterson is our founder, Director of Design and Engineering, and Director. Mr. Peterson was the Chief Executive Officer of the Company
from the time of founding in 2011 until January 1, 2018. Mr. Peterson then moved to a member of the board of directors and Director of
Design and Engineering of the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Timothy
Henrichs, Director</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
</FONT>Henrichs has been a finance executive for the last 14 years. Mr. Henrichs currently serves as the Chief Financial Officer
of HomeRenew Buyer, Inc. (d/b/a Renovo Home Partners), a privately held short-term home improvement installer of bathrooms, kitchens,
windows, doors, cabinets, roofing and siding across the United States. Prior to joining Renovo Home Partners, Mr. Henrichs served as
the Executive Vice President and Chief Financial Officer from 2008 to 2022 of Follett Corporation, a privately held retailer and distributor
of print and digital course materials, textbooks, trade books, library books and general merchandise and developer of software technology
to the educational market including 80,000 schools. From 2005 to 2008, Mr. Henrichs served as the Global Controller of General Electric
Company&rsquo;s Healthcare Clinical Systems division responsible for the manufacture and distribution of patient monitoring, maternal
and infant care, ultrasound, diagnostic cardiology and anesthesiology equipment. From 2003 to 2005, Mr. Henrichs served as the Financial
Reporting Manager at Federal Signal Corporation. From 1995 to 2003, Mr. Henrichs served in various roles of increasing responsibility
at Ernst &amp; Young LLP in Chicago, Illinois and Frankfurt, Germany including Capital Markets and Mergers and Acquisitions Transaction
Support, ultimately serving as a Senior Manager in the Audit and Assurance practice. Mr. Henrichs holds a B.B.A in Accounting from the
University of Notre Dame and is a Certified Public Accountant with an inactive license in the State of Illinois.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Bradley
Mitch Watkins, Director</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bradley
Mitch Watkins has overseen four companies through their early commercialization periods within the medical device sector over the last
12 years. He has reported to the CEO or BOD directly and operated as the lead for all field operations. These duties have groomed Mr.
Watkins with a wide array of responsibilities beyond sales, including marketing, clinical study design, manufacturing, research and development,
FDA submissions as well as fiscal oversight are all areas of experience and competence. Mr. Watkins has been the National Sales Manager
of Terumo Interventional Systems since 2015, where he has led multiple new technology sales teams within the peripheral IV and Electrophysiology
markets. He now manages corporate accounts and GPO contracts for the Cardiovascular line of products. Over his 18 years in a multitude
of medical device markets, Mr. Watkins has overseen $410 million in company acquisitions in an array of leadership roles. He has reported
directly to CEOs and Board of Directors and has thrived in early commercialization, recruitment, and strategic company direction. Mr.
Watkins received his bachelor&rsquo;s degree in Behavioral Science from the University of Maryland. Mr. Watkins agreed to join the Company&rsquo;s
board of directors with proven expertise in commercial operational efficiency and sales effectiveness for startups and large corporations.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Beth
Keyser, Director</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
more than 20 years&rsquo; experience in executive roles in population health, Beth Keyser is skilled at understanding the unique, complex
needs of multiple market segments and devises solutions that meet their specific goals. Ms.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Keyser is the President, BCBS of Indiana at Anthem, Inc. since 2020. From 2018 to 2020, Ms. Keyser served as the President, Create at
Brighton Health Plan Solutions. From 2015 to 2020, Ms. Keyser served as the Senior Vice President, International and Hawaii Markets at
Sharecare, Inc. Ms. Keyser received her master&rsquo;s degree in Executive Master of Science, Health Administration, from University
of Alabama at Birmingham.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Family
Relationships</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
Carrico, our Chief Executive Officer and Director, is the son of Thomas Carrico, our Chief Regulatory Officer. There are no other
family relationships between or among any of our executive officers or other directors.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Role
of the Board</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the paramount duty of the board to oversee our management in the competent and ethical operation of the Company on a day-to-day basis
and to assure that the long-term interests of the stockholders are being served. To satisfy this duty, the directors take a proactive,
focused approach to their positions, and set standards to ensure that we are committed to business success through maintenance of ambitious
standards of responsibility and ethics.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director
Terms; Qualifications</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors are elected for a term of one year and until their successors qualified, nominated, and appointed or elected.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
considering whether directors and nominees have the experience, qualifications, attributes and skills to enable the board of directors
to satisfy its oversight responsibilities effectively in light of the Company&rsquo;s business and structure, the board of directors
focuses primarily on the industry and transactional experience, and other background, in addition to any unique skills or attributes
associated with a director.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director
or Officer Involvement in Certain Legal Proceedings</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no material proceedings to which any director or officer, or any associate of any such director or officer, is a party that is adverse
to our Company or any of our subsidiaries or has a material interest adverse to our Company or any of our subsidiaries. No director or
executive officer has been a director or executive officer of any business which has filed a bankruptcy petition or had a bankruptcy
petition filed against it during the past ten years. No director or executive officer has been convicted of a criminal offense or is
the subject of a pending criminal proceeding during the past ten years. No director or executive officer has been the subject of any
order, judgment or decree of any court permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement
in any type of business, securities or banking activities during the past ten years. No director or officer has been found by a court
to have violated a federal or state securities or commodities law during the past ten years.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Directors
and Officers Liability Insurance</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company plans to obtain directors&rsquo; and officers&rsquo; liability insurance insuring its directors and officers against
liability for acts or omissions in their capacities as directors or officers, subject to certain exclusions. Such insurance may also
insure the Company against losses, which it may incur in indemnifying its officers and directors. In addition, officers and directors
also have indemnification rights under applicable laws, and the Company&rsquo;s Articles of Incorporation and Bylaws.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director
Independence</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
listing rules of Nasdaq require that independent directors must comprise a majority of a listed company&rsquo;s board of directors. In
addition, the rules of Nasdaq require that, subject to specified exceptions, each member of a listed company&rsquo;s audit, compensation,
and nominating and governance committees be independent. Audit committee members must also satisfy the independence criteria set forth
in Rule 10A-3 under the Exchange Act. Under the rules of Nasdaq, a director will only qualify as an &ldquo;independent director&rdquo;
if, in the opinion of that company&rsquo;s board of directors, that person does not have a relationship that would interfere with the
exercise of independent judgment in carrying out the responsibilities of a director.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has undertaken a review of the independence of our directors and considered whether any director has a material relationship
with it that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. Based
upon information requested from and provided by each director concerning his background, employment and affiliations, including family
relationships, the board of directors has determined that three are &ldquo;independent&rdquo; as that term is defined under the applicable
rules and regulations of the SEC and the listing standards of Nasdaq. In making these determinations, our board of directors considered
the current and prior relationships that each non-employee director has with the Company and all other facts and circumstances our board
of directors deemed relevant in determining their independence.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Committees</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the effectiveness of the registration statement of which this prospectus forms a part, the following three standing committees will
be established: Audit Committee; Compensation Committee; and Nominating and Corporate Governance Committee. Each
of our independent directors, Timothy Henrichs, Bradley Mitch Watkins, and Beth Keyser, will serve on each committee. Our board has adopted
written charters for each of these committees, and those charters will be effective upon the effectiveness of the registration statement
of which this prospectus forms a part. Upon completion of this offering, copies of the charters will be available on our website. Our
board may establish other committees as it deems necessary or appropriate from time to time.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
Committee</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee, among other things, will be responsible for:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing;
    approving the compensation of; overseeing the work of; and assessing the independence, qualifications, and performance of the independent
    auditor;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    the internal audit function, including its independence, plans, and budget;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving,
    in advance, audit and any permissible non-audit services performed by our independent auditor;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    our internal controls with the independent auditor, the internal auditor, and management;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    the adequacy of our accounting and financial controls as reported by the independent auditor, the internal auditor, and management;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    our financial compliance system; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    our major risk exposures regarding the Company&rsquo;s accounting and financial reporting policies, the activities of our internal
    audit function, and information technology.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors has affirmatively determined that each member of the Audit Committee meets the additional independence criteria applicable
to audit committee members under SEC rules and Nasdaq listing rules. Effective upon the completion of this offering the board of directors
will adopt a written charter setting forth the authority and responsibilities of the Audit Committee. The board of directors has affirmatively
determined that each member of the Audit Committee is financially literate, and that Mr. Henrichs meets the qualifications of an Audit
Committee financial expert.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee will consist of Timothy Henrichs, Bradley Mitch Watkins, and Beth Keyser. Mr. Henrichs will chair the Audit Committee.
We believe that, after consummation of this offering, the functioning of the Audit Committee will comply with the applicable requirements
of the rules and regulations of the Nasdaq listing rules and the SEC.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee will be responsible for:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#9679;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and making recommendations to the Board with respect to the compensation of our officers and directors, including the CEO;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    and administering the Company&rsquo;s executive compensation plans, including equity-based awards;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">negotiating
    and overseeing employment agreements with officers and directors; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    how the Company&rsquo;s compensation policies and practices may affect the Company&rsquo;s risk management practices and/or risk-taking
    incentives.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee will consist of Timothy Henrichs, Bradley Mitch Watkins, and Beth Keyser, and Mr. Watkins will serve as chair
of the Compensation Committee. The board of directors has affirmatively determined that each member of the Compensation Committee meets
the independence criteria applicable to compensation committee members under SEC rules and Nasdaq listing rules. The Company believes
that, after the consummation of the offering, the composition of the Compensation Committee will meet the requirements for independence
under, and the functioning of such Compensation Committee will comply with, any applicable requirements of the rules and regulations
of Nasdaq listing rules and the SEC.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Nominating
and Corporate Governance Committee</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee, among other things, will be responsible for:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and assessing the development of the executive officers and considering and making recommendations to the Board regarding promotion
    and succession issues;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating
    and reporting to the Board on the performance and effectiveness of the directors, committees and the board of directors as a whole;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">working
    with the board to determine the appropriate and desirable mix of characteristics, skills, expertise and experience, including diversity
    considerations, for the full Board and each committee;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually
    presenting to the board a list of individuals recommended to be nominated for election to the board;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing,
    evaluating, and recommending changes to the Company&rsquo;s committee charters;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    to the board individuals to be elected to fill vacancies and newly created directorships;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    the Company&rsquo;s compliance program, including the Code of Conduct; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    and evaluating how the Company&rsquo;s corporate governance and legal and regulatory compliance policies and practices, including
    leadership, structure, and succession planning, that may affect the Company&rsquo;s major risk exposures.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee will consist of Timothy Henrichs, Bradley Mitch Watkins, and Ms. Keyser will serve as chair.
The Company&rsquo;s board of directors has determined that each member of the Nominating and Corporate Governance Committee is independent
within the meaning of the independent director guidelines of Nasdaq listing rules.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee Interlocks and Insider Participation</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&rsquo;s executive officers serves, or in the past has served, as a member of the board of directors or compensation committee,
or other committee serving an equivalent function, of any entity that has one or more executive officers who serve as members of the
Company&rsquo;s board of directors or its compensation committee. None of the members of the Company&rsquo;s compensation committee is,
or has ever been, an officer or employee of the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s board of directors has adopted a code of business conduct and ethics (&ldquo;Code of Conduct&rdquo;) applicable to its
employees, directors and officers, in accordance with applicable U.S. federal securities laws and the corporate governance rules of Nasdaq.
The Code of Conduct will be effective upon the effectiveness of the registration statement of which this prospectus forms a part and
publicly available on the Company&rsquo;s website following completion of this offering. Any substantive amendments or waivers of the
Code of Conduct may be made only by the Company&rsquo;s board of directors and will be promptly disclosed as required by applicable U.S.
federal securities laws and the corporate governance rules of Nasdaq.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_002"></A>EXECUTIVE
OFFICER AND DIRECTOR COMPENSATION</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Officers Compensation</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Summary
Compensation Table</I></B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning all compensation earned by or paid to our Chief Executive Officer and two other persons
who served as executive officers as, at, or during the year ended December 31, 2022, and who earned compensation exceeding $100,000
during 2022 (the &ldquo;Named Executive Officers&rdquo;), for services as executive officers for the last two years.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Name and Principal Position</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Salary ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Bonus($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Total($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%; text-align: left">Brian Carrico</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: center">2022</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">373,578</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">373,578</P></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">369,231</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">494,732</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">863,963</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Thomas Carrico</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">287,196</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">&mdash;</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">287,196</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Regulatory Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">297,347</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">141,243</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">438,590</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adrian Miranda</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,346</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">&mdash;</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">266,346</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Medical Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">254,231</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">&mdash;</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">254,231</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>





<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents payments to
  our executive officers pursuant to their respective employment agreements. For more information, see &ldquo; <I>&mdash;Employment Agreements.</I></FONT></TD></TR>
</TABLE>



<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at Fiscal Year-End</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding equity awards held by the Named Executive Officers as of December 31, 2022.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Name</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Securities Underlying Unexercised Options, Exercisable (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Securities Underlying Unexercised Options, Not Exercisable (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">Option</P>
                                                                                <P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">Exercise</P>
                                                                                <P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">Price</P>
                                                                                <P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">($)</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">Option</P>
                                                                                <P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">Expiration</P>
                                                                                <P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">Date</P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 32%; text-align: left">Brian Carrico</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">320,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">6.94</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 12%">09/13/29</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Thomas Carrico</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">306,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.94</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">09/13/29</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adrian Miranda</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">337,204</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.94</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">09/13/29</TD></TR>
  </TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    option awards were granted under the Innovative Health Solutions, Inc. 2017 Stock Compensation Plan and vested
    fully upon grant.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Innovative Health Solutions,
Inc. 2017 Stock Compensation Plan, As Amended</B></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On October 12, 2017, the Company adopted
the Innovative Health Solutions, Inc. 2017 Stock Compensation Plan, as amended on September 13, 2019, September 9, 2021, and November
1, 2022 (collectively, the &ldquo;2017 Plan&rdquo;). The purpose of the 2017 Plan is to grant incentive stock options, nonqualified stock
options, or restricted stock awards to our officers, employees, directors, advisors, and consultants. The maximum numbers of shares of
common stock that may be issued pursuant to awards granted were 1,319,394. Cancelled and forfeited stock options and stock awards may
again become available for grant under the 2017 Plan. As of the date of March 31, 2023, options to purchase all 1,319,394 shares
of common stock have been granted under the 2017 Plan and remain outstanding, and no shares remain available for issuance under the 2017
Plan. The following summary briefly describes the principal features of the 2017 Plan and is qualified in its entirety by reference to
the full text of the 2017 Plan, which is filed as an exhibit to the registration statement of which this prospectus forms a part.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Purpose
of the 2017 Plan</I>: The purposes of the 2017 Plan are to encourage ownership of shares by eligible employees and key
non-employees in order to attract and retain such eligible employees in the employ of the Company or an affiliated entity, or to attract
such key non-employees to provide services to the Company or an affiliated entity, and to provide additional incentive for such persons
to promote the long-term success of the Company or an affiliated entity.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Administration
of the Plan</I>: The 2017 Plan is administered by the board of directors, or the committee to which the board of directors delegates
the power to act. Among other things, the administrator has the authority to select persons who will receive awards, determine the types
of awards and the number of shares to be covered by awards, and to establish the terms, conditions, restrictions and other provisions
of awards. The administrator has authority to establish, amend and rescind rules and regulations relating to the 2017 Plan.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eligible
Recipients</I>: Persons eligible to receive awards under the 2017 Plan are those officers, employees, directors, advisors, and
consultants of the Company or an affiliated entity who are selected by the administrator.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><I>Shares Available under the 2017 Plan</I>:
The maximum number of shares of our common stock that may be delivered to participants under the 2017 Plan is 1,319,394 shares,
subject to adjustment for certain corporate changes affecting the shares, such as stock splits. No new grants will be made under the
2017 Plan, and shares subject to an award under the 2017 Plan for which the award is canceled, forfeited or expires will become available
for grants under the 2022 Plan described below. Shares subject to an award that is settled in cash will not again be made available for
grants under the 2017 Plan.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Options</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General</U><I>.
</I>Subject to the provisions of the 2017 Plan, the administrator has the authority to determine all grants of stock options,
although there are currently no shares of common stock remaining reserved for grants under the 2017 Plan.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Option
Price</U>. The exercise price for stock options is determined at the time of grant. The exercise price may not be less
than the fair market value on the date of grant. Additionally, incentive stock option grants to any person owning more than 10%
of our voting stock must have an exercise price of not less than 110% of the fair market value on the grant date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
of Options</U><I>.</I> An option may be exercised only in accordance with the terms and conditions for the option agreement as established
by the administrator at the time of the grant. The option must be exercised by notice to us, accompanied by payment of the exercise price.
Payments may be made in cash or, at the option of the administrator, by actual or constructive delivery of shares of common stock to
the holder of the option based upon the fair market value of the shares on the date of exercise.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Expiration
or Termination</U><I>.</I> Options, if not previously exercised, will expire on the expiration date established by the administrator
at the time of grant. In the case of incentive stock options, such term cannot exceed ten years provided that in the case of holders
of more than 10% of our voting stock, such term cannot exceed five years. Options will terminate before their expiration date only if
the holder&rsquo;s service with our Company or an affiliate terminates before the expiration date and the holder is terminated
for cause. The option may remain exercisable until the expiration date of the option after terminations of employment for any reason
other than for cause, including terminations as a result of death, disability or retirement.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Incentive
and Non-Qualified Options</U><I>.</I> An incentive stock option is an option that is intended to qualify under certain provisions of
the Internal Revenue Code, for more favorable tax treatment than applies to non-qualified stock options. Any option that does not
qualify as an incentive stock option will be a non-qualified stock option. Under the Code, certain restrictions apply to incentive
stock options. For example, the exercise price for incentive stock options may not be less than the fair market value of the shares
on the grant date and the term of the option may not exceed ten years. In addition, an incentive stock option may not be
transferred, other than by will or the laws of descent and distribution and is exercisable during the holder&rsquo;s lifetime only
by the holder. In addition, no incentive stock options may be granted to a holder that is first exercisable in a single year if that
option, together with all incentive stock options previously granted to the holder that also first become exercisable in that year,
relate to shares having an aggregate market value in excess of $100,000, measured at the grant date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><I>Restricted Stock Awards:</I> Restricted stock
awards could have also been granted under the 2017 Plan, although there are currently no shares of common stock
remaining reserved for grants under the 2017 Plan. A restricted stock award is a grant of shares of common stock or of a right
to receive shares in the future.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Material Provisions</I><B>:</B> Awards are evidenced by a written agreement, in such form as may be approved by the administrator. In
the event of various changes to the capitalization of our Company, such as stock splits, stock dividends and similar re-capitalizations,
an appropriate adjustment will be made by the administrator to the number of shares covered by outstanding awards or to the exercise
price of such awards. The administrator is also permitted to include in the written agreement provisions that provide for certain changes
in the award in the event of a change of control of our Company, including acceleration of vesting. Except as otherwise determined
by the administrator at the date of grant, awards will not be transferable, other than by will or the laws of descent and distribution.
Prior to any award distribution, we are permitted to deduct or withhold amounts sufficient to satisfy any employee withholding tax requirements.
Our board of directors also has the authority, at any time, to discontinue the granting of awards. The Plan may be amended by the board
of directors and such amendment shall become effective upon adoption by the board of directors; provided, however, that any amendment
shall be subject to the approval of the stockholders of the Company at or before the next annual meeting of the stockholders of the Company
if such stockholder approval is required by applicable laws. No amendment that would adversely affect any outstanding award made under
the Plan can be made without the consent of the holder of such award.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">No new grants can be made under the
2017 Plan. The terms and conditions of awards granted under the 2017 Plan prior to the effective date of the 2022 Plan
will not be affected by the adoption or approval of the 2022 Plan, and the 2017 Plan will remain effective with respect to such
awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. 2022 Omnibus Securities and Incentive Plan, As Amended</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On November 1, 2022, the Company adopted the
Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (as amended January 18, 2023, the &ldquo;2022 Plan&rdquo;). The purpose
of the 2022 Plan is to attract, retain and provide incentives to key management employees and non-employee directors of, and non-employee
consultants to, the Company and its affiliates, and to align the interests of such employees, non-employee directors and non-employee
consultants with those of the Company&rsquo;s stockholders. The maximum numbers of shares of common stock that may be issued pursuant
to awards granted are 300,000. Cancelled and forfeited stock options and stock awards may again become available for grant under
the 2022 Plan. As of the date of this prospectus, no awards have been granted under the 2022 Plan, and 300,000 shares of
common stock remain available for issuance under the 2022 Plan. The following summary briefly describes the principal features of the
2022 Plan and is qualified in its entirety by reference to the full text of the 2022 Plan.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Purpose
of the 2022 Plan</I>: The purposes of the 2022 Plan is to benefit the stockholders of the Company, by assisting the Company to
attract, retain and provide incentives to key management employees and non-employee directors of, and non-employee consultants to,
the Company and its affiliates, and to align the interests of such employees, non-employee directors and non-employee consultants
with those of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Administration
of the 2022 Plan</I>: The 2022 Plan shall be administered by the board of directors or the committee designated by the board of directors.
Among other things, the administrator has the authority to select persons who will receive awards, determine the time or times when an
award shall be made, what type of award shall be granted, the term of an award, the date or dates on which an award vests (including
acceleration of vesting), the form of any payment to be made pursuant to an award, the terms and conditions of an award (including the
forfeiture of the award (and/or any financial gain) if the holder of the award violates any applicable restrictive covenant thereof),
the restrictions under a restricted stock award and the number of common stock which may be issued under an award, all as applicable.
In addition, subject to the express provisions of the 2022 Plan, the administrator is authorized to construe the 2022 Plan and the respective
award agreements executed thereunder, to prescribe such rules and regulations relating to the 2022 Plan as it may deem advisable to carry
out the intent of the 2022 Plan, to determine the terms, restrictions and provisions of each award, and to make all other determinations
necessary or advisable for administering the 2022 Plan.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Eligible
Recipients</I>: Persons eligible to receive awards under the 2022 Plan will be those officers, employees, directors, advisors, and consultants
of the Company or an affiliated entity who are selected by the administrator.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shares
Available under the Plan</I>: The maximum number of shares of our common stock that may be delivered to participants under the 2022 Plan
is 300,000 shares, subject to adjustment for certain corporate changes affecting the shares, such as stock splits. Shares subject
to an award under the 2022 Plan for which the award is lapses, expires, is canceled, terminated unexercised or ceases to be exercisable
again become available for grants under the 2022 Plan.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Options</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>General.
</I>Subject to the provisions of the 2022 Plan, the administrator has the authority to determine all grants of stock options.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Option
Price.</I> The exercise price for stock options is determined at the time of grant. The exercise price may not be less than the fair
market value on the date of grant. Additionally, incentive stock option grants to any person owning more than 10% of our voting stock
must have an exercise price of not less than 110% of the fair market value on the grant date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Exercise
of Options.</I> An option may be exercised only in accordance with the terms and conditions for the option agreement as established by
the administrator at the time of the grant. The option must be exercised by notice to us, accompanied by payment of the exercise price.
Payments may be made in cash or, at the option of the administrator, by actual or constructive delivery of shares of common stock to
the holder of the option based upon the fair market value of the shares on the date of exercise.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Expiration
or Termination.</I> Options, if not previously exercised, will expire on the expiration date established by the administrator at the
time of grant. In the case of incentive stock options, such term cannot exceed ten years provided that in the case of holders of more
than 10% of our voting stock, such term cannot exceed five years. Options will terminate before their expiration date if the holder&rsquo;s
service with our Company or a subsidiary terminates before the expiration date. The option may remain exercisable for specified periods
after certain terminations of employment, including terminations as a result of death, disability or retirement, with the precise period
during which the option may be exercised to be established by the administrator and reflected in the grant evidencing the award.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Incentive
and Non-Qualified Options.</I> As described elsewhere in this summary, an incentive stock option is an option that is intended to qualify
under certain provisions of the Code, for more favorable tax treatment than applies to non-qualified stock options. Any option that does
not qualify as an incentive stock option will be a non-qualified stock option. Under the Code, certain restrictions apply to incentive
stock options. For example, generally, the exercise price for incentive stock options may not be less than the fair market value of the
shares on the grant date and the term of the option may not exceed ten years. In addition, an incentive stock option may not be transferred,
other than by will or the laws of descent and distribution, and is exercisable during the holder&rsquo;s lifetime only by the holder.
In addition, to the extent that the aggregate fair market value of common stock with respect to which incentive stock options are exercisable
for the first time by an individual during any calendar year under all plans of the Company and any parent corporation or subsidiary
corporation thereof which provide for the grant of incentive stock options exceeds $100,000, the portion of such incentive stock options
that exceeds such threshold shall be treated as non-qualified stock options. Incentive stock options shall be granted to employees only.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock Awards:</I> Restricted stock awards can be granted under the 2022 Plan. A restricted stock award is a grant of shares of common
stock or of a right to receive shares in the future. These awards will be subject to such conditions, restrictions and contingencies
as the administrator shall determine at the date of grant. Those may include requirements for continuous service and/or the achievement
of specified performance goals.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Unrestricted
Stock Awards</I>: Unrestricted stock awards can also be granted under the 2022 Plan. An unrestricted stock award is a grant of shares
of common stock which is not subject to restrictions, in consideration for past services rendered thereby to the Company or an affiliate
or for other valid consideration.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Restricted
Stock Unit Awards</I>: Restricted stock unit awards (&ldquo;RSUs&rdquo;) can be granted under the 2022 Plan upon the satisfaction
of predetermined individual service related vesting requirements. The holder of a restricted stock unit shall be entitled to receive
a cash payment equal to the fair market value of shares of common stock, for each unit awarded to the holder.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Performance
Stock Unit Awards</I>: Performance stock unit awards can be granted under the 2022 Plan. A holder of performance stock units shall be
entitled to receive a cash payment equal to the dollar value or number of shares of common stock assigned to such units if the holder
and/or the Company satisfy the predetermined performance goals and objectives.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Distribution
Equivalent Rights</I>: Distribution equivalent right awards can be granted under the 2022 Plan. A distribution equivalent right award
entitles the holder to receive bookkeeping credits, cash payments and/or common stock distributions equal in amount to the distributions
that would have been made to the holder had the holder held a specified number of common stock during the period the holder held the
distribution equivalent right.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock
Appreciation Right</I>s: Stock appreciation rights can also be granted under the 2022 Plan, which is a right, granted alone or in
connection with a related Option, to receive a payment on the date of exercise. The base value of the stock appreciation right shall
be set forth by the administrator and shall not be less than the fair market value of the common stock at the date of grant for the
stock appreciation right which is not a tandem stock appreciation right. No stock appreciation right shall be exercisable after the
expiration of ten (10) years from the date of its grant. Upon the exercise of some or all of the portion of a stock appreciation
right, the holder shall receive a payment from the Company, in cash or in the form of common stock having an equivalent fair market
value or in a combination of both. If the administrator grants a stock appreciation right which is intended to be a tandem stock
appreciation right, the tandem stock appreciation right shall be granted at the same time as the related option.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Material Provisions</I>: Awards are evidenced by a written agreement, in such form as may be approved by the administrator. In the event
of various changes to the capitalization of our Company, such as stock splits, stock dividends and similar re-capitalizations,
an appropriate adjustment will be made by the administrator to the number of shares covered by outstanding awards or to the exercise
price of such awards. The administrator is also permitted to include in the written agreement provisions that provide for certain changes
in the award in the event of a change of control of our Company, including acceleration of vesting. Except as otherwise determined
by the administrator at the date of grant, awards will not be transferable, other than by will or the laws of descent and distribution.
Prior to any award distribution, we are permitted to deduct or withhold amounts sufficient to satisfy any employee withholding tax requirements.
Our board of directors also has the authority, at any time, to discontinue the granting of awards. The 2022 Plan may be amended by the
board of directors and such amendment shall become effective upon adoption by the board of directors; provided, however, that any amendment
shall be subject to the approval of the stockholders of the Company at or before the next annual meeting of the stockholders of the Company
if such stockholder approval is required by applicable laws. No amendment that would adversely affect any outstanding award made under
the 2022 Plan can be made without the consent of the holder of such award. The 2022 Plan shall continue in effect, unless sooner terminated,
until the tenth (10th) anniversary of the date on which it is adopted by the board of directors.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employment
Agreements</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Brian
Carrico</I>, our Chief Executive Officer, entered into an employment agreement with the Company, dated August 9, 2022 and amended
on May 4, 2023, which has a five-year initial term and provides for a base salary of $330,000, which shall be increased each year
by not less than 3% per annum. Mr. Carrico also will receive a one-time incentive payment in the amount of $435,577, which
amount consists of accrued and unpaid salary and a bonus to incentivize Mr. Carrico to remain with the Company for future service. Neither
the accrued and unpaid salary nor bonus was the subject of any contract or agreement between Mr. Carrico and the Company
prior to the execution of the employment agreement. The agreement contemplated that the incentive payment would be paid by December 15,
2022, but due to administrative impracticability, payment will now be made with a portion of the proceeds from this offering. See &ldquo;<I>Use
of Proceeds</I>.&rdquo; In addition, Mr. Carrico is entitled to payment of a deferred bonus in an amount equal to (i) the aggregate of
the strike price or exercise price of all 320,000 unexercised options to purchase stock or shares of the Company held by Mr. Carrico
(the &ldquo;Aggregate Strike Price&rdquo;) plus (ii) a tax gross-up payment on the Aggregate Strike Price reasonably calculated by the
Company at the highest marginal rates so that after payment of all ordinary income taxes on such Aggregate Strike Price, there remains
an amount sufficient to pay such ordinary income taxes. The special deferred bonus will be paid in substantially equal 20% installments
(the &ldquo;Annual Deferred Bonus Payment&rdquo;) on January 2 on each of 2024, 2025, 2026, 2027, and 2028 (the &ldquo;Scheduled
Payment Dates&rdquo;), with a condition that on or before each Scheduled Payment Date, Mr. Carrico shall exercise at least
64,000 of the stock options; provided, however, Mr. Carrico shall not receive any Annual Deferred Bonus Payment unless this offering
is effective. If a Scheduled Payment Date occurs prior to the effective date of this offering, the corresponding Annual Deferred Bonus
Payment will be forfeited. Mr. Carrico may exercise any portion of the stock options after a Scheduled Payment Date; provided, however,
an exercise after the applicable Scheduled Payment Date shall result in forfeiture of the related Annual Deferred Bonus Payment. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company without cause (as defined in the employment agreement), Mr. Carrico will receive any accrued compensation (as defined
in the employment agreement) and is entitled to severance payments as follows:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs during the initial term, the severance payment shall be the amount equal
                                            to the greater of (a) three times Mr. Carrico&rsquo;s base salary as of the termination date;
                                            and (b) three times the total amount of Mr. Carrico&rsquo;s bonus payments the Company paid
                                            Mr. Carrico over the one year prior to the termination date, to be paid in substantially
                                            equal monthly installments over the course of the three years.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs after the initial term, the severance payment shall be the amount equal
                                            to the greater of (a) one and one half (1.5) times Mr. Carrico&rsquo;s base salary as of
                                            the termination date; and (b) one and one half (1.5) times the total amount of Mr. Carrico&rsquo;s
                                            bonus payments the Company paid Mr. Carrico over the one (1) year prior to the termination
                                            date, to be paid in substantially equal monthly installments over the course of 18 months
                                            following the termination date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, as part of the severance payment, we agreed to pay Mr. Carrico monthly COBRA premiums
                                            for continuation of health coverage for 18 months post termination.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company for cause, Mr. Carrico will forfeit any unpaid Annual Deferred Bonus Payment, but will receive any unpaid base salary that has been
earned at the time of such termination, reimbursement of any expenses properly incurred prior to the Mr. Carrico&rsquo;s termination
date; and accrued and unused paid time off (&ldquo;PTO&rdquo;), if any, in accordance with the Company&rsquo;s PTO policy in effect on
Mr. Carrico&rsquo;s termination date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Carrico may terminate the employment agreement without good reason upon more than thirty (30) days&rsquo; prior written notice or for
good reason without prior written consent, and will receive accrued compensation (as defined in the employment agreement) and the unpaid
balance of the deferred bonus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> In the event that Mr. Carrico is terminated without
cause after this offering, non-forfeited portions of the deferred bonus will be paid in equal installments over the remaining scheduled
payment dates, if vested options as scheduled are exercised before the scheduled payment dates. A deferred bonus tranche will be forfeited
if its corresponding options have expired. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> On a change in control (as defined in the employment agreement), full vesting of the Annual
Deferred Bonus Payment will occur and be paid in a single lump sum within 30 days after the change in control. The offering shall not
be considered a change in control. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, Mr. Carrico also agreed to (i) not disclose to any unauthorized person or use for his own account any confidential
information without the prior written consent of the Company or the board of directors, (ii) will not, directly or indirectly encourage,
solicit, induce (or attempt to encourage, solicit or induce) any employee or agent of the Company that was employed (or otherwise engaged)
at the time of his separation during his employment and for 24 months after his separation from that employment for any reason; (iii)
will not, directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have
any business connection or business or employment relationship with any entity or person which competes with Company; (iv) will not,
directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have any business
connection or business or employment relationship with any entity or person which competes with the Company during his employment and,
(v) will not, directly or indirectly and in a competitive capacity own, manage, finance, operate, control or participate in ownership,
management, or operation of, act as an agent, consultant, or be employed with, any business engaged in the design, manufacture, marketing,
sale or servicing of any service or product with which Mr. Carrico was involved during his last year of employment with the Company;
or which the Company is developing, producing, marketing, selling or servicing (or plans to develop, produce, market, sale or service)
and about which Mr. Carrico gained any confidential information in the course of his employment with the Company for a period of 24 months
after his separation from the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dan
Clarence</I>, our Chief Operating Officer, entered into an employment agreement with the Company, dated August 9, 2022 and amended
on May 4, 2023, which provides has a two-year initial term and provides for a base salary of $275,000 with annual compensation increase.
Mr. Clarence also will receive a one-time incentive payment in the amount of $34,889, which amount includes accrued and unpaid
salary and a bonus to incentivize Mr. Clarence to remain with the Company for future service. Neither the accrued and unpaid salary nor
bonus was the subject of any contract or agreement between Mr. Clarence and the Company prior to the execution of the employment
agreement. The agreement contemplated that the incentive payment would be paid by December 15, 2022, but due to administrative impracticability,
payment will now be made with a portion of the proceeds from this offering. See &ldquo;<I>Use of Proceeds</I>.&rdquo; In addition, Mr.
Clarence shall be entitled to payment of a deferred bonus in an amount equal to (i) the aggregate of the strike price or exercise price
of all 68,818 unexercised options to purchase stock or shares of the Company held by Mr. Clarence (the &ldquo;Aggregate Strike Price&rdquo;)
plus (ii) a tax gross-up payment on the Aggregate Strike Price reasonably calculated by the Company at the highest marginal rates so
that after payment of all ordinary income taxes on such Aggregate Strike Price, there remains an amount sufficient to pay such ordinary
income taxes. The special deferred bonus will be paid in substantially equal 20% installments (the &ldquo;Annual Deferred Bonus Payment&rdquo;)
on January 2 on each of 2024, 2025, 2026, 2027, and 2028 (the &ldquo;Scheduled Payment Dates&rdquo;), with a condition that
on or before each Scheduled Payment Date, Mr. Clarence shall exercise at least 13,764 of the stock options; provided, however,
Mr. Clarence shall not receive any Annual Deferred Bonus Payment unless this offering is effective. If a Scheduled Payment Date occurs
prior to the effective date of this offering, the corresponding Annual Deferred Bonus Payment will be forfeited. Mr. Clarence may exercise
any portion of the stock options after a Scheduled Payment Date; provided, however, an exercise after the applicable Scheduled Payment
Date shall result in forfeiture of the related Annual Deferred Bonus Payment. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company without cause (as defined in the employment agreement) occurs during the term of the agreement, Mr. Clarence will
receive any accrued compensation (as defined in the employment agreement) and is entitled to certain amount of severance payments as
follows:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs during the initial term, the Company shall provide Mr. Clarence with severance
                                            compensation in the form of salary continuation at his Base Salary as of the termination
                                            date and ending the later of (i) 6 months or (ii) on the expiration date of the initial term.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs after the initial term, the severance payment shall be the amount equal
                                            to one half (1/2) of Mr. Clarence&rsquo;s Base Salary as of the termination date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, if termination occurs during the initial term, as part of the severance payment,
                                            we agreed to pay Mr. Clarence reimbursement of his monthly COBRA premiums for continuation
                                            of health coverage for 18 months post termination.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company for cause, Mr. Clarence will forfeit any unpaid Annual Deferred Bonus Payment, but will receive any unpaid base salary that has been
earned at the time of such termination, reimbursement of any expenses properly incurred prior to the Mr. Clarence&rsquo;s termination
date; and accrued and unused PTO, if any, in accordance with the Company&rsquo;s PTO policy in effect on Mr. Clarence&rsquo;s termination
date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Clarence may terminate the employment agreement without good reason upon more than thirty (30) days&rsquo; prior written notice or for
good reason without prior written consent and will receive accrued compensation (as defined in the employment agreement) and the unpaid
balance of the deferred bonus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> In
the event that Mr. Clarence is terminated without cause after this offering, non-forfeited portions of the deferred bonus will be paid
in equal installments over the remaining scheduled payment dates, if vested options as scheduled are exercised before the scheduled payment
dates. A deferred bonus tranche will be forfeited if its corresponding options have expired. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> On
a change in control (as defined in the employment agreement), full vesting of the Annual Deferred Bonus Payment will occur and be paid
in a single lump sum within 30 days after the change in control. The offering shall not be considered a change in control. </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, Mr. Clarence also agreed to (i) not disclose to any unauthorized person or use for his own account any confidential
information without the prior written consent of the Company or the board of directors, (ii) will not, directly or indirectly encourage,
solicit, induce (or attempt to encourage, solicit or induce) any employee or agent of the Company that was employed (or otherwise engaged)
at the time of his separation during his employment and for 24 months after his separation from that employment for any reason; (iii)
will not, directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have
any business connection or business or employment relationship with any entity or person which competes with Company; (iv) will not,
directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have any business
connection or business or employment relationship with any entity or person which competes with the Company during his employment and,
(v) will not, directly or indirectly and in a competitive capacity own, manage, finance, operate, control or participate in ownership,
management, or operation of, act as an agent, consultant, or be employed with, any business engaged in the design, manufacture, marketing,
sale or servicing of any service or product with which Mr. Clarence was involved during his last year of employment with the Company;
or which the Company is developing, producing, marketing, selling or servicing (or plans to develop, produce, market, sale or service)
and about which Mr. Clarence gained any confidential information in the course of his employment with the Company for a period of 24
months after his separation from the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Adrian
Miranda</I>, our Chief Medical Officer and Senior Vice President of Science and Technology, entered into an employment agreement
with the Company, dated August 17, 2022, which has a two-year initial term and provides for a base salary of $300,000 with annual
compensation increase. In addition, Dr. Miranda shall be entitled to payment of a special deferred bonus in an amount equal to (i)
the aggregate of the strike price or exercise price of all 337,204 unexercised options to purchase stock or shares of the Company
held by Dr. Miranda (the &ldquo;Aggregate Strike Price&rdquo;) plus (ii) a tax gross-up payment on the Aggregate Strike Price
reasonably calculated by the Company at the highest marginal rates so that after payment of all ordinary income taxes on such
Aggregate Strike Price, there remains an amount sufficient to pay such ordinary income taxes. The deferred bonus will be paid in
substantially equal 20% installments (the &ldquo;Annual Deferred Bonus Payment&rdquo;) on January 2 on each of 2024, 2025,
2026, 2027, and 2028, with a condition that on or before each scheduled payment date, Dr. Miranda shall exercise at least 67,441 of
the stock options.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company without cause (as defined in the employment agreement) occurs during the term of the agreement, Dr. Miranda will
receive any accrued compensation (as defined in the employment agreement) and is entitled to certain amount of severance payments as
follows:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs during the initial term, the Company shall provide Dr. Miranda with severance
                                            compensation in the form of salary continuation at his Base Salary as of the termination
                                            date and ending the later of (i) 6 months or (ii) on the expiration date of the initial term.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs after the initial term, the severance payment shall be the amount equal
                                            to one half (1/2) of Dr. Miranda&rsquo;s Base Salary as of the termination date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, if termination occurs during the initial term, as part of the severance payment,
                                            we agreed to pay Dr. Miranda reimbursement of his monthly COBRA premiums for continuation
                                            of health coverage for 18 months post termination.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company for cause, Dr. Miranda will forfeit any unpaid Annual Deferred Bonus Payment, but will receive any unpaid base salary that has been
earned at the time of such termination, reimbursement of any expenses properly incurred prior to the Dr. Miranda&rsquo;s termination
date; and (iii) accrued and unused PTO, if any, in accordance with the Company&rsquo;s PTO policy in effect on Dr. Miranda&rsquo;s termination
date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Miranda may terminate the employment agreement without good reason upon more than thirty (30) days&rsquo; prior written notice or for
good reason without prior written consent, and will receive accrued compensation (as defined in the employment agreement) and the unpaid
balance of the special deferred bonus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> In
the event that Dr. Miranda is terminated without cause after this offering, non-forfeited portions of the deferred bonus will be paid
in equal installments over the remaining scheduled payment dates, if vested options as scheduled are exercised before the scheduled payment
dates. A deferred bonus tranche will be forfeited if its corresponding options have expired. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> On
a change in control (as defined in the employment agreement), full vesting of the Annual Deferred Bonus Payment will occur and be paid
in a single lump sum within 30 days after the change in control. The offering shall not be considered a change in control. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, Dr. Miranda also agreed to (i) not disclose to any unauthorized person or use for his own account any confidential
information without the prior written consent of the Company or the board of directors, (ii) will not, directly or indirectly encourage,
solicit, induce (or attempt to encourage, solicit or induce) any employee or agent of the Company that was employed (or otherwise engaged)
at the time of his separation during his employment and for 24 months after his separation from that employment for any reason; (iii)
will not, directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have
any business connection or business or employment relationship with any entity or person which competes with Company; (iv) not, directly
or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have any business connection
or business or employment relationship with any entity or person which competes with the Company during his employment and (v) will not,
directly or indirectly and in a competitive capacity own, manage, finance, operate, control or participate in ownership, management,
or operation of, act as an agent, consultant, or be employed with, any business engaged in the design, manufacture, marketing, sale or
servicing of any service or product with which Dr. Miranda was involved during his last year of employment with the Company; or which
the Company is developing, producing, marketing, selling or servicing (or plans to develop, produce, market, sale or service) and about
which Dr. Miranda gained any confidential information in the course of his employment with the Company for a period of 24 months after
his separation from the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Thomas
Carrico</I>, Chief Regulatory Officer, entered into an employment agreement with the Company, dated August 9, 2022 and amended on
May 4, 2023, which has a two-year initial term and provides for a base salary of $275,000 with annual compensation increase. Mr.
Carrico will also receive a one-time incentive payment in the amount of $135,655, which amount includes accrued and unpaid salary
and a bonus to incentivize Mr. Carrico to remain with the Company for future service. Neither the accrued and unpaid salary nor
bonus was the subject of any contract or agreement between Mr. Carrico and the Company prior to the execution of the employment
agreement. The agreement contemplated that the incentive payment would be paid by December 15, 2022, but due to administrative impracticability,
payment will now be made with a portion of the proceeds from this offering. See &ldquo;<I>Use of Proceeds</I>.&rdquo; In addition, Mr.
Carrico shall be entitled to payment of a deferred bonus in an amount equal to (i) the aggregate of the strike price or exercise price
of all 306,236 unexercised options to purchase stock or shares of the Company held by Mr. Carrico (the &ldquo;Aggregate Strike Price&rdquo;)
plus (ii) a tax gross-up payment on the Aggregate Strike Price reasonably calculated by the Company at the highest marginal rates so
that after payment of all ordinary income taxes on such Aggregate Strike Price, there remains an amount sufficient to pay such ordinary
income taxes. The special deferred bonus will be paid in substantially equal 20% installments (the &ldquo;Annual Deferred Bonus Payment&rdquo;)
on January 2 on each of 2024, 2025, 2026, 2027, and 2028 (the &ldquo;Scheduled Payment Dates&rdquo;), with a condition that
on or before each Scheduled Payment Date, Mr. Carrico shall exercise at least 61,247 of the stock options; provided, however,
Mr. Carrico shall not receive any Annual Deferred Bonus Payment unless this offering is effective. If a Scheduled Payment Date occurs
prior to the effective date of this offering, the corresponding Annual Deferred Bonus Payment will be forfeited. Mr. Carrico may exercise
any portion of the stock options after a Scheduled Payment Date; provided, however, an exercise after the applicable Scheduled Payment
Date shall result in forfeiture of the related Annual Deferred Bonus Payment. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company without cause (as defined in the employment agreement) occurs during the term of the agreement, Mr. Carrico will
receive any accrued compensation (as defined in the employment agreement) and is entitled to certain amount of severance payments as
follows:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs during the initial term, the Company shall provide Mr. Carrico with severance
                                            compensation in the form of salary continuation at his Base Salary as of the termination
                                            date and ending the later of (i) 6 months or (ii) on the expiration date of the initial term.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs after the initial term, the severance payment shall be the amount equal
                                            to one half (1/2) of Mr. Carrico&rsquo;s Base Salary as of the termination date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, if termination occurs during the initial term, as part of the severance payment,
                                            we agreed to pay Mr. Carrico reimbursement of his Medicare, Medicare Supplement and prescription
                                            drug coverage insurance premiums for continuation of health coverage for 18 months post termination.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company for cause, Mr. Carrico will forfeit any unpaid Annual Deferred Bonus Payment, but will receive any unpaid base salary that has been
earned at the time of such termination, reimbursement of any expenses properly incurred prior to the Mr. Carrico&rsquo;s termination
date; and (iii) accrued and unused PTO, if any, in accordance with the Company&rsquo;s PTO policy in effect on Mr. Carrico&rsquo;s termination
date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Carrico may terminate the employment agreement without good reason upon more than thirty (30) days&rsquo; prior written notice or for
good reason without prior written consent, and will receive accrued compensation (as defined in the employment agreement) and the unpaid
balance of the special deferred bonus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> In the event that Mr. Carrico is terminated without
cause after this offering, non-forfeited portions of the deferred bonus will be paid in equal installments over the remaining scheduled
payment dates, if vested options as scheduled are exercised before the scheduled payment dates. A deferred bonus tranche will be forfeited
if its corresponding options have expired. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> On a change in control (as defined in the employment agreement), full vesting of the Annual Deferred Bonus Payment
will occur and be paid in a single lump sum within 30 days after the change in control. The offering shall not be considered a change
in control. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, Mr. Carrico also agreed to (i) not disclose to any unauthorized person or use for his own account any confidential
information without the prior written consent of the Company or the board of directors, (ii) will not, directly or indirectly encourage,
solicit, induce (or attempt to encourage, solicit or induce) any employee or agent of the Company that was employed (or otherwise engaged)
at the time of his separation during his employment and for 24 months after his separation from that employment for any reason; (iii)
will not, directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have
any business connection or business or employment relationship with any entity or person which competes with Company; (iv) not, directly
or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have any business connection
or business or employment relationship with any entity or person which competes with the Company during his employment and (v) will not,
directly or indirectly and in a competitive capacity own, manage, finance, operate, control or participate in ownership, management,
or operation of, act as an agent, consultant, or be employed with, any business engaged in the design, manufacture, marketing, sale or
servicing of any service or product with which Mr. Carrico was involved during his last year of employment with the Company; or which
the Company is developing, producing, marketing, selling or servicing (or plans to develop, produce, market, sale or service) and about
which Mr. Carrico gained any confidential information in the course of his employment with the Company for a period of 24 months after
his separation from the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Christopher
Robin Brown</I>, our Director of Innovation, entered into an employment agreement with the Company, dated August 9, 2022 and amended
on May 4, 2023, which has a two-year initial term and provides for a base salary of $200,000 with annual compensation increase. Mr.
Brown also will receive a one-time incentive payment in the amount of $35,294, which amount includes accrued and unpaid salary
and a bonus to incentivize Mr. Brown to remain with the Company for future service. Neither the accrued and unpaid salary nor
bonus was the subject of any contract or agreement between Mr. Brown and the Company prior to the execution of the employment
agreement. The agreement contemplated that the incentive payment would be paid by December 15, 2022, but due to administrative impracticability,
payment will now be made with a portion of the proceeds from this offering. See &ldquo;<I>Use of Proceeds</I>.&rdquo;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company without cause (as defined in the employment agreement), Mr. Brown will receive any accrued compensation (as defined
in the employment agreement) and is entitled to certain amount of severance payments as follows:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs during the initial term, the Company shall provide Mr. Brown with severance
                                            compensation in the form of salary continuation at his Base Salary as of the termination
                                            date and ending the later of (i) 3 months or (ii) on the expiration date of the initial term.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs after the initial term, the severance payment shall be the amount equal
                                            to one fourth (1/4th) of Mr. Brown&rsquo;s Base Salary as of the termination date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, if termination occurs during the initial term, as part of the severance payment,
                                            we agreed to pay Mr. Brown reimbursement of his Medicare, Medicare Supplement and prescription
                                            drug coverage insurance premiums for continuation of health coverage for eighteen (18) months
                                            post termination.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company for cause, Mr. Brown will receive any unpaid base salary that has been earned at
the time of such termination, reimbursement of any expenses properly incurred prior to the Mr. Brown&rsquo;s termination date; and accrued
and unused PTO, if any, in accordance with the Company&rsquo;s PTO policy in effect on Mr. Brown&rsquo;s termination date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Brown may terminate the employment agreement without good reason upon more than thirty (30) days&rsquo; prior written notice or for good
reason without prior written consent, and will receive accrued compensation (as defined in the employment agreement) and the unpaid balance
of the special deferred bonus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, Mr. Brown also agreed to (i) not disclose to any unauthorized person or use for his own account any confidential
information without the prior written consent of the Company or the board of directors, (ii) will not, directly or indirectly encourage,
solicit, induce (or attempt to encourage, solicit or induce) any employee or agent of the Company that was employed (or otherwise engaged)
at the time of his separation during his employment and for 24 months after his separation from that employment for any reason; (iii)
will not, directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have
any business connection or business or employment relationship with any entity or person which competes with Company; (iv) not, directly
or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have any business connection
or business or employment relationship with any entity or person which competes with the Company during his employment and (v) will not,
directly or indirectly and in a competitive capacity own, manage, finance, operate, control or participate in ownership, management,
or operation of, act as an agent, consultant, or be employed with, any business engaged in the design, manufacture, marketing, sale or
servicing of any service or product with which Mr. Brown was involved during his last year of employment with the Company; or which the
Company is developing, producing, marketing, selling or servicing (or plans to develop, produce, market, sale or service) and about which
Mr. Brown gained any confidential information in the course of his employment with the Company for a period of 24 months after his separation
from the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gary
Peterson</I>, our Director of Design and Engineering, entered into an employment agreement with the Company, dated August 9, 2022 and
amended on May 4, 2023, which has a two-year initial term and provides for a base salary of $200,000 with annual compensation increase
and a one-time incentive payment in the amount of $6,731, which amount includes accrued and unpaid salary and a bonus incentivize
Mr. Carrico to remain with the Company for future service. Neither the accrued and unpaid salary nor bonus was the subject
of any contract or agreement between Mr. Peterson and the Company prior to the execution of the employment agreement. The agreement contemplated
that the incentive payment would be paid by December 15, 2022, but due to administrative impracticability, payment will now be made with
a portion of the proceeds from this offering. See &ldquo;<I>Use of Proceeds</I>.&rdquo;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the employment agreement is terminated by the Company without cause, Mr. Peterson will receive accrued compensation (as defined in the
employment agreement) and certain amount of severance payments as follows:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs during the initial term, the Company shall provide Mr. Peterson with severance
                                            compensation in the form of salary continuation at his Base Salary as of the termination
                                            date and ending the later of (i) 6 months or (ii) on the expiration date of the initial term.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            termination occurs after the initial term, the severance payment shall be the amount equal
                                            to one half (1/2) of Mr. Peterson&rsquo;s Base Salary as of the termination date.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, if termination occurs during the initial term, as part of the severance payment,
                                            we agreed to pay Mr. Peterson reimbursement of his COBRA premiums for continuation of health
                                            coverage for 18 months post termination.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the employment agreement is terminated by the Company for cause (as defined in the employment agreement),</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Mr. Peterson will receive any unpaid base salary that has been earned at the time of such termination, reimbursement of any expenses
properly incurred prior to the Mr. Peterson&rsquo;s termination date; and accrued and unused PTO, if any, in accordance with the Company&rsquo;s
PTO policy in effect on Mr. Peterson&rsquo;s termination date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Peterson may terminate the employment agreement without good reason upon more than thirty (30) days&rsquo; prior written notice or for
good reason without prior written consent, and will receive accrued compensation (as defined in the employment agreement) and the unpaid
balance of the special deferred bonus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the employment agreement, Mr. Peterson also agreed to (i) not disclose to any unauthorized person or use for his own account any confidential
information without the prior written consent of the Company or the board of directors, (ii) will not, directly or indirectly encourage,
solicit, induce (or attempt to encourage, solicit or induce) any employee or agent of the Company that was employed (or otherwise engaged)
at the time of his separation during his employment and for 24 months after his separation from that employment for any reason; (iii)
will not, directly or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have
any business connection or business or employment relationship with any entity or person which competes with Company; (iv) not, directly
or indirectly, have any ownership interest in, work for, advise, manage, act as an agent or consultant for, or have any business connection
or business or employment relationship with any entity or person which competes with the Company during his employment and (v) will not,
directly or indirectly and in a competitive capacity own, manage, finance, operate, control or participate in ownership, management,
or operation of, act as an agent, consultant, or be employed with, any business engaged in the design, manufacture, marketing, sale or
servicing of any service or product with which Mr. Peterson was involved during his last year of employment with the Company; or which
the Company is developing, producing, marketing, selling or servicing (or plans to develop, produce, market, sale or service) and about
which Mr. Peterson gained any confidential information in the course of his employment with the Company for a period of 24 months after
his separation from the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
none of our directors is compensated for their service as directors, and we do not expect to compensate directors who also become
our employees in the future. Following completion of this offering, we do expect to compensate our independent directors $100,000
annually, with an additional $20,000 payable to the chair of our board of directors, apportioned equally between cash and RSUs and payable
quarterly as of March 31, June 30, September 30 and December 31 of each year, beginning with a pro-rated payment on March 31, 2023. The
RSUs will be granted under the 2022 Plan, and the number of RSUs granted will be determined at the discretion of the Compensation Committee
based on one or more accepted valuation methodologies, such as the Black-Scholes model. The RSUs will vest upon the third anniversary
of issuance.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_003"></A>PRINCIPAL
STOCKHOLDERS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> The following
table sets forth certain information, as of March 31, 2023, with respect to the holdings of: (i) each person who is the
beneficial owner of more than 5% of our common stock, (ii) each of our directors, (iii) each executive officer, and (iv) all of our
executive officers and directors as a group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership of the common stock is determined in accordance with the rules of the SEC and includes any shares of our common stock over
which a person exercises sole or shared voting or investment power, or of which a person has a right to acquire ownership at any
time within 60 days of March 31,  2023. Applicable percentage ownership in the following table is based on (i) [&#9679;]
shares of common stock issued and outstanding on March 31, 2023, plus an aggregate of 1,013,270 shares of common stock
issuable upon conversion of our Series A Preferred Stock and an aggregate of 230,954 shares of common stock issuable upon conversion
of our Series Seed Preferred Stock, as all shares of our preferred stock are expected to convert into shares of common stock in
connection with this offering, and (ii) after the offering, assumes the issuance of [&#9679;] shares of common stock in the
offering, which excludes shares of common stock which may be sold upon exercise of the Underwriter&rsquo;s over-allotment option,
(iii) after the offering, assumes the issuance of 250,000 and 50,000 shares of common stock issued to Exchange Listing, LLC and
Lucosky Brookman LP, respectively, in connection with this listing of our common stock on Nasdaq, (iv) plus, for each individual,
any securities that person has the right to acquire within 60 days of March 31, 2023 through exercise of warrants, stock
options or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best of our knowledge, each of the persons named in the table has sole voting and investment power with respect to the shares of
our common stock beneficially owned by such person, except to the extent such power may be shared with a spouse. To our knowledge, none
of the shares listed below are held under a voting trust or similar agreement. To our knowledge, there is no arrangement, including any
pledge by any person of securities of the Company, the operation of which may at a subsequent date result in a change in control of the
Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Owner</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares of Common Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned Beneficially</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percent of Class Before the Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percent of Class After the Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">5% Holders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 55%; text-align: left">Masimo Corporation (1)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">821,327</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">21.6</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">14.5</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Brian P. Hannasch (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">337,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.2</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Executive Officers and Directors (3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Brian Carrico (4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">347,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="margin: 0pt 0pt 0pt 0">6.1</P></TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">John Seale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dan Clarence (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">275,709</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.1</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adrian Miranda (6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">337,204</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.9</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Thomas Carrico (7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">316,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Christopher Robin Brown</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">792,837</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14.7</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gary Peterson (8)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">543,120</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.1</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Timothy Henrichs*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&mdash;</P></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Bradley Mitch Watkins*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Beth Keyser*</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Officers and directors as a group (10 persons)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,612,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40.7</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Timothy
Henrichs, Bradley Mitch Watkins, Beth Keyser have accepted nomination to our board of directors and will become members of our board
of directors immediately upon the effectiveness of the registration statement of which this prospectus forms a part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            business address for Masimo Corporation is 52 Discovery, Irvine, California 92618. Shares
                                            of common stock beneficially owned includes 531,548 shares of common stock issuable
                                            upon the conversion of Series A Preferred Stock, and 289,779 shares of common stock
                                            issuable upon the exercise of prefunded warrants.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            business address for Mr. Hannasch is 8815 West State Road 46, Columbus, Indiana 47201. Shares
                                            of common stock beneficially owned includes 245,710 shares of common stock issuable
                                            upon the conversion of Series A Preferred Stock, and 52,852 shares of common stock
                                            issuable upon the exercise of warrants.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            business address for each executive officer and director is 11550 N. Meridian Street, Suite
                                            325 Carmel, IN. 46032.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock beneficially owned includes 320,000 shares of common stock issuable
                                            upon the exercise of stock options.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock beneficially owned consists of 5,299 shares of common stock issuable
                                            upon the conversion of Series A Preferred Stock, 28,069 shares of common stock issuable
                                            upon conversion of Series Seed Preferred Stock, and 68,818 shares of common stock
                                            issuable upon the exercise of stock options.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock beneficially owned consists of 337,204 shares of common stock issuable
                                            upon the exercise of stock options.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
                                            of common stock beneficially owned includes 306,236 shares of common stock issuable
                                            upon the exercise of stock options.</FONT></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
                                                                                                <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">(8)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">In
                                            January 2023, Mr. Peterson sold 25,000 shares of common stock to an existing investor. Giving
                                            effect to this transaction, Mr. Peterson&rsquo;s beneficial ownership before the offering
                                            is 14.8% and after the offering will be 9.6%.</TD></TR>
                                                                                                </TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_004"></A>CERTAIN
RELATIONSHIPS AND RELATED PERSONS TRANSACTIONS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
rules require us to disclose any transaction since the beginning of our last fiscal year or any currently proposed transaction in which
we are a participant in which the amount involved exceeded or will exceed $120,000 and in which any related person has or will have a
direct or indirect material interest. A related person is any executive officer, director, nominee for director, or holder of 5% or more
of our common stock, or an immediate family member of any of those persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two demand notes receivable from its two founding shareholders, Christopher Robin Brown and Gary Peterson, related to
the sale of common stock on January 1, 2016. The initial balances of both notes were $506,400, with interest
calculated monthly based on applicable federal rates. No payments have been received on the notes. As of March 31, 2023, the
balances of both notes were $506,400. The entire $1,012,800 balance has been fully reserved as of December 31, 2020. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has loans payable to Christopher Robin Brown, one of our founders and a member of our board of directors, related to funding
needs for operations with original principal amounts of $55,000 and $50,000 each bearing interest at 15% per annum. As of March 31, 2023, the outstanding balances of the loans were $20,051 and $38,000, respectively. We will use a portion of the proceeds
from this offering to repay these loans payable. See &ldquo;<I>Use of Proceeds</I>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
Seale, our Chief Financial Officer, is also the managing partner of RBSK. Mr. Seale, through RBSK, has prepared the Company&rsquo;s financial
statements since 2017. For the three months ended March 31, 2023, and the fiscal years ended December 31, 2022 and 2021, the
Company paid RBSK $17,551, $116,542 and $80,394, respectively, for accounting services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a formal policy that our executive officers, directors, holders of more than 5% of any class of our voting securities, and
any member of the immediate family of and any entity affiliated with any of the foregoing persons, are not permitted to enter into a
related party transaction with us without the prior consent of our Audit Committee, or other independent members of our Board of Directors
if it is inappropriate for our audit committee to review such transaction due to a conflict of interest. Any request for us to enter
into a transaction with an executive officer, director, principal shareholder, or any of their immediate family members or affiliates,
in which the amount involved exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed
fiscal years must first be presented to our audit committee for review, consideration and approval. In approving or rejecting any such
proposal, our Audit Committee is to consider the relevant facts and circumstances available and deemed relevant to the audit committee,
including, but not limited to, whether the transaction is on terms no less favorable than terms generally available to an unaffiliated
third party under the same or similar circumstances and the extent of the related party&rsquo;s interest in the transaction.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="se_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
STOCKHOLDERS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Selling Stockholders are offering an aggregate
of [&#9679;] shares of common stock, registered for resale hereby. The [&#9679;] shares of common stock offered by the
Selling Stockholders are defined herein as the &ldquo;Selling Stockholder Shares.&rdquo;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may sell some, all or none of their Selling Stockholder Shares. Unless otherwise indicated in the footnotes below,
the Selling Stockholders have not had any material relationship with us or any of our affiliates within the past three years other than
as a security holder. To the best of our knowledge, the named parties in the table that follows are the beneficial owners and have the
sole voting and investment power over all shares or rights to the Selling Stockholder Shares reported. None of the Selling Stockholders
is a spouse or minor child of another Selling Stockholder.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have prepared the following table based on written representations and information furnished to us by or on behalf of the Selling Stockholders.
Unless otherwise indicated in the footnotes below, we believe that: (i) the Selling Stockholders are not a broker-dealer or affiliate
of a broker-dealer, and (ii) the Selling Stockholders have not had direct or indirect agreements or understandings with any person to
distribute their Selling Stockholder Shares. To the extent the Selling Stockholders identified below are, or are affiliated with, a broker-dealer,
it could be deemed, to be an &ldquo;underwriter&rdquo; within the meaning of the&nbsp;Securities Act. Information about the Selling Stockholders
may change over time.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information regarding the Selling Stockholders and the Selling Stockholder Shares that they may offer and sell
from time to time under this prospectus. The table is prepared based on information supplied to us by the Selling Stockholders, and reflects
their respective holdings as of February 13, 2023, unless otherwise noted in the footnotes to the table. Beneficial ownership is determined
in accordance with the rules of the SEC, and thus represents voting or investment power with respect to our securities. Under such rules,
beneficial ownership includes any shares over which the individual has sole or shared voting power or investment power as well as any
shares that the individual has the right to acquire within 60 days after the date of this table, to our knowledge and subject to applicable
community property rules, the persons and entities named in the table have sole voting and sole investment power with respect to all
equity interests beneficially owned. The percentage of shares beneficially owned before and after this offering is based on shares of
our common stock issued and outstanding on [&#9679;], 2023.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold">Selling Stockholder</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Shares Beneficially Owned Before
    this Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
    of Outstanding Shares Beneficially Owned Before this Offering</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
    to be Sold in this Offering</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>Shares
    Beneficially Owned After this Offering</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Percentage of Outstanding Shares
    Beneficially Owned After this Offering (1)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 34%; text-align: left">Savanna C. Stapp</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right"><P STYLE="margin: 0"></P>[50,356]</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">50,356</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Mark T. Volz</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,712</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,712</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Abby E. (Brown) Baier</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Jessica L. (Brown) Snodgrass</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,356</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Todd and Nancy Maxwell</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gary Peterson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">518,120</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">518,120</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Exchange Listing LLC</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,000</TD><TD STYLE="text-align: left">(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.2</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Lucosky Brookman LLP</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,119,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,119,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Less than 1%.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Assumes all shares offered by the Selling Stockholders are sold and that the Selling Stockholders buy or sell no additional shares of
common stock prior to the completion of this Offering. The registration of these shares does not necessarily mean that the Selling Stockholders
will sell all or any portion of the shares covered by this prospectus.&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">(2) Shares of common stock to be issued prior to the closing of this offering.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Plan
of Distribution</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the Selling Stockholder Shares issuable to permit the resale of the Selling Stockholder Shares by the Selling Stockholders
from time to time after the date of this prospectus. We will not receive any of the proceeds from the sale of the Selling Stockholder
Shares. We will bear all fees and expenses incident to the registration of the Selling Stockholder Shares in the registration statement
of which this prospectus forms a part. The Selling Stockholder Shares will not be sold through the underwriters in this public offering.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may sell all or a portion of the Selling Stockholder Shares beneficially owned by them and offered hereby from time
to time directly or through one or more broker-dealers or agents. If the Selling Stockholder Shares are sold through broker-dealers,
the Selling Stockholders will be responsible for commissions or agent&rsquo;s commissions. The Selling Stockholder Shares may be sold
in one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the
time of sale, or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions,</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
                                            any national securities exchange or quotation service on which the securities may be listed
                                            or quoted at the time of sale;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the over-the-counter market;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            transactions otherwise than on these exchanges or systems or in the over-the-counter market;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
                                            brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
                                            trades in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
                                            by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
                                            negotiated transactions;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">short
                                            sales;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            transactions through broker-dealers that agree with the Selling Stockholders to sell a specified
                                            number of such securities at a stipulated price per security;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
                                            the writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            combination of any such methods of sale; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other method permitted pursuant to applicable law.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the&nbsp;Securities Act,
if available, rather than under this prospectus. However, the Selling Stockholders will not sell any Selling Stockholder Shares until
after the closing of this initial public offering.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Selling Stockholders effect such transactions by Selling Stockholder Shares to or through underwriters, broker-dealers or agents,
such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from the Selling
Stockholders or commissions from purchasers of the Selling Stockholder Shares for whom they may act as agent or to whom they may sell
as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess of
those customary in the types of transactions involved). In connection with sales of the Selling Stockholder Shares or otherwise, the
Selling Stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the Selling
Stockholder Shares in the course of hedging in positions they assume. The Selling Stockholders may also sell Selling Stockholder Shares
short and deliver Selling Stockholder Shares covered by this prospectus to close out short positions and to return borrowed shares in
connection with such short sales. The Selling Stockholders may also loan or pledge Selling Stockholder Shares to broker-dealers that
in turn may sell such shares.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may pledge or grant a security interest in some or all of the Selling Stockholder Shares owned by them and, if they
default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the Selling Stockholder Shares
from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision
of the&nbsp;Securities Act, amending, if necessary, the list of Selling Stockholders to include the pledgee, transferee or other successors
in interest as Selling Stockholders under this prospectus. The Selling Stockholders also may transfer and donate the Selling Stockholder
Shares in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealer participating in the distribution of the Selling Stockholder Shares may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the&nbsp;Securities Act, and any commission paid, or any discounts or concessions allowed to, any such broker-dealer
may be deemed to be underwriting commissions or discounts under the&nbsp;Securities Act. At the time a particular offering of the Selling
Stockholder Shares is made, a prospectus supplement, if required, will be distributed which will set forth the aggregate amount of Selling
Stockholder Shares being offered and the terms of this offering, including the name or names of any broker-dealers or agents, any discounts,
commissions and other terms constituting compensation from the Selling Stockholders and any discounts, commissions or concessions allowed
or reallowed or paid to broker-dealers.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the securities laws of some states, the Selling Stockholder Shares may be sold in such states only through registered or licensed brokers
or dealers. In addition, in some states the Selling Stockholder Shares may not be sold unless such shares have been registered or qualified
for sale in such state or an exemption from registration or qualification is available and is complied with.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that any Selling Stockholder will sell any or all of the Selling Stockholder Shares registered pursuant to the registration
statement, of which this prospectus forms a part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any other person participating in such distribution will be subject to applicable provisions of the&nbsp;Securities
Exchange Act of 1934, as amended, and the rules and regulations thereunder, including, without limitation,&nbsp;Regulation M&nbsp;of
the&nbsp;Exchange Act, which may limit the timing of purchases and sales of any of the Selling Stockholder Shares by the Selling Stockholders
and any other participating person.&nbsp;Regulation M&nbsp;may also restrict the ability of any person engaged in the distribution of
the Selling Stockholder Shares to engage in market-making activities with respect to the Selling Stockholder Shares. All of the foregoing
may affect the marketability of the Selling Stockholder Shares and the ability of any person or entity to engage in market-making activities
with respect to the Selling Stockholder Shares.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
sold under the registration statement, of which this prospectus forms a part, the Selling Stockholder Shares will be freely tradeable
in the hands of persons other than our affiliates.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_005"></A>DESCRIPTION
OF OUR SECURITIES</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation authorizes us to issue up to 101,120,000 shares of capital stock, consisting of 100,000,000 shares of common
stock, par value $0.001 per share, and 1,120,000 shares of preferred stock, par value $0.001 per share, 1,000,000 of which are designated
as Series A Preferred Stock and 120,000 of which are designated as Series Seed Preferred Stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As
of March 31, 2023, there were 1,963,322 shares of our common stock, 506,637 shares of our Series A Preferred
Stock, and 115,477 shares of our Series Seed Preferred Stock issued outstanding.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation authorizes the issuance of 100,000,000 shares of common stock, par value $0.001 per share. The holders of
common stock are entitled to one vote per share on each matter submitted to a vote at any meeting of stockholders. Shares of common stock
do not carry cumulative voting rights and, therefore, a majority of the shares of outstanding common stock will be able to elect the
entire board of directors and, if they do so, minority stockholders would not be able to elect any persons to the board of directors.
Our bylaws provide that a majority of our issued and outstanding shares constitutes a quorum for stockholders&rsquo; meetings, except
respecting certain matters for which a greater percentage quorum is required by statute or the bylaws.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stockholders have no pre-emptive rights to acquire additional shares of common stock or other securities. The common stock
is not subject to redemption and carries no subscription or conversion rights. In the event of our liquidation, the shares of common
stock are entitled to share equally in corporate assets after satisfaction of all liabilities and after the payment of liquidation
preferences, if any, on any outstanding shares of preferred stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of common stock are entitled to receive such dividends as the board of directors may, from time to time, declare out of funds legally
available for the payment of dividends. We seek growth and expansion of our business through the reinvestment of profits, if any, and
do not anticipate that we will pay dividends in the foreseeable future.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividend
Rights</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock are entitled
to receive dividends out of funds legally available if our Board, in its discretion, determines to declare and pay dividends and then
only at the times and in the amounts that our Board may determine.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
Rights</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of our common stock are entitled to one vote for each share held on all matters properly submitted to a vote of stockholders on which
holders of common stock are entitled to vote. We have not provided for cumulative voting for the election of directors in our Certificate
of Incorporation.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
Pre-emptive or Similar Rights</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is not entitled to pre-emptive rights, and is not subject to conversion, redemption or sinking fund provisions.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Right
to Receive Liquidation Distributions</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we become subject to a liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would
be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the
payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Our
certificate of incorporation authorizes the issuance of 1,120,000 shares of preferred stock, par value $0.001 per share, 1,000,000 of
which are designated as Series A Preferred Stock and 120,000 of which are designated as Series Seed Preferred Stock. As of the date of
hereof, there are 506,635 shares of our Series A Preferred Stock, and 115,477 shares of our Series Seed Preferred Stock
outstanding. The requisite holder of our outstanding Series A Preferred Stock and Series Seed Preferred Stock have delivered a consent,
dated December 22, 2022, to automatically convert all shares of preferred stock into shares of common stock (on a 2-for-1 basis) upon
consummation of this offering.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Voting
Rights</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
Series A Preferred Stock and Series Seed Preferred Stock shall vote together with the common stock on an as-converted basis, and
not as separate classes.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Conversion</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
Series A Preferred Stock and Series Seed Preferred Stock initially convert 1:1 to common stock at any time at option
of holder, subject to adjustments for stock dividends, splits, combinations, and similar events and as described below under </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<FONT STYLE="font-weight: normal">Anti-dilution
Provisions.</FONT>&rdquo; Due to a 4-for-1 stock split that occurred in September of 2021, and a subsequent 1-for-2 reverse stock split
that occurred in January of 2023 each (1) share of Series A Preferred and Series Seed is currently convertible to two (2) shares of common
stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Dividends</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
Series A Preferred will carry an annual 8% cumulative dividend, payable upon any liquidation, dissolution or winding up of the Company
(the </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<FONT STYLE="font-weight: normal">Accruing
Dividend</FONT>&rdquo;<FONT STYLE="font-weight: normal">). For any other dividends or distributions, participation with common stock
on an as-converted basis.</FONT></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidation</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In
the event of any liquidation, dissolution or winding up of the Company, the proceeds shall be paid in the following priority:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">First,
                                            to the Series A Preferred in proportion to each holder</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&rsquo;<FONT STYLE="font-weight: normal">s
                                            respective pro rata Series A original purchase price, plus any pro rata share of the
                                            Accruing Dividend until the entire Series A original purchase price and Accruing Dividend
                                            are paid; </FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Second,
                                            to the Series Seed Preferred Stock in proportion to each holder</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&rsquo;<FONT STYLE="font-weight: normal">s
                                            respective pro rata Series Seed original purchase price until the entire amount of
                                            the Series Seed original purchase price is paid;</FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Thereafter,
                                            the Series A Preferred Stock and Series Seed Preferred Stock participate with the common
                                            stock pro rata on an as-converted basis.</FONT></TD></TR></TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">A
merger or consolidation (other than one in which stockholders of the Company own a majority by voting power of the outstanding shares
of the surviving or acquiring corporation) and a sale, lease, transfer, exclusive license or other disposition of all or substantially
all of the assets of the Company will be treated as a liquidation event (a </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<FONT STYLE="font-weight: normal">Deemed
Liquidation Event</FONT>&rdquo;<FONT STYLE="font-weight: normal">), thereby triggering payment of the liquidation preferences described.</FONT></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Anti-dilution
Provisions</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The
Series A Preferred have full-ratchet anti-dilution protection so that the conversion price will be reduced to 80% of the price at which
any future shares are issued, if less than the Series A original purchase price.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><B>Stockholders&rsquo; Agreement</B>:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">All stockholders of the Company currently are subject
to the Innovative Health Solutions, Inc. Amended and Restated Shareholders&rsquo; Agreement dated as of October 12, 2017, as amended
on January 30, 2019 (collectively, the &ldquo;Stockholders&rsquo; Agreement&rdquo;). The Stockholders&rsquo; Agreement contains provisions
restricting the transfer of the Company&rsquo;s shares by our current stockholders, provisions related to certain preemptive rights and
rights of first offer, and certain corporate governance requirements and restrictions, among other things. Upon the effectiveness of
the registration statement of which this prospectus forms a part, the Stockholders&rsquo; Agreement will terminate and be of no further
force or effect pursuant to an amendment to the Stockholders&rsquo; Agreement dated January 8, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><I>Restrictions on Transfer</I>: As a general
matter, the Stockholders&rsquo; Agreement currently provides that no stockholder may transfer the whole or any part of their shares,
except as otherwise permitted by the Stockholders&rsquo; Agreement. The Company&rsquo;s board of directors may, however, waive in writing
any or all of the restrictions on transfer set forth in the Stockholders&rsquo; Agreement. Furthermore, transfers to any one or more
members of a class consisting of a stockholder&rsquo;s spouse, descendants, guardian or conservator, or to a trust for the benefit of
any one or more members of such class (a &ldquo;Family Transferee&rdquo;) are free of any restrictions on transfer; <I>provided, however</I>,
that such no such transfer shall be permitted unless the transferring stockholder retains the sole legal and equitable rights to vote
the shares being transferred to the Family Transferee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><I>Preemptive Rights and Rights of First Offer</I>:
Except as otherwise permitted in the Stockholders&rsquo; Agreement, a stockholder may not transfer any or all of the shares of the Company
owned by that stockholder to any transferee unless (i) the stockholder desiring to effectuate the transfer shall have first made the
offer to sell to the Company, then to non-transferring stockholders within the circumstances and time periods prescribed in the Stockholders&rsquo;
Agreement and (ii) that offer shall not have been accepted by the Company or the non-transferring stockholders within the prescribed
circumstances and time periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><I>Governance Provisions</I>: The Stockholders&rsquo;
Agreement currently requires the stockholders to vote in such a manner as to ensure the current directors of the Company are elected,
appointed, and maintained as directors. Furthermore, certain extraordinary business decisions must be approved affirmatively by one of
Gary Peterson or Christopher Robin Brown (&ldquo;Group 1 Stockholders&rdquo;), before the Company may implement them (&ldquo;Extraordinary
Decisions&rdquo;). Such Extraordinary Decisions include (a) amending the Company&rsquo;s certificate of incorporation, (b) amending the
Company&rsquo;s Bylaws, (c) amending the Stockholders&rsquo; Agreement, (d) acquiring substantially all of the assets of the Company
or another business (with certain exceptions), (e) incurring debt or liability in excess of $100,000 in each instance, (f) issuing options
or equity in the Company, (g) undertaking a matter outside the ordinary course of business, (h) substantially changing the scope of an
officer&rsquo;s duties with the Company, (i) terminating a Group 1 Stockholder&rsquo;s employment with the Company, (j) making distributions,
and (k) conducting certain affiliate transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0">Transfers during Lifetime and upon Death: The
Stockholders&rsquo; Agreement also currently prescribes that, upon the termination of an employment agreement between the Company and
any stockholders except for the Group 1 Stockholders for any reason other than death, the Company may purchase all of the stockholder&rsquo;s
shares of the Company at an agreed value established by the Board each year or the fair market value as of the date of such termination.
Furthermore, upon the death of a stockholder, the Company shall have the right, for the longer of 3 months following receipt of notice
of the death or 6 months from the date of death, to purchase such stockholder&rsquo;s shares at an agreed value established by the Board
or the fair market value.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Agreements</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Masimo
Side Letters</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2020, the Company entered into a side letter with Masimo (the &ldquo;Masimo Side Letter&rdquo;) in connection with Masimo&rsquo;s
purchase of shares of our Series A Preferred Stock under that certain purchase agreement (the &ldquo;Masimo Series A Purchase
Agreement&rdquo;). Pursuant to the Masimo Side Letter, Masimo is entitled to specify one individual to serve as a non-voting observer
at all meetings of the board of directors and certain information and inspection rights. The Company also agreed to not enter into any
agreement or arrangement with any investor providing for rights, benefits, powers, preferences, priorities or privileges more favorable
to such investor than the rights, benefits, powers, preferences, priorities or privileges provided to Masimo under the Masimo
Series A Purchase Agreement, unless Massimo is offered such opportunity.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a new letter agreement with Masimo, dated December 22, 2022, pursuant to which Masimo has
agreed to relinquish its rights under the Masimo Side Letter immediately upon the effectiveness of the registration statement of
which this prospectus forms a part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Brian
Hannasch Side Letters</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 6, 2019, the Company entered into an investor rights agreement with Brian Hannasch (the &ldquo;Investor Rights Agreement&rdquo;)
in connection with Brian Hannasch&rsquo;s purchase of shares of our Series A Preferred Stock under certain purchase agreements (the &ldquo;Series
A Purchase Agreements&rdquo;). Pursuant to the Investor Rights Agreement, Mr. Hannasch is entitled to certain information and inspection
rights. As long as Mr. Hannasch holds at least 62,500 shares of Series A Preferred Stock, he is considered a major investor and,
as such, is entitled to right of first offer if the Company proposes to sell any new securities, which shall terminate immediately before
the consummation of this offering, or when the Company becomes subject to periodic reporting requirements of Section 12(g) or 15(d) of
the Exchange Act, or upon the closing of a Deemed Liquidation Event, and may appoint one (1) observer to attend and be present at the
meeting of board of directors. The Company also agreed not to, without Mr. Hannasch&rsquo;s approval (so long as Mr. Hannasch holds at
least 62,500 shares of Series A Preferred Stock), (i) make any loan to any person, subsidiarity or other entity except expenditures
in the ordinary course of business or under an employee stock option plan, (ii) own any securities of any subsidiarity or other entity
unless it is wholly owned by the Company, (iii) guarantee any indebtedness except for trade accounts arising in the ordinary course of
business, (iv) make any investment inconsistent with any investment policy approved by the board of directors, (v) enter into any material
transaction with insiders of the Company outside the ordinary and usual course of business, (vi) authorize any plan for the issuance
of any employee incentive equity rights, management incentive plans payable on the basis of equity proceeds or amend the 2017 Stock Compensation
plan, or (vii) allow previous common stockholders who own more than $100,000 of common stock, except for certain common stockholders
as indicated in the Investor Rights Agreement, to participate in the purchase of Series A Preferred Stock, unless such common stockholder
purchases at least $100,000 of Series A Preferred Stock valued at the Series A original issue price.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a new letter agreement with Brian Hannasch, dated July 7, 2022, pursuant to which Mr. Hannasch has agreed to relinquish
his rights under the Investor Rights Agreement immediately upon the effectiveness of the registration statement of which this prospectus
forms a part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">As
of March 31, 2023, warrants to purchase an aggregate of 405,962 shares of our common stock, and 144,890
shares of Series A Preferred Stock were outstanding.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 6, 2019, we issued warrants to purchase 40,000 shares of common stock  to Brian P. Hannasch, in connection with certain
his purchase of our Series A Preferred Stock. Pursuant to the terms of the warrants, the warrant exercise price is equal to $0.01 per
share, subject to certain adjustments. If unexercised, these warrants will expire on the 10<SUP>th </SUP>anniversary of their issuance
dates. The warrants will neither expire nor be automatically exercised upon the closing of this offering. The warrants provide that the
holder thereof may elect to exercise the warrant on a net &ldquo;cashless&rdquo; basis at any time prior to the expiration thereof. Assuming
the closing of this offering occurs, the fair market value of one share of our common stock in connection with any cashless exercise
shall be the based on the average of the daily closing prices per share for the 30 consecutive trading day period ending on the second
trading day prior to such date.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2020, we issued pre-funded warrants to purchase 144,890 shares of Series A Preferred Stock (which are convertible into 289,779
shares of common stock) to Masimo, in connection with its purchase of our Series A Preferred Stock. Pursuant to the terms of the
warrants, the warrant exercise price is equal to $0.0001 per share, subject to adjustments, and these warrants will not expire. The aggregate
purchase price of these warrants, in the amount of approximately $2.7 million, equating to $18.87 per warrant share, was pre-funded to
the Company and, consequently, no additional consideration shall be required to be paid by Masimo to effect any exercise of the warrants,
except for the payment of the exercise price. The warrants will neither expire nor be automatically exercised upon the closing of this
offering. The warrants provide that Masimo may elect to exercise the warrant on a net &ldquo;cashless&rdquo; basis at any time prior
to the expiration thereof. Assuming the closing of this offering occurs, the fair market value of one share of our Series A Preferred
Stock in connection with any cashless exercise shall be (i) the closing price or last sale price of a share of common stock reported
for the business day immediately before the date on which Masimo delivers this warrant together with its notice of exercise to the Company,
multiplied by the number of shares of common stock into which a share of Series A Preferred Stock is then convertible, if the common
stock is then traded on a trading market, or (ii) the fair market value of Series A Preferred Stock, as mutually determined in writing
by the Company and Masimo. Masimo may not exercise the warrant in excess of that number of shares which would cause the aggregate number
of shares of common stock beneficially owned by Masimo to exceed 19.99% of the total number of issued and outstanding shares of common
stock following such exercise, or the combined voting power of the securities beneficially owned by Masimo to exceed 19.99% of the combined
voting power of all of the securities of the Company then outstanding following such exercise.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
June through November of 2022, we issued five-year warrants exercisable for an aggregate of 353,111 shares of common stock to Leonite
Fund I, LP, Emmis Capital II, LLC, Bigger Capital Fund, LP, District 2 Capital Fund, LP, and Exchange Listing, LLC, pursuant to certain
Securities Purchase Agreements (the &ldquo;2022 SPAs&rdquo;) which provide for advances of up to $3 million in proceeds to us, subject
to our satisfaction of certain conditions. The exercise price of the warrants shall be the lower of (a) $11.80 and (b) a 12% discount
to the price per share in any subsequent offering by the Company.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
March through May 2023, we issued five-year warrants exercisable for an aggregate of [&#9679;] shares of common stock to 19 investors,
pursuant to certain Securities Purchase Agreements (the &ldquo;SPAs&rdquo;) which provide for advances of up to $6 million in proceeds
to us, subject to our satisfaction of certain conditions (the &ldquo;2023 Private Placement&rdquo;). The exercise price of the warrants
shall be 25% premium to the conversion price, which will be set at a 30% discount to the public offering price, or $[&#9679;] per share,
subject to anti-dilution, issuable on a pro rata basis at each funding.</FONT> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certain
Anti-Takeover Provisions of Delaware Law, Our Certificate of Incorporation and Our Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
203 of the DGCL provides that if a person acquires 15% or more of the voting stock of a Delaware corporation, such person becomes an
&ldquo;interested stockholder&rdquo; and may not engage in certain &ldquo;Business Combinations&rdquo; with such corporation for a period
of three years from the time such person acquired 15% or more of such corporation&rsquo;s voting stock, unless: (1) the board of directors
of such corporation approves the acquisition of stock or the merger transaction before the time that the person becomes an interested
stockholder, (2) the interested stockholder owns at least 85% of the outstanding voting stock of such corporation at the time the merger
transaction commences (excluding voting stock owned by directors who are also officers and certain employee stock plans), or (3) the
merger transaction is approved by the board of directors and at a meeting of stockholders, not by written consent, by the affirmative
vote of 2/3 of the outstanding voting stock which is not owned by the interested stockholder. A Delaware corporation may elect in its
certificate of incorporation or Bylaws not to be governed by this particular Delaware law.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation, our bylaws and the DGCL contain provisions that could have the effect of rendering more difficult, delaying,
or preventing an acquisition deemed undesirable by our board of directors. These provisions could also make it difficult for stockholders
to take certain actions, including electing directors who are not nominated by the members of our board of directors or taking other
corporate actions, including effecting changes in our management. For instance, our certificate of incorporation does not provide for
cumulative voting in the election of directors. Our board of directors are empowered to elect a director to fill a vacancy created by
the expansion of the board of directors or the resignation, death, or removal of a director in certain circumstances; and our advance
notice provisions in our bylaws require that stockholders must comply with certain procedures in order to nominate candidates to our
board of directors or to propose matters to be acted upon at a stockholders&rsquo; meeting.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized but unissued common stock will be available for future issuances without stockholder approval and could be utilized for a
variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence
of authorized but unissued and unreserved common stock could render more difficult or discourage an attempt to obtain control of us by
means of a proxy contest, tender offer, merger or otherwise.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certificate
of incorporation and Bylaws</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
other things, our certificate of incorporation and our bylaws:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">do
    not provide for cumulative voting in the election of directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provides
    for the exclusive right of the board of directors to elect a director to fill a vacancy created by the expansion of the board of
    directors or the resignation, death, or removal of a director by stockholders;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">requires
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that a special meeting of stockholders may be
    called only by the Board of Directors, or by a committee of the Board of Directors that has been designated by the Board of Directors;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">limits
    the liability of, and providing indemnification to, our directors and officers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">controls
    the procedures for the conduct and scheduling of stockholder meetings;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">grants
    the ability to remove directors only for cause by the affirmative vote of at least two-thirds of the voting power of all of the then
    outstanding shares of voting stock of the Company entitled to vote at an election of directors; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provides
    for advance notice procedures that stockholders must comply with in order to nominate candidates to the board of directors or to
    propose matters to be acted upon at a stockholders&rsquo; meeting.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combination of these provisions will make it more difficult for our existing stockholders to replace our board of directors as well as
for another party to obtain control of us by replacing our board of directors. Since our board of directors has the power to retain and
discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change
in management.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies
and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability
to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect
of discouraging others from making tender offers for our shares of common stock and may have the effect of delaying changes in our control
or management. As a consequence, these provisions may also inhibit fluctuations in the market price of our common stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><B>Forum for Litigation</B></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Article VIII of our Certificate of Incorporation
identifies the Court of Chancery of the State of Delaware (referring to Delaware State Courts) as the exclusive forum for certain litigation,
including any derivative action. To the extent that the applicability such provision may be sought in connection with actions arising
under the Securities Act or Exchange Act, pursuant to Section 27 of the Exchange Act, exclusive federal jurisdiction is
created over all suits brought to enforce any duty or liability created by the&nbsp;Exchange Act&nbsp;or the rules and regulations thereunder,
which would result in federal courts instead having jurisdiction over such claims. Pursuant to Section 22 of the Securities Act, concurrent
jurisdiction is created for federal and state courts over all suits brought to enforce any duty or liability created by the&nbsp;Securities
Act or the rules and regulations thereunder. Accordingly, there is uncertainty as to whether a court would enforce such provision
in an action arising under the&nbsp;Securities Act or Exchange Act.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company does not intend for such exclusive
forum provision to apply to claims arising under the Securities Act or the Exchange Act. With respect to claims arising
under the Securities Act, note that investors cannot waive compliance with the federal securities laws and rules and regulations
thereunder.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limitation
of Liability and Indemnification</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws provide that we will indemnify our directors to the fullest extent authorized or permitted by applicable law. Under our Bylaws,
we are required to indemnify each of our directors and officers if the basis of the indemnitee&rsquo;s involvement was by reason of the
fact that the indemnitee is or was our director or officer or was serving at our request as a director, officer, employee or agent for
another entity. We must indemnify our officers and directors against all expenses (including attorneys&rsquo; fees), judgments, fines
and amounts paid in settlement actually and reasonably incurred by the indemnitee in connection with such action, suit or proceeding
if the indemnitee acted in good faith and in a manner the indemnitee reasonably believed to be in or not opposed to the best interests
of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the indemnitee&rsquo;s conduct
was unlawful. Our bylaws also require us to advance expenses (including attorneys&rsquo; fees) incurred by a director or officer in defending
any civil, criminal, administrative or investigative action, suit or proceeding, provided that such person will repay any such advance
if it is ultimately determined that such person is not entitled to indemnification by us. Any claims for indemnification by our directors
and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available
to us.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vstock
Transfer LLC is the Company&rsquo;s transfer agent with respect to our common stock. The principal business address of the transfer agent
is 18 Lafayette Place, Woodmere, NY 11598. Phone: 212-828-8436.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_006"></A>SHARES
ELIGIBLE FOR FUTURE SALE</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has no public market for the Company&rsquo;s common stock, and a liquid trading market for its common stock may
not develop or be sustained after this offering. Future sales of substantial amounts of the Company&rsquo;s common stock in the public
market, or the anticipation of these sales, could materially and adversely affect market prices prevailing from time to time, and could
impair the Company&rsquo;s ability to raise capital through sales of equity or equity-related securities.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
a limited number of shares of the Company&rsquo;s common stock will be available for sale in the public market for a period of several
months after completion of this offering due to contractual and legal restrictions on resale described below. Nevertheless, sales of
a substantial number of shares of the Company&rsquo;s common stock in the public market after such restrictions lapse, or the perception
that those sales may occur, could materially and adversely affect the prevailing market price of its common stock. Although the Company
intends to list its common stock on the Nasdaq, the Company cannot assure you that there will be an active market for its common stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the shares to be outstanding immediately after the completion of this offering, we expect that the shares to be sold in this offering
will be freely tradable without restriction under the Securities Act unless purchased by our &ldquo;affiliates,&rdquo; as that term is
defined in Rule 144 under the Securities Act; these restricted securities may be sold in the public market only if registered or pursuant
to an exemption from registration, such as Rule 144 or Rule 701 under the Securities Act.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
144</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 144 as currently in effect, once the Company has been subject to the public company reporting requirements of Section
13 or Section 15(d) of the Exchange Act for at least 90 days, a person who is not deemed to have been one of the Company&rsquo;s affiliates
for purposes of the Securities Act at any time during the 90 days preceding a sale and who has beneficially owned the shares of its common
stock proposed to be sold for at least six months is entitled to sell those shares without complying with the manner of sale, volume
limitation or notice provisions of Rule 144, subject to compliance with the public information requirements of Rule 144. If such a person
has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than
Company affiliates, then that person would be entitled to sell those shares without complying with any of the requirements of Rule 144.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Rule 144, as currently in effect, the Company&rsquo;s affiliates or persons selling shares of its common stock on behalf
of its affiliates are entitled to sell upon expiration of the market standoff agreements and lock-up agreements described above, within
any three-month period, a number of shares that does not exceed the greater of:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1%
    of the number of shares of the Company&rsquo;s capital stock then outstanding; or </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    average weekly trading volume of the Company&rsquo;s common stock during the four calendar weeks preceding the filing of a notice
    on Form 144 with respect to that sale.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
under Rule 144 by the Company&rsquo;s affiliates or persons selling shares of its common stock on behalf of its affiliates are also subject
to certain manner of sale provisions and notice requirements and to the availability of current public information about the Company.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
701</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
701 generally allows a stockholder who purchased shares of the Company&rsquo;s common stock pursuant to a written compensatory plan or
contract, such as stock options granted under the 2017 Plan, and who is not deemed to have been an affiliate of the Company during
the immediately preceding 90 days to sell these shares in reliance upon Rule 144, but without being required to comply with the public
information, holding period, volume limitation, or notice provisions of Rule 144. Rule 701 also permits affiliates of the Company to
sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. All holders of Rule 701
shares, however, are required to wait until 90 days after the date of this prospectus before selling such shares pursuant to Rule 701
and until expiration of the lock-up period described below.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreements</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, the Company, and its officers, directors and 5% stockholders have agreed to a &ldquo;lock-up&rdquo; period,
in the case of the Company, a period of 180 days after the date the registration statement, of which this prospectus forms a part is
declared effective, and in the case of our directors and executive officers and our 5% and greater stockholders, a period of 180 days
after the date the registration statement, of which this prospectus forms a part, is declared effective, with respect to the shares that
they beneficially own, including shares issuable upon the exercise of convertible securities and options that are currently outstanding
or which may be issued. This means that, for a period of 180 days following the closing of this offering, such persons may not offer,
sell, pledge or otherwise dispose of these securities without the prior written consent of the Underwriter. Officers&rsquo; and directors&rsquo;
180-day restricted period is subject to extension upon certain events and the terms of the lock-up agreements may be waived at the Underwriter&rsquo;s
discretion. The lock-up restrictions, specified exceptions and the circumstances under which the 180-day lock-up period may be extended
are described in more detail under &ldquo;<I>Underwriting</I>.&rdquo;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_007"></A>MATERIAL
UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of some of the possible U.S. tax consequences that should be anticipated in connection with an investment in our
common stock. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), the U.S. Treasury
regulations promulgated thereunder and administrative and judicial interpretations thereof, all as in effect on the date hereof and all
of which are subject to change, possibly with retroactive effect. There can be no assurance that their Internal Revenue Service (the
&ldquo;IRS&rdquo;) will not challenge one or more of the tax consequences described herein, and we have not obtained, and do not intend
to obtain, an opinion of counsel or ruling from the IRS with respect to the U.S. federal income tax considerations relating to the purchase,
ownership, or disposition of our common stock. <B>Each prospective investor is urged to consult their own tax advisor about the tax consequences
of an investment in our common stock in light of the investor&rsquo;s own circumstances</B>.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consequences
For U.S. Holders</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion describes the material U.S. federal income tax consequences relating to the ownership and disposition of our common
stock by U.S. Holders. As used in this discussion, the term &ldquo;U.S. Holder&rdquo; means a beneficial owner of our common stock that
is, for U.S. federal income tax purposes, (1) an individual who is a citizen or resident of the United States, (2) a corporation (or
entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States,
any state thereof, or the District of Columbia, (3) an estate the income of which is subject to U.S. federal income tax regardless of
its source, or (4) a trust (i) with respect to which a court within the United States is able to exercise primary supervision over its
administration and one or more United States persons have the authority to control all of its substantial decisions, or (ii) that has
elected to be treated as a domestic trust for U.S. federal income tax purposes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion applies to U.S. Holders that purchase our common stock pursuant to this offering and hold such common stock as capital assets.
This discussion does not address all of the U.S. federal income tax consequences that may be relevant to specific U.S. Holders in light
of their particular circumstances, or to U.S. Holders subject to special treatment under U.S. federal income tax law (such as certain
financial institutions, insurance companies, broker-dealers and traders in securities or other persons that generally mark their securities
to market for U.S. federal income tax purposes, tax-exempt entities, retirement plans, regulated investment companies, real estate investment
trusts, certain former citizens or residents of the United States, persons who hold our common stock as part of a &ldquo;straddle&rdquo;,
&ldquo;hedge&rdquo;, &ldquo;conversion transaction&rdquo;, &ldquo;synthetic security&rdquo; or integrated investment, persons that have
a &ldquo;functional currency&rdquo; other than the U.S. dollar, persons that own directly, indirectly or through attribution 10% or more
of the voting power of our common stock, corporations that accumulate earnings to avoid U.S. federal income tax, persons subject to special
tax accounting rules under Section 451(b) of the Code, partnerships and other pass-through entities, and investors in such pass-through
entities). This discussion does not address any U.S. state or local or non-U.S. tax consequences or any U.S. federal estate, gift or
alternative minimum tax consequences. If an entity treated as a partnership for U.S. federal income tax purposes holds our common stock,
the U.S. federal income tax consequences relating to an investment in our common stock will depend in part upon the status and activities
of such entity and the particular partner. Any such entity should consult its own tax advisor regarding the U.S. federal income tax consequences
applicable to it and its partners of the purchase, ownership and disposition of our common stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Distributions</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder that receives a distribution with respect to our common stock generally will be required to include the gross amount of such
distribution in income as a dividend when actually or constructively received, to the extent of the U.S. Holder&rsquo;s pro rata share
of our current and/or accumulated earnings and profits (as determined under U.S. federal income tax principles). To the extent a distribution
received by a U.S. Holder is not a dividend because it exceeds the U.S. Holder&rsquo;s pro rata share of our current and accumulated
earnings and profits, it will be treated first as a tax-free return of capital and reduce (but not below zero) the adjusted tax basis
of the U.S. Holder&rsquo;s common stock. To the extent the distribution exceeds the adjusted tax basis of the U.S. Holder&rsquo;s common
stock, the remainder will be taxed as capital gain.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sale,
Exchange or Other Disposition of our Common Stock</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder generally will recognize capital gain or loss for U.S. federal income tax purposes upon the sale, exchange or other disposition
of our common stock in an amount equal to the difference, if any, between the amount realized (i.e., the amount of cash plus the fair
market value of any property received) on the sale, exchange or other disposition, and such U.S. Holder&rsquo;s adjusted tax basis in
the shares that were transferred. Such capital gain or loss generally will be long-term capital gain or long-term capital loss if, on
the date of sale, exchange or other disposition, the transferred shares were held by the U.S. Holder for more than one year. Long-term
capital gains of individual investors are generally subject to lower tax rates than those imposed on ordinary income. Any capital gain
of a non-corporate U.S. Holder that is not long-term capital gain is taxed at ordinary income rates. Capital losses might not be permitted
to offset the full amount of an individual&rsquo;s ordinary income.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Medicare
Tax on Net Investment Income</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S. Holders who are individuals, estates or trusts are subject to an additional 3.8% U.S. federal income tax on all or a portion of
their &ldquo;net investment income,&rdquo; which generally includes dividends on the shares, and net gains from the disposition of common
stock. U.S. Holders that are individuals, estates or trusts should consult their tax advisors regarding the applicability of the Medicare
tax.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Information
Reporting and Backup Withholding</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
we must report annually to the IRS (with a copy of such report provided to you) the amount of dividends paid to you, your name and address,
and the amount of tax withheld, if any. Backup withholding may apply to amounts subject to reporting if the U.S. Holder (1) fails to
provide an accurate United States taxpayer identification number or otherwise establish a basis for exemption, or (2) is described in
certain other categories of persons. However, U.S. Holders that are corporations generally are excluded from these information reporting
and backup withholding tax rules. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules
generally will be allowed as a refund or a credit against a U.S. Holder&rsquo;s U.S. federal income tax liability if the required information
is furnished by the U.S. Holder on a timely basis to the IRS.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Foreign
Account Tax Compliance Act</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Foreign Account Tax Compliance Act (&ldquo;FATCA&rdquo;) generally imposes withholding tax at a rate of 30% on dividends on and gross
proceeds from the sale or other disposition of securities that are beneficially owned by certain U.S. persons where held in a &ldquo;foreign
financial institution&rdquo; (as specially defined under those rules), unless such institution enters into an agreement with the U.S.
government to, among other things, withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information
regarding the U.S. account holders of such institution (which includes certain equity and debt holders of such institution, as well as
certain account holders that are foreign entities with U.S. owners), or otherwise establishes an exemption. If a U.S. Holder owns our
common stock in a foreign financial institution, they should obtain specific advice from an expert on the implications of FATCA.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consequences
to Non-U.S. Holders</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the material U.S. federal income tax considerations for Non-U.S. Holders relating to the purchase, ownership
and disposition of the common stock purchased in this offering. A &ldquo;Non-U.S. Holder&rdquo; is a beneficial owner of our securities
(other than a partnership or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that, for U.S. federal
income tax purposes, is not a U.S. holder. This summary is for general information purposes only and does not purport to be a complete
analysis of all the potential tax considerations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Distributions</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below regarding effectively connected income, any dividend (including any taxable constructive stock dividend) paid
to a Non-U.S. Holder generally will be subject to U.S. withholding tax either at a rate of 30% of the gross amount of the dividend, or
such lower rate as may be specified by an applicable income tax treaty. In order to receive a reduced treaty rate, a Non-U.S. Holder
must provide us with an IRS Form W-8BEN, IRS Form W-8BEN-E or other applicable IRS Form W-8 properly certifying qualification for the
reduced rate. These forms must be updated periodically. A Non-U.S. Holder eligible for a reduced rate of U.S. withholding tax pursuant
to an income tax treaty may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the
IRS. If a Non-U.S. Holder holds our common stock through a financial institution or other agent acting on the Non-U.S. Holder&rsquo;s
behalf, the Non-U.S. Holder will be required to provide appropriate documentation to the agent, which then may be required to provide
certification to us or our paying agent, either directly or through other intermediaries.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
received by a Non-U.S. Holder that are effectively connected with its conduct of a U.S. trade or business (and, if required by an applicable
income tax treaty, attributable to a permanent establishment or fixed base maintained by the Non-U.S. Holder in the United States) are
generally exempt from such withholding tax if the Non-U.S. Holder satisfies certain certification and disclosure requirements. In order
to obtain this exemption, the Non-U.S. Holder must provide us with an IRS Form W-8ECI or other applicable IRS Form W-8 properly certifying
such exemption. Such effectively connected dividends, although not subject to withholding tax, are taxed at the same graduated U.S. federal
income tax rates applicable to U.S. holders, net of certain deductions and credits. In addition, dividends received by a corporate Non-U.S.
Holder that are effectively connected with its conduct of a U.S. trade or business may also be subject to a branch profits tax at a rate
of 30% or such lower rate as may be specified by an applicable income tax treaty. Non-U.S. Holders should consult their own tax advisors
regarding any applicable tax treaties that may provide for different rules.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Gain
on Sale, Exchange or Other Taxable Disposition of Common Stock</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below regarding backup withholding and foreign accounts, a Non-U.S. Holder generally will not be required to pay U.S.
federal income tax on any gain realized upon the sale, exchange or other taxable disposition of our common stock unless:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    gain is effectively connected with the Non-U.S. Holder&rsquo;s conduct of a U.S. trade or business (and, if required by an applicable
    income tax treaty, the gain is attributable to a permanent establishment or fixed base maintained by the Non-U.S. Holder in the United
    States);</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Non-U.S. Holder is a non-resident alien individual who is present in the United States for a period or periods aggregating 183 days
    or more during the calendar year in which the sale or disposition occurs, and certain other conditions are met; or</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    of our common stock constitute U.S. real property interests by reason of our status as a &ldquo;United States real property holding
    corporation&rdquo; (a USRPHC) for U.S. federal income tax purposes at any time within the shorter of the five-year period preceding
    the Non-U.S. Holder&rsquo;s disposition of, or the non- U.S. holder&rsquo;s holding period for, our common stock. </FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that we are not currently and will not become a USRPHC for U.S. federal income tax purposes, and the remainder of this discussion
so assumes. However, because the determination of whether we are a USRPHC depends on the fair market value of our U.S. real property
relative to the fair market value of our other business assets, there can be no assurance that we will not become a USRPHC in the future.
Even if we become a USRPHC, however, as long as our common stock is regularly traded on an established securities market, such common
stock will be treated as U.S. real property interests only if the Non-U.S. Holder actually or constructively holds more than five percent
of such regularly traded common stock at any time during the shorter of the five-year period preceding the Non-U.S. Holder&rsquo;s disposition
of, or the Non-U.S. Holder&rsquo;s holding period for, our common stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Non-U.S. Holder is described in the first bullet above, they will be required to pay tax on the net gain derived from the sale, exchange
or other taxable disposition under regular graduated U.S. federal income tax rates, and a corporate Non-U.S. Holder described in the
first bullet above also may be subject to the branch profits tax at a rate of 30%, or such lower rate as may be specified by an applicable
income tax treaty. An individual Non-U.S. Holder described in the second bullet above will be required to pay a flat 30% tax (or such
lower rate specified by an applicable income tax treaty) on the gain derived from the sale, exchange or other taxable disposition, which
gain may be offset by U.S. source capital losses for the year (provided the Non-U.S. Holder has timely filed U.S. federal income tax
returns with respect to such losses). Non-U.S. Holders should consult their own tax advisors regarding any applicable income tax or other
treaties that may provide for different rules.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Information
Reporting and Backup Withholding</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
we must report annually to the IRS (with a copy of such report provided to you) the amount of dividends paid to you, your name and address,
and the amount of tax withheld, if any. Pursuant to applicable income tax treaties or other agreements, the IRS may make these reports
available to tax authorities in your country of residence.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
of dividends on or of proceeds from the disposition of our common stock made to you may be subject to backup withholding unless you establish
an exemption, for example, by properly certifying your non-U.S. status on an IRS Form W-8BEN or IRS Form W-8BEN-E or other applicable
IRS Form W-8. Notwithstanding the foregoing, backup withholding may apply if either we or our paying agent has actual knowledge, or reason
to know, that you are a U.S. person. Backup withholding is not an additional tax; rather, the U.S. federal income tax liability of persons
subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund
or credit may generally be obtained from the IRS, provided that the required information is furnished to the IRS in a timely manner.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_008"></A>UNDERWRITING</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, we will enter into an underwriting agreement with Alexander Capital L.P. as the Underwriter of this offering.
The Underwriter, and each other underwriter named in the underwriting agreement, if any, has severally agreed to purchase from us, on
a firm commitment basis, the number of shares, set forth opposite its name below, at the public offering price, less the underwriting
discount set forth on the cover page of this prospectus.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriter</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Shares </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
    Capital L.P.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter is committed to purchase all of the shares offered by us other than those covered by the option to purchase additional
securities described below, if they purchase any such securities. The obligations of the Underwriter may be terminated upon the occurrence
of certain events specified in the underwriting agreement. Furthermore, pursuant to the underwriting agreement, the Underwriter&rsquo;s
obligations are subject to customary conditions, representations and warranties contained in the underwriting agreement, such as receipt
by the Underwriter of the officers&rsquo; certificates and legal opinions.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed to indemnify the Underwriter against specified liabilities, including liabilities under the Securities Act of and to contribute to payments the Underwriter may be required to make in respect thereof.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter is offering the shares subject to prior sale, when, as and if issued to and accepted by them, subject to approval
of legal matters by their counsel and other conditions specified in the underwriting agreement. The Underwriter reserves the right to
withdraw, cancel or modify offers to the public and to reject orders in whole or in part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over-allotment
Option</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We
have granted the Underwriter an over-allotment option. This option, which is exercisable for up to 45 days after the date of this
prospectus, permits the Underwriter to purchase up to a total of [&#9679;] shares of common stock at [&#9679;] per
share (equal to fifteen percent (15%) of the aggregate number of shares sold in this offering) and exercisable at a price per
share equal to the public offering price less the underwriting discounts and commissions set forth on the cover of this prospectus
in any combination thereof. We will be obligated, pursuant to the option, to sell these additional shares of common stock to the
Underwriter to the extent the option is exercised.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discount</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes
either no exercise or full exercise by the Underwriter of its over-allotment option.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per
    Share </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    Without Over-Allotment Option</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total
    With Over Allotment Option</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
    offering price</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
    discount (7.0%)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds,
    before expenses, to us</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter proposes to offer the shares offered by us to the public at the public offering price per share set forth on
the cover of this prospectus. In addition, the Underwriter may offer some of the shares to other securities dealers at such price
less a concession of $[&#9679;] per share. </FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will pay the out-of-pocket accountable expenses of the Underwriter in connection with this offering. The underwriting agreement,
however, provides that in the event the offering is terminated, any advance expense deposits paid to the Underwriter will be returned
to the extent that offering expenses are not actually incurred in accordance with FINRA Rule 5110(g)(4)(A). The Company will receive
a $25,000 advance expense deposit towards accountable expenses.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed to pay the Underwriter an Underwriter&rsquo;s fee of seven percent (7%) of the amount raised in this offering.
If any capital is raised in a pre-offering bridge round, the placement fee will be equal to a nine percent (9%) cash fee, plus
the Underwriter&rsquo;s Warrants. The Company has agreed to pay for a certain amount of the Underwriter&rsquo;s accountable expenses,
including actual accountable road show expenses for the offering; prospectus tracking and compliance software for the offering; the
reasonable and documented fees and disbursements of the Underwriter&rsquo;s counsel up to an amount of $[&#9679;]; background checks
of the Company&rsquo;s officers and directors; preparation of bound volumes and cube mementos in such quantities as the Underwriter may
reasonably request. The total amount of accountable expenses to be paid, reimbursed, or paid on behalf of the Underwriter will not
exceed $175,000. In addition, we have also agreed to pay to the underwriters a non-accountable expense allowance in the amount of
1% of the gross offering amount (including shares purchased upon exercise of the over-allotment option).</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates that the total expenses of the offering payable by us, excluding underwriting discounts and commissions, will be approximately
$[&#9679;].</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have been advised by the Underwriter that it proposes to offer the shares offered by us to the public at the public offering price
per share set forth on the cover of this prospectus. In addition, the Underwriter may offer some of the shares to other
securities dealers at such price less a concession of $[&#9679;] per share. After the initial offering, the public offering price
and concession to dealers may be changed.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Underwriter
Warrants</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of this offering, we have agreed to issue to the Underwriter a five-year warrant to purchase a number of shares of common
stock equal in the aggregate to six percent (6%) of the total number of shares issued by us in this offering. The Underwriter&rsquo;s
Warrants will be exercisable at a per share exercise price equal to one hundred twenty percent (120%) of the public offering price per
Unit. The Underwriter&rsquo;s Warrants will be exercisable at any time, and from time to time, in whole or in part, during the period
from the effective date of the offering, which period shall not extend further than five years from the date of commencement of sales
in this offering in compliance with FINRA Rule 5110. The Underwriter&rsquo;s Warrants are also exercisable on a cashless basis. The Underwriter&rsquo;s
Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to FINRA Rule 5110. Except as
permitted by Rule 5110, the Underwriter (or permitted assignees under the Rule) will not sell, transfer, assign, pledge, or hypothecate
the Underwriter&rsquo;s Warrants or the securities underlying the Underwriter&rsquo;s Warrants, nor will any of them engage in any hedging,
short sale, derivative, put, or call transaction that would result in the effective economic disposition of the option or the underlying
securities for a period of 180 days from the commencement of sales under this prospectus. The exercise price and number of securities
upon exercise of the Underwriter&rsquo;s Warrants may be adjusted in certain circumstances including in the event of a share dividend,
extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation. However, the Underwriter&rsquo;s Warrant
exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the Underwriter&rsquo;s
Warrant exercise price.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Underwriter&rsquo;s
Warrants include piggy-back registration and mandatory registration rights in favor of the Underwriter. The piggy-back registration rights
provide that the Company will, subject to certain limitations, include common stock underlying the Underwriter&rsquo;s Warrants in any
registration statement filed by the Company while the Underwriter&rsquo;s Warrants are exercisable. The mandatory registration rights
require the Company to prepare and file at the written request of the warrant holder, on a one-time basis, a registration statement on
Form F-3 covering any remaining unregistered common stock underlying the Underwriter&rsquo;s Warrants so long as such warrants are exercisable.
The underwriting agreement and the accompanying exhibits, including the form of the Underwriter&rsquo;s Warrant agreement, have been
filed with this offering&rsquo;s registration statement of which this prospectus forms a part as Exhibit No. 1.1.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discretionary
Accounts</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter does not intend to confirm sales of the securities offered hereby to any accounts over which they have discretionary authority.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreements</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the underwriting agreement and certain &ldquo;lock-up&rdquo; agreements, the Company, its executive officers, directors and certain
holders of the Company&rsquo;s common stock and securities exercisable for or convertible into its common stock outstanding immediately
upon the closing of this offering, have agreed, subject to certain exceptions, not to offer, sell, assign, transfer, pledge, contract
to sell, or otherwise dispose of or announce the intention to otherwise dispose of, or enter into any swap, hedge or similar agreement
or arrangement that transfers, in whole or in part, the economic risk of ownership of, directly or indirectly, engage in any short selling
of any common stock or securities convertible into or exchangeable or exercisable for any common stock, whether currently owned or subsequently
acquired, without the prior written consent of the Underwriter, for a period of 180 days from the date of effectiveness of the registration
statement, of which this prospectus forms a part.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Right
of First Refusal</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the Underwriter a right of first refusal, for a period of 12 months from the closing of this offering, to act as sole investment
banker, sole book runner and/or sole Underwriter at the Underwriter&rsquo;s discretion, for each and every future public or private equity
financing for the Company, or any successor to or subsidiary of the Company. The right of first refusal may be terminated by the Company
for cause, which including a material breach by the Underwriter or a material failure by the Underwriter to provide services as contemplated.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Electronic
Offer, Sale and Distribution of Securities</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
prospectus in electronic format may be made available on the websites maintained by the Underwriter, if any, participating in this offering
and the Underwriter participating in this offering may distribute prospectuses electronically. The Underwriter may agree to allocate
a number of shares for sale to its online brokerage account holders. Internet distributions will be allocated by the Underwriter that
will make internet distributions on the same basis as other allocations. Other than the prospectus in electronic format, the information
on these websites is not part of, nor incorporated by reference into, this prospectus or the registration statement of which this prospectus
forms a part, has not been approved or endorsed by us or the Underwriter in its capacity as the Underwriter, and should not be relied
upon by investors.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stabilization</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, the Underwriter may engage in stabilizing transactions, over-allotment transactions, covered transactions,
penalty bids and purchases to cover positions created by short sales.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stabilizing
    transactions permit bids to purchase securities so long as the stabilizing bids do not exceed a specified maximum and are
    engaged in for the purpose of preventing or retarding a decline in the market price of the common stock while the offering is in
    progress.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over-allotment
    transactions involve sales by the Underwriter of securities in excess of the number of shares the Underwriter is obligated
    to purchase. This creates a covered short position which may be either a covered short position or a naked short position. In a covered
    short position, the number of securities over-allotted by the Underwriter is not greater than the number of securities that they
    may purchase in the over-allotment option. In a naked short position, the number of securities involved is greater than the number
    of securities in the over-allotment option. The Underwriter may close out any short position by exercising its over-allotment option
    and/or purchasing securities in the open market.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covered
    transactions involve purchases of shares of common stock in the open market after the distribution has been completed in order to
    cover syndicate short positions. In determining the source of shares of common stock to close out the short position, the Underwriter
    will consider, among other things, the price of shares of common stock available for purchase in the open market as compared with
    the price at which it may purchase shares of common stock through exercise of the over- allotment option. If the Underwriter sells
    more shares of common stock than could be covered by exercise of the over-allotment option and, therefore, have a naked short position,
    the position can be closed out only by buying shares of common stock in the open market. A naked short position is more likely to
    be created if the Underwriter is concerned that after pricing there could be downward pressure on the price of the shares of common
    stock in the open market that could adversely affect investors who purchase in the offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalty
    bids permits the Underwriter to reclaim a selling concession from a syndicate member when the securities originally sold by
    the Underwriter are purchased in stabilizing or covered transactions to cover short positions.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stabilizing transactions, covered transactions and penalty bids may have the effect of raising or maintaining the market price of the
shares of common stock or preventing or retarding a decline in the market price of its shares of common stock. As a result, the price
of the common stock in the open market may be higher than it would otherwise be in the absence of these transactions. Neither the Company
nor the Underwriter make any representation or prediction as to the effect that the transactions described above may have on the price
of the Company&rsquo;s common stock. These transactions may be effected on the Nasdaq Capital Market, in the over-the-counter market
or otherwise and, if commenced, may be discontinued at any time.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Passive
Market Making</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, the Underwriter may engage in passive market making transactions in the Company&rsquo;s common stock on
The Nasdaq Capital Market in accordance with Rule 103 of Regulation M under the Exchange Act, during a period before the commencement
of offers or sales of the securities and extending through the completion of the distribution. A passive market maker must display
its bid at a price not in excess of the highest independent bid of that security. However, if all independent bids are lowered below
the passive market maker&rsquo;s bid, then that bid must then be lowered when specified purchase limits are exceeded.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Relationships</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter and their respective affiliates may, in the future provide various investment banking, commercial banking and other financial
services for the Company and its affiliates for which they have received, and may in the future receive, customary fees. However, except
as disclosed in this prospectus, the Company has no present arrangements with the Underwriter for any further services.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offer
Restrictions Outside the United States</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than in the United States, no action has been taken by us or the Underwriter that would permit a public offering of the securities offered
by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are
advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_009"></A>LEGAL
MATTERS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the common stock offered by us in this offering will be passed upon for us by Lucosky Brookman LLP, Woodbridge, New
Jersey. Certain legal matters will be passed upon for the Underwriter by Carmel, Milazzo &amp; Feil LLP, New York, New York.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="z_001"></A>INTERESTS
OF NAMED EXPERTS AND COUNSEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as noted below, no expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given
an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering
of the securities was employed on a contingency basis, or had, or is to receive, in connection with the offering, a substantial interest,
direct or indirect, in the registrant or any of its parents or subsidiaries. Nor was any such person connected with the registrant or
any of its parents or subsidiaries as a promoter, managing or principal underwriter, voting trustee, director, officer, or employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP, counsel to the Company in connection with this initial public offering, will own 50,000 shares of the Company&rsquo;s common
stock. These 50,000 shares of Common Stock will be issued upon the closing of the initial public offering as partial payment for legal
services rendered in connection with the initial public offering.</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_010"></A>EXPERTS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements as of December 31, 2022 and 2021, included in this registration statement have been so included in reliance
upon the report of Rosenberg Rich Baker Berman, P.A., an independent registered public accounting firm, given on the authority of said
firm as an expert in auditing and accounting.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ka_011"></A>WHERE
YOU CAN FIND MORE INFORMATION</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities offered by
this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set
forth in the registration statement, some of which is contained in exhibits to the registration statement as permitted by the rules and
regulations of the SEC. For further information with respect to us and our common stock, we refer you to the registration statement,
including the exhibits filed as a part of the registration statement. Statements contained in this prospectus concerning the contents
of any contract or any other document are not necessarily complete. If a contract or document has been filed as an exhibit to the registration
statement, please see the copy of the contract or document that has been filed. Each statement in this prospectus relating to a contract
or document filed as an exhibit is qualified in all respects by the filed exhibit.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information reporting requirements of the Exchange Act, and we will file reports, proxy statements and other information
with the SEC. These reports, proxy statements and other information will be available on the website of the SEC referred to above. The
information contained in, or that can be accessed through, our website is not part of this prospectus, and you should not consider the
contents of our website in making an investment decision with respect to our common stock.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B><A NAME="index_001"></A>Index to Financial Statements</B> </P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: center"> <B>&nbsp;</B> </P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: center"> <B>NEURAXIS, INC.</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page(s)</B></FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
    THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022</B></FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ky_001">Condensed
    Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022</A></FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ky_002">Condensed
    Statements of Operations (unaudited) for the Three Months Ended March 31, 2023 and 2022</A></FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>3 </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ky_003">Statements
    of Stockholders&rsquo; Deficit (unaudited) for the Three Months Ended March 31, 2023 and 2022</A></FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>4 </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ky_004">Condensed
    Statements of Cash Flows (unaudited) for the Three Months Ended March 31, 2023 and 2022</A></FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>5 </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#ky_005">Notes
    to Financial Statements (unaudited)</A></FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>6 </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE YEARS ENDED DECEMBER 31, 2022 AND 2021</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page(s)</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#Hz_001">Report of Independent Registered Public Accounting Firm (PCAOB Firm ID 0089)</A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">F-34</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#bals_001">Balance Sheets as of December 31, 2022 and 2021</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-35</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#Z_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Operations for the Years Ended December 31, 2022 and 2021</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>37</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#Z_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Stockholders&rsquo; Equity (Deficit) for the Years Ended December 31, 2022 and 2021</FONT></A></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>38</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A HREF="#Z_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements of Cash Flows for the Years Ended December 31, 2022 and 2021</FONT></A></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-39</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#Z_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Financial Statements</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</FONT>40</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 122 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="ky_001"></A>Neuraxis,
Inc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Balance Sheet</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">March
                                            31,</FONT> </P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Unaudited)</FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">December
                                            31,</FONT> </P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Current Assets:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and
    cash equivalents</FONT> </TD><TD STYLE="width: 2%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">45,463</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">253,699</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts receivable,
    net</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">363,485</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">174,399</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Inventories</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">77,018</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">48,133</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaids
    and other current assets</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">19,761</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">726</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current assets</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">505,727</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">476,957</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Property and equipment, at cost:</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">413,453</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">405,845</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Less
    - accumulated depreciation</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(325,062</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(317,834</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">88,391</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">88,011</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Other Assets:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred offering costs</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">815,708</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">736,736</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Operating lease right
    of use asset</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">93,602</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">101,382</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">74,937</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">77,558</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Assets</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,578,365</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,480,644</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The accompanying notes are an integral part of these unaudited financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 123; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
                                            Inc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Balance Sheet</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
                                            31,</B></FONT> </P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2023</B></FONT> </P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
                                            31,</B></FONT> </P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2022</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Current Liabilities:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable</FONT> </TD><TD STYLE="width: 2%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,060,788</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,592,116</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued expenses</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,020,891</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">834,062</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Notes payable</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">210,090</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">202,834</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Current portion of operating
    lease payable</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">37,328</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">33,395</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Notes payable - related
    party</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Notes payable - convertible notes, net
    of unamortized discount of $4,481,355 and $3,327,213 as of March 31, 2023 and December 31, 2022</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">313,089</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">228,342</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Customer deposits</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">72,072</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">59,174</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative liabilities</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,947,630</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,541,532</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">9,261,471</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">6,978,058</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Non-current Liabilities:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease payable, net of current portion</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">63,917</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">76,199</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    non-current liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">63,917</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">76,199</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt; padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">9,325,388</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">7,054,257</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Commitments and contingencies (see note
    16)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo; Deficit</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible Series A Preferred stock, $0.001 par value; 1,000,000
    shares authorized; 506,637 issued and outstanding as of March 31, 2023 and December 31, 2022</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible Series Seed Preferred Stock, $0.001 par value; 120,000
    shares authorized; 115,477 issued and outstanding as of March 31, 2023 and December 31, 2022</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock, $0.001 par value; 100,000,000 shares authorized; 1,963,322 issued and outstanding as of March 31, 2023 and December 31, 2022</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,963</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,963</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid in capital</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">28,355,230</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">28,355,230</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated deficit</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(36,104,838</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(33,931,428</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt; padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
stockholders&rsquo; deficit</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(7,747,023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(5,573,613</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
Liabilities and Stockholders&rsquo; Deficit</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,578,365</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,480,644</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The accompanying notes are an integral part of these unaudited financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 124 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="ky_002"></A>Neuraxis,
Inc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Statements of Operations (Unaudited)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Three Months Ended March 31,</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net Sales</FONT> </TD><TD STYLE="width: 2%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">805,110</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">770,267</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cost of Goods Sold</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">95,900</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">75,200</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Gross Profit</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">709,210</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">695,067</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Selling Expenses</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">107,932</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">135,880</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Research and Development</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">16,797</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">44,398</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">General and Administrative</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,480,755</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,028,096</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    Loss</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(896,274</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(513,307</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Other Income (Expense):</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Financing charges</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,772</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(161,689</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(26,100</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Change in fair value
    of warrant liability</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">234,807</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Change in fair value
    of derivative liability</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">191,297</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt discount
    and issuance cost</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,662,655</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Extinguishment of
    derivative liabilities</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,129,498</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Other income</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,550</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    expense</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(7,172</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">257</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense), net</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1,277,136</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(25,833</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Loss</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,173,410</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(539,140</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Per-share Data</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Basic
    and diluted loss per share</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1.18</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(0.37</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted Average Shares Outstanding</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Basic
    and diluted</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,003,322</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,968,004</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The accompanying notes are an integral part of these unaudited financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT> </P>




<!-- Field: Page; Sequence: 125 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="ky_003"></A>Neuraxis,
Inc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Statements of Stockholders&rsquo; Deficit (Unaudited)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Three Months Ended March 31, 2023, and 2022</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Series A Preferred Stock</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Series Seed Preferred Stock</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    Stock</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Additional
    Paid In</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo; </FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Capital</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Deficit</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Deficit</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, January 1, 2022</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,637</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115,477</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,928,004</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,928</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">28,323,157</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(29,151,366</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 4%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(825,659</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Stock based compensation</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">11,994</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">11,994</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(539,140</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(539,140</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, March 31,
    2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,637</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115,477</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,928,004</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,928</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">28,335,151</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(29,690,506</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1,352,805</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, January 1, 2023</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,637</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115,477</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,963,322</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,963</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">28,355,230</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(33,931,428</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(5,573,613</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,173,410</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,173,410</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance, March 31,
    2023</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,637</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115,477</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,963,322</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,963</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">28,355,230</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(36,104,838</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(7,747,023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The accompanying notes are an integral part of these unaudited financial statements.</I></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 126 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="ky_004"></A>Neuraxis,
Inc.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Condensed
Statements of Cash Flows (Unaudited)</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Three Months Ended March 31,</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash Flows from Operating
    Activities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net Loss</FONT> </TD><TD STYLE="width: 2%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,173,410</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(539,140</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments to reconcile
    net loss to net cash used by operating activities:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt discount
    and issuance cost</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,662,655</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation and amortization</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">9,849</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">8,379</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Provisions for losses
    on accounts receivable</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(3,787</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">8,273</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Non-cash lease expense</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">7,780</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">6,648</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Stock based compensation</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">11,994</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Extinguishment of derivative
    liability</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1,129,498</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Finance Charges</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,772</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Change in fair value
    of derivative liabilities</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(191,297</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Change in fair value
    of warrant liabilities</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(234,807</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Changes in operating
    assets and liabilities:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts receivable</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(185,299</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(89,782</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(28,885</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(750</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaids and other current
    assets</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(19,035</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(141</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">468,672</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">207,028</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 30pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued expenses</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">186,829</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">223,196</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 30pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Customer deposits</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">12,898</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(22,722</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 30pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease liability</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(8,349</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(6,896</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash used by operating activities</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(622,912</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(193,913</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash Flows from Investing
    Activities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Additions
    to property and equipment</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(7,608</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash used by investing activities</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(7,608</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash Flows from Financing
    Activities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Principal payments on
    notes payable</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,695,344</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(41,035</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from notes
    payable</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">52,600</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from convertible
    notes, net of fees</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,144,000</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Offering
    costs paid</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(78,972</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(405</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash provided (used) by financing activities</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">422,284</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(41,440</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net Decrease in Cash
    and Cash Equivalents</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(208,236</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(235,353</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and Cash Equivalents
    at Beginning of Period</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">253,699</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">320,858</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and Cash Equivalents at End of Period</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">45,463</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">85,505</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Supplemental Disclosure
    of Non-cash Cash Activities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash paid for interest</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">35,865</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">23,923</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cash paid for income
    taxes</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Supplemental Schedule
    of Non-cash Investing and Financing Activities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of warrants issued with convertible notes</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,541,955</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of derivative
    liabilities of conversion feature from convertible notes</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,532,725</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I></I></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <I>The accompanying notes are an integral part
of these unaudited financial statements.</I> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 127 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="ky_005"></A>Neuraxis,
Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to the Unaudited Financial Statements</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
Basis of Presentation, Organization and Other Matters </B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc. (&ldquo;we,&rdquo; &ldquo;us,&rdquo; the &ldquo;Company,&rdquo; or &ldquo;Neuraxis&rdquo;) was established in 2011 and incorporated
in the state of Indiana on April 17, 2012, under the name of Innovative Health Solutions, Inc. The name was changed to Neuraxis, Inc.
in March of 2022. Additionally, the Company filed a Certificate of Conversion to become a Delaware corporation on June 23, 2022. The
authorized shares were increased, and a par value established.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 7, 2021, the Company&rsquo;s board of directors authorized a 4-for-1 stock split. They also increased the number of authorized
common stock shares from 2,700,000 to 10,800,000. Furthermore, on September 9, 2021, the board authorized an increase of authorized shares
of common stock from 10,800,000 to 13,400,000 in anticipation of a capital offering. Furthermore, on January 10, 2023, the Company&rsquo;s
board of directors authorized a 1-for-2 reverse stock split. All per share information has been adjusted for this reverse stock split.
The reverse split became effective on January 12, 2023. All share and per share amounts for the common stock have been retroactively
restated to give effect to the splits. See Subsequent Events footnote.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the conversion to a Delaware corporation, the total number of shares of all classes of stock which the Corporation shall have
authority to issue is (1) 100,000,000 shares of Common Stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;) and (ii) 1,120,000
shares of Preferred Stock, par value $0.001 per share (&ldquo;Preferred Stock&rdquo;), 1,000,000 of which is hereby designated as &ldquo;Series
A Preferred Stock&rdquo; and 120,000 of which is hereby designated as &ldquo;Series Seed Preferred Stock&rdquo; with the rights, preferences,
powers, privileges and restrictions, qualifications and limitations set forth in this Article IV of the Delaware Certificate of Incorporation.
All share amounts have been retroactively restated to give effect to these changes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is headquartered in Versailles, Indiana. The Company specializes in the development, production, and sale of medical neuromodulation
devices.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has developed three FDA cleared products, the IB-STIM (DEN180057, 2019), the NSS-2 Bridge (DEN170018, 2017), and the original
510(K) clearance (K140530, 2014).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    IB-STIM is a percutaneous electrical nerve field stimulator (PENFS) device that is indicated in patients 11-18 years of age with
    functional abdominal pain associated with irritable bowel syndrome. The IB-STIM currently is the only product marketed and sold by
    the Company. </FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NSS-2 Bridge is a percutaneous nerve field stimulator (PNFS) device indicated for use in the reduction of the symptoms of opioid
    withdrawal. The NSS-2 Bridge device was licensed to Masimo Corporation in April 2020, and the Company received a one-time licensing
    fee of $250,000 from Masimo. Masimo markets and sells this product as its Masimo Bridge, and the Company will not receive any further
    licensing payments or other revenue from this product. </FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    original 510(K) device was the EAD, an electroacupuncture device, now called NeuroStim. The EAD is no longer being manufactured,
    sold or distributed but reserved only for research purposes. </FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>


<!-- Field: Page; Sequence: 128 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Summary of Significant Accounting Policies</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summary of significant accounting policies of Neuraxis, Inc. is presented to assist in understanding the Company&rsquo;s financial statements.
The financial statements and notes are representations of the Company&rsquo;s management, who is responsible for their integrity and
objectivity. These accounting policies conform to U.S. generally accepted accounting principles and have been consistently applied in
the preparation of the financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of Presentation</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s condensed financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&ldquo;U.S. GAAP&rdquo;) and following the requirements of the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;)
for interim reporting. As permitted under those rules, certain footnotes or other financial information that are normally required by
U.S. GAAP can be condensed or omitted. These interim financial statements have been prepared on the same basis as the Company&rsquo;s
annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments,
which are necessary for a fair statement of the Company&rsquo;s financial information. These interim results are not necessarily indicative
of the results to be expected for the year ending December 31, 2023, or any other interim period or for any other future year. These
unaudited condensed financial statements should be read in conjunction with the Company&rsquo;s audited financial statements and the
notes thereto for the year ended December 31, 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Estimates and Critical Accounting Estimates and Assumptions</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements
and the reported amounts of revenues and expenses during the reporting periods.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these
estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial
statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values
of assets and liabilities that are not readily apparent from other sources.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes
in facts and circumstances, historical experience, and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates
are adjusted accordingly. The Company uses estimates in accounting for, among other items, revenue recognition, allowance for doubtful
accounts, stock-based compensation, income tax provisions, excess and obsolete inventory reserve, impairment of intellectual property, and valuations of warrant and derivative liabilities.
Actual results could differ from those estimates.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 129 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
and Cash Equivalents</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company
did not hold any cash equivalents as of March 31, 2023 and December 31, 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trade
Accounts Receivable</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are stated at the amount management expects to collect from balances outstanding at year-end. Management considers
the following factors when determining the collectability of specific customer accounts: customer creditworthiness, past transaction
history with the customer, current economic industry trends, and changes in customer payment terms. Based on management&rsquo;s assessment
of the credit history with customers having outstanding balances and current relationships with them, it has concluded that realization
losses on balances outstanding at year-end will be immaterial. Interest is not charged on past due customer accounts.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Credit Losses</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are stated net of credit losses. We estimate credit losses by evaluating specific
accounts where information indicates our customers may have an inability to meet financial obligations, such as customer payment history,
credit worthiness and receivable amounts outstanding for an extended period beyond contractual terms. We use assumptions and judgment,
based on the best available facts and circumstances, to record an allowance to reduce the receivable to the amount expected to be collected.
Credit losses were $27,457 and $31,275 at March 31, 2023 and December 31, 2022, respectively. During the three months
ended March 31, 2023 and 2022, the Company recorded ($3,787) and $8,273, respectively, as a (recovery)/bad debt expense.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Customer
Deposits</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
deposits consists of billings, payments, and returned devices from clients in advance of revenue recognition. The Company will recognize
the customer deposits over the next year. As of March 31, 2023, and December 31, 2022, the Company had customer deposits of $72,072 and
$59,174, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inventories</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are valued at the lower of cost or net realizable value. Cost is determined using the weighted average method. The inventory is comprised
of finished medical devices on hand. Certain components within the devices have an expiration date that are removed from current inventory
and expensed at the date of expiration. For the three months ended March 31, 2023 and 2022, $0 were expensed as expired inventory.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Deferred
Offering Costs</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs consist of costs incurred in connection with the preparation of an initial public offering. These costs, together with
the underwriting discounts and commissions, will be charged to additional paid in capital upon completion of the proposed public offering
or charged to operations if the proposed public offering is not completed. As of March 31, 2023 and December 31, 2022, the Company had
deferred offering costs of $815,708 and $736,736, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 130 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Property
and Equipment </U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is calculated using the following estimated useful lives:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Classification</B></FONT> </TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Years</B></FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    Improvements</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-20</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Machinery
    and Equipment</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7-10</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Furniture
    and Fixtures</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-10</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Research
and Development</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
for research and development are expensed as incurred. Research and development expenses consist primarily of clinical research studies,
and new product development.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Intangible
Assets</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets consist of patents and a trademark. Patents are stated at their historical cost and amortized on a straight-line basis over their
expected useful lives. Capitalized patent costs, net of accumulated amortization, includes legal costs incurred for patent applications.
In accordance with ASC 350, once a patent is granted, we amortize the capitalized patent costs over the remaining life of the patent
using the straight-line method. If the patent is not granted, we write-off any capitalized patent costs at that time.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement for a trademark related to the Company&rsquo;s name on July 11, 2022. The agreement called for an initial
payment of $10,000 upon execution of the agreement. A second and final payment of $40,000 is contingent upon the completion of the Company&rsquo;s
planned initial public offering. The second payment has not been recorded in these financial statements. The trademark does not have
a determinate life and therefore the cost is not being amortized. See Note 16 Commitments and Contingencies.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review intangible assets for impairment annually or when events or circumstances indicate that their carrying amount may not be recoverable.
During the three months ended March 31, 2023 and 2022, the Company recorded no impairment charges for intangible assets.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
Taxes</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in
the Company&rsquo;s financial statements and tax returns. Deferred tax assets and liabilities are determined based upon the differences
between the financial statement carrying amounts, and the tax bases of existing assets and liabilities for the loss and credit carryforwards
using enacted tax rates expected to be in effect in the year in which the differences are expected to reverse. Deferred tax assets are
reduced by a valuation allowance if it is more likely than not that these assets may not be realized. The Company determines whether
a tax position will be sustained upon examination. If it is not more likely than not that a position will be sustained, none of the benefit
attributable to the position is recognized. The tax benefit to be recognized for any tax position that meets the more likely than not
recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the contingency.
The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 131 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No interest or penalties have been accrued or charged to expense as of March 31, 2023 and 2022 and for the three
months then ended.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s income tax returns are subject to examination by the taxing authorities until the expiration of the related statutes
of limitations on those tax returns. In general, the federal and state income tax return have a three-year statute of limitations. As
of March 31, 2023, the following tax years are subject to examination:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jurisdiction</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Open
    Years for Filed Returns</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020
    &ndash; 2022</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Various
    States</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020
    &ndash; 2022</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advertising
Cost</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
costs are expensed as incurred and amounted to $8,000 and $8,300 for the three months ended March 31, 2023 and 2022, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Derivative
Liabilities</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for derivative financial instruments embedded in convertible debt as either equity or liabilities in accordance
with ASC Topic 815, <I>Derivatives and Hedging</I>, or ASC 815, based on the characteristics and provisions of each instrument.
Embedded derivatives are required to be bifurcated from the host instruments and recorded at fair value if the derivatives are not
clearly and closely related to the host instruments on the date of issuance. Derivative instrument liabilities are classified in the balance sheets as current or non-current based on whether or not net-cash settlement of the derivative instrument could
be required within 12 months of the balance sheet date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrant
Liabilities</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
evaluates all of the Company&rsquo;s financial instruments, including issued Warrants to purchase its Class A common stock, to
determine if such instruments are liabilities or contain features that qualify as derivatives, pursuant to ASC 480 and ASC
815-15, respectively. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as
equity, is re-assessed at the end of each reporting period.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes a Monte Carlo simulation model for warrants that have an option to convert at a variable number of shares to compute
the fair value of the derivative and to mark to market the fair value of the liabilities at each balance sheet date. The inputs utilized
in the application of the Monte Carlo model included a starting stock price, an expected remaining term of each warrant as of the valuation
date, estimated volatility, drift, and a risk-free rate. The Company records the change in the fair value of the derivative as other
income or expense in the statements of operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>


<!-- Field: Page; Sequence: 132 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value Measurements</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for financial instruments in accordance with ASC 820, Fair Value Measurements and Disclosures (&ldquo;ASC 820&rdquo;).
ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and
the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described
below:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &ndash; Quoted prices (unadjusted) for identical unrestricted assets or liabilities in active markets that the reporting entity has
the ability to access as of the measurement date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &ndash; Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities: quoted
prices in markets that are not active; or financial instruments for which all significant inputs are observable or can be corroborated
by observable market date, either directly or indirectly.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &ndash; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets
or liabilities. These unobservable inputs reflect that reporting entity&rsquo;s own assumptions about assumptions that market participants
would use in pricing the asset or liability. Level 3 assets and liabilities include financial instruments whose value is determined using
pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair
value require significant management judgment or estimation.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Level 1 assets/liabilities include cash, accounts receivable, accounts payable, prepaids, and other current assets. Management
believes the estimated fair value of these accounts on March 31, 2023 approximate their carrying value as reflected in the balance sheets
due to the short-term nature of these instruments or the use of market interest rates for debt instruments.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Level 3 assets/liabilities include derivative and warrant liabilities. Inputs to determine fair value are generally
unobservable and typically reflect management&rsquo;s estimates of assumptions that market participants would use in pricing the
asset or liability. The Company utilizes a Monte Carlo simulation model for warrant and derivative liabilities that have an option
to convert or exercise at a variable number of shares to compute the fair value of the liabilities and to mark to market the fair
value of the liabilities at each balance sheet date. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables provides a summary of the relevant assets and liabilities that are measured at fair value on recurring basis:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
Value Measurements as of</B></FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
31, 2023</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    1)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    2)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    3)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 36%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,541,532</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,541,532</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,947,630</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,947,630</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">5,489,162</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">5,489,162</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>


<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
Value Measurements as of</B></FONT> </P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2022</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    1)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    2)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    3)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 36%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,970,084</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,970,084</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 133 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the valuation methodology and unobservable inputs for Level 3 assets and liabilities measured at fair value on
recurring basis as of March 31, 2023 and December 31, 2022:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
                                            Value</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
                                            of</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>March
                                            31 2023</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
                                            Value</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
                                            of</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
                                            31 2022</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Valuation</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Methodology</B></FONT> </P></TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unobservable</B></FONT> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inputs</B></FONT> </P></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 24%; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant liabilities</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,541,532</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 16%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Monte Carlo model</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 16%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Future value of the Company&rsquo;s common stock; probability and timing of a potential equity offering.</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative liabilities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,947,630</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Monte Carlo model</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Future value of the Company&rsquo;s common stock; probability and timing of a potential equity offering.</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no transfers between any of the levels during three months ended March 31, 2023 and year ended December 31, 2022. In addition to
assets and liabilities that are recorded at fair value on a recurring basis, the Company&rsquo;s assets and liabilities are also subject
to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment
charges.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basic
and Diluted Net Income (Loss) per Share</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
or loss per share (&ldquo;EPS&rdquo;) is computed by dividing net income (loss), net of preferred stock dividends, by the weighted average
number of shares of common stock outstanding during the period. Basic weighted average shares for the year ended March 31, 2023 include
40,000 vested warrants to purchase common shares. As the shares underlying these warrants can be purchased for little to no consideration
($0.01 per share exercise price), they are included in the computation of basic earnings per share. Diluted EPS is computed by dividing
net income (loss) by the weighted average of all potentially dilutive shares of common stock that were outstanding during the periods
presented. Preferred stock dividends (not declared or paid) were $2,378,706 and $2,190,102 as of March 31, 2023 and December 31, 2022,
respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common
shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares
outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, which
is the case for March 31, 2023 and 2022 presented in these financial statements, the weighted-average number of common shares outstanding
excludes common stock equivalents because their inclusion would be anti-dilutive.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had the following potentially dilutive common stock equivalents at March 31, 2023 and 2022:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 68%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible Series A Preferred
    Stock</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,013,270</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 12%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,013,270</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible Series Seed Preferred Stock</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">230,954</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">230,954</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Options</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-Funded Warrants for Convertible Series
    A</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred Stock</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">289,779</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">289,779</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">954,044</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">365,967</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible Bridge
    Debt</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">717,432</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">376,652</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Totals</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">4,524,873</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,596,016</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>


<!-- Field: Page; Sequence: 134 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the calculation of the basic and diluted net loss per share and the effect of preferred stock dividends.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Three Months Ended March 31,</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Numerator</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 64%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,173,410</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(539,140</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    stock dividends</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(188,604</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(188,604</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,362,014</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(727,744</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Denominator</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average
    shares of common stock outstanding - basic and diluted</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,003,322</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,968,004</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Basic and diluted
    net loss per share</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1.18</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(0.37</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock-Based
Compensation</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for all stock-based payments and awards under the fair value-based method. The Company recognizes its stock-based compensation
expense using the straight-line method. Compensation cost is not adjusted for estimated forfeitures, but instead is adjusted upon an
actual forfeiture of a stock option.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the granting of stock options to employees and non-employees using the fair value method whereby all awards are
measured at fair value on the date of the grant. The fair value of all employee stock options is expensed over the requisite service
period with a corresponding increase to additional paid-in capital. Upon exercise of stock options, the consideration paid by the option
holder is recorded in additional paid-in capital, while the par value of the shares received is reclassified from additional paid in
capital to common stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
payments to non-employees are measured based on the fair value of the equity instrument issued. Compensation expense for non-employee
stock awards is recognized over the requisite service period following the measurement of the fair value on the grant date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes option-pricing model to calculate the fair value of stock options. The use of the Black-Scholes option-pricing
model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common
stock consistent with the expected term of the option, risk-free interest rates, the value of the common stock and expected dividend
yield of the common stock. Changes in these assumptions can materially affect the fair value estimate.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 135 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
Recognition </U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc. specializes in the development, production, and sale of medical neuromodulation devices to healthcare providers primarily located
in the United States. Patented and trademarked neuromodulation devices is the Company&rsquo;s major product line. Products are generally
transferred at a point in time (rather than over time). Essentially all the Company&rsquo;s revenue is generated from purchase order
contracts.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with FASB&rsquo;s ASC 606, Revenue from Contracts with Customers, (&ldquo;ASC 606&rdquo;), the Company recognizes revenue
when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects
to be entitled in exchange for those goods or services, in an amount that reflects the consideration which the Company expects to be
entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within
the scope of ASC 606, it performs the following five steps:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
    the contract(s) with a customer&#894;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
    the performance obligations in the contract&#894;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
    the transaction price&#894;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate
    the transaction price to the performance obligations in the contract&#894; and</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize
    revenue when (or as) the entity satisfies a performance obligation.</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applies the five-step model to contracts when it determines that it is probable it will collect substantially all of the consideration
it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined
to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that
are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the
amount of the transaction price, after consideration of variability and constraints, if any, that is allocated to the respective performance
obligation when the performance obligation is satisfied.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates credit losses on accounts receivable by estimating expected credit losses over the contractual term of the receivable
using a discounted cash flow method. When developing this estimate of expected credit losses, the Company considers all available information
(past, current, and future) relevant to assessing the collectability of cash flows.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers a Patient Assistance Program for patients without insurance coverage for IB-Stim. This program extends potential self-pay
discounts for IB-Stim devices, based upon household income and size.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
the Company offers providers an opt-in program to address adequate insurance claim payments on IB-Stim devices. This program may extend
a rebate or invoice credit where the insurance payment and patient responsibility (i.e., deductible, co-payment, and/or co-insurance
amounts required by the Payer) are less than the acquisition cost of the IB-Stim device. The Company recognizes revenue at such a time
that collection of the amount due is assured.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 136 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table disaggregates the Company&rsquo;s revenue based on the customer&rsquo;s location by state for the three months ended
March 31:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">California</FONT> </TD><TD STYLE="width: 2%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 15%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">212,620</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 30%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Wisconsin</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 15%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">266,980</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Ohio</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">133,955</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Ohio</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">129,670</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Wisconsin</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">111,040</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">California</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">76,975</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Massachusetts</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">51,900</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Missouri</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">47,800</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Missouri</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">49,410</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Indiana</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">32,238</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">All other states</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">246,185</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">All other states</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">216,604</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">805,110</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">770,267</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following economic factors affect the nature, amount, timing, and uncertainty of the Company&rsquo;s revenue and cash flows as indicated:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type
of customer:</B> Based on dollar amounts of revenue, essentially all of the goods sold by the Company are sold to healthcare customers
including hospitals and clinics. Sales to healthcare customers lack seasonality and have a mild correlation with economic cycles.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Geographical
location of customers:</B> Sales to customers located within the United States represent essentially all of the Company&rsquo;s sales.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type
of contract:</B> Sales contracts consist of purchase order contracts that tend to be short-term (i.e., less than or equal to one year
in duration).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opening and closing balances of trade receivables, contract assets, and contract liabilities from contracts with customers are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 97%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Trade
    Receivables</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Contract
    Assets</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Contract
    Liabilities</FONT> </TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance 1/1/2022</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">115,301</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance 12/31/22 and 1/1/2023</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">174,399</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance 3/31/2023</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">363,485</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Company&rsquo;s
Performance Obligations with Customers:</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Timing
of Satisfaction</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically satisfies its performance obligations as the goods are delivered.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goods
that are shipped to customers are typically shipped FOB shipping point with freight prepaid by the Company. As such, ownership of goods
in transit transfer to the customer when shipped and the customer bears the associated risks (e.g., loss, damage, delay). In some cases,
a customer will take delivery directly from the Company&rsquo;s inventory (i.e., consigned inventory), at which point ownership and the
associated risks pass to the customer at that time.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling costs are recorded as general and administrative expenses in the Statement of Operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 137 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Significant
Payment Terms</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
for goods sold by the Company is typically due after an invoice is sent to the customer, within 30 days. However, other payment terms
are frequently negotiated with customers ranging from due upon receipt to due within 90 days. Some payment terms may call for payment
only after the healthcare provider receives their insurance reimbursement. Invoices for goods are typically sent to customers within
three calendar days of shipment. The Company does not offer discounts if the customer pays some or all of an invoiced amount prior to
the due date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&rsquo;s contracts have a significant financing component.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Nature</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
devices that the Company contracts to sell and transfer to customers are manufactured by one specific third-party manufacturer. The manufacturer
is located within the state of Indiana. In no case does the Company act as an agent (i.e., the Company does not provide a service of
arranging for another party to transfer goods to the customer).</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Returns,
Refunds, etc. </U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orders
may not be cancelled after shipment. Customers may return devices within 10 days of delivery if the goods are found to be defective,
nonconforming, or otherwise do not meet the stated technical specifications. At the option of the customer, the Company shall either:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refund
    the price paid for any defective or nonconforming products</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supply
    and deliver to the customer replacement conforming products</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimburse
    the customer for the cost of repairing any defective or nonconforming products</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time revenue is recognized, the Company estimates expected returns and excludes those amounts from revenue. The Company also maintains
appropriate accounts to reflect the effects of expected returns on the Company&rsquo;s financial position and periodically adjusts those
accounts to reflect its actual return experience. Historically, returns have been immaterial, and the Company currently does not provide
a provision for this liability.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warranties
</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
most cases, goods that customers purchase from the Company are covered by manufacturers&rsquo; warranties. The Company does not sell
warranties separately.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
manufacturer guarantees the product for the period up to the expiration date printed on the device&rsquo;s label or twelve months from
the date of purchase, whichever comes first. The guarantee applies to flaws of material and workmanship. The Company&rsquo;s warranties
provide customers with assurance that purchased devices comply with published specifications, inspection standards, and workmanship.
At the time revenue is recognized, the Company estimates the cost of expected future warranty claims but does not exclude any amounts
from revenue. The Company maintains appropriate accounts to reflect the effects of expected future warranty claims on the Company&rsquo;s
financial position and periodically adjusts those accounts to reflect its actual warranty claim experience. Historically, warranty claims
have been immaterial, and the Company currently does not provide a provision for this liability.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 138 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically satisfies its performance obligations for goods at a point in time. In most cases, goods are shipped by common carrier
to customers under &ldquo;FOB Shipping Point&rdquo; terms. As such, customers typically obtain control of the goods upon shipment. The
Company&rsquo;s management exercises judgment in determining when performance obligations for goods have been satisfied. In making such
judgments, management typically relies on shipping information obtained from common carriers to evaluate when the customer has obtained
control of the goods.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s contracts with customers typically do not involve variable consideration. The information that the Company uses to determine
the transaction price for a contract is similar to the information that the Company&rsquo;s management uses in establishing the prices
of goods to be sold.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Leases</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B>At
the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and
circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use
assets and current and non-current lease liabilities, as applicable.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over
the expected remaining lease term. Certain adjustments to the right-of-use asset may be required for items such as incentives received.
The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental
borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis
the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company
will adjust the right-of-use assets for straight-line rent expense, or any incentives received and remeasure the lease liability at the
net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date. The Company
has elected not to recognize leases with an original term of one year or less on the balance sheet. The Company typically only includes
an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in the Company&rsquo;s assessment
unless there is reasonable certainty that the Company will renew.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
made by the Company at the commencement date are re-evaluated upon occurrence of certain events, including a lease modification. A lease
modification results in a separate contract when the modification grants the lessee an additional right of use not included in the original
lease and when lease payments increase commensurate with the standalone price for the additional right of use. When a lease modification
results in a separate contract, it is accounted for in the same manner as a new lease.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entities
may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together
as a single lease component for all underlying assets and allocate all the contract consideration to the lease component only.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Impairment
of Long-Lived Assets</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may
not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable,
we compare the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated
by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment
to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group.
Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 139 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Concentrations
of Credit Risk</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s business activity consists of the sale of medical neuromodulation devices to doctors, clinics, and hospitals across the
country.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
consist of unsecured amounts due from customers. As of March 31, 2023, accounts receivable from two customers with balances due in
excess of 10% of total accounts receivable were approximately 31%, 13%, respectively. As of December 31, 2022, accounts receivable
from three customer with balances due in excess of 10% of total accounts receivable were approximately 23%, 15%, and 12%, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the Company&rsquo;s customers that accounted for greater than 10% of its revenues in one of the periods ended
March 31, 2023 and 2022, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Percentage
    of Sales</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Percentage
    of Sales</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-size: 11pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 24%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Hospital A</FONT> </TD><TD STYLE="width: 2%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 15%; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">153,020</FONT> </TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 15%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">19</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 15%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">73,475</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 15%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Hospital B</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">122,200</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">122,200</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">16</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Hospital C</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">90,350</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">11</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">238,300</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">31</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 11pt; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">365,570</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">45</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">433,975</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">56</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company&rsquo;s bank balances may exceed the FDIC limit of $250,000; however, management does not feel that this has
a material impact on the financial condition. At March 31, 2023 and December 31, 2022, the Company&rsquo;s uninsured cash balances totaled
$0.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Going
Concern</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred losses since inception and have funded our operations primarily with a combination of sales, debt, and the sale of
capital stock. As of March 31, 2023, we had an stockholders&rsquo; deficit of approximately $7.7 million. At March 31, 2023, we had
short-term outstanding borrowings of approximately $581 thousand, net of discounts of $4,481,355. As of March 31, 2023, we had cash
of approximately $45 thousand and a working capital deficit of approximately $8.8 million.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future capital requirements will depend upon many factors, including progress with developing, manufacturing, and marketing our technologies,
the time and costs involved in preparing, filing, prosecuting, maintaining, and enforcing patent claims and other proprietary rights,
our ability to establish collaborative arrangements, marketing activities and competing technological and market developments, including
regulatory changes and overall economic conditions in our target markets. Our ability to generate revenue and achieve profitability requires
us to successfully market and secure purchase orders for our products from customers currently identified in our sales pipeline and to
new customers as well. The primary activity that will drive all customers and revenues is the adoption of insurance coverage by commercial
insurance carriers nationally, so this is a top priority of the Company. These activities, including our planned research and development
efforts, will require significant uses of working capital through the rest of 2023 and beyond. Based on our current operating plans,
we believe that our existing cash at the time of this filing will only be sufficient to meet our anticipated operating needs through
July 2023.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 140 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
evaluates whether there are conditions or events that raise substantial doubt about the Company&rsquo;s ability to continue as a going
concern for a period of one year from the date the financial statements are issued.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, the Company has experienced operating losses and negative cash flows from operations. Management believes that increased sales
and acceptance of their product by insurance providers will allow the Company to achieve profitability in the near term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company believes in the viability of its strategy to further implement its business plan and generate sufficient revenues and in
its ability to raise additional funds by way of a public or private offering of its debt or equity securities, there can be no assurance
that it will be able to do so on reasonable terms, or at all. The ability of the Company to continue as a going concern is dependent
upon its ability to further implement its business plan and generate sufficient revenues and its ability to raise additional funds by
way of a public or private offering. Neither future cash generated from operating activities, nor management&rsquo;s contingency plans
to mitigate the risk and extend cash resources through the evaluation period, are considered probable, substantial doubt is deemed to
exist about the Company&rsquo;s ability to continue as a going concern. As we continue to incur losses, our transition to profitability
is dependent upon achieving a level of revenues adequate to support its cost structure. We may never achieve profitability, and unless
and until doing so, we intend to fund future operations through additional dilutive or nondilutive financing. There can be no assurances,
however, that additional funding will be available on terms acceptable to us, if at all.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the
amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recently
Issued Accounting Pronouncements</U></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &ndash; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments, which requires measurement and recognition of expected credit losses for financial assets held and requires enhanced disclosures
regarding significant estimates and judgments used in estimating credit losses. In November 2019, the FASB issued ASU 2019-10, Financial
Instruments &ndash; Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which amends
the effective date of ASU 2016-13. Public business entities meeting the definition of an SEC filer, excluding entities eligible to be
a Smaller Reporting Company (&ldquo;SRC&rdquo;) as defined by the SEC, are required to adopt the standard for fiscal years beginning
after December 15, 2019, including interim periods within those fiscal years. All other entities are required to adopt the standard for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of this guidance did not have a
material impact on the Company&rsquo;s financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 141 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
Related Party Transactions</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two demand notes receivable from shareholders related to the sale of common stock on January 1, 2016. Both notes&rsquo; initial
balances were $506,400, with interest calculated monthly based on applicable federal rates. No payments have been received on the notes.
Since repayment is not assured, the Company provided an allowance for the entire balance of principal and interest as of December 31,
2019. The current allowance is $1,117,798 as of March 31, 2023. The current loan balances are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Income</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">52,566</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">5,496</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 2</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">52,432</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">5,496</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,012,800</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">104,998</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">10,992</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Allowance for Collection
    Risk</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1,012,800</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(104,998</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(10,992</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Balance</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
</TABLE>

<P STYLE="margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Income</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">47,071</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">11,523</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 2</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">46,936</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">11,523</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,012,800</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">94,007</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">23,046</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Allowance for Collection
    Risk</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1,012,800</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(94,007</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(23,046</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Balance</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has loans payable to shareholders related to funding needs for operations. The current loan details for all related party loans
are as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    &amp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Service
    Fee</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2023</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Due
    Date</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Rate</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Paid</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 11%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">June, 2019</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">20,051</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">8,912</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">June, 2019</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">38,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">24,906</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Other Convertibles</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Various</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">66,648</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">100,466</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>


<P STYLE="margin: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    &amp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Service
    Fee</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Due
    Date</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Rate</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Balance</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Paid</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 11%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">June, 2019</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">20,051</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">8,161</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 9%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">June, 2019</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">38,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">23,481</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Other Convertibles</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: right; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Various</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">66,648</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">98,290</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Chief Financial Officer, John Seale, CPA.CITP, is contracted for services through RBSK Partners PC (RBSK). Mr. Seale
is RBSK&rsquo;s managing partner and majority shareholder. RBSK is engaged by the Company to provide accounting and tax services on
a continuous basis. Fees paid to RBSK for services were $17,551 and $16,722 for the three months ended March 31, 2023 and 2022,
respectively. The Company owed RBSK for open invoices of $165,177 and $68,142 that are included in accounts payable as of March 31,
2023 and December 31, 2022, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 142 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> <B>Notes to the Unaudited Financial Statements</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
Property and Equipment</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net consists of the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">March 31,</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Furniture and fixtures</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">87,148</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">87,148</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Computer hardware</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">23,060</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15,452</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Leasehold improvements</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">21,064</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">21,064</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Machinery and equipment</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">282,181</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">282,181</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total property and equipment</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">413,453</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">405,845</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Less:
    accumulated depreciation</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(325,062</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(317,834</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">88,391</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">88,011</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $7,228 and $7,894 for the three months ended March 31, 2023 and 2022, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
Intangible Assets</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net consists of the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">March 31,</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Software Implementation</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">49,815</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">49,815</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Patents</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">32,463</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">32,463</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Patents</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">10,000</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">10,000</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total intangible assets</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">92,278</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">92,278</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Less:
    accumulated amortization</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(17,341</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(14,720</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">74,937</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">77,558</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense was $2,621 and $485 for the three months ended March 31, 2023 and 2022, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
Accrued Expenses</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses consisted of the following:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Wages</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 18%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">503,855</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 18%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">523,003</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Employee benefits</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">21,536</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">16,555</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Commissions</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">113,036</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Capital raise fees</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">55,250</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">88,259</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Property taxes</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,060</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">777</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">292,336</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">173,826</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Related party interest</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">33,818</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">31,642</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    accrued expenses</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,020,891</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">834,062</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
Notes Payable</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company borrowed $250,000 on December 16, 2021, from Channel Partners Capital. The note calls for 65 weekly payments of $4,923 with
the final payment scheduled for March 16, 2023. The note&rsquo;s interest rate computes to a nominal rate of 40.856%. The principal
outstanding at January 1, 2022 was $244,048. The Company borrowed $122,000 on September 16, 2022 to bring the principal balance back
to $250,000. The principal outstanding at December 31, 2022 was $202,834. The terms of the note are the same as the previous note
with the final payment scheduled for December 16, 2023. The principal outstanding at March 31, 2023 was $157,490. The Company
determined that the advancement of additional funds is a minor modification to the terms of the existing loan since the difference
in present value of the cash flows under the terms of the new loan is less than 10% of the present value of the remaining cash flows
under the terms of the original loan. As a result, the modification was accounted for as a modification of debt.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lender was granted and assigned a continuing security interest in all the Company&rsquo;s personal property assets including, but not
limited to, business equipment, inventory, accounts, accounts receivable, intellectual property, chattel paper, instruments, deposit
accounts, commercial tort claims, contract rights, licenses, claims, and general intangibles.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
future minimum principal payments to be paid in 2023 are $157,490.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 15, 2023, the Company signed a promissory note with Exchange Listing, LLC in the amount of $52,600. The
note carries an interest rate of 1%. The interest shall accrue on the outstanding balance until the date of repayment and shall be payable
at the time and place and in the manner provided in this promissory note. The Note shall be paid on the earlier of (i) three months from
the date hereof or (ii) the Company receiving a financing in the minimum of $3,000,000.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
Convertible Notes</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
March of 2023, the Company conducted multiple closings of a private placement offering to accredited investors for aggregate gross proceeds
of $3,888,889 or net proceeds of $3,500,000.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notes consisted of (a) a Convertible Promissory Note that accrues interest at 12% that can be paid in cash or PIK. The notes automatically
convert into common shares at a 30% discount to the IPO. The notes mature on the sooner of the six-month anniversary date from issuance
or a successful IPO on primary exchange in the U.S. (b) a five-year warrant to purchase common stock equal to fifty percent (50%) of
the shares into which the 2023 Convertible Notes can be converted into at issuance. The warrants have a strike price at a 25% premium
to the Conversion Price subject to anti-dilution, issuable on a pro rata basis at each funding.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
facilitators to the notes Signature Bank and Alexander Capital, L.P. will receive certain fees. Signature Bank received a $6,000 escrow
fee from the first round of funding. Alexander Capital, L.P. has and will continue to receive (i) a cash commission of ten percent (10%)
of the proceeds raised in the Offering from Investors introduced to the Company by the Placement Agent; (ii) the granting to the Placement
Agent of a warrant for the purchase of a number of shares of Common Stock equal to 6% of the number of Underlying Securities; and (iii)
the other matters set forth in the engagement letter between the Company and the Placement Agent dated April 13, 2022. As of March 31,
2023, Alexander Capital, L.P. has earned $350,000 in commissions which are recorded as a debt discount.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 143 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company conducted multiple closings of a private placement offering to accredited investors for
aggregate gross amount of $3,555,556 and net proceeds of $3,070,000.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Convertible Notes signed from June 3, 2022 to November 30, 2022 have aggregate gross amounts of $3,333,333 and net proceeds of $2,870,000
and consisted of (a) a Convertible Promissory Note that accrues interest at the greater of Prime rate plus 8.5% or 12%. The notes convert
into common shares at the lower of $9.44 or 30% discount to the price per share of any subsequent offering. The notes mature on the one-year
anniversary date from issuance. (b) a five-year warrant to purchase common stock equal to one hundred percent (100%) of the shares into
which the 2022 Convertible Notes can be converted into at issuance. The warrants have an exercise price at the lower of $11.80 per share
or a 12.5% discount to the price per share of any subsequent offering. (c) shares of the Company&rsquo;s common stock equal to 10% of
the principal amount of these notes, at a value per share equal to the conversion price. The 35,318 shares of common stock issued to
investors had a relative fair value of $4,789.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an additional incentive for entering into the Convertible note offering, the Company offered an original issue discount equal to 10%
of the principal amount of the notes. The Company also paid $130,000 to law firms related to this offering.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March of 2023, the Company used borrowings from the 2023 convertible notes to pay the principal balance of some of the previously
issued notes totaling, $2.65 million.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Convertible Notes signed on December 19, 2022 have aggregate gross proceeds of $222,222 or net proceeds of $200,000 and consisted
of an original issue discount of 10% of the principal amount and have an interest rate of 12% per annum. The notes will mature at the
earlier of (i) twelve (12) months from the issue date or (ii) the date upon which the Company completes a registered public offering
of shares of the Company, which encompasses the closing of this offering. The notes are convertible into shares of common stock at the
higher of (i) $9.44 per share, or (ii) the price per share of common stock issued pursuant to the next registered public offering of
shares of the Company made prior to the conversion of any portion of the note. Interest accrues on the aggregate principal amount (which
includes original issue discount) and is payable on the maturity date, at the Company&rsquo;s election, in cash or in-kind. The holders
of the notes are entitled to piggyback registration rights on any registration statement filed by the Company, other than the registration
statement of which this prospectus forms a part and any registration filed on Form S-4 or Form S-8. The warrants and conversion shares
are subject to anti-dilution adjustments outlined in the Agreement.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has applied ASC 815 and ASC 480, due to the potential for settlement in a variable quantity of shares. Since these convertible
notes and warrants have the option to convert or be exercised at a variable amount, they are subject to derivative liability treatment.
The conversion feature has been measured at fair value using a Monte Carlo model at the date of issuance and is adjusted to fair value
at each reporting period. The fair value of the embedded derivative and the warrant liability at date of issuance was $3,982,414 and
$4,350,286, respectively. See notes 13 and 14.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 144 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the incentives given to investors totaled $9,567,934. Since the value of the incentives given to investors was in excess of
the principal value of the notes, the Company recognized $7,242,946 as debt discount and expensed the remaining $2,324,988 as
financing fees. The debt discount is being amortized over the life of these notes to amortization of debt discount and issuance
cost. As of March 31, 2023, the Company has amortized $2,761,590 of the debt discount. The remaining balance of $4,481,356 will be
amortized over the remaining life of the notes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the periods ended March 31, 2023 and December 21, 2022, the Company accrued interest of $225,687 and $107,178, respectively,
included in accrued expenses on the balance sheet.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
Leases</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s leases are comprised of operating leases for office space. At the inception of the lease, the Company determines whether
the lease contract conveys the right to control the use of identified property for a period of time in exchange for consideration. Leases
are classified as operating or finance leases at the commencement date of the lease. Operating leases are recorded as operating lease
right-of-use assets, other current liabilities, and operating lease liabilities in the Balance Sheets. The Company did not have any finance
leases at March 31, 2023 and December 31, 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had three leases primarily consisting of office space in Versailles and Carmel Indiana. Two of the leases in Versailles started
January 1, 2017. Both have an initial term of five years with an option for an additional five-year term. The monthly lease payments
for these leases are $550 and $1,600 with a 3% per annum increase starting with the optional five-year term. The lease in Carmel started
March 1, 2016. The initial term is five years and three months with an option for an additional three-year term. The monthly lease payment
started at $1,472 with an annual increase of approximately 2.7%. On December 16, 2020, the Company entered into an amendment of the Carmel
lease that extended the initial term by two years.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the
lease term. As the implicit interest rate is generally not readily determinable, the Company uses an incremental borrowing rate based
on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate
reflects the estimated rate of interest that the Company would pay to borrow on a collateralized basis over a similar economic environment.
Lease expense for the operating lease is recognized on a straight-line basis over the lease term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases
may include renewal options, and the renewal option is included in the lease term if the Company concludes that it is reasonably certain
that the option will be exercised. Certain leases may contain rent escalation clauses, either fixed or adjusted periodically for inflation
of market rates, that are factored into the calculation of lease payments to the extent they are fixed and determinable at lease inception.
The Company also has variable lease payments that do not depend on a rate or index, primarily for items such as common area maintenance
and real estate taxes, which are recorded as expenses when incurred.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended March 31, 2023 and 2022, the Company recognized $11,729 and $13,107 of operating lease expense,
including short-term lease expense and variable lease costs.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 145 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information related to the Company&rsquo;s operating leases:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use assets</FONT> </TD><TD STYLE="width: 2%; font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">93,602</FONT> </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 16%; border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">101,382</FONT> </TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Other current liabilities</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">37,328</FONT> </TD><TD STYLE="font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">33,395</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Operating lease liabilities</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">63,917</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">76,199</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">101,245</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">109,594</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average remaining lease term (in
    years)</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3.75</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">4.00</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average discount rate</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15.0</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">15.0</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2023, the maturities of the Company&rsquo;s operating lease liabilities were as follows:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2023 (9 months)</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 20%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">34,550</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">36,302</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2025</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">28,192</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2026</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">29,038</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total lease payments</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">128,082</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Less: imputed interest</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">26,837</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Total present value
    of lease payments</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">101,245</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
Common Stock and Warrants</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 7, 2021, the Company&rsquo;s board of directors authorized a 4-for-1 stock split. They also increased the number of authorized
common stock shares from 2,700,000 to 10,800,000. Furthermore, on September 9, 2021, the board authorized an increase of authorized shares
of common stock from 10,800,000 to 13,400,000 in anticipation of a capital offering. As part of the conversion to a Delaware Corporation
in June of 2022, the total number of common stock shares authorized was increased to 100,000,000.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
on January 10, 2023, the Company&rsquo;s board of directors authorized a 2-for-1 reverse stock split. All share information in these
financial statements has been adjusted for this reverse stock split.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with a bridge loan, the Company issued a warrant to a shareholder, Brian Hannasch, on September 18, 2018. The warrant allows
the holder to purchase common stock from the Company at a share price of $4.38 per share. The number of shares was based on a formula
tied to the amount of loans made by the holder. The number of shares based on this formula is 12,852. The warrant contains certain rights
in the event of liquidation, merger, or consolidation of the Company. If the fair market value of one share is greater than the warrant
price, the holder may elect to receive a number of shares equal to the value of the warrant. If the exercise is in connection with the
sale of the Company, the holder may, at its option, condition its exercise of the warrant upon the consummation of such transaction.
The warrant expires on September 18, 2028 and can be exercisable either in whole or from time to time in part prior to the expiration
date.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a second warrant to Brian Hannasch on September 6, 2019, under similar terms. This is a penny warrant that allows the
holder to purchase 40,000 shares of common stock and is subject to adjustment for certain equity events. The warrant contains certain
rights in the event of liquidation, merger, or consolidation of the Company. The warrant expires on September 6, 2029.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 146 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a third warrant to Masimo Corporation on April 9, 2020. This warrant was pre-funded in the amount of $2,734,340. The warrant
allows the holder to purchase 289,779 shares of Series A Preferred Stock at $9.44 per share and is subject to adjustment
for certain equity events. The warrant contains certain rights in the event of liquidation, merger, or consolidation of the Company.
There will be no additional purchase price for the Warrants. In the event that all outstanding shares of Series A Preferred Stock are
converted, automatically or by action of the holders thereof, into Common Stock, including, without limitation, in connection with the
Company&rsquo;s initial, underwritten public offering and sale of its Common Stock pursuant to an effective registration statement under
the Act (the &ldquo;IPO&rdquo;), then from and after the date on which all outstanding shares of Series A Preferred Stock have been so
converted, this Warrant shall be exercisable for such number of shares of Common Stock into which the Warrant Shares would have been
converted had the Warrant Shares been outstanding on the date of such conversion, and the Exercise Price shall equal the Exercise Price
in effect as of immediately prior to such conversion divided by the number of shares of Common Stock into which one share of Series A
Preferred Stock would have been converted, all subject to further adjustment thereafter from time to time in accordance with the provisions
of this Warrant.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2022, the Company issued 353,110 five-year warrants to purchase common stock equal to one hundred percent (100%) of the shares into which
the 2022 convertible notes can be converted into at issuance. The warrants have an exercise price at the lower of $11.80 per share or
a 12.5% discount to the price per share of any subsequent offering. The number of Warrant Shares is determined based on the number of the Company&rsquo;s common shares that would be
issued upon full conversion of the Note. Initially, this will be calculated based on the first prong of the Conversion Price definition
in Section 2.2(a) of the Note ($9.44 per share). If the conversion price is adjusted downwards pursuant to the Note, so that the number
of shares issuable upon the full conversion of the Note increases, the number of Warrant Shares will be adjusted accordingly.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of warrant activity for common stock during the periods ended March 31, 2023 and December 31, 2022:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"> &nbsp; </TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Number of </TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Weighted-Avg. </TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Weighted-Avg. </TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Warrants for </TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Exercise </TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Remaining </TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> &nbsp; </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Common Stock </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Price </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Contractual Life </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; font-weight: bold"> Outstanding as of January 1, 2022 </TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 14%; text-align: right"> 52,852 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"> $ </TD><TD STYLE="width: 14%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.13 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 14%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.44 </TD><TD STYLE="width: 1%; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> Granted </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 353,110 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 11.80 </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 5.00 </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> Cancelled/Expired </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> Exercised </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &mdash; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &mdash; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &mdash; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> Outstanding as of December 31, 2022 </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 405,962 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 10.54 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 4.84 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> Granted </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> Cancelled/Expired </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left"> &nbsp; </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> Exercised </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &mdash; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &mdash; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> Outstanding as of March 31, 2023 </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 405,962 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> $ </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 10.54 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 4.59 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> &nbsp; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 147 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of warrant activity for preferred stock during the periods ended March 31, 2023 and December 31, 2022:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-Avg.</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants
    for</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Stock</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Price</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding as of January 1,
    2022</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 16%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding as of
    December 31, 2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding as of
    March 31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the Company&rsquo;s warrants outstanding and exercisable as of March 31, 2023.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Expiration</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Price</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 42%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Brian Hannasch W-01</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 15%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">12,852</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 15%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">8.7600</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 18%; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">September 18, 2028</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Brian Hannasch W-02</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0.0050</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">September 6, 2029</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Masimo Corporation PSA-01</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">None</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2022 Convertible Notes</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">353,110</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">11.8000</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Various</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">550,852</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a party to two investment banking and advisory agreements with a consulting firm engaged in connection with listing our common
stock for trading on Nasdaq. Pursuant to the first advisory agreement, dated March 3, 2022, the Company agreed to pay the consulting
firm a monthly consulting fee of $5,000 and a final payment of $50,000 upon a successful Nasdaq listing, and, also upon such listing,
to issue the consulting firm shares of our common stock representing 1.5% of our outstanding shares after giving effect to the offering
and to issue the consulting firm five-year warrants to purchase shares of our common stock representing 2.0% of our outstanding shares
after giving effect to this offering on a fully-diluted basis with an exercise price per share representing the public offering price
per share. Pursuant to the second advisory agreement with consulting firm, dated June 20, 2022, and amended December 20, 2022, the Company
agreed to pay fees in the aggregate of up to $136,166 for advice in connection with communication and other related matters leading up
to, and in connection with, this offering and to issue the consulting firm 25,000 shares of common stock upon a successful Nasdaq listing.
The Company agreed to piggyback registration rights with respect to all shares issued to the consulting firm under both advisory agreements,
including shares issuable upon exercise of the warrants. The Company evaluated the agreements and determined that the shares will not
be recorded and valued until the performance condition is satisfied.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 148 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
Preferred Stock</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has authorized 1,120,000 shares of preferred stock of which 1,000,000 has been designated Series A Preferred and 120,000 has
been designated Series Seed Preferred, of which 506,637 shares of Series A Preferred and 115,477 shares of Series Seed Preferred are
issued and outstanding as of March 31, 2023 and December 31, 2022. </FONT> The requisite holder of our outstanding Series A Preferred Stock and Series Seed Preferred Stock have delivered a consent, dated December 22, 2022, to automatically convert all shares of preferred stock into shares of common stock (on a 2-for-1 basis) upon consummation of this offering. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate purchase price of the Series A Preferred Stock was $9,321,165, of which $7,692,664 was comprised of cash and the remaining
$1,628,501 was comprised of converted debt and common stock. The aggregate purchase price of the Series Seed Preferred shares was $0,
as all the Series Seed shares were converted from common stock as an incentive to reinvest in Series A Preferred Stock.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of Preferred Stock terms:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Voting
Rights</U> - The Series A Preferred and Series Seed Preferred shall vote together with the Common Stock on an as-converted basis, and
not as separate classes.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conversion
</U>- The Series A Preferred and Series Seed initially convert 1:1 to Common Stock at any time at option of holder, subject to adjustments
for stock dividends, splits, combinations, and similar events and as described below under &ldquo;Anti-dilution Provisions.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Dividends
</U>- The Series A Preferred will carry an annual 8% cumulative dividend, payable upon any liquidation, dissolution or winding up of
the Company (the &ldquo;Accruing Dividend&rdquo;). For any other dividends or distributions, participation with Common Stock on an as-converted
basis.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Liquidation
</U>- In the event of any liquidation, dissolution or winding up of the Company, the proceeds shall be paid in the following priority:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
to the Series A Preferred in proportion to each holder&rsquo;s respective pro rata Series A Original Purchase Price, plus any pro rata
share of the Accruing Dividend until the entire Series A Original Purchase Price and Accruing Dividend are paid;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
to the Series Seed Preferred in proportion to each holder&rsquo;s respective pro rata Series Seed Original Purchase Price until the entire
amount of the Series Seed Original Purchase Price is paid;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter,
the Series A Preferred and Series Seed Preferred participate with the Common Stock pro rata on an as-converted basis.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
merger or consolidation (other than one in which stockholders of the Company own a majority by voting power of the outstanding shares
of the surviving or acquiring corporation) and a sale, lease, transfer, exclusive license or other disposition of all or substantially
all of the assets of the Company will be treated as a liquidation event (a &ldquo;Deemed Liquidation Event&rdquo;), thereby triggering
payment of the liquidation preferences described.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Anti-dilution
Provisions</U> - The Series A Preferred have full-ratchet anti-dilution protection so that the conversion price will be reduced to 80%
of the price at which any future shares are issued, if less than the Series A Original Purchase Price.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for shareholders to make an additional investment in the Company, upon the purchase of the Series A Preferred stock by
the shareholder, the Company converted the existing common shares held by shareholders to Series Seed Preferred Stock at a $100 million
valuation and at a 120% share premium. As of March 31, 2023 and December 31, 2022, there were 97,702 common shares converted into 115,477
shares of Series Seed Preferred shares that have no par value and are outstanding.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 149 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
Stock Options and Awards</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of stock option activity for the periods ended March 31, 2023 and December 31, 2022:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Avg.</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Contractual
    Life</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Avg.</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate</FONT> </TD><TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Options</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(in
    years)</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Intrinsic
    Value</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding as of January 31,
    2022</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">5.78</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding as of
    December 31, 2022</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">4.78</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding as of
    March 31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">4.55</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Vested and Exercisable
    as of March 31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">4.55</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense is classified in the Company&rsquo;s statements of operations as general and administrative expense. The amounts
were $0 and $11,994 for periods ended March 31, 2023 and 2022, respectively. As of March 31, 2023, there was $0 of total unrecognized
compensation expense related to unvested options granted under the Company&rsquo;s share-based compensation plans.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
Warrant Liabilities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated financial instruments arising from an adjustable exercise price for warrants that are issued and outstanding as
of March 31, 2023 and December 31, 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes a Monte Carlo simulation model for warrants that have an option to convert at a variable number of shares to
compute the fair value of the warrant liabilities and to mark to market the fair value of the warrant liabilities at each balance
sheet date. The inputs utilized in the application of the Monte Carlo model included a starting stock price of $9.20 per share, an
expected remaining term of each warrant as of the valuation date, estimated volatility of 80%, drift, and a risk-free rate ranging
from 4.00% to 4.06%.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note adjusted to be on a continuous return basis to align
with the Black-Scholes option-pricing model.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring
dividends in the near future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility:
The Company calculates the expected volatility based on comparable company&rsquo;s historical stock prices with a look back period commensurate
with the period to maturity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
term: The Company&rsquo;s remaining term is based on the remaining contractual maturity of the warrants.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 150 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the changes in the warrant liabilities during the year ended March 31, 2023 and December 31, 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant liabilities as of January
    1, 2022</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,808,331</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in fair value of warrant liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(606,049</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant liabilities as of January 1, 2023</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,541,955</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in fair value of warrant liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(234,807</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant liabilities
    as of March 31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">3,541,532</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
Derivative Liabilities</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified derivative instruments arising from the conversion shares discussed in the Convertible Notes section of note 6
as of March 31, 2023 and December 31, 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes a Monte Carlo simulation model for commitment shares that have an option to convert at a variable number of shares to
compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The inputs
utilized in the application of the Monte Carlo model included a starting stock price of $9.20 per share, an expected remaining term of
each warrant as of the valuation date, estimated volatility of 80%, drift, and a risk-free rate ranging from 4.00% to 4.73%.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note adjusted to be on a continuous return basis to align
with the Black-Scholes option-pricing model.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring
dividends in the near future.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility:
The Company calculates the expected volatility based on comparable company&rsquo;s historical stock prices with a look back period commensurate
with the period to maturity.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
term: The Company&rsquo;s remaining term is based on the remaining contractual maturity of the warrants.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the changes in the warrant liabilities during the year ended March 31, 2023 and December 31, 2022.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative liabilities as of January 1,
    2022</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 46%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 2%"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="width: 14%; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,449,689</FONT> </TD><TD STYLE="width: 1%; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in fair value of Derivative liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(713,989</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative liabilities as of January 1,
    2023</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,532,725</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Changes in fair value
    of Derivative liabilities</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(191,297</FONT> </TD><TD STYLE="text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Extinguishment
    of Derivative liabilities</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(1,129,498</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative liabilities
    as of March 31, 2023</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD><TD STYLE="padding-bottom: 1.5pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT> </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,947,630</FONT> </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 151 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
Retirement Plan</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sponsors a 401(k)-retirement plan for its employees. Employees are eligible to participate in the elective deferral portion of
the plan after twelve months and 1,000 hours of service. The Company matches the employee&rsquo;s contribution up to 3%. The Company
can also make an optional profit-sharing contribution to the employee accounts on an annual basis. There was an expense of $4,981 and
$3,144 for three months ended March 31, 2023 and 2022, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16</B>.
<B>Commitments and Contingencies</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Manufacturing
Services Agreement</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 21, 2020, the Company entered into a Manufacturing Services Agreement (MSA) for the manufacture and supply of the Company&rsquo;s
IB-STIM device based upon the Company&rsquo;s product specifications as set forth in the MSA. This agreement terminated any prior manufacturing
agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides the necessary equipment to the manufacturer and retains ownership. The manufacturer bears the risk of loss of and damage
to the equipment and consigned materials. Performance under the MSA is initiated by orders issued by the Company and accepted by the
manufacturer.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the MSA is 24 months and shall automatically renew for renewal terms of twelve months unless either party provides a written
termination notice to the other party within 180 days prior to the end of the then-current term.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trademark
Agreement</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2022, the Company entered into an agreement for a trademark related to the Company&rsquo;s name. An initial payment of $10,000
was paid upon execution of the agreement. A second and final payment of $40,000 is contingent upon the completion of the Company&rsquo;s
planned initial public offering. The second payment has not been recorded in these financial statements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Employment Agreements</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, as authorized by the board of directors, entered into employment agreements with nine key employees to provide incentives to
improve shareholder value and to contribute to the growth and financial success of the Company. The agreements had an employment start
date of October 1, 2022, with initial terms from 2 to 5 years and optional one-year renewals.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total base salaries for the nine key employees in the agreements are $1.92 million per year with various provisions for annual increases.
In addition to base salaries, eight of the employees have a provision for a special one-time incentive payment to be paid in a lump sum
after the start date. The total amount of these special incentive payments is $1.11 million. The special incentive payment amount includes
any accrued backpay wages for the employee. That accrued amount for backpay was $417,390 and has been recorded and is reflected in the
financial statements at March 31, 2023.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are seven key employees that have stock options of the Company totaling 2,477,424 shares. These key employees have a provision in their
agreements whereas the Company will pay a special bonus equal to the aggregate of the strike price or exercise price of all their stock
options plus a tax gross-up payment. The special bonus shall be paid in twenty percent (20%) installments starting January 2, 2024, and
the same date each of the next four years. As a condition of the payment, the key employee must exercise at least 20% of their stated
number of stock options. There are additional provisions to cover termination and change of control events.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 152 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2023, the Company amended the employee agreements to, among other things, clarify that the special one-time incentive payment and
the deferred bonus are contingent upon the effective date of the planned public offering (IPO). The amendment also sets forth a process
for executives to exercise the stock options in accordance with the terms of the stock option agreement in effect as of the date of the
employment agreement and to clarify that there is no modification to the stock option agreements.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has recorded the backpay portion of the incentive bonus noted above. The balance of the incentive bonuses of $694,056 and the
special options bonuses of $14.82 million that are contingent upon a successful IPO have not been recorded.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Litigation</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time in the normal course of our business operations, we may become subject to litigation that may result in liability material
to our financial condition as a whole or may negatively affect our operating results if changes to our business operations are required.
The cost to defend such litigation may be significant and may require a significant diversion of our resources, and there is no guarantee
that we will be able to successfully defend against any such litigation regardless of particular merits. There also may be adverse publicity
associated with litigation that could negatively affect customer perception of our business, regardless of whether the allegations are
valid or whether we are ultimately found liable. Insurance may not be available on favorable terms, at all, or in sufficient amounts
to cover any liabilities with respect to these or other matters. A judgment or other liability in excess of our insurance coverage for
any claims could adversely affect our business, financial condition and the results of our operations.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2019, plaintiff Ritu Bharnbhani, M.D., initiated a lawsuit against Innovative Health Solutions, Inc. and others in the United
States District Court for the District of Maryland. Plaintiffs Bhambhani and Sudhir Rao subsequently amended the complaint, with the
Third Amended Complaint (&ldquo;Complaint&rdquo;) containing the most recent set of allegations. The Complaint asserted claims under
the RICO Act, as well as of fraudulent misrepresentation, intentional misrepresentation by concealment, and civil conspiracy and sought
compensatory damages in excess of $5 million, pre-judgment interest, punitive damages, attorney&rsquo;s fees, court costs and designation
of the case as a class action. The Complaint states that the Company, distributors of the Company&rsquo;s product, and medical billing
and coding consultants allegedly made misrepresentations to the plaintiffs that the Company&rsquo;s NeuroStim device and related procedures
could be billed to, and reimbursed by, Medicare and other insurance payors as a surgically implantable neurostimulator. Plaintiffs claim
to have suffered damages when Medicare administrative contractors declined to pay plaintiffs for their use of the device.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 11, 2022, the Company filed a motion for summary judgment based upon the plaintiffs not being proper parties to assert claims
against the Company. On June 14, 2022, the Court granted the Company&rsquo;s motion for summary judgment and dismissed the Complaint.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2022, plaintiffs Ritu Bhambhani and Sudhir Rao filed a notice of appeal with the Fourth Circuit Court of Appeals. The Company
filed a motion to dismiss. On January 4, 2023, the Court issued an order that stated it was deferring a ruling on the motion to dismiss
the appeal and that it would address those arguments at the same time that it addressed the substantive merits of the case. As of May
5, 2023, the parties have submitted their appellate briefs to the Fourth Circuit. No date has been set for either oral argument or for
issuance of a decision by the court. While it is too early to predict the ultimate outcome of this matter, we continue to believe we
have meritorious defenses, that the dismissal of the Complaint should be upheld, and intend to continue to defend this matter vigorously.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 153 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2022, plaintiffs Ritu Bhambhani, LLC; Box Hill Surgery Center, LLC; Pain and Spine Specialists of Maryland, LLC; and SimCare
ASC, LLC initiated a lawsuit against the Company and others in the United States District Court for the District of Maryland. The plaintiffs
in this lawsuit are business entities owned or partially owned by the plaintiffs that initiated the litigation described above. The Complaint
asserted claims under the RICO Act, as well as fraudulent misrepresentation, intentional misrepresentation by concealment, and civil
conspiracy and seeks compensatory damages in excess of $75,000, pre-judgment interest, punitive damages, attorney&rsquo;s fees, and court
costs. The Complaint states that the Company, distributors of the Company&rsquo;s product, and medical billing and coding consultants
allegedly made misrepresentations to the plaintiffs that the Company&rsquo;s NeuroStim device and related procedures could be billed
to, and reimbursed by, Medicare and other insurance payors as a surgically implantable neurostimulator. Plaintiffs claim to have suffered
damages when Medicare administrative contractors declined to pay plaintiffs for their use of the device.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company has filed a motion to dismiss all claims, but no ruling has been issued. No date had been established
for the court to rule on that motion. While it is too early to predict the ultimate outcome of this matter, we believe we have meritorious
defenses and intend to defend this matter vigorously.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> On May 26, 2023, we received notice from the
Court that it had entered an Order and a Memorandum Opinion to rule upon the Company&rsquo;s motion to dismiss. The Order and Memorandum Opinion
are dated May 25, 2023. Substantively, the Order and Memorandum Opinion dismiss, with prejudice, the plaintiffs&rsquo; attempt to assert Racketeering
Influenced and Corrupt Organizations statutory claims. The Court further ruled that the remaining claims are permitted to proceed. No
trial date or other pretrial deadlines have been scheduled for this case. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
Health Benefit Plan</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a self-funded program employer agreement in 2018 in conjunction with a group health plan for the benefit of eligible
employees. This plan is a level funded plan, and the services and products include:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    self-funded employer health benefit plan.</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stop
    loss insurance purchased from a stop loss insurance company.</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
    party administrator to provide administrative services with regard to the plan.</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains a stop loss contract that reimburses the Company for claims paid under the plan if they exceed a predetermined level.
The Company makes contributions for health care costs and associated expenses that are expected during the plan year. The amount of contributions
is determined annually based on the Company&rsquo;s maximum liability for expected claims, administrative expenses, and premiums for
the stop loss policy. The Company paid premiums of $196,929 and $158,831 for the periods ended March 31, 2023 and 2022, respectively.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is responsible for the monthly premiums, as established, and nothing further. The stop loss policy covers the claims if they
exceed the claims funds. After a certain time, and if there is a surplus in the claims fund, the Company may be entitled to receive a
48.5% refund from the fund. This amount is recognized by the Company when received.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.
Subsequent Events</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events through the date of issuance. The following changes occurred subsequent to March 31, 2023:</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Additional
Borrowing</U> &ndash; The Company borrowed additional funds subsequent to March 31, 2023, and up through the date of this report.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
April 12, 2023 to May 15, 2023 the Company conducted multiple closings of a private placement offering to accredited investors for aggregate
gross proceeds of $844,444 or net proceeds of $760,000.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 154 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc.</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes to the Unaudited Financial Statements</B></FONT> </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notes consisted of (a) a Convertible Promissory Note that accrues interest at 12% that can be paid in cash or PIK. The notes automatically
convert into common shares at a 30% discount to the IPO. The notes mature on the sooner of the six-month anniversary date from issuance
or a successful IPO on primary exchange in the U.S. (b) a five-year warrant to purchase common stock equal to fifty percent (50%) of
the shares into which the 2023 Convertible Notes can be converted into at issuance. The warrants have a strike price at a 25% premium
to the Conversion Price subject to anti-dilution, issuable on a pro rata basis at each funding.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
facilitators to the notes Alexander Capital, L.P. will receive certain fees. Alexander Capital, L.P. has and will continue to receive
(i) a cash commission of ten percent (10%) of the proceeds raised in the Offering from Investors introduced to the Company by the Placement
Agent; (ii) the granting to the Placement Agent of a warrant for the purchase of a number of shares of Common Stock equal to 6% of the
number of Underlying Securities; and (iii) the other matters set forth in the engagement letter between the Company and the Placement
Agent dated April 13, 2022. At the close of the round, Alexander Capital, L.P., has received $468,250 and 68,467 warrants.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
Agreements</U> &ndash; In April 2023, the Company amended the employee agreements to, among other things, clarify that the special one-time
incentive payment and the deferred bonus are contingent upon the effective date of the planned public offering (IPO). The amendment also
sets forth a process for executives to exercise the stock options in accordance with the terms of the stock option agreement in effect
as of the date of the employment agreement and to clarify that there is no modification to the stock option agreements. See executive
employment agreements in the commitments and contingency footnote.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>


<!-- Field: Page; Sequence: 155 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="Hz_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and Stockholders of Neuraxis, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
on the Financial Statements</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying balance sheets of Neuraxis, Inc. (the Company) as of December 31, 2022, and 2021, and the related statements
of operations, stockholders&rsquo; equity (deficit), and cash flows for each of the years then ended, and the related notes (collectively
referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years
then ended, in conformity with accounting principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantial
Doubt about the Company&rsquo;s Ability to Continue as a Going Concern</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 2 to
the financial statements, the Company has experienced operating losses and negative cash flows from operations since inception that raise
substantial doubt about its ability to continue as a going concern. Management&rsquo;s plans in regard to these matters are also described
in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basis
for Opinion</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&rsquo;s internal control over financial reporting. Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> /s/ Rosenberg Rich Baker Berman P.A. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 8pt; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have served as the Company&rsquo;s auditor since 2022.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Somerset,
    New Jersey</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1, 2023</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>


<!-- Field: Page; Sequence: 156 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="bals_001"></A>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Balance
Sheet</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Assets</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    Assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">253,699</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">320,858</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    receivable, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">174,399</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,301</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventories</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48,133</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39,180</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaids
    and other current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">726</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,670</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">476,957</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">491,009</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    and Equipment, at cost:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">405,845</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">404,455</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less
    - accumulated depreciation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(317,834</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(286,913</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">88,011</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">117,542</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    Assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Deferred
    offering costs</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">736,736</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Operating
    lease right of use asset, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">101,382</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">127,975</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Intangible
    assets, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">77,558</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,956</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,480,644</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">760,482</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notes
to financial statements are an integral part of these statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 157 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Balance
Sheet</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    Liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,592,116</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">483,790</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">834,062</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">561,638</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    portion of long-term notes payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">202,834</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">192,356</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    portion of operating lease payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,395</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,582</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notes
    payable - related party</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notes
    payable - convertible notes, net of unamortized discount of $3,327,213 and $0 as December 31, 2022 and 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">228,342</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Customer
    deposits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">59,174</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">69,337</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,978,058</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,424,856</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-current
    Liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease payable, net of current portion <B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">76,199</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">109,594</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Note
    payable, net of current portion</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51,692</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    non-current liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">76,199</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">161,286</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,054,257</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,586,142</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
    and contingencies (see note 16) </FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo;
    Equity (Deficit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Series A Preferred stock, $0.001 par value; 1,000,000 shares authorized; 506,637 issued and outstanding as of December 31, 2022 and
    2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Series Seed Preferred Stock, $0.001 par value; 120,000 shares authorized; 115,477 issued and outstanding as of December 31, 2022
    and 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    stock, $0.001 par value; 100,000,000 shares authorized; 1,963,322 and 1,928,004 issued and outstanding as of December 31, 2022 and
    2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,963</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,928</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional
    paid in capital</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,355,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,323,157</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(33,931,428</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(29,151,367</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    stockholders&rsquo; equity (deficit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5,573,613</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(825,660</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Liabilities and Stockholders&rsquo; Equity (Deficit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,480,644</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">760,482</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notes
to financial statements are an integral part of these statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 158 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="Z_002"></A><B>Neuraxis,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Statements
of Operations </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Sales</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,684,735</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,721,286</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost
    of Goods Sold</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">297,060</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">467,656</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gross
    Profit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,387,675</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,253,630</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling
    Expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">410,883</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">455,879</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and Development</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">225,610</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">203,414</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and Administrative</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,123,420</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,564,371</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    Loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,372,238</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,970,034</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    Income (Expense):</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financing
    charges</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,322,216</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(318,666</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(36,928</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value of warrant liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">606,049</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(29,342</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value of derivative liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">713,989</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">of
    debt discount and issuance cost</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(98,935</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    income</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,956</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,272</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,407,823</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(57,998</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,780,061</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,028,032</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Per-share
    Data</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Basic
    and diluted loss per share</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2.77</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1.92</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Shares Outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Basic
    and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,003,322</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,968,004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notes
to financial statements are an integral part of these statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 159 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><A NAME="Z_003"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Statements
of Stockholders&rsquo; Equity (Deficit) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Years Ended December 31, 2022, and 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Convertible
    Series A Preferred Stock</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Convertible
    Series Seed Preferred Stock</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Common
    Stock</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Additional<BR>Paid
    In</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Accumulated</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stockholder&rsquo;s</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Shares</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Amount</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Shares</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Amount</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Shares</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Amount</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B> Capital</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Deficit</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B> Equity (Deficit)</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 28%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance,
    January 1, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">479,612</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">480</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,477</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,928,004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,928</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,764,539</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(26,123,335</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,643,727</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Stock
    based compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48,641</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48,641</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Sale
    of Convertible Series A Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,025</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">509,977</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">510,004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Net
    loss for the year ended December 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,028,032</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,028,032</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">506,637</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,477</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,928,004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,928</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,323,157</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(29,151,367</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(825,660</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Stock
    based compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,319</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,319</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Common
    stock commitment shares from convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35,318</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,754</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,789</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Net
    loss for the year ended December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,780,061</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,780,061</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance,
    December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">506,637</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">507</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,477</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,963,322</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,963</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,355,230</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(33,931,428</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5,573,613</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notes
to financial statements are an integral part of these statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 160 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Z_004"></A>Neuraxis,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Statements of Cash Flows </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Years Ended September 30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    Flows from Operating Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,780,061</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,028,032</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments
    to reconcile net loss to net cash used by operating activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization
    </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">of debt discount and issuance cost</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">98,935</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation
    and amortization</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37,133</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36,708</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provisions
    for losses on accounts receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">19,505</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,770</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-cash
    lease expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,593</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,811</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    based compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,319</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48,641</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finance
    charges</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,322,216</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value of derivative liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(713,989</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in fair value of warrant liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(606,049</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,342</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in operating assets and liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(78,603</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">184,258</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8,953</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">67,666</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaids
    and other current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,944</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">132,619</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">1,108,326</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">319,232</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">272,425</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(105,367</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Customer
    deposits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10,163</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">69,337</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(27,582</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(23,311</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash used by operating activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(2,298,004</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,234,326</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    Flows from Investing Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additions
    to property and equipment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,390</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,390</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additions
    to intangible assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(59,815</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash used by investing activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(61,205</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,390</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    Flows from Financing Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from sale of convertible Series A Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">510,004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Principal
    payments on notes payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(163,214</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(98,905</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from notes payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">122,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">250,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,070,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Offering
    Costs Paid</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">(736,736</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"> <FONT STYLE="font-family: Times New Roman, Times, Serif">2,292,050</FONT> </TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">661,099</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Decrease in Cash and Cash Equivalents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(67,159</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,574,617</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and Cash Equivalents at Beginning of Period</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">320,858</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,895,475</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and Cash Equivalents at End of Period</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">253,699</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">320,858</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Supplemental
    Disclosure of Non-cash Cash Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    paid for interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">202,781</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,631</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    paid for income taxes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Supplemental
    Schedule of Non-cash Investing and Financing Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of warrant liabilities of warrants from convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,808,331</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of derivative liabilities of conversion feature from convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,449,689</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Relative
    fair value of shares issued with convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,789</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Notes
to financial statements are an integral part of these statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 161 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="Z_005"></A>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
Basis of Presentation, Organization and Other Matters </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc. (&ldquo;we,&rdquo; &ldquo;us,&rdquo; the &ldquo;Company,&rdquo; or &ldquo;Neuraxis&rdquo;) was established in 2011 and incorporated
in the state of Indiana on April 17, 2012, under the name of Innovative Health Solutions, Inc. The name was changed to Neuraxis, Inc.
in March of 2022. Additionally, the Company filed a Certificate of Conversion to become a Delaware corporation on June 23, 2022. The
authorized shares were increased, and a par value established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 7, 2021, the Company&rsquo;s board of directors authorized a 4-for-1 stock split. They also increased the number of authorized
common stock shares from 2,700,000 to 10,800,000. Furthermore, on September 9, 2021, the board authorized an increase of authorized shares
of common stock from 10,800,000 to 13,400,000 in anticipation of a capital offering. Furthermore, on January 10, 2023, the Company&rsquo;s
board of directors authorized a 1-for-2 reverse stock split. All per share information has been adjusted for this reverse stock split.
The reverse split became effective on January 12, 2023. All share and per share amounts for the common stock have been retroactively
restated to give effect to the splits. See Subsequent Events footnote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the conversion to a Delaware corporation, the total number of shares of all classes of stock which the Corporation shall have
authority to issue is (1) 100,000,000 shares of Common Stock, par value $0.001 per share (&ldquo;Common Stock&rdquo;) and (ii) 1,120,000
shares of Preferred Stock, par value $0.001 per share (&ldquo;Preferred Stock&rdquo;), 1,000,000 of which is hereby designated as &ldquo;Series
A Preferred Stock&rdquo; and 120,000 of which is hereby designated as &ldquo;Series Seed Preferred Stock&rdquo; with the rights, preferences,
powers, privileges and restrictions, qualifications and limitations set forth in this Article IV of the Delaware Certificate of Incorporation.
All share amounts have been retroactively restated to give effect to these changes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is headquartered in Versailles, Indiana. The Company specializes in the development, production, and sale of medical neuromodulation
devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has developed three FDA cleared products, the IB-STIM (DEN180057, 2019), the NSS-2 Bridge (DEN170018, 2017), and the original
510(K) clearance (K140530, 2014).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    IB-STIM is a percutaneous electrical nerve field stimulator (PENFS) device that is indicated in patients 11-18 years of age with
    functional abdominal pain associated with irritable bowel syndrome. The IB-STIM currently is the only product marketed and sold by
    the Company. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    NSS-2 Bridge is a percutaneous nerve field stimulator (PNFS) device indicated for use in the reduction of the symptoms of opioid
    withdrawal. The NSS-2 Bridge device was licensed to Masimo Corporation in April 2020, and the Company received a one-time licensing
    fee of $250,000 from Masimo. Masimo markets and sells this product as its Masimo Bridge, and the Company will not receive any further
    licensing payments or other revenue from this product. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    original 510(K) device was the EAD, an electroacupuncture device, now called NeuroStim. The EAD is no longer being manufactured,
    sold or distributed but reserved only for research purposes. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 162 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Summary of Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summary of significant accounting policies of Neuraxis, Inc. is presented to assist in understanding the Company&rsquo;s financial statements.
The financial statements and notes are representations of the Company&rsquo;s management, who is responsible for their integrity and
objectivity. These accounting policies conform to U.S. generally accepted accounting principles and have been consistently applied in
the preparation of the financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing
the Company&rsquo;s financial statements in conformity with accounting principles generally accepted in the United States of America
(&ldquo;GAAP&rdquo;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Estimates and Critical Accounting Estimates and Assumptions</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements
and the reported amounts of revenues and expenses during the reporting periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these
estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial
statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values
of assets and liabilities that are not readily apparent from other sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes
in facts and circumstances, historical experience, and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates
are adjusted accordingly. The Company uses estimates in accounting for, among other items, revenue recognition, allowance for doubtful
accounts, stock-based compensation, income tax provisions, excess and obsolete inventory reserve, and impairment of intellectual property.
Actual results could differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
and Cash Equivalents</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company
did not hold any cash equivalents as of December 31, 2022 and 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trade
Accounts Receivable</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are stated at the amount management expects to collect from balances outstanding at year-end. Management considers
the following factors when determining the collectability of specific customer accounts: customer creditworthiness, past transaction
history with the customer, current economic industry trends, and changes in customer payment terms. Based on management&rsquo;s assessment
of the credit history with customers having outstanding balances and current relationships with them, it has concluded that realization
losses on balances outstanding at year-end will be immaterial. Interest is not charged on past due customer accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 163 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Allowance
for Doubtful Accounts</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are stated net of an allowance for doubtful accounts. We estimate allowance for doubtful accounts by evaluating specific
accounts where information indicates our customers may have an inability to meet financial obligations, such as customer payment history,
credit worthiness and receivable amounts outstanding for an extended period beyond contractual terms. We use assumptions and judgment,
based on the best available facts and circumstances, to record an allowance to reduce the receivable to the amount expected to be collected.
The allowance for doubtful accounts was $31,275 and $11,770 at December 31, 2022 and December 31, 2021, respectively. During the years
ended December 31, 2022 and 2021, the Company recorded $64,197 and $11,770, respectively as a bad debt expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Customer
Deposits</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
deposits consists of billings and payments from clients in advance of revenue recognition. The Company will recognize the customer deposits
over the next year. As of December 31, 2022, and 2021, the Company had customer deposits of $59,174 and $69,337, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inventories</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are valued at the lower of cost or net realizable value. Cost is determined using the weighted average method. The inventory is comprised
of finished medical devices on hand. Certain components within the devices have an expiration date that are removed from current inventory
and expensed at the date of expiration. For the years ended December 31, 2022 and 2021, $10,026 and $48,488 were expensed as expired
inventory, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Deferred
Offering Costs</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
offering costs consist of costs incurred in connection with the preparation of an initial public offering. These costs, together with
the underwriting discounts and commissions, will be charged to additional paid in capital upon completion of the proposed public offering
or charged to operations if the proposed public offering is not completed. As of December 31, 2022 and 2021, the Company had deferred
offering costs of $736,736 and $0, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Property
and Equipment </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is calculated using the following estimated useful lives:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Classification</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 49%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Years</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">L
    Leasehold Improvements</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-20</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Machinery
    and Equipment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">7-10</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furniture
    and Fixtures</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">5-10</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $30,920 and $34,767 during the years ended December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 164 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Research
and Development</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
for research and development are expensed as incurred. Research and development expenses consist primarily of clinical research studies,
and new product development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Intangible
Assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets consist of patents and a trademark. Patents are stated at their historical cost and amortized on a straight-line basis over their
expected useful lives. Capitalized patent costs, net of accumulated amortization, includes legal costs incurred for patent applications.
In accordance with ASC 350, once a patent is granted, we amortize the capitalized patent costs over the remaining life of the patent
using the straight-line method. If the patent is not granted, we write-off any capitalized patent costs at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into an agreement for a trademark related to the Company&rsquo;s name on July 11, 2022. The agreement called for an initial
payment of $10,000 upon execution of the agreement. A second and final payment of $40,000 is contingent upon the completion of the Company&rsquo;s
planned initial public offering. The second payment has not been recorded in these financial statements. The trademark does not have
a determinate life and therefore the cost is not being amortized. See Note 16 Commitments and Contingencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
review intangible assets for impairment annually or when events or circumstances indicate that their carrying amount may not be recoverable.
During the years ended December 31, 2022 and 2021, the Company recorded no impairment charges for intangible assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense was $6,213 and $1,941 during the years ended December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
Taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in
the Company&rsquo;s financial statements and tax returns. Deferred tax assets and liabilities are determined based upon the differences
between the financial statement carrying amounts, and the tax bases of existing assets and liabilities for the loss and credit carryforwards
using enacted tax rates expected to be in effect in the year in which the differences are expected to reverse. Deferred tax assets are
reduced by a valuation allowance if it is more likely than not that these assets may not be realized. The Company determines whether
a tax position will be sustained upon examination. If it is not more likely than not that a position will be sustained, none of the benefit
attributable to the position is recognized. The tax benefit to be recognized for any tax position that meets the more likely than not
recognition threshold is calculated as the largest amount that is more than 50% likely of being realized upon resolution of the contingency.
The Company accounts for interest and penalties related to uncertain tax positions as part of its provision for income taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the results of management&rsquo;s evaluation, adoption of the rules did not have a material effect on the Company&rsquo;s financial
statements. Further, no interest or penalties have been accrued or charged to expense as of December 31, 2022 and 2021 and for the years
then ended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s income tax returns are subject to examination by the taxing authorities until the expiration of the related statutes
of limitations on those tax returns. In general, the federal and state income tax return have a three-year statute of limitations. As
of December 31, 2022, the following tax years are subject to examination:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 24%; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jurisdiction</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 36%; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Open
    Years for Filed Returns</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 36%; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Return
    to File in 2023</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Federal</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019
    &ndash; 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Various
    States</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019
    &ndash; 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 165 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advertising
Cost</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
costs are expensed as incurred and amounted to $14,900 and $34,316 for the years ended December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Derivative
Liabilities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for derivative financial instruments as either equity or liabilities in accordance with ASC Topic 815, <I>Derivatives
and Hedging</I>, or ASC 815, based on the characteristics and provisions of each instrument. Embedded derivatives are required to be
bifurcated from the host instruments and recorded at fair value if the derivatives are not clearly and closely related to the host instruments
on the date of issuance. Derivative instrument liabilities are classified in the balance sheets as current or non-current
based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrant
Liabilities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
evaluates all of the Company&rsquo;s financial instruments, including issued Warrants to purchase its Class A common stock, to determine
if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes a Monte Carlo simulation model for warrants that have an option to convert at a variable number of shares to compute
the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The inputs utilized
in the application of the Monte Carlo model included a starting stock price, an expected remaining term of each warrant as of the valuation
date, estimated volatility, drift, and a risk-free rate. The Company records the change in the fair value of the derivative as other
income or expense in the statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value Measurements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for financial instruments in accordance with ASC 820, Fair Value Measurements and Disclosures (&ldquo;ASC 820&rdquo;).
ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and
the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described
below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &ndash; Quoted prices (unadjusted) for identical unrestricted assets or liabilities in active markets that the reporting entity has
the ability to access as of the measurement date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &ndash; Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities: quoted
prices in markets that are not active; or financial instruments for which all significant inputs are observable or can be corroborated
by observable market date, either directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &ndash; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets
or liabilities. These unobservable inputs reflect that reporting entity&rsquo;s own assumptions about assumptions that market participants
would use in pricing the asset or liability. Level 3 assets and liabilities include financial instruments whose value is determined using
pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair
value require significant management judgment or estimation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 166 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Level 1 assets/liabilities include cash, accounts receivable, accounts payable, prepaids, and other current assets. Management
believes the estimated fair value of these accounts on December 31, 2022 approximate their carrying value as reflected in the balance
sheets due to the short-term nature of these instruments or the use of market interest rates for debt instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Level 3 assets/liabilities include derivative and warrant liabilities. Inputs to determine fair value are generally unobservable
and typically reflect management&rsquo;s estimates of assumptions that market participants would use in pricing the asset or liability.
The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash flow models.
Unobservable inputs used in the models are significant to the fair values of the assets and liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables provides a summary of the relevant assets and liabilities that are measured at fair value on recurring basis:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
Value Measurements as of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2022</B></FONT></P>



<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    1)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    2)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    3)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,970,084</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,970,084</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
Value Measurements as of</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    1)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    2)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Level
    3)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the valuation methodology and unobservable inputs for Level 3 assets and liabilities measured at fair value on
recurring basis as of December 31, 2022 and December 31, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Valuation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unobservable</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Methodology</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inputs</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 18%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 18%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Monte
    Carlo model</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 24%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Future value of the Company&rsquo;s common stock; probability and timing of a potential equity offering.</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Monte
    Carlo model</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Future value of the Company&rsquo;s common stock; probability and timing of a potential equity offering.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no transfers between any of the levels during the years ended December 31, 2022 and 2021. In addition to assets and liabilities
that are recorded at fair value on a recurring basis, the Company&rsquo;s assets and liabilities are also subject to nonrecurring fair
value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 167 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basic
and Diluted Net Income (Loss) per Share</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
or loss per share (&ldquo;EPS&rdquo;) is computed by dividing net income (loss), net of preferred stock dividends, by the weighted average
number of shares of common stock outstanding during the period. Basic weighted average shares for the year ended December 31, 2022 include
40,000 vested warrants to purchase common shares. As the shares underlying these warrants can be purchased for little to no consideration
($0.01 per share exercise price), they are included in the computation of basic earnings per share. Diluted EPS is computed by dividing
net income (loss) by the weighted average of all potentially dilutive shares of common stock that were outstanding during the periods
presented. Preferred stock dividends (not declared or paid) were $2,190,102 and $1,425,209 as of December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common
shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares
outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, which
is the case for December 31, 2022 and 2021 presented in these financial statements, the weighted-average number of common shares outstanding
excludes common stock equivalents because their inclusion would be anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had the following potentially dilutive common stock equivalents at December 31, 2022 and 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Series A Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,013,270</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,013,270</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Series Seed Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">230,954</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">230,954</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-Funded
    Warrants for Convertible Series A Preferred Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">289,779</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">289,779</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">365,962</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,852</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Bridge Debt</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">376,653</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Totals</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,596,012</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,866,249</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 168 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the calculation of the basic and diluted net loss per share and the effect of preferred stock dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Numerator</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,780,061</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,028,032</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    stock dividends</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(764,893</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(748,832</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5,544,954</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,776,864</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Denominator</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average
    shares of common stock outstanding - basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,003,322</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,968,004</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Basic
    and diluted net loss per share</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2.77</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1.92</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock-Based
Compensation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for all stock-based payments and awards under the fair value-based method. The Company recognizes its stock-based compensation
expense using the straight-line method. Compensation cost is not adjusted for estimated forfeitures, but instead is adjusted upon an
actual forfeiture of a stock option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the granting of stock options to employees and non-employees using the fair value method whereby all awards are
measured at fair value on the date of the grant. The fair value of all employee stock options is expensed over the requisite service
period with a corresponding increase to additional paid-in capital. Upon exercise of stock options, the consideration paid by the option
holder is recorded in additional paid-in capital, while the par value of the shares received is reclassified from additional paid in
capital to common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
payments to non-employees are measured based on the fair value of the equity instrument issued. Compensation expense for non-employee
stock awards is recognized over the requisite service period following the measurement of the fair value on the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes option-pricing model to calculate the fair value of stock options. The use of the Black-Scholes option-pricing
model requires management to make assumptions with respect to the expected term of the option, the expected volatility of the common
stock consistent with the expected term of the option, risk-free interest rates, the value of the common stock and expected dividend
yield of the common stock. Changes in these assumptions can materially affect the fair value estimate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
Recognition </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc. specializes in the development, production, and sale of medical neuromodulation devices to healthcare providers primarily located
in the United States. Patented and trademarked neuromodulation devices is the Company&rsquo;s major product line. Products are generally
transferred at a point in time (rather than over time). Essentially all the Company&rsquo;s revenue is generated from purchase order
contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with FASB&rsquo;s ASC 606, Revenue from Contracts with Customers, (&ldquo;ASC 606&rdquo;), the Company recognizes revenue
when its customer obtains control of promised goods or services, in an amount that reflects the consideration which the Company expects
to be entitled in exchange for those goods or services, in an amount that reflects the consideration which the Company expects to be
entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within
the scope of ASC 606, it performs the following five steps:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
  the contract(s) with a customer&#894;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
  the performance obligations in the contract&#894;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine
  the transaction price&#894;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate
  the transaction price to the performance obligations in the contract&#894; and</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize
  revenue when (or as) the entity satisfies a performance obligation.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 169 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company applies the five-step model to contracts when it determines that it is probable it will collect substantially all of the consideration
it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined
to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that
are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the
amount of the transaction price, after consideration of variability and constraints, if any, that is allocated to the respective performance
obligation when the performance obligation is satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company estimates credit losses on accounts receivable by estimating expected credit losses over the contractual term of the receivable
using a discounted cash flow method. When developing this estimate of expected credit losses, the Company considers all available information
(past, current, and future) relevant to assessing the collectability of cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers a Patient Assistance Program for patients without insurance coverage for IB-Stim. This program extends potential self-pay
discounts for IB-Stim devices, based upon household income and size.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
the Company offers providers an opt-in program to address adequate insurance claim payments on IB-Stim devices. This program may extend
a rebate or invoice credit where the insurance payment and patient responsibility (i.e., deductible, co-payment, and/or co-insurance
amounts required by the Payer) are less than the acquisition cost of the IB-Stim device. The Company recognizes revenue at such a time
that collection of the amount due is assured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table disaggregates the Company&rsquo;s revenue based on the customer&rsquo;s location by state for the periods ended December
31:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Wisconsin</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">670,245</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">665,157</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ohio</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">500,260</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">462,350</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">California</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">408,645</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">549,466</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Florida</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">231,480</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">117,670</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Missouri</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">174,980</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">96,795</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
    other states</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">699,125</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">829,848</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,684,735</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,721,286</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 170 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following economic factors affect the nature, amount, timing, and uncertainty of the Company&rsquo;s revenue and cash flows as indicated:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type
of customer:</B> Based on dollar amounts of revenue, essentially all of the goods sold by the Company are sold to healthcare customers
including hospitals and clinics. Sales to healthcare customers lack seasonality and have a mild correlation with economic cycles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Geographical
location of customers:</B> Sales to customers located within the United States represent essentially all of the Company&rsquo;s sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Type
of contract:</B> Sales contracts consist of purchase order contracts that tend to be short-term (i.e., less than or equal to one year
in duration).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opening and closing balances of trade receivables, contract assets, and contract liabilities from contracts with customers are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trade
    Receivables</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contract
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contract
    Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    1/1/2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">311,329</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    12/31/21 and 1/1/2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,301</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance 12/31/2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">174,399</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Company&rsquo;s
Performance Obligations with Customers:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Timing
of Satisfaction</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically satisfies its performance obligations as the goods are delivered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goods
that are shipped to customers are typically shipped FOB shipping point with freight prepaid by the Company. As such, ownership of goods
in transit transfer to the customer when shipped and the customer bears the associated risks (e.g., loss, damage, delay). In some cases,
a customer will take delivery directly from the Company&rsquo;s inventory (i.e., consigned inventory), at which point ownership and the
associated risks pass to the customer at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling costs are recorded as general and administrative expenses in the Statement of Operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Significant
Payment Terms</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
for goods sold by the Company is typically due after an invoice is sent to the customer, within 30 days. However, other payment terms
are frequently negotiated with customers ranging from due upon receipt to due within 90 days. Some payment terms may call for payment
only after the healthcare provider receives their insurance reimbursement. Invoices for goods are typically sent to customers within
three calendar days of shipment. The Company does not offer discounts if the customer pays some or all of an invoiced amount prior to
the due date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&rsquo;s contracts have a significant financing component.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Nature</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
devices that the Company contracts to sell and transfer to customers are manufactured by one specific third-party manufacturer. The manufacturer
is located within the state of Indiana. In no case does the Company act as an agent (i.e., the Company does not provide a service of
arranging for another party to transfer goods to the customer).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 171 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Returns,
Refunds, etc. </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Orders
may not be cancelled after shipment. Customers may return devices within 10 days of delivery if the goods are found to be defective,
nonconforming, or otherwise do not meet the stated technical specifications. At the option of the customer, the Company shall either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refund
    the price paid for any defective or nonconforming products</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supply
    and deliver to the customer replacement conforming products</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimburse
    the customer for the cost of repairing any defective or nonconforming products</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time revenue is recognized, the Company estimates expected returns and excludes those amounts from revenue. The Company also maintains
appropriate accounts to reflect the effects of expected returns on the Company&rsquo;s financial position and periodically adjusts those
accounts to reflect its actual return experience. Historically, returns have been immaterial, and the Company currently does not provide
a provision for this liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warranties
</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
most cases, goods that customers purchase from the Company are covered by manufacturers&rsquo; warranties. The Company does not sell
warranties separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
manufacturer guarantees the product for the period up to the expiration date printed on the device&rsquo;s label or twelve months from
the date of purchase, whichever comes first. The guarantee applies to flaws of material and workmanship. The Company&rsquo;s warranties
provide customers with assurance that purchased devices comply with published specifications, inspection standards, and workmanship.
At the time revenue is recognized, the Company estimates the cost of expected future warranty claims but does not exclude any amounts
from revenue. The Company maintains appropriate accounts to reflect the effects of expected future warranty claims on the Company&rsquo;s
financial position and periodically adjusts those accounts to reflect its actual warranty claim experience. Historically, warranty claims
have been immaterial, and the Company currently does not provide a provision for this liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically satisfies its performance obligations for goods at a point in time. In most cases, goods are shipped by common carrier
to customers under &ldquo;FOB Shipping Point&rdquo; terms. As such, customers typically obtain control of the goods upon shipment. The
Company&rsquo;s management exercises judgment in determining when performance obligations for goods have been satisfied. In making such
judgments, management typically relies on shipping information obtained from common carriers to evaluate when the customer has obtained
control of the goods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s contracts with customers typically do not involve variable consideration. The information that the Company uses to determine
the transaction price for a contract is similar to the information that the Company&rsquo;s management uses in establishing the prices
of goods to be sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Leases</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2021, the Company adopted Accounting Standards Updated (&ldquo;ASU&rdquo;) No. 2016-02, <I>Leases (Topic 842)</I> (&ldquo;ASU
2016-02&rdquo; or &ldquo;ASC 842&rdquo;), using the full retrospective method, the cumulative effect of the accounting change is recognized
as an adjustment to the opening balance of retained earnings in the first comparative period presented. At the inception of an arrangement,
the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement.
Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease
liabilities, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 172 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over
the expected remaining lease term. Certain adjustments to the right-of-use asset may be required for items such as incentives received.
The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental
borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis
the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company
will adjust the right-of-use assets for straight-line rent expense, or any incentives received and remeasure the lease liability at the
net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date. The Company
has elected not to recognize leases with an original term of one year or less on the balance sheet. The Company typically only includes
an initial lease term in its assessment of a lease arrangement. Options to renew a lease are not included in the Company&rsquo;s assessment
unless there is reasonable certainty that the Company will renew.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions
made by the Company at the commencement date are re-evaluated upon occurrence of certain events, including a lease modification. A lease
modification results in a separate contract when the modification grants the lessee an additional right of use not included in the original
lease and when lease payments increase commensurate with the standalone price for the additional right of use. When a lease modification
results in a separate contract, it is accounted for in the same manner as a new lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entities
may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together
as a single lease component for all underlying assets and allocate all the contract consideration to the lease component only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Impairment
of Long-Lived Assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may
not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable,
we compare the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated
by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment
to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group.
Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Concentrations
of Credit Risk</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s business activity consists of the sale of medical neuromodulation devices to doctors, clinics, and hospitals across the
country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
consist of unsecured amounts due from customers. As of December 31, 2022, accounts receivable from three customers with balances due
in excess of 10% of total accounts receivable were approximately 23%, 15%, and 12%, respectively. As of December 31, 2021, accounts receivable
from three customers with balances due in excess of 10% of total accounts receivable were 15%, 13%, and 11%, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 173 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth the Company&rsquo;s customers that accounted for greater than 10% of its revenues in one of the periods ended
December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Percentage
    of</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Percentage
    of</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2022</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Sales</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>2021</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Sales</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hospital
    A</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">554,325</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">574,185</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hospital
    B</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">484,900</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">444,965</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hospital
    C</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">355,613</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">321,964</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Hospital
    D</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">148,200</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">226,293</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,543,038</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,567,407</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">From
time to time, the Company&rsquo;s bank balances may exceed the FDIC limit of $250,000; however, management does not feel that this has
a material impact on the financial condition. At December 31, 2022 and December 31, 2021, the Company&rsquo;s uninsured cash balances
totaled $0 and $20,850, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Going
Concern</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred losses since inception and have funded our operations primarily with a combination of sales, debt, and the sale of capital
stock. As of December 31, 2022, we had an stockholders&rsquo; deficit of approximately $5.6 million. At December 31, 2022, we had short-term
borrowings outstanding, of approximately $489 thousand, net of discounts of $3,327,213. At December 31, 2022 there were no long term
borrowings. As of December 31, 2022, we had cash of approximately $104 thousand and a working capital deficit of approximately $6.5 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future capital requirements will depend upon many factors, including progress with developing, manufacturing, and marketing our technologies,
the time and costs involved in preparing, filing, prosecuting, maintaining, and enforcing patent claims and other proprietary rights,
our ability to establish collaborative arrangements, marketing activities and competing technological and market developments, including
regulatory changes and overall economic conditions in our target markets. Our ability to generate revenue and achieve profitability requires
us to successfully market and secure purchase orders for our products from customers currently identified in our sales pipeline and to
new customers as well. The primary activity that will drive all customers and revenues is the adoption of insurance coverage by commercial
insurance carriers nationally, so this is a top priority of the Company. These activities, including our planned research and development
efforts, will require significant uses of working capital through the end of first quarter 2023 and beyond. Based on our current operating
plans, we believe that our existing cash at the time of this filing will only be sufficient to meet our anticipated operating needs through
June 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
evaluates whether there are conditions or events that raise substantial doubt about the Company&rsquo;s ability to continue as a going
concern for a period of one year from the date the financial statements are issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, the Company has experienced operating losses and negative cash flows from operations. Management believes that increased sales
and acceptance of their product by insurance providers will allow the Company to achieve profitability in the near term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 174 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Company believes in the viability of its strategy to further implement its business plan and generate sufficient revenues and in
its ability to raise additional funds by way of a public or private offering of its debt or equity securities, there can be no assurance
that it will be able to do so on reasonable terms, or at all. The ability of the Company to continue as a going concern is dependent
upon its ability to further implement its business plan and generate sufficient revenues and its ability to raise additional funds by
way of a public or private offering. Neither future cash generated from operating activities, nor management&rsquo;s contingency plans
to mitigate the risk and extend cash resources through the evaluation period, are considered probable, substantial doubt is deemed to
exist about the Company&rsquo;s ability to continue as a going concern. As we continue to incur losses, our transition to profitability
is dependent upon achieving a level of revenues adequate to support our cost structure. We may never achieve profitability, and unless
and until doing so, we intend to fund future operations through additional dilutive or nondilutive financing. There can be no assurances,
however, that additional funding will be available on terms acceptable to us, if at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the
amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recently
Issued Accounting Pronouncements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU 2016-13, Financial Instruments &ndash; Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments, which requires measurement and recognition of expected credit losses for financial assets held and requires enhanced disclosures
regarding significant estimates and judgments used in estimating credit losses. In November 2019, the FASB issued ASU 2019-10, Financial
Instruments &ndash; Credit Losses (Topic 326), Derivatives and Hedging (Topic 815) and Leases (Topic 842): Effective Dates, which amends
the effective date of ASU 2016-13. Public business entities meeting the definition of an SEC filer, excluding entities eligible to be
a Smaller Reporting Company (&ldquo;SRC&rdquo;) as defined by the SEC, are required to adopt the standard for fiscal years beginning
after December 15, 2019, including interim periods within those fiscal years. All other entities are required to adopt the standard for
fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company meets the definition
of an SRC and therefore the standard will not be effective until the beginning of 2023. The adoption of this guidance did not have a
material impact on the Company&rsquo;s financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 175 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has two demand notes receivable from shareholders related to the sale of common stock on January 1, 2016. Both notes&rsquo; initial
balances were $506,400, with interest calculated monthly based on applicable federal rates. No payments have been received on the notes.
Since repayment is not assured, the Company provided an allowance for the entire balance of principal and interest as of December 31,
2019. The current allowance is $1,106,807 as of December 31, 2022. The current loan balances are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47,071</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,523</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder
    2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">46,936</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,523</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,012,800</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">94,007</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,046</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Allowance
    for Collection Risk</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,012,800</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(94,007</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(23,046</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Balance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35,548</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">827</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder
    2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">506,400</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35,414</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">827</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,012,800</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70,962</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,654</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Allowance
    for Collection Risk</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,012,800</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(70,962</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,654</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Balance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has loans payable to shareholders related to funding needs for operations. The current loan details for all related party loans
are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    &amp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Service
    Fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Due
    Date</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paid</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">June,
    2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,051</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,161</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">June,
    2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,481</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    Convertibles</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Various</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">66,648</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">98,290</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font-family: Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    &amp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Service
    Fee</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Due
    Date</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paid</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Demand</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">June,
    2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.15</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">June,
    2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,051</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,153</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholder 3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">June,
    2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,781</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    Convertibles</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Various</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,582</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">66,648</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,051</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">89,582</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,592</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s Chief Financial Officer, John Seale, CPA.CITP, is contracted for services through RBSK Partners PC (RBSK). Mr. Seale
is RBSK&rsquo;s managing partner and majority shareholder. RBSK is engaged by the Company to provide accounting and tax services on a
continuous basis. Fees paid to RBSK for services were $116,542 and $80,394 for the years ended December 31, 2022 and 2021, respectively.
The Company owed RBSK for open invoices of $68,142 and $3,386 that are included in accounts payable as of December 31, 2022 and 2021,
respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 176 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
Property and Equipment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment, net consists of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furniture
    and fixtures</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">87,148</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">87,148</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Computer
    hardware</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,452</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,062</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Leasehold
    improvements </FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,064</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,064</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Machinery
    and equipment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">282,181</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">282,181</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    property and equipment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">405,845</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">404,455</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less:
    accumulated depreciation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(317,834</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(286,913</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">88,011</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">117,542</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $30,920 and $34,767 for the years ended December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
Intangible Assets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets, net consists of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 64%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Software
    Implementation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">49,815</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Patents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,463</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,463</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Patents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    intangible assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">92,278</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,463</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less:
    accumulated amortization</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(14,720</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8,507</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">77,558</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,956</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense was $6,213 and $1,941 for the years ended December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.
Accrued Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
expenses consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Wages</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">523,003</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">451,974</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employee
    benefits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,555</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,734</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commissions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">88,259</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,785</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    taxes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">777</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">563</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">173,826</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">66,648</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Related
    party interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,642</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,934</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    accrued expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">834,062</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">561,638</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 177 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.
Notes Payable</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company borrowed $250,000 on December 16, 2021, from Channel Partners Capital. The note calls for 65 weekly payments of $4,923.08 with
the final payment scheduled for March 16, 2023. The note&rsquo;s interest rate computes to a nominal rate of 40.856%. The principal outstanding
at December 31, 2021 was $244,048. The Company borrowed $122,000 on September 16, 2022 to bring the principal balance back to $250,000.
The terms of the note are the same as the previous note with the final payment scheduled for December 16, 2023. The principal outstanding
at December 31, 2022 was $202,834. The Company believes that the advancement of additional funds is a minor modification to the terms
of the existing loan since the difference in present value of the cash flows under the terms of the new loan is less than 10% of the
present value of the remaining cash flows under the terms of the original loan. As a result, the modification was accounted for as a
modification of debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lender was granted and assigned a continuing security interest in all the Company&rsquo;s personal property assets including, but not
limited to, business equipment, inventory, accounts, accounts receivable, intellectual property, chattel paper, instruments, deposit
accounts, commercial tort claims, contract rights, licenses, claims, and general intangibles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
future minimum principal payments to be paid in 2023 are $202,834.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2022, the Company conducted multiple closings of a private placement offering to accredited investors for
aggregate gross amount of $3,555,556 and net proceeds of $3,070,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Convertible Notes signed from June 3, 2022 to November 30, 2022 have aggregate gross amounts of $3,333,333 and net proceeds of $2,870,000
and consisted of (a) a Convertible Promissory Note that accrues interest at the greater of Prime rate plus 8.5% or 12%. The notes convert
into common shares at the lower of $9.44 or 30% discount to the price per share of any subsequent offering. The notes mature on the one-year
anniversary date from issuance. (b) a five-year warrant to purchase common stock equal to one hundred percent (100%) of the shares into
which the 2022 Convertible Notes can be converted into at issuance. The warrants have an exercise price at the lower of $11.80 per share
or a 12.5% discount to the price per share of any subsequent offering. (c) shares of the Company&rsquo;s common stock equal to 10% of
the principal amount of these notes, at a value per share equal to the conversion price. The 35,318 shares of common stock issued to
investors had a relative fair value of $4,789.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an additional incentive for entering into the Convertible note offering, the Company offered an original issue discount equal to 10%
of the principal amount of the notes. The Company also paid $130,000 to law firms related to an expected offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Convertible Notes signed on December 19, 2022 have aggregate gross proceeds of $200,000 or net proceeds of $222,222 and consisted
of an original issue discount of 10% of the principal amount and have an interest rate of 12% per annum. The notes will mature at the
earlier of (i) twelve (12) months from the issue date or (ii) the date upon which the Company completes a registered public offering
of shares of the Company, which encompasses the closing of this offering. The notes are convertible into shares of common stock at the
higher of (i) $9.44 per share, or (ii) the price per share of common stock issued pursuant to the next registered public offering of
shares of the Company made prior to the conversion of any portion of the note. Interest accrues on the aggregate principal amount (which
includes original issue discount) and is payable on the maturity date, at the Company&rsquo;s election, in cash or in-kind. The holders
of the notes are entitled to piggyback registration rights on any registration statement filed by the Company, other than the registration
statement of which this prospectus forms a part and any registration filed on Form S-4 or Form S-8. The warrants and conversion shares
are subject to anti-dilution adjustments outlined in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 178 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has applied ASC 815 and ASC 480, due to the potential for settlement in a variable quantity of shares. Since these convertible
notes and warrants have the option to convert or be exercised at a variable amount, they are subject to derivative liability treatment.
The conversion feature has been measured at fair value using a Monte Carlo model at the date of issuance and is adjusted to fair value
at each reporting period. The fair value of the embedded derivative and the warrant liability at date of issuance was $1,735,700 and
$2,234,384, respectively. See notes 13 and 14. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
value of the incentives given to investors totaled $5,748,365. Since the value of the incentives given to investors was in excess of
the principal value of the notes, the Company recognized $3,426,149 as debt discount and expensed the remaining $2,322,216 as financing
fees. The debt discount is being amortized over the life of these notes. As of December 31, 2022, the Company has amortized
$98,935 of the debt discount at effective interest rates ranging from 73.857% to 1411.091%. The remaining balance of $3,324,214 will
be amortized over the remaining life of the notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2022, the Company accrued interest of $107,178 included in accrued expenses on the balance sheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Leases</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s leases are comprised of operating leases for office space. At the inception of the lease, the Company determines whether
the lease contract conveys the right to control the use of identified property for a period of time in exchange for consideration. Leases
are classified as operating or finance leases at the commencement date of the lease. Operating leases are recorded as operating lease
right-of-use assets, other current liabilities, and operating lease liabilities in the Balance Sheets. The Company did not have any finance
leases at December 31, 2022 and December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had three leases primarily consisting of office space in Versailles and Carmel Indiana. Two of the leases in Versailles started
January 1, 2017. Both have an initial term of five years with an option for an additional five-year term. The monthly lease payments
for these leases are $550 and $1,600 with a 3% per annum increase starting with the optional five-year term. The lease in Carmel started
March 1, 2016. The initial term is five years and three months with an option for an additional three-year term. The monthly lease payment
started at $1,472 with an annual increase of approximately 2.7%. On December 16, 2020, the Company entered into an amendment of the Carmel
lease that extended the initial term by two years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the
lease term. As the implicit interest rate is generally not readily determinable, the Company uses an incremental borrowing rate based
on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate
reflects the estimated rate of interest that the Company would pay to borrow on a collateralized basis over a similar economic environment.
Lease expense for the operating lease is recognized on a straight-line basis over the lease term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leases
may include renewal options, and the renewal option is included in the lease term if the Company concludes that it is reasonably certain
that the option will be exercised. Certain leases may contain rent escalation clauses, either fixed or adjusted periodically for inflation
of market rates, that are factored into the calculation of lease payments to the extent they are fixed and determinable at lease inception.
The Company also has variable lease payments that do not depend on a rate or index, primarily for items such as common area maintenance
and real estate taxes, which are recorded as expenses when incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the periods ended December 31, 2022 and 2021, the Company recognized $47,571 and $4,725 of operating lease expense, including short-term
lease expense and variable lease costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 179 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information related to the Company&rsquo;s operating leases:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">101,382</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">127,975</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    current liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,395</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,582</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">76,199</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">109,594</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">109,594</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">137,176</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average
    remaining lease term (in years)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average
    discount rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, the maturities of the Company&rsquo;s operating lease liabilities were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; width: 80%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47,606</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36,302</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2025</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,192</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2026</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,038</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    lease payments</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">141,138</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less:
    imputed interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,544</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    present value of lease payments</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">109,594</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common Stock and Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 7, 2021, the Company&rsquo;s board of directors authorized a 4-for-1 stock split. They also increased the number of authorized
common stock shares from 2,700,000 to 10,800,000. Furthermore, on September 9, 2021, the board authorized an increase of authorized shares
of common stock from 10,800,000 to 13,400,000 in anticipation of a capital offering. As part of the conversion to a Delaware Corporation
in June of 2022, the total number of common stock shares authorized was increased to 100,000,000. All share and per share amounts for
the common stock have been retroactively restated to give effect to the split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
on January 10, 2023, the Company&rsquo;s board of directors authorized a 2-for-1 reverse stock split. All share information in these
financial statements has been adjusted for this reverse stock split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with a bridge loan, the Company issued a warrant to a shareholder, Brian Hannasch, on September 18, 2018. The warrant allows
the holder to purchase common stock from the Company at a share price of $4.38 per share. The number of shares was based on a formula
tied to the amount of loans made by the holder. The number of shares based on this formula is 12,852. The warrant contains certain rights
in the event of liquidation, merger, or consolidation of the Company. If the fair market value of one share is greater than the warrant
price, the holder may elect to receive a number of shares equal to the value of the warrant. If the exercise is in connection with the
sale of the Company, the holder may, at its option, condition its exercise of the warrant upon the consummation of such transaction.
The warrant expires on September 18, 2028 and can be exercisable either in whole or from time to time in part prior to the expiration
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a second warrant to Brian Hannasch on September 6, 2019, under similar terms. This is a penny warrant that allows the
holder to purchase 40,000 shares of common stock and is subject to adjustment for certain equity events. The warrant contains certain
rights in the event of liquidation, merger, or consolidation of the Company. The warrant expires on September 6, 2029.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 180 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued a third warrant to Masimo Corporation on April 9, 2020. This warrant was pre-funded in the amount of $2,734,340. The warrant
allows the holder to purchase 289,779 shares of Series A Preferred Stock at $9.44 per share and is subject to adjustment
for certain equity events. The warrant contains certain rights in the event of liquidation, merger, or consolidation of the Company.
There will be no additional purchase price for the Warrants. In the event that all outstanding shares of Series A Preferred Stock are
converted, automatically or by action of the holders thereof, into Common Stock, including, without limitation, in connection with the
Company&rsquo;s initial, underwritten public offering and sale of its Common Stock pursuant to an effective registration statement under
the Act (the &ldquo;IPO&rdquo;), then from and after the date on which all outstanding shares of Series A Preferred Stock have been so
converted, this Warrant shall be exercisable for such number of shares of Common Stock into which the Warrant Shares would have been
converted had the Warrant Shares been outstanding on the date of such conversion, and the Exercise Price shall equal the Exercise Price
in effect as of immediately prior to such conversion divided by the number of shares of Common Stock into which one share of Series A
Preferred Stock would have been converted, all subject to further adjustment thereafter from time to time in accordance with the provisions
of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company issued 353,110 five-year warrants to purchase common stock equal to one hundred percent (100%) of the shares into which the 2022
convertible notes can be converted into at issuance. The warrants have an exercise price at the lower of $11.80 per share or a 12.5%
discount to the price per share of any subsequent offering.  The number of Warrant Shares is determined based on the number of the Company&rsquo;s common shares that would be issued upon full conversion of the Note. Initially, this will be calculated based on the first prong of the Conversion Price definition in Section 2.2(a) of the Note ($9.44 per share). If the conversion price is adjusted downwards pursuant to the Note, so that the number of shares issuable upon the full conversion of the Note increases, the number of Warrant Shares will be adjusted accordingly. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of warrant activity for common stock during the periods ended December 31, 2022 and December 31, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Number of</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Weighted-Avg.</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Weighted-Avg. </TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Warrants for</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Exercise</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"> Remaining </TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"> Contractual Life </TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; font-weight: bold">Outstanding as of January 1, 2021</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">52,852</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.13</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left"> &nbsp; </TD><TD STYLE="width: 14%; text-align: right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.44 </TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Cancelled/Expired</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &mdash; </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Exercised</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &mdash; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December 31, 2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,852</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2.13</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 7.44 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">353,110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">9.44</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> 5.00 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Cancelled/Expired</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left"> &nbsp; </TD><TD STYLE="text-align: right"> &nbsp; </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Exercised</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> &nbsp; </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt">Outstanding as of December 31, 2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">405,962</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8.49</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"> &nbsp; </TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"> 4.84 </TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 181 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of warrant activity for preferred stock during the periods ended December 31, 2022 and December 31, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Number of</TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Weighted-Avg.</TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants
    for</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    as of January 1, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    as of December 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    as of December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the Company&rsquo;s warrants outstanding and exercisable as of December 31, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expiration</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 42%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Brian
    Hannasch W-01</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,852</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.7600</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    18, 2028</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Brian
    Hannasch W-02</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0050</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    6, 2029</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Masimo
    Corporation PSA-01</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">144,890</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.0001</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">None</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Convertible
    Notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">353,110</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.4400</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Various</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">550,852</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -58.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a party to two investment banking and advisory agreements with a consulting firm engaged in connection with listing our common
stock for trading on Nasdaq. Pursuant to the first advisory agreement, dated March 3, 2022, the Company agreed to pay the consulting
firm a monthly consulting fee of $5,000 and a final payment of $50,000 upon a successful Nasdaq listing, and, also upon such listing,
to issue the consulting firm shares of our common stock representing 1.5% of our outstanding shares after giving effect to the offering
and to issue the consulting firm five-year warrants to purchase shares of our common stock representing 2.0% of our outstanding shares
after giving effect to an offering on a fully-diluted basis with an exercise price per share representing the public offering price per
share. Pursuant to the second advisory agreement with consulting firm, dated June 20, 2022, and amended December 20, 2022, the Company
agreed to pay fees in the aggregate of up to $136,166 for advice in connection with communication and other related matters leading up
to, and in connection with an offering, and to issue the consulting firm 25,000 shares of common stock upon a successful Nasdaq listing.
The Company agreed to piggyback registration rights with respect to all shares issued to the consulting firm under both advisory agreements,
including shares issuable upon exercise of the warrants. The Company evaluated the agreements and determined that the shares will not
be recorded and valued until the performance condition is satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has authorized 1,120,000 shares of preferred stock of which 1,000,000 has been designated Series A Preferred and 120,000 has
been designated Series Seed Preferred, of which 506,637 shares of Series A Preferred and 115,477 shares of Series Seed Preferred are
issued and outstanding as of December 31, 2022 and December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 182 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
requisite holder of our outstanding Series A Preferred Stock and Series Seed Preferred Stock have delivered a consent, dated December
22, 2022, to automatically convert all shares of preferred stock into shares of common stock (on a 2-for-1 basis) upon consummation of
this offering.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate purchase price of the Series A Preferred Stock was $9,321,165, of which $7,692,664 was comprised of cash and the remaining
$1,628,501 was comprised of converted debt and common stock. The aggregate purchase price of the Series Seed Preferred shares was $0,
as all the Series Seed shares were converted from common stock as an incentive to reinvest in Series A Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of Preferred Stock terms:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Voting
Rights</U> - The Series A Preferred and Series Seed Preferred shall vote together with the Common Stock on an as-converted basis, and
not as separate classes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Conversion
</U>- The Series A Preferred and Series Seed initially convert 1:1 to Common Stock at any time at option of holder, subject to adjustments
for stock dividends, splits, combinations, and similar events and as described below under &ldquo;Anti-dilution Provisions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Dividends
</U>- The Series A Preferred will carry an annual 8% cumulative dividend, payable upon any liquidation, dissolution or winding up of
the Company (the &ldquo;Accruing Dividend&rdquo;). For any other dividends or distributions, participation with Common Stock on an as-converted
basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Liquidation
</U>- In the event of any liquidation, dissolution or winding up of the Company, the proceeds shall be paid in the following priority:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
to the Series A Preferred in proportion to each holder&rsquo;s respective pro rata Series A Original Purchase Price, plus any pro rata
share of the Accruing Dividend until the entire Series A Original Purchase Price and Accruing Dividend are paid;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
to the Series Seed Preferred in proportion to each holder&rsquo;s respective pro rata Series Seed Original Purchase Price until the entire
amount of the Series Seed Original Purchase Price is paid;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter,
the Series A Preferred and Series Seed Preferred participate with the Common Stock pro rata on an as-converted basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
merger or consolidation (other than one in which stockholders of the Company own a majority by voting power of the outstanding shares
of the surviving or acquiring corporation) and a sale, lease, transfer, exclusive license or other disposition of all or substantially
all of the assets of the Company will be treated as a liquidation event (a &ldquo;Deemed Liquidation Event&rdquo;), thereby triggering
payment of the liquidation preferences described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Anti-dilution
Provisions</U> - The Series A Preferred have full-ratchet anti-dilution protection so that the conversion price will be reduced to 80%
of the price at which any future shares are issued, if less than the Series A Original Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for shareholders to make an additional investment in the Company, upon the purchase of the Series A Preferred stock by
the shareholder, the Company converted the existing common shares held by shareholders to Series Seed Preferred Stock at a $100 million
valuation and at a 120% share premium. As of December 31, 2022 and December 31, 2021, there were 97,702 common shares converted into
115,477 shares of Series Seed Preferred shares that have no par value and are outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 183 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
                                            Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock Options and Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2017, the Company adopted the 2017 Stock Compensation Plan authorizing the issuance of 1,435,652 shares of common stock.
On September 13, 2019 the Company entered into a Stock Option Cancellation agreement with all holders of these stock options effective
on that date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
plan was then amended on September 13, 2019, to increase the share amount to 2,638,788. This plan was enacted to enable the Company to
retain the services of certain key employees, officers, and directors of the Company. The Plan provides for the grant of stock options,
including incentive stock options, or ISOs, and nonqualified stock options, or NSOs and restricted stock, and they were estimated using
the Black-Scholes option-pricing model with the following weighted-average assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assumptions
    as of<BR> December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fully
    Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 76%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.20</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected
    term</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
                                            years</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected
    volatility</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">80</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free
    interest rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.06</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend
    rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of stock option activity for the periods ended December 31, 2022 and 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Avg.</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contractual
    Life</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Avg.</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(in
    years)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intrinsic
    Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 36%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    as of January 1, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.78</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    as of December 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.78</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancelled/Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    as of December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.78</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.94</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested
    and Exercisable as of December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,319,394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.78</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.94</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense is classified in the Company&rsquo;s statements of operations as general and administrative expense. The amounts
were $27,319 and $36,381 for periods ended December 31, 2022 and 2021, respectively. As of December 31, 2022, there was $0 of total unrecognized
compensation expense related to unvested options granted under the Company&rsquo;s share-based compensation plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>13.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrant Liabilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated financial instruments arising from an adjustable exercise price for warrants that are issued and outstanding as
of December 31, 2022 and December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes a Monte Carlo simulation model for warrants that have an option to convert at a variable number of shares to compute
the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The inputs utilized
in the application of the Monte Carlo model included a starting stock price of $9.20 per share, an expected remaining term of each warrant
as of the valuation date, estimated volatility of 80%, drift, and a risk-free rate ranging from 4.00% to 4.06%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 184 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note adjusted to be on a continuous return basis to align
with the Black-Scholes option-pricing model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring
dividends in the near future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility:
The Company calculates the expected volatility based on comparable company&rsquo;s historical stock prices with a look back period commensurate
with the period to maturity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
term: The Company&rsquo;s remaining term is based on the remaining contractual maturity of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the changes in the warrant liabilities during the year ended December 31, 2022 and December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 46%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities as of January 1, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,760</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in fair value of warrant liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,342</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities as of December 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,102</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,808,331</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in fair value of warrant liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(606,049</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    liabilities as of December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,234,384</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>14.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Derivative Liabilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified derivative instruments arising from the conversion shares discussed in the Convertible Notes section of note 6
as of December 31, 2022 and December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes a Monte Carlo simulation model for commitment shares that have an option to convert at a variable number of shares to
compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The inputs
utilized in the application of the Monte Carlo model included a starting stock price of $9.20 per share, an expected remaining term of
each warrant as of the valuation date, estimated volatility of 80%, drift, and a risk-free rate ranging from 4.00% to 4.73%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free
interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note adjusted to be on a continuous return basis to align
with the Black-Scholes option-pricing model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate declaring
dividends in the near future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility:
The Company calculates the expected volatility based on comparable company&rsquo;s historical stock prices with a look back period commensurate
with the period to maturity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
term: The Company&rsquo;s remaining term is based on the remaining contractual maturity of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 185 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following are the changes in the warrant liabilities during the year ended December 31, 2022 and December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Level
    3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities as of January 1, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in fair value of Derivative liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities as of December 31, 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Addition</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,449,689</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in fair value of Derivative liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(713,989</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative
    liabilities as of December 31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,735,700</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Retirement Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company sponsors a 401(k)-retirement plan for its employees. Employees are eligible to participate in the elective deferral portion of
the plan after twelve months and 1,000 hours of service. The Company matches the employee&rsquo;s contribution up to 3%. The Company
can also make an optional profit-sharing contribution to the employee accounts on an annual basis. There was an expense of $17,183 and
$22,501 for years ended December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commitments and Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Manufacturing
Services Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 21, 2020, the Company entered into a Manufacturing Services Agreement (MSA) for the manufacture and supply of the Company&rsquo;s
IB-STIM device based upon the Company&rsquo;s product specifications as set forth in the MSA. This agreement terminated any prior manufacturing
agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides the necessary equipment to the manufacturer and retains ownership. The manufacturer bears the risk of loss of and damage
to the equipment and consigned materials. Performance under the MSA is initiated by orders issued by the Company and accepted by the
manufacturer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the MSA is 24 months and shall automatically renew for renewal terms of twelve months unless either party provides a written
termination notice to the other party within 180 days prior to the end of the then-current term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trademark
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2022, the Company entered into an agreement for a trademark related to the Company&rsquo;s name. An initial payment of $10,000
was paid upon execution of the agreement. A second and final payment of $40,000 is contingent upon the completion of the Company&rsquo;s
planned initial public offering. The second payment has not been recorded in these financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Employment Agreements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company, as authorized by the board of directors, entered into employment agreements with nine key employees to provide incentives to
improve shareholder value and to contribute to the growth and financial success of the Company. The agreements had an employment start
date of October 1, 2022, with initial terms from 2 to 5 years and optional one-year renewals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 186 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total base salaries for the nine key employees in the agreements are $1.92 million per year with various provisions for annual increases.
In addition to base salaries, eight of the employees have a provision for a special one-time incentive payment to be paid in a lump sum
after the start date. The total amount of these special incentive payments is $1.11 million. The special incentive payment amount includes
any accrued backpay wages for the employee. That accrued amount for backpay was $417,390 and has been recorded and is reflected in the
financial statements at December 31, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are seven key employees that have stock options of the Company totaling 2,477,424 shares. These key employees have a provision in their
agreements whereas the Company will pay a special bonus equal to the aggregate of the strike price or exercise price of all their stock
options plus a tax gross-up payment. The special bonus shall be paid in twenty percent (20%) installments starting January 2, 2024, and
the same date each of the next four years. As a condition of the payment, the key employee must exercise at least 20% of their stated
number of stock options. There are additional provisions to cover termination and change of control events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2023, the Company amended the employee agreements to, among other things, clarify that the special one-time incentive payment and
the deferred bonus are contingent upon the effective date of the planned public offering (IPO). The amendment also sets forth a process
for executives to exercise the stock options in accordance with the terms of the stock option agreement in effect as of the date of the
employment agreement and to clarify that there is no modification to the stock option agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has recorded the backpay portion of the incentive bonus noted above. The balance of the incentive bonuses of $694,056 and the
special options bonuses of $14.82 million that are contingent upon a successful IPO have not been recorded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Litigation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time in the normal course of our business operations, we may become subject to litigation that may result in liability material
to our financial condition as a whole or may negatively affect our operating results if changes to our business operations are required.
The cost to defend such litigation may be significant and may require a significant diversion of our resources, and there is no guarantee
that we will be able to successfully defend against any such litigation regardless of particular merits. There also may be adverse publicity
associated with litigation that could negatively affect customer perception of our business, regardless of whether the allegations are
valid or whether we are ultimately found liable. Insurance may not be available on favorable terms, at all, or in sufficient amounts
to cover any liabilities with respect to these or other matters. A judgment or other liability in excess of our insurance coverage for
any claims could adversely affect our business, financial condition, and the results of our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2019, plaintiff Ritu Bharnbhani, M.D., initiated a lawsuit against Innovative Health Solutions, Inc. and others in the United
States District Court for the District of Maryland. Plaintiffs Bhambhani and Sudhir Rao subsequently amended the complaint, with the
Third Amended Complaint (&ldquo;Complaint&rdquo;) containing the most recent set of allegations. The Complaint asserted claims under
the RICO Act, as well as of fraudulent misrepresentation, intentional misrepresentation by concealment, and civil conspiracy and sought
compensatory damages in excess of $5 million, pre-judgment interest, punitive damages, attorney&rsquo;s fees, court costs and designation
of the case as a class action. The Complaint states that the Company, distributors of the Company&rsquo;s product, and medical billing
and coding consultants allegedly made misrepresentations to the plaintiffs that the Company&rsquo;s NeuroStim device and related procedures
could be billed to, and reimbursed by, Medicare and other insurance payors as a surgically implantable neurostimulator. Plaintiffs claim
to have suffered damages when Medicare administrative contractors declined to pay plaintiffs for their use of the device.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 187 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 11, 2022, the Company filed a motion for summary judgment based upon the plaintiffs not being proper parties to assert claims
against the Company. On June 14, 2022, the Court granted the Company&rsquo;s motion for summary judgment and dismissed the Complaint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2022, plaintiffs Ritu Bhambhani and Sudhir Rao filed a notice of appeal with the Fourth Circuit Court of Appeals. The Company
filed a motion to dismiss. On January 4, 2023, the Court issued an order that stated it was deferring a ruling on the motion to dismiss
the appeal and that it would address those arguments at the same time that it addressed the substantive merits of the case. As of May
5, 2023, the parties have submitted their appellate briefs to the Fourth Circuit. No date has been set for either oral argument or for
issuance of a decision by the court. While it is too early to predict the ultimate outcome of this matter, we continue to believe we
have meritorious defenses, that the dismissal of the Complaint should be upheld, and intend to continue to defend this matter vigorously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 14, 2022, plaintiffs Ritu Bhambhani, LLC; Box Hill Surgery Center, LLC; Pain and Spine Specialists of Maryland, LLC; and SimCare
ASC, LLC initiated a lawsuit against the Company and others in the United States District Court for the District of Maryland. The plaintiffs
in this lawsuit are business entities owned or partially owned by the plaintiffs that initiated the litigation described above. The Complaint
asserted claims under the RICO Act, as well as fraudulent misrepresentation, intentional misrepresentation by concealment, and civil
conspiracy and seeks compensatory damages in excess of $75,000, pre-judgment interest, punitive damages, attorney&rsquo;s fees, and court
costs. The Complaint states that the Company, distributors of the Company&rsquo;s product, and medical billing and coding consultants
allegedly made misrepresentations to the plaintiffs that the Company&rsquo;s NeuroStim device and related procedures could be billed
to, and reimbursed by, Medicare and other insurance payors as a surgically implantable neurostimulator. Plaintiffs claim to have suffered
damages when Medicare administrative contractors declined to pay plaintiffs for their use of the device.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 28, 2022, the Company has filed a motion to dismiss all claims, but no ruling has been issued. No date had been established
for the court to rule on that motion. While it is too early to predict the ultimate outcome of this matter, we believe we have meritorious
defenses and intend to defend this matter vigorously.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> On May 26, 2023, we received notice from the
Court that it had entered an Order and a Memorandum Opinion to rule upon the Company&rsquo;s motion to dismiss. The Order and Memorandum Opinion
are dated May 25, 2023. Substantively, the Order and Memorandum Opinion dismiss, with prejudice, the plaintiffs&rsquo; attempt to assert Racketeering
Influenced and Corrupt Organizations statutory claims. The Court further ruled that the remaining claims are permitted to proceed. No
trial date or other pretrial deadlines have been scheduled for this case. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>17.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Health Benefit Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a self-funded program employer agreement in 2018 in conjunction with a group health plan for the benefit of eligible
employees. This plan is a level funded plan, and the services and products include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 0.25in"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
  self-funded employer health benefit plan.</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stop
  loss insurance purchased from a stop loss insurance company.</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third
  party administrator to provide administrative services with regard to the plan.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains a stop loss contract that reimburses the Company for claims paid under the plan if they exceed a predetermined level.
The Company makes contributions for health care costs and associated expenses that are expected during the plan year. The amount of contributions
is determined annually based on the Company&rsquo;s maximum liability for expected claims, administrative expenses, and premiums for
the stop loss policy. The Company paid premiums of $196,929 and $158,831 for the years ended December 31, 2022 and 2021, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 188 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is responsible for the monthly premiums, as established, and nothing further. The stop loss policy covers the claims if they
exceed the claims funds. After a certain time, and if there is a surplus in the claims fund, the Company may be entitled to receive a
48.5% refund from the fund. This amount is recognized by the Company when received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Income Taxes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Tax Legislation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Inflation Reduction Act was signed into law on August 16, 2022, imposing a 15% corporate alternative minimum tax on adjusted financial
statement income and a 1% excise tax on stock repurchases after January 1, 2023. The Act did not have an impact on the Company&rsquo;s
2022financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Tax Cuts and Jobs Act (&ldquo;TCJA&rdquo;) requires taxpayers to capitalize and amortize research and experimental (&ldquo;R&amp;D&rdquo;)
expenditures undersection 174 for tax years beginning after December 31, 2021. This rule became effective for the Company during the
year ended December31, 2022, and resulted in the capitalization of R&amp;D costs of $225,466 for tax purposes. The Company is amortizing
these costs over 5 years ifthe R&amp;D was performed in the US and over 15 years if the R&amp;D was performed outside the US. The Company
did not recognize a current provision for income taxes for 2021 and 2020 since there were net operating losses reported in both years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes are provided for the temporary differences between the financial reporting basis and the tax basis of the Company&rsquo;s
assets and liabilities. Differences are primarily attributable to net operating loss carryforwards and depreciation on assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not reflect a deferred tax asset in its financial statements but includes that calculation and valuation in its footnotes.
The net deferred tax amounts include the following components:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets - Non-current</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(16,098</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(22,010</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19,290</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5,992</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrual
    to cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">767,861</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">509,743</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    based compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,653,490</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,667,546</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected
    income tax benefit from NOL carry-forwards</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,309,340</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,409,546</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less
    valuation allowance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,695,303</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,558,833</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    tax assets, net of valuation allowance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 189 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income taxes
is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Federal
    statutory income tax rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">%<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">State
    tax rate, net of federal benefit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.9</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nondeductible
    expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nontaxable
    income</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance on net deferred tax assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(24.9</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(25.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Effective
    income tax rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left">%<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no income tax expense due to the operating loss incurred for the years ended December 31, 2022 and 2021. The Company&rsquo;s
management has evaluated the positive and negative evidence bearing upon the realizability of its deferred tax assets and has determined
that it is more likely than not that the Company will not recognize the benefits of the net deferred tax assets. As a result, the Company
recorded a full valuation allowance at December 31, 2022 and 2021. The valuation allowance increased by $1,136,470 during the year ended
December 31, 2022, due to the increase in deferred tax assets, primarily due to net operating loss carryforwards. The valuation allowance
increased by $701,706 for the year ended December 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2022, the Company has Federal and state net operating loss (NOL) carryforwards totaling $13,303,602 and $13,319,120, respectively.
These loss carryforwards may be offset against future taxable income. There is no limitation on the number of years to utilize the Federal
NOL. The Federal deduction will be limited to 80% of modified taxable income. The state deduction for NOL allows up to 100% of taxable
income to be offset and can be carried forward no longer than twenty years after the year of the taxable loss.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
and state tax laws impose limitations on the utilization of net operating losses and credit carryforwards in the event of an
ownership change for tax purposes, as defined in Section 382 of the Internal </FONT>Revenue Code. Accordingly, the Company&rsquo;s
ability to utilize these carryforwards may be limited as a result of an ownership change which may have already happened or may
happen in the future. Such an ownership <FONT STYLE="font-family: Times New Roman, Times, Serif">change could result in a limitation
in the use of the net operating losses in future years and possibly a reduction of the net operating losses available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
not used, the state carryforwards will expire as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 50%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2038</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">888,389</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2039</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,898,067</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2040</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,457,495</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2041</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,406,225</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2042</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,668,944</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>19.
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsequent Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events through the date of issuance. The following changes occurred subsequent to December 31, 2022:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reverse
Stock Split </U>- On January 10, 2023, the Company&rsquo;s board of directors authorized a 1-for-2 reverse stock split. All per share
information has been adjusted for this reverse stock split. The reverse split became effective on January 12, 2023. All share and per
share amounts for the common stock have been retroactively restated to give effect to the splits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 190 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Financial Statements </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Addition
Borrowing</U> &ndash; The Company borrowed additional funds subsequent to December 31, 2022, and up through the date of this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2023, The Company signed a promissory note with Exchange Listing, LLC in the amount of $52,600. The note carries an interest
rate of 1%. The interest shall accrue on the outstanding balance until the date of repayment and shall be payable at the time and place
and in the manner provided in this promissory note. The Note shall be paid on the earlier of (i) three months from the date hereof or
the Company receiving a financing in the minimum of $3,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
March 10, 2023 to April 12, 2023 the Company conducted multiple closings of a private placement offering to accredited investors for
aggregate gross proceeds of $3,800,000 or net proceeds of $4,222,222.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
notes consisted of (a) a Convertible Promissory Note that accrues interest at 12% that can be paid in cash or PIK. The notes automatically
convert into common shares at a 30% discount to the IPO. The notes mature on the sooner of the six-month anniversary date from issuance
or a successful IPO on primary exchange in the U.S. (b) a five-year warrant to purchase common stock equal to fifty percent (50%) of
the shares into which the 2023 Convertible Notes can be converted into at issuance. The warrants have a strike price at a 25% premium
to the Conversion Price subject to anti-dilution, issuable on a pro rata basis at each funding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
facilitators to the notes Signature Bank and Alexander Capital, L.P. will receive certain fees. Signature Bank received a $6,000 escrow
fee from the first round of funding. Alexander Capital, L.P. has and will continue to receive (i) a cash commission of ten percent (10%)
of the proceeds raised in the Offering from Investors introduced to the Company by the Placement Agent; (ii) the granting to the Placement
Agent of a warrant for the purchase of a number of shares of Common Stock equal to 6% of the number of Underlying Securities; and (iii)
the other matters set forth in the engagement letter between the Company and the Placement Agent dated April 13, 2022. As of April 4,
2023, Alexander Capital, L.P., has received $318,250 and 61,074 warrants from this round.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
Agreements</U> &ndash; In April 2023, the Company amended the employee agreements to, among other things, clarify that the special one-time
incentive payment and the deferred bonus are contingent upon the effective date of the planned public offering (IPO). The amendment also
sets forth a process for executives to exercise the stock options in accordance with the terms of the stock option agreement in effect
as of the date of the employment agreement and to clarify that there is no modification to the stock option agreements. See executive
employment agreements in the commitments and contingency footnote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>2022
Stock Compensation Plan</U> &ndash; The Company adopted a new compensation plan effective November 1, 2022. The 2022 Plan will be applicable
only to awards granted on or after the date the 2022 Plan becomes effective according to its terms and will replace the 2017 Plan for
awards granted on or after the effective date. No new grants will be made under the 2017 Plan after the effective date. The terms and
conditions of awards granted under the 2017 Plan prior to the effective date was not be affected by the adoption of the 2022 Plan, and
the 2017 Plan will remain effective with respect to such awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600,000
shares of common stock, par value $0.001 per share, of common stock will be set aside and reserved for issuance pursuant to the 2022
Plan, subject to adjustments as may be required in accordance with the terms of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 191 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> <B>[</B>&#9679;<B>]</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
</B></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="forms-1a_001.jpg" ALT="" STYLE="height: 120px; width: 320px"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>NEURAXIS,
INC.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sole
Book Running Manager</I></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALEXANDER
CAPITAL L.P.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[&#9679;]<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2023</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Through
and including [&#9679;], 2023 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities,
whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&rsquo;s obligation
to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 192 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 1.5pt solid; margin-right: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="margin-right: 0pt; break-before: page; margin-top: 0pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
13. Other Expenses of Issuance and Distribution.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is an estimate of the expenses (all of which are to be paid by the Company) that we may incur in connection with the securities
being registered hereby.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offering
    Expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 82%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC registration
    fee</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; text-align: right"> 3,273 </TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><P STYLE="margin: 0pt 0pt 0pt 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq
                                 listing fee</FONT></P>


</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"> 80,000 </TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA filing fee</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"> 5,000 </TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal fees and expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"> 550,000 </TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting fees and expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"> 375,000 </TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"> 91,727 </TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"> 1,105,000 </TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
14. Indemnification of Directors and Officers.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to or is threatened to be
made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
(other than an action by or in the right of the corporation), because he or she is or was a director, officer, employee or agent of the
corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts
paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if he or she acted
in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with
respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145(b) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be made
a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor
because the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses
(including attorneys&rsquo; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such
action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests
of the corporation, except that no indemnification shall be made with respect to any claim, issue or matter as to which he or she shall
have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court
determines that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is fairly and reasonably
entitled to indemnity for such expenses that the Court of Chancery or other adjudicating court shall deem proper.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145(g) of the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who is or was
a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer,
employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against
such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation
would have the power to indemnify the person against such liability under Section 145 of the DGCL.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 193; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
our bylaws eliminates our directors&rsquo; liability to the fullest extent permitted under the DGCL. The DGCL provides that directors
of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    any transaction from which the director derives an improper personal benefit;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    any unlawful payment of dividends or redemption of shares; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for
    any breach of a director&rsquo;s duty of loyalty to the corporation or its stockholders.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability
of the Company&rsquo;s directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also expressly authorized to carry directors&rsquo; and officers&rsquo; insurance to protect our directors, officers, employees and
agents against liabilities for actions taken in their capacities as directors and officers.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
15. Recent Sales of Unregistered Securities.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information relates to all securities issued or sold by us within the past three years and not registered under the Securities
Act.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2019, the Company granted stock options to purchase 1,319,394 shares of common stock in the aggregate under the Innovative Health
Solutions, Inc. 2017 Stock Compensation Plan adopted October 12, 2017 (the &ldquo;Plan&rdquo;) with exercise prices of $6.94
per share and a term of ten years.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
September 2019 to November 2019, we entered into Series A Preferred Stock Purchase Agreements with 16 investors. Pursuant to the Series
A Preferred Stock Purchase Agreements, we issued a total of 189,092 shares of Series A Preferred Stock, at a price of $18.87
per share, all of which will be converted into shares of common stock upon the closing of this offering. Pursuant to the Series A
Preferred Stock Purchase Agreements, we issued a total of 115,477 shares of Series Seed Preferred Stock in exchange of the share
of common stock held by the investors.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 6, 2019, in connection with the conversion of certain secured convertible promissory note, in the amount of $347,379.45, that
the Company issued to Brian Hannasch on January 31, 2019, we issued 20,056 shares of Series A Preferred Stock to Brian Hannasch,
at a conversion price of $17.32 per share.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 6, 2019, we issued warrants to purchase 40,000 shares of common stock to Brian P. Hannasch, in connection with certain
Series A Preferred Stock Purchase Agreement. Pursuant to the terms of the warrants, the warrant exercise price is equal to $0.02
per share. If unexercised, these warrants will expire on the 10<SUP>th</SUP> anniversary of their issuance dates. The warrants will neither
expire nor be automatically exercised upon the closing of this offering. The warrants provide that the holder thereof may elect to exercise
the warrant on a net &ldquo;cashless&rdquo; basis at any time prior to the expiration thereof. Assuming the closing of this offering
occurs, the fair market value of one share of our common stock in connection with any cashless exercise shall be the based on the average
of the daily closing prices per share for the 30 consecutive trading day period ending on the second trading day prior to such date.</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 194 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">From April 2020 to June
2021, we entered into five Series A Preferred Stock Purchase Agreements with investors. Pursuant to the Series A Preferred Stock Purchase
Agreements, we issued a total of 315,545 shares of Series A Preferred Stock, at a price of $18.87 per share, all of which
will be converted into shares of common stock upon the closing of this offering.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On April 9, 2020, we entered
into a Series A Preferred Stock Purchase Agreements with Masimo. Pursuant to the Series A Preferred Stock Purchase Agreement, we issued
a total of 265,774 shares of Series A Preferred Stock, at a price of $18.87 per share, all of which will be converted into
shares of common stock upon the closing of this offering.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the same day, we issued pre-funded warrants to purchase 144,890 shares of Series A Preferred Stock to Masimo, in connection with
its Series A Preferred Stock Purchase Agreement. Pursuant to the terms of the warrants, the warrant exercise price is equal to $0.0001
per share, subject to adjustments, and these warrants will not expire. The aggregate purchase price of this Warrant, in the amount of
$2,734,340.40, equating to $18.87 per warrant share, was pre-funded to the Company and, consequently, no additional consideration
shall be required to be paid by Masimo to any Person to effect any exercise of this Warrant, except for the payment of the exercise price.
The warrants will neither expire nor be automatically exercised upon the closing of this offering. The warrants provide that Masimo thereof
may elect to exercise the warrant on a net &ldquo;cashless&rdquo; basis at any time prior to the expiration thereof. Assuming the closing
of this offering occurs, the fair market value of one share of our Series A Preferred Stock in connection with any cashless exercise
shall be the closing price or last sale price of a share of common stock reported for the business day immediately before the date on
which Masimo delivers this warrant together with its notice of exercise to the Company, multiplied by the number of shares of common
stock into which a share of Series A Preferred Stock is then convertible, if the common stock is then traded on a trading market, or
the fair market value of Series A Preferred Stock, as mutually determined in writing by the Company and Masimo. Masimo may not exercise
the warrant in excess of that number of shares which would cause the aggregate number of shares of common stock beneficially owned by
Masimo to exceed 19.99% of the total number of issued and outstanding shares of common stock following such exercise, or the combined
voting power of the securities beneficially owned by Masimo to exceed 19.99% of the combined voting power of all of the securities of
the Company then outstanding following such exercise.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">On
October 19, 2020, the Company entered into a Series A Preferred Stock Purchase Agreement with Dresner Investment Services, Inc. d/b/a
Dresner Partners (&ldquo;Dresner&rdquo;). Pursuant to the Series A Preferred Stock Purchase Agreement, the Company issued 18,546
shares of Series A Preferred Stock to Dresner and six (6) of its designees in consideration of the fee owed to Dresner in connection
with an engagement letter, dated April 16, 2020, at a price of $18.87 per share. We plan to convert all of the Series A Preferred
Stock into shares of common stock upon the closing of this offering.</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On September 9, 2021,
the Company cancelled and reissued all previously issued stock options in connection with a 4-to-1 stock split that occurred on the same
date. No new optionees were awarded options on this date, but all prior stock option holders received four times the number of options
they had before the split, and the exercise price was divided by four due to the split.</P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
June 3, 2022 to November 30, 2022, the Company entered into SPAs with Leonite Fund I, LP, Emmis Capital II, LLC, District 2 Capital Fund,
LP, and Exchange Listing, LLC, which provide for advances of up to $2.4 million in proceeds to us, subject to our satisfaction of certain
conditions. Pursuant to the SPAs, from June 3, 2022 to November 30, 2022, we (i) issued 2022 Senior Secured Convertible Promissory
Notes with an aggregate principal amount of $2,777,777, which amount included an OID of $222,223, resulting in advance proceeds to
us of $2.370 million. In connection with the issuance of the 2022 Senior Secured Convertible Promissory Notes, we also issued
five-year warrants exercisable for 353,111 shares of common stock with an exercise price of the lower of (a) $11.80 and (b) a 12.5% discount
to the price per share in any subsequent offering by the Company, and we entered into a Pledge and Security Agreement with Leonite Fund
I, LP, dated June 3, 2022. The 2022 Senior Secured Convertible Promissory Notes carry an OID of 10% of the principal amount and
have an interest rate of the greater of (a) the prime rate of interest, as published by the Wall Street Journal, plus 8.5% per annum,
or (b) 12%. The 2022 Senior Secured Convertible Promissory Notes will mature in twelve (12) months from the issue dates. The 2022
Senior Secured Convertible Promissory Notes are convertible into shares of common stock at the lower of (a) $9.44 per share, or (b)
a discount of 30% to the price per share in any subsequent offering, subject to adjustment in the event of common stock distribution,
stock splits, fundamental transactions, dilutive issuances or similar events affecting our common stock and the conversion price. Interest
accrues on the aggregate principal amount (which includes OID) and is payable monthly, at the Company&rsquo;s election, in cash or in-kind.
Upon the advance of consideration under the SPAs, the Company is required to issue to the noteholders a number of shares of common stock,
calculated based on the value of 10% of the principal amount of 2022 Senior Secured Convertible Promissory Notes issued in such
advance, at a value per share equal to the conversion price of the 2022 Senior Secured Convertible Promissory Notes. Accordingly,
from June 3, 2022 to November 30, 2022, in connection with the initial advance and issuance of 2022 Senior Secured Convertible Promissory
Notes, we also issued 35,317 shares of common stock to the noteholders. We plan to use a portion of the proceeds of this offering
to repay the entire amount owed pursuant to these 2022 Senior Secured Convertible Promissory Notes. See &ldquo;<I>Use of Proceeds</I>&rdquo;
for additional information.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
December 2022 through January 2023, the Company issued unsecured convertible promissory notes to three existing investors, Todd Maxwell,
Rogan O&rsquo;Donnell and Michael &amp; Michele Robuck, with an aggregate principal amount of $222,222, which amount included an OID
of $22,222, resulting in advance proceeds of $200,000. The notes carry an OID of 10% of the principal amount and have an interest
rate of 12% per annum. The notes will mature at the earlier of (i) twelve (12) months from the issue date or (ii) the date upon which
the Company completes a registered public offering of shares of the Company, which encompasses this offering. The note is convertible
into shares of common stock at the higher of (i) $9.44 per share, or (ii) the price per share of common stock issued pursuant
to the next registered public offering of shares of the Company made prior to the conversion of any portion of the note. Interest accrues
on the aggregate principal amount (which includes OID) and is payable on the maturity date, at the Company&rsquo;s election, in cash
or in-kind.</FONT></P>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 12, 2023, we filed a certificate of amendment to our certificate of incorporation with the Secretary of State of the State of
Delaware and effectuated a reverse stock split of our common stock at a ratio of 1-for-2.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
March through May 2023, we entered into Securities Purchase Agreements (the &ldquo;SPAs&rdquo;) which provide for advances of up to $3 million in proceeds to us, subject to our satisfaction of certain conditions (&ldquo;2023 Private Placement&rdquo;). Pursuant to the
SPAs, from March through May of 2023, we issued Senior Secured Convertible Promissory Notes (&ldquo;Notes&rdquo;) with an aggregate principal
amount of $4,733,333, which amount included an original issue discount (&ldquo;OID&rdquo;) of $473,333, and underwriter fees for $338,250,
resulting in advance proceeds to us of $3.9 million. The notes automatically convert into Common Stock at IPO on primary exchange. Conversion
Price will be set at a 30% discount to the IPO price or $5.60 per share. As a result, the notes will convert into 845,254 shares of common
stock at IPO. In connection with the issuance of the Notes, we also issued five-year warrants exercisable for an aggregate of 295,850
shares of common stock with a strike price at a 25% premium to the Conversion Price or $7.00 per share subject to anti-dilution, issuable
on a pro rata basis at each funding. For more information regarding the warrants issued under the SPAs, see &ldquo;<I>Description of
Our Securities&mdash;Other Outstanding Warrants</I>.&rdquo;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes were issued with OID of 10% of the principal amount and bear interest at 12%. The Notes will mature in six (6) months from their
respective issue dates or a successful IPO on primary exchange in the U.S. (whichever comes sooner). If the IPO is not completed or the
Note is not repaid by the Maturity Date the following will ensue: a) principal amount of the note will be automatically increased by
20%; b) the warrant coverage will be increased to 75%; c) the default interest rate will begin to accrue at 20% per annum until the Default
is cured (default interest will be repaid in cash monthly); d) noteholder will be paid 30% of gross revenues in cash on a monthly basis
until the default is cured or the note is repaid in full. Interest accrues on the aggregate principal amount (which includes OID) and
is payable monthly, at the Company&rsquo;s election, in cash or in-kind.</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 195 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise stated above, the issuances of these securities were made in reliance upon exemptions provided by Section 4(a)(2) of the Securities
Act, Regulation D promulgated thereunder, or Securities Act Rule 701 for the offer and sale of securities not involving a public offering.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
underwriter was engaged in connection with the foregoing sales of securities. The Company has reason to believe that all of the foregoing
purchasers were familiar with or had access to information concerning the operations and financial conditions of the Company, and all
of those individuals purchasing securities represented that they were accredited investors, acquiring the shares for investment and without
a view to the distribution thereof. At the time of issuance, all of the foregoing securities were deemed to be restricted securities
for purposes of the Securities Act and the certificates representing such securities bore legends to that effect<B>.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
16. Exhibits and Financial Statement Schedules</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex1-1.htm">Form of Underwriting Agreement</A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Incorporation (incorporated by reference to exhibit 3.1 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223002577/ex3-2.htm" STYLE="-sec-extract: exhibit">Certificate
    of Amendment to Certificate of Incorporation (incorporated by reference to exhibit 3.2 to Registration Statement on Form S-1,filed
    on January 26, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex3-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws (incorporated by reference to exhibit 3.3 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of warrant issued to Brian P. Hannasch (incorporated by reference to exhibit 4.1 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded Warrant to Purchase Series A Preferred Stock issued to Masimo Corporation, dated April 9, 2020 (incorporated by reference to exhibit 4.2 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Leonite Fund I, LP, dated June 3, 2022 (incorporated by reference to exhibit 4.3 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Leonite Fund I, LP, dated July 8, 2022 (incorporated by reference to exhibit 4.4 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Leonite Fund I, LP, dated October 3, 2022 (incorporated by reference to exhibit 4.5 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Leonite Fund I, LP, dated November 30, 2022 (incorporated by reference to exhibit 4.6 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Emmis Capital II, LLC, dated June 10, 2022 (incorporated by reference to exhibit 4.7 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223002577/ex4-8.htm" STYLE="-sec-extract: exhibit">Common
    Share Purchase Warrant issued to Emmis Capital II, LLC, dated November 30, 2022 (incorporated by reference to exhibit 4.8 to Registration
    Statement on Form S-1, filed on January 26, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-9.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Exchange Listing, LLC, dated July 12, 2022 (incorporated by reference to exhibit 4.9 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-10.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Exchange Listing, LLC, dated October 4, 2022 (incorporated by reference to exhibit 4.10 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-11.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to District 2 Capital Fund LP, dated August 15, 2022 (incorporated by reference to exhibit 4.11 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-12.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to District 2 Capital Fund LP, dated October 4, 2022 (incorporated by reference to exhibit 4.12 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-13.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to District 2 Capital Fund LP, dated November 30, 2022 (incorporated by reference to exhibit 4.13 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-14.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Bigger Capital Fund, LP, dated August 15, 2022 (incorporated by reference to exhibit 4.14 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-15.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Share Purchase Warrant issued to Bigger Capital Fund, LP, dated October 4, 2022 (incorporated by reference to exhibit 4.15 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter Agreement between Innovative Health Solutions, Inc. and Masimo Corporation, dated April 9, 2020 (incorporated by reference to exhibit 4.16 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-17.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Side Letter between NeurAxis, Inc. and Masimo Corporation, dated December 22, 2022 (incorporated by reference to exhibit 4.17 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-18.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Side Letter between NeurAxis, Inc. and Brian P. Hannasch, dated July 7, 2022 (incorporated by reference to exhibit 4.18 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-19.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investor Rights Agreement between Innovative Health Solutions, Inc. and Brian Hannasch, dated September 6, 2019 (incorporated by reference to exhibit 4.19 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-20.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Shareholders&rsquo; Agreement, dated June 13, 2016, and First Amendment to Shareholders&rsquo; Agreement, dated January 30, 2019 (incorporated by reference to exhibit 4.20 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex4-21.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment to Shareholders&rsquo; Agreement, dated January 8, 2023 (incorporated by reference to exhibit 4.21 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223004377/ex1-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Underwriter Warrant (included as Exhibit A to Exhibit 1.1)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 4.23 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex4-23.htm"> Form of Warrant related to 2023 Private Placement </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223004377/ex5-1.htm" STYLE="-sec-extract: exhibit">Legal opinion of Lucosky Brookman LLP (incorporated by reference to exhibit 5.1 to Registration Statement on Form S-1, filed on February 13, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License and Collaboration Agreement, dated April 9, 2020, by and between Innovative Health Solutions, Inc. and Masimo Corporation (incorporated by reference to exhibit 10.1 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive License Agreement, by and between Innovative Health Solutions, Inc. and TKBMN, LLC (incorporated by reference to exhibit 10.2 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223002577/ex10-3.htm" STYLE="-sec-extract: exhibit">Securities
    Purchase Agreement, dated June 3, 2022, by and between the Neuraxis, Inc. and Leonite Fund I, L.P., Emmis Capital II, LLC, Exchange
    Listing, LLC, District 2 Capital Fund LP, and Bigger Capital Fund, LP (incorporated by reference to exhibit 10.3 to Registration
    Statement on Form S-1, filed on January 26, 2023)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Convertible Note related to Exhibits 10.3 (incorporated by reference to exhibit 10.4 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated December 19, 2022, between the Neuraxis, Inc. and Michele and Michael Robuck (incorporated by reference to exhibit 10.5 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured Convertible Promissory Note issued to Michele and Michael Robuck, dated December 19, 2022 (incorporated by reference to exhibit 10.6 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated December 19, 2022, between the Neuraxis, Inc. and Rogan O&rsquo;Donnell (incorporated by reference to exhibit 10.7 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-8.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured Convertible Promissory Note issued to Rogan O&rsquo;Donnell, dated December 19, 2022 (incorporated by reference to exhibit 10.8 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-9.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Purchase Agreement, dated December 19, 2022, between the Neuraxis, Inc. and Todd Maxwell (incorporated by reference to exhibit 10.9 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-10.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured Convertible Promissory Note issued to Todd Maxwell, dated December 19, 2022 (incorporated by reference to exhibit 10.10 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  </TABLE>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 196 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-11.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pledge and Security Agreement, dated June 3, 2022, between Neuraxis, Inc. and Leonite Fund I, LP (incorporated by reference to exhibit 10.11 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12&dagger;**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-12.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement between Neuraxis, Inc. and Brian Carrico, dated as of August 9, 2022 (incorporated by reference to exhibit 10.12 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.13&dagger; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex10-13.htm"> First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Brian Carrico, dated as of May 4, 2023 </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14&dagger;**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-13.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement between Neuraxis, Inc. and Adrian Miranda, dated as of August 17, 2022 (incorporated by reference to exhibit 10.13 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15&dagger;**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-14.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement between Neuraxis, Inc. and Thomas Carrico, dated as of August 9, 2022 (incorporated by reference to exhibit 10.14 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.16&dagger; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex10-16.htm"> First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Thomas Carrico, dated as of May 4, 2023 </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17&dagger;**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-15.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement between Neuraxis, Inc. and Dan Clarence, dated as of August 9, 2022 (incorporated by reference to exhibit 10.15 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.18&dagger; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <A HREF="ex10-18.htm">First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Dan Clarence, dated as of May 4, 2023</A> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19&dagger;**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement between Neuraxis, Inc. and Christopher Robin Brown, dated as of August 9, 2022 (incorporated by reference to exhibit 10.16 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.20&dagger; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <A HREF="ex10-20.htm">First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Christopher Robin Brown, dated as of May 4, 2023</A> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21&dagger;**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-17.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement between Neuraxis, Inc. and Gary Peterson, dated as of August 9, 2022 (incorporated by reference to exhibit 10.17 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.22&dagger; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <A HREF="ex10-22.htm">First Amendment to Executive Employment Agreement between Neuraxis, Inc. and Gary Peterson, dated as of May 4, 2023</A> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-18.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory note of Gary Peterson, dated as of January 1, 2016 (incorporated by reference to exhibit 10.18 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-19.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory note of Christopher Robin Brown, dated as of January 1, 2016 (incorporated by reference to exhibit 10.19 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25&dagger;**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-20.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Innovative Health Solutions, Inc. 2017 Stock Compensation Plan, as amended (incorporated by reference to exhibit 10.20 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26&dagger;**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-21.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (incorporated by reference to exhibit 10.21 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-22.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing Services Agreement between Neuraxis, Inc. and GMI Corporation, dated as of August 21, 2020 (incorporated by reference to exhibit 10.22 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-23.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quality Agreement between Neuraxis, Inc. and GMI Corporation, dated as of August 24, 2020 (incorporated by reference to exhibit 10.23 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-24.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advisory Agreement, date March 3, 2022, between Exchange Listing, LLC and Neuraxis, Inc. (incorporated by reference to exhibit 10.24 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex10-25.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advisory Agreement, date March 3, 2022, between Exchange Listing, LLC and Neuraxis, Inc., as amended December 22, 2022 (incorporated by reference to exhibit 10.25 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"> 10.31&dagger;** </P>
</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223002577/ex10-26.htm" STYLE="-sec-extract: exhibit">First
                                            Amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (incorporated by
                                            reference to exhibit 10.26 to Registration Statement on Form S-1, filed on January 26, 2023)</A></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.32 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex10-32.htm"> Form of Securities Purchase Agreement related to 2023 Private Placement </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.33 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex10-33.htm"> Form of Senior Secured Convertible Note related to 2023 Private Placement </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.34 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex10-34.htm"> Form of Security Agreement related to 2023 Private Placement </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> 10.35 </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex10-35.htm"> Form of Registration Rights Agreement related to 2023 Private Placement </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex14-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Ethics and Business Conduct (incorporated by reference to exhibit 14.1 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex21-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries of Neuraxis, Inc. (incorporated by reference to exhibit 21.1 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Rosenberg Rich Baker Berman, P.A.</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223004377/ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Lucosky Brookman LLP (included in Exhibit 5.1)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#vj_001">Power of Attorney (included on the signature page hereto)</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Timothy Henrichs (incorporated by reference to exhibit 99.1 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Bradley Mitch Watkins (incorporated by reference to exhibit 99.2 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223001110/ex99-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Beth Keyser (incorporated by reference to exhibit 99.3 to Registration Statement on Form S-1, filed on January 10, 2023)</FONT></A></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-4.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Committee Charter</FONT> </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-5.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Committee Charter</FONT> </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-6.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nominating and Corporate Governance Charter</FONT> </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.7</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex99-7.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider Trading Policy</FONT> </A></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instance Document</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Schema Document</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Calculation Linkbase Document</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Definition Linkbase Document</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Label Linkbase Document</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Presentation Linkbase Document</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1933567/000149315223004377/ex-107.htm" STYLE="-sec-extract: exhibit">Filing Fee Table (incorporated by reference to exhibit 107 to Registration Statement on Form S-1, filed on February 13,  2023)</A></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**
Previously filed.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger; Executive compensation plan or arrangement.</FONT></P>


<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 197 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
17. Undertakings.</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
    if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price
    set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement; and</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    include any material information with respect to the plan of distribution not previously disclosed in the registration statement
    or any material change to such information in the registration statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment will be deemed
    to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time will
    be deemed to be the initial bona fide offering thereof.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser, each prospectus filed
    pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on
    Rule 430B or other than prospectuses filed in reliance on Rule 430A, will be deemed to be part of and included in the registration
    statement as of the date it is first used after effectiveness. <U>Provided</U>, <U>however</U>, that no statement made in a registration
    statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference
    into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract
    of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that
    was part of the registration statement or made in any such document immediately prior to such date of first use.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution
    of the securities:</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold
to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to such purchaser:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities
and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred
or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes that:</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part
of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule
424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was
declared effective.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at
that time shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 198 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-1 and has duly caused this registration statement or amendment thereto to be signed on its behalf
by the undersigned, thereunto duly authorized on June 1, 2023.</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
    Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian Carrico</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="poa_001"></A>POWER
OF ATTORNEY</B></FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities
held on the dates indicated.</FONT></P>

<P STYLE="margin-right: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: left; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian Carrico</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1,
    2023</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    executive officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    John Seale</I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I> </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financing Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1,
    2023</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Seale</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal
    financial officer and principal accounting officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">*</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1,
    2023</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
    Clarence</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">*</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1,
    2023</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
    Miranda</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">*</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1,
    2023</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrico</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">*</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1,
    2023</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Robin Brown</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">*</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1,
    2023</FONT> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Peterson</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="vj_001"></A>*
POWER OF ATTORNEY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
Carrico, by signing his name hereto, does sign this document on behalf of each of the persons indicated above for whom he is attorney-in-fact
pursuant to a power of attorney duly executed by such person and filed with the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian Carrico</I> </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico<BR>
    Chief Executive Officer and Director</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 199; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ex1-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>between</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEURAXIS,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(the
&ldquo;Company&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALEXANDER
CAPITAL, L.P.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(the
&ldquo;Representative&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEURAXIS,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITING
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander Capital, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17 State Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10004</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Neuraxis, Inc., a corporation formed under the laws of the State of Delaware (the &ldquo;<B>Company</B>&rdquo;), hereby
confirms its agreement (this &ldquo;<B>Agreement</B>&rdquo;) with Alexander Capital, L.P. (the &ldquo;<B>Representative</B>&rdquo;),
and with the other underwriters named on <U>Schedule 1</U> hereto, if any, for which the Representative is acting as representative (the
Representative and such other underwriters being collectively called the &ldquo;<B>Underwriters</B>&rdquo; and, individually, an &ldquo;<B>Underwriter</B>&rdquo;)
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Purchase and Sale of Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Firm Shares</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.1. <U>Purchase
of Firm Shares</U>. On the basis of the representations and warranties herein contained, but subject to the terms and conditions
herein set forth, the Company agrees to issue and sell to the several Underwriters, severally and not jointly, and the Underwriters
agree to purchase from the Company, severally and not jointly, an aggregate of [&#9679;] shares (&ldquo;<B>Firm Shares</B>&rdquo;)
of the Company&rsquo;s common stock, $0.001 par value per share (the &ldquo;<B>Common Stock</B>&rdquo;) as set forth opposite their
respective names on <U>Schedule 1</U> hereto and made a part hereof, at a purchase price (net of
discounts and commissions) of $[&#9679;] per Firm Share, being equal to 93% of the public offering price of the Firm Shares. The Firm
Shares are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus (as defined in
Section 2.1.1 hereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1.2.
<U>Payment and Delivery</U>. Delivery and payment for the Firm Shares shall be made no later than 10:00 a.m., Eastern time, on the second
(2nd) Business Day (as defined below) following the effective date (the &ldquo;<B>Effective Date</B>&rdquo;) of the Registration Statement
(as defined in Section 2.1.1 below) (or the third (3rd) Business Day following the Effective Date if the Registration Statement is declared
effective after 4:01 p.m., Eastern time) or at such other time as shall be agreed upon by the Representative and the Company, at the
offices of Carmel, Milazzo &amp; Feil LLP, counsel to the Underwriters (&ldquo;<B>Underwriters Counsel</B>&rdquo;), or at such other
place (or remotely by facsimile or other electronic transmission) as shall be agreed upon by the Representative and the Company. The
hour and date of delivery and payment for the Firm Shares is called the &ldquo;<B>Closing Date</B>.&rdquo; Payment for the Firm Shares
shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order of the Company upon delivery to
the Representative of certificates (in form and substance satisfactory to the Representative) representing the Firm Shares (or through
the facilities of the Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;)) for the account of the Underwriters. The Firm Shares shall
be registered in such name or names and in such authorized denominations as the Representative may request in writing at least two (2)
Business Days prior to the Closing Date. The Company will permit the Representative to examine and package the Firm Shares for delivery,
at least one (1) full Business Day prior to the Closing Date. The Company shall not be obligated to sell or deliver the Firm Shares except
upon tender of payment by the Representative for all the Firm Shares. The term &ldquo;<B>Business Day</B>&rdquo; means any day other than
a Saturday, a Sunday or a legal holiday or any other day on which commercial banks in The City of New York, New York, are authorized
or required by law to remain closed; provided, however, that, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home,&rdquo; &ldquo;shelter-in-place,&rdquo; &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York, New York,
are generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.
<U>Over-Allotment Option</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.1.
<U>Option Securities</U>. The Company hereby grants to the Underwriters an option to purchase up to fifteen percent (15%) of the Firm
Shares sold in the offering (the &ldquo;<B>Option Shares</B>&rdquo;), from the Company, the net proceeds of which will be deposited in
the Company&rsquo;s account (the &ldquo;<B>Over-Allotment Option</B>&rdquo;). Upon the purchase of such additional Option Shares and/or Option Warrants,
the net proceeds will be deposited in the Company&rsquo;s account. The purchase price to be paid per Option Share shall be equal to $[&#9679;]<SUP>
</SUP>and the purchase price to be paid per Option Warrant shall be $[&#9679;] per Option Warrant. The purchase price to be paid per
Option Share shall be equal to $[&#9679;]<SUP>1</SUP> and per Option Warrant shall be equal to $0.01 per warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><SUP>1</SUP> [&#9679;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">1.2.2.
<U>Exercise of Option</U>. The Over-Allotment Option granted pursuant to Section 1.2.1 hereof may be exercised by the Representative
as to all (at any time) or any part (from time to time) of the Option Shares and the Option Warrants or the Option Shares or the Option
Warrants 45 days after the Effective Date. The Underwriters shall not be under any obligation to purchase any Option Shares or Option
Warrants prior to the exercise of the Over-Allotment Option. The Over-Allotment Option granted hereby may be exercised by the giving
of oral notice to the Company by the Representative, which must be confirmed in accordance with Section 9.1 hereof setting forth the
number of Option Shares to be purchased and the date and time for delivery of and payment for the Option Shares and/or Option Warrants
(the &ldquo;<B>Option Closing Date</B>&rdquo;), which shall not be later than five (5) full Business Days after the date of the notice
or such other time as shall be agreed upon by the Company and the Representative, at the offices of Underwriters Counsel or at such other
place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative.
If such delivery and payment for the Option Shares and/or Option Warrants does not occur on the Closing Date, the Option Closing Date
will be as set forth in the notice. Upon exercise of the Over-Allotment Option with respect to all or any portion of the Option Shares
and/or Option Warrants, subject to the terms and conditions set forth herein, the Company shall become obligated to sell to the Underwriters
the number of Option Shares and/or Option Warrants specified in such notice and, subject to the terms and conditions set forth herein,
the Underwriters, acting severally and not jointly, shall purchase the number of Option Shares and/or Option Warrants specified in any
such notice.

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2.3.
<U>Payment and Delivery</U>. Payment for the Option Shares and/or Option Warrants shall be made on the Option Closing Date by wire transfer
in Federal (same day) funds, payable to the order of the Company upon delivery to the Representative of certificates (in form and substance
satisfactory to the Representative) representing the Option Shares and/or Option Warrants (or through the facilities of DTC) for the
account of the Underwriters. The Option Shares and/or Option Warrants shall be registered in such name or names and in such authorized
denominations as the Representative may request in writing at least two (2) full Business Days prior to the Option Closing Date. The
Company will permit the Representative to examine and package the Option Shares and/or Option Warrants for delivery, at least one (1)
full Business Day prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the Option Shares and/or Option
Warrants except upon tender of payment by the Representative for applicable Option Shares. The Option Closing Date may be simultaneous
with, but not earlier than, the Closing Date; and in the event that such time and date are simultaneous with the Closing Date, the term
&ldquo;<I>Closing Date</I>&rdquo; shall refer to the time and date of delivery of the Firm Shares and Option Shares and/or Option Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.
<U>Representative&rsquo;s Warrants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.1.
<U>Purchase Warrants</U>. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date
a warrant (&ldquo;<B>Representative&rsquo;s Warrant</B>&rdquo;) for the purchase of an aggregate of [&#9679;] Firm Shares, representing
6.0% of the aggregate number of shares of Common Stock sold in the Offering pursuant to a warrant agreement, substantially in the form
attached as <U>Exhibit A</U> hereto (the &ldquo;<B>Representative&rsquo;s Warrant Agreement</B>&rdquo;). The Representative&rsquo;s Warrant
shall be exercisable, in whole or in part, commencing on a date which is six (6) months after the Effective Date and expiring on the
five-year anniversary of the Effective Date at an initial exercise price per share of Common Stock of $[&#9679;], which is equal to 120.0%
of the initial public offering price of the Firm Shares. The Representative&rsquo;s Warrant Agreement and the Common Stock issuable upon
exercise thereof are hereinafter referred to together as the &ldquo;<B>Representative&rsquo;s Securities</B>.&rdquo; The Representative
understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 upon transfer of the Representative&rsquo;s
Warrant and the Common Stock issuable upon exercise of the Representative&rsquo;s Warrant during the one hundred eighty (180) day period
after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the
Representative&rsquo;s Warrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction
that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days beginning on
the date of commencement of sales of the public equity offering to anyone other than (i) an Underwriter or a selected dealer in connection
with the Offering, or (ii) a bona fide officer or partner of the Representative or of any such Underwriter or selected dealer; and only
if any such transferee agrees to the foregoing restrictions and those in the Representative&rsquo;s Warrant Agreement. The Underwriters&rsquo;
warrants may be exercised as to all or a lesser number of shares and will provide for cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3.2.
<U>Delivery</U>. Delivery of the Representative&rsquo;s Warrants shall be made on the Closing Date and shall be issued in the name or
names and in such authorized denominations as the Representative may request in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Underwriters as of the Applicable Time
(as defined below), as of the Closing Date and as of the Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
<U>Filing of Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1.
<U>Pursuant to the Securities Act</U>. The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
a registration statement, and any amendment or amendments thereto, on Form S-1 (File No. 333-269179), including any related prospectus
or prospectuses, for the registration of the Public Securities and the Common Stock issuable upon exercise of the Representative&rsquo;s
Warrant under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), which registration statement and amendment
or amendments have been prepared by the Company in conformity with the requirements of the Securities Act and the rules and regulations
of the Commission under the Securities Act (the &ldquo;<B>Securities Act Regulations</B>&rdquo;). Except as the context may otherwise
require, such registration statement, as amended, on file with the Commission at the time the registration statement became effective
(including the Preliminary Prospectus included in the registration statement, financial statements, schedules, exhibits and all other
documents filed as a part thereof or incorporated therein and all information deemed to be a part thereof as of the Effective Date pursuant
to paragraph (b) of Rule 430A of the Securities Act Regulations (the &ldquo;<B>Rule 430A Information</B>&rdquo;)), is referred to herein
as the &ldquo;<B>Registration Statement</B>.&rdquo; If the Company files any registration statement pursuant to Rule 462(b) of the Securities
Act Regulations, then after such filing, the term &ldquo;<B>Registration Statement</B>&rdquo; shall include such registration statement
filed pursuant to Rule 462(b). The Registration Statement has been declared effective by the Commission on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
prospectus used prior to the effectiveness of the Registration Statement, and each prospectus that omitted the Rule 430A Information
that was used after such effectiveness and prior to the execution and delivery of this Agreement, is herein called a &ldquo;<B>Preliminary
Prospectus</B>.&rdquo; The Preliminary Prospectus, subject to completion, dated [&#9679;], 2023, that was included in the Registration
Statement immediately prior to the Applicable Time is hereinafter called the &ldquo;<B>Pricing Prospectus</B>.&rdquo; The final prospectus
in the form first furnished to the Underwriters for use in the Offering is hereinafter called the &ldquo;<B>Prospectus</B>.&rdquo; Any
reference to the &ldquo;most recent Preliminary Prospectus&rdquo; shall be deemed to refer to the latest Preliminary Prospectus included
in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Applicable
Time</B>&rdquo; means 5:00 p.m., Eastern time, on the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
Free Writing Prospectus</B>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Securities Act
Regulations (&ldquo;<B>Rule 433</B>&rdquo;), including without limitation any &ldquo;free writing prospectus&rdquo; (as defined in Rule
405 of the Securities Act Regulations) relating to the Public Securities that is (i) required to be filed with the Commission by the
Company, (ii) a &ldquo;road show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i), whether or not required
to be filed with the Commission, or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a
description of the Public Securities or of the Offering that does not reflect the final terms, in each case in the form filed or required
to be filed with the Commission or, if not required to be filed, in the form retained in the Company&rsquo;s records pursuant to Rule
433(g).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
General Use Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to
prospective investors (other than a &ldquo;<I>bona fide</I> electronic road show,&rdquo; as defined in Rule 433(h)(5) under the Securities
Act (the &ldquo;<B>Bona Fide Electronic Road Show</B>&rdquo;)), as evidenced by its being specified in <U>Schedule 3-B</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Issuer
Limited Use Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing
Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Pricing
Disclosure Package</B>&rdquo; means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Pricing
Prospectus and the information included on <U>Schedule 3-A</U> hereto, all considered together.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2.
<U>Pursuant to the Exchange Act</U>. The Company has filed with the Commission a Form 8-A (File No. 001-[&#9679;]) providing for the
registration pursuant to Section 12(b) under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;),
of the Common Stock. The registration of the Common Stock under the Exchange Act has become effective on or prior to the date hereof.
The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under
the Exchange Act, nor has the Company received any notification that the Commission is contemplating terminating such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
<U>Stock Exchange Listing</U>. The Common Stock has been approved for listing on The Nasdaq Capital Market (the &ldquo;<B>Exchange</B>&rdquo;),
subject only to official notice of issuance, and the Company has taken no action designed to, or likely to have the effect of, delisting
the Common Stock from the Exchange, nor has the Company received any notification that the Exchange is contemplating terminating such
listing except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
<U>No Stop Orders, etc</U>. Neither the Commission nor, to the Company&rsquo;s knowledge, any state regulatory authority has issued any
order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted
or, to the Company&rsquo;s knowledge, threatened to institute, any proceedings with respect to such an order. The Company has complied
with each request (if any) from the Commission for additional information. For purposes of this Agreement, the terms &ldquo;Company&rsquo;s
knowledge&rdquo; or &ldquo;known to the Company&rdquo; or phrases having a similar meaning, shall be defined as the actual knowledge
of the Company&rsquo;s board of directors and named executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.
<U>Disclosures in Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.1.
<U>Compliance with Securities Act and 10b-5 Representation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
At the time of effectiveness of the Registration Statement (or at the time of any post-effective amendment to the Registration Statement)
and at all times subsequent thereto up to the Closing Date and the Option Closing Date, if any, the Registration Statement, the Preliminary
Prospectus and the Prospectus do and will contain all material statements that are required to be stated therein in accordance with the
Securities Act and the Securities Act Regulations, and did or will, in all material respects, conform to the requirements of the Securities
Act and the Securities Act Regulations. Each of the Registration Statement and any post-effective amendment thereto, at the time it became
effective, complied in all material respects with the requirements of the Securities Act and the Securities Act Regulations. Each Preliminary
Prospectus, including the prospectus filed as part of the Registration Statement as originally filed or as part of any amendment or supplement
thereto, and the Prospectus, at the time each was filed with the Commission, complied in all material respects with the requirements
of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriters for use in connection
with this Offering and the Prospectus was or will be identical to the electronically transmitted copies thereof filed with the Commission
pursuant to the Commission&rsquo;s EDGAR filing system (&ldquo;<B>EDGAR</B>&rdquo;), except to the extent permitted by Regulation S-T
promulgated under the Securities Act (&ldquo;<B>Regulation S-T</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Neither the Registration Statement nor any amendment thereto, at its effective time, as of the Applicable Time, at the Closing Date or
at any Option Closing Date (if any), contained, contains or will contain an untrue statement of a material fact or omitted, omits or
will omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The Pricing Disclosure Package, as of the Applicable Time, at the Closing Date and at any Option Closing Date (if any), did not, does
not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free Writing Prospectus
does not conflict in any material respect with the information contained in the Registration Statement, any Preliminary Prospectus, the
Pricing Prospectus or the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together
with the Pricing Prospectus as of the Applicable Time, did not include an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading; provided,
however, that this representation and warranty shall not apply to statements made or statements omitted in reliance upon and in conformity
with written information furnished to the Company with respect to the Underwriters by the Representative expressly for use in the Registration
Statement, the Pricing Prospectus or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree
that such information provided by or on behalf of any Underwriter consists solely of the following: the names of the Underwriters and
the information contained in the table in the subsection &ldquo;Discounts&rdquo; and the dealer concession per share amount in the paragraph
following such table, and in the subsections &ldquo;Stabilization&rdquo; and &ldquo;Passive Market Making&rdquo; contained in the &ldquo;Underwriting&rdquo;
section of any Pricing Prospectus and the Prospectus (the &ldquo;<B>Underwriters&rsquo; Information</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Neither the Prospectus nor any amendment or supplement thereto, as of its issue date, at the time of any filing with the Commission pursuant
to Rule 424(b), at the Closing Date or at any Option Closing Date, included, includes or will include an untrue statement of a material
fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to the Underwriters&rsquo;
Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.2.
<U>Disclosure of Agreements</U>. The agreements and documents described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus conform in all material respects to the descriptions thereof contained therein and there are no agreements or other
documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been
so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by
which it or any of its properties is or may be bound or affected and that is (i) referred to in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, or (ii) material to the Company&rsquo;s business, has been duly authorized and validly executed
by the Company, is in full force and effect in all material respects and constitutes the legal, valid and binding obligation of the Company,
enforceable against the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except
(x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights
generally, (y) as enforceability of any indemnification or contribution provision may be limited under the federal and state securities
laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable
defenses and to the discretion of the court before which any proceeding therefor may be brought. Except as disclosed in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, none of such agreements or instruments has been assigned by the Company,
and neither the Company nor, to the Company&rsquo;s knowledge, any other party is in default thereunder and, to the Company&rsquo;s knowledge,
no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder except for
such defaults that would not reasonably be expected to result in a Material Adverse Change (as defined in Section 2.5.1 below). To the
best of the Company&rsquo;s knowledge, performance by the Company of the provisions of such agreements or instruments will not result
in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic
or foreign, having jurisdiction over the Company or any of its assets or businesses (each, a &ldquo;<B>Governmental Entity</B>&rdquo;),
including, without limitation, those relating to environmental laws and regulations except for such violations that would not reasonably
be expected to result in a Material Adverse Change (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.3.
<U>Prior Securities Transactions</U>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit
of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration
Statement, the Pricing Disclosure Package and the Preliminary Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.4.
<U>Regulations</U>. The disclosures in the Registration Statement, the Pricing Disclosure Package and the Prospectus concerning the effects
of material applicable federal, state, local and any applicable foreign laws, rules and regulations relating to the Offering and the
Company&rsquo;s business as currently conducted or contemplated are correct and complete in all material respects and no other such laws,
rules or regulations are required to be disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus which
are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4.5.
<U>No Other Distribution of Offering Materials.</U> The Company has not, directly or indirectly, distributed and will not distribute
any offering material in connection with the Offering other than any Preliminary Prospectus, any Issuer Free Writing Prospectus, the
Prospectus and other materials, if any, permitted under the Securities Act and consistent with Section 3.2 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.
<U>Changes After Dates in Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.1.
<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse change
in the financial condition or results of operations of the Company on a consolidated basis, or its business or assets nor, to the Company&rsquo;s
knowledge, any change or development that, individually or in the aggregate, would have a material adverse effect on the condition (financial
or otherwise), results of operations, business, assets or prospects of the Company (a &ldquo;<B>Material Adverse Change</B>&rdquo;);
(ii) there have been no material transactions entered into by the Company except as set forth in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, other than as contemplated pursuant to this Agreement; and (iii) no executive officer or director
of the Company has resigned from any position with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5.2.
<U>Recent Securities Transactions</U>. Subsequent to the respective dates as of which information is given in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has not: (i) issued any securities, other than
shares issued or issuable pursuant to then outstanding convertible securities, which in each case were disclosed in the Prospectus, Pricing
Disclosure Package or the Registration Statement, or incurred any liability or obligation, direct or contingent, for borrowed money;
or (ii) declared or paid any dividend or made any other distribution on or in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.6.
<U>Disclosures in Commission Filings</U>. None of the Company&rsquo;s filings with, or other documents furnished to, the Commission contained
any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided, however, that this representation and warranty shall
not apply to the Underwriters&rsquo; Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.7.
<U>Independent Accountants</U>. Rosenberg Rich Baker Berman, P.A. (the &ldquo;<B>Auditor</B>&rdquo;), whose report is filed with the
Commission as part of the Registration Statement, the Pricing Disclosure Package and the Prospectus, is an independent registered public
accounting firm as required by the Securities Act and the Securities Act Regulations and is currently registered and in good standing
with the Public Company Accounting Oversight Board (&ldquo;<B>PCAOB</B>&rdquo;), including the rules and regulations promulgated by such
entity. The Auditor has not, during the periods covered by the financial statements included in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, provided to the Company any non-audit services, within the meaning of such term in Section 10A(g)
of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.8.
<U>Financial Statements, etc</U>. The financial statements, including the notes thereto and supporting schedules (if any) included in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, fairly in all material respects present the balance sheets,
the statements of operations, statements of stockholders&rsquo; equity (deficits) and the statements of cash flows of the Company at
the dates and for the periods to which they apply; and such financial statements have been prepared in conformity with U.S. generally
accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;), consistently applied throughout the periods involved (provided that unaudited
interim financial statements are subject to year-end audit adjustments that are not expected to be material in the aggregate and do not
contain all footnotes required by GAAP); and the supporting schedules, if any, included in the Registration Statement present fairly
in all material respects the information required to be stated therein. Except as included therein, no other historical or pro forma
financial statements or supporting schedules are required to be included in the Registration Statement, the Pricing Disclosure Package
or the Prospectus under the Securities Act or the Securities Act Regulations. The &ldquo;as adjusted&rdquo; financial information and
the related notes, if any, included in the Registration Statement, the Pricing Disclosure Package and the Prospectus present fairly in
all material respects the information shown therein, and, in the judgment of the Company, the assumptions used in the preparation thereof
are reasonable and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein.
The Company has no material off-balance sheet transactions, arrangements, obligations (including contingent obligations), and other relationships
of the Company with unconsolidated entities or other persons that may have a material current or future effect on the Company&rsquo;s
financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues
or expenses. Except as disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, (a) since the date
of the last balance sheet included in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has
not incurred any material liabilities or obligations, direct or contingent, or entered into any material transactions other than in the
ordinary course of business, (b) the Company has not declared or paid any dividends or made any distribution of any kind with respect
to its capital stock, (c) there has not been any change in the capital stock of the Company, or, other than in the ordinary course of
business, any grants under any stock compensation plan, and (d) there has not been any Material Adverse Change in the Company&rsquo;s
long-term or short-term debt. The Company represents that it has no direct or indirect subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.9.
<U>Authorized Capital; Options</U> The Company had, at the date or dates indicated in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions
stated in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company will have on the Closing Date or
on the Option Closing Date, as the case may be, the adjusted stock capitalization set forth therein. Except as set forth in, or contemplated
by, the Registration Statement, the Pricing Disclosure Package and the Prospectus, on the Effective Date, as of the Applicable Time and
on the Closing Date and any Option Closing Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire
any authorized, but unissued shares of Common Stock of the Company or any security convertible into or exercisable for any class of capital
stock of the Company, or any contracts or commitments to issue or sell any class of capital stock or any such options, warrants, rights
or convertible securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.
<U>Valid Issuance of Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.1.
<U>Outstanding Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by
this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights
of rescission or the ability to require the Company to repurchase such securities with respect thereto, and are not subject to personal
liability by reason of being such holders; and none of such securities were issued in violation of the preemptive rights, rights of first
refusal or rights of participation of any holders of any security of the Company or similar contractual rights granted by the Company.
The authorized shares of Common Stock conform in all material respects to all statements relating thereto contained in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. All offers and sales of the outstanding Common Stock, options, warrants
and other rights to purchase or exchange such securities for shares of Common Stock were at all relevant times either registered under
the Securities Act and the applicable state securities or &ldquo;blue sky&rdquo; laws or based in part on the representations and warranties
of the purchasers of such shares or other securities, exempt from such registration requirements. The Company has no stock option, stock
bonus and other stock or equity compensation plans or arrangements other than those described in the Registration Statement, the Pricing
Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.10.2.
<U>Securities Sold Pursuant to this Agreement</U>. The Public Securities and Representative&rsquo;s Securities have been duly authorized
for issuance and sale and, when issued and paid for, will be validly issued, fully paid and non-assessable; the holders thereof will
not be subject to personal liability by reason of being such holders; the Public Securities and Representative&rsquo;s Securities are
not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted
by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Public Securities and Representative&rsquo;s
Securities has been duly and validly taken. The Public Securities and Representative&rsquo;s Securities conform in all material respects
to all statements with respect thereto contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.11.
<U>Registration Rights of Third Parties</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus, no holders of any securities of the Company or any options, warrants, rights or other securities exercisable for or convertible
or exchangeable into securities of the Company have the right to require the Company to register any such securities of the Company under
the Securities Act or to include any such securities in a registration statement to be filed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.12.
<U>Validity and Binding Effect of Agreements</U>. Each of this Agreement and the Representative&rsquo;s Warrant Agreement has been duly
and validly authorized by the Company, and, when executed and delivered by the Company, will constitute, the legal valid and binding
agreement of the Company, enforceable against the Company in accordance with its terms, except in each case: (i) as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally; (ii) as enforceability
of any indemnification or contribution provision may be limited under the federal and state securities laws; and (iii) that the remedy
of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefor may be brought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.13.
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement, the Representative&rsquo;s Warrant Agreement
and all other documents ancillary hereto and thereto, the consummation by the Company of the transactions herein and therein contemplated
and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the
lapse of time or both: (i) result in any violation of the provisions of the Company&rsquo;s Certificate of Incorporation (as amended
or restated from time to time, the &ldquo;<B>Charter</B>&rdquo;) or the bylaws of the Company (the &ldquo;<B>Bylaws</B>&rdquo;); (ii)
result in a material breach or violation of, or conflict in any material respect with any of the terms and provisions of, or constitute
a material default under, or result in the creation, modification, termination or imposition of any lien, charge or encumbrance upon
any property or assets of the Company pursuant to the terms of any agreement or instrument to which the Company is a party or as to which
any property of the Company is subject; or (iii) violate any applicable law, rule, regulation, judgment, order or decree of any Governmental
Entity as of the date hereof; except in the case of clause (iii) above, for those violations, which (individually or in the aggregate)
have not resulted, or would not reasonably be expected to result, in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.14.
<U>No Defaults; Violations</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
no default exists in the due performance and observance of any term, covenant or condition of any material license, contract, indenture,
mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation for borrowed money,
or any other material agreement or instrument to which the Company is a party or by which the Company may be bound or to which any of
the properties or assets of the Company is subject, except, in each case, for those defaults which have not resulted, or would not reasonably
be expected to result, in a Material Adverse Change. The Company is not in violation of any franchise, license, permit, applicable law,
rule, regulation, judgment, order or decree of any Governmental Entity, except for such that which have not resulted, or would not reasonably
be expected to result, in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.
<U>Corporate Power; Licenses; Consents</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.1.
<U>Conduct of Business</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the
Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates,
and permits (collectively, &ldquo;<B>Authorizations</B>&rdquo;) of and from all Governmental Entities required as of the date hereof
for the Company to conduct its business as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus,
except, in each case, where the failure to have such Authorizations has not resulted, and would not reasonably be expected to result,
in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15.2.
<U>Transactions Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement and the Representative&rsquo;s
Warrant Agreement and to carry out the provisions and conditions hereof and thereof, and all Authorizations required in connection therewith
have been obtained. No Authorization of, and no filing with, any Governmental Entity is required for the valid issuance, sale and delivery
of the Public Securities and the Representative&rsquo;s Securities and the consummation of the transactions and agreements contemplated
by this Agreement and the Representative&rsquo;s Warrant Agreement and as contemplated by the Registration Statement, the Pricing Disclosure
Package and the Prospectus, except with respect to applicable federal and state securities, the rules of The Nasdaq Stock Market, LLC
and the rules and regulations of FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16.
<U>D&amp;O Questionnaires</U>. All information contained in the questionnaires (the &ldquo;<B>Questionnaires</B>&rdquo;) completed by
each of the Company&rsquo;s directors and officers prior to the Offering (the &ldquo;<B>Insiders</B>&rdquo;) as supplemented by all information
concerning the Company&rsquo;s directors and officers set forth in the Registration Statement, the Pricing Disclosure Package and the
Prospectus provided to the Representative and its counsel, is, to the knowledge of the Company, true and correct and the Company has
not become aware of any information which would cause the information disclosed in the Questionnaires to become materially inaccurate
or incomplete in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17.
<U>Litigation; Governmental Proceedings</U>. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or
governmental proceeding pending or, to the Company&rsquo;s knowledge, threatened, against, or involving the Company or, to the Company&rsquo;s
knowledge, any executive officer or director which has not been disclosed in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, or in connection with the Company&rsquo;s listing application for the listing of the Public Securities on the Exchange,
which individually or in the aggregate, if determined adversely to the Company would reasonably be expected to have a Material Adverse
Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.18.
<U>Good Standing</U>. The Company has been duly incorporated and is validly existing as a corporation and is in good standing under the
laws of the State of Delaware, as of the date hereof. The Company is duly qualified to do business and is in good standing as a foreign
corporation in each other jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification,
except where the failure to be so qualified or in good standing, individually or in the aggregate, has not resulted, and would not reasonably
be expected to result, in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.19.
<U>Insurance</U>. On the Closing Date the Company will carry or will be entitled to the benefits of insurance (including, without limitation,
directors&rsquo; and officers&rsquo; insurance), with reputable insurers, in such amounts and covering such risks which the Company believes
are adequate, and all such insurance is in full force and effect, except where the failure to maintain such insurance has not resulted,
and would not reasonably be expected to result in a Material Adverse Change. The Company has no reason to believe that it will not be
able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar
institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not reasonably be expected
to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20
<U>Transactions Affecting Disclosure to FINRA</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.1.
<U>Finder&rsquo;s Fees</U>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there
are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder&rsquo;s, consulting or origination
fee by the Company or, to the Company&rsquo;s knowledge, any Insider with respect to the sale of the Public Securities hereunder or any
other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its stockholders that may
affect the Underwriters&rsquo; compensation, as determined by FINRA and, neither the Company nor, to the Company&rsquo;s knowledge any
Insider has paid any moneys or other compensation or issued any securities to any member of FINRA, or to any affiliate or associate of
such a member, or to any person in consideration for such person raising funds for the Company, or providing consulting services to the
Company regarding this Offering and no such compensation has heretofore been paid to any third party regarding this Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.2.
<U>Payments Within Twelve (12) Months</U>. Except as disclosed in writing to the Representative or as described in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, the Company has not made any direct or indirect payments in connection with the Offering
(in cash, securities or otherwise) to: (i) any person, as a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such
person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii) any
FINRA member; or (iii) any person or entity that has any direct or indirect affiliation or association with any FINRA member, within
the twelve (12) months prior to the Effective Date, other than the payment to the Underwriters as provided hereunder in connection with
the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.3.
<U>Use of Proceeds</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its
affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.4.
<U>FINRA Affiliation</U>. To the Company&rsquo;s knowledge, there is no (i) officer or director of the Company, (ii) beneficial owner
of 10% or more of any class of the Company&rsquo;s securities or (iii) beneficial owner of the Company&rsquo;s unregistered equity securities,
who acquired any equity securities of the Company during the 180-day period immediately preceding the filing of the Registration Statement
that is an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules
and regulations of FINRA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20.5.
<U>Information</U>. All information provided by the Company in its FINRA questionnaire to Underwriters Counsel specifically for use in
connection with its public offering system (&ldquo;<B>Public Offering System</B>&rdquo;) filings (and related disclosure) with FINRA
is true, correct and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21.
<U>Foreign Corrupt Practices Act</U>. None of the Company or, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any other person acting on behalf of the Company, has, directly or indirectly, given or agreed to give
any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business) to any customer,
supplier, employee or agent of a customer or supplier, or official or employee of any Governmental Entity (domestic or foreign) or any
political party or candidate for office (domestic or foreign) or other person who was, is, or may be in a position to help or hinder
the business of the Company (or assist it in connection with any actual or proposed transaction) that (i) might subject the Company to
any damage or penalty in any civil, criminal or governmental litigation or proceeding, (ii) if not given in the past, might have had
a Material Adverse Change or (iii) if not continued in the future, might adversely affect the assets, business, operations or prospects
of the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause
the Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.22.
<U>Compliance with OFAC</U>. None of the Company or, to the Company&rsquo;s knowledge, any director, officer, agent, employee or affiliate
of the Company or any other person acting on behalf of the Company, is currently subject to any U.S. sanctions administered by the Office
of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;<B>OFAC</B>&rdquo;), and the Company will not, directly or indirectly,
use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture
partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.23
<U>Money Laundering Laws</U>. The operations of the Company are and have been conducted at all times in material compliance in all material
respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, including the Money Laundering Control Act of 1986, as amended, and the rules and regulations thereunder and any related
or similar money laundering statutes, rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively,
&ldquo;<B>Money Laundering Laws</B>&rdquo;); and no action, suit or proceeding by or before any Governmental Entity involving the Company
with respect to Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24
<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to the Representative
or to Underwriters Counsel on the Closing Date or on the Option Closing Date shall be deemed a representation and warranty by the Company
to the Underwriters as to the matters covered thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25.
<U>Lock-Up Agreements</U>. <U>Schedule 4 </U>hereto contains a complete and accurate list of the Company&rsquo;s officers, directors
and each owner of 5% or more of the Company&rsquo;s outstanding Common Stock (or securities convertible, exchangeable or exercisable
into Common Stock) (collectively, the &ldquo;<B>Lock-Up Parties</B>&rdquo;). The Company has caused each of the Lock-Up Parties, excluding
Masimo Corporation, to deliver to the Representative an executed Lock-Up Agreement, substantially in the form of <U>Exhibit B</U> hereto
<B>(</B>the &ldquo;<B>Lock-Up Agreement</B>&rdquo;), prior to the execution of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.26.
[Reserved.]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.27.
<U>Related Party Transactions</U>. There are no business relationships or related party transactions involving the Company or any other
person required to be described in the Registration Statement, the Pricing Disclosure Package and the Prospectus that have not been described
as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.28.
<U>Board of Directors</U>. The Board of Directors of the Company is comprised of the persons set forth under the heading of the Pricing
Prospectus and the Prospectus captioned &ldquo;Management.&rdquo; The qualifications of the persons serving as board members and the
overall composition of the board comply with the Exchange Act, the rules and regulations of the Commission promulgated thereunder (the
&ldquo;<B>Exchange Act Regulations</B>&rdquo;), the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder (the &ldquo;<B>Sarbanes-Oxley
Act</B>&rdquo;) applicable to the Company and the listing rules of the Exchange. At least one member of the Audit Committee of the Board
of Directors of the Company qualifies as an &ldquo;audit committee financial expert,&rdquo; as such term is defined under Regulation
S-K and the listing rules of the Exchange. In addition, at least a majority of the persons serving on the Board of Directors qualify
as &ldquo;independent,&rdquo; as defined under the listing rules of the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.
<U>Sarbanes-Oxley Compliance</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.1.
<U>Disclosure Controls</U>. The Company has taken all necessary actions to ensure that, in the time periods required, the Company will
comply in all material respects with Rule 13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures will
be effective to ensure that all material information concerning the Company will be made known on a timely basis to the individuals responsible
for the preparation of the Company&rsquo;s Exchange Act filings and other public disclosure documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.29.2.
<U>Compliance</U>. The Company is and at the Applicable Time and on the Closing Date will be, in material compliance with the provisions
of the Sarbanes-Oxley Act applicable to it, and has implemented or will implement such programs and has taken reasonable steps to ensure
the Company&rsquo;s future compliance (not later than the relevant statutory and regulatory deadlines therefor) with all of the material
provisions of the Sarbanes-Oxley Act then applicable to it.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30.
<U>Accounting Controls</U>. The Company is in the process of establishing systems of &ldquo;internal control over financial reporting&rdquo;
(as defined under Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that will comply in all material respects with the requirements
of the Exchange Act and have been designed by, or under the supervision of, their respective principal executive and principal financial
officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s general or
specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences. Except as disclosed in the Registration Statement, the Pricing Disclosure
Package and the Prospectus, the Company is not aware of any material weaknesses in its internal controls. The Company&rsquo;s auditors
and the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design
or operation of internal controls over financial reporting which are known to the Company&rsquo;s management and that have adversely
affected or are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial
information; and (ii) any fraud known to the Company&rsquo;s management, whether or not material, that involves management or other employees
who have a significant role in the Company&rsquo;s internal controls over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.31.
<U>No Investment Company Status</U>. The Company is not and, after giving effect to the Offering and the application of the net proceeds
thereof as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be, required to register
as an &ldquo;investment company,&rdquo; as defined in the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.32.
<U>No Labor Disputes</U>. No labor dispute with the employees of the Company exists or, to the knowledge of the Company, is threatened.
The Company is not aware that any key employee or significant group of employees of the Company plans to terminate employment with the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33.
<U>Intellectual Property Rights</U>. The Company owns or possesses or has valid rights to use all patents, patent applications, trademarks,
service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets and
similar rights (&ldquo;<B>Intellectual Property Rights</B>&rdquo;) described in the Registration Statement, the Pricing Disclosure Package
and the Prospectus and necessary for the conduct of the business of the Company as currently carried on and as described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus. To the knowledge of the Company and except as may be disclosed in the Registration
Statement, the Pricing Disclosure Package and the Prospectus, no action or use by the Company necessary for the conduct of its business
as currently carried on and as described in the Registration Statement and the Prospectus will involve or give rise to any infringement
of, or license or similar fees for, any Intellectual Property Rights of others, other than potential claims that would not reasonably
be expected to result, individually or in the aggregate, in a Material Adverse Change. The Company has not received any notice alleging
any such infringement, fee or conflict with asserted Intellectual Property Rights of others. Except as would not reasonably be expected
to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the Company, there is no infringement,
misappropriation or violation by third parties of any of the Intellectual Property Rights owned by the Company; (B) there is no pending
or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the rights of the Company in
or to any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable basis for any such
claim, that would, individually or in the aggregate, together with any other claims in this Section 2.33, reasonably be expected to result
in a Material Adverse Change; (C) the Intellectual Property Rights owned by the Company and, to the knowledge of the Company, the Intellectual
Property Rights licensed to the Company have not been adjudged by a court of competent jurisdiction invalid or unenforceable, in whole
or in part, and there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others challenging
the validity or scope of any such Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable
basis for any such claim that would, individually or in the aggregate, together with any other claims in this Section 2.33, reasonably
be expected to result in a Material Adverse Change; (D) there is no pending or, to the Company&rsquo;s knowledge, threatened action,
suit, proceeding or claim by others that the Company infringes, misappropriates or otherwise violates any Intellectual Property Rights
or other proprietary rights of others, the Company has not received any written notice of such claim and the Company is unaware of any
other facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other
claims referred to in this Section 2.33, reasonably be expected to result in a Material Adverse Change; and (E) to the Company&rsquo;s
knowledge, no employee of the Company is in or has ever been in violation in any material respect of any term of any employment contract,
patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement
or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s employment
with the Company, or actions undertaken by the employee while employed with the Company and could reasonably be expected to result, individually
or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s knowledge, all material technical information developed by
and belonging to the Company which has not been patented has been kept confidential. The Company is not a party to or bound by any options,
licenses or agreements with respect to the Intellectual Property Rights of any other person or entity that are required to be set forth
in the Registration Statement, the Pricing Disclosure Package and the Prospectus and are not described therein. To the knowledge of the
Company, none of the technology employed by the Company has been obtained or is knowingly being used by the Company in material violation
of any contractual obligation binding on the Company or, to the Company&rsquo;s knowledge, any of its officers, directors or employees,
or otherwise in material violation of the rights of any persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.34.
<U>Taxes</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Change, the Company has: (i) filed all returns (as hereinafter defined) required to be filed with taxing authorities prior to
the date hereof or has duly obtained extensions of time for the filing thereof; and (ii) paid all taxes (as hereinafter defined) shown
as due on such returns that were filed and has paid all taxes imposed on or assessed against the Company. The provisions for taxes payable,
if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient for all accrued and unpaid
taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements. Except as disclosed
in writing to the Underwriters, (i) no issues have been raised (and are currently pending) by any taxing authority in connection with
any of the returns or taxes asserted as due from the Company, and (ii) no waivers of statutes of limitation with respect to the returns
or collection of taxes have been given by or requested from the Company. There are no tax liens against the assets, properties or business
of the Company other than liens for taxes not yet delinquent or being contested in good faith by appropriate proceedings and for which
reserves in accordance with GAAP have been established in the Company&rsquo;s books and records or liens the foreclosure of which, individually
and in the aggregate, would not result in a Material Adverse Change. The term &ldquo;<B>taxes</B>&rdquo; means all federal, state, local,
foreign and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service,
service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties
or other taxes, fees, assessments or charges of any kind whatever, together with any interest and any penalties, additions to tax or
additional amounts with respect thereto. The term &ldquo;<B>returns</B>&rdquo; means all returns, declarations, reports, statements and
other documents required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35.
<U>ERISA Compliance</U>. The Company and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement Income Security
Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;<B>ERISA</B>&rdquo;)) established
or maintained by the Company or its &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all material respects with
ERISA. &ldquo;<B>ERISA Affiliate</B>&rdquo; means, with respect to the Company, any member of any group of organizations described in
Sections 414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations
thereunder (the &ldquo;<B>Code</B>&rdquo;) of which the Company is a member. No &ldquo;reportable event&rdquo; (as defined under ERISA)
has occurred or is reasonably expected to occur with respect to any &ldquo;employee benefit plan&rdquo; established or maintained by
the Company or any of its ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established or maintained by the Company or any of
its ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any &ldquo;amount of unfunded benefit liabilities&rdquo;
(as defined under ERISA). Neither the Company nor any of its ERISA Affiliates has incurred or reasonably expects to incur any material
liability under (i) Title IV of ERISA with respect to termination of, or withdrawal from, any &ldquo;employee benefit plan&rdquo; or
(ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo; established or maintained by the Company
or any of its ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code is so qualified and, to the knowledge
of the Company, nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.36.
<U>Compliance with Laws</U>. The Company: (A) is and at all times has been in compliance with all statutes, rules, or regulations applicable
to the business of the Company as currently conducted (&ldquo;<B>Applicable Laws</B>&rdquo;), except as could not, individually or in
the aggregate, reasonably be expected to have a Material Adverse Change; (B) has not received any warning letter or other correspondence
or notice from any Governmental Entity alleging or asserting noncompliance with any Applicable Laws or any Authorizations; (C) possesses
all material Authorizations and such Authorizations are valid and in full force and effect and are not in material violation of any term
of any such Authorizations; (D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation,
arbitration or other action from any Governmental Entity or third party alleging that any activity conducted by the Company is in violation
of any Applicable Laws or Authorizations and has no knowledge that any such Governmental Entity or third party is considering any such
claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has not received written notice that any Governmental
Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and has no knowledge that
any such Governmental Entity is considering such action; and (F) has filed, obtained, maintained or submitted all material reports, documents,
forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations
and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete
and correct in all material respects on the date filed (or were corrected or supplemented by a subsequent submission).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.37.
<U>Emerging Growth Company</U>. From the time of the initial submission of the Registration Statement to the Commission (or, if earlier,
the first date on which the Company engaged directly in or through any person authorized to act on its behalf in any Testing-the-Waters
Communication) through the date hereof, the Company has been and is an &ldquo;emerging growth company,&rdquo; as defined in Section 2(a)
of the Securities Act (an &ldquo;<B>Emerging Growth Company</B>&rdquo;). &ldquo;<B>Testing-the-Waters Communication</B>&rdquo; means
any oral or written communication with potential investors undertaken in reliance on Section 5(d) of the Securities Act. The Company
has not (i) alone engaged in any Testing-the-Waters Communications, other than Testing-the-Waters Communications with the written consent
of the Representative and with entities that are qualified institutional buyers within the meaning of Rule 144A under the Securities
Act or institutions that are accredited investors within the meaning of Rule 501 under the Securities Act and (ii) authorized anyone
other than the Representative to engage in Testing-the-Waters Communications. The Company confirms that the Representative has been authorized
to act on its behalf in undertaking Testing-the-Waters Communications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.38.
<U>Environmental Laws</U>. The Company is in compliance with all foreign, federal, state and local rules, laws and regulations relating
to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment
which are applicable to their businesses (&ldquo;<B>Environmental Laws</B>&rdquo;), except where the failure to comply would not, singularly
or in the aggregate, result in a Material Adverse Change. There has been no storage, generation, transportation, handling, treatment,
disposal, discharge, emission, or other release of any kind of toxic or other wastes or other hazardous substances by, due to, or caused
by the Company (or, to the Company&rsquo;s knowledge, any other entity for whose acts or omissions the Company is or may otherwise be
liable) upon any of the property now or previously owned or leased by the Company, in violation of any law, statute, ordinance, rule,
regulation, order, judgment, decree or permit or which would, under any law, statute, ordinance, rule (including rule of common law),
regulation, order, judgment, decree or permit, give rise to any liability, except for any violation or liability which would not have,
singularly or in the aggregate with all such violations and liabilities, a Material Adverse Change; and there has been no disposal, discharge,
emission or other release of any kind onto such property or into the environment surrounding such property of any toxic or other wastes
or other hazardous substances with respect to which the Company has knowledge, except for any such disposal, discharge, emission, or
other release of any kind which would not have, singularly or in the aggregate with all such discharges and other releases, a Material
Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.39.
<U>Title to Property</U>. Except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company
has good and marketable title in fee simple to, or have valid rights to lease or otherwise use, all items of real or personal property
which are material to the business of the Company, in each case free and clear of all liens, encumbrances, security interests, claims
and defects that do not, singly or in the aggregate, materially affect the value of such property and do not materially interfere with
the use made and proposed to be made of such property by the Company; and all of the leases and subleases material to the business of
the Company, and under which the Company holds properties described in the Registration Statement, the Pricing Disclosure Package and
the Prospectus, are in full force and effect, and the Company has not received any notice of any material claim of any sort that has
been asserted by anyone adverse to the rights of the Company under any of the leases or subleases mentioned above, or affecting or questioning
the rights of the Company to the continued possession of the leased or subleased premises under any such lease or sublease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.40.
<U>Contracts Affecting Capital</U>. There are no transactions, arrangements or other relationships between and/or among the Company,
any of its affiliates (as such term is defined in Rule 405 under the Securities Act) and any unconsolidated entity, including, but not
limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected to materially affect
the Company&rsquo;s liquidity or the availability of or requirements for their capital resources required to be described or incorporated
by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus which have not been described or incorporated
by reference as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.41.
<U>Loans to Directors or Officers</U>. There are no outstanding loans, advances (except normal advances for business expenses in the
ordinary course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors of
the Company or any of their respective family members, except as disclosed in the Registration Statement, the Pricing Disclosure Package
and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.42.
<U>Ineligible Issuer</U>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the Effective
Date and at the time of any amendment thereto, at the earliest time thereafter that the Company or the Underwriter made a bona fide offer
(within the meaning of Rule 164(h)(2) under the Securities Act) of the Public Securities and at the Effective Date, the Company was not
and is not an &ldquo;ineligible issuer,&rdquo; as defined in Rule 405, without taking account of any determination by the Commission
pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.43.
<U>Smaller Reporting Company</U>. As of the time of filing of the Registration Statement, the Company was a &ldquo;smaller reporting
company,&rdquo; as defined in Rule 12b-2 of the Exchange Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.44.
<U>Industry Data</U>. The statistical and market-related data included in each of the Registration Statement, the Pricing Disclosure
Package and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and
accurate or represent the Company&rsquo;s good faith estimates that are made on the basis of data derived from such sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.45.
<U>Electronic Road Show</U>. The Company has made available a Bona Fide Electronic Road Show in compliance with Rule 433(d)(8)(ii) of
the Securities Act Regulations such that no filing of any &ldquo;road show&rdquo; (as defined in Rule 433(h) of the Securities Act Regulations)
is required in connection with the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.46.
<U>Margin Securities</U>. The Company owns no &ldquo;margin securities&rdquo; as that term is defined in Regulation U of the Board of
Governors of the Federal Reserve System (the &ldquo;<B>Federal Reserve Board</B>&rdquo;), and none of the proceeds of Offering will be
used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring
any indebtedness which was originally incurred to purchase or carry any margin security or for any other purpose which might cause any
of the Common Stock to be considered a &ldquo;purpose credit&rdquo; within the meanings of Regulation T, U or X of the Federal Reserve
Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.47.
<U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) contained in the Registration Statement, the Pricing Disclosure Package or the Prospectus has been made or reaffirmed
without a reasonable basis or has been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.48.
<U>Integration</U>. Neither the Company nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause the Offering
to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration of any such
securities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.49.
<U>Confidentiality and Non-Competition</U>. To the Company&rsquo;s knowledge, no director, officer, key employee or consultant of the
Company is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any employer
(other than the Company) or prior employer that could materially affect his or her ability to be and act in his or her respective capacity
of the Company or reasonably be expected to result in a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50.
<U>Corporate Records</U>. The minute books of the Company have been made available to the Representative and Underwriters Counsel and
such books (i) contain minutes of all material meetings and actions of the Board of Directors (including each board committee) and stockholders
of the Company, and (ii) reflect all material transactions referred to in such minutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.51.
<U>Diligence Materials</U>. The Company has provided to the Representative and Underwriters Counsel all materials required or necessary
to respond in all material respects to the diligence request submitted to the Company or its counsel by the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.52.
<U>Stabilization</U>. Neither the Company nor, to its knowledge, any of its employees, directors or stockholders (without the consent
of the Representative) has taken, directly or indirectly, any action designed to or that has constituted or that might reasonably be
expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Covenants of the Company</U>. The Company covenants and agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.
<U>Amendments to Registration Statement</U>. Until the later of the Closing Date and the exercise in full or expiration of the Over-Allotment
Option specified in Section 1.2 hereof, the Company shall deliver to the Representative, prior to filing, any amendment or supplement
to the Registration Statement or Prospectus proposed to be filed after the Effective Date and not file any such amendment or supplement
to which the Representative shall reasonably object in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.
<U>Federal Securities Laws</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1.
<U>Compliance</U>. Until the later of the Closing Date and the exercise in full or expiration of the Over-Allotment Option specified
in Section 1.2 hereof, the Company, subject to Section 3.2.2, shall comply in all material respects with the requirements of Rule 430A
of the Securities Act Regulations, and will notify the Representative promptly, and confirm the notice in writing, (i) when any post-effective
amendment to the Registration Statement shall become effective or any amendment or supplement to the Prospectus shall have been filed;
(ii) of its receipt of any comments from the Commission; (iii) of any request by the Commission for any amendment to the Registration
Statement or any amendment or supplement to the Prospectus or for additional information; (iv) of the issuance by the Commission of any
stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order preventing or suspending
the use of any Preliminary Prospectus or the Prospectus, or of the suspension of the qualification of the Public Securities and Representative&rsquo;s
Securities for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes
or of any examination pursuant to Section 8(d) or 8(e) of the Securities Act concerning the Registration Statement and (v) if the Company
becomes the subject of a proceeding under Section 8A of the Securities Act in connection with the Offering of the Public Securities and
Representative&rsquo;s Securities. The Company shall effect all filings required under Rule 424(b) of the Securities Act Regulations,
in the manner and within the time period required by Rule 424(b), and shall take such steps as it deems necessary to ascertain promptly
whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that
it was not, it will promptly file such prospectus. The Company shall use its commercially reasonable efforts to prevent the issuance
of any stop order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible
moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.2.
<U>Continued Compliance</U>. The Company shall comply in all material respects with the Securities Act, the Securities Act Regulations,
the Exchange Act and the Exchange Act Regulations so as to permit the completion of the distribution of the Public Securities as contemplated
in this Agreement and in the Registration Statement, the Pricing Disclosure Package and the Prospectus. If at any time when a prospectus
relating to the Public Securities is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations (&ldquo;<B>Rule
172</B>&rdquo;), would be) required by the Securities Act to be delivered in connection with sales of the Public Securities, any event
shall occur or condition shall exist as a result of which it is necessary, in the opinion of counsel to the Company or to the underwriters,
to (i) amend the Registration Statement in order that the Registration Statement will not include an untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii) amend
or supplement the Pricing Disclosure Package or the Prospectus in order that the Pricing Disclosure Package or the Prospectus, as the
case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein not misleading in the light of the circumstances existing at the time it is delivered to a purchaser or (iii) amend
the Registration Statement or amend or supplement the Pricing Disclosure Package or the Prospectus, as the case may be, in order to comply
with the requirements of the Securities Act or the Securities Act Regulations, the Company will promptly (A) give the Representative
notice of such event; (B) prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the
Registration Statement, the Pricing Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time
prior to any proposed filing or use, furnish the Representative with copies of any such amendment or supplement and (C) file with the
Commission any such amendment or supplement; provided that the Company shall not file or use any such amendment or supplement to which
the Representative or Underwriters Counsel shall reasonably object. The Company will furnish to the Underwriters such number of copies
of such amendment or supplement as the Underwriters may reasonably request. The Company will give the Representative notice of any filings
made pursuant to the Exchange Act or the Exchange Act Regulations within two (2) Business Days prior to the Applicable Time. The Company
shall give the Representative notice of its intention to make any such filing from the Applicable Time until the later of the Closing
Date and the exercise in full or expiration of the Over-Allotment Option specified in Section 1.2 hereof and will furnish the Representative
with copies of the related document(s) a reasonable amount of time prior to such proposed filing, as the case may be, and will not file
or use any such document to which the Representative or its counsel shall reasonably object.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.3.
<U>Exchange Act Registration</U>. The Company shall use its commercially reasonable efforts to maintain the registration of the Common
Stock under the Exchange Act (except in connection with a going-private transaction) for a period of three years from the Effective Date,
or until the Company is liquidated or is acquired, if earlier. For a period of three years from the Effective Date, the Company shall
not deregister any of the Common Stock under the Exchange Act without prior written notice to the Representative</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.4.
<U>Free Writing Prospectuses</U>. The Company agrees that, unless it obtains the prior written consent of the Representative, it shall
not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise
constitute a &ldquo;free writing prospectus,&rdquo; or a portion thereof, required to be filed by the Company with the Commission or
retained by the Company under Rule 433; provided that the Representative shall be deemed to have consented to each Issuer General Use
Free Writing Prospectus set forth in <U>Schedule 3-B</U>. The Company represents that it has treated or agrees that it will treat each
such free writing prospectus consented to, or deemed consented to, by the Representative as an &ldquo;issuer free writing prospectus,&rdquo;
as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including
timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing
Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would
conflict with the information contained in the Registration Statement or included or would include an untrue statement of a material
fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement,
at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.5.
<U>Testing-the-Waters Communications</U>. If at any time following the distribution of any Testing-the-Waters Communication that is a
written communication within the meaning of Rule 405 of the Securities Act Regulations (a &ldquo;<B>Written Testing-the-Waters Communication</B>&rdquo;)
there occurred or occurs an event or development as a result of which such Written Testing-the-Waters Communication included or would
include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company shall promptly notify the Representative
and shall promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate or correct such
untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3.
<U>Delivery to the Underwriters of Registration Statements</U>. The Company has delivered or made available or shall deliver or make
available to the Representative and Underwriters Counsel, without charge, signed copies of the Registration Statement as originally filed
and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of experts, and will
also deliver to each Underwriter, without charge, a conformed copy of the Registration Statement as originally filed and each amendment
thereto (without exhibits) upon receipt of a written request therefor from such Underwriter. The copies of the Registration Statement
and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with
the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4.
<U>Delivery to the Underwriters of Prospectuses</U>. The Company has delivered or made available or will deliver or make available to
each Underwriter, without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and the Company
hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to each Underwriter,
without charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded by Rule
172 of the Securities Act Regulations, would be) required to be delivered under the Securities Act, such number of copies of the Prospectus
(as amended or supplemented) as such Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto furnished
to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except
to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5.
<U>Effectiveness and Events Requiring Notice to the Representative</U>. The Company shall use its commercially reasonable efforts to
cause the Registration Statement to remain effective with a current prospectus for at least nine (9) months after the Applicable Time,
and shall notify the Representative promptly and confirm the notice in writing: (i) of the effectiveness of the Registration Statement
and any amendment thereto; (ii) of the issuance by the Commission of any stop order or of the initiation, or the threatening, of any
proceeding for that purpose; (iii) of the issuance by any state securities commission of any proceedings for the suspension of the qualification
of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that
purpose; (iv) of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or
Prospectus; (v) of the receipt of any comments or request for any additional information from the Commission; and (vi) of the occurrence
of any event during the period described in this Section 3.5 that, in the reasonable judgment of the Company, makes any statement of
a material fact made in the Registration Statement, the Pricing Disclosure Package or the Prospectus untrue or that requires the making
of any changes in (a) the Registration Statement in order to make the statements therein not misleading, or (b) in the Pricing Disclosure
Package or the Prospectus in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading. If the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time,
the Company shall use its commercially reasonable efforts to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6.
<U>Review of Financial Statements.</U> For a period of three (3) years after the date of this Agreement, the Company, at its expense,
shall cause its regularly engaged independent registered public accounting firm to review (but not audit) the Company&rsquo;s financial
statements for each of the three fiscal quarters immediately preceding the announcement of any quarterly financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7.
<U>Listing</U>. The Company shall use its commercially reasonable efforts to maintain the listing of the Common Stock (including the
Option Shares) on the Exchange for at least three (3) years from the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8.
<U>PCAOB Firm; Investor Relations Firm</U>. As of the Effective Date, the Company shall have retained: (i) a independent PCAOB registered
public accounting firm, which will have responsibility for the preparation of the financial statements and the financial exhibits reasonably
acceptable to the Representative and the Company, which shall initially be Rosenberg Rich Baker Berman, P.A. for at least three (3) year
from the date of this Agreement; and (ii) a financial public relations firm reasonably acceptable to the Representative and the Company,
which shall initially be Gilmartin Group which firm shall be experienced in assisting issuers in initial public offerings of securities
and in their relations with their security holders for at least one (1) year from the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.
<U>Reports to the Representative</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.1.
<U>Periodic Reports</U>. For a period of three (3) years after the date of this Agreement, the Company shall furnish or make available
to the Representative copies of such financial statements and other periodic and special reports as the Company from time to time furnishes
generally to holders of any class of its securities and also promptly furnish to the Representative: (i) a copy of each periodic report
the Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations; (ii) a copy of every
press release and every news item and article with respect to the Company or its affairs released by the Company; (iii) a copy of each
Current Report on Form 8-K prepared and filed by the Company; (iv) a copy of each registration statement filed by the Company under the
Securities Act; (v) a copy of each report or other communication furnished to stockholders and (vi) such additional documents and information
with respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably
request; provided, that if the information requested is confidential information that is not publicly available, the Representative shall
sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative
and Underwriters Counsel in connection with the Representative&rsquo;s receipt of such information. Documents filed with the Commission
via its EDGAR system shall be deemed to have been delivered to the Representative pursuant to this Section 3.9.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9.2.
<U>Transfer Agent; Transfer Sheets</U>. For a period of three (3) years after the date of this Agreement, the Company shall retain a
transfer agent and registrar acceptable to the Representative (the &ldquo;<B>Transfer Agent</B>&rdquo;) and, for one (1) year after the
date of this Agreement, the Company shall furnish to the Representative at the Company&rsquo;s sole cost and expense such transfer sheets
of the Company&rsquo;s securities as the Representative may reasonably request, including the daily and monthly consolidated transfer
sheets of the Transfer Agent and DTC. Vstock Transfer LLC is acceptable to the Representative to act as Transfer Agent for the Common
Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10.
<U>Payment of Expenses</U>. The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if any, to the
extent not paid at the Closing Date, or upon demand if there is no Closing, all expenses related to the Offering or otherwise incident
to the performance of the obligations of the Company under this Agreement, including, but not limited to: (a) all filing fees and communication
expenses relating to the registration of the Common Stock to be sold in the Offering (including the Option Shares) with the Commission;
(b) all Public Filing System filing fees associated with the review of the Offering by FINRA; (c) all fees and expenses relating to the
listing of such Public Securities on the Exchange and such other stock exchange or exchanges as the Company and the Representative may
together determine, including any fees charged by DTC; (d) all fees, expenses and disbursements relating to background checks of the
Company&rsquo;s officers and directors; (e) all fees, expenses and disbursements relating to the registration, qualification or exemption
of the Public Securities under the securities laws of such states or foreign jurisdictions as the Representative may reasonably designate;
(f) the costs of all mailing and printing of the underwriting documents (including, without limitation, the Underwriting Agreement, any
Blue Sky Surveys and, if appropriate, any Agreement Among Underwriters, Selected Dealers&rsquo; Agreement, Underwriters&rsquo; Questionnaire
and Power of Attorney), Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary
and final Prospectuses as the Representative may reasonably deem necessary; (g) the costs and expenses of a public relations firm; (h)
the costs of preparing, printing and delivering certificates representing the Public Securities; (i) fees and expenses of the transfer
agent for the Common Stock; (j) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to
the Underwriters; (k) the fees and expenses of the Company&rsquo;s accountants; (l) the fees and expenses of the Company&rsquo;s legal
counsel and other agents and representatives; (m) the fees and expenses of Underwriters Counsel up to an amount of $125,000 (which maximum
shall apply solely to such fees and disbursements of counsel and not to other fees and expenses provided for in this Section); (n) translation
cost for due diligence purposes, the reasonable cost for roadshow meetings and the preparation of a power point presentation; and (o)
the Underwriters&rsquo; actual accountable expenses for the Offering, including, without limitation, expenses related to the &ldquo;road
show.&rdquo; Notwithstanding the foregoing, the Company&rsquo;s obligations to reimburse the Representative for any out-of-pocket expenses
actually incurred as set forth in the preceding sentence shall not exceed $175,000 in the aggregate, including but not limited to travel,
communication, third party expenses, etc., the legal fees and disbursements of Underwriters Counsel and road show expenses as described
therein (provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions of this
Agreement). Additionally, the Company had provided an expense advance (the &ldquo;<B>Advance</B>&rdquo;) to the Representative of $25,000.
The Advance shall be applied towards out-of-pocket expense set forth herein and any portion of the Advance shall be returned back to
the Company to the extent not actually incurred. The Representative may deduct from the net proceeds of the Offering payable to the Company
on the Closing Date, or the Option Closing Date, if any, the expenses set forth herein to be paid by the Company to the Underwriters
other than amounts already advanced to the Representative. In addition, the Company hereby agrees to pay the Underwriter a non-accountable
expense allowance computed at the rate of one percent (1.0%) of the gross proceeds of the Public Securities sold in the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11.
<U>Application of Net Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent
with the application thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Pricing Disclosure
Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12.
<U>Delivery of Earnings Statements to Security Holders</U>. The Company shall make generally available to its security holders as soon
as practicable, but not later than the first day of the fifteenth (15<SUP>th</SUP>) full calendar month following the date of this Agreement,
an earnings statement (which need not be certified by an independent registered public accounting firm unless required by the Securities
Act or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act)
covering a period of at least twelve (12) consecutive months beginning after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13.
<U>Stabilization</U>. Neither the Company nor, to its knowledge, any of its employees, directors or stockholders has taken or shall take
(without the prior written consent of the Representative), directly or indirectly, any action designed to or that has constituted or
that might reasonably be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14.
<U>Internal Controls</U>. The Company shall use its reasonable best efforts maintain a system of internal controls over financial reporting
sufficient to provide reasonable assurances that: (i) transactions are executed in accordance with management&rsquo;s general or specific
authorization; (ii) transactions are recorded as necessary in order to permit preparation of financial statements in accordance with
GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management&rsquo;s general
or specific authorization; and (iv) the recorded accountability for assets is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15.
<U>Accountants</U>. As of the date of this Agreement, the Company has retained an independent registered public accounting firm, as required
by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board, reasonably acceptable to
the Representative, and the Company shall continue to retain a nationally recognized independent registered public accounting firm for
a period of at least three (3) years after the date of this Agreement. The Representative acknowledges that the Auditor is acceptable
to the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16.
<U>FINRA</U>. For a period of 60 days from the later of the Closing Date or the Option Closing Date, the Company shall advise the Representative
(who shall make an appropriate filing with FINRA) if it is or becomes aware that (i) any officer or director of the Company, (ii) any
beneficial owner of 10% or more of any class of the Company&rsquo;s securities or (iii) any beneficial owner of the Company&rsquo;s unregistered
equity securities which were acquired during the 180 days immediately preceding the filing of the Registration Statement is or becomes
an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations
of FINRA).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17.
<U>No Fiduciary Duties</U>. The Company acknowledges and agrees that the Underwriters&rsquo; responsibility to the Company is solely
contractual in nature and that none of the Underwriters or their affiliates or any selling agent shall be deemed to be acting in a fiduciary
capacity, or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other
transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18.
<U>Company and Insider Lock-Up Agreements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18.1.
<U>Restriction on Sales of Capital Stock</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior
written consent of the Representative, it will not, for a period of one hundred and eighty (180) days after the date of this Agreement
(the &ldquo;<B>Lock- Up Period</B>&rdquo;), (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase
any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or
indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of
capital stock of the Company; or (ii) complete any offering of debt securities of the Company (other than debt securities convertible
into shares of Common Stock of the Company); or (iii) enter into any swap or other arrangement that transfers to another, in whole or
in part, any of the economic consequences of ownership of capital stock of the Company, whether any such transaction described in clause
(i) or (ii) above is to be settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise.
The restrictions contained in this Section 3.18.1 shall not apply to (i) the shares of Common Stock to be sold hereunder, (ii) the issuance
by the Company of shares of Common Stock upon the exercise of a stock option or warrant or the conversion of a security outstanding on
the date hereof, of which the Representative has been advised in writing or as disclosed in the Registration Statement, the Pricing Disclosure
Package or the Prospectus, (iii) the issuance by the Company of stock options or shares of capital stock of the Company under any equity
compensation plan of the Company, or (iv) the filing of a registration statement on Form S-8 with the Commission (&ldquo;<B>Exempt Issuance</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if (i) during the last 17 days of the Lock-Up Period, the Company issues an earnings release or material news or a material
event relating to the Company occurs, or (ii) prior to the expiration of the Lock-Up Period, the Company announces that it will release
earnings results or becomes aware that material news or a material event will occur during the 16-day period beginning on the last day
of the Lock-Up Period, the restrictions imposed by this Section 3.18.1 shall continue to apply until the expiration of the 18-day period
beginning on the issuance of the earnings release or the occurrence of such material news or material event, as applicable, unless the
Representative waives, in writing, such extension; provided, however, that this extension of the Lock-Up Period shall not apply to the
extent that FINRA has amended or repealed NASD Rule 2711(f)(4), or has otherwise provided written interpretive guidance regarding such
rule, in each case, so as to eliminate the prohibition of any broker, dealer, or member of a national securities association from publishing
or distributing any research report, with respect to the securities of an Emerging Growth Company prior to or after the expiration of
any agreement between the broker, dealer, or member of a national securities association and the Emerging Growth Company or its stockholders
that restricts or prohibits the sale of securities held by the Emerging Growth Company or its stockholders after the initial public offering
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18.2
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18.3
<U>Insider Lock-Up Agreements</U>. The Company&rsquo;s directors and officers and any other holder of five (5%) percent or more of the
outstanding shares of Common Stock as of the effective date of the Registration Statement, will enter into customary &ldquo;lock-up&rdquo;
agreements in favor of the Representative pursuant to which such persons and entities will agree, for a period of one hundred and eighty
(180) days from the Closing (&ldquo;<B>D&amp;O Lockup Period</B>&rdquo;), that they will neither offer, issue, sell, contract to sell,
encumber, grant any option for the sale of or otherwise dispose of any securities of the Company without Representative &lsquo;s prior
written consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19.
<U>Release of D&amp;O Lock-up Period</U>. If the Representative, in its sole discretion, agrees to release or waive the restrictions
set forth in the Lock-Up Agreements described in Section 2.25 hereof for an officer or director of the Company and provides the Company
with notice of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver, the
Company agrees to announce the impending release or waiver by a press release substantially in the form of <U>Exhibit C</U> hereto through
a major news service at least two (2) Business Days before the effective date of the release or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20.
<U>Blue Sky Qualifications</U>. The Company shall use its commercially reasonable efforts, in cooperation with the Underwriters, if necessary,
to qualify the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic
or foreign) as the Representative may reasonably designate and to maintain such qualifications in effect so long as required to complete
the distribution of the Public Securities; provided, however, that the Company shall not be obligated to file any general consent to
service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified
or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21.
<U>Reporting Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the
exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will use its reasonable best efforts to
file all documents required to be filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange
Act and Exchange Act Regulations. Additionally, the Company shall report the use of proceeds from the issuance of the Public Securities
as may be required under Rule 463 under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22.
<U>Emerging Growth Company Status</U>. The Company shall promptly notify the Representative if the Company ceases to be an Emerging Growth
Company at any time prior to the later of (i) completion of the distribution of the Public Securities within the meaning of the Securities
Act and (ii) fifteen (15) days following the completion of the Lock-Up Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.23.
<U>Press Releases</U>. Prior to the Closing Date and any Option Closing Date, the Company shall not issue any press release or other
communication directly or indirectly or hold any press conference with respect to the Company, its condition, financial or otherwise,
or earnings, business affairs or business prospects (except for routine oral marketing communications in the ordinary course of business
and consistent with the past practices of the Company and of which the Representative is notified), without the prior written consent
of the Representative, which consent shall not be unreasonably withheld, unless in the judgment of the Company and its counsel, and after
notification to the Representative, such press release or communication is required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24.
<U>Sarbanes-Oxley</U>. The Company shall at all times comply in all material respects with all applicable provisions of the Sarbanes-Oxley
Act in effect from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Conditions of Underwriters&rsquo; Obligations</U>. The obligations of the Underwriters to purchase and pay for the Public Securities,
as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date
hereof and as of each of the Closing Date and the Option Closing Date, if any; (ii) the accuracy of the statements of officers of the
Company made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Regulatory Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1.
<U>Effectiveness of Registration Statement; Rule 430A Information</U>. The Registration Statement shall have become effective not later
than 5:30 p.m., Eastern time, on the date of this Agreement or such later date and time as shall be consented to in writing by the Representative,
and, at each of the Closing Date and any Option Closing Date, no stop order suspending the effectiveness of the Registration Statement
or any post-effective amendment thereto shall have been issued by the Commission under the Securities Act, no order preventing or suspending
the use of any Preliminary Prospectus or the Prospectus shall have been issued and no proceedings for any of those purposes shall have
been instituted or are pending or, to the Company&rsquo;s knowledge, contemplated by the Commission. The Company has complied with each
request (if any) from the Commission for additional information. A prospectus containing the Rule 430A Information shall have been filed
with the Commission in the manner and within the time frame required by Rule 424(b) under the Securities Act Regulations or a post-effective
amendment providing such information shall have been filed with, and declared effective by, the Commission in accordance with the requirements
of Rule 430A under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2.
<U>FINRA Clearance</U>. On or before the date of this Agreement, the Representative shall have received clearance from FINRA as to the
amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3.
<U>Exchange Clearance</U>. On the Closing Date, the shares of Common Stock underlying the Public Securities shall have been approved for listing
on the Exchange, subject only to official notice of issuance. On the first Option Closing Date (if any), the Option Shares shall have
been approved for listing on the Exchange, subject only to official notice of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Opinion Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.1.
<U>Closing Date Opinion of Company Counsel</U>. On the Closing Date, the Representative shall have received (i) the opinion and (ii)
a written statement providing certain &ldquo;10b-5&rdquo; negative assurances, in each case, of Lucosky Brookman LLP (&ldquo;<B>Company
Counsel</B>&rdquo;), counsel to the Company, dated the Closing Date and addressed to the Representative, in form and substance reasonably
satisfactory to the Representative and Underwriters Counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.2.
<U>Option Closing Date Opinions of Company Counsel</U>. On the Option Closing Date, if any, the Representative shall have received the
opinion of counsel and letter listed in Section 4.2.1, dated the Option Closing Date, addressed to the Representative and in form and
substance reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the opinion and statements made by
such counsel in its opinion and negative assurance statement delivered on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.3
<U>Closing Date Negative Assurance of Underwriters Counsel</U>. On the Closing Date, the Representative shall have received a written
statement providing certain &ldquo;10b-5&rdquo; negative assurances of Underwriters Counsel, dated the Closing Date and addressed to
the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.4
<U>Option Closing Date Negative Assurance of Underwriters Counsel</U>. On the Option Closing Date, if any, the Representative shall have
received the letter listed in Section 4.2.3, dated the Option Closing Date, addressed to the Representative and in form and substance
reasonably satisfactory to the Representative, confirming as of the Option Closing Date, the statements made by such counsel in its negative
assurance statement delivered on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.
<U>Comfort Letters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1.
<U>Cold Comfort Letter</U>. At the time this Agreement is executed, the Representative shall have received a cold comfort letter from
the Auditor containing statements and information of the type customarily included in accountants&rsquo; comfort letters with respect
to the financial statements and certain financial information contained in the Registration Statement, the Pricing Disclosure Package
and the Prospectus, addressed to the Representative as representative of the Underwriters and in form and substance satisfactory to Underwriters
Counsel, dated as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.2.
<U>Bring-down Comfort Letter</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received
from the Auditor a letter, dated as of the Closing Date or the Option Closing Date, as applicable, to the effect that the Auditor reaffirms
the statements made in the letter furnished pursuant to Section 4.3.1, except that the specified date referred to shall be a date not
more than three (3) Business Days prior to the Closing Date or the Option Closing Date, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.
<U>Officers&rsquo; Certificates</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.1.
<U>Officers&rsquo; Certificate</U>. The Company shall have furnished to the Representative a certificate, dated the Closing Date and
any Option Closing Date (if such date is other than the Closing Date), of its Chief Executive Officer or President stating on behalf
of the Company and not in an individual capacity that (i) such officer has carefully examined the Registration Statement, the Pricing
Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and, such officer believes that the Registration Statement
and each amendment thereto after the Effective Date, as of the Applicable Time and as of the Closing Date (or any Option Closing Date
if such date is other than the Closing Date) did not include any untrue statement of a material fact and did not omit to state a material
fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading, and the Pricing Disclosure Package, as of the Applicable Time and as of the Closing Date (or any Option Closing Date
if such date is other than the Closing Date), any Issuer Free Writing Prospectus as of its date and as of the Closing Date (or any Option
Closing Date if such date is other than the Closing Date), the Prospectus and each amendment or supplement thereto after the Effective
Date, as of the respective date thereof and as of the Closing Date, did not include any untrue statement of a material fact and did not
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading, (ii) since the Effective Date of the Registration Statement, no event has occurred which should have been set forth
in a supplement or amendment to the Registration Statement, the Pricing Disclosure Package or the Prospectus, (iii) to the best of such
officer&rsquo;s knowledge after reasonable investigation, as of the Closing Date (or any Option Closing Date if such date is other than
the Closing Date), the representations and warranties of the Company in this Agreement are true and correct and the Company has complied
with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date (or
any Option Closing Date if such date is other than the Closing Date), and (iv) there has not been, subsequent to the date of the most
recent audited financial statements included in the Pricing Disclosure Package, a Material Adverse Change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4.2.
<U>Secretary&rsquo;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have
received a certificate of the Company signed by the Secretary of the Company, dated the Closing Date or the Option Closing Date, as the
case may be, respectively, certifying on behalf of the Company and not in an individual capacity: (i) that each of the Charter and Bylaws
is true and complete, has not been amended or modified and is in full force and effect; (ii) that the resolutions of the Company&rsquo;s
Board of Directors relating to the Offering are in full force and effect and have not been modified or rescinded; and (iii) as to the
incumbency of the officer of the Company who has signed the certificate set forth in Section 4.4.1. The documents referred to in such
certificate shall be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5.
<U>No Material Changes</U>. Prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been
no Material Adverse Change in the condition, financial or otherwise, business or prospects of the Company from the date of this Agreement;
(ii) no action, suit or proceeding, at law or in equity, shall have been pending or, to the knowledge of the Company, threatened against
the Company or any Insider before or by any court or federal or state commission, board or other administrative agency wherein an unfavorable
decision, ruling or finding may reasonably be expected to cause a Material Adverse Change, except as set forth in the Registration Statement,
the Pricing Disclosure Package and the Prospectus; (iii) no stop order shall have been issued by the Commission under the Securities
Act and no proceedings therefor shall have been initiated or threatened by the Commission; and (iv) the Registration Statement, the Pricing
Disclosure Package and the Prospectus and any amendments or supplements thereto shall contain all material statements which are required
to be stated therein in accordance with the Securities Act and the Securities Act Regulations and shall conform in all material respects
to the requirements of the Securities Act and the Securities Act Regulations, and neither the Registration Statement, the Pricing Disclosure
Package nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6.
<U>No Material Misstatement or Omission</U>. The Underwriters shall not have discovered and disclosed to the Company on or prior to the
Closing Date and any Option Closing Date that the Registration Statement or any amendment or supplement thereto contains an untrue statement
of a fact which, in the opinion of Underwriters Counsel, is material or omits to state any fact which, in the opinion of such counsel,
is material and is required to be stated therein or is necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading, or that the Registration Statement, the Pricing Disclosure Package, any Issuer Free Writing Prospectus
or the Prospectus or any amendment or supplement thereto contains an untrue statement of fact which, in the opinion of Underwriters Counsel,
is material or omits to state any fact which, in the opinion of Underwriters Counsel, is material and is necessary in order to make the
statements, in the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7.
<U>Corporate Proceedings</U>. All corporate proceedings and other legal matters incident to the authorization, form and validity of each
of this Agreement, the Public Securities, the Registration Statement, the Pricing Disclosure Package, each Issuer Free Writing Prospectus,
if any, and the Prospectus and all other legal matters relating to this Agreement, the Representative&rsquo;s Warrant Agreement and the
transactions contemplated hereby and thereby shall be reasonably satisfactory in all material respects to Underwriters Counsel, and the
Company shall have furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon
such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.
<U>Delivery of Agreements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.1.
<U>Lock-Up Agreements</U>. On or before the date of this Agreement, the Company shall have delivered to the Representative executed copies
of the Lock-Up Agreements from each of the persons listed in <U>Schedule 4</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8.2.
<U>Representative&rsquo;s Warrant Agreement</U>. On the Closing Date, the Company shall have delivered to the Representative an executed
copy of the Representative&rsquo;s Warrant Agreement as set forth in <U>Exhibit A</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9.
<U>Additional Documents</U>. At the Closing Date and at each Option Closing Date (if any) Underwriters Counsel shall have been furnished
with such documents as they may reasonably require for the purpose of enabling Underwriters Counsel to deliver an opinion to the Underwriters,
or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions, herein
contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Securities and the Representative&rsquo;s
Securities as herein contemplated shall be satisfactory in form and substance to the Representative and its counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.
<U>Indemnification of the Underwriters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.1.
<U>General</U>. The Company shall indemnify and hold harmless each Underwriter, its affiliates and each of its and their respective directors,
officers, members, employees, representatives, partners, shareholders, affiliates, counsel and agents and each person, if any, who controls
any such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively the &ldquo;<B>Underwriter
Indemnified Parties</B>,&rdquo; and each an &ldquo;<B>Underwriter Indemnified Party</B>&rdquo;), against any and all loss, liability,
claim, damage and expense whatsoever (including but not limited to any and all legal or other expenses reasonably incurred in investigating,
preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, between any of the Underwriter Indemnified
Parties and any third party, or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act
or any other statute or at common law or otherwise or under the laws of foreign countries, arising out of or based upon any untrue statement
or alleged untrue statement of a material fact contained in (i) the Registration Statement, the Pricing Disclosure Package, the Preliminary
Prospectus, the Prospectus or any Issuer Free Writing Prospectus (as from time to time each may be amended and supplemented); (ii) any
materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the Offering,
including any &ldquo;road show&rdquo; or investor presentations made to investors by the Company (whether in person or electronically);
or (iii) any application or other document or written communication (in this Section 5, collectively called &ldquo;<B>application</B>&rdquo;)
executed by the Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the Public
Securities and Representative&rsquo;s Securities under the securities laws thereof or filed with the Commission, any state securities
commission or agency, the Exchange or any other national securities exchange; or the omission or alleged omission therefrom of a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading, unless such statement or omission was made in reliance upon, and in conformity with, the Underwriters&rsquo; Information.
With respect to any untrue statement or omission or alleged untrue statement or omission made in the Registration Statement, the Pricing
Disclosure Package, the Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus, the indemnity agreement contained
in this Section 5.1.1 shall not inure to the benefit of any Underwriter Indemnified Party to the extent that any loss, liability, claim,
damage or expense of such Underwriter Indemnified Party results from the fact that a copy of the Prospectus was not given or sent to
the person asserting any such loss, liability, claim or damage at or prior to the written confirmation of sale of the Public Securities
to such person as required by the Securities Act and the Securities Act Regulations, and if the untrue statement or omission has been
corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of non-compliance by the Company with its obligations
under Section 3.4 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.2.
<U>Procedure</U>. If any action is brought against an Underwriter Indemnified Party in respect of which indemnity may be sought against
the Company pursuant to Section 5.1.1, such Underwriter Indemnified Party shall promptly notify the Company in writing of the institution
of such action and the Company shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly
notified indemnifying party, to assume the defense of such action, including the employment and fees of counsel (subject to the reasonable
approval of such Underwriter Indemnified Party) and payment of actual expenses. Such Underwriter Indemnified Party shall have the right
to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Underwriter
Indemnified Party unless (i) the employment of such counsel at the expense of the Company shall have been authorized in writing by the
Company in connection with the defense of such action, or (ii) the Company shall not have employed counsel to have charge of the defense
of such action, or (iii) such indemnified party or parties shall have been advised by its counsel that there may be defenses available
to it or them which are different from or additional to those available to the Company (in which case the Company shall not have the
right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events the reasonable fees
and expenses of not more than one additional firm of attorneys selected by the Underwriter Indemnified Parties who are party to such
action (in addition to local counsel) shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if any
Underwriter Indemnified Party shall assume the defense of such action as provided above, the Company shall have the right to approve
the terms of any settlement of such action, which approval shall not be unreasonably withheld, conditioned or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.
<U>Indemnification of the Company</U>. Each Underwriter, severally and not jointly, shall indemnify and hold harmless the Company, its
directors, its officers and persons who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act against any and all loss, liability, claim, damage and expense described in the foregoing indemnity from the Company to
the several Underwriters, as incurred, but only with respect to such losses, liabilities, claims, damages and expenses (or actions in
respect thereof) which arise out of or are based upon untrue statements or omissions made in the Registration Statement, any Preliminary
Prospectus, the Pricing Disclosure Package or Prospectus or any amendment or supplement thereto or in any application, in reliance upon,
and in strict conformity with, the Underwriters&rsquo; Information. In case any action shall be brought against the Company or any other
person so indemnified based on any Preliminary Prospectus, the Registration Statement, the Pricing Disclosure Package or Prospectus or
any amendment or supplement thereto or any application, and in respect of which indemnity may be sought against any Underwriter, such
Underwriter shall have the rights and duties given to the Company, and the Company and each other person so indemnified shall have the
rights and duties given to the several Underwriters by the provisions of Section 5.1.2. The Company agrees promptly to notify the Representative
of the commencement of any litigation or proceedings against the Company or any of its officers, directors or any person, if any, who
controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, in connection with the
issuance and sale of the Public Securities or in connection with the Registration Statement, the Pricing Disclosure Package, the Prospectus
or any Issuer Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.
<U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.1.
<U>Contribution Rights</U>. If the indemnification provided for in this Section 5 shall for any reason be unavailable to or insufficient
to hold harmless an indemnified party under Section 5.1 or 5.2 in respect of any loss, claim, damage or liability, or any action in respect
thereof, referred to therein, then each indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the amount
paid or payable by such indemnified party as a result of such loss, claim, damage or liability, or action in respect thereof, (i) in
such proportion as shall be appropriate to reflect the relative benefits received by the Company, on the one hand, and each of the Underwriters,
on the other hand, from the Offering, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of
the Company, on the one hand, and the Underwriters, on the other, with respect to the statements or omissions that resulted in such loss,
claim, damage or liability, or action in respect thereof, as well as any other relevant equitable considerations. The relative benefits
received by the Company, on the one hand, and the Underwriters, on the other, with respect to such Offering shall be deemed to be in
the same proportion as the total proceeds from the Offering purchased under this Agreement (before deducting expenses) received by the
Company bear to the total underwriting discount and commissions received by the Underwriters in connection with the Offering, in each
case as set forth in the table on the cover page of the Prospectus. The relative fault of the Company, on the one hand, and the Underwriters,
on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the
Underwriters, on the other, the intent of the parties and their relative knowledge, access to information and opportunity to correct
or prevent such untrue statement, omission, act or failure to act; provided that the parties hereto agree that the written information
furnished to the Company through the Representative by or on behalf of any Underwriter for use in any Preliminary Prospectus, any Registration
Statement or the Prospectus, or in any amendment or supplement thereto, consists solely of the Underwriters&rsquo; Information. The Company
and the Underwriters agree that it would not be just and equitable if contributions pursuant to this Section 5.3.1 were to be determined
by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to
herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage, expense, liability, action, investigation
or proceeding referred to above in this Section 5.3.1 shall be deemed to include, for purposes of this Section 5.3.1, any legal or other
expenses reasonably incurred by such indemnified party in connection with investigating, preparing to defend or defending against or
appearing as a third party witness in respect of, or otherwise incurred in connection with, any such loss, claim, damage, expense, liability,
action, investigation or proceeding. Notwithstanding the provisions of this Section 5.3.1 no Underwriter shall be required to contribute
any amount in excess of the total discount and commission received by such Underwriter in connection with the Offering. No person guilty
of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.2.
<U>Contribution Procedure</U>. Within fifteen (15) days after receipt by any party to this Agreement (or its representative) of notice
of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made
against another party (&ldquo;<B>contributing party</B>&rdquo;), notify the contributing party of the commencement thereof, but the failure
to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution
hereunder. In case any such action, suit or proceeding is brought against any party, and such party notifies a contributing party or
its representative of the commencement thereof within the aforesaid 15 days, the contributing party will be entitled to participate therein
with the notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any
party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking contribution
without the written consent of such contributing party. The contribution provisions contained in this Section 5.3.2 are intended to supersede,
to the extent permitted by law, any right to contribution under the Securities Act, the Exchange Act or otherwise available. The Underwriters&rsquo;
obligations to contribute as provided in this Section 5.3 are several and in proportion to their respective underwriting obligation,
and not joint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Default by an Underwriter</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.
<U>Default Not Exceeding 10% of Firm Shares or Option Shares</U>. If any Underwriter or Underwriters shall default in its or their obligations
to purchase the Firm Shares or the Option Shares, if the Over-Allotment Option is exercised hereunder, and if the number of the Firm Shares
or Option Shares with respect to which such default relates does not exceed in the aggregate 10% of the number of Firm Shares or Option
Shares that all Underwriters have agreed to purchase hereunder, then such Firm Shares or Option Shares to which the default relates shall
be purchased by the non-defaulting Underwriters in proportion to their respective commitments hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2.
<U>Default Exceeding 10% of Firm Shares or Option Shares</U>. In the event that the default addressed in Section 6.1 relates to more than
10% of the Firm Shares or Option Shares, the Representative may in its discretion arrange for itself or for another party or parties to
purchase such Firm Shares or Option Shares to which such default relates on the terms contained herein. If, within one (1) Business Day
after such default relating to more than 10% of the Firm Shares or Option Shares, the Representative does not arrange for the purchase
of such Firm Shares or Option Shares, then the Company shall be entitled to a further period of one (1) Business Day within which to procure
another party or parties reasonably satisfactory to the Representative to purchase said Firm Shares or Option Shares on such terms. In
the event that neither the Representative nor the Company arrange for the purchase of the Firm Shares or Option Shares to which a default
relates as provided in this Section 6, this Agreement will automatically be terminated by the Representative or the Company without liability
on the part of the Company (except as provided in Sections 3.10 hereof), or the several Underwriters; provided, however, that if such
default occurs with respect to the Option Shares or Option Warrants, this Agreement will not terminate as to the Firm Shares; and provided,
further, that nothing herein shall relieve a defaulting Underwriter of its liability, if any, to the other Underwriters and to the Company
for damages occasioned by its default hereunder. For the avoidance of doubt, nothing contained in this Section shall excuse a default
by the Representative (in its capacity as an Underwriter) in its obligations to purchase the Firm Shares or the Option Shares, if the
Over-Allotment Option is exercised hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3.
<U>Postponement of Closing Date</U>. In the event that the Firm Shares or Option Shares to which the default relates are to be purchased
by the non-defaulting Underwriters, or are to be purchased by another party or parties as aforesaid, the Representative or the Company
shall have the right to postpone the Closing Date or Option Closing Date for a reasonable period, but not in any event exceeding five
(5) Business Days, in order to effect whatever changes may thereby be made necessary in the Registration Statement, the Pricing Disclosure
Package or the Prospectus or in any other documents and arrangements, and the Company agrees to file promptly any amendment to the Registration
Statement, the Pricing Disclosure Package or the Prospectus that in the opinion of Underwriters Counsel may thereby be made necessary.
The term &ldquo;<B>Underwriter</B>&rdquo; as used in this Agreement shall include any party substituted under this Section 6 with like
effect as if it had originally been a party to this Agreement with respect to such Firm Shares or Option Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Additional Covenants</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1.
<U>Board Composition and Board Designations</U>. The Company shall ensure that: (i) the qualifications of the persons serving as members
of the Board of Directors and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act, the Exchange Act
and the listing rules of the Exchange or any other national securities exchange, as the case may be, in the event the Company seeks to
have its Public Securities listed on another exchange or quoted on an automated quotation system, and (ii) if applicable, at least one
member of the Audit Committee of the Board of Directors qualifies as an &ldquo;audit committee financial expert,&rdquo; as such term
is defined under Regulation S-K and the listing rules of the Exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2.
<U>Prohibition on Press Releases and Public Announcements</U>. The Company shall not issue press releases or engage in any other publicity,
without the Representative&rsquo;s prior written consent (which consent shall not be unreasonably withheld), for a period ending at 5:00
p.m., Eastern time, on the first (1<SUP>st</SUP>) Business Day following the fortieth (40<SUP>th</SUP>) day after the Closing Date, other
than normal and customary releases issued in the ordinary course of the Company&rsquo;s business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3.
<U>Right of First Refusal</U>. Following the Closing of the Offering, the Representative shall have an irrevocable right of first refusal
(the &ldquo;<B>Right of First Refusal</B>&rdquo;), for a period of twelve (12) months after the date the Offering is completed (the &ldquo;<B>RoFR
Period</B>&rdquo;), to act as sole investment banker, sole book-runner, and/or sole underwriter, at the Representative&rsquo;s sole discretion,
for each and every future public and private equity and debt offering, including all equity linked financings (each, a &ldquo;Subject
Transaction&rdquo;), during such twelve (12) month period, of the Company, or any successor to or any current or future subsidiary of
the Company, on terms and conditions customary to the Representative for such Subject Transactions. The Representative shall have the
sole right to determine whether or not any other broker dealer shall have the right to participate in a Subject Transaction and the economic
terms of such participation. For the avoidance of any doubt, the Company shall not retain, engage or solicit any additional investment
banker, book-runner, financial advisor, underwriter and/or placement agent in a Subject Transaction without the express written consent
of the Representative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Effective Date of this Agreement and Termination Thereof</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1.
<U>Effective Date</U>. This Agreement shall become effective when both the Company and the Representative have executed the same and
delivered counterparts of such signatures to the other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2.
<U>Termination</U>. The Representative shall have the right to terminate this Agreement at any time prior to any Closing Date, (i) if
any domestic or international event or act or occurrence has materially disrupted, or in the Representative&rsquo;s reasonable opinion
will in the immediate future materially disrupt, general securities markets in the United States; or (ii) if trading on the New York
Stock Exchange or the Nasdaq Stock Market LLC shall have been suspended or materially limited, or minimum or maximum prices for trading
shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or
any other government authority having jurisdiction; or (iii) if the United States shall have become involved in a new war or an escalation
in major hostilities; or (iv) if a banking moratorium has been declared by a New York State or federal authority; or (v) if a moratorium
on foreign exchange trading has been declared which materially adversely impacts the United States securities markets; or (vi) if the
Company shall have sustained a material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious
act which, whether or not such loss shall have been insured, will, in the Representative&rsquo;s opinion, make it inadvisable to proceed
with the delivery of the Firm Shares or Option Shares; or (vii) if the Company is in material breach of any of its representations, warranties
or covenants hereunder; or (viii) if the Representative shall have become aware after the date hereof of a Material Adverse Change, or
an adverse material change in general market conditions as in the Representative&rsquo;s judgment would make it impracticable to proceed
with the offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriters for the sale of the
Public Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3.
<U>Expenses</U>. Notwithstanding anything to the contrary in this Agreement, except in the case of a default by the Underwriters, pursuant
to Section 6.2 above, in the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified
herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Underwriters their actual
and accountable out-of-pocket expenses related to the transactions contemplated herein then due and payable up to $175,000 less amounts
previously advanced, and upon demand the Company shall pay the full amount thereof to the Representative on behalf of the Underwriters
and the Representative shall return any portion of the Advance not used to pay its accountable out-of-pocket expenses actually incurred;
provided, however, that such expense cap in no way limits or impairs the indemnification and contribution provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4.
<U>Survival of Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any
termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Section 5 shall remain in
full force and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this
Agreement or any part hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1.
<U>Notices</U>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed
(registered or certified mail, return receipt requested), personally delivered or sent by email and confirmed and shall be deemed given
when so delivered or emailed and confirmed or if mailed, two (2) days after such mailing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Representative:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
Capital, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 5<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn.:
Jonathan Gazdak - Managing Director - Head of Investment Banking</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct:
(646) 787-8898</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
<U>jgazdak@alexandercapitallp.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carmel,
Milazzo &amp; Feil LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55
West 39th Street</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18th
Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Ross Carmel, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
rcarmel@cmfllp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11550
N. Meridian Street, Suite 325</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carmel,
IN 46032</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Mr. Brian Carrico, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>bcarrico@neuraxis.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
a copy (which shall not constitute notice) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South, 5th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
NJ 08830</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Joseph M. Lucosky, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
jlucosky@lucbro.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2.
<U>Headings</U>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3.
<U>Amendment</U>. This Agreement may only be amended by a written instrument executed by each of the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4.
<U>Entire Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection
with this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5.
<U>Binding Effect</U>. This Agreement shall inure solely to the benefit of the parties hereto and the indemnified parties referred to
in Section 5 and their respective successors, heirs and assigns, and shall be binding upon each of them, and no other person shall have
or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any provisions
herein contained. The term &ldquo;successors and assigns&rdquo; shall not include a purchaser, in its capacity as such, of securities
from any of the Underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6.
<U>Governing Law; Consent to Jurisdiction; Trial by Jury</U>. This Agreement shall be governed by and construed and enforced in accordance
with the law of the State of New York. The Company hereby agrees that any action, proceeding or claim against it arising out of, or relating
in any way to this Agreement shall be brought and enforced in the Supreme Court of the State of New York sitting in the County of New
York, or in the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which
jurisdiction shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent
an inconvenient forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered
or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.1 hereof. Such mailing
shall be deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company agrees
that the prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo;
fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company (on
its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each of the Underwriters
hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7.
<U>Execution in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the
same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
to each of the other parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall
constitute valid and sufficient delivery thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8.
<U>Waiver</U>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed
or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision hereof or
the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach, non-compliance
or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by
the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or
non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[Signature
Page Follows]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided
below for that purpose, whereupon this letter shall constitute a binding agreement between us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
    Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confirmed
as of the date first written above, on behalf of itself and as Representative of the several Underwriters named on <U>Schedule 1</U>
hereto:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ALEXANDER
    CAPITAL, L.P. </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan Gazdak</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head of Investment Banking</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Signature
Page]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEURAXIS,
INC</B><FONT STYLE="font-variant: small-caps">. &ndash; <B>UNDERWRITING AGREEMENT</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total Number of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Firm Shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>to be Purchased</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Option Shares to be Purchased if the Over-Allotment Option is Fully Exercised</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Alexander Capital, L.P.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt">TOTAL</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
3-A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pricing
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Firm Shares: [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Option Shares: [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Option Warrants: [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Firm Share: $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
Offering Price per Option Share: $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Discount per Firm Share: $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting
Discount per Option Share: $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Firm Share (before expenses): $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Option Share (before expenses): $[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
to Company per Option Warrant (before expenses): $ [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
3-B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issuer
General Use Free Writing Prospectuses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Free
Writing Prospectus filed with the SEC on January 26, 2023, 2023 and linked to here: https://www.sec.gov/Archives/edgar/data/1933567/000149315223002553/formfwp.htm</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULE
4</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>List
of Lock-Up Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
    Inc.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Timothy
    Henrichs</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
    Carrico</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    Seale</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Peterson</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dan
    Clarence</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
Robin Brown</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bradley
    Mitch Watkins</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beth
    Keyser</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adrian
    Miranda</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5%
Holders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Masimo
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian P. Hannasch</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Representative&rsquo;s Warrant Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY (180) DAYS FOLLOWING THE COMMENCEMENT OF SALES OF THE OFFERING TO
ANYONE OTHER THAN (I) ALEXANDER CAPITAL, L.P., OR A REPRESENTATIVE OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA
FIDE OFFICER OR PARTNER OF ALEXANDER CAPITAL, L.P., OR OF ANY SUCH UNDERWRITERS OR SELECTED DEALER.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [&#9679;], 2028.<SUP>2</SUP> VOID AFTER 5:00 P.M., EASTERN TIME, [&#9679;], 2028.<SUP>3</SUP></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERWRITER&rsquo;S
WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE PURCHASE OF </B>[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SHARES
OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEURAXIS,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Purchase Warrant</U>. THIS CERTIFIES THAT, pursuant to that certain Underwriting Agreement by and between Neuraxis, Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), on one hand, and Alexander Capital, L.P., on the other hand, dated [&#9679;], 2023, as
amended (the &ldquo;<B>Underwriting Agreement</B>&rdquo;), [&#9679;] (&ldquo;<B>Holder</B>&rdquo;) and its assignees, as registered holders
of this Purchase Warrant, is entitled, at any time or from time to time from [&#9679;], 2023 (the &ldquo;<B>Exercise Date</B>&rdquo;),
the date that is six (6) months after the effective date of the Company&rsquo;s Registration Statement on Form S-1 with the Securities
and Exchange Commission (the &ldquo;<B>Effective Date</B>&rdquo;), and at or before 5:00 p.m., Eastern time, on [&#9679;], 2023 (five
(5) years from the Effective Date) (the &ldquo;<B>Expiration Date</B>&rdquo;), but not thereafter, to subscribe for, purchase and receive,
in whole or in part, up to [&#9679;] shares of Common Stock of the Company, $0.001 par value per share (the &ldquo;<B>Common Stock</B>&rdquo;)
(equal to six (6.0%) percent of the Common Stock sold in the offering), subject to adjustment as provided in <U>Section 6</U> hereof.
If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised
on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date,
the Company agrees not to take any action that would terminate this purchase warrant (&ldquo;<B>Purchase Warrant</B>&rdquo;). This Purchase
Warrant is initially exercisable at $[&#9679;] per share of Common Stock (120% of the price of the Common Stock sold in the Offering);
<I>provided, however,</I> that upon the occurrence of any of the events specified in <U>Section 6</U> hereof, the rights granted by this
Purchase Warrant, including the exercise price per share and the number of shares of Common Stock to be received upon such exercise,
shall be adjusted as therein specified. The term &ldquo;<B>Exercise Price</B>&rdquo; shall mean the initial exercise price as set forth
above or the adjusted exercise price as a result of the events set forth in Section 6 below, depending on the context.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><SUP>2</SUP> A date that is 180 days after the
Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><SUP>3</SUP> A date that is five years after the
Effective Date.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 47; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Exercise Form</U>. In order to exercise this Purchase Warrant, the exercise form attached hereto as <U>Exhibit A</U> must be duly
executed and completed and delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Common
Stock being purchased payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified
check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date,
this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Cashless Exercise</U>. At any time after the Exercise Date and until the Expiration Date, Holder may elect to receive the number of
shares of Common Stock equal to the value of this Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase
Warrant to the Company, together with the exercise form attached hereto, in which event the Company shall issue to Holder, Shares in
accordance with the following formula: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X = <U>Y(A-B)</U></FONT></TD>
  </TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B</FONT></TD>
  </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X=The
    number of shares of Common Stock to be issued to Holder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y=The
    number of shares of Common Stock for which the Purchase Warrant is being exercised;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A=The
    fair market value of one share of Common Stock; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B=The
    Exercise Price.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this <U>Section 2.2</U>, the &ldquo;fair market value&rdquo; of a share of Common Stock is defined as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
if the Common Stock is traded on a national securities exchange or the OTCQB Market (or similar quotation system), the value shall be
deemed to be the closing price on such exchange or quotation system the trading day immediately prior to the exercise form being submitted
in connection with the exercise of this Purchase Warrant; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
if there is no market for the Common Stock, the value shall be the fair market value thereof, as determined in good faith by the Company&rsquo;s
Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Legend</U>. Each certificate for the Common Stock purchased under this Purchase Warrant shall bear a legend as follows unless such
Common Stock has been registered under the Securities Act of 1933, as amended (the &ldquo;<B>Act</B>&rdquo;), or are exempt from registration
under the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;The
Common Stock represented by this certificate has not been registered under the Securities Act of 1933, as amended (the &ldquo;Act&rdquo;),
or applicable state law. Neither the Common Stock nor any interest therein may be offered for sale, sold or otherwise transferred except
pursuant to an effective registration statement under the Act, or pursuant to an exemption from registration under the Act and applicable
state law which, in the opinion of counsel to the Company, is available.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Transfer</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>General Restrictions</U>. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder
will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days following
the Effective Date to anyone other than: (i) the Underwriter or a representative or a selected dealer participating in the Offering,
or (ii) a bona fide officer or partner of the Underwriter or of any such selected dealer, in each case in accordance with FINRA Conduct
Rule 5110(g)(1), or (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging, short sale,
derivative, put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the securities
hereunder, except as provided for in FINRA Rule 5110(g)(2). On and after that date that is one hundred eighty (180) days after the Effective
Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. In order to make any
permitted assignment, the Holder must deliver to the Company the assignment form attached hereto as <U>Exhibit B</U> duly executed and
completed, together with this Purchase Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company
shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase
Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number
of shares of Common Stock purchasable hereunder or such portion of such number as shall be contemplated by any such assignment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Restrictions Imposed by the Act</U>. The securities evidenced by this Purchase Warrant shall not be transferred unless and until:
(i) the Company has received the opinion of counsel for the Company that the securities may be transferred pursuant to an exemption from
registration under the Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction
of the Company, (ii) a registration statement or a post-effective amendment to the Registration Statement relating to the offer and sale
of such securities that has been declared effective by the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
and includes a current prospectus or (iii) a registration statement, pursuant to which the Holder has exercised its registration rights
pursuant to Sections 4.1 and 4.2 herein, relating to the offer and sale of such securities has been filed and declared effective by the
Commission and compliance with applicable state securities law has been established.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Registration Rights.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>&ldquo;Piggy-Back&rdquo; Registration</U>. Unless all of the Common Stock underlying the Purchase Warrants (collectively, the &ldquo;<B>Registrable
Securities</B>&rdquo;) are included in an effective registration statement with a current prospectus, the Holder shall have the right,
until the Expiration Date, to include the remaining Registrable Securities as part of any other registration of securities filed by the
Company (other than in connection with a transaction contemplated by Rule 145 promulgated under the Act or pursuant to Form S-8 or any
equivalent form); provided, however, that if, solely in connection with any primary underwritten public offering for the account of the
Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number of shares of Common
Stock of Registrable Securities which may be included in the registration statement because, in such underwriter(s)&rsquo; judgment,
marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated
to include in such registration statement only such limited portion of the Registrable Securities with respect to which the Holder requested
inclusion hereunder as the underwriter shall reasonably permit; and further provided that no such piggy-back rights shall exist for so
long as the Registrable Securities (which term shall include those paid as consideration pursuant to the cashless exercise provisions
of this Warrant) may be sold pursuant to Rule 144 of the Act without restriction. Any exclusion of Registrable Securities shall be made
pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities sought to
be included by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless the Company has
first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such Registration
Statement or are not entitled to pro rata inclusion with the Registrable Securities. In the event of such a proposed registration, the
Company shall furnish the then Holders of outstanding Registrable Securities with not less than fifteen (15) days written notice prior
to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration
statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder. The holders of the
Registrable Securities shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice, within seven
(7) days of the receipt of the Company&rsquo;s notice of its intention to file a registration statement. Except as otherwise provided
in this Purchase Warrant, there shall be no limit on the number of times the Holder may request registration under this Section 4.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Mandatory Registration</U>. Solely in the event there is not then a current registration statement concerning the resale of the Registrable
Securities, the Company shall prepare and file with the SEC on one occasion at its sole expense, upon the written notice of the Holder
at any time commencing six (6) months after the date that this Warrant becomes exercisable and on or before the fifth anniversary date
of the Effective Date, a required registration statement (the &ldquo;Required Registration Statement&rdquo;) concerning the resale of
all of the Registrable Securities. The Required Registration Statement shall be on Form F-3 if available for such a registration and
if unavailable, the Company shall register the resale of the Registrable Securities on Form S-1 or another appropriate form reasonably
acceptable to the Holder and undertake to register the resale of the Registrable Securities on Form F-3 as soon as such form is available,
provided that the Company shall maintain the effectiveness of all Registration Statements then in effect until such time as a Registration
Statement on Form F-3 covering the resale of all of the Registrable Securities has been declared effective by the SEC and the prospectus
contained therein is available for use. Within ten (10) days after receiving written notice from the Holder, the Company shall give notice
to the other Holders of the Purchase Warrants advising that the Company is proceeding with such registration statement and offering to
include therein Purchase Warrants of such other Holders. The Company shall not be obligated to any such other Holder unless such other
Holder shall accept such offer by notice in writing to the Company within five (5) days thereafter. The Company shall use its best efforts
to have such Required Registration Statement, and each other Registration Statement required to be filed pursuant to the terms of this
Purchase Warrant, declared effective by the SEC as soon as practicable. The Company shall pay the costs and expenses thereof, for one
time only, which costs and expenses shall include &ldquo;Blue Sky&rdquo; fees for counsel for the Underwriter and &ldquo;Blue Sky&rdquo;
filing fees to qualify the Purchase Warrants in those jurisdictions requested by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>General Terms</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.1
<U>Expenses of Registration</U>. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant
to Section 4 hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by
the Holders to represent them in connection with the sale of the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.2
<U>Indemnification</U>. The Company shall indemnify, to the fullest extent permitted by applicable laws, the Holder(s) of the Registrable
Securities to be sold pursuant to any registration statement hereunder and each person, if any, who controls such Holders within the
meaning of Section 15 of the Act or Section 20 (a) of the Securities Exchange Act of 1934, as amended (&ldquo;<B>Exchange Act</B>&rdquo;),
against all loss, claim, damage, expense or liability (including all reasonable attorneys&rsquo; fees and other expenses reasonably incurred
in investigating, preparing or defending against any claim whatsoever) to which any of them may become subject under the Act, the Exchange
Act or otherwise, arising from such registration statement but only to the same extent and with the same effect as the provisions pursuant
to which the Company has agreed to indemnify the Underwriter contained in Section 6 of the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.3
<U>Exercise of Purchase Warrants</U>. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise
their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.4
<U>Documents to be Delivered by Holder(s).</U> Each of the Holder(s) participating in any registration statement filed by the Company
shall furnish to the Company a completed and executed questionnaire provided by the Company requesting information customarily sought
of selling security holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.5
<U>Damages</U>. Should the registration or the effectiveness thereof required by <U>Section 4</U> hereof be delayed by the Company or
the Company otherwise fails to comply with such provisions, the Holder(s) shall, in addition to any other legal or other relief available
to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief against the threatened
breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages and without the necessity
of posting bond or other security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>New Purchase Warrants to be Issued</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Partial Exercise or Transfer</U>. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned
in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation,
together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax if exercised
pursuant to Section 2.1 hereof, the Company shall cause to be delivered to the Holder without charge a new Purchase Warrant of like tenor
to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number of shares of Common Stock
purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Lost Certificate</U>. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of
this Purchase Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver
a new Purchase Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft,
mutilation or destruction shall constitute a substitute contractual obligation on the part of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Adjustments to Exercise Price and Number of Shares of Common Stock</U>. The Exercise Price and the number of shares of Common Stock
underlying this Purchase Warrant shall be subject to adjustment from time to time as hereinafter set forth:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.1
<U>Share Dividends; Split Ups</U>. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of shares
of outstanding Common Stock is increased by a stock dividend payable in Common Stock or by a split up of the Common Stock or other similar
event, then, on the effective day thereof, the number of shares of Common Stock purchasable hereunder shall be increased in proportion
to such increase in outstanding shares of Common Stock, and the Exercise Price shall be proportionately decreased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.2
<U>Aggregation of Shares of Common Stock</U>. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number
of outstanding shares of Common Stock is decreased by a consolidation, combination or reclassification of the Common Stock or other similar
event, then, on the effective date thereof, the number of shares of Common Stock purchasable hereunder shall be decreased in proportion
to such decrease in outstanding shares, and the Exercise Price shall be proportionately increased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.3
<U>Replacement of Common Stock upon Reorganization, etc</U>. In case of any reclassification or reorganization of the outstanding Common
Stock other than a change covered by Section 6.1.1 or Section 6.1.2 hereof or that solely affects the par value of such Common Stock,
or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation (other than
a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and that does not result in
any reclassification or reorganization of the outstanding Common Stock), or in the case of any sale or conveyance to another corporation
or entity of the property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved,
the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this Purchase Warrant)
to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such event, the kind
and amount of Common Stock or other securities or property (including cash) receivable upon such reclassification, reorganization, share
reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the number
of shares of Common Stock of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any
reclassification also results in a change in Common Stock covered by Section 6.1.1 or Section 6.1.2, then such adjustment shall be made
pursuant to Section 6.1.1, Section 6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive
reclassifications, reorganizations, share reconstructions or amalgamations, or consolidations, sales or other transfers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.4
<U>Fundamental Transaction</U>. If, at any time while this Purchase Warrant is outstanding, (i) the Company, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of the Common Stock are permitted to sell, tender or
exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common
Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or
recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into
or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions
consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spinoff or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of
the outstanding Common Stock (not including any Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with, the other Persons making or party to such stock or share purchase agreement or other business combination) (each
a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then, upon any subsequent exercise of this Purchase Warrant, the Holder shall have the
right to receive, for each Purchase Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence
of such Fundamental Transaction, the number Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
corporation, and any additional or alternative consideration (the &ldquo;<B>Alternative Consideration</B>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Purchase Warrant is exercisable immediately
prior to such Fundamental Transaction. For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternative Consideration based on the amount of Alternative Consideration issuable in respect of one share
of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternative Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternative Consideration. If holders of the
Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder
shall be given the same choice as to the Alternative Consideration it receives upon any exercise of this Purchase Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the &ldquo;<B>Successor Entity</B>&rdquo;) to assume in writing all of the obligations of the Company under this Purchase Warrant, and
to deliver to the Holder in exchange for this Purchase Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Purchase Warrant which is exercisable for a corresponding number of shares of capital stock of
such Successor Entity (or its parent entity) equivalent to the Common Stock acquirable and receivable upon exercise of this Purchase
Warrant prior to such Fundamental Transaction, and with an exercise price which applies the Exercise Price hereunder to such shares of
capital stock (but taking into account the relative value of the Common Stock pursuant to such Fundamental Transaction and the value
of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the
economic value of this Purchase Warrant immediately prior to the consummation of such Fundamental Transaction). Upon the occurrence of
any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such
Fundamental Transaction, the provisions of this Purchase Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of, the Company and shall assume all of the obligations
of the Company, under this Purchase Warrant and the other Transaction Documents with the same effect as if such Successor Entity had
been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1.5
<U>Changes in Form of Purchase Warrant</U>. This form of Purchase Warrant need not be changed because of any change pursuant to this
Section 6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of shares of Common
Stock as are stated in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance
of new Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring
after the date hereof or the computation thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Substitute Purchase Warrant</U>. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the
Company with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in
any reclassification or change of the outstanding Common Stock), the corporation formed by such consolidation or share reconstruction
or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase Warrant
then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant) to receive,
upon exercise of such Purchase Warrant, the kind and amount of shares of Common Stock and other securities and property receivable upon
such consolidation or share reconstruction or amalgamation, by a holder of the number of shares of Common Stock of the Company for which
such Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation, sale or
transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided for in
this Section 6. The above provision of this Section 6 shall similarly apply to successive consolidations or share reconstructions or
amalgamations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Elimination of Fractional Interests</U>. The Company shall not be required to issue certificates representing fractions of a share
of Common Stock upon the exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional
interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up to the nearest
whole number of shares of Common Stock or other securities, properties or rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Reservation and Listing</U>. The Company shall at all times reserve and keep available out of its authorized Common Stock, solely
for the purpose of issuance upon exercise of this Purchase Warrant, such number of shares of Common Stock or other securities, properties
or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Warrant
and payment of the Exercise Price therefor, in accordance with the terms hereby, all Common Stock and other securities issuable upon
such exercise shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder.
As long as this Purchase Warrant shall be outstanding, the Company shall use its commercially reasonable efforts to cause all Common
Stock issuable upon exercise of this Purchase Warrant to be listed (subject to official notice of issuance) on all national securities
exchanges (or, if applicable, on the OTCQB Market or any successor quotation system) on which the Common Stock issued to the public in
the Offering may then be listed and/or quoted (if at all).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Certain Notice Requirements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1
<U>Holder&rsquo;s Right to Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holders the right to vote or
consent or to receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as
a shareholder of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the
events described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event
at least fifteen days prior to the date fixed as a record date or the date of closing the transfer books (the &ldquo;<B>Notice Date</B>&rdquo;)
for the determination of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription
rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date
or the date of the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each
Holder a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that such notice
is given to the shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.2
<U>Events Requiring Notice</U>. The Company shall be required to give the notice described in this <U>Section 8</U> upon one or more
of the following events: (i) if the Company shall take a record of the holders of its Common Stock for the purpose of entitling them
to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of
retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company
shall offer to all the holders of its Common Stock any additional shares of the Company or securities convertible into or exchangeable
for shares of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding up of
the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially
all of its property, assets and business shall be proposed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.3
<U>Notice of Change in Exercise Price</U>. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant
to <U>Section 6</U> hereof, send notice to the Holders of such event and change (&ldquo;<B>Price Notice</B>&rdquo;). The Price Notice
shall describe the event causing the change and the method of calculating same and shall be certified as being true and accurate by the
Company&rsquo;s Chief Financial Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.4
<U>Transmittal of Notices</U>. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing
and shall be deemed to have been duly made if made in accordance with the notice provisions of the Underwriting Agreement to the addresses
and contact information for the Holder appearing on the books and records of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
to the Holder, then to:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
Capital, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17
State Street, 5<SUP>th</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn.:
Jonathan Gazdak - Managing Director - Head of Investment Banking</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:
<U>jgazdak@alexandercapitallp.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>With
a copy to:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carmel,
Milazzo &amp; Feil LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55
West 39th Street, 18th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, New York 10018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Ross Carmel, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
rcarmel@cmfllp.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>If
to the Company:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11550
N. Meridian Street, Suite 325</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carmel,
IN 46032</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Mr. Brian Carrico, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>bcarrico@neuraxis.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>With
a copy to:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South, 5th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
NJ 08830</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Joseph M. Lucosky</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
jlucosky@lucbro.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Miscellaneous.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1
<U>Amendments</U>. The Company and the Underwriter may from time to time supplement or amend this Purchase Warrant without the approval
of any of the Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or
inconsistent with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that
the Company and the Underwriter may deem necessary or desirable and that the Company and the Underwriter deem shall not adversely affect
the interest of the Holders. All other modifications or amendments shall require the written consent of and be signed by the party against
whom enforcement of the modification or amendment is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.2
<U>Headings</U>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Purchase Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.3
<U>Entire Agreement</U>. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and supersedes
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.4
<U>Binding Effect</U>. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company
and their permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed
to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions
herein contained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.5
<U>Governing Law; Submission to Jurisdiction; Trial by Jury</U>. This Purchase Warrant shall be governed by and construed and enforced
in accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby
agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought
and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New
York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any objection to
such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be served upon the Company
may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to
it at the address set forth in <U>Section 8</U> hereof. Such mailing shall be deemed personal service and shall be legal and binding
upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing party(ies) in any such action
shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to such action
or proceeding and/or incurred in connection with the preparation therefor. The Company (on its behalf and, to the extent permitted by
applicable law, on behalf of its stockholders and affiliates) and the Holder hereby irrevocably waive, to the fullest extent permitted
by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6
<U>Waiver</U>. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not
be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision
hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of
any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in
a written instrument executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any
such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance
or non-fulfillment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.7
<U>Exchange Agreement</U>. As a condition of the Holder&rsquo;s receipt and acceptance of this Purchase Warrant, Holder agrees that,
at any time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and the Underwriter enter into an agreement
(&ldquo;<B>Exchange Agreement</B>&rdquo;) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities
or cash or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.8
<U>Execution in Counterparts</U>. This Purchase Warrant may be executed in one or more counterparts, and by the different parties hereto
in separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the
same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered
to each of the other parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic transmission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>[Signature
Page to Follow]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the [&#9679;]day
of [&#9679;], 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
to be used to exercise Purchase Warrant:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
__________, 20___</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects irrevocably to exercise the Purchase Warrant for ______ shares of Common Stock of Neuraxis, Inc., (the &ldquo;<B>Company</B>&rdquo;)
and hereby makes payment of $____ (at the rate of $____ per share of Common Stock) in payment of the Exercise Price pursuant thereto.
Please issue the Common Stock as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if
applicable, a new Purchase Warrant representing the number of shares of Common Stock for which this Purchase Warrant has not been exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects irrevocably to convert its right to purchase ___ Common Stock under the Purchase Warrant for ______ Common
Stock, as determined in accordance with the following formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD ROWSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; vertical-align: bottom; width: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y(A-B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares of Common Stock to be issued to Holder;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Y</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    number of shares of Common Stock for which the Purchase Warrant is being exercised;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    fair market value of one share of Common Stock which is equal to $_____; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Exercise Price which is equal to $______ per share of Common Stock</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees and acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement
with respect to the calculation shall be resolved by the Company in its sole discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
issue the Common Stock as to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable,
a new Purchase Warrant representing the number of shares of Common Stock for which this Purchase Warrant has not been converted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:
_____________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Guaranteed</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INSTRUCTIONS
FOR REGISTRATION OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:_______________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
in Block Letters)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:
_____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE:
The signature to this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement
or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership
on a registered national securities exchange.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
to be used to assign Purchase Warrant: ASSIGNMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be executed by the registered Holder to effect a transfer of the within Purchase Warrant):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, _______________________________ does hereby sell, assign and transfer unto the right to purchase <B>__________ </B>shares
of Common Stock, Neuraxis, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), evidenced by the Purchase Warrant and does
hereby authorize the Company to transfer such right on the books of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:<B>______</B>,
20<B>____</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature:
_______________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Guaranteed</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or
enlargement or any change whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm
having membership on a registered national securities exchange.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Lock-Up Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Lock-Up
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>for
Officers, Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>and
5% or Greater Shareholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&#9679;]</B>,
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexander
Capital, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45
Broadway, 2<SUP>nd</SUP> Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY 10006</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Mr. Christopher Carlin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, an officer, director and/or holder of common stock (the &ldquo;<B>Common Stock</B>&rdquo;), or rights to acquire shares
of Common Stock (the &ldquo;<B>Shares</B>&rdquo;), of Neuraxis, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), understands
that you are the representative (the &ldquo;<B>Representative</B>&rdquo;) of the several underwriters, if any (collectively, the &ldquo;<B>Underwriters</B>&rdquo;),
named or to be named in the final form of <U>Schedule I</U> to the underwriting agreement (the &ldquo;<B>Underwriting Agreement</B>&rdquo;)
to be entered into among the Underwriters and the Company, providing for the public offering (the &ldquo;<B>Public Offering</B>&rdquo;)
of securities of the Company (the &ldquo;<B>Securities</B>&rdquo;) pursuant to a registration statement filed or to be filed (the &ldquo;<B>Registration
Statement</B>&rdquo;) with the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;). Capitalized terms used herein
and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the Underwriters&rsquo; agreement to enter into the Underwriting Agreement and to proceed with the Public Offering of
the Securities, and for other good and valuable consideration, receipt of which is hereby acknowledged, the undersigned hereby agrees,
for the benefit of the Company, the Representative and the other Underwriters that, without the prior written consent of the Representative,
the undersigned will not, during the period commencing on the date of this Lock-Up Agreement and continuing and including the date that
is one hundred eighty (180) days after the closing of the Public Offering (the &ldquo;<B>Lock-Up Period</B>&rdquo;), directly or indirectly,
unless otherwise provided herein, (a) offer, sell, agree to offer or sell, solicit offers to purchase, grant any call option or purchase
any put option with respect to, pledge, encumber, assign, borrow or otherwise dispose of (each a &ldquo;<B>Transfer</B>&rdquo;) any Relevant
Security (as defined below) or otherwise publicly disclose the intention to do so, or (b) establish or increase any &ldquo;put equivalent
position&rdquo; or liquidate or decrease any &ldquo;call equivalent position&rdquo; with respect to any Relevant Security (in each case
within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and the
rules and regulations thereunder) with respect to any Relevant Security or otherwise enter into any swap, derivative or other transaction
or arrangement that Transfers to another, in whole or in part, any economic consequence of ownership of a Relevant Security, whether
or not such transaction is to be settled by the delivery of Relevant Securities, other securities, cash or other consideration, or otherwise
publicly disclose the intention to do so. As used herein, the term &ldquo;<B>Relevant Security</B>&rdquo; means any Share, any warrant
to purchase Shares or any other security of the Company or any other entity that is convertible into, or exercisable or exchangeable
for, Shares or any other equity security of the Company, in each case owned beneficially or otherwise by the undersigned on the date
of closing of the Public Offering or acquired by the undersigned during the Lock-Up Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
restrictions in the foregoing paragraph shall not apply to: (a) any exercise (including a cashless exercise or broker-assisted exercise
and payment of tax obligations) of options or warrants to purchase Shares; provided that any Shares received upon such exercise, conversion
or exchange will be subject to the Lock-Up Period, (b) any establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange
Act for the transfer of Shares (a &ldquo;<B>Trading Plan</B>&rdquo;); provided that: (i) the Trading Plan shall not provide for or permit
any transfers, sales or other dispositions of Shares during the Lock-Up Period, and (ii) the Trading Plan would not require any filing
under Section 16(a) of the Exchange Act and no such filing is voluntarily made, or (c) any transfer of Shares acquired in open market
transactions following the closing of the Public Offering, provided the transfer would not require any filing under Section 16(a) of
the Exchange Act and no such filing is voluntarily made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the undersigned further agrees that, except for the Registration Statement, during the Lock-Up Period, the undersigned will
not, without the prior written consent of the Representative: (a) file or participate in the filing with the SEC of any registration
statement or circulate or participate in the circulation of any preliminary or final prospectus or other disclosure document, in each
case with respect to any proposed offering or sale of a Relevant Security beneficially owned by the undersigned, or (b) exercise any
rights the undersigned may have to require registration with the SEC of any proposed offering or sale of a Relevant Security beneficially
owned by the undersigned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
furtherance of the undersigned&rsquo;s obligations hereunder, the undersigned hereby authorizes the Company during the Lock-Up Period
to cause the transfer agent for the Relevant Securities to decline to transfer, and to note stop transfer restrictions on the stock register
and other records relating to, Relevant Securities for which the undersigned is the record owner and the transfer of which would be a
violation of this Lock-Up Agreement and, in the case of Relevant Securities for which the undersigned is the beneficial but not the record
owner, agrees that during the Lock-Up Period it will use its reasonable best efforts to cause the record owner to authorize the Company
to cause the relevant transfer agent to decline to transfer, and to note stop transfer restrictions on the stock register and other records
relating to, such Relevant Securities to the extent such transfer would be a violation of this Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing or anything contained herein to the contrary, the undersigned may transfer the undersigned&rsquo;s Relevant Securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    a <I>bona fide</I> gift or gifts;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    any trust, partnership, limited liability company or other legal entity commonly used for estate planning purposes which is established
    for the direct or indirect benefit of the undersigned or a member or members of the immediate family of the undersigned;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (1) to another corporation,
    partnership, limited liability company, trust or other business entity that is a direct or indirect Affiliate (as defined in Rule
    405 under the Securities Act of 1933, as amended) of the undersigned, (2) to limited partners, limited liability company members
    or stockholders of the undersigned or holders of similar equity interests in the undersigned, or (3) in connection with a sale, merger
    or transfer of all or substantially all of the assets of the undersigned or any other change of control of the undersigned, not undertaken
    for the purpose of avoiding the restrictions imposed by this Lock-Up Agreement; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
    the undersigned is a trust, to the beneficiary of such trust;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    testate or intestate succession;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
    operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pursuant
    to the Underwriting Agreement; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
    the Company solely in an amount necessary to satisfy tax obligations (withholding or otherwise) in connection with any grant of restricted
    Shares, exercise or vesting of options or warrants to purchase Shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided,
</I>in the case of clauses (i)-(vi), that (A) such transfer shall not involve a disposition for value, (B) the transferee agrees in writing
with the Underwriters and the Company to be bound by the terms of this Lock-Up Agreement, and (C) such transfer would not require any
filing under Section 16(a) of the Exchange Act and no such filing is voluntarily made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Lock-Up Agreement, &ldquo;immediate family&rdquo; shall mean any relationship by blood, marriage or adoption, not more
remote than first cousin.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
(x) during the last 17 days of the lock-up period, the Company issues an earnings release or other press release of material information
or a material event relating to the Company occurs or (y) prior to the expiration of the lock-up period, the Company announces that it
will release its earnings results during the 16-day period beginning on the last day of the restricted period, the lock-up period shall
be extended by, and the restrictions imposed by this Lock-Up Agreement shall continue to apply until the expiration of, the 18-day period
beginning on the issuance of the earnings or other press release or the occurrence of the material event. If the lock-up period is so
extended, the undersigned shall not engage in any transaction that may be restricted by this Lock-Up Agreement during the extended lock-up
period unless the undersigned requests and receives prior written confirmation from the Representative or the Company that the restrictions
imposed by this Lock-Up Agreement have expired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the undersigned is an officer or director of the Company, (i) the Representative agrees that, at least three business days before the
effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of Common Stock, the Representative
will notify the Company of the impending release or waiver and (ii) the Company has agreed in the Underwriting Agreement to announce
the impending release or waiver by press release through a major news service at least two business days before the effective date of
the release or waiver. Any release or waiver granted by the Representative hereunder to any such officer or director shall only be effective
two business days after the publication date of such press release. The provisions of this paragraph will not apply if (a) the release
or waiver is effected solely to permit a transfer not for consideration and (b) the transferee has agreed in writing to be bound by the
same terms described in this letter to the extent and for the duration that such terms remain in effect at the time of the transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, whether or not participating in the Public Offering, understands that the Underwriters are entering into the Underwriting
Agreement and proceeding with the Public Offering in reliance upon this Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the
provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to
be sold thereunder, the undersigned shall be released from all obligations under this Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement and
that this Lock-Up Agreement has been duly authorized (if the undersigned is not a natural person) and constitutes the legal, valid and
binding obligation of the undersigned, enforceable in accordance with its terms. Upon request, the undersigned will execute any additional
documents necessary in connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the successors
and assigns of the undersigned from the date of this Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict
of laws principles thereof. Delivery of a signed copy of this Lock-Up Agreement by facsimile or e-mail/.pdf transmission shall be effective
as the delivery of the original hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[SIGNATURE
PAGE FOLLOWS]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><I>Very truly yours,</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature:</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Name (printed):</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Title (if applicable):</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Entity (if applicable): </I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[SIGNATURE
PAGE TO LOCK-UP AGREMENT]</B>&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form
of Press Release</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neuraxis,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc., (the &ldquo;<B>Company</B>&rdquo;) announced today that Alexander Capital, L.P., acting as representative for the underwriters
in the Company&rsquo;s recent public offering of <B>[&#9679;]</B> of the Company&rsquo;s Common Stock, is [waiving] [releasing] a lock-up
restriction with respect to <B>[&#9679;]</B> shares of Common Stock held by [certain officers or directors] [an officer or director]
of the Company. The [waiver] [release] will take effect on <B>[&#9679;]</B>, 2023, and the securities may be sold on or after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>This
press release is not an offer or sale of the securities in the United States or in any other jurisdiction where such offer or sale is
prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration
under the Securities Act of 1933, as amended.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 66; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.23
<SEQUENCE>3
<FILENAME>ex4-23.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.23</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>APPENDIX
<FONT STYLE="letter-spacing: -0.2pt">C</FONT></U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>FORM
OF <FONT STYLE="letter-spacing: -0.15pt">WARRANT</FONT></U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE <FONT STYLE="letter-spacing: -0.05pt">COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE</FONT> IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT <FONT STYLE="letter-spacing: -0.05pt">UNDER THE SECURITIES ACT OR PURSUANT TO AN</FONT> AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF <FONT STYLE="letter-spacing: -0.05pt">THE SECURITIES</FONT> ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEURAXIS,
INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">COMMON
STOCK PURCHASE WARRANT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
Exercise Date: February ___, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received,___________________ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the <FONT STYLE="letter-spacing: 0.05pt">Initial Exercise Date set forth hereinabove </FONT>(the &ldquo;<U>Initial
Exercise Date</U>&rdquo;) and on or prior to 5:00 p.m. (New York City time) on February ___, 2028 (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Neuraxis, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up
to the Initial Warrant Number of Shares (as hereinafter defined) of Common Stock (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;). The purchase price of one share of Common Stock under this Warrant shall <FONT STYLE="letter-spacing: 1pt">be equal
</FONT>to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this Warrant, the term &ldquo;<U>Initial Warrant Number of Shares</U>&rdquo; is the number obtained by dividing: (i) fifty percent (50%)
of the aggregate Original Principal Amount of Note(s) originally issued under the Purchase Agreement (as such terms are hereinafter defined)
to the original Holder of this Warrant by (ii) the offering price per share of Common Stock paid in the first Liquidity Event following
the Initial Exercise Date; <I>provided, however, </I>that (i) if a Liquidity Event shall not have occurred on or prior to November ___,
2023 then, from and after such date, the percentage expressed in the foregoing clause (i) shall be seventy-five percent (75%) in lieu
of fifty percent (50%), and (ii) if the first Liquidity Event to occur after the Initial Exercise Date includes, for each one share of
Common Stock issued in such Liquidity Event: (x) one warrant to purchase Common Stock or similar right then, from and after such date,
the percentage expressed in the foregoing clause (i) shall be one hundred percent (100%) in lieu of fifty percent (50%) or seventy-five
percent (75%), as applicable, and (y) more than one warrant to purchase Common Stock or similar right then, from and after such date,
the percentage expressed in the foregoing clause (i) shall be two hundred percent (200%) in lieu of fifty percent (50%) or seventy-five
percent (75%), as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated as of February ___, 2023, by and among the Company
and the Investors signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Business Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i)) following the date of exercise as aforesaid, the Holder shall deliver to the Company the aggregate Exercise Price
for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Business
Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in <FONT STYLE="letter-spacing: -0.05pt">purchases
of a</FONT> portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number
of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company
shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares
hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the
face hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. The exercise price per share of Common Stock under this Warrant shall be equal to the product of (x) the Conversion
Price (as defined in the Notes) and (y) one hundred twenty five percent (125%) (as subject to adjustment hereunder, the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Cashless Exercise</U>. Solely in the event that if at any time after the Maturity Date (as defined in the Note) (&ldquo;<U>Registration
Deadline</U>&rdquo;) there is no effective registration statement registering, or no currently prospectus available for, the resale of
the Warrant Shares by the Holder (a &ldquo;Registration Default&rdquo;), then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares
equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(64)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the
VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock
on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the applicable Notice
of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within
two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant
to Section 2(a) or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading
Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Bid
Price&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is
then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the &ldquo;Pink Sheets&rdquo;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;VWAP&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in the &ldquo;Pink Sheets&rdquo;
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding
and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
its transfer agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if, following the consummation of a Liquidity
Event, the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder
without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical
delivery of a certificate, registered in the Company&rsquo;s share register in the name of the Holder or its designee, for the number
of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise
by the date that is the earliest of (i) two (2) Business Days after the delivery to the Company of the Notice of Exercise, (ii) one (1)
Business Day after delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard
Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate (but not Rule 144) purposes to have become the
holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of
the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) (other than
in the case of a cashless exercise) is received within the earlier of (i) two (2) Business Days and (ii) the number of Trading Days comprising
the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder
the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash,
as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the volume <FONT STYLE="letter-spacing: -0.05pt">weighted
average price of the</FONT> Common Stock on the date of the applicable Notice of Exercise), $10 per Business Day (increasing to $20 per
Trading Day on the fifth (5<SUP>th</SUP>) Business Day after such liquidated damages begin to accrue) for each Business Day after such
Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. Following consummation of a Liquidity
Event the Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Rescission Rights</U>. If the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if, following a Liquidity Event, the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares
in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and
if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s
brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
the Holder anticipated receiving upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder
the amount, if any, by which (x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of
Common Stock so purchased exceeds (y) the product of (1) the number of Warrant Shares that the Company was required to deliver to the
Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was
executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for
which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares
of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For
example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy- In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure
to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or <FONT STYLE="letter-spacing: -0.05pt">other incidental expense</FONT> in respect of the issuance of such Warrant Shares, all of which
taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or
names as may be directed by the Holder; <U>provided</U>, <U>however</U>, that in the event that Warrant Shares are to be issued in a
name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached
hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse
it for any transfer tax incidental thereto. The Company shall pay all transfer agent fees required for same-day processing of any Notice
of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required
for same-day electronic delivery of the Warrant Shares. The Company shall pay all attorney fees required for the issuance of attorney
legal opinions for removal of restrictive legends on Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, non-exercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or <FONT STYLE="letter-spacing: -0.05pt">Attribution Parties and (ii) exercise
or conversion of the unexercised</FONT> or unconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this
Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in
accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall
be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject
to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding
shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s
most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company
or (C) a more recent written notice by the Company or its transfer agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the
number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates
or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase
or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in
no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
<FONT STYLE="letter-spacing: -0.05pt">the terms</FONT> of this Section 2(e) to correct this paragraph (or any portion hereof) which <FONT STYLE="letter-spacing: -0.05pt">may
be defective or inconsistent with</FONT> the intended Beneficial Ownership Limitation herein contained or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor
holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Subsequent Equity Sales</U>. If and whenever, at any time while this Warrant is outstanding, the Company issues or sells, announces
any offer, sale, or other disposition of, or in accordance with this Section 3 is deemed to have issued, sold or granted (or makes an
announcement regarding the same), any shares of Common Stock and/or Common Stock Equivalents (including the issuance or sale of shares
of Common Stock owned or held by or for the account of the Company, but excluding any securities issued or sold or deemed to have been
issued or sold solely in connection with an Exempt Issuance) for a consideration per share (the &ldquo;<U>New Issuance Price</U>&rdquo;)
less than a price equal to the Exercise Price in effect immediately prior to such issuance or sale or deemed issuance or sale (such Exercise
Price then in effect is referred to herein as the &ldquo;<U>Applicable Price</U>&rdquo;) (the foregoing a &ldquo;<U>Dilutive Issuance</U>&rdquo;),
then immediately after such Dilutive Issuance, (i) the Exercise Price then in effect shall be reduced to an amount equal to the New Issuance
Price ; and (ii) the number of Warrant Securities issuable hereunder shall be increased such that the aggregate Exercise Price payable
hereunder, after taking into account the decrease in the Exercise Price, (subject to adjustment as provided herein). For all purposes
of the foregoing (including, without limitation, determining the adjusted Exercise Price and the New Issuance Price under this Section
3(b)), the following shall be applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Issuance of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell)
any Options (as defined below) and the lowest price per share for which one Common Stock is at any time issuable upon the exercise of
any such Option (as defined below) or upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of
any such Option (as defined below) or otherwise pursuant to the terms thereof is less than the Applicable Price, then such Common Stock
shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option
(as defined below) for such price per share. For purposes of this Section 3(b)(i), the &ldquo;lowest price per share for which one Common
Stock is at any time issuable upon the exercise of any such Options (as defined below) or upon conversion, exercise or exchange of any
Common Stock Equivalents issuable upon exercise of any such Option (as defined below) or otherwise pursuant to the terms thereof&rdquo;
shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company
with respect to any one share of Common Stock upon the granting, issuance or sale of such Option (as defined below), upon exercise of
such Option (as defined below) and upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of such
Option (as defined below) or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option (as defined
below) for which one Common Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any
such Options (as defined below) or upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any
such Option (as defined below) or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder
of such Option (or any other Person) upon the granting, issuance or sale of such Option (as defined below), upon exercise of such Option
(as defined below) and upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of such Option (as
defined below) or otherwise pursuant to the terms thereof plus the value of any other consideration received or receivable by, or benefit
conferred on, the holder of such Option (as defined below) (or any other Person). Except as contemplated below, no further adjustment
of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock or of such Common Stock Equivalents upon
the exercise of such Options (as defined below) or otherwise pursuant to the terms of or upon the actual issuance of such shares of Common
Stock upon conversion, exercise or exchange <FONT STYLE="letter-spacing: -0.05pt">of such Common Stock Equivalents.</FONT> &ldquo;<U>Option</U>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities, other than an option
issued in an Exempt Issuance. &ldquo;<U>Convertible Securities</U>&rdquo; means any shares or other security (other than Options) that
is at any time and under any circumstances, directly or indirectly, convertible into, exercisable or exchangeable for, or which otherwise
entitles the holder thereof to acquire, any shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Issuance of Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell)
any Common Stock Equivalents and the lowest price per share for which one share of Common Stock is at <U>any</U> time issuable upon the
conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such shares
of Common Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale
of such Common Stock Equivalents for such price per share. For the purposes of this Section 3(b)(ii), the &ldquo;lowest price per share
for which one Common Stock is at any time issuable upon the conversion, exercise or exchange thereof or otherwise pursuant to the terms
thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable
by the Company with respect to one Common Stock upon the issuance or sale of the Common Stock Equivalents and upon conversion, exercise
or exchange of such Common Stock Equivalents or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth
in such Common Stock Equivalents for which one share of Common Stock is issuable (or may become issuable assuming all possible market
conditions) upon conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts
paid or payable to the holder of such Common Stock Equivalents (or any other <FONT STYLE="letter-spacing: -0.05pt">Person) upon the issuance
</FONT>or sale of such Common Stock Equivalents plus the value of any other consideration received or receivable by, or benefit conferred
on, the holder of such Common Stock Equivalents (or any other Person). Except as contemplated below, no further adjustment of the Exercise
Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such Common Stock
Equivalents or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Common Stock Equivalents is made upon
exercise of any Options for which adjustment of this Warrant has been or is to be made pursuant to other provisions of this Section 3(b),
except as contemplated below, no further adjustment of the Exercise Price shall be made by reason of such issuance or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Change in Option Price or Rate of Conversion</U>. If the purchase or <FONT STYLE="letter-spacing: -0.05pt">exercise price provided
for in any</FONT> Options, the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Common
Stock Equivalents, <U>or</U> the rate at which any Common Stock Equivalents are convertible into or exercisable or exchangeable for shares
of Common Stock increases or decreases at any time (other than proportional changes in conversion or exercise prices, as applicable,
in connection with an event referred to in Section 3(a)), the Exercise Price in effect at the time of such increase or decrease shall
be adjusted to the Exercise Price which would have been in effect at such time had such Options or Common Stock Equivalents provided
for such increased or decreased purchase price, additional consideration or increased or decreased conversion rate, as the case may be,
at the time initially granted, issued or sold. For purposes of this Section 3(b)(iii), if the terms of any Option or Common Stock Equivalents
that was outstanding as of the date this Warrant was issued are increased or decreased in the manner described in the immediately preceding
sentence, then such Option or Common Stock Equivalents and the shares of Common Stock deemed issuable upon exercise, conversion or exchange
thereof shall be deemed to have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section 3(b)
shall be made if such adjustment would result in an increase of the Exercise Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Change in Option Price or Rate of Conversion</U>. If any Option and/or Common Stock Equivalents and/or Adjustment Right (as defined
below) is issued in connection with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined
by the Holder, the &ldquo;Primary Security&rdquo;, and such Option and/or Common Stock Equivalents and/or Adjustment Right (as defined
below), the &ldquo;Secondary Securities&rdquo;), together comprising one integrated transaction, <FONT STYLE="letter-spacing: -0.05pt">(or
one or more transactions</FONT> if such issuances or sales or deemed issuances or sales of securities of the Company either (A) have
at least one investor or purchaser in common, (B) are consummated in reasonable proximity to each other and/or (C) are consummated under
the same plan of financing) the aggregate consideration per share of Common Stock with respect to such Primary Security shall be deemed
to be equal to the difference of (x) the lowest price per share for which one Common Stock was issued (or was deemed to be issued pursuant
to Section 3(b)(i) or 3(b)(ii) above, as applicable) in such integrated transaction solely with respect to such Primary Security, minus
(y) with respect to such Secondary Securities, the sum of (I) the Black Scholes Value (as defined below) of each such Option, if any,
(II) the fair market value (as determined by the Holder in good faith) or the Black Scholes Value (as defined below), as applicable,
of such Adjustment Right (as defined below), if any, and (III) the fair market value (as determined by the Holder) of such Common Stock
Equivalents, if any, in each case, as determined on a per share basis in accordance with this section 3(b)(iv). If any shares of Common
Stock, Options or Common Stock Equivalents are issued or sold or deemed to have been issued or sold for cash, the consideration received
therefor (for the purpose of determining the consideration paid for such Common Stock, Option or Common Stock Equivalents, but not for
the purpose of the calculation of the Black Scholes Value) will be deemed to be the net amount of consideration received by the Company
therefor. If any shares of Common Stock, Options or Common Stock Equivalents are issued or sold for a consideration other than cash,
the amount of such consideration received by the Company (for the purpose of determining the consideration paid for such Common Stock,
Option or Common Stock Equivalents, but not for the purpose of the calculation of the Black Scholes Value) will be the fair value of
such consideration, except where such consideration consists of publicly traded securities, in which case the amount of consideration
received by the Company for such securities will be the arithmetic average of the volume weighted average prices of such security for
each of the five (5) Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Common Stock Equivalents
are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity, the
amount of consideration therefor (for the purpose of determining the consideration paid for such shares of Common Stock, Option or Common
Stock Equivalents, but not for the purpose of the calculation of the Black Scholes Value) will be deemed to be the fair value of such
portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock, Options or Common
Stock Equivalents (as the case may be). The fair value of any consideration other than cash or publicly traded securities will be determined
jointly by the Company and the Holder. If such parties are unable to reach agreement within ten (10) days after the occurrence of an
event requiring valuation (the &ldquo;<U>Valuation Event</U>&rdquo;), the fair value of such consideration will be determined within
five (5) Trading Days after the tenth (10th) day following such Valuation Event by an independent, reputable appraiser jointly selected
by the Company and the Holder. The determination of such appraiser shall be final and binding upon all parties absent manifest error
and the fees and expenses of such appraiser shall be borne by the Company). &ldquo;<U>Adjustment Right</U>&rdquo; means any right granted
with respect to any securities issued in connection with, or with respect to, any issuance or sale (or deemed issuance or sale hereunder)
of Common Stock (other than rights of the type described in sections 3(c) and 3(d) hereof) that could result in a decrease in the net
consideration received by the Company in connection with, or with respect to, such securities (including, without limitation, any cash
settlement rights, cash adjustment or other similar rights).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Change in Option Price or Rate of Conversion</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose
of entitling them (A) to receive a dividend or other distribution payable in shares of Common Stock, Options or in Common Stock Equivalents
or (B) to subscribe for or purchase shares of Common Stock, Options or Common Stock Equivalents, then such record date will be deemed
to be the date of the issuance or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such
dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase (as the case
may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<I>provided, however,</I> that, to the extent
that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a <U>series</U> of related transactions(including any asset or <U>group</U> of assets, regardless whether then so classified by
the Company, which would constitute a Significant Subsidiary, as such term is defined in Rule 1-02(w) of Regulation S-X), (iii) any,
direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to
which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been
accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common
Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party
to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then,
upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been
issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitations in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or
acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate
Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock
for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section
2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of
Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in
a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock
are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given
the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined
below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within thirty <FONT STYLE="letter-spacing: 0.05pt">(</FONT>30)
days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental
Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined
below) of the remaining unexercised portion of this Warrant on the date of the consummation of such Fundamental Transaction. &ldquo;<U>Black
Scholes Value</U>&rdquo; means the value this Warrant based on the Black-Scholes Option Pricing Model obtained from the &lsquo;OV&rsquo;
function on Bloomberg L.P. determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and
reflecting: (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of
the public announcement of the applicable Fundamental Transaction and the Termination Date; (B) an expected volatility equal to the greater
of hundred percent (100%) and the hundred (100) day volatility obtained from the HVT function on Bloomberg <FONT STYLE="letter-spacing: 0.05pt">L.P.
</FONT>as of the Trading day immediately following the public announcement of the applicable Fundamental Transaction; (C) the underlying
price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus
the value of any non- cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last
volume weighted average price immediately prior to the public announcement of such Fundamental Transaction and (y) the last volume weighted
average price immediately prior to the consummation of such Fundamental Transaction and (D) a remaining option time equal to the time
between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date. The payment of the Black
Scholes Value will be made by wire transfer of immediately available funds within five (5) Business Days of the Holder&rsquo;s election
(or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written
agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior
to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and <FONT STYLE="letter-spacing: -0.05pt">after</FONT> the date of such Fundamental Transaction, the
provisions of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor
Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant
and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the <FONT STYLE="letter-spacing: -0.05pt">Common
</FONT>Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required
in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or
transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted
into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or
winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder
at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days
prior to the applicable record or effective date herein after specified, a notice stating (x) the date on which a record is to be taken
for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which
the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined
or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect
the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant
constitutes, or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly
set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.01 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Business Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the <FONT STYLE="letter-spacing: -0.05pt">Company shall</FONT> execute and deliver a new Warrant or Warrants in exchange
for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall
be dated the Initial Exercise Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 4.01 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with <FONT STYLE="letter-spacing: -0.05pt">a
view to or for distributing or reselling</FONT> such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
state securities law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section
3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to Section 2(c) or
to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash
settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<FONT STYLE="letter-spacing: -0.05pt"><U>Saturdays, Sundays, Holidays, etc</U>. If</FONT> the last or appointed day for the taking of
<FONT STYLE="letter-spacing: -0.05pt">any action or</FONT> the expiration of any right required or granted herein shall not be a Business
Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock
a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this <U>Warrant</U>.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may
be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality
of the foregoing, the Company will (A) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (B) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant, and (C) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, <FONT STYLE="letter-spacing: -0.05pt">the</FONT> Company shall obtain all such authorizations or exemptions thereof,
or consents hereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws, and if the Holder does not utilize cashless exercise, will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Amendment; Waivers</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder. Further, any modifications, amendments or waivers of the provisions hereof shall be subject to Section 5.05 of the Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Equal Treatment of Holders</U>. No consideration (including any modification of this Warrant) shall be offered or paid to any Person
(as such term is defined in the Purchase Agreement) to amend or consent to a waiver or modification of any provision hereof unless the
same consideration is also offered to all of the Holders. For clarification <FONT STYLE="letter-spacing: -0.05pt">purposes, this</FONT>
provision constitutes a separate right granted to each Holder by the Company and negotiated separately by each Holder, and is intended
for the Company to treat the Holders as a class and shall not in any way be construed as the Holders acting in concert or as a group
with respect to the Warrants or the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature
Page Follows)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEURAXIS,
    INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:
[___________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase_______________________ Warrant Shares of the Company pursuant to the terms of the attached
Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
shall take the form of lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
] [if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
The Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 45%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 45%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 45%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity:____________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
of Authorized Signatory of Investing Entity:______________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory:________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory:_________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:____________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">EXHIBIT
B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 5.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 5.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -2.85pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">Dated:________________
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">,__________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address:________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>4
<FILENAME>ex10-13.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>E</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">xhibit
<FONT STYLE="text-transform: uppercase">10.13</FONT></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>First
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT TO</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>Executive
Employment AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this &ldquo;Amendment&rdquo;) is executed effective the 4<SUP>th</SUP> day of May,
2023 by and between <FONT STYLE="font-variant: small-caps">NeurAxis, Inc (f/k/a Innovative Health Solutions, Inc.)</FONT>, a Delaware
corporation (the &ldquo;Company&rdquo;) and Brian Carrico, an individual (&ldquo;Executive&rdquo;). Each of the Company and Executive
may be referred to herein as a &ldquo;Party&rdquo; or collectively as the &ldquo;Parties&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BACKGROUND</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company and the Executive are parties to that certain Executive Employment Agreement (the &ldquo;Employment Agreement&rdquo;)
dated as of August 9, 2022 (capitalized terms not otherwise defined in this Amendment shall have the meanings ascribed to such terms
in the Employment Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Company plans to file a registration statement on Form S-1 (the &ldquo;Registration Statement&rdquo;) with the U.S. Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) relating to the offering of the Company&rsquo;s shares of Common Stock in connection
with a firm commitment underwritten initial public offering (the &ldquo;IPO&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Parties desire to amend the Employment Agreement to, among other things, (i) clarify the special one-time incentive payment set
forth in Section 4(d) of the Employment Agreement and the Deferred Bonus set forth in Section 4(h) of the Employment Agreement are
contingent upon the effective date of the IPO and (ii) set forth a process for Executive to exercise the Stock Options in accordance
with the terms of the Stock Option agreements in effect as of the date of the Employment Agreement to clarify no modification of any
such Stock Option agreements was or is intended by the terms of the Employment Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AMENDMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby amend
the Employment Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Section 4(d) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(d) shall read as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
    One-Time Incentive Payment</U>. In accordance with Treasury Regulation Section 1.409A-1(b)(4)(ii), as soon as administratively practical,
    to reward past service, and incentivize Executive to remain with the Company for future service, a special one-time incentive payment
    of $435,576.92 shall be due and paid immediately in a single lump sum to Executive contingent upon and concurrently with the effective
    date of the IPO, and such special one-time incentive payment will be subject to taxes and withholdings.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Section 4(h) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(h) shall
read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(h)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
    Deferred Bonus</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Subject
    to the terms and conditions set forth in this Section 4(h), Executive shall be entitled to payment of a special deferred bonus (the
    &ldquo;Deferred Bonus&rdquo;) in an amount equal to (i) the aggregate of the strike price or exercise price of all Stock Options,
    as defined hereinafter (the &ldquo;Aggregate Strike Price&rdquo;) plus (ii) a tax gross-up payment on the Aggregate Strike Price
    reasonably calculated by the Company at the highest marginal rates so that after payment of all ordinary income taxes on such Aggregate
    Strike Price, there remains an amount sufficient to pay such ordinary income taxes (the &ldquo;Gross-Up Payment&rdquo;). &ldquo;Stock
    Options&rdquo; as used in this Agreement shall mean the 320,000 unexercised options to purchase stock or shares of the Company or
    its predecessors-in-interest held by Executive as of the Effective Date (as adjusted by the 2 for 1 stock split effective as of January
    12, 2023, the &ldquo;Adjustment&rdquo;). For purposes of clarity, the number of Stock Options stated in this Agreement reflect the
    numbers after the Adjustment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
    to Section 4(h)(iii) herein, the Deferred Bonus shall be paid in substantially equal twenty percent (20%) installments (collectively,
    the &ldquo;Annual Deferred Bonus Payments&rdquo; and each an &ldquo;Annual Deferred Bonus Payment&rdquo;) on January 2nd (or if such
    date falls on a weekend day or holiday, then on the next business day) on each of 2024, 2025, 2026, 2027, and 2028 (collectively,
    the &ldquo;Scheduled Payment Dates&rdquo; and each a &ldquo;Scheduled Payment Date&rdquo;) subject to withholding for taxes and other
    applicable deductions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    a condition of the payment of each Annual Deferred Bonus Payment, Executive must, on or before the Scheduled Payment Date, exercise
    at least 64,000 of the Stock Options; provided, however, Executive shall not be eligible to receive any Annual Deferred Bonus Payment
    unless and until the IPO is effective. If a Scheduled Payment Date occurs prior to the effective date of the IPO, the corresponding
    Annual Deferred Bonus Payment will be forfeited by Executive. Executive may exercise any portion of the Stock Options after a Scheduled
    Payment Date (if the applicable Stock Options have not expired or have not otherwise been terminated pursuant to any other provision
    of the applicable Stock Option agreement); provided, however, an exercise after the applicable Scheduled Payment Date shall result
    in forfeiture of the related Annual Deferred Bonus Payment. After the IPO, for each Stock Option exercise during the years of Stock
    Option exercise set forth above, the corresponding Annual Deferred Bonus Payment, payable net of taxes withheld and applicable deductions,
    shall be used to offset the total strike price of the exercised Stock Options (if payment of the Annual Deferred Bonus Payment and
    exercise of the Stock Option are in the same year), which shall comprise payment of the applicable Annual Deferred Bonus Payment
    as compensation to Executive for the year of Stock Option exercise. Executive shall exercise the Stock Options in accordance with
    Section 4(h)(v) below. Since the Stock Options are non-qualified stock options, on exercise, Executive understands that he will be
    liable for any taxes that may result should the fair market value exceed the strike price of the underlying stock at the time of
    exercise and accordingly, Executive will make arrangements for such tax liability to be paid, whether through the cash out of sufficient
    shares, withholding of other compensation due to him from the Company, or otherwise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
    on the IPO becoming effective, if Executive is terminated without Cause or he terminates his employment for any reason, (including
    in any event death or Disability), the remaining Annual Deferred Bonus Payments that have not been forfeited under this Section 4(h)
    shall be paid to Executive in substantially equal installments on the remaining Scheduled Payment Dates, provided he exercises his
    vested Stock Options as scheduled prior to the Scheduled Payment Dates, and provided further that such exercise will not be permitted
    after expiration of the applicable Stock Option, and upon such expiration, any corresponding Annual Deferred Bonus Payment will be
    forfeited. If Executive&rsquo;s employment is terminated by the Company for Cause, then he will forfeit the balance of his Deferred
    Bonus that remains unpaid, whether or not vested.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    order to exercise the Stock Options, Executive shall enclose payment in full of the total exercise price in cash (by certified or
    bank check) (the &ldquo;Exercise Notice&rdquo;), receipt of which shall be timely acknowledged by the Company. Each Exercise Notice
    shall indicate the number of Stock Options being exercised, the exercise price per share, and the total exercise price for all Stock
    Options being exercised. Upon exercise, Executive shall deliver any other documents that the Company requires.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    a &ldquo;Change in Control&rdquo; (as defined below), Executive will fully vest in the unvested portion of his Deferred Bonus, and
    the remaining unpaid balance of the Deferred Bonus will be paid to Executive in a single lump sum within thirty (30) calendar days
    after a Change in Control, subject to withholding for taxes and applicable deductions. For purposes of this Agreement, &ldquo;Change
    in Control&rdquo; means the consummation of a transaction that constitutes a &ldquo;change in the ownership&rdquo; of the Company
    or a &ldquo;change in the ownership of a substantial portion of the assets&rdquo; of the Company within the meaning of Treasury Regulation
    Section 1.409A-3(i)(5)(v) or (vii), respectively.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In all other respects, the Employment Agreement shall remain unchanged.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
This Amendment may be executed in counterparts, and each executed counterpart shall have the same force and effect as an original
instrument. The signature pages to this Amendment may be delivered via electronic mail (including .pdf or any electronic signature
complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any signature page so
delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of Page Left Blank Intentionally.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties hereto have executed this Amendment as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NeurAxis,
    Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Christopher R. Brown</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    R. Brown</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    of Innovation</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian Carrico</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Page to First Amendment to Executive Employment Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>5
<FILENAME>ex10-16.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.16</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>First
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT TO</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>Executive
Employment AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this &ldquo;Amendment&rdquo;) is executed effective the 4<SUP>th</SUP> day of May,
2023 by and between <FONT STYLE="font-variant: small-caps">NeurAxis, Inc (f/k/a Innovative Health Solutions, Inc.)</FONT>, a Delaware
corporation (the &ldquo;Company&rdquo;) and Thomas J. Carrico, an individual (&ldquo;Executive&rdquo;). Each of the Company and Executive
may be referred to herein as a &ldquo;Party&rdquo; or collectively as the &ldquo;Parties&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BACKGROUND</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. The
Company and the Executive are parties to that certain Executive Employment Agreement (the &ldquo;Employment Agreement&rdquo;) dated as
of August 9, 2022 (capitalized terms not otherwise defined in this Amendment shall have the meanings ascribed to such terms in the Employment
Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. The
Company plans to file a registration statement on Form S-1 (the &ldquo;Registration Statement&rdquo;) with the U.S. Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) relating to the offering of the Company&rsquo;s shares of Common Stock in connection with a firm commitment
underwritten initial public offering (the &ldquo;IPO&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C. The
Parties desire to amend the Employment Agreement to, among other things, (i) clarify the special one-time incentive payment set forth
in Section 4(d) of the Employment Agreement and the Deferred Bonus set forth in Section 4(h) of the Employment Agreement are contingent
upon the effective date of the IPO and (ii) set forth a process for Executive to exercise the Stock Options in accordance with the terms
of the Stock Option agreements in effect as of the date of the Employment Agreement to clarify no modification of any such Stock Option
agreements was or is intended by the terms of the Employment Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AMENDMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby amend
the Employment Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Section
4(d) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(d) shall read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
                                            One-Time Incentive Payment</U>. In accordance with Treasury Regulation Section 1.409A-1(b)(4)(ii),
                                            as soon as administratively practical, to reward past service, and incentivize Executive
                                            to remain with the Company for future service, a special one-time incentive payment of $135,655.74
                                            shall be due and paid immediately in a single lump sum to Executive contingent upon and concurrently
                                            with the effective date of the IPO, and such special one-time incentive payment will be subject
                                            to taxes and withholdings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Section
4(h) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(h) shall read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
                                            Deferred Bonus</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Subject
                                            to the terms and conditions set forth in this Section 4(h), Executive shall be entitled to
                                            payment of a special deferred bonus (the &ldquo;Deferred Bonus&rdquo;) in an amount equal
                                            to (i) the aggregate of the strike price or exercise price of all Stock Options, as defined
                                            hereinafter (the &ldquo;Aggregate Strike Price&rdquo;) plus (ii) a tax gross-up payment on
                                            the Aggregate Strike Price reasonably calculated by the Company at the highest marginal rates
                                            so that after payment of all ordinary income taxes on such Aggregate Strike Price, there
                                            remains an amount sufficient to pay such ordinary income taxes (the &ldquo;Gross-Up Payment&rdquo;).
                                            &ldquo;Stock Options&rdquo; as used in this Agreement shall mean the 306,236 unexercised
                                            options to purchase stock or shares of the Company or its predecessors-in-interest held by
                                            Executive as of the Effective Date (as adjusted by the 2 for 1 stock split effective as of
                                            January 12, 2023, the &ldquo;Adjustment&rdquo;). For purposes of clarity, the number of Stock
                                            Options stated in this Agreement reflect the numbers after the Adjustment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to Section 4(h)(iii) herein, the Deferred Bonus shall be paid in substantially equal twenty
                                            percent (20%) installments (collectively, the &ldquo;Annual Deferred Bonus Payments&rdquo;
                                            and each an &ldquo;Annual Deferred Bonus Payment&rdquo;) on January 2nd (or if such date
                                            falls on a weekend day or holiday, then on the next business day) on each of 2024, 2025,
                                            2026, 2027, and 2028 (collectively, the &ldquo;Scheduled Payment Dates&rdquo; and each a
                                            &ldquo;Scheduled Payment Date&rdquo;) subject to withholding for taxes and other applicable
                                            deductions.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a condition of the payment of each Annual Deferred Bonus Payment, Executive must, on or before
                                            the Scheduled Payment Date, exercise at least 61,247 of the Stock Options; provided, however,
                                            Executive shall not be eligible to receive any Annual Deferred Bonus Payment unless and until
                                            the IPO is effective. If a Scheduled Payment Date occurs prior to the effective date of the
                                            IPO, the corresponding Annual Deferred Bonus Payment will be forfeited by Executive. Executive
                                            may exercise any portion of the Stock Options after a Scheduled Payment Date (if the applicable
                                            Stock Options have not expired or have not otherwise been terminated pursuant to any other
                                            provision of the applicable Stock Option agreement); provided, however, an exercise after
                                            the applicable Scheduled Payment Date shall result in forfeiture of the related Annual Deferred
                                            Bonus Payment. After the IPO, for each Stock Option exercise during the years of Stock Option
                                            exercise set forth above, the corresponding Annual Deferred Bonus Payment, payable net of
                                            taxes withheld and applicable deductions, shall be used to offset the total strike price
                                            of the exercised Stock Options (if payment of the Annual Deferred Bonus Payment and exercise
                                            of the Stock Option are in the same year), which shall comprise payment of the applicable
                                            Annual Deferred Bonus Payment as compensation to Executive for the year of Stock Option exercise.
                                            Executive shall exercise the Stock Options in accordance with Section 4(h)(v) below. Since
                                            the Stock Options are non-qualified stock options, on exercise, Executive understands that
                                            he will be liable for any taxes that may result should the fair market value exceed the strike
                                            price of the underlying stock at the time of exercise and accordingly, Executive will make
                                            arrangements for such tax liability to be paid, whether through the cash out of sufficient
                                            shares, withholding of other compensation due to him from the Company, or otherwise.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
                                            on the IPO becoming effective, if Executive is terminated without Cause or he terminates
                                            his employment for any reason, (including in any event death or Disability), the remaining
                                            Annual Deferred Bonus Payments that have not been forfeited under this Section 4(h) shall
                                            be paid to Executive in substantially equal installments on the remaining Scheduled Payment
                                            Dates, provided he exercises his vested Stock Options as scheduled prior to the Scheduled
                                            Payment Dates, and provided further that such exercise will not be permitted after expiration
                                            of the applicable Stock Option, and upon such expiration, any corresponding Annual Deferred
                                            Bonus Payment will be forfeited. If Executive&rsquo;s employment is terminated by the Company
                                            for Cause, then he will forfeit the balance of his Deferred Bonus that remains unpaid, whether
                                            or not vested.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            order to exercise the Stock Options, Executive shall enclose payment in full of the total
                                            exercise price in cash (by certified or bank check) (the &ldquo;Exercise Notice&rdquo;),
                                            receipt of which shall be timely acknowledged by the Company. Each Exercise Notice shall
                                            indicate the number of Stock Options being exercised, the exercise price per share, and the
                                            total exercise price for all Stock Options being exercised. Upon exercise, Executive shall
                                            deliver any other documents that the Company requires.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            a &ldquo;Change in Control&rdquo; (as defined below), Executive will fully vest in the unvested
                                            portion of his Deferred Bonus, and the remaining unpaid balance of the Deferred Bonus will
                                            be paid to Executive in a single lump sum within thirty (30) calendar days after a Change
                                            in Control, subject to withholding for taxes and applicable deductions. For purposes of this
                                            Agreement, &ldquo;Change in Control&rdquo; means the consummation of a transaction that constitutes
                                            a &ldquo;change in the ownership&rdquo; of the Company or a &ldquo;change in the ownership
                                            of a substantial portion of the assets&rdquo; of the Company within the meaning of Treasury
                                            Regulation Section 1.409A-3(i)(5)(v) or (vii), respectively.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In all other respects, the Employment Agreement shall remain unchanged.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. This
Amendment may be executed in counterparts, and each executed counterpart shall have the same force and effect as an original instrument.
The signature pages to this Amendment may be delivered via electronic mail (including .pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any signature page so delivered shall be
deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of Page Left Blank Intentionally.]<BR STYLE="clear: both">
&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties hereto have executed this Amendment as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NeurAxis,
    Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 42%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Brian Carrico</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    &amp; Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Thomas J. Carrico</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas
J. Carrico</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Page to First Amendment to Executive Employment Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>6
<FILENAME>ex10-18.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.18</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>First
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT TO</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>Executive
Employment AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this &ldquo;Amendment&rdquo;) is executed effective the 4<SUP>th</SUP> day of May,
2023 by and between <FONT STYLE="font-variant: small-caps">NeurAxis, Inc (f/k/a Innovative Health Solutions, Inc.)</FONT>, a Delaware
corporation (the &ldquo;Company&rdquo;) and Daniel Clarence, an individual (&ldquo;Executive&rdquo;). Each of the Company and Executive
may be referred to herein as a &ldquo;Party&rdquo; or collectively as the &ldquo;Parties&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BACKGROUND</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company and the Executive are parties to that certain Executive Employment Agreement (the &ldquo;Employment Agreement&rdquo;) dated
as of August 9, 2022 (capitalized terms not otherwise defined in this Amendment shall have the meanings ascribed to such terms in the
Employment Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Company plans to file a registration statement on Form S-1 (the &ldquo;Registration Statement&rdquo;) with the U.S. Securities and
Exchange Commission (the &ldquo;SEC&rdquo;) relating to the offering of the Company&rsquo;s shares of Common Stock in connection with
a firm commitment underwritten initial public offering (the &ldquo;IPO&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Parties desire to amend the Employment Agreement to, among other things, (i) clarify the special one-time incentive payment set forth
in Section 4(d) of the Employment Agreement and the Deferred Bonus set forth in Section 4(h) of the Employment Agreement are contingent
upon the effective date of the IPO and (ii) set forth a process for Executive to exercise the Stock Options in accordance with the terms
of the Stock Option agreements in effect as of the date of the Employment Agreement to clarify no modification of any such Stock Option
agreements was or is intended by the terms of the Employment Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AMENDMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby amend
the Employment Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Section 4(d) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(d) shall read as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
                                            One-Time Incentive Payment</U>. In accordance with Treasury Regulation Section 1.409A-1(b)(4)(ii),
                                            as soon as administratively practical, to reward past service, and incentivize Executive
                                            to remain with the Company for future service, a special one-time incentive payment of $34,888.62
                                            shall be due and paid immediately in a single lump sum to Executive contingent upon and concurrently
                                            with the effective date of the IPO, and such special one-time incentive payment will be subject
                                            to taxes and withholdings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Section 4(h) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(h) shall read as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
                                            Deferred Bonus</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Subject
                                            to the terms and conditions set forth in this Section 4(h), Executive shall be entitled to
                                            payment of a special deferred bonus (the &ldquo;Deferred Bonus&rdquo;) in an amount equal
                                            to (i) the aggregate of the strike price or exercise price of all Stock Options, as defined
                                            hereinafter (the &ldquo;Aggregate Strike Price&rdquo;) plus (ii) a tax gross-up payment on
                                            the Aggregate Strike Price reasonably calculated by the Company at the highest marginal rates
                                            so that after payment of all ordinary income taxes on such Aggregate Strike Price, there
                                            remains an amount sufficient to pay such ordinary income taxes (the &ldquo;Gross-Up Payment&rdquo;).
                                            &ldquo;Stock Options&rdquo; as used in this Agreement shall mean the 68,818 unexercised options
                                            to purchase stock or shares of the Company or its predecessors-in-interest held by Executive
                                            as of the Effective Date (as adjusted by the 2 for 1 stock split effective as of January
                                            12, 2023, the &ldquo;Adjustment&rdquo;). For purposes of clarity, the number of Stock Options
                                            stated in this Agreement reflect the numbers after the Adjustment.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to Section 4(h)(iii) herein, the Deferred Bonus shall be paid in substantially equal twenty
                                            percent (20%) installments (collectively, the &ldquo;Annual Deferred Bonus Payments&rdquo;
                                            and each an &ldquo;Annual Deferred Bonus Payment&rdquo;) on January 2nd (or if such date
                                            falls on a weekend day or holiday, then on the next business day) on each of 2024, 2025,
                                            2026, 2027, and 2028 (collectively, the &ldquo;Scheduled Payment Dates&rdquo; and each a
                                            &ldquo;Scheduled Payment Date&rdquo;) subject to withholding for taxes and other applicable
                                            deductions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a condition of the payment of each Annual Deferred Bonus Payment, Executive must, on or before
                                            the Scheduled Payment Date, exercise at least 13,764 of the Stock Options; provided, however,
                                            Executive shall not be eligible to receive any Annual Deferred Bonus Payment unless and until
                                            the IPO is effective. If a Scheduled Payment Date occurs prior to the effective date of the
                                            IPO, the corresponding Annual Deferred Bonus Payment will be forfeited by Executive. Executive
                                            may exercise any portion of the Stock Options after a Scheduled Payment Date (if the applicable
                                            Stock Options have not expired or have not otherwise been terminated pursuant to any other
                                            provision of the applicable Stock Option agreement); provided, however, an exercise after
                                            the applicable Scheduled Payment Date shall result in forfeiture of the related Annual Deferred
                                            Bonus Payment. After the IPO, for each Stock Option exercise during the years of Stock Option
                                            exercise set forth above, the corresponding Annual Deferred Bonus Payment, payable net of
                                            taxes withheld and applicable deductions, shall be used to offset the total strike price
                                            of the exercised Stock Options (if payment of the Annual Deferred Bonus Payment and exercise
                                            of the Stock Option are in the same year), which shall comprise payment of the applicable
                                            Annual Deferred Bonus Payment as compensation to Executive for the year of Stock Option exercise.
                                            Executive shall exercise the Stock Options in accordance with Section 4(h)(v) below. Since
                                            the Stock Options are non-qualified stock options, on exercise, Executive understands that
                                            he will be liable for any taxes that may result should the fair market value exceed the strike
                                            price of the underlying stock at the time of exercise and accordingly, Executive will make
                                            arrangements for such tax liability to be paid, whether through the cash out of sufficient
                                            shares, withholding of other compensation due to him from the Company, or otherwise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
                                            on the IPO becoming effective, if Executive is terminated without Cause or he terminates
                                            his employment for any reason, (including in any event death or Disability), the remaining
                                            Annual Deferred Bonus Payments that have not been forfeited under this Section 4(h) shall
                                            be paid to Executive in substantially equal installments on the remaining Scheduled Payment
                                            Dates, provided he exercises his vested Stock Options as scheduled prior to the Scheduled
                                            Payment Dates, and provided further that such exercise will not be permitted after expiration
                                            of the applicable Stock Option, and upon such expiration, any corresponding Annual Deferred
                                            Bonus Payment will be forfeited. If Executive&rsquo;s employment is terminated by the Company
                                            for Cause, then he will forfeit the balance of his Deferred Bonus that remains unpaid, whether
                                            or not vested.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            order to exercise the Stock Options, Executive shall enclose payment in full of the total
                                            exercise price in cash (by certified or bank check) (the &ldquo;Exercise Notice&rdquo;),
                                            receipt of which shall be timely acknowledged by the Company. Each Exercise Notice shall
                                            indicate the number of Stock Options being exercised, the exercise price per share, and the
                                            total exercise price for all Stock Options being exercised. Upon exercise, Executive shall
                                            deliver any other documents that the Company requires.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            a &ldquo;Change in Control&rdquo; (as defined below), Executive will fully vest in the unvested
                                            portion of his Deferred Bonus, and the remaining unpaid balance of the Deferred Bonus will
                                            be paid to Executive in a single lump sum within thirty (30) calendar days after a Change
                                            in Control, subject to withholding for taxes and applicable deductions. For purposes of this
                                            Agreement, &ldquo;Change in Control&rdquo; means the consummation of a transaction that constitutes
                                            a &ldquo;change in the ownership&rdquo; of the Company or a &ldquo;change in the ownership
                                            of a substantial portion of the assets&rdquo; of the Company within the meaning of Treasury
                                            Regulation Section 1.409A-3(i)(5)(v) or (vii), respectively.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In all other respects, the Employment Agreement shall remain unchanged.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
This Amendment may be executed in counterparts, and each executed counterpart shall have the same force and effect as an original instrument.
The signature pages to this Amendment may be delivered via electronic mail (including .pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any signature page so delivered shall be
deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of Page Left Blank Intentionally.]<BR STYLE="clear: both">
&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties hereto have executed this Amendment as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NeurAxis,
    Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"><IMG SRC="ex10-18_001.jpg" ALT="" STYLE="height: 44px; width: 180px"></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    &amp; Chief Executive Officer</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><IMG SRC="ex10-18_002.jpg" ALT="" STYLE="height: 52px; width: 180px"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Daniel
    Clarence</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Page to First Amendment to Executive Employment Agreement</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>7
<FILENAME>ex10-20.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 10.20</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>First
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT TO</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>Executive
Employment AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this &ldquo;Amendment&rdquo;) is executed effective the 4th day of May, 2023 by and
between <FONT STYLE="font-variant: small-caps">NeurAxis, Inc (f/k/a Innovative Health Solutions, Inc.)</FONT>, a Delaware corporation
(the &ldquo;Company&rdquo;) and Christopher R. Brown, an individual (&ldquo;Executive&rdquo;). Each of the Company and Executive may
be referred to herein as a &ldquo;Party&rdquo; or collectively as the &ldquo;Parties&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BACKGROUND</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company and the Executive are parties to that certain Executive Employment Agreement (the &ldquo;Employment Agreement&rdquo;)
dated as of August 9, 2022 (capitalized terms not otherwise defined in this Amendment shall have the meanings ascribed to such terms
in the Employment Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Company plans to file a registration statement on Form S-1 (the &ldquo;Registration Statement&rdquo;) with the U.S. Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) relating to the offering of the Company&rsquo;s shares of Common Stock in connection
with a firm commitment underwritten initial public offering (the &ldquo;IPO&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Parties desire to amend the Employment Agreement to, among other things, clarify the special one-time incentive payment set
forth in Section 4(d) of the Employment Agreement is contingent upon the effective date of the IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AMENDMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby amend
the Employment Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Section 4(d) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(d) shall read as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
    One-Time Incentive Payment</U>. In accordance with Treasury Regulation Section 1.409A-1(b)(4)(ii), as soon as administratively practical,
    to reward past service, and incentivize Executive to remain with the Company for future service, a special one-time incentive payment
    of $35,294.36 shall be due and paid immediately in a single lump sum to Executive contingent upon and concurrently with the effective
    date of the IPO, and such special one-time incentive payment will be subject to taxes and withholdings.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In all other respects, the Employment Agreement shall remain unchanged.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
This Amendment may be executed in counterparts, and each executed counterpart shall have the same force and effect as an original
instrument. The signature pages to this Amendment may be delivered via electronic mail (including .pdf or any electronic signature
complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any signature page so
delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of Page Left Blank Intentionally.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties hereto have executed this Amendment as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NeurAxis,
    Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><IMG SRC="ex10-20_001.jpg" ALT="" STYLE="height: 37px; width: 150px"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    &amp; Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><IMG SRC="ex10-20_002.jpg" ALT="" STYLE="height: 35px; width: 180px"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Christopher R. Brown</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Page to First Amendment to Executive Employment Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>8
<FILENAME>ex10-22.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.22</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>First
</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AMENDMENT TO</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><U>Executive
Employment AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this &ldquo;Amendment&rdquo;) is executed effective the 4<SUP>th</SUP> day of May,
2023 by and between <FONT STYLE="font-variant: small-caps">NeurAxis, Inc (f/k/a Innovative Health Solutions, Inc.)</FONT>, a Delaware
corporation (the &ldquo;Company&rdquo;) and Gary Peterson, an individual (&ldquo;Executive&rdquo;). Each of the Company and Executive
may be referred to herein as a &ldquo;Party&rdquo; or collectively as the &ldquo;Parties&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BACKGROUND</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company and the Executive are parties to that certain Executive Employment Agreement (the &ldquo;Employment Agreement&rdquo;) dated
as of August 9, 2022 (capitalized terms not otherwise defined in this Amendment shall have the meanings ascribed to such terms in the
Employment Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
The Company plans to file a registration statement on Form S-1 (the &ldquo;Registration Statement&rdquo;) with the U.S. Securities and
Exchange Commission (the &ldquo;SEC&rdquo;) relating to the offering of the Company&rsquo;s shares of Common Stock in connection with
a firm commitment underwritten initial public offering (the &ldquo;IPO&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Parties desire to amend the Employment Agreement to, among other things, clarify the special one-time incentive payment set forth
in Section 4(d) of the Employment Agreement is contingent upon the effective date of the IPO.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>AMENDMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby amend
the Employment Agreement as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Section 4(d) of the Employment Agreement shall be completely amended and restated, such that, as revised, Section 4(d) shall read as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><U>Special
                                            One-Time Incentive Payment</U>. In accordance with Treasury Regulation Section 1.409A-1(b)(4)(ii),
                                            as soon as administratively practical, to reward past service, and incentivize Executive
                                            to remain with the Company for future service, a special one-time incentive payment of $6,730.77
                                            shall be due and paid immediately in a single lump sum to Executive contingent upon and concurrently
                                            with the effective date of the IPO, and such special one-time incentive payment will be subject
                                            to taxes and withholdings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In all other respects, the Employment Agreement shall remain unchanged.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
This Amendment may be executed in counterparts, and each executed counterpart shall have the same force and effect as an original instrument.
The signature pages to this Amendment may be delivered via electronic mail (including .pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any signature page so delivered shall be
deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Remainder
of Page Left Blank Intentionally.]<BR STYLE="clear: both">
&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Parties hereto have executed this Amendment as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPANY:</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NeurAxis,
    Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"><IMG SRC="ex10-22_001.jpg" ALT="" STYLE="height: 45px; width: 180px"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    &amp; Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><IMG SRC="ex10-22_002.jpg" ALT="" STYLE="height: 65px; width: 150px"></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Peterson</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
Page to First Amendment to Executive Employment Agreement</FONT></P>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.32
<SEQUENCE>9
<FILENAME>ex10-32.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.32</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<B>Agreement</B>&rdquo;) is dated as of February ___, 2023 between NEURAXIS, INC., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), and each purchaser identified on the <B><I><U>Annex A</U></I></B> hereto (each, including
its successors and assigns, an &ldquo;<B>Investor</B>&rdquo; or &ldquo;<B>Holder</B>&rdquo;) and collectively, the &ldquo;<B>Investors</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>the Investors wish to purchase from the Company, and the Company wishes to sell and issue to the Investors: (i) senior secured convertible
notes reflecting a 10% original issue discount in the form of <B><U>Appendix B</U></B> hereto (each, a &ldquo;<B>Note</B>&rdquo; and
collectively, the &ldquo;<B>Notes</B>&rdquo;) in an aggregate principal amount of up to $6,666,666.67, and (ii) warrants to purchase
shares of Common Stock, in the form of <B><U>Appendix C</U></B> hereto (each, a &ldquo;<B>Warrant</B>&rdquo; and collectively, the &ldquo;<B>Warrants</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
Alexander Capital, L.P. (the &ldquo;<B>Placement Agent</B>&rdquo;) is acting as the exclusive placement agent for the offering of Notes
and Warrants contemplated by this Agreement (the &ldquo;<B>Offering</B>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and Investors are executing and delivering this Agreement in reliance upon an exemption from securities registration requirements
of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), afforded by the provisions of Section 4(a)(2) and/or
Rule 506(b) of Regulation D promulgated thereunder by the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Company and each Investor agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
I</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1.01. <U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Notes (as defined herein), and
(b) the following terms have the meanings set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>$</U>&rdquo;
means United States Dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.01(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
of any Person means any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or
is under common control with such first Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day on which
banking institutions in the State of New York are authorized or required by law or other governmental action to close. If the last or
appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then
such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.01.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means for any Securities, the Business Day when all of the Transaction Documents for such Securities have been executed
and delivered by the applicable parties thereto, and conditions precedent to: (i) the applicable Investors&rsquo; obligations to pay
the Subscription Amount and (ii) the Company&rsquo;s obligations to deliver such Securities have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalent</U>&rdquo; means any convertible security or warrant, option or other right to subscribe for or purchase any additional
shares of Common Stock or any convertible security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Confidential
Investor Questionnaire</U>&rdquo; means the Confidential Investor Questionnaire attached as <B><U>Appendix A</U></B> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; has the meaning provided in the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -3.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; has the meaning provided in the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of: (i) shares of Common Stock or options to employees, officers, or directors of the Company
pursuant to any stock or option plan duly adopted by a majority of the Board of Directors of the Company or a majority of the members
of a committee of directors established for such purpose, (ii) shares of Common Stock or options to management of the Company pursuant
to any management incentive plan duly adopted by a majority of the Board of Directors of the Company or a majority of the members of
a committee of directors established for such purpose, and (iii) shares of Common Stock issued to an Investor in repayment of interest
under any Note as agreed upon by the Company and the applicable Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exercise
Price</U>&rdquo; has the meaning provided in the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Existing
Convertible Notes</U>&rdquo; the convertible notes of the Company issued during 2022 in the aggregate principal amount of $3,555,555.56.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Final
Maturity Date</U>&rdquo; has the meaning provided in the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FINRA</U>&rdquo;
means the Financial Industry Regulatory Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.01(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lead
Investor</U>&rdquo; means _______________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.01(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
shall mean a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other restriction or adverse claim
of a third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidity
Event</U>&rdquo; has the meaning provided in the Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning ascribed to such term in Section 3.01(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Maximum
Offering Amount</U>&rdquo; means an aggregate Subscription Amount of up to Six Million Dollars ($6,000,000), equating to an aggregate
maximum Original Principal Amount of Notes of $6,666,666.67 after applying the Original Issue Discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Notes</U>&rdquo;
means the senior secured convertible notes reflecting a 10% original issue discount issued by the Company to the Investors hereunder,
in the form of <B><U>Appendix B</U></B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Offering
Price</U>&rdquo; means the price per share of the Common Stock paid in the first Liquidity Event to occur after the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Discount</U>&rdquo; and &ldquo;<U>OID</U>&rdquo; mean 10%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Principal Amount</U>&rdquo; means, with respect to any Investor&rsquo;s Note(s), the amount obtained by <I>dividing</I>: (i) the Subscription
Amount for such Note(s) under this Agreement <I>by</I> (ii) 100% <I>less</I> the OID (or 90%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Liens</U>&rdquo; has the meaning provided in the Security Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or un-incorporated association, joint-venture, limited liability
company, joint-stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; shall have the meaning ascribed to such term in the recitals hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent Warrant</U>&rdquo; shall have the meaning ascribed to such term in section 3.01(r).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement in the form of <B><U>Appendix E</U></B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.01(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Minimum</U>&rdquo; means, as of any date, upon the request of the Holder, 200% of the maximum aggregate number of shares of Underlying
Securities then issued or potentially issuable in the future pursuant to this Agreement, conversion of all Notes and exercise of all
Warrants, ignoring any conversion or exercise limits set forth therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Notes and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Security
Agreement</U>&rdquo; means the Security Agreement, dated as of the date hereof, in the form of <B><U>Appendix D</U></B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>State
Securities Laws</U>&rdquo; means the securities (or &ldquo;blue sky&rdquo;) rules, regulations, or other similar laws of a particular
state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Investor, the aggregate amount to be paid for Securities purchased hereunder as specified below such
Investor&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Aggregate Subscription Amount,&rdquo; in
United States Dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any direct or indirect subsidiary of the Company as set forth on Section 3.01(a), if any, and shall, where applicable, include
any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Termination
Date</U>&rdquo; means a date determined by the Company on which the offering of the Securities shall terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed for trading or quoted on the date
in question: the NYSE, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, or the Nasdaq Global Select Market (or
any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Notes, the Warrants, the Placement Agent Warrant, the Security Agreement, the Registration
Rights Agreement and all appendices, exhibits and schedules hereto and thereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Underlying
Securities</U>&rdquo; means the Conversion Shares and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means the warrants issued by the Company to the Investors hereunder, in the form of <B><U>Appendix C</U></B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of or otherwise pursuant to the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
II</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.01 <U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with
the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Investors, severally and not
jointly, agree to purchase Securities. At the Closing, the Investors shall deliver, via wire transfer, immediately available funds equal
to the Investors&rsquo; aggregate Subscription Amounts to the Company and the Company shall deliver to each Investor its Securities.
The Company and each Investor shall deliver the other items set forth in Section 2.02 deliverable at the Closing. Upon satisfaction of
the conditions set forth in Sections 2.02 and 2.03, the Closing shall occur at the offices of the Company&rsquo;s counsel, or such other
location as the parties shall mutually agree or may be closed remotely by electronic delivery of documents. The Company may conduct multiple
closings for the sale of the Securities until it has received the Maximum Offering Amount. The Closing Date for any Securities shall
be the date indicated on the applicable Investor signature pages attached hereto and the final Closing Date shall be no later than the
Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.02 <U>Closing Deliverables</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>By Each Investor</U>. On or prior to the Closing Date, each Investor shall deliver or cause to be delivered to the Company the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                            Agreement duly executed by such Investor;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            duly completed and signed Confidential Investor Questionnaire, a copy of which is attached
                                            hereto as <B><U>Appendix A</U></B>,</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Security Agreement, the form of which is attached hereto as <B><U>Appendix D</U></B>, duly
                                            executed by such Investor;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Registration Rights Agreement, the form of which is attached hereto as <B><U>Appendix E</U></B>,
                                            duly executed by such Investor; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
                                            Investor&rsquo;s Subscription Amount by wire transfer to counsel to the Placement Agent pursuant
                                            to the wiring instructions set forth in Section 2.03(c).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>By the Company</U>. On or prior to the Closing Date, the Company shall deliver or cause to be delivered to the Placement Agent the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">this
                                            Agreement, duly executed by an authorized officer of behalf of the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            Note, the form of which is attached hereto as <B><U>Appendix B</U></B>, registered in the
                                            name of each relevant Investor, with a principal amount equal to such Investor&rsquo;s Original
                                            Principal Amount, duly executed by an authorized officer of behalf of the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            Warrant, the form of which is attached hereto as <B><U>Appendix C</U></B>, registered in
                                            the name of each relevant Investor, duly executed by an authorized officer of behalf of the
                                            Company, to purchase a number of shares of Common Stock determined by <I>dividing</I> (A)
                                            50% of the Original Principal Amount of such Investor&rsquo;s Note <I>by</I> (B) the Offering
                                            Price;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Security Agreement, the form of which is attached hereto as <B><U>Appendix D</U></B>, duly
                                            executed by an authorized officer on behalf of the Company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Registration Rights Agreement, the form of which is attached hereto as <B><U>Appendix E</U></B>,
                                            duly executed by an authorized officer on behalf of the Company</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Placement Agent Warrant, duly executed by an authorized officer on behalf of the Company;
                                            and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            officer&rsquo;s certificate of the Company certifying the Company&rsquo;s: (a) certified
                                            charter (or similar formation document); (b) good standing certificate in its state of incorporation
                                            (or formation); (c) bylaws (or similar governing document); and (d) resolutions of its Board
                                            of Directors (or similar governing body) approving and authorizing the execution, delivery
                                            and performance of the Transaction Documents and the transactions contemplated thereby.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2.03 <U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            accuracy in all material respects on the Closing Date of each Investor&rsquo;s representations
                                            and warranties contained herein;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            obligations, covenants and agreements of each Investor required to be performed at or prior
                                            to the Closing Date shall have been performed; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            delivery by each Investor of the items set forth in Section 2.02(a) of this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Investors hereunder in connection with the Closing are subject to the following conditions being met
(it being understood that the Company may waive any of the conditions for any Closing hereafter):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            accuracy in all material respects (or, to the extent representations or warranties are qualified
                                            by materiality or Material Adverse Effect, in all respects) when made and on the Closing
                                            Date of the representations and warranties of the Company contained herein (unless as of
                                            a specific date therein in which case they shall be accurate as of such date);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            obligations, covenants and agreements of the Company required to be performed at or prior
                                            to the Closing Date shall have been performed;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            delivery by the Company of the items set forth in Section 2.02(b) of this Agreement; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
                                            shall have been no Material Adverse Effect with respect to the Company since the date hereof.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The wiring instructions for counsel to the Placement Agent are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
    Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    Bank</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">565
    Fifth Avenue</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York 10017</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Routing
    No.:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">026013576</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    No.:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1505039390</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    Bank as Escrow Agent for Neuraxis, Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Swift
    Code:*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNUS33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*International only)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
III</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.01 <U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each
Investor as of the date hereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. The Company does not have any Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company is an entity duly incorporated or otherwise organized, validly existing and in good
standing under the laws of the State of Delaware, with the requisite power and authority to own and use its properties and assets and
to carry on its business as currently conducted. The Company is not in violation or default of any of the provisions of its articles
of incorporation or bylaws, each, as amended and in effect. A complete and correct copy of the Company&rsquo;s certificate or articles
of incorporation and bylaws, each as amended and in effect on the date of this Agreement and as they will be in effect on the Closing
Date, is attached to the officer&rsquo;s certificate referenced in Section 2.02(b)(vii). There are no other organizational or charter
documents of the Company. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other
entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary,
except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result
in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document; (ii) a material adverse effect
on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company or any of its material
assets or lines of business, individually; or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<B>Material Adverse Effect</B>&rdquo;)
and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification; <I>provided, however</I>, that &ldquo;Material Adverse Effect&rdquo; shall not include any
event, occurrence, fact, condition or change, directly or indirectly, arising out of or attributable to: (i) general economic or political
conditions, (ii) conditions generally affecting the industry in which the Company or any Subsidiary operates, (iii) any changes in financial
or securities markets in general, (iv) acts of war (whether or not declared), armed hostilities or terrorism, or the escalation or worsening
thereof, (v) any pandemic, epidemics or human health crises (including COVID-19), (vi) any changes in applicable laws or accounting rules,
(vii) the announcement, pendency or completion of the transactions contemplated by the Transaction Documents, or (viii) any action required
or permitted by the Transaction Documents or any action taken (or omitted to be taken) with the written consent of or at the written
request of the Investors holding a majority in principal amount outstanding of the Notes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by each of the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution
and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and
thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company,
the Board of Directors or the Company&rsquo;s stockholders in connection therewith other than in connection with the Required Approvals.
Each Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered
in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against
the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally; (ii) as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; and (iii) insofar
as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of the Transaction Documents to which it is a party, the
issuance and sale of the Securities and Placement Agent Warrants, the issuance of the Underlying Securities in accordance with the provisions
of the Transaction Documents, and the consummation by the Company of the other transactions contemplated hereby and thereby do not and
will not: (i) conflict with or violate any provision of the Company&rsquo;s certificate of incorporation, bylaws or other organizational
or charter documents; (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become
a default) under, result in the creation of any Lien upon any of the properties or assets of the Company (other than the Liens granted
under the Security Agreement), or give to others any rights of termination, amendment, acceleration or cancellation (with or without
notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise)
or other understanding to which the Company is a party or by which any property or asset of the Company is bound or affected; or (iii)
subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company is subject (including federal and State Securities
Laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii)
and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or <U>registration</U> with, any court or other federal, state, local or other governmental authority or
other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i)
such consents, waivers, or authorizations as have been obtained before the Closing; and (ii) the filing of Form D with the Commission
and such filings as are required to be made under applicable State Securities Laws (collectively, the &ldquo;<B>Required Approvals</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and/or paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens other than restrictions
on transfer provided for in the Transaction Documents. The Underlying Securities, when issued in accordance with the terms of the Securities,
will be validly issued, fully paid and nonassessable, free and clear of all Liens other than restrictions on transfer provided for in
the Securities. The Company has reserved from its duly authorized capital stock a number of shares of Common Stock for issuance of the
Underlying Securities at least equal to the Required Minimum on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The Company has authorized: (i) 100,000,000 shares of Common Stock, of which ___________shares are issued and
outstanding as of the Closing Date, and (ii) 1,120,000 shares of Preferred Stock, par value $0.001 per share (&ldquo;<B>Preferred Stock</B>&rdquo;),
of which (x) 1,000,000 has been designated Series A Preferred Stock (&ldquo;<B>Series A Preferred</B>&rdquo;), of which [506,637] shares
are issued and outstanding as of the Closing Date, and (y) 120,000 has been designated as Series Seed Preferred, of which none (0) of
which are issued and outstanding as of the Closing Date. Other than Exempt Issuances, the Existing Convertible Notes, such shares of
Series A Preferred, the Securities and the Placement Agent Warrant, there are no outstanding options, warrants, script rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable
or exchangeable for, or giving any person any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments,
understandings or arrangements by which the Company is or may become bound to issue additional shares of Common Stock, or securities
or rights convertible or exchangeable into shares of Common Stock. No Person has any right of first refusal, preemptive right, right
of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents except for such,
if any, as will have been validly waived before the Closing. The issuance and sale of the Securities and Placement Agent Warrant will
not obligate the Company to issue shares of Common Stock or other securities to any Person (other than the Investors) and will not result
in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such securities.
All of the outstanding shares of capital stock of the Company are validly issued, fully paid and nonassessable, have been issued in compliance
with all federal law and State Securities Laws, and none of such outstanding shares was issued in violation of any preemptive rights
or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors
or others is required for the issuance and sale of the Securities, except for such approvals as have been obtained prior to Closing.
There are no stockholders&rsquo; agreements, voting agreements or voting trusts, investor rights agreements, rights of first refusal,
preemptive rights, co-sale agreements, drag-along agreements, transfer restrictions or other similar agreements with respect to the Company&rsquo;s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Financial Statements</U>. The financial statements of the Company made available to the Placement Agent and Investors prior to the
date hereof have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis
during the periods involved (&ldquo;<B>GAAP</B>&rdquo;), except as may be otherwise specified in such financial statements or the notes
thereto, and fairly present in all material respects the financial position of the Company as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Undisclosed Liabilities</U>. The Company has no liability, indebtedness, obligation, expense, claim, deficiency or guaranty of any
type, whether accrued, absolute, contingent, matured, unmatured or otherwise, required to be reflected in financial statements in accordance
with GAAP, which individually or in the aggregate: (A) has not been reflected in the latest balance sheet included in the financial statements
referenced hereinabove; or (B) has not arisen: (i) in the ordinary course of business, consistent with past practices, since the date
of the latest balance sheet included in such financial statements in an amount that does not exceed $25,000 in any one case or $50,000
in the aggregate, (ii) pursuant to or in connection with this Agreement or other Transaction Document, or (c) are executory performance
obligations to be performed after the date hereof in the ordinary course of business pursuant to agreement(s) entered into in the ordinary
course of business, consistent with past practices. The Company is not in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Material Changes</U>. Since the date of the latest financial statements made available to the Placement Agent and Investors prior
to the date hereof: (A) there has been no event, occurrence or development that has had or that could reasonably be expected to result
in a Material Adverse Effect; (B) the Company has not incurred any liabilities (contingent or otherwise) other than (i) trade payables
and accrued expenses incurred in the ordinary course of business consistent with past practice, and (ii) liabilities not required to
be reflected in the Company&rsquo;s financial statements pursuant to GAAP; (C) the Company has not altered their method of accounting;
(D) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed
or made any agreements to purchase or redeem any shares of its capital stock except; and (E) the Company has not issued any equity securities
except in favor of an officer, director or consultant pursuant to an existing Company equity incentive plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Litigation</U>. Except as set forth on Schedule 3.01(k), there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, or any of its properties, before or by any
court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively,
an &ldquo;<B>Action</B>&rdquo;) which: (A) adversely affects or challenges the legality, validity or enforceability of any of the Transaction
Documents or the Securities; or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material
Adverse Effect. None of the Company or any director or officer thereof, is or has been the subject of any Action involving: (x) a claim
of violation of or liability under the Securities Act, the Exchange Act, FINRA rules or any State Securities Laws; (y) breach of fiduciary
duty; or (z) fraud (statutory or common law), embezzlement, misappropriation or conversion of property or rights, or any other crime
involving deceit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Labor Relations</U>. To the knowledge of the Company, no labor dispute exists or is imminent with respect to any of the employees
of the Company which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s employees is a
member of a union that relates to such employee&rsquo;s relationship with the Company, and the Company is not a party to any collective
bargaining agreement. The Company believes that its relationships with its employees are good. No executive officer, to the knowledge
of the Company, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure
or proprietary information agreement or non- competition agreement, or any other contract or agreement or any restrictive covenant in
favor of any third party, and the continued employment of each such executive officer does not subject the Company to any liability with
respect to any of the foregoing matters. To the best of the Company&rsquo;s knowledge, it is in compliance with all U.S. federal, state,
local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages
and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Compliance</U>. The Company: (i) is neither in default under nor in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company under), nor has the Company received notice of a
claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived); (ii)
is not in violation of any order of any court, arbitrator or governmental body; and (iii) is not and has not been in material violation
of any statute, law, rule or regulation of any governmental authority, including without limitation all foreign, federal, state and local
laws applicable to its business and all such laws that affect the environment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company possesses all certificates, authorizations and permits issued by the appropriate federal, state,
local or foreign regulatory authorities necessary to conduct its business, except where the failure to possess such permits could not
reasonably be expected to result in a Material Adverse Effect, and to the knowledge of the Company, the Company has not received any
notice of proceedings relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company has good and marketable title in fee simple to all real property and good and marketable title in
all personal property owned by it that, in each case, is material to the business of the Company, in each case free and clear of all
Liens, except for Permitted Liens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Patents and Trademarks</U>. (i) The Company has, or has rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses <U>and</U> other intellectual property rights and similar
rights as necessary or material for use in connection with its business and which the failure to so have could reasonably be expected
to have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property Rights</B>&rdquo;); (ii) to the knowledge of the
Company, the Company has not received a notice (written or otherwise) that any of the Intellectual Property Rights violates or infringes
upon the intellectual property rights of any other Person; (iii) all Intellectual Property Rights are enforceable by the Company, and
to the knowledge of the Company, there is no existing infringement by any other Person of any of the Intellectual Property Rights, except
where the failure to be so enforceable or for such infringements as would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect; and (iv) the Company has taken reasonable security measures to protect the secrecy, confidentiality
and value of all of its Intellectual Property Rights, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Transactions with Officers, Directors and Employees</U>. None of the officers or directors of the Company and, to the knowledge of
the Company, none of the employees of the Company, is presently a party to any transaction with the Company (other than for services
as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services
to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from, any such officer,
director or employee or, to the knowledge of the Company, any entity in which any such officer, director or employee has a substantial
interest or is an officer, director, trustee, member or partner, in each case other than for: (x) payment of salary or fees for services
rendered; (y) reimbursement for expenses incurred on behalf of the Company; and (z) other employee benefits, including stock option agreements
under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Certain Fees</U>. Other than fees, commissions and expense reimbursement payable to the Placement Agent (which include: (i) a cash
commission of ten percent (10%) of the proceeds raised in the Offering from Investors introduced to the Company by the Placement Agent;
(ii) the granting to the Placement Agent of a warrant for the purchase of a number of shares of Common Stock equal to 6% of the number
of Underlying Securities (the &ldquo;<B>Placement Agent Warrant</B>&rdquo;); and (iii) the other matters set forth in the engagement
letter between the Company and the Placement Agent dated April 13, 2022), no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person
with respect to the Offering or any of the transactions contemplated by the Transaction Documents. The Investors shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this
Section 3.01(r) that may be due in connection with the Offering or any of the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Private Placement</U>. Assuming the accuracy of the Investors&rsquo; representations and warranties set forth in Section 3.02, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Investors as contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities
will not be or be an Affiliate of, an &lsquo;investment company&rsquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not be an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Registration Rights</U>. Other than pursuant to the Transaction Documents and those granted to holders of Existing Convertible Notes,
no Person has any right to demand the Company to file a registration statement under the Securities Act covering the sale of any securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Disclosure</U>. Except with respect to: (i) the material terms and conditions of the transactions contemplated by the Transaction
Documents; and (ii) information given to the Investors, if any, which the Company hereby confirms will not constitute material non-public
information, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Investors or their
agents or counsel with any information that it believes constitutes or might constitute material, nonpublic information. The Company
understands and confirms that the Investors will rely on the foregoing representation in effecting transactions in securities of the
Company. All disclosure furnished by or on behalf of the Company to the Investors regarding the Company, its business and the transactions
contemplated hereby, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>No Integrated Offering</U>. Assuming the accuracy of the Investors&rsquo; representations and warranties set forth in Section 3.02,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of the Securities Act which would require the registration of any such
securities under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date after giving effect to the receipt
by the Company of the proceeds from the sale of the Securities hereunder: (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature; (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, and projected capital requirements and capital availability thereof; and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking
into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company will not, after the Closing Date, incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company has filed all federal, state and foreign income and franchise tax returns and have paid or accrued
all taxes shown as due thereon, and the Company has no knowledge of a tax deficiency which has been asserted or threatened against the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
or Underlying Securities by any form of general solicitation or general advertising. The Company has offered the Securities and Underlying
Securities for sale only to the Investors and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the
Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Insurance</U>. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as management of the Company reasonably believes to be prudent and customary in the businesses in which the Company is engaged.
The Company has never been refused any insurance coverage sought or applied for, and the Company has no reason to believe that it will
not be able to renew all existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Acknowledgment Regarding Investors&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Investors
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Investor is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Investor or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Investors&rsquo; purchase of the Securities. The Company further represents to each Investor that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>No Disqualification Events</U>. With respect to Securities to be offered and sold hereunder in reliance on Rule 506(b) under the Securities
Act (&ldquo;Regulation D Securities&rdquo;), none of the Company, any of its predecessors, any affiliated issuer, any director, executive
officer, other officer of the Company participating in the offering hereunder, any beneficial owner of twenty percent (10%) or more of
the Company&rsquo;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is
defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;Issuer
Covered Person&rdquo; and, together, &ldquo;Issuer Covered Persons&rdquo;) is subject to any of the &lsquo;Bad Actor&rsquo; disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;Disqualification Event&rdquo;), except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is
subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e),
and has furnished to the Investors a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Other Covered Persons</U>. The Company is not aware of any person (other than any Issuer Covered Person or the Placement Agent) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Regulation
D Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Notice of Disqualification Events</U>. The Company will notify the Investors in writing, prior to the Closing Date of: (i) any Disqualification
Event relating to any Issuer Covered Person; and (ii) any event that would, with the passage of time, become a Disqualification Event
relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Foreign Corrupt Practices</U>. Neither the Company nor, to the knowledge of the Company, no agent or other person acting on behalf
of the Company, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses
related to foreign or domestic political activity; (ii) made any unlawful payment to foreign or domestic government officials or employees
or to any foreign or domestic political parties or campaigns from corporate funds; (iii) failed to disclose fully any contribution made
by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law; or (iv) violated
in any material respect any provision of the Foreign Corrupt Practices Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Office of Foreign Assets Control</U>. Neither the Company nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or Affiliate of the Company, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S.
Treasury Department (&ldquo;OFAC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon an Investor&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Affiliates is subject to the Bank Holding Company Act of 1956, as
amended (&ldquo;BHCA&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (&ldquo;Federal Reserve&rdquo;).
Neither the Company nor any of its Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding
shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Affiliates exercises a controlling influence
over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Money Laundering</U>. The operations of the Company are and have been conducted at all times in compliance with applicable financial
record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money
laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;Money Laundering Laws&rdquo;), and no Action
or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to
the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Representations</U>. The representations and warranties of the Company contained in this Agreement, and the certificate(s) furnished
or to be furnished to the Investors at the Closing, when taken as a whole, do not contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements contained herein or therein not misleading in light of the circumstances
under which they were made. The Company acknowledges and agrees that the representations contained in section 3.02 shall not modify,
amend or affect such Investor&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained in this section 3.01
or elsewhere in this Agreement or any representations and warranties contained in any other Transaction Document, or any other document
or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3.02 <U>Representations and Warranties of the Investors</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Investor, for itself and for no other Investor, hereby represents and warrants as of the date hereof and as of the Closing Date to the
Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Authority; Organization</U>. Such Investor has full power and authority (and, if such Investor is an individual, the capacity) to
enter into this Agreement and to perform all obligations required to be performed by it hereunder. If an entity, Such Investor is an
entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization with full right,
corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Investor of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate or
similar action on the part of such Investor. Each Transaction Document to which it is a party has been duly executed by such Investor,
and when delivered by such Investor in accordance with the terms hereof, will constitute the valid and legally binding obligation of
such Investor, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable
bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights
generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies,
and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Own Account</U>. Such Investor understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable State Securities Law and is acquiring the Securities as principal for its own account and
not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
State Securities Law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
State Securities Law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities (this representation and warranty not limiting such Investor&rsquo;s right to sell the Securities in
compliance with applicable federal and State Securities Laws) in violation of the Securities Act or any applicable State Securities Law.
Such Investor is acquiring the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Non-Transferrable</U>. Such Investor agrees: (i) that the Investor will not sell, assign, pledge, give, transfer or otherwise dispose
of the Securities or any interest therein, or make any offer or attempt to do any of the foregoing, except pursuant to a registration
of the Securities under the Securities Act and all applicable State Securities Laws, or in a transaction which is exempt from the registration
provisions of the Securities Act and all applicable State Securities Laws, (ii) that the certificates representing the Securities will
bear a legend making reference to the foregoing restrictions, and (iii) that the Company and its Affiliates shall not be required to
give effect to any purported transfer of such Securities except upon compliance with the foregoing restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Investor Status</U>. Such Investor is an &ldquo;accredited investor&rdquo; as defined in Rule 501(a) under Regulation D of the Securities
Act. The undersigned agrees to furnish any additional information requested by the Company or any of its Affiliates to assure compliance
with applicable U.S. federal and state securities laws in connection with the purchase and sale of the Securities. The undersigned has
completed the Confidential Investor Questionnaire contained in <B><U>Appendix A</U></B> and the information contained therein is complete
and accurate as of the date thereof and is hereby affirmed as of the Closing Date. Any information that has been furnished or that will
be furnished by the undersigned to evidence its status as an accredited investor is accurate and complete, and does not contain any misrepresentation
or material omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Experience of Such Investor</U>. Such Investor, either alone or together with its representatives, has such knowledge, sophistication,
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Investor is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>No Trading Market</U>. Such Investor acknowledges that there is currently no Trading Market for the Securities and Underlying Securities
and that none is expected to develop for the Securities and the Underlying Securities unless a Liquidity Event occurs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>General Solicitation</U>. Such Investor undersigned acknowledges that neither the Company nor any other person offered to sell the
Securities to it by means of any form of general solicitation or advertising, including, but not limited to: (i) any advertisement, article,
notice, or other communication published in any newspaper, magazine or similar media or broadcast over television or radio, or (ii) any
seminar or meeting whose attendees were invited by any general solicitation or general advertising.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Confidentiality</U>. Other than to other Persons party to this Agreement and its advisors who have agreed to keep information confidential
or have a fiduciary obligation to keep such information confidential, such Investor has maintained the confidentiality of all disclosures
made to it in connection with the transaction (including the existence and terms of this transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Foreign Investor</U>. If such Investor is not a United States person, such Investor represents that it has satisfied itself as to
the full observance of the laws of its jurisdiction in connection with any invitation to subscribe for the Securities or any use of this
Agreement, including: (i) the legal requirements within its jurisdiction for the purchase of the Securities, (ii) any foreign exchange
restrictions applicable to such purchase, (iii) any governmental or other consents that may need to be obtained, and (iv) the income
tax and other tax consequences, if any, that may be relevant to the purchase, holding, redemption, sale or transfer of the Securities.
The Investor further represents that its payment for, and its continued beneficial ownership of the Securities, will not violate any
applicable securities or other laws of its jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Information from Company</U>. Such Investor and its investment managers, if any, have been afforded the opportunity to obtain any
information necessary to verify the accuracy of any representations or information presented by the Company in this Agreement and have
had all inquiries to the Company answered, and have been furnished all requested materials, relating to the Company and the Offering
and sale of the Securities and anything set forth in the Transaction Documents. Neither the Investor nor the Investor&rsquo;s investment
managers, if any, have been furnished any offering literature by the Company or any of its Affiliates, associates, or agents other than
the Transaction Documents, and the agreements referenced therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Matters Concerning the Placement Agent</U>. Such Investor acknowledges that the Placement Agent is acting as the exclusive Placement
Agent for the Offering and that the Placement Agent will receive a cash commission in the amount of ten percent (10%) of the proceeds
raised in the Offering and will receive the Placement Agent Warrant. The Placement Agent Warrant will: (i) be non-exercisable or transferrable
for six (6) months after the Closing Date (other than as permitted by FINRA Rule 5110), (ii) expire five (5) years after the Closing
Date, (iii) be exercisable at an exercise price of one hundred twenty percent (120%) of the Liquidity Event Price (as defined in the
Notes), and (iv) will contain customary anti-dilution provisions and protections (adjustments in the number and price of such warrants
and the shares underlying such warrants resulting from certain corporate events (such as stock dividends, stock splits, recapitalizations,
reorganizations and mergers). The Placement Agent has received one-time demand registration rights and unlimited piggyback registration
rights relating to the securities underlying the Placement Agent Warrant. The Placement Agent is acting as placement agent for the Company,
and, in that capacity, is not acting as investment advisor to the Investors in connection with the Securities being offered in this Offering.
Each Investor must make his own investment decisions. In making those decisions, the Investors should be aware that the Placement Agent
will receive a placement fee and other compensation as described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Speculative Nature of Investment; Risk Factors</U>. <B>SUCH INVESTOR UNDERSTANDS THAT AN INVESTMENT IN THE SECURITIES INVOLVES A HIGH
DEGREE OF RISK.</B> Such Investor acknowledges that: (i) any projections, forecasts or estimates as may have been provided to the Investor
are purely speculative and cannot be relied upon to indicate actual results that may be obtained through this investment; any such projections,
forecasts and estimates are based upon assumptions which are subject to change and which are beyond the control of the Company or its
management, (ii) the tax effects which may be expected by this investment are not susceptible to absolute prediction, and new developments
and rules of the Internal Revenue Service, audit adjustment, court decisions or legislative changes may have an adverse effect on one
or more of the tax consequences of this investment, and (iii) the Investor has been advised to consult with his own advisor regarding
legal matters and tax consequences involving this investment. The Investor represents that the Investor&rsquo;s investment objective
is speculative in that the Investor seeks the maximum total return through an investment in a broad spectrum of securities, which involves
a higher degree of risk than other investment styles and therefore the Investor&rsquo;s risk exposure is also speculative. The Securities
offered hereby are highly speculative and involve a high degree of risk and Investor should only purchase these securities if Investor
can afford to lose their entire investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Matters Concerning the Placement Agent.</U> Such Investor acknowledges that the Placement Agent is acting as the exclusive Placement
Agent for the Offering and that the Placement Agent will receive a Cash Fee and Placement Agent Warrant. The Placement Agent is acting
as placement agent for the Company, and, in that capacity, is not acting as investment advisor to the Investors in connection with the
Securities or Underlying Securities; and (C) the Investor must make his own investment decisions. In making those decisions, the Investor
should be aware that the Placement Agent will receive a placement fee and other compensation as described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Money Laundering</U>. If an entity, the operations of such Investor are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in Section 3.02 shall not modify, amend or affect such Investor&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transaction contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
IV</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.01 <U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities and Underlying Securities may only be disposed of in compliance with state and federal securities laws. In connection
with any transfer of Securities or Underlying Securities other than pursuant to an effective registration statement or Rule 144, the
Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably
acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that
such transfer does not require registration of such transferred Securities or Underlying Securities under the Securities Act. The Securities
may not be sold or transferred by the Investors without the written consent of the Company, which shall not be unreasonably withheld.
As a condition of such sale or transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall
have the rights of an Investor under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Investors agree to the imprinting, so long as is required by this Section 4.01, of a legend on any of the Securities and Underlying
Securities in the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[NEITHER]
THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS [CONVERTIBLE/EXERCISABLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES
AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE &ldquo;<B>SECURITIES ACT</B>&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL
OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Upon the Investor&rsquo;s request in connection with a proposed sale of Underlying Securities pursuant to Rule 144 and if the Company
reasonably determines it is so required, upon receipt of customary documentation from Investor&rsquo;s broker (if the Underlying Securities
are sold in brokers transactions), the Company shall, at its own cost and effort, retain legal counsel to provide an opinion letter to
the Company&rsquo;s transfer agent opining that the Underlying Securities may be resold without registration under the Securities Act,
pursuant to Rule 144, promulgated thereunder, so long as the requirements of Rule 144 are met for any Underlying Securities to be resold
thereunder. The Company shall arrange for any such opinion letter to be provided not later than two (2) Business Days after the date
of delivery to and receipt by the Company of a written request by any Investor together with (if required in order to render the opinion)
any broker&rsquo;s representation letter of other customary documentation reasonably requested by the Company evidencing compliance with
Rule 144 (the &ldquo;<B>Legend Removal Date</B>&rdquo;), and such opinion letter may be a &ldquo;blanket&rdquo; opinion letter covering
Underlying Securities held by more than one Investor (if applicable to more than one Investor).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Each Investor, severally and not jointly with the other Investors, agrees that such Investor will sell any Securities and Underlying
Securities only pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery
requirements, or an exemption therefrom, and that if Securities or Underlying Securities are sold pursuant to a registration statement,
they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive
legend from certificates representing Securities as set forth in this Section 4.01 is predicated upon the Company&rsquo;s reliance upon
this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.02 <U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Underlying Securities may result in dilution
of the outstanding shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges
that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Underlying Securities
pursuant to the Securities, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have against any Investor and regardless of the dilutive effect
that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.03 <U>Registration Rights</U>. The Company shall cause the Registration Rights Agreement to remain in full force and effect and the
Company shall comply in all material respects with the terms thereof, a copy of which is annexed hereto as <B><U>Appendix E</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.04 <U>Integration</U>. The Company shall not sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities to the Investors
in a manner that would require the registration under the Securities Act of the sale of the Securities to the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.05 <U>Publicity</U>. The Company and each Investor shall consult with each other in issuing any other press releases with respect to
the transactions contemplated hereby, and neither the Company nor any Investor shall issue any such press release nor otherwise make
any such public statement without the prior consent of the Company with respect to any press release of any Investor, or without the
prior consent of each Investor with respect to any press release of the Company mentioning such Investor, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.06 <U>Indemnification of Investors</U>. The Company shall indemnify, reimburse and hold harmless the Investors and their respective
partners, members, shareholders, officers, directors, employees and agents (and any other persons with other titles that have similar
functions) (collectively, &ldquo;<B>Indemnitees</B>&rdquo;) from and against any and all losses, claims, liabilities, damages, penalties,
suits, costs and expenses, of any kind or nature, (including fees relating to the cost of investigating and defending any of the foregoing)
imposed on, incurred by or asserted against such Indemnitee in any way related to or arising from or alleged to arise from: (i) any breach
of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction
Documents and (ii) any action instituted against such Indemnitee in any capacity, or any of them or their respective Affiliates, by any
stockholder of the Company who is not an Affiliate of such Indemnitee, with respect to any of the transactions contemplated by the Transaction
Documents (unless such action is based upon a breach of such Indemnitee&rsquo;s representations, warranties or covenants under the Transaction
Documents or any agreements or understandings such Indemnitee may have with any such stockholder or any violations by such Indemnitee
of state or federal securities laws or any conduct by such Indemnitee which results from the gross negligence or willful misconduct of
the Indemnitee as determined by a final, nonappealable decision of a court of competent jurisdiction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.07 <U>Reservation of Underlying Securities</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the Securities in such
amount, as the Required Minimum, as may then be required to fulfill its obligations in full under the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum
on such date, then the Board of Directors shall use commercially reasonable efforts to amend the Company&rsquo;s certificate or articles
of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at such time,
as soon as possible and in any event not later than the 60th day after such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.08 <U>Actions Taken in Connection with the Liquidity Event</U>. Notwithstanding anything contained herein to the contrary, in the event
that the Company is required to complete any corporate action, including, without limitation, any action required by any state or federal
securities governing entity or other agency, which in its good faith and commercially reasonable discretion, is necessary to consummate
a Liquidity Event, it shall be permitted to undertake and complete such action in order to consummate such Liquidity Event but without
prejudice to the rights and remedies of the Investors under the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.09 <U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder to: (a) cover the expenses
related to the Offering, (b) to pay-down up to $2,470,000 principal amount (excluding original issue discount and interest) of Existing
Convertible Notes held by Leonite Fund I, LP, Bigger Capital Fund, LP and/or District 2 Capital Fund, LP, (c) to pay-down up to the outstanding
principal amount (excluding original issue discount and interest) of Existing Convertible Notes held by Emmis Capital II, LLC or Exchange
Listing, LLC; and (d) for general working capital purposes and shall not use such proceeds: (i) for the satisfaction of any portion of
the Company&rsquo;s debt (other than payment of (x) trade payables in the ordinary course of the Company&rsquo;s business and prior practices
and Existing Convertible Notes as aforesaid); (ii) for the redemption of any Common Stock or Common Stock Equivalents; (iii) for the
settlement of any outstanding litigation; (iv) in violation of FCPA or OFAC regulations; or (v) to lend, give credit or make advances
to any officers, directors, employees or Affiliates of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4.10 <U>Subsidiaries</U>. The Company shall cause each of its Subsidiaries formed or acquired subsequent to the date hereof to execute
and deliver, for the benefit of Investors, an assumption agreement with respect to the Security Agreement promptly after such formation
or acquisition (as applicable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ARTICLE
V</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.01 <U>Termination</U>. This Agreement may be terminated by any Investor, as to such Investor&rsquo;s obligations hereunder only and
without any effect whatsoever on the obligations between the Company and the other Investors, by written notice to the other parties,
if the Closing has not been consummated on or before the Termination Date; provided, however, that such termination will not affect the
right of any party to sue for any breach by the other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.02 <U>Fees and Expenses</U>. The Company shall reimburse the Placement Agent and each other Investor for any and all expenses incurred
by them in connection with the negotiation, preparation, execution, delivery and performance of the Transaction Documents, including,
without limitation, reasonable attorneys&rsquo; and consultants&rsquo; fees and expenses, transfer agent fees, fees for stock quotation
services, fees relating to any amendments or modifications of the Transaction Documents or any consents or waivers of provisions in the
Transaction Documents, fees for the preparation of opinions of counsel, escrow fees, and costs of restructuring the transactions contemplated
by the Documents. When possible, the Company must pay these fees directly, including, but not limited to, any and all wire fees, otherwise
the Company must make immediate payment for reimbursement to an Investor for all fees and expenses immediately upon written notice by
an Investor or the submission of an invoice by an Investor. At Closing, the Company&rsquo;s initial obligation with respect to this transaction
is to reimburse the Placement Agent&rsquo;s legal expenses, which shall not exceed $_________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.03 <U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with
respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.04 <U>Notices</U>. Any notice, request, instruction or other document to be given hereunder by any party to the others shall be in
writing and delivered personally or sent by registered or certified mail, postage prepaid, or by or email:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>if
to Investor:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the address set forth on such Investor&rsquo;s signature page hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>if
to the Company:</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">829
S Adams St.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Versailles,
IN 47042</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Brian Carrico, CEO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>bcarrico@neuraxis.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy (for informational purposes only) to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lucosky
Brookman LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
Wood Avenue South, 5th Floor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodbridge,
NJ 08830</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(732) 395-4400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Joseph M. Lucosky, Esq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:
jlucosky@lucbro.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
to such other persons or addresses as may be designated in writing by the party to receive such notice as provided above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.05 <U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented, or amended except in a written
instrument signed, in the case of an amendment, by the Company and the Investors holding at least a majority in principal amount of the
Notes then outstanding and the Lead Investor or, in the case of a waiver, by the party against whom enforcement of any such waived provision
is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a
continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof,
nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.06 <U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Investor (other than by merger). Any Investor may assign any or all of its rights under this Agreement to any Person to whom
such Investor assigns or transfers any Securities, provided that such transfer complies with all applicable federal and State Securities
Laws and that such transferee agrees in writing with the Company to be bound, with respect to the transferred Securities, by the provisions
of the Transaction Documents that apply to the &ldquo;Investors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.07 <U>No Third-Party Beneficiaries</U>. Except for the Placement Agent, who is an intended third-party beneficiary of this Agreement,
including the representations and warranties made by the Company hereunder, this Agreement is intended for the benefit of the parties
hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.08 <U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of Arizona, without regard to the principles
of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the
transactions contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors,
officers, shareholders, employees or agents) shall be commenced exclusively in the federal and state courts sitting in the County of
New York, New York (the &ldquo;<B>New York Courts</B>&rdquo;). Each party hereto hereby irrevocably submits to the exclusive jurisdiction
of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York
Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto
hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to the Transaction Documents or the transactions contemplated hereby. If any party shall commence an action
or proceeding to enforce any provisions of the Transaction Documents, then the prevailing party in such action or proceeding shall be
reimbursed by the other party for its attorney&rsquo;s fees and other costs and expenses incurred in the investigation, preparation and
prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.09 <U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.10 <U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page was an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.11 <U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.12 <U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Investor exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Investor may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of a conversion
of a Note, the Investor shall be required to return any shares of Common Stock subject to any such rescinded conversion or exercise notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.13 <U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.14 <U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Investors and the Company will be entitled to seek specific performance under the Transaction Documents. The parties agree
that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense
that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.15 <U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Investor pursuant to any Transaction
Document or an Investor enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement
or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law
(including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent
of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force
and effect as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.16 <U>Independent Nature of Investors&rsquo; Obligations and Rights</U>. The obligations of each Investor under any Transaction Document
are several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance
or non-performance of the obligations of any other Investor under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Investor pursuant thereto, shall be deemed to constitute the Investors as a partnership,
an association, a joint venture, or any other kind of entity, or create a presumption that the Investors are in any way acting in concert
or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Investor shall be
entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or
out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any
proceeding for such purpose. Each Investor has been represented by its own separate legal counsel in their review and negotiation of
the Transaction Documents. The Company has elected to provide all Investors with the same terms and Transaction Documents for the convenience
of the Company and not because it was required or requested to do so by the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.17 <U>Construction</U>. The parties agree that each of them and/or their respective counsel has reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved
against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments hereto. In addition,
each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.18 <U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5.19 <U>WAIVER OF JURY TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<B>SIGNATURE
PAGES FOLLOW</B>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEURAXIS,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; width: 3%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Brian Carrico</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Chief Executive Officer</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTORS:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Investors executing the Signature Page in the form <B>attached</B> hereto as <B><U>Annex A</U></B> and delivering the same to the
    Company or its agents shall be deemed to have executed this Agreement and agreed to the terms hereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annex
A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
Purchase Agreement Investor Counterpart Signature Page</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, desiring to: (i) enter into this Securities Purchase Agreement dated as of February ___, 2023 (the &ldquo;<B>Agreement</B>&rdquo;),
with the undersigned, Neuraxis, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), in or substantially in the form furnished
to the undersigned and (ii) purchase the Securities as set forth below, hereby agrees to purchase such Securities from the Company as
of the Closing and further agrees to join the Agreement as a party thereto, with all the rights and privileges appertaining thereto,
and to be bound in all respects by the terms and conditions thereof. The undersigned specifically acknowledges having read the representations
in this Agreement&rsquo;s section entitled &ldquo;Representations Warranties of the Investors&rdquo;, and hereby represents that the
statements contained therein are complete and accurate with respect to the undersigned as an Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR </B>(<I>if an individual</I>):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR
    </B>(<I>if an entity</I>):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Legal
    Name of Entity)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR </B>(<I>if investing jointly</I>)</FONT></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State/Country
    of Domicile or Formation: _________________________________________________________________</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Aggregate Subscription Amount: $ ____________________________________________________________________</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">SS#/EIN/ITIN: ____________________________________________________________________________________</TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address: ________________________________________________________________________________________</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[<B>CONFIDENTIAL
INVESTOR QUESTIONNAIRE</B>]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
B</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[<B>FORM
OF SENIOR SECURED CONVERTIBLE NOTE</B>]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
C</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[<B>FORM
OF WARRANT</B>]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
D</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[<B>FORM
OF SECURITY AGREEMENT</B>]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>APPENDIX
E</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>[<B>FORM
OF REGISTRATION RIGHTS AGREEMENT</B>]</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.33
<SEQUENCE>10
<FILENAME>ex10-33.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
10.33</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>APPENDIX
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.9pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>FORM
OF SENIOR SECURED CONVERTIBLE NOTE]</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; text-align: left">Original Issue Date: February __, 2023</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 34%; text-align: left">Subscription Amount:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[_________]</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Date of this Note: February __, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Original Issue Discount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[_____]</FONT></TD><TD STYLE="text-align: left"><SUP>1</SUP></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Final Maturity Date: November __, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Original Principal Amount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[_________]</FONT></TD><TD STYLE="text-align: left"><SUP>2</SUP></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEURAXIS,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SENIOR
SECURED CONVERTIBLE NOTE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SENIOR SECURED CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of Neuraxis, Inc., a Delaware corporation
(the &ldquo;<B>Company</B>&rdquo;), designated as its Senior Secured Convertible Note reflecting a 10% original issue discount (this
note, this &ldquo;<B>Note</B>&rdquo; and, collectively with the other notes of such series, the &ldquo;<B>Notes</B>&rdquo;). This Note
carries such original issue discount as indicated hereinabove.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the Company promises to pay to [______________], or its registered assigns (&ldquo;<B>Holder</B>&rdquo;), or shall have
paid pursuant to the terms hereunder, the principal sum of $<U>_________________</U><SUP>2</SUP> (the &ldquo;<B>Original Principal Amount</B>&rdquo;)
on the earlier to occur of (x) the date of the first Liquidity Event to occur after the Original Issue Date and (y) the date specified
above (the &ldquo;<B>Final Maturity Date</B>&rdquo;) that is nine (9) months after the Original Issue Date (as the case may be, the &ldquo;<B>Maturity
Date</B>&rdquo;) or such earlier date as this Note is required or permitted to be repaid as provided hereunder, and to pay interest to
the Holder on the aggregate unconverted and then outstanding Original Principal Amount of this Note in accordance with the provisions
hereof. This Note is subject to the following additional provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1.</B> Definitions. For the purposes hereof, in addition to the terms defined elsewhere in this Note: (a) capitalized terms not otherwise
defined herein shall have the meanings set forth in the Purchase Agreement, and (b) the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Alternate
Consideration</U>&rdquo; shall have the meaning set forth in Section 5(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><SUP>1 </SUP>[Subscription Amount <I>divided by</I> 90%] <I>less</I>
Subscription Amount</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><SUP>2 </SUP>Subscription Amount <I>divided by</I> 90%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bankruptcy
Event</U>&rdquo; means any of the following events: (a) the Company or any Significant Subsidiary (as such term is defined in Rule 1-02(w)
of Regulation S-X) thereof commences a case or other proceeding under any bankruptcy, reorganization, arrangement, adjustment of debt,
relief of debtors, dissolution, insolvency or liquidation or similar law of any jurisdiction relating to the Company or any Significant
Subsidiary thereof, (b) there is commenced against the Company or any Significant Subsidiary thereof any such case or proceeding that
is not dismissed within 60 days after commencement, (c) the Company or any Significant Subsidiary thereof is adjudicated insolvent or
bankrupt or any order of relief or other order approving any such case or proceeding is entered, (d) the Company or any Significant Subsidiary
thereof suffers any appointment of any custodian or the like for it or any substantial part of its property that is not discharged or
stayed within 60 calendar days after such appointment, (e) the Company or any Significant Subsidiary thereof makes a general assignment
for the benefit of creditors, (f) the Company or any Significant Subsidiary thereof calls a meeting of its creditors with a view to arranging
a composition, adjustment or restructuring of its debts, (g) the Company or any Significant Subsidiary thereof admits in writing that
it is generally unable to pay its debts as they become due, (h) the Company or any Significant Subsidiary thereof, by any act or failure
to act, expressly indicates its consent to, approval of or acquiescence in any of the foregoing or takes any corporate or other action
for the purpose of effecting any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Beneficial
Ownership Limitation</U>&rdquo; shall have the meaning set forth in Section 4(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Change
of Control Transaction</U>&rdquo; means the occurrence after the date hereof of any of: (a) an acquisition after the date hereof by an
individual or legal entity or &ldquo;group&rdquo; (as described in Rule 13d-5(b)(1) promulgated under the Exchange Act) of effective
control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in excess of 50%
of the voting securities of the Company (other than by means of conversion of the Notes), (b) the Company merges into or consolidates
with any other Person, or any Person merges into or consolidates with the Company and, after giving effect to such transaction, the stockholders
of the Company immediately prior to such transaction own less than 50% of the aggregate voting power of the Company or the successor
entity of such transaction, (c) the Company sells or transfers all or substantially all of its assets to another Person and the stockholders
of the Company immediately prior to such transaction own less than 50% of the aggregate voting power of the acquiring entity immediately
after the transaction, (d) a replacement at one time or within a three year period of more than one-half of the members of the Board
of Directors which is not approved by a majority of those individuals who are members of the Board of Directors on the Original Issue
Date (or by those individuals who are serving as members of the Board of Directors on any date whose nomination to the Board of Directors
was approved by a majority of the members of the Board of Directors who are members on the date hereof), or (e) the execution by the
Company of an agreement to which the Company is a party or by which it is bound, providing for any of the events set forth in clauses
(a) through (d) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion</U>&rdquo;
means a conversion of this Note pursuant to Section 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Amount</U>&rdquo; means the Principal Amount or Mandatory Default Amount of this Note optionally or mandatorily converted in accordance
with Section 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Date</U>&rdquo; means the date of any Conversion in accordance with the terms of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Price</U>&rdquo; means the product of (x) the Liquidity Event Price and (y) the Discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Conversion
Shares</U>&rdquo; With respect to any Conversion of this Note (in whole or in part), a number of shares of Common Stock equal to the
quotient (rounded down to the nearest whole share) obtained by dividing (x) the Conversion Amount of such Conversion by (y) the Conversion
Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Discount</U>&rdquo;
means 0.70 (representing a discount of thirty percent (30%)).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: .5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
of Default</U>&rdquo; shall have the meaning set forth in Section 7(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Fundamental
Transaction</U>&rdquo; shall have the meaning set forth in Section 5(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
means any liabilities of the Company for borrowed money or amounts owed and all guaranties made by the Company of borrowed money or amounts
owed by others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Interest
Payment Date</U>&rdquo; means the first (1<SUP>st</SUP>) day of each calendar month following the Original Issue Date until payment in
full of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidity
Event</U>&rdquo; means a public offering of Common Stock (or units consisting of Common Stock and warrants to purchase Common Stock)
resulting in the listing for trading or quoting of the Common Stock on a Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liquidity
Event Price</U>&rdquo; shall mean the Offering Price; <I>provided</I> that if per share the Liquidity Event includes the issuance of
units of Common Stock and/or Common Stock Equivalents, then &ldquo;Liquidity Event Price&rdquo; shall mean the unit price divided by
the number of shares of Common Stock contained in a unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Mandatory
Default Amount</U>&rdquo; means the sum of: (1) the product of (x) the outstanding balance of the Original Principal Amount of this Note
and (y) 120%, <I>plus</I> (2) all accrued and unpaid interest under this Note, if any, <I>plus</I> (3) all other amounts, costs, expenses,
and liquidated damages due under or in respect of this Note, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>New
York Courts</U>&rdquo; shall have the meaning set forth in Section 8(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 70.55pt; text-align: justify; text-indent: 7.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Note
Register</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Original
Issue Date</U>&rdquo; means the date of the first issuance of the Notes, regardless of any transfers of any Note and regardless of the
number of instruments which may be issued to evidence such Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prepayment
Amount</U>&rdquo; means the sum of: (1) the product of (x) the outstanding balance of the Original Principal Amount of this Note and
(y) 115%, <I>plus</I> (2) all accrued and unpaid interest under this Note, if any, <I>plus</I> (3) all other amounts, costs, expenses,
and liquidated damages due under or in respect of this Note, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Permitted
Indebtedness</U>&rdquo; means: (a) the Indebtedness evidenced by the Notes, and (b) additional Indebtedness of up to an aggregate of
$100,000, inclusive of any interest, fees, penalties or other amounts due or payable thereunder, <I>provided</I> that such Indebtedness
(x) is fully subordinated to the Indebtedness evidenced by the Notes and (y) if secured, is secured by Liens are fully subordinated to
the Liens granted under the Security Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Principal
Amount</U>&rdquo; means the sum of: (1) the outstanding balance of the Original Principal Amount of this Note, <I>plus </I>(2) all accrued
and unpaid interest under this Note, if any, <I>plus</I> (3) all other amounts, costs, expenses, and liquidated damages due under or
in respect of this Note, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45.35pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pro
Rata Share</U>&rdquo; of this Note means, at any time, the percentage obtained by <I>dividing</I> (i) the Original Principal Amount of
this Note <I>by</I> (ii) the &ldquo;Original Principal Amounts&rdquo; of all Notes then outstanding (including this Note).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchase
Agreement</U>&rdquo; means the Securities Purchase Agreement, dated as of February ___, 2023 by and among the Company and the original
Holders, as amended, modified, or supplemented from time to time in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Share
Delivery Date</U>&rdquo; shall have the meaning set forth in Section 4(b)(ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Successor
Entity</U>&rdquo; shall have the meaning set forth in Section 5(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means any day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed for trading or quoted on the date
in question: the NYSE, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, or the Nasdaq Global Select Market (or
any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2.</B> <U>Interest; Payment and Prepayment</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Interest Calculations</U>. Interest shall accrue on the Original Principal Amount of this Note from and after the Original Issue Date,
and such interest shall be payable in cash on each Interest Payment Date at an annual rate of twelve percent (12%); provided, that from
and after the occurrence of an Event of Default) such interest shall accrue on the Mandatory Default Amount at an annual rate of twenty
percent (20%). Such interest shall be calculated on the basis of a 360-day year, consisting of twelve 30 calendar day periods, and shall
accrue daily commencing on the Original Issue Date until payment in full of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Payment and Prepayment</U>. On the Maturity Date, the entire Principal Amount (or, if an Event of Default shall have previously occurred,
the entire Mandatory Default Amount) shall become due and payable. The Company may prepay this Note in full at any time after the Original
Issue Date and prior to the Maturity Date in an amount equal to the Prepayment Amount (or, if an Event of Default shall have previously
occurred, the Mandatory Default Amount).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3.</B> <U>Registration of Transfers and Exchanges</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Different Denominations</U>. This Note is exchangeable for an equal aggregate Original Principal Amount of Notes of different authorized
denominations, as requested by the Holder surrendering the same. No service charge will be payable for such registration of transfer
or exchange.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Investment Representations</U>. This Note has been issued subject to certain investment representations of the original Holder set
forth in the Purchase Agreement and may be transferred or exchanged only in compliance with the Purchase Agreement and applicable federal
and state securities laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Reliance on Note Register</U>. Prior to due presentment for transfer to the Company of this Note, the Company and any agent of the
Company may treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving
payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Company nor any such agent
shall be affected by notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4.</B> <U>Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Conversion</U>. On any date after the Original Issue Date, the Holder shall have the right, at the Holder&rsquo;s option, to convert
the Principal Amount (or, from and after the date of the occurrence of an Event Default, the Mandatory Default Amount) of this Note,
in whole or in part into Conversion Shares by following the mechanics of conversion set forth in Section 4(b). In addition, effective
automatically on the effective date of the first of the Liquidity Event to occur after the Original Issue Date, the entire Principal
Amount (or, from and after the date of the occurrence of an Event Default, the entire Mandatory Default Amount) of this Note shall mandatorily
convert into Conversion Shares in accordance with this Section 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 96pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Mechanics of Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Conversion Notice</U>. At least seven (7) calendar days prior to the consummation of a Liquidity Event the Company will provide the
Holder with written notice, which includes notice via email, of the Liquidity Event (the &ldquo;<B>Liquidity Event Notice</B>&rdquo;).
If the Holder wishes to effect a Conversion of this Note at its option in accordance with the first sentence of Section 4(a), in whole
or in part, shall deliver to the Company: (A) written notice of its election to convert this Note pursuant to this Section 4, including
the Conversion Amount, and (B) in the case of a Conversion of the entire Conversion Amount of this Note, the original Note instrument
(or a notice to the effect that such original Note has been lost, stolen or destroyed).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Delivery of Conversion Shares Upon Conversion</U>. Not later than three (3) Trading Days after the Conversion Date (the &ldquo;<B>Share
Delivery Date</B>&rdquo;), the Company shall deliver, or cause to be delivered, to the Holder the Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>Failure to Deliver Conversion Shares</U>. If, in the case of any Conversion, the Conversion Shares are not delivered to or as directed
by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Company at any time
on or before its receipt of such Conversion Shares to rescind the Conversion, in which event the Company shall promptly return to the
Holder any original Note delivered to the Company and the Holder shall promptly return to the Company the Conversion Shares (if any)
issued to such Holder pursuant to the rescinded Conversion Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
<U>Obligation Absolute; Partial Liquidated Damages</U>. The Company&rsquo;s obligations to issue and deliver the Conversion Shares upon
conversion of this Note in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by
the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any
Person or any action to enforce the same, or any set off, counter claim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder
or any other Person (unless the Conversion would violate any law applicable to the Company), and irrespective of any other circumstance
which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of such Conversion Shares; <I>provided,
however, </I>that such delivery shall not operate as a waiver by the Company of any such action the Company may have against the Holder.
In the event the Holder of this Note shall elect to convert any or all of the Conversion Amount hereof, the Company may not refuse conversion
based on any claim that the Holder or anyone associated or affiliated with the Holder has been engaged in any violation of law, agreement
or for any other reason, unless an injunction from a court, on notice to Holder, restraining and or enjoining conversion of all or part
of this Note shall have been sought and obtained, and the Company posts a surety bond for the benefit of the Holder in the amount of
150% of the Payment Amount of this Note, which is subject to the injunction, which bond shall remain in effect until the completion of
arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to the Holder to the extent it obtains judgment.
In the absence of such injunction, the Company shall issue Conversion Shares or, if applicable, cash, upon a properly noticed conversion.
If the Company fails for any reason to deliver to the Holder such Conversion Shares pursuant to Section 4(b)(ii) by the Share Delivery
Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Conversion Amount
being converted, $10 per Trading Day (increasing to $20 per Trading Day on the fifth (5th) Trading Day after such liquidated damages
begin to accrue) for each Trading Day after such Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such
conversion. Nothing herein shall prohibit the Holder from seeking to enforce damages pursuant to any other section hereof or under applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Reservation of Shares Issuable Upon Conversion</U>. The Company covenants that it will at all times reserve and keep available out
of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon Conversion, free from preemptive rights or
any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Notes). The Company covenants
that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable
and, if a registration statement covering the resale of the Conversion Shares is then effective under the Securities Act, shall be registered
for public resale in accordance with such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
<U>Fractional Shares</U>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note.
As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Company shall at its
election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion
Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
<U>Transfer Taxes and Expenses</U>. The issuance of Conversion Shares on conversion of this Note shall be made without charge to the
Holder hereof for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,
provided that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such Conversion Shares upon conversion in a name other than that of the Holder of this Note so converted and the
Company shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance
thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company that such
tax has been paid. The Company shall pay all Transfer Agent fees required for same-day processing of any conversion and all fees to the
Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic
delivery of the Conversion Shares. The Company shall pay all attorney fees required for the issuance of attorney legal opinions for removal
of restrictive legends on Conversion Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Holder&rsquo;s Conversion Limitations</U>. The Company shall not affect any conversion of this Note, and a Holder shall not have the
right to convert any portion of this Note, to the extent that after giving effect to the conversion, the Holder (together with the Holder&rsquo;s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<B>Attribution
Parties</B>&rdquo;)) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock issuable upon conversion of this Note with respect to which such determination is
being made, but shall exclude the number of shares of Common Stock which are issuable upon: (i) conversion of the remaining, unconverted
Conversion Amount of this Note beneficially owned by the Holder or any of its Affiliates or Attribution Parties, and (ii) exercise or
conversion of the unexercised or unconverted portion of any other securities of the Company subject to a limitation on conversion or
exercise analogous to the limitation contained herein (including, without limitation, any other Notes or the Warrants) beneficially owned
by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section
4(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. To the extent that the limitation contained in this Section 4(c) applies, the determination of whether this Note is convertible
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which Conversion Amount
of this Note is convertible shall be in the sole discretion of the Holder. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 4(c), in determining the number of outstanding shares of Common Stock, the Holder may rely on the number
of outstanding shares of Common Stock as stated in the most recent of the following: (A) the Company&rsquo;s most recent periodic or
annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company, or (C) a more recent
written notice by the Company or the Company&rsquo;s transfer agent setting forth the number of shares of Common Stock outstanding. Upon
the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Company, including this Note, by the Holder or its Affiliates since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be
4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon conversion of this Note held by the Holder. The Holder, upon notice to the Company, may increase or decrease the Beneficial
Ownership Limitation provisions of this Section 4(c), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of
the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion
of this Note held by the Holder and the Beneficial Ownership Limitation provisions of this Section 4(c) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company.
The Beneficial Ownership Limitation provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this Section 4(c) to correct this paragraph (or any portion hereof) which may be defective or inconsistent
with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5.</B> <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Stock Dividends and Stock Splits</U>. If the Company, at any time while this Note is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents (which,
for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of, or payment of interest
on, the Notes), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of
a reverse stock split) outstanding <U>shares</U> of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification
of shares of the Common Stock, any shares of capital stock of the Company, then the Conversion Price shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company) outstanding immediately
before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event.
Any adjustment made pursuant to this Section 5 shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Subsequent Equity Sales</U>. Other than with respect to a Liquidity Event, if at any time while this Note is outstanding, the Company
issues or sells, announces any offer, sale, or other disposition of, or in accordance with this Section 5 is deemed to have issued, sold
or granted (or makes an announcement regarding the same), any shares of Common Stock and/or Common Stock Equivalents (including the issuance
or sale of shares of Common Stock owned or held by or for the account of the Company, but excluding any securities issued or sold or
deemed to have been issued or sold solely in connection with an Exempt Issuance) for a consideration per share (the &ldquo;New Issuance
Price&rdquo;) less than a price equal to the Conversion Price in effect immediately prior to such issuance or sale or deemed issuance
or sale (such Conversion Price then in effect is referred to herein as the &ldquo;Applicable Price&rdquo;) (the foregoing a &ldquo;Dilutive
Issuance&rdquo;), then immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal
to the New Issuance Price; provided, however, that the foregoing adjustment shall only be in effect one time only. For all purposes of
the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance Price under this Section
5(b)), the following shall be applicable:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Issuance of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell)
any Options (as defined below) and the lowest price per share for which one Common Stock is at any time issuable upon the exercise of
any such Option or upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any such Option or
otherwise pursuant to the terms thereof is less than the Applicable Price, then such Common Stock shall be deemed to be outstanding and
to have been issued and sold by the Company at the time of the granting or sale of such Option for such price per share. For purposes
of this Section 5(c), the &ldquo;lowest price per share for which one Common Stock is at any time issuable upon the exercise of any such
Options or upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of any such Option or otherwise
pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received
or receivable by the Company with respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of such Option or otherwise
pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one Common Stock is issuable (or may
become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or exchange
of any Common Stock Equivalents issuable upon exercise of any such Option or otherwise pursuant to the terms thereof minus (2) the sum
of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting, issuance or sale of such Option,
upon exercise of such Option and upon conversion, exercise or exchange of any Common Stock Equivalents issuable upon exercise of such
Option or otherwise pursuant to the terms thereof plus the value of any other consideration received or receivable by, or benefit conferred
on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment of the Conversion Price shall
be made upon the actual issuance of such shares of Common Stock or of such Common Stock Equivalents upon the exercise of such Options
or otherwise pursuant to the terms of or upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange
of such Common Stock Equivalents. &ldquo;Option&rdquo; means any rights, warrants or options to subscribe for or purchase shares of Common
Stock or Convertible Securities other than Exempt Issuances. &ldquo;Convertible Securities&rdquo; means any shares or other security
(other than Options) that is at any time and under any circumstances, directly or indirectly, convertible into, exercisable or exchangeable
for, or which otherwise entitles the holder thereof to acquire, any shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell)
any Common Stock Equivalents and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such shares of Common
Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale of such Common
Stock Equivalents for such price per share. For the purposes of this Section 5(d), the &ldquo;lowest price per share for which one Common
Stock is at any time issuable upon the conversion, exercise or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall
be equal to (1) the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect
to one Common Stock upon the issuance or sale of the Common Stock Equivalents and upon conversion, exercise or exchange of such Common
Stock Equivalents or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Common Stock Equivalents
for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such
Common Stock Equivalents (or any other Person) upon the issuance or sale of such Common Stock Equivalents plus the value of any other
consideration received or receivable by, or benefit conferred on, the holder of such Common Stock Equivalents (or any other Person).
Except as contemplated below, no further adjustment of the Conversion Price shall be made upon the actual issuance of such shares of
Common Stock upon conversion, exercise or exchange of such Common Stock Equivalents or otherwise pursuant to the terms thereof, and if
any such issuance or sale of such Common Stock Equivalents is made upon exercise of any Options for which adjustment of this Note has
been or is to be made pursuant to other provisions of this Section 5(d), except as contemplated below, no further adjustment of the Conversion
Price shall be made by reason of such issuance or sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Change in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Common Stock Equivalents, or the rate at which any Common Stock
Equivalents are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other
than proportional changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section 5(a)),
the Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been
in effect at such time had such Options or Common Stock Equivalents provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes
of this Section 5(e), if the terms of any Option or Common Stock Equivalents that was outstanding as of the date this Note was issued
are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Common Stock Equivalents
and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of
the date of such increase or decrease. No adjustment pursuant to this Section 5(e) shall be made if such adjustment would result in an
increase of the Conversion Price then in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Change in Option Price or Rate of Conversion</U>. If any Option and/or Common Stock Equivalents and/or Adjustment Right (as defined
below) is issued in connection with the issuance or sale or deemed issuance or sale of any other securities of the Company (as determined
by the Holder, the &ldquo;Primary Security&rdquo;, and such Option and/or Common Stock Equivalents and/or Adjustment Right (as defined
below), the &ldquo;Secondary Securities&rdquo;), together comprising one integrated transaction, (or one or more transactions if such
issuances or sales or deemed issuances or sales of securities of the Company either (A) have at least one investor or purchaser in common,
(B) are consummated in reasonable proximity to each other and/or (C) are consummated under the same plan of financing) the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be equal to the difference of (x) the
lowest price per share for which one Common Stock was issued (or was deemed to be issued pursuant to Section 5(a)(i) or 5(a)(ii) above,
as applicable) in such integrated transaction solely with respect to such Primary Security, minus (y) with respect to such Secondary
Securities, the sum of the fair market value (as determined by the Holder in good faith) and the fair market value (as determined by
the Holder) of such Common Stock Equivalents, if any, in each case, as determined on a per share basis in accordance with this Section
5(f). If any shares of Common Stock, Options or Common Stock Equivalents are issued or sold or deemed to have been issued or sold for
cash, the consideration received therefor will be deemed to be the net amount of consideration received by the Company therefor. If any
shares of Common Stock, Options or Common Stock Equivalents are issued or sold for a consideration other than cash, the amount of such
consideration received by the Company will be the fair value of such consideration, except where such consideration consists of publicly
traded securities, in which case the amount of consideration received by the Company for such securities will be the arithmetic average
of the &ldquo;VWAPs&rdquo; of such security for each of the five (5) Trading Days immediately preceding the date of receipt. If any shares
of Common Stock, Options or Common Stock Equivalents are issued to the owners of the non-surviving entity in connection with any merger
in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion
of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock, Options or Common Stock
Equivalents (as the case may be). The fair value of any consideration other than cash or publicly traded securities will be determined
jointly by the Company and the Holder. If such parties are unable to reach agreement within ten (10) days after the occurrence of an
event requiring valuation (the &ldquo;Valuation Event&rdquo;), the fair value of such consideration will be determined within five (5)
Trading Days after the tenth (10th) day following such Valuation Event by an independent, reputable appraiser jointly selected by the
Company and the Holder. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the
fees and expenses of such appraiser shall be borne by the Company). &ldquo;Adjustment Right&rdquo; means any right granted with respect
to any securities issued in connection with, or with respect to, any issuance or sale (or deemed issuance or sale hereunder) of Common
Stock (other than rights of the type described in Sections 3(c) and 3(d) hereof) that could result in a decrease in the net consideration
received by the Company in connection with, or with respect to, such securities (including, without limitation, any cash settlement rights,
cash adjustment or other similar rights).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Change in Option Price or Rate of Conversion</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose
of entitling them (A) to receive a dividend or other distribution payable in shares of Common Stock, Options or in Common Stock Equivalents
or (B) to subscribe for or purchase shares of Common Stock, Options or Common Stock Equivalents, then such record date will be deemed
to be the date of the issuance or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such
dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase (as the case
may be).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 5(a) above, if at any time while this Note is
outstanding, the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;Purchase Rights&rdquo;), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Note (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however,
that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the
Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall
be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial
Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Pro Rata Distributions</U>. During such time as this Note is outstanding, if the Company shall declare or make any dividend or other
distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise
(including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;Distribution&rdquo;), at any
time after the issuance of this Note, then, in each such case, the Holder shall be entitled to participate in such Distribution to the
same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon
complete conversion of this Note (without regard to any limitations on conversion hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Fundamental Transaction</U>. If, at any time while this Note is outstanding, (i) the Company, directly or indirectly, in one or more
related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the
Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off,
merger or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common
Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated
with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;Fundamental
Transaction&rdquo;), then, upon any subsequent conversion of this Note, the Holder shall have the right to receive, for each Conversion
Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without
regard to any limitation in Section 4(c) on the conversion of this Note), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<B>Alternate Consideration</B>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Note is convertible
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 4(c) on the conversion of this Note).
For purposes of any such conversion, the determination of the Conversion Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one (1) share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Conversion Price among the Alternate Consideration in a reasonable manner reflecting
the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to
the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the
Alternate Consideration it receives upon any conversion of this Note following such Fundamental Transaction. The Company shall cause
any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<B>Successor Entity</B>&rdquo;)
to assume in writing all of the obligations of the Company under this Note and the other Transaction Documents (as defined in the Purchase
Agreement) in accordance with the provisions of this Section 5(j) pursuant to written agreements in form and substance reasonably satisfactory
to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option
of the holder of this Note, deliver to the Holder in exchange for this Note a security of the Successor Entity evidenced by a written
instrument substantially similar in form and substance to this Note which is convertible for a corresponding number of shares of capital
stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion
of this Note (without regard to any limitations on the conversion of this Note) prior to such Fundamental Transaction, and with a conversion
price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the
shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares
of capital stock and such conversion price being for the purpose of protecting the economic value of this Note immediately prior to the
consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence
of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of
such Fundamental Transaction, the provisions of this Note and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Note and the other Transaction Documents with the same effect as if such Successor Entity had been named as
the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Calculations</U>. All calculations under this Section 5 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 5, the number of shares of Common Stock <U>deemed</U> to be issued and outstanding as of a
given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Company) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Adjustment to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section 5, the Company
shall promptly deliver to each Holder a notice setting forth the Conversion Price after such adjustment and setting forth a brief statement
of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6.</B> <U>Negative Covenants</U>. As long as any portion of this Note remains outstanding, unless the holders (including the Lead Investor)
of a majority in Original Principal Amount of the then outstanding Notes shall have otherwise given prior written consent, the Company
shall not, and shall not permit any of its Subsidiaries (if any) to, directly or indirectly:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
other than Permitted Indebtedness, enter into, create, incur, assume, guarantee or suffer to exist any Indebtedness;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
amend its charter documents, including, without limitation, its certificate of incorporation and bylaws, in any manner that materially
and adversely affects any rights of the Holder unless consented to by the Holder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its Common Stock or Common
Stock Equivalents other than as to (i) the Conversion Shares or Warrant Shares as permitted or required under the Transaction Documents,
(ii) repurchases of Common Stock or Common Stock Equivalents of departing officers and directors of the Company, provided that such repurchases
shall not exceed an aggregate of $25,000 for all officers and directors during the term of this Note, (iii) repurchases of Common Stock
or Common Stock Equivalents, pursuant to existing repurchase agreements, provided that such repurchases shall not exceed an aggregate
of $25,000 during the term of this Note, or (iv) shares of Common Stock and Common Stock Equivalents which do not vest or are otherwise
forfeited, provided (in case of forfeiture) that such Common Stock and Common Stock Equivalents are not acquired for cash;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
repay, repurchase or offer to repay, repurchase or otherwise acquire any Indebtedness, other than the Notes if on a pro-rata basis, other
than regularly scheduled principal and interest payments as such terms are in effect as of the Original Issue Date, provided that such
payments shall not be permitted if, at such time, or after giving effect to such payment, any Event of Default exist or occur;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
pay cash dividends or distributions on any equity securities of the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
enter into any material transaction with any Affiliate of the Company, unless such transaction is made on an arm&rsquo;s-length basis
and expressly approved by a majority of the disinterested directors of the Company (even if less than a quorum otherwise required for
board approval);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
create, permit or suffer to exist any Lien on any of its or any Subsidiaries properties and assets other than (x) Permitted Liens (as
defined in the Security Agreement) and (y) Liens that are fully subordinated to the Liens granted under the Security Agreement; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
enter into any agreement with respect to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7.</B> <U>Events of Default</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Event of Default</U>&rdquo; means, wherever used herein, any of the following events (whatever the reason for such event and
whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of
any court, or any order, rule or regulation of any administrative or governmental body):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
a registration statement for a Liquidity Event is not declared effective by the Final Maturity Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
any default in the payment of: (A) the principal amount of any Note, or (B) interest, liquidated damages and other amounts owing to a
Holder on any Note, as and when the same shall become due and payable (whether on a Conversion Date or the Maturity Date or by acceleration
or otherwise) which default, solely in the case of an interest payment or other default under clause (B) above, is not cured within 5
Trading Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Company shall fail to observe or perform any other covenant or agreement contained in the Notes (other than a breach by the Company
of its obligations to deliver shares of Common Stock to the Holder upon conversion, which breach is addressed in clause (x) below) or
in any Transaction Document, which failure is not cured, if possible to cure, within the earlier to occur of (A) five (5) Trading Days
after notice of such failure sent by the Holder or by any other Holder to the Company and (B) seven (7) Trading Days after the Company
has become or should have become aware of such failure;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
a default or event of default (subject to any grace or cure period provided in the applicable agreement, document or instrument) shall
occur under (A) any of the Transaction Documents or (B) any other material agreement, lease, document or instrument to which the Company
is obligated (and not covered by clause (vii) below);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
any material representation or warranty made in this Note, any other Transaction Documents, any written statement pursuant hereto or
thereto or any other report, financial statement or certificate made or delivered to the Holder or any other Holder shall be untrue or
incorrect in any material respect as of the date when made;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the Company or any Significant Subsidiary (as such term is defined in Rule 1-02(w) of Regulation S-X) shall be subject to a Bankruptcy
Event;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Company shall default on any of its obligations under any mortgage, credit agreement or other facility, indenture agreement, capital
lease, factoring agreement or other instrument under which there may be issued, or by which there may be secured or evidenced, any Indebtedness
for borrowed money or money due under any long term leasing or factoring arrangement that (a) involves an obligation greater than $200,000,
whether such Indebtedness now exists or shall hereafter be created, and (b) results in such Indebtedness becoming or being declared due
and payable prior to the date on which it would otherwise become due and payable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the Company shall be a party to any Change of Control Transaction or Fundamental Transaction or shall agree to sell or dispose of all
or in excess of 33% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a
Change of Control Transaction);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
the Company shall fail for any reason to deliver Conversion Shares to a Holder prior to the fifth Trading Day after a Conversion Date
pursuant to Section 4(b) or the Company shall provide at any time notice to the Holder, including by way of public announcement, of the
Company&rsquo;s intention to not honor requests for conversions of any Notes in accordance with the terms hereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
a final non-appealable judgment by any competent court in Canada or the United States for the payment of money in an amount of at least
$200,000 is rendered against the Company, and the same remains undischarged and unpaid for a period of 60days during which execution
of such judgment is not effectively stayed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
Liens granted under the Security Agreement shall become invalid or unperfected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Remedies Upon Event of Default</U>. If any Event of Default occurs and continues, this Note shall become, at the Holder&rsquo;s election,
immediately due and payable in cash in the Mandatory Default Amount. Upon the payment or conversion in full of the Mandatory Default
Amount in accordance with the terms of this Note, the Holder shall promptly surrender this Note to or as directed by the Company. In
connection with such acceleration described herein, the Holder need not provide, and the Company hereby waives, any presentment, demand,
protest or other notice of any kind, and the Holder may immediately and without expiration of any grace period enforce any and all of
its rights and remedies hereunder and all other remedies available to it under applicable law. Such acceleration may be rescinded and
annulled by Holder at any time prior to payment hereunder and the Holder shall have all rights as a holder of the Note until such time,
if any, as the Holder receives full payment pursuant to this Section 7(b). No such rescission or annulment shall affect any subsequent
Event of Default or impair any right consequent thereon. In addition, during the occurrence and continuance of an Event of Default, the
Holder shall be entitled to collect from the Company an amount equal to the product of: (x) 30% of all revenues received by the Company
and its Subsidiaries (if any) following the occurrence and during the continuance of an Event of Default and (y) the Pro Rata Share of
this Note, which portion of such revenues will (notwithstanding anything to the contrary set forth herein or the other Transaction Documents)
will be payable the Holder no less frequently than monthly on each Interest Payment Date. The Collateral Agent under (and as defined
in) the Security Agreement shall be entitled on behalf of the Holders to sweep the cash in the bank accounts of the Company and Subsidiaries
(if any) for such amounts, which shall be treated as repayments of amounts due and owing hereunder. The Company agrees to execute and
deliver such additional documents and will provide such additional information as may reasonably be required to carry out this Section
7(b), it being understood that the Company shall use its best efforts to request that any of the applicable banks agree to any deposit
account control agreement that may reasonably be required by the Collateral Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8.</B> <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Notices</U>. Any and all notices or other communications or deliveries to be provided by the Holder hereunder shall be in writing
and delivered personally, by email attachment, or sent by a nationally recognized overnight courier service, addressed to the Company,
at the address set forth on in the Purchase Agreement, or such other, email address, or address as the Company may specify for such purposes
by notice to the Holder delivered in accordance with this Section 8(a). Any and all notices or other communications or deliveries to
be provided by the Company hereunder shall be in writing and delivered personally, by facsimile, by email attachment, or sent by a nationally
recognized overnight courier service addressed to each Holder at the facsimile number, email address or address of the Holder appearing
on the books of the Company, or if no such facsimile number or email attachment or address appears on the books of the Company, at the
principal place of business of such Holder, as set forth in the Purchase Agreement. Any notice or other communication or deliveries hereunder
shall be deemed given and effective on the earliest of: (i) the date of transmission, if such notice or communication is delivered via
facsimile at the facsimile number or email attachment to the email address set forth on the signature pages attached hereto prior to
5:30 p.m. (Eastern time) on any date, (ii) the next Business Day after the date of transmission, if such notice or communication is delivered
via facsimile at the facsimile number or email attachment to the email address set forth on the signature pages attached hereto on a
day that is not a Business Day or later than 5:30 p.m. (Eastern time) on any Business Day, (iii) the second Business Day following the
date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such
notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Absolute Obligation; Ranking</U>. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation
of the Company, which is absolute and unconditional, to pay the principal of, liquidated damages and accrued interest, as applicable,
on this Note at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation of the
Company. This Note: (i) is a direct debt obligation of the Company; (ii) is secured under the Security Agreement, (iii) ranks <I>pari
passu</I> with the Existing Convertible Notes, and (iv) ranks <I>pari-passu</I> with all other Notes now or hereafter issued under the
terms of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Lost or Mutilated Note</U>. If this Note shall be mutilated, lost, stolen or destroyed, the Company shall execute and deliver, in
exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed
Note, a new Note for the Original Principal Amount of this Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence
of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Note shall be governed
by and construed and enforced in accordance with the internal laws of the State of Arizona, without regard to the principles of conflict
of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions
contemplated by any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers,
shareholders, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the County of New York,
New York (the &ldquo;<B>New York Courts</B>&rdquo;). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the
New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or
discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such New York
Courts, or such New York Courts are improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each party hereto hereby
irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising
out of or relating to this Note or the transactions contemplated hereby. If any party shall commence an action or proceeding to enforce
any provisions of this Note, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney&rsquo;s
fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Waiver</U>. Any waiver by the Company or the Holder of a breach of any provision of this Note shall not operate as or be construed
to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Company
or the Holder to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive
that party of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion.
Any waiver by the Company or the Holder must be in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Severability</U>. If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect,
and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and
circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing
usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under
applicable law. The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or
in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law or other law which would prohibit
or forgive the Company from paying all or any portion of the principal of or interest on this Note as contemplated herein, wherever enacted,
now or at any time hereafter in force, or which may affect the covenants or the performance of this Note, and the Company (to the extent
it may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants that it will not, by resort to
any such law, hinder, delay or impede the execution of any power herein granted to the Holder, but will suffer and permit the execution
of every such as though no such law has been enacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief</U>. The remedies provided in this Note shall be cumulative
and in addition to all other remedies available under this Note and any of the other Transaction Documents at law or in equity (including
a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the Holder&rsquo;s right to pursue actual
and consequential damages for any failure by the Company to comply with the terms of this Note. The Company covenants to the Holder that
there shall be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided
for herein with respect to payments, conversion and the like (and the computation thereof) shall be the amounts to be received by the
Holder and shall not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof).
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy
at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach,
the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any such breach or any such threatened
breach, without the necessity of showing economic loss and without any bond or other security being required. The Company shall provide
all information and documentation to the Holder that is reasonably requested by the Holder to enable the Holder to confirm the Company&rsquo;s
compliance with the terms and conditions of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Next Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment
shall be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Headings</U>. The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed
to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9.</B> <U>Amendments; Waivers</U>. Any modifications, amendments or waivers of the provisions hereof shall be subject to Section 5.05
of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10. </B><U>Usury</U>. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever
claim and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any Action or Proceeding that may be brought by any Holder in order to enforce any right
or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document, it is
expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the nature of interest
shall not exceed the maximum lawful rate authorized under applicable law (the &ldquo;Maximum Rate&rdquo;), and, without limiting the
foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature
of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is agreed that if the
maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or
any official governmental action subsequent to the date hereof, the new maximum contract rate of interest allowed by law will be the
Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by
applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company to any Holder with
respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Holder to the unpaid principal amount
of any such indebtedness or be refunded to the Company, the manner of handling such excess to be at such Holder&rsquo;s election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the Company has caused this Note to be duly executed by a duly authorized officer as of the date first above indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEURAXIS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 50%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Brian Carrico</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT>:
    </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.34
<SEQUENCE>11
<FILENAME>ex10-34.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.34</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>APPENDIX
D</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>FORM
OF SECURITY AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
SECURITY AGREEMENT, dated as of February ___, 2023 (this &ldquo;<B>Agreement</B>&rdquo;), is among Neuraxis, Inc., a Delaware corporation
(the &ldquo;<B>Company</B>&rdquo; or &ldquo;<B>Debtor</B>&rdquo;) and the holder(s) of the Company&rsquo;s 10% original issue discount
senior secured convertible notes in the aggregate original principal amount of up to $6,666,666.67 (collectively, the &ldquo;<B>Notes</B>&rdquo;)
signatory hereto, their endorsees, transferees and assigns (each holder a &ldquo;<B>Secured Party</B>,&rdquo; and collectively, the &ldquo;<B>Secured
Parties</B>&rdquo;). Each of the Company, and the Secured Parties are a &ldquo;party&rdquo; to this Agreement, and one or more of them
are the &ldquo;parties&rdquo; hereto as the context may require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WITNESSETH:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>pursuant to the Securities Purchase Agreement dated as of February ___, 2023 (the &ldquo;<B>Purchase Agreement</B>&rdquo;) and the
Notes, the Secured Parties have severally agreed to extend loans to the Company evidenced by the Notes; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>in order to induce the Secured Parties to extend the loans evidenced by the Notes, the Debtor has agreed to execute and deliver to
the Secured Parties this Agreement and to grant the Secured Parties a lien security interest in all of the assets of the Company to secure
the prompt payment, performance and discharge in full of all of the Company&rsquo;s obligations (whether at the stated maturity, by acceleration
or otherwise) under the Purchase Agreement and the Notes (the &ldquo;<B>Obligations</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE,</B> in consideration of the agreements herein contained and for other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1 <U>Certain Definitions.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Agreement, the following terms shall have the meanings set forth in this section 1. Terms used but not otherwise defined
in this Agreement that are defined in Article 9 of the UCC (such as &lsquo;<B>account</B>&rsquo;, &lsquo;<B>chattel paper&rsquo;</B>,
&lsquo;<B>commercial tort claim&rsquo;</B>, &lsquo;<B>deposit account&rsquo;</B>, &lsquo;<B>document</B>&rsquo;, &lsquo;<B>equipment</B>&rsquo;,
&lsquo;<B>fixtures</B>&rsquo;, &lsquo;<B>general intangibles&rsquo;</B>, &lsquo;<B>goods</B>&rsquo;, &lsquo;<B>instruments</B>&rsquo;,
&lsquo;<B>inventory</B>&rsquo;, &lsquo;<B>investment property&rsquo;</B>, <B>&lsquo;letter-of-credit rights</B>&rsquo;, &lsquo;<B>proceeds</B>&rsquo;,
&lsquo;<B>securities</B>&rsquo;, and &lsquo;<B>supporting obligations&rsquo;</B>) shall have the respective meanings given such terms
in Article 9 of the UCC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 41pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>Collateral</B>&rdquo; means the collateral in which the Secured Parties are granted a lien and security interest by this Agreement
and which shall include only the following property of the Company (as defined below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<B>All assets of the Company</B>, wherever located or deemed located, now owned or at any time hereafter acquired by the Company or in
which the Company now has or at any time in the future may acquire any right, title or interest including, without limitation, all machinery,
equipment, fixtures, goods, inventory, furnishings, computers, software, motor vehicles, trucks, tanks, boats, ships, appliances, furniture,
special and general tools, fixtures, test and quality control devices and other equipment of every kind and nature, together with all
attachments, components, parts, equipment and accessories installed thereon or affixed thereto, wherever situated, all Intellectual Property,
together with all documents of title and documents representing the same, all additions and accessions thereto, replacements therefor,
all parts therefor, and all substitutes for any of the foregoing and all other items used and useful in connection with any Company&rsquo;s
businesses and all improvements thereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
All accounts of the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
All chattel paper of the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
All commercial tort claims of the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
All, general intangibles, including: (A) all rights of the Company to receive moneys due and to become due to it thereunder or in connection
therewith; (B) all rights of the Company to receive proceeds of any insurance, indemnity, warranty or guarantee with respect thereto;
(C) all claims of the Company for damages arising out of any breach of or default thereunder; and (D) all rights of the Company to terminate,
amend, supplement, modify or exercise rights or options thereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
All documents, deposit accounts, goods, instruments, investment property (including all securities, security entitlements and commodity
contracts), and letter of credit rights,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
All deposits and all money; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
All books and records pertaining to the Collateral; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
All Intellectual Property of the Company, including, but not limited to those set forth on <U>Schedule F</U> hereto; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
All Proceeds and products of any of the foregoing, and all substitutions or replacements of any Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, nothing herein shall be deemed to constitute an assignment of any asset which, in the event of an assignment, becomes
void by operation of applicable law or the assignment of which is otherwise prohibited by applicable law (in each case to the extent
that such applicable law is not overridden by Sections 9-406, 9-407 and/or 9-408 of the UCC or other similar applicable law); <U>provided</U>,
<U>however</U>, that to the extent permitted by applicable law, this Agreement shall create a valid lien security interest in such asset
and, to the extent permitted by applicable law, this Agreement shall create a valid lien security interest in the proceeds of such asset
(subject, in each case, to Permitted Liens).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>Intellectual Property</B>&rdquo; means the collective reference to all rights, priorities and privileges relating to the intellectual
property of the Company, whether arising under United States, multinational or foreign laws or otherwise, including, without limitation:
(i) all copyrights arising under the laws of the United States, any other country or any political subdivision thereof, whether registered
or unregistered and whether published or unpublished, all registrations and recordings thereof, and all applications in connection therewith,
including, without limitation, all registrations, recordings and applications in the United States Copyright Office; (ii) all letters
patent of the United States, any other country or any political subdivision thereof, all reissues and extensions thereof, and all applications
for letters patent of the United States or any other country and all divisions, continuations and continuations-in-part thereof (&ldquo;<B>Patent
Rights</B>&rdquo;); (iii) all trademarks, trade names, corporate names, company names, business names, fictitious business names, trade
dress, service marks, logos, domain names, business listings and other source or business identifiers, and all goodwill associated therewith,
now existing or hereafter adopted or acquired, all registrations and recordings thereof, and all applications in connection therewith,
whether in the United States Patent and Trademark Office or in any similar office or agency of the United States, any State thereof or
any other country or any political subdivision thereof, or otherwise, and all common law rights related thereto (&ldquo;<B>Trademark
Rights</B>&rdquo;); (iv) all trade secrets arising under the laws of the United States, any other country or any political subdivision
thereof; (v) all rights to obtain any reissues, renewals or extensions of the foregoing; (vi) all licenses for any of the foregoing;
and (vii) all causes of action for infringement of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Obligations</B>&rdquo; means all of the liabilities and obligations (primary, secondary, direct, contingent, sole, joint or
several) of any Debtor due or to become due, or that are now or may be hereafter contracted or acquired, or owing to, the Secured Parties,
including, without limitation, all obligations under this Agreement, the Purchase Agreement, the Notes, and any other instruments, agreements
or other documents executed and/or delivered in connection herewith or therewith, in each case, whether now or hereafter existing, voluntary
or involuntary, direct or indirect, absolute or contingent, liquidated or unliquidated, whether or not jointly owed with others, and
whether or not from time to time decreased or extinguished and later increased, created or incurred, and all or any portion of such obligations
or liabilities that are paid, to the extent all or any part of such payment is avoided or recovered directly or indirectly from any of
the Secured Parties as a preference, fraudulent transfer or otherwise as such obligations may be amended, supplemented, converted, extended
or modified from time to time. Without limiting the generality of the foregoing, the term &ldquo;<B>Obligations</B>&rdquo; shall include,
without limitation: (i) principal of, and interest on and all expenses related to, the Notes and the loans extended pursuant thereto;
(ii) any and all other fees, indemnities, costs, obligations and liabilities of the Debtor from time to time under or in connection with
this Agreement, the Purchase Agreement, the Notes, and any other instruments, agreements or other documents executed and/or delivered
in connection herewith or therewith; and (iii) all amounts (including but not limited to post-petition interest) in respect of the foregoing
that would be payable but for the fact that the obligations to pay such amounts are unenforceable or not allowable due to the existence
of a bankruptcy, reorganization or similar proceeding involving any Debtor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Permitted Liens</B>&rdquo; shall mean, with respect to any Person: (i) pledges or deposits by such Person under workmen&rsquo;s
compensation laws, unemployment insurance laws, or similar legislation, or good faith deposits in connection with bids, tenders, contracts
(other than for the payment of Indebtedness), or leases to which such Person is a party, or deposits to secure public or statutory obligations
of such Person or deposits of cash or U.S. government bonds to secure surety or appeal bonds to which such Person is a party, or deposits
as security for the payment of rent or deposits made to secure obligations arising from contractual or warranty refunds, in each case,
Incurred in the ordinary course of business; (ii) liens imposed by law, such as carriers&rsquo;, warehousemen&rsquo;s, materialmen&rsquo;s,
repairmen&rsquo;s, and mechanics&rsquo; liens, in each case, incurred in the ordinary course of business and for sums not yet overdue
for a period of more than thirty (30) days or, if more than thirty (30) days overdue, are unfiled and no other action has been taken
to enforce such lien or that are being contested in good faith by appropriate proceedings or other liens arising out of judgments or
awards against such Person with respect to which such Person shall then be proceeding with an appeal or other proceedings for review
if adequate reserves with respect thereto are maintained on the books of such Person in accordance with generally accepted accounting
principles (&ldquo;<B>GAAP</B>&rdquo;); (iii) liens for taxes, assessments, or other governmental charges, not yet overdue for a period
of more than thirty (30) days or which are being contested in good faith by appropriate proceedings if adequate reserves with respect
thereto are maintained on the books of such Person in accordance with GAAP; (iv) liens in favor of issuers of performance, surety, bid,
indemnity, warranty, release, appeal, or similar bonds or with respect to other regulatory requirements or letters of credit or bankers&rsquo;
acceptances issued, and completion guarantees provided for, in each case pursuant to the request of and for the account of such Person
in the ordinary course of its business; (v) minor survey exceptions, minor encumbrances, ground leases, easements, or reservations of,
or rights of others for, licenses, rights-of-way, servitudes, sewers, electric lines, drains, telegraph and telephone and cable television
lines, gas and oil pipelines, and other similar purposes, or zoning, building codes, or other restrictions (including, without limitation,
minor defects or irregularities in title and similar encumbrances) as to the use of real properties or liens incidental, to the conduct
of the business of such Person or to the ownership of its properties in each case which were not incurred in connection with the Notes
and which do not materially interfere with the business of the Company; (vi) leases, subleases, licenses, or sublicenses (including of
Intellectual Property) granted to others in the ordinary course of business and which do not materially interfere with the business of
the Company; (vii) deposits made or other security provided to secure liabilities to insurance carriers under insurance or self-insurance
arrangements in the ordinary course of business; (viii) restrictive covenants affecting the use to which real property may be put; provided
that the covenants are complied with in all material respects; (ix) security given to a public utility or any municipality or governmental
authority when required by such utility or authority in connection with the operations of that Person in the ordinary course of business;
(x) zoning by-laws and other land use restrictions, including, without limitation, site plan agreements, development agreements, and
contract zoning agreements; (xi) liens arising out of conditional sale, title retention, consignment, or similar arrangements for sale
of goods entered into by the Company in the ordinary course of business; (xii) liens arising under this Agreement or documents or instruments
related to the Notes; (xiii) Liens to secure Permitted Indebtedness (as defined in the Notes); and (xiv) with respect to any mortgaged
property, the matters listed as exceptions to title on Schedule B of a standard title policy covering such mortgaged property and the
matters disclosed in any survey delivered to the lender with respect to such mortgaged property to the extent such matters are reasonably
acceptable to the lender. For purposes of this definition, the term &ldquo;<B>indebtedness</B>&rdquo; shall be deemed to include interest
on, and fees, expenses and other obligations payable with respect to, such indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Proceeds</B>&rdquo; shall mean all &ldquo;<B><U>proceeds</U></B>&rdquo; as such term is defined in Article 9 of the UCC and,
in any event, shall include with respect to the Company, any consideration received from the sale, exchange, license, lease or other
disposition of any asset or property that constitutes Collateral, any value received as a consequence of the possession of any Collateral
and any payment received from any insurer or other person or entity (&ldquo;<B>Person</B>&rdquo;) as a result of the destruction, loss,
theft, damage or other involuntary conversion of whatever nature of any asset or property that constitutes Collateral, and shall include:
(i) all cash and negotiable instruments received by or held (by the Company or any other Person) on behalf of the Secured Parties; (ii)
any claim of any Debtor against any third party for (and the right to sue and recover for and the rights to damages or profits due or
accrued arising out of or in connection with) (A) past, present or future infringement or other violation of any patent now or hereafter
owned by any Debtor; (B) past, present or future infringement or dilution or other violation of any trademark now or hereafter owned
by any Debtor or injury to the goodwill of the business connected with the use thereof or symbolized thereby, (C) past, present or future
infringement or other violation of any copyright now or hereafter owned by any Debtor, (D) past, present or future infringement, misappropriation
or misuse or other violation or impairment of any other Intellectual Property now or hereafter owned by any Debtor; and (iii) any and
all other amounts from time to time paid or payable under or in connection with any of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;UCC&rdquo; means the Uniform Commercial Code of the State of Delaware, or any other applicable law of any state or states which
has jurisdiction with respect to all, or any portion of, the Collateral or this Agreement, from time to time. It is the intent of the
parties that defined terms in the UCC should be construed in their broadest sense so that the term &ldquo;Collateral&rdquo; will be construed
in its broadest sense. Accordingly, if there are from time to time, changes to defined terms in the UCC that broaden the definitions,
they are incorporated herein and if existing definitions in the UCC are broader than the amended definitions, the existing ones shall
be controlling.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2 <U>Grant of Security Interest in Collateral.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As an inducement for the Secured Parties to extend the loans as evidenced by the Notes and to secure the complete and timely payment,
performance and discharge in full of all of the Obligations as set forth in the Purchase Agreement and the Notes, as the case may be,
of all of the other Obligations, Debtor hereby unconditionally and irrevocably pledges, grants and hypothecates to the Secured Parties
(subject in each case to Permitted Liens) a priority security interest in and to, and lien upon and a right of set-off against all of
their respective right, title and interest of whatsoever kind and nature in and to, the Collateral as defined above (&ldquo;<B>Security
Interest</B>&rdquo; and, collectively, the &ldquo;<B>Collateral</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Debtor hereby agrees to provide to the Secured Parties or the Collateral Agent (defined as the party appointed by a majority of the Secured
Parties) promptly upon request, any information reasonably necessary to effectuate the filings or recordings authorized by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 41pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Secured Parties or the Collateral Agent are further authorized to file with the United States Patent and Trademark Office, the United
States Copyright Office or any similar office in any state of the United States (or any successor office), with the signature of each
applicable Debtor, such documents as may be necessary or advisable for the purpose of perfecting, confirming, continuing, enforcing or
protecting the Security Interest granted hereunder to the Patent Rights and Trademark Rights, all right, title and interest to which
have been assigned or will be assigned to the Debtor, by Debtor and naming any Debtor or the Debtors as debtors and the Secured Parties,
as the case may be, as secured party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Security Interest is granted as security only and shall not subject the Secured Parties to, or in any way alter or modify, any obligation
or liability of any Debtor with respect to or arising out of the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3 <U>Delivery of Certain Collateral.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contemporaneously
or prior to the execution of this Agreement, Debtor shall deliver or cause to be delivered to the Collateral Agent any and all documents,
instruments, certificates and all other physical evidence representing any of the other Collateral, in each case, together with all necessary
endorsements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4 <U>Representations, Warranties, Covenants and Agreements of the Debtor</U></B><U>.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Debtor represents and warrants to, and covenants and agrees with, the Secured Parties as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Debtor has the requisite corporate, partnership, limited liability company or other power and authority to enter into this Agreement
and otherwise to carry out its obligations hereunder. The execution, delivery and performance by Debtor of this Agreement and the filings
contemplated therein have been duly authorized by all necessary action on the part of Debtor and no further action is required by Debtor.
This Agreement has been duly executed by Debtor. This Agreement constitutes the legal, valid and binding obligation of Debtor, enforceable
against Debtor in accordance with its terms except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization
and similar laws of general application relating to or affecting the rights and remedies of creditors and by general principles of equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Except for the Security Interest granted to the Secured Parties pursuant to this Agreement, and Permitted Liens, Debtor owns, or has
valid leaseholds in or the right to use, each item of the Collateral free and clear of any and all liens or other encumbrances. No security
agreement, financing statement or other public notice with respect to all or any part of the Collateral that evidences a lien securing
any indebtedness is on file or of record in any public office, except such as: (i) have been filed in favor of and for the benefit of
the Secured Parties pursuant to this Agreement; (ii) relate to obligations no longer outstanding or are in respect of commitments to
lend which have been terminated. No written claim has been received that any Collateral or any Debtor&rsquo;s use of any Collateral violates
the rights of any third party. There has been no adverse decision to any Debtor&rsquo;s claim of ownership rights in or exclusive rights
to use the Collateral in any jurisdiction or to any Debtor&rsquo;s right to keep and maintain such Collateral in full force and effect,
and there is no proceeding involving said rights pending or, to the best knowledge of any Debtor, threatened before any court, judicial
body, administrative or regulatory agency, arbitrator or other governmental authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Debtor shall at all times maintain its books of account and records relating to the Collateral at its principal place of business and
its Collateral at the locations set forth on Schedule A attached hereto and may not relocate such books of account and records or tangible
Collateral unless it delivers to the Secured Parties at least thirty (30) days prior to such relocation: (i) written notice of such relocation
and the new location thereof (which must be within the United States); and (ii) evidence that appropriate financing statements under
the UCC and other necessary documents have been filed and recorded and other steps have been taken to perfect the Collateral to create
in favor of the Secured Parties a valid, perfected and continuing perfected lien in the Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This Agreement is effective to create in favor of the Secured Parties a valid lien and security interest in the Collateral, subject only
to Permitted Liens, securing the payment and performance of the Obligations. Upon making the filings described in the immediately following
paragraph, all security interests created hereunder in any Collateral which may be perfected by filing Uniform Commercial Code financing
statements shall have been duly perfected. Except for the filing of the Uniform Commercial Code financing statements referred to in the
immediately following paragraph, the recordation of the Intellectual Property Security Agreement with respect to copyrights and copyright
applications in the United States Copyright Office, the execution and delivery of deposit account control agreements satisfying the requirements
of Section 9-104(a)(2) of the UCC with respect to each deposit account of the Debtor, and the delivery of the certificates and other
instruments provided in section 3, no action is necessary to create, perfect or protect the security interests created hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Debtor hereby authorizes the Collateral Agent to file one or more financing statements under the UCC, with respect to the Collateral,
with the proper filing and recording agencies in any jurisdiction deemed proper by it. Debtor agrees that at any time and from time to
time, at the expense of the Debtor, it will execute any and all further documents, financing statements, agreements and instruments,
and take all such further actions (including the filing and recording of financing statements and other documents), which may be required
under any applicable law, or which the Collateral Agent may reasonably request, in order: (i) to grant, preserve, protect and perfect
the validity and priority of the Security Interest created or intended to be created hereby; or (ii) to enable the Collateral Agent to
exercise and enforce its rights and remedies hereunder with respect to any Collateral, including the filing of any financing or continuation
statements under the UCC in effect in any jurisdiction with respect to the Security Interest created hereby, all at the expense of such
Debtor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The execution, delivery and performance of this Agreement by the Debtor does not: (i) violate any of the provisions of any articles or
certificate of incorporation or bylaws or other organizational documents (&ldquo;<B>Organizational Documents</B>&rdquo;) of any Debtor
or any judgment, decree, order or award of any court, governmental body or arbitrator or any applicable law, rule or regulation applicable
to any Debtor; or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or
both) of, any agreement, credit facility, debt or other instrument (evidencing any Debtor&rsquo;s debt or otherwise) or other understanding
to which any Debtor is a party or by which any property or asset of any Debtor is bound or affected. If any, all required consents (including,
without limitation, from stockholders or creditors of any Debtor) necessary for any Debtor to enter into and perform its obligations
hereunder have been obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Debtor shall at all times maintain the liens and Collateral provided for hereunder as valid and perfected liens and security interests
in the Collateral in favor of the Secured Parties until this Agreement and the Security Interest hereunder shall be terminated pursuant
to section 14 hereof. Debtor hereby agrees to defend the same against the claims of any and all Persons and entities. Debtor shall safeguard
and protect all Collateral and hold it in trust for the account of the Secured Parties. At the request of the Collateral Agent, Debtor
will sign and deliver to the Collateral Agent on behalf of the Secured Parties at any time or from time to time one or more financing
statements pursuant to the UCC in form reasonably satisfactory to the Collateral Agent and will pay the cost of filing the same in all
public offices wherever filing is, or is deemed by the Collateral Agent to be, necessary or desirable to effect the rights and obligations
provided for herein. Without limiting the generality of the foregoing, Debtor shall pay all fees, taxes and other amounts necessary to
maintain the Collateral and the Collateral hereunder, and Debtor shall obtain and furnish to the Collateral Agent from time to time,
upon demand, such releases and/or subordinations of claims and liens which may be required to maintain the priority of the Collateral
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Debtor will not transfer, pledge, hypothecate, encumber, license, sell or otherwise dispose of any of the Collateral (except for non-exclusive
licenses granted by a Debtor in its ordinary course of business and sales of inventory by a Debtor in its ordinary course of business)
without the prior written consent of a Majority in Interest (defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Debtor shall keep and preserve its equipment, inventory and other tangible Collateral in good condition, repair and order and shall not
operate or locate any such Collateral (or cause to be operated or located) in any area excluded from insurance coverage or outside the
reach of the Collateral Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Debtor shall maintain with financially sound and reputable insurers, insurance with respect to the Collateral, including Collateral hereafter
acquired, against loss or damage of the kinds and in the amounts customarily insured against by entities of established reputation having
similar properties similarly situated and in such amounts as are customarily carried under similar circumstances by other such entities
and otherwise as is prudent for entities engaged in similar businesses but in any event sufficient to cover the full replacement cost
thereof. Debtor shall cause each insurance policy issued in connection herewith to provide, and the insurer issuing such policy to certify
to the Collateral Agent, that: (i) the Collateral Agent or the Secured Parties will be named as lender loss payee and additional insured
under each such insurance policy; (ii) if such insurance be proposed to be cancelled or materially changed for any reason whatsoever,
such insurer will promptly notify the Collateral Agent and such cancellation or change shall not be effective as to the Collateral Agent
for at least thirty (30) days after receipt by the Collateral Agent of such notice, unless the effect of such change is to extend or
increase coverage under the policy; and (iii) the Collateral Agent will have the right (but no obligation) at its election to remedy
any default in the payment of premiums within thirty (30) days of notice from the insurer of such default at the expense of the Debtor.
If no Event of Default (as defined in the Notes) exists and if the proceeds arising out of any claim or series of related claims do not
exceed $100,000, loss payments in each instance will be applied by the applicable Debtor to the repair and/or replacement of property
with respect to which the loss was incurred to the extent reasonably feasible, and any loss payments or the balance thereof remaining,
to the extent not so applied, shall be payable to the applicable Debtor; provided, however, that payments received by any Debtor after
an Event of Default occurs and is continuing or in excess of$100,000 for any occurrence or series of related occurrences shall be paid
to the Collateral Agent on behalf of the Secured Parties and, if received by Debtor, shall be held in trust for the Secured Parties and
immediately paid over to the Collateral Agent unless otherwise directed in writing by the Collateral Agent. Copies of such policies or
the related certificates, in each case, naming the Collateral Agent as lender loss payee and additional insured shall be delivered to
the Collateral Agent upon the execution of this Agreement and at least annually and at the time any new policy of insurance is issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Debtor shall, within ten (10) days of obtaining knowledge thereof, advise the Secured Parties promptly, in sufficient detail, of any
material adverse change in the Collateral, and of the occurrence of any event which would have a material adverse effect on the value
of the Collateral or on the Secured Parties&rsquo; security interest, through the Collateral Agent, therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
Debtor shall permit the Collateral Agent and its representatives and agents to inspect the Collateral during normal business hours and
upon reasonable prior notice, and to make copies of records pertaining to the Collateral as may be reasonably requested by the Collateral
Agent from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
Debtor shall, <I>sua sponte</I>, take all steps reasonably necessary to diligently pursue and seek to preserve, enforce and collect any
rights, claims, causes of action and accounts receivable in respect of the Collateral without the need for a request therefore from the
Collateral Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
Debtor shall promptly notify the Secured Parties in sufficient detail upon becoming aware of any attachment, garnishment, execution or
other legal process levied against any Collateral and of any other information received by Debtor that may materially affect the value
of the Collateral, the Security Interest or the rights and remedies of the Secured Parties hereunder and shall promptly take all necessary
or appropriate action to remediate, mitigate or eliminate such adverse action at its own expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
All information heretofore, herein or hereafter supplied to the Secured Parties by or on behalf of Debtor with respect to the Collateral
is accurate and complete in all material respects as of the date furnished.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
The Debtor shall at all times preserve and keep in full force and effect their respective valid existence and good standing and any rights
and franchises material to its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
At any time and from time to time that any Collateral consists of instruments, certificated securities or other items that require or
permit possession by the Secured Parties to perfect the security interest created hereby, the applicable Debtor shall deliver such Collateral
to the Collateral Agent upon demand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
Debtor, in its capacity as issuer, hereby agrees to comply with any and all orders and instructions of Collateral Agent regarding the
Collateral consistent with the terms of this Agreement without the further consent of any Debtor as contemplated by Section 8-106 (or
any successor Section) of the UCC. Further, Debtor agrees that it shall not enter into a similar agreement (or one that would confer
&ldquo;<B>control</B>&rdquo; within the meaning of Article 8 of the UCC) with any other Person or entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
Debtor shall cause all tangible chattel paper constituting Collateral to be delivered to the Collateral Agent, or, if such delivery is
not possible, then to cause such tangible chattel paper to contain a legend noting that it is subject to the security interest created
by this Agreement. To the extent that any Collateral consists of electronic chattel paper, the applicable Debtor shall cause the underlying
chattel paper to be &lsquo;marked&rsquo; within the meaning of Section 9-105 of the UCC (or successor Section thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
Debtor shall immediately provide written notice to the Secured Parties of any and all accounts which arise out of contracts with any
governmental authority and, to the extent necessary to perfect or continue the perfected status of the Collateral in such accounts and
proceeds thereof, shall execute and deliver to the Collateral Agent an assignment of claims for such accounts and cooperate with the
Collateral Agent in taking any other steps required, in its judgment, under the Federal Assignment of Claims Act or any similar federal,
state or local statute or rule to perfect or continue the perfected status of the Collateral in such accounts and proceeds thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 76.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
Debtor will from time to time, at the joint and several expense of the Debtor, promptly execute and deliver all such further instruments
and documents, and take all such further action as may be necessary or desirable, or as the Collateral Agent may reasonably request,
in order to perfect and protect any security interest granted or purported to be granted hereby or to enable the Secured Parties to exercise
and enforce their rights and remedies hereunder and with respect to any Collateral or to otherwise carry out the purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5 <U>Effect of Pledge on Certain Rights.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the Collateral subject to this Agreement consists of nonvoting equity or ownership interests (regardless of class, designation,
preference or rights) that may be converted into voting equity or ownership interests upon the occurrence of certain events (including,
without limitation, upon the transfer of all or any of the other stock or assets of the issuer), it is agreed that the pledge of such
equity or ownership interests pursuant to this Agreement or the enforcement of any of Collateral Agent&rsquo;s rights hereunder shall
not be deemed to be the type of event which would trigger such conversion rights notwithstanding any provisions in the Organizational
Documents or agreements to which any Debtor is subject or to which any Debtor is party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6 <U>Defaults.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following events shall be &ldquo;<B>Events of Default</B>&rdquo;:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The occurrence of an Event of Default (as defined in the Notes) under the Notes;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any representation or warranty of any Debtor in this Agreement shall prove to have been incorrect in any material respect when made;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The failure by any Debtor to observe or perform any of its obligations hereunder for ten (10) days after receipt by Debtor of notice
of such failure by or on behalf of a Secured Party unless such default is capable of cure but cannot be cured within such time frame
and Debtor is using best efforts to cure same in a timely fashion, provided that if no cure is provided to the satisfaction of the Secured
Parties within twenty (20) days after such notice, then the failure shall be deemed an Event of Default; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If any provision of this Agreement shall at any time for any reason be declared to be null and void, or the validity or enforceability
thereof shall be contested by any Debtor, or a proceeding shall be commenced by any Debtor, or by any governmental authority having jurisdiction
over any Debtor, seeking to establish the invalidity or unenforceability thereof, or any Debtor shall deny that any Debtor has any liability
or obligation purported to be created under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7 <U>Duty to Hold in Trust.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the occurrence of any Event of Default and at any time thereafter, Debtor shall, upon receipt of any revenue, income, dividend,
interest or other sums subject to the Collateral, whether payable pursuant to the Notes or otherwise, or of any check, draft, note, trade
acceptance or other instrument evidencing an obligation to pay any such sum, hold the same in trust for the Secured Parties and shall
forthwith endorse and transfer any such sums or instruments, or both, to the Secured Parties, pro-rata in proportion to their respective
then-currently outstanding principal amount of Notes for application to the satisfaction of the Obligations (and if any Note is not outstanding,
pro-rata in proportion to the initial purchases of the remaining Notes).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
If any Debtor shall become entitled to receive or shall receive any securities or other property (including, without limitation, shares
of pledged securities or instruments representing pledged securities acquired after the date hereof, or any options, warrants, rights
or other similar property or certificates representing a dividend, or any distribution in connection with any recapitalization, reclassification
or increase or reduction of capital, or issued in connection with any reorganization of Debtor or any of its direct or indirect subsidiaries)
in respect of the pledged securities (whether as an addition to, in substitution of, or in exchange for, such pledged securities or otherwise),
Debtor agrees to: (i) accept the same as the Collateral Agent of the Secured Parties; and (ii) hold the same in trust on behalf of and
for the benefit of the Secured Parties; and (iii) to deliver any and all certificates or instruments evidencing the same to Collateral
Agent on or before the close of business on the fifth business day following the receipt thereof by Debtor, in the exact form received
together with the necessary endorsements, to be held by Collateral Agent subject to the terms of this Agreement as Collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8 <U>Rights and Remedies Upon Default.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Upon the occurrence of any Event of Default and at any time thereafter if such breach is not cured, the Secured Parties, acting through
the Collateral Agent, shall have the right to exercise all of the remedies conferred hereunder and under the Purchase Agreement and the
Notes, and the Secured Parties shall have all the rights and remedies of a secured party under the UCC. Without limitation, the Collateral
Agent, for the benefit of the Secured Parties, shall have the following rights and powers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Collateral Agent shall have the right to take possession of the Collateral and, for that purpose, enter, with the aid and assistance
    of any Person, any premises where the Collateral, or any part thereof, is or may be placed and remove the same, and Debtor shall
    assemble the Collateral and make it available to the Collateral Agent at places which the Collateral Agent shall reasonably select,
    whether at Debtor&rsquo;s premises or elsewhere, and make available to the Collateral Agent, without rent, all of Debtor&rsquo;s
    respective premises and facilities for the purpose of the Collateral Agent taking possession of, removing or putting the Collateral
    in saleable or disposable form.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
    notice to the Debtor by Collateral Agent, all rights of Debtor to exercise the voting and other consensual rights which it would
    otherwise be entitled to exercise and all rights of Debtor to receive the dividends and interest which it would otherwise be authorized
    to receive and retain, shall cease. Upon such notice, Collateral Agent shall have the right to receive, for the benefit of the Secured
    Parties, any interest, cash dividends or other payments on the Collateral and, at the option of Collateral Agent, to exercise in
    such Collateral Agent&rsquo;s discretion all voting rights pertaining thereto. Without limiting the generality of the foregoing,
    Collateral Agent shall have the right (but not the obligation) to exercise all rights with respect to the Collateral as it were the
    sole and absolute owner thereof, including, without limitation, to vote and/or to exchange, at its sole discretion, any or all of
    the Collateral in connection with a merger, reorganization, consolidation, recapitalization or other readjustment concerning or involving
    the Collateral or any Debtor or any of its direct or indirect subsidiaries.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Collateral Agent shall have the right to operate the business of Debtor using the Collateral and shall have the right to assign,
    sell, lease or otherwise dispose of and deliver all or any part of the Collateral, at public or private sale or otherwise, either
    with or without special conditions or stipulations, for cash or on credit or for future delivery, in such parcel or parcels and at
    such time or times and at such place or places, and upon such terms and conditions as the Collateral Agent may deem commercially
    reasonable, all without (except as shall be required by applicable statute and cannot be waived) advertisement or demand upon or
    notice to any Debtor or right of redemption of a Debtor, which are hereby expressly waived. Upon each such sale, lease, assignment
    or other transfer of Collateral, the Collateral Agent, for the benefit of the Secured Parties, may, unless prohibited by applicable
    law which cannot be waived, purchase all or any part of the Collateral being sold, free from and discharged of all trusts, claims,
    right of redemption and equities of any Debtor, which are hereby waived and released.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Collateral Agent shall have the right (but not the obligation) to notify any account debtors and any obligors under instruments or
    accounts to make payments directly to the Collateral Agent, on behalf of the Secured Parties, and to enforce the Debtor&rsquo;s rights
    against such account debtors and obligors. Anything herein to the contrary notwithstanding, Debtor shall remain liable under each
    of the accounts to observe and perform all the conditions and obligations to be observed and performed by it thereunder, all in accordance
    with the terms of any agreement giving rise thereto. Unless the Collateral Agent has expressly in writing assumed the obligations
    and liabilities with respect thereto, and released the Debtors therefrom, neither the Collateral Agent nor any Secured Party shall
    have any obligation or liability under any account (or any agreement giving rise thereto) by reason of or arising out of this Agreement
    or the receipt by the Collateral Agent or any Secured Party of any payment relating thereto, nor shall the Collateral Agent or any
    Secured Party be obligated in any manner to perform any of the obligations of any Debtor under or pursuant to any account (or any
    agreement giving rise thereto), to make any payment, to make any inquiry as to the nature or the sufficiency of any payment received
    by it or as to the sufficiency of any performance by any party thereunder, to present or file any claim, to take any action to enforce
    any performance or to collect the payment of any amounts which may have been assigned to it or to which it may be entitled at any
    time or times.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Collateral Agent, for the benefit of the Secured Parties, may (but is not obligated to) direct any financial intermediary or any other
Person or entity holding any investment property to transfer the same to the Collateral Agent, on behalf of the Secured Parties, or its
designee and all Proceeds received by any Debtor consisting of cash, checks and other near cash items shall be held by such Debtor in
trust for the Collateral Agent and the Secured Parties, segregated from other funds of such Debtor, and shall, forthwith upon receipt
by such Debtor, be turned over to the Collateral Agent in the exact form received by such Debtor (duly endorsed by such Debtor to the
Collateral Agent, if required). All Proceeds received by the Collateral Agent hereunder shall be held by the Collateral Agent in a Collateral
Account maintained under its dominion and control and on terms and conditions reasonably satisfactory to the Collateral Agent. All Proceeds
while held by the Collateral Agent in a Collateral Account (or by such Debtor in trust for the Collateral Agent and the Secured Parties)
shall continue to be held as collateral security for all the Obligations and shall not constitute payment thereof until applied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.85pt; text-indent: 0in; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.85pt; text-indent: 0in; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.85pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Collateral Agent may (but is not obligated to) transfer any or all Intellectual Property registered in the name of any Debtor at
    the United States Patent and Trademark Office and/or Copyright Office into the name of the Secured Parties or any designee or any
    purchaser of any Collateral.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Collateral Agent shall comply with any applicable law in connection with a disposition of Collateral and such compliance will not
be considered adversely to affect the commercial reasonableness of any sale of the Collateral. The Collateral Agent may sell the Collateral
without giving any warranties and may specifically disclaim such warranties. If the Collateral Agent sells any of the Collateral on credit,
the Debtor will only be credited with payments actually made by the purchaser. In addition, Debtor waives any and all rights that it
may have to a judicial hearing in advance of the enforcement of any of the Collateral Agent&rsquo;s rights and remedies hereunder, including,
without limitation, its right following an Event of Default to take immediate possession of the Collateral and to exercise its rights
and remedies with respect thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
For the purpose of enabling the Collateral Agent to further exercise rights and remedies under this section 8 or elsewhere provided by
agreement or applicable law, Debtor hereby grants to the Collateral Agent, for the benefit of the Collateral Agent and the Secured Parties,
an irrevocable, nonexclusive license (exercisable without payment of royalty or other compensation to Debtor) to use, license or sublicense
following an Event of Default, any Intellectual Property now owned or hereafter acquired by Debtor, and wherever the same may be located,
and including in such license access to all media in which any of the licensed items may be recorded or stored and to all computer software
and programs used for the compilation or printout thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
9 <U>Application of Proceeds.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
proceeds of any such sale, lease or other disposition of the Collateral hereunder or from payments made on account of any insurance policy
insuring any portion of the Collateral shall be applied first, to the expenses of retaking, holding, storing, processing and preparing
for sale, selling, and the like (including, without limitation, any taxes, fees and other costs incurred in connection therewith) of
the Collateral, to the reasonable attorneys&rsquo; fees and expenses incurred by the Collateral Agent in enforcing the Secured Parties&rsquo;
rights hereunder and in connection with collecting, storing and disposing of the Collateral, and then to satisfaction of the Obligations
<I>pro rata</I> among the Secured Parties (based on then-outstanding principal amounts of Notes at the time of any such determination),
and to the payment of any other amounts required by applicable law, after which the Secured Parties shall pay to the applicable Debtor
any surplus proceeds. If, upon the sale, license or other disposition of the Collateral, the proceeds thereof are insufficient to pay
all amounts to which the Secured Parties are legally entitled, the Debtors will be personally liable, jointly and severally, for the
deficiency, together with interest thereon, at the rate of 15% per annum or the lesser amount permitted by applicable law (&ldquo;<B>Default
Rate</B>&rdquo;), and the reasonable fees and expenses of any attorneys employed by the Secured Parties to collect such deficiency. To
the extent permitted by applicable law, Debtor waives all claims, damages and demands against the Secured Parties arising out of the
repossession, removal, retention or sale of the Collateral, unless due solely to the gross negligence or willful misconduct of the Secured
Parties as determined by a final judgment (not subject to further appeal) of a court of competent jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
10 <U>Securities Law Provision.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debtor
recognizes that Collateral Agent may be limited in its ability to effect a sale to the public of all or part of the Pledged Securities
by reason of certain prohibitions in the Securities Act of 1933, as amended, or other federal or state securities laws (collectively,
the &ldquo;<B>Securities Laws</B>&rdquo;), and may be compelled to resort to one or more sales to a restricted group of purchasers who
may be required to agree to acquire the pledged securities set forth in Schedule A (&ldquo;<B>Pledged Securities</B>&rdquo;) for their
own account, for investment and not with a view to the distribution or resale thereof. Debtor agrees that sales so made may be at prices
and on terms less favorable than if the Pledged Securities were sold to the public, and that Collateral Agent has no obligation to delay
the sale of any Pledged Securities for the period of time necessary to register the Pledged Securities for sale to the public under the
Securities Laws. Debtor shall cooperate with Collateral Agent in its attempt to satisfy any requirements under the Securities Laws (including,
without limitation, registration thereunder if requested by Collateral Agent) applicable to the sale of the Pledged Securities by Collateral
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
11 <U>Costs and Expenses.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debtor
agrees to pay all reasonable out-of-pocket fees, costs and expenses incurred in connection with any filing required hereunder, including
without limitation, any financing statements pursuant to the UCC, continuation statements, partial releases and/or termination statements
related thereto or any expenses of any searches reasonably required by the Collateral Agent. The Debtor shall also pay all other claims
and charges which in the reasonable opinion of the Collateral Agent is reasonably likely to prejudice, imperil or otherwise affect the
Collateral or the Collateral therein. The Debtor will also, upon demand, pay to the Collateral Agent the amount of any and all reasonable
expenses, including the reasonable fees and expenses of its counsel and of any experts and Collateral Agents, which the Collateral Agent,
for the benefit of the Secured Parties, may incur in connection with the creation, perfection, protection, satisfaction, foreclosure,
collection or enforcement of the Security Interest and the preparation, administration, continuance, amendment or enforcement of this
Agreement and pay to the Collateral Agent the amount of any and all reasonable expenses, including the reasonable fees and expenses of
its counsel and of any experts and Collateral Agents, which the Collateral Agent, for the benefit of the Secured Parties, and the Secured
Parties may incur in connection with: (i) the enforcement of this Agreement; (ii) the custody or preservation of, or the sale of, collection
from, or other realization upon, any of the Collateral; or (iii) the exercise or enforcement of any of the rights of the Secured Parties
under the Notes. Until so paid, any fees payable hereunder shall be added to the principal amount of the Notes and shall bear interest
at the Default Rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
12 <U>Responsibility for Collateral.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Debtor assumes all liabilities and responsibility in connection with all Collateral, and the Obligations shall in no way be affected
or diminished by reason of the loss, destruction, damage or theft of any of the Collateral or its unavailability for any reason. Without
limiting the generality of the foregoing, (a) neither the Collateral Agent nor any Secured Party (i) has any duty (either before or after
an Event of Default) to collect any amounts in respect of the Collateral or to preserve any rights relating to the Collateral, or (ii)
has any obligation to clean-up or otherwise prepare the Collateral for sale, and (b) Debtor shall remain obligated and liable under each
contract or agreement included in the Collateral to be observed or performed by Debtor thereunder. Neither the Collateral Agent nor any
Secured Party shall have any obligation or liability under any such contract or agreement by reason of or arising out of this Agreement
or the receipt by the Collateral Agent or any Secured Party of any payment relating to any of the Collateral, nor shall the Collateral
Agent or any Secured Party be obligated in any manner to perform any of the obligations of any Debtor under or pursuant to any such contract
or agreement, to make inquiry as to the nature or sufficiency of any payment received by the Collateral Agent or any Secured Party in
respect of the Collateral or as to the sufficiency of any performance by any party under any such contract or agreement, to present or
file any claim, to take any action to enforce any performance or to collect the payment of any amounts which may have been assigned to
the Collateral Agent or to which the Collateral Agent or any Secured Party may be entitled at any time or times.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
13 <U>Collateral Absolute.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
rights of the Secured Parties and all obligations of the Debtor hereunder, shall be absolute and unconditional, irrespective of: (i)
any lack of validity or enforceability of this Agreement, the Purchase Agreement, the Notes or any agreement entered into in connection
with the foregoing, or any portion hereof or thereof; (ii) any change in the time, manner or place of payment or performance of, or in
any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to any departure from the Purchase
Agreement, the Notes or any other agreement entered into in connection with the foregoing; (iii) any exchange, release or non-perfection
of any of the Collateral, or any release or amendment or waiver of or consent to departure from any other collateral for, or any guarantee,
or any other security, for all or any of the Obligations; (iv) any action by the Secured Parties to obtain, adjust, settle and cancel
in its sole discretion any insurance claims or matters made or arising in connection with the Collateral; or (v) any other circumstance
which might otherwise constitute any legal or equitable defense available to a Debtor, or a discharge of all or any part of the Collateral
granted hereby. Until the Obligations shall have been paid and performed in full, the rights of the Secured Parties shall continue even
if the Obligations are barred for any reason, including, without limitation, the running of the statute of limitations or bankruptcy.
Debtor expressly waives presentment, protest, notice of protest, demand, notice of nonpayment and demand for performance. In the event
that at any time any transfer of any Collateral or any payment received by the Secured Parties hereunder shall be deemed by final order
of a court of competent jurisdiction to have been a voidable preference or fraudulent conveyance under the bankruptcy or insolvency laws
of the United States, or shall be deemed to be otherwise due to any party other than the Secured Parties, then, in any such event, Debtor&rsquo;s
obligations hereunder shall survive cancellation of this Agreement, and shall not be discharged or satisfied by any prior payment thereof
and/or cancellation of this Agreement, but shall remain a valid and binding obligation enforceable in accordance with the terms and provisions
hereof. Debtor waives all right to require the Secured Parties to proceed against any other person or entity or to apply any Collateral
which the Secured Parties may hold at any time, or to marshal assets, or to pursue any other remedy. Debtor waives any defense arising
by reason of the application of the statute of limitations to any obligation secured hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
14 <U>Term of Agreement.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement and the Collateral shall terminate on the date on which all payments under the Notes have been indefeasibly paid in full and
all other Obligations under the Purchase Agreement have been paid or discharged; provided, however, that all indemnities of the Debtor
contained in this Agreement shall survive and remain operative and in full force and effect regardless of the termination of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
15 <U>Power of Attorney; Further Assurances.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Debtor authorizes the Collateral Agent, and does hereby make, constitute and appoint the Collateral Agent and its officers, Collateral
Agents, successors or assigns with full power of substitution, as Debtor&rsquo;s true and lawful attorney-in-fact, with power, in the
name of the Collateral Agent or Debtor, to, after the occurrence and during the continuance of an Event of Default: (i) endorse any note,
checks, drafts, money orders or other instruments of payment (including payments payable under or in respect of any policy of insurance)
in respect of the Collateral that may come into possession of the Collateral Agent; (ii) to sign and endorse any financing statement
pursuant to the UCC or any invoice, freight or express bill, bill of lading, storage or warehouse receipts, drafts against debtors, assignments,
verifications and notices in connection with accounts, and other documents relating to the Collateral; (iii) to pay or discharge taxes,
liens, security interests or other encumbrances at any time levied or placed on or threatened against the Collateral; (iv) to demand,
collect, receipt for, compromise, settle and sue for monies due in respect of the Collateral; (v) to transfer any Intellectual Property
or provide licenses respecting any Intellectual Property; and (vi) generally, at the option of the Collateral Agent, and at the expense
of the Debtor, at any time, or from time to time, to execute and deliver any and all documents and instruments and to do all acts and
things which the Collateral Agent deems necessary to protect, preserve and realize upon the Collateral and the Collateral granted therein
in order to effect the intent of this Agreement and the Notes all as fully and effectually as the Debtor might or could do; and Debtor
hereby ratifies all that said attorney shall lawfully do or cause to be done by virtue hereof. This power of attorney is coupled with
an interest and shall be irrevocable for the term of this Agreement and thereafter as long as any of the Obligations shall be outstanding.
The designation set forth herein shall be deemed to amend and supersede any inconsistent provision in the Organizational Documents or
other documents or agreements to which any Debtor is subject or to which any Debtor is a party. Without limiting the generality of the
foregoing, after the occurrence and during the continuance of an Event of Default, each Secured Party is specifically authorized to execute
and file any applications for or instruments of transfer and assignment of any patents, trademarks, copyrights or other Intellectual
Property with the United States Patent and Trademark Office and the United States Copyright Office.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 70.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On a continuing basis, Debtor will make, execute, acknowledge, deliver, file and record, as the case may be, with the proper filing and
recording agencies in any jurisdiction, including, without limitation, the jurisdictions indicated on Schedule C attached hereto, all
such instruments, and take all such action as may reasonably be deemed necessary or advisable, or as reasonably requested by the Collateral
Agent, to perfect the Collateral granted hereunder and otherwise to carry out the intent and purposes of this Agreement, or for assuring
and confirming to the Collateral Agent the grant or perfection of a perfected security interest in all the Collateral under the UCC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 70.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Debtor hereby irrevocably appoints the Collateral Agent as Debtor&rsquo;s attorney-in-fact, with full authority in the place and instead
of Debtor and in the name of Debtor, from time to time in the Collateral Agent&rsquo;s discretion, to take any action and to execute
any instrument which the Collateral Agent may deem necessary or advisable to accomplish the purposes of this Agreement, including the
filing, in its sole discretion, of one or more financing or continuation statements and amendments thereto, relative to any of the Collateral
without the signature of Debtor where permitted by law, which financing statements may (but need not) describe the Collateral as &lsquo;all
assets&rsquo;, &lsquo;all assets now owned or hereafter acquired&rsquo; or &lsquo;all personal property&rsquo; or words of like import,
and ratifies all such actions taken by the Collateral Agent. Debtor hereby also authorizes the Collateral Agent, at any time and from
time to time, to file continuation statements with respect to previously filed financing statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 41pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This power of attorney is coupled with an interest and shall be irrevocable for the term of this Agreement and thereafter as long as
any of the Obligations shall be outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
16 <U>Notices.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
notices, requests, demands and other communications hereunder shall be subject to the notice provision of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
17 <U>Power of Attorney; Further Assurances.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that the Obligations are now or hereafter secured by property other than the Collateral or by the guarantee, endorsement or
property of any other Person, firm, corporation or other entity, then the Collateral Agent shall have the right, in its sole discretion,
to pursue, relinquish, subordinate, modify or take any other action with respect thereto, without in any way modifying or affecting any
of the Secured Parties&rsquo; rights and remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
18 <U>Appointment of Collateral Agent.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Secured Parties may appoint a person or entity to act on their behalf with respect to the Collateral pledged hereby (&ldquo;<B>Collateral
</B>Agent&rdquo;) and any action to be taken hereunder by the Secured Parties may be taken by the Collateral Agent on their behalf and
in their place and stead without further action on the part of the Secured Parties. The initial Collateral Agent shall be the Lead Investor.
The name and contact information of the Collateral Agent and any replacement Collateral Agent shall be provided in writing to the Debtor
at any time or from time to time and shall be binding upon the parties hereto without more. Any reference herein to the Collateral Agent
or to the Secured Parties may apply to either or both as the context may require. The fees and reasonable expenses of the Collateral
Agent shall be the obligation of the Debtor which hereby agrees to pay such fees and expenses upon demand. Any such appointment shall
continue until revoked in writing by a majority of the then outstanding principal balance in interest of the Notes (&ldquo;<B>Majority
in Interest</B>&rdquo;), at which time a Majority in Interest shall appoint a new Collateral Agent. The Collateral Agent, if any, shall
have the rights, responsibilities and immunities set forth in Schedule B hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
19 <U>Miscellaneous.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
No course of dealing between the Debtor and the Secured Parties or the Collateral Agent, nor any failure to exercise, nor any delay in
exercising, on the part of the Secured Parties or the Collateral Agent, any right, power or privilege hereunder or under the Purchase
Agreement or the Notes shall operate as a waiver thereof; nor shall any single or partial exercise of any right, power or privilege hereunder
or thereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
All of the rights and remedies of the Secured Parties with respect to the Collateral, whether established hereby or by the Notes or by
any other agreements, instruments or documents or by law shall be cumulative and may be exercised singly or concurrently.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
This Agreement, the Purchase Agreement and the Notes, together with the exhibits and schedules hereto and thereto, contain the entire
understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or
written, with respect to such matters, which the parties acknowledge have been merged into this Agreement and the exhibits and schedules
hereto. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the
case of an amendment, by the Debtor and the Secured Parties holding 67% or more of the principal amount of Notes then outstanding, or,
in the case of a waiver, by the party against whom enforcement of any such waived provision is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall
any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 58.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company
may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Secured Party (other than
by merger). Any Secured Party may assign any or all of its rights under this Agreement to any Person (as defined in the Purchase Agreement)
to whom such Secured Party assigns or transfers any Obligations, provided such transferee agrees in writing to be bound, with respect
to the transferred Obligations, by the provisions of this Agreement that apply to the &ldquo;Secured Parties.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Each party shall take such further action and execute and deliver such further documents as may be necessary or appropriate in order
to carry out the provisions and purposes of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Except to the extent mandatorily governed by the jurisdiction or situs where the Collateral is located, all questions concerning the
construction, validity, enforcement, and interpretation of this Agreement shall be governed by and construed and enforced in accordance
with the internal laws of the State of Arizona, without regard to the principles of conflicts of law thereof. Except to the extent mandatorily
governed by the jurisdiction or situs where the Collateral is located, Debtor agrees that all proceedings concerning the interpretations,
enforcement and defense of the transactions contemplated by this Agreement, the Purchase Agreement and the Notes (whether brought against
a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or Collateral Agents) shall
be commenced exclusively in the state and federal courts sitting in the County of New York, New York (&ldquo;<B>New York Courts</B>&rdquo;).
Except to the extent mandatorily governed by the jurisdiction or situs where the Collateral is located, Debtor hereby irrevocably submits
to the jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any proceeding, any claim that it
is not personally subject to the jurisdiction of any such court, that such proceeding is improper. Each party hereto hereby irrevocably
waives personal service of process and consents to process being served in any such proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Purchase Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably
waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of
or relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and, all
of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile or electronic
transmission, such signature shall create a valid binding obligation of the party executing (or on whose behalf such signature is executed)
the same with the same force and effect as if such facsimile signature were the original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Debtor shall indemnify, reimburse and hold harmless the Collateral Agent and the Secured Parties and their respective partners, members,
shareholders, officers, directors, employees and agents, including Reverse Securities LLC, the Company&rsquo;s placement agent for the
Notes (and any other persons with other titles that have similar functions) (collectively, &ldquo;<B>Indemnitees</B>&rdquo;) from and
against any and all losses, claims, liabilities, damages, penalties, suits, costs and expenses, of any kind or nature, (including fees
relating to the cost of investigating and defending any of the foregoing) imposed on, incurred by or asserted against such Indemnitee
in any way related to or arising from or alleged to arise from the Purchase Agreement, the Notes, this Agreement or the Collateral, except
any such losses, claims, liabilities, damages, penalties, suits, costs and expenses which result from the gross negligence or willful
misconduct of the Indemnitee as determined by a final, non-appealable decision of a court of competent jurisdiction. This indemnification
provision is in addition to, and not in limitation of, any other indemnification provision in the Notes, the Purchase Agreement or any
other agreement, instrument or other document executed or delivered in connection herewith or therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Nothing in this Agreement shall be construed to subject Collateral Agent or any Secured Party to liability as a fiduciary, joint-venturer,
agent or partner in any Debtor or any if its direct or indirect subsidiaries that is a partnership or as a member or manager in any Debtor
or any of its direct or indirect subsidiaries that is a limited liability company, nor shall Collateral Agent or any Secured Party be
deemed to have assumed any obligations under any partnership agreement or limited liability company agreement, as applicable, of any
Debtor or any of its direct or indirect subsidiaries or otherwise, unless and until any such Secured Party exercises its right to be
substituted for Debtor as a partner or member, as applicable, pursuant hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
To the extent that the grant of the security interest in the Collateral and the enforcement of the terms hereof require the consent,
approval or action of any partner or member, as applicable, of any Debtor or any direct or indirect subsidiary of any Debtor or compliance
with any provisions of any of the Organizational Documents, the Debtor hereby grants such consent and approval and waives any such noncompliance
with the terms of said documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
Debtor further agrees that, if any payment made by the Company or other Person and applied to the Obligations is at any time annulled,
avoided, set aside, rescinded, invalidated, declared to be fraudulent or preferential or otherwise required to be refunded or repaid,
or the proceeds of Collateral are required to be returned by any Secured Party to the Company, its estate, trustee, receiver or any other
Person, including any Debtor, under any bankruptcy law, state or federal law, common law or equitable cause, then, to the extent of such
payment or repayment, any lien or other Collateral securing such liability shall be and remain in full force and effect, as fully as
if such payment had never been made or, if prior thereto the lien granted hereby or other Collateral securing such liability hereunder
shall have been released or terminated by virtue of such cancellation or surrender, such lien or other Collateral shall be reinstated
in full force and effect, and such prior cancellation or surrender shall not diminish, release, discharge, impair or otherwise affect
any lien or other Collateral securing the obligations of any debtor in respect of the amount of such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>Signature
Page Follows</I>)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties hereto have caused this Security Agreement to be duly executed on the day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 22pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEURAXIS,
    INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian
    Carrico</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[SIGNATURE
PAGE OF HOLDERS FOLLOWS]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>APPENDIX
D</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE
PAGE OF HOLDERS OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>10%
ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE NOTES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing entity</I>: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing entity</I>: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">DA-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.35
<SEQUENCE>12
<FILENAME>ex10-35.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.35</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>APPENDIX
<FONT STYLE="letter-spacing: -0.2pt">E</FONT></U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF REGISTRATION RIGHTS AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
REGISTRATION RIGHTS AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;), dated as of February ___, 2023 (this &ldquo;<B>Agreement</B>&rdquo;),
is by and among Neuraxis, Inc., a Delaware corporation (&ldquo;<B>Company</B>&rdquo;), and each of the investors listed on the signature
pages hereto under the caption &ldquo;<B>Investors</B>&rdquo; (collectively, &ldquo;<B>Investors</B>&rdquo;). Except as otherwise specified
herein or in the Purchase Agreement (defined below), all capitalized terms used in this Agreement are defined in <U>Exhibit B</U> attached
hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company and the Investors are parties to that Securities Purchase Agreement dated as of February ___, 2023 (&ldquo;<B>Purchase Agreement</B>&rdquo;)
pursuant to which the Investors have loaned funds to the Company in exchange for the Company&rsquo;s senior secured convertible notes
reflecting a 10% original issue discount in the aggregate original principal amount of up to $6,666,666.67 (collectively, the &ldquo;<B>Notes</B>&rdquo;)
and Warrants (as such terms are defined in the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
As an inducement for the Investors to purchase the Notes and Warrants, the Company has agreed to register the Registrable Securities
(as defined below) pursuant to the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties to this Agreement hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
1 </B><U>Piggyback Registrations.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Right to Piggyback.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Whenever the Company is required or proposes to register any of its equity securities under the Securities Act (including primary and
secondary registrations, and other than pursuant to an Excluded Registration) (&ldquo;<B>Piggyback Registration</B>&rdquo;), the Company
will give at least fifteen (15) days prior written notice to all Holders of its intention to effect such Piggyback Registration and,
subject to the terms of Section 1(b), will include in such Piggyback Registration (and in all related registrations or qualifications
under blue sky laws and in any related underwriting) all Registrable Securities with respect to which the Company has received written
requests for inclusion therein within ten (10) days after delivery of the Company&rsquo;s notice. Such written requests for inclusion
will inform the Company of the number of Registrable Securities such Holder wishes to include in such registration statement. If a Holder
decides not to include all of its Registrable Securities in any registration statement thereafter filed by the Company, such Holder will
nevertheless continue to have the right to include any Registrable Securities in any subsequent registration statement or registration
statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein.
Any Participating Investors may withdraw its request for inclusion at any time prior to executing the underwriting agreement, or if none,
prior to the applicable registration statement becoming effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(ii)
If a registration statement under which the Company gives notice under this section 1 is for an underwritten offering, then the Company
will so advise the Holders of Registrable Securities. In such event, the right of any such Holder&rsquo;s Registrable Securities to be
included in a registration pursuant to this section 1 will be conditioned upon such Holder&rsquo;s participation in such underwriting
and the inclusion of such Holder&rsquo;s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing
to distribute their Registrable Securities through such underwriting will enter into an underwriting agreement in customary form with
the managing underwriter or underwriter(s) selected for such underwriting. If any Holder disapproves of the terms of any such underwriting,
such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter, delivered at least five (5) Business
Days prior to the effective date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting
will be excluded and withdrawn from the registration but are eligible for a future registration. For any Holder which is a partnership
or corporation, the partners, retired partners and shareholders of such Holder, or the estates and Family Group of any such partners
and retired partners and any trusts for the benefit of any of the foregoing persons will be deemed to be a single &lsquo;Holder,&rsquo;
and any pro rata reduction with respect to such &lsquo;Holder&rsquo; will be based upon the aggregate amount of shares carrying registration
rights owned by all entities and individuals included in such &lsquo;Holder,&rsquo; as defined in this sentence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="text-decoration: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Priority on Primary Registrations. </U>If a Piggyback Registration is an underwritten primary registration on behalf of the Company,
and the managing underwriters advise the Company in writing that in their good faith opinion the number of securities requested to be
included in such registration exceeds the number which can be sold in such offering without adversely affecting the marketability, proposed
offering price, timing or method of distribution of the offering, the Company will include in such registration: (i) first, the securities
the Company proposes to sell; (ii) second, any Registrable Securities requested to be included in such registration by any Investor which,
in the opinion of the underwriters, can be sold without any such adverse effect, <I>pro rata </I>among such Investors on the basis of
the number of Registrable Securities owned by each such Investor; and (iii) third, other securities requested to be included in such
registration which, in the opinion of the underwriters, can be sold without any such adverse effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Priority on Secondary Registrations</U>. If a Piggyback Registration is an underwritten secondary registration on behalf of holders
of the Company&rsquo;s equity securities and the managing underwriters advise the Company in writing that in their good faith opinion
the number of securities requested to be included in such registration exceeds the number which can be sold in such offering without
adversely affecting the marketability, proposed offering price, timing or method of distribution of the offering, the Company will include
in such registration: (i) <U>first</U>, the Registrable Securities requested to be included in such registration, <I>pro rata</I> among
the Participating Investors holding such Registrable Securities on the basis of the number of Registrable Securities owned by each such
Participating Investors which, in the opinion of the underwriters, can be sold without any such adverse effect; and (ii) <U>second</U>,
other securities requested to be included in such registration which, in the opinion of the underwriters, can be sold without any such
adverse effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Right to Terminate Registration</U>. The Company will have the right to terminate or withdraw any registration initiated by it under
this section 1, whether or not any holder of Registrable Securities has elected to include securities in such registration. The Company
shall give prompt written notice of such termination to all Participating Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Selection of Underwriters</U>. If any Piggyback Registration is an underwritten offering, the legal counsel for the Company, the investment
banker(s) and manager(s) for the offering shall be selected by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
2 </B><U>Stockholder Lock-Up Agreements.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with any underwritten Public Offering, each Holder will enter into any customary lock-up, holdback or similar agreements requested
by the underwriter(s) managing such offering, in each case with such modifications and exceptions as may be approved by the Investors.
Without limiting the generality of the foregoing, each Holder hereby agrees that in connection with any Piggyback Registration that is
an underwritten Public Offering, not to: (i) offer, sell, contract to sell, pledge or otherwise dispose of (including sales pursuant
to Rule 144), directly or indirectly, any equity securities of the Company (including equity securities of the Company that may be deemed
to be beneficially owned by such Holder in accordance with the rules and regulations of the SEC) (collectively, &ldquo;<B>Securities</B>&rdquo;),
or any securities, options or rights convertible into or exchangeable or exercisable for Securities (collectively, &ldquo;<B>Other Securities</B>&rdquo;);
(ii) enter into a transaction which would have the same effect as described in clause (i) above; (iii) enter into any swap, hedge or
other arrangement that transfers, in whole or in part, any of the economic consequences or ownership of any Securities or Other Securities,
whether such transaction is to be settled by delivery of such Securities or Other Securities, in cash or otherwise (each of (i), (ii)
and (iii) above, a &ldquo;<B>Sale Transaction</B>&rdquo;); or (iv) publicly disclose the intention to enter into any Sale Transaction,
commencing on the date on which the Company gives notice to the Holders that a preliminary prospectus has been circulated for such underwritten
Public Offering or the &lsquo;pricing&rsquo; of such offering and continuing to the date that is 180 days following the date of the final
prospectus in the case of any other such underwritten Public Offering (such period, or such shorter period as agreed to by the managing
underwriters, a &ldquo;<B>Holdback Period</B>&rdquo;); provided, however, that all executive officers and directors of the Company then
holding Common Stock of the Company shall enter into similar agreements. The Company may impose stop-transfer instructions with respect
to any Securities or Other Securities subject to the restrictions set forth in this section 2 until the end of such Holdback Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
3 </B><U>Registration Procedures.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Company Obligations.</U> If and whenever the Company causes the registration of any of its equity securities under the Securities
Act (including primary and secondary registrations, and other than pursuant to an Excluded Registration) as provided in this Agreement,
the Company will use its best efforts to effect the registration and the sale of such Registrable Securities in accordance with the intended
method of disposition thereof, and pursuant thereto the Company will as expeditiously as possible:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
prepare and file with (or submit confidentially to) the SEC a registration statement, and all amendments and supplements thereto and
related prospectuses, with respect to such Registrable Securities and use its best efforts to cause such registration statement to become
effective, all in accordance with the Securities Act and all applicable rules and regulations promulgated thereunder (provided that before
filing or confidentially submitting a registration statement or prospectus or any amendments or supplements thereto, the Company will
furnish to the counsel selected by the Investors covered by such registration statement copies of all such documents proposed to be filed
or submitted, which documents will be subject to the review and comment of such counsel);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection therewith
as may be necessary to keep such registration statement effective for a period ending when all of the securities covered by such registration
statement have been disposed of in accordance with the intended methods of distribution by the sellers thereof set forth in such registration
statement (but not in any event before the expiration of any longer period required under the Securities Act or, if such registration
statement relates to an underwritten Public Offering, such longer period as in the opinion of counsel for the underwriters a prospectus
is required by law to be delivered in connection with the sale of Registrable Securities by an underwriter or dealer) and comply with
the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement during
such period in accordance with the intended methods of disposition by the sellers thereof set forth in such registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
furnish, without charge, to each seller of Registrable Securities thereunder and each underwriter, if any, such number of copies of such
registration statement, each amendment and supplement thereto, the prospectus included in such registration statement (including each
preliminary prospectus) (in each case including all exhibits and documents incorporated by reference therein), each amendment and supplement
thereto, each Free Writing Prospectus and such other documents as such seller or underwriter, if any, may reasonably request in order
to facilitate the disposition of the Registrable Securities owned by such seller (the Company hereby consenting to the use in accordance
with all applicable laws of each such registration statement, each such amendment and supplement thereto, and each such prospectus (or
preliminary prospectus or supplement thereto) or Free Writing Prospectus by each such seller of Registrable Securities and the underwriters,
if any, in connection with the offering and sale of the Registrable Securities covered by such registration statement or prospectus);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
use its best efforts to register or qualify such Registrable Securities under such other securities or blue sky laws of such jurisdictions
as any seller reasonably requests and do any and all other acts and things which may be reasonably necessary or advisable to enable such
seller to consummate the disposition in such jurisdictions of the Registrable Securities owned by such seller (<U>provided</U> that the
Company will not be required to: (A) qualify generally to do business in any jurisdiction where it would not otherwise be required to
qualify but for this subparagraph; (B) consent to general service of process in any such jurisdiction; or (C) subject itself to taxation
in any such jurisdiction);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
notify in writing each seller of such Registrable Securities: (A) promptly after it receives notice thereof, of the date and time when
such registration statement and each post-effective amendment thereto has become effective or a prospectus or supplement to any prospectus
relating to a registration statement has been filed and when any registration or qualification has become effective under a state securities
or blue sky law or any exemption thereunder has been obtained; (B) promptly after receipt thereof, of any request by the SEC for the
amendment or supplementing of such registration statement or prospectus or for additional information; and (C) at any time when a prospectus
relating thereto is required to be delivered under the Securities Act, of the happening of any event or of any information or circumstances
as a result of which the prospectus included in such registration statement contains an untrue statement of a material fact or omits
any fact necessary to make the statements therein not misleading, and, if required by applicable law or to the extent requested by the
Investors, the Company will use its best efforts to promptly prepare and file a supplement or amendment to such prospectus so that, as
thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain an untrue statement of a material
fact or omit to state any fact necessary to make the statements therein not misleading; and (D) if at any time the representations and
warranties of the Company in any underwriting agreement, securities sale agreement, or other similar agreement, relating to the offering
shall cease to be true and correct;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
use its best efforts to provide a transfer agent and registrar for all such Registrable Securities not later than the effective date
of such registration statement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
enter into and perform such customary agreements (including, as applicable, underwriting agreements in customary form) and take all such
other actions as the Investors or the underwriters, if any, reasonably request in order to expedite or facilitate the disposition of
such Registrable Securities (including, without limitation, making available the executive officers of the Company and participating
in &lsquo;road shows&rsquo;, investor presentations, marketing events and other selling efforts and effecting a stock or unit split or
combination, recapitalization or reorganization);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
make available for inspection by any seller of Registrable Securities, any underwriter participating in any disposition or sale pursuant
to such registration statement and any attorney, accountant or other agent retained by any such seller or underwriter, all financial
and other records, pertinent corporate and business documents and properties of the Company as will be necessary to enable them to exercise
their due diligence responsibility, and cause the Company&rsquo;s officers, directors, employees, agents, representatives and independent
accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant or agent in connection
with such registration statement and the disposition of such Registrable Securities pursuant thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
take all actions to ensure that any prospectus utilized in connection with any Piggyback Registration hereunder complies in all material
respects with the Securities Act, is filed in accordance with the Securities Act to the extent required thereby, is retained in accordance
with the Securities Act to the extent required thereby and, when taken together with the related prospectus, prospectus supplement and
related documents, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
otherwise use its best efforts to comply with all applicable rules and regulations of the SEC, and make available to its security holders,
as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first
day of the Company&rsquo;s first full calendar quarter after the effective date of the registration statement, which earnings statement
will satisfy the provisions of section 11(a) of the Securities Act and Rule 158 thereunder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)
use its reasonable best efforts to cause such Registrable Securities covered by such registration statement to be registered with or
approved by such other governmental agencies or authorities as may be necessary to enable the sellers thereof to consummate the disposition
of such Registrable Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)
if requested by any managing underwriter, include in any prospectus or prospectus supplement updated financial or business information
for the Company&rsquo;s most recent period or current quarterly period (including estimated results or ranges of results) if required
for purposes of marketing the offering in the view of the managing underwriter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)
take no direct or indirect action prohibited by Regulation M under the Exchange Act; <U>provided</U>, <U>however</U>, that to the extent
that any prohibition is applicable to the Company, the Company will take such action as is necessary to make any such prohibition inapplicable;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)
use its best efforts to provide: (A) a legal opinion of the Company&rsquo;s outside counsel, dated the effective date of such registration
statement addressed to the Company; and (B) on the date that such Registrable Securities are delivered to the underwriters for sale in
connection with a Piggy-Back Registration, if such securities are being sold through underwriters, or, if such securities are not being
sold through underwriters, on the closing date of the applicable sale, (1) one or more legal opinions of the Company&rsquo;s outside
counsel, dated such date, in form and substance as customarily given to underwriters in an underwritten public offering or, in the case
of a non-underwritten offering, to the broker, placement agent or other agent of the Holders assisting in the sale of the Registrable
Securities, and (2) one or more &lsquo;negative assurances letters&rsquo; of the Company&rsquo;s outside counsel, dated such date, in
form and substance as is customarily given to underwriters in an underwritten public offering or, in the case of a non-underwritten offering,
to the broker, placement agent or other agent of the Holders assisting in the sale of the Registrable Securities, in each case, addressed
to the underwriters, if any, or, if requested, in the case of a non-underwritten offering, to the broker, placement agent or other agent
of the Holders assisting in the sale of the Registrable Securities, (3) a &lsquo;comfort&rsquo; letter dated as of such date, from the
independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public
accountants to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders requesting
registration, or, in the case of a non-underwritten offering, to the broker, placement agent or other agent of the Holders assisting
in the sale of the Registrable Securities, in each case, addressed to the underwriters, if any, or, if requested, in the case of a non-underwritten
offering, to the broker, placement agent or other agent of the Holders assisting in the sale of the Registrable Securities and to the
Holders, and (4) customary certificates executed by authorized officers of the Company as may be requested by any Holder or any underwriter
of such Registrable Securities;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Additional Information.</U> The Company may require each seller of Registrable Securities as to which any registration is being effected
to furnish the Company such information regarding such seller and the distribution of such securities as the Company may from time to
time reasonably request in writing, as a condition to such seller&rsquo;s participation in such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Other.</U> To the extent that any of the Investors are or may be deemed to be an &lsquo;underwriter&rsquo; of Registrable Securities
pursuant to any SEC comments or policies, the Company agrees that: (i) the indemnification and contribution provisions contained in section
5 shall be applicable to the benefit of such Investors in their role as an underwriter or deemed underwriter in addition to their capacity
as a Holder, and (ii) such Investors shall be entitled to conduct the due diligence which they would normally conduct in connection with
an offering of securities registered under the Securities Act, including without limitation receipt of customary opinions and comfort
letters addressed to such Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
4 </B><U>Registration Expenses.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as expressly provided herein, all out-of-pocket expenses incurred by the Company or any Investors in connection with the performance
of or compliance with this Agreement and/or in connection with any Piggyback Registration, whether or not the same shall become effective,
shall be paid by the Company, including, without limitation: (i) all registration and filing fees, and any other fees and expenses associated
with filings required to be made with the SEC or FINRA; (ii) all fees and expenses in connection with compliance with any securities
or &lsquo;blue sky&rsquo; laws; (iii) all printing, duplicating, word processing, messenger, telephone, facsimile and delivery expenses
(including expenses of printing certificates for the Registrable Securities in a form eligible for deposit with The Depository Trust
Company or other depositary and of printing prospectuses and Company Free Writing Prospectuses); (iv) all fees and disbursements of all
independent certified public accountants of the Company (including the expenses of any special audit and cold comfort letters required
by or incident to such performance); (v) Securities Act liability insurance or similar insurance if the Company so desires or the underwriters
so require in accordance with then-customary underwriting practice; (vi) all fees and expenses incurred in connection with the listing
of the Registrable Securities on any securities exchange on which similar securities of the Company are then listed (or on which exchange
the Registrable Securities are proposed to be listed); (vii) all applicable rating agency fees with respect to the Registrable Securities;
(viii) all fees and disbursements of legal counsel for the Company; (ix) any fees and disbursements of underwriters customarily paid
by issuers or sellers of securities; (x) all fees and expenses of any special experts or other Persons retained by the Company in connection
with any Registration; (xi) all of the Company&rsquo;s internal expenses (including all salaries and expenses of its officers and employees
performing legal or accounting duties); and (xii) all expenses related to the &lsquo;road-show&rsquo; for any underwritten offering,
including all travel, meals and lodging. All such expenses are referred to herein as &ldquo;<B>Registration Expenses</B>.&rdquo; The
Company shall not be required to pay, and each Person that sells securities pursuant to a Piggyback Registration hereunder will bear
and pay, all underwriting discounts and commissions applicable to the Registrable Securities sold for such Person&rsquo;s account and
all transfer taxes (if any) attributable to the sale of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
5 </B><U>Indemnification and Contribution.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>By the Company</U>. The Company will indemnify and hold harmless, to the fullest extent permitted by law and without limitation as
to time, each Holder, such Holder&rsquo;s affiliates and their respective officers, directors employees, agents, fiduciaries, stockholders,
managers, partners, members, affiliates, direct and indirect equity holders, consultants and representatives, and any successors and
assigns thereof, and each Person who controls such Holder (within the meaning of the Securities Act or the Exchange Act) (&ldquo;<B>Indemnified
Parties</B>&rdquo;) against all losses, claims, actions, damages, liabilities and expenses (including with respect to actions or proceedings,
whether commenced or threatened, and including reasonable attorney fees and expenses) (collectively, &ldquo;<B>Losses</B>&rdquo;) caused
by, resulting from, arising out of, based upon or related to any of the following (each, a &ldquo;<B>Violation</B>&rdquo;) by the Company:
(i) any untrue or alleged untrue statement of material fact contained in: (A) any registration statement, prospectus, preliminary prospectus
or Free-Writing Prospectus, or any amendment thereof or supplement thereto, or (B) any application or other document or communication
(in this section 5, collectively called an &ldquo;<B><U>application</U></B>&rdquo;) executed by or on behalf of the Company or based
upon written information furnished by or on behalf of the Company filed in any jurisdiction in order to qualify any securities covered
by such registration under the &ldquo;<B>blue sky</B>&rdquo; or securities laws thereof; (ii) any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein not misleading; or (iii) any violation or alleged violation
by the Company of the Securities Act or any other similar federal or state securities laws or any rule or regulation promulgated thereunder
applicable to the Company and relating to action or inaction required of the Company in connection with any such registration, qualification
or compliance. In addition, the Company will reimburse such Indemnified Party for any legal or any other expenses reasonably incurred
by them in connection with investigating, defending or settling any such Losses. Notwithstanding the foregoing, the Company will not
be liable in any such case to the extent that any such Losses result from, arise out of, are based upon, or relate to an untrue statement,
or omission, made in such registration statement, any such prospectus, preliminary prospectus or any amendment or supplement thereto,
or in any application, in reliance upon, and in conformity with, written information prepared and furnished in writing to the Company
by such Indemnified Party expressly for use therein or by such Indemnified Party&rsquo;s failure to deliver a copy of the registration
statement or prospectus or any amendments or supplements thereto after the Company has furnished such Indemnified Party with a sufficient
number of copies of the same. In connection with an underwritten offering, the Company will indemnify such underwriters, their officers
and directors, and each Person who controls such underwriters (within the meaning of the Securities Act or the Exchange Act) to the same
extent as provided above with respect to the indemnification of the Indemnified Parties or as otherwise agreed to in the underwriting
agreement executed in connection with such underwritten offering. Such indemnity and reimbursement of expenses shall remain in full force
and effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of such securities
by such seller.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>By Holders.</U> In connection with any registration statement in which a Holder is participating, each such Holder will furnish to
the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such registration
statement or prospectus and, to the extent permitted by law, will indemnify the Company, its officers, directors, employees, agents and
representatives, and each Person who controls the Company (within the meaning of the Securities Act or the Exchange Act) against any
Losses resulting from (as determined by a final and non-appealable judgment, order or decree of a court of competent jurisdiction) any
untrue statement of material fact contained in the registration statement, prospectus or preliminary prospectus or any amendment thereof
or supplement thereto or any omission of a material fact required to be stated therein or necessary to make the statements therein not
misleading, but only to the extent that such untrue statement or omission is contained in any information or affidavit so furnished in
writing by such Holder expressly for use therein; provided that the obligation to indemnify will be individual, not joint and several,
and <I>pro-rata </I>based on the number of Registrable Shares included in such registration statement for each Holder and will be limited
to the net amount of proceeds received by such Holder from the sale of Registrable Securities pursuant to such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Claim Procedure.</U> Any Person entitled to indemnification hereunder will: (i) give prompt written notice to the indemnifying party
of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice will impair any Person&rsquo;s
right to indemnification hereunder only to the extent such failure has prejudiced the indemnifying party); and (ii) unless in such indemnified
party&rsquo;s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to
such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified
party. If such defense is assumed, the indemnifying party will not be subject to any liability for any settlement made by the indemnified
party without its consent (but such consent will not be unreasonably withheld, conditioned or delayed). An indemnifying party who is
not entitled to, or elects not to, assume the defense of a claim will not be obligated to pay the fees and expenses of more than one
counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified
party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such
claim or the indemnifying party. In such instance, the conflicted indemnified parties will have a right to retain one separate counsel,
chosen by the majority of the conflicted indemnified parties involved in the indemnification and approved by the Investors, at the expense
of the indemnifying party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution.</U> If the indemnification provided for in this section 5 is held by a court of competent jurisdiction to be unavailable
to, or is insufficient to hold harmless, an indemnified party or is otherwise unenforceable with respect to any Loss referred to herein,
then such indemnifying party will contribute to the amounts paid or payable by such indemnified party as a result of such Loss: (i) in
such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party
on the other hand in connection with the statements or omissions which resulted in such Loss as well as any other relevant equitable
considerations; or (ii) if the allocation provided by clause (i) of this Section 5(d) is not permitted by applicable law, then in such
proportion as is appropriate to reflect not only such relative fault but also the relative benefit of the Company on the one hand and
of the sellers of Registrable Securities and any other sellers participating in the registration statement on the other in connection
with the statement or omissions which resulted in such Losses, as well as any other relevant equitable considerations; provided that
the maximum amount of liability in respect of such contribution will be individual, not joint and several, and <I>pro-rata </I>based
on the number of Registrable Securities included in such registration statement for each Holder and shall be limited, in the case of
each seller of Registrable Securities, to an amount equal to the net proceeds actually received by such seller from the sale of Registrable
Securities effected pursuant to such registration. The relative fault of the indemnifying party and of the indemnified party will be
determined by reference to, among other things, whether the untrue (or, as applicable alleged) untrue statement of a material fact or
the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto
agree that it would not be just or equitable if the contribution pursuant to this Section 5(d) were to be determined by <I>pro rata </I>allocation
or by any other method of allocation that does not take into account such equitable considerations. The amount paid or payable by an
indemnified party as a result of the Losses referred to herein will be deemed to include any legal or other expenses reasonably incurred
by such indemnified party in connection with investigating or defending against any action or claim which is the subject hereof. No person
guilty of fraudulent misrepresentation (within the meaning of section 11(f) of the Securities Act) will be entitled to contribution from
any Person who is not guilty of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Release.</U> No indemnifying party will, except with the consent of the indemnified party, consent to the entry of any judgment or
enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified
party of a full and unconditional release from all liability in respect to such claim or litigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Non-exclusive Remedy; Survival.</U> The indemnification and contribution provided for under this Agreement will be in addition to
any other rights to indemnification or contribution that any indemnified party may have pursuant to law or contract (and the Company
and its Subsidiaries shall be considered the indemnitors of first resort in all such circumstances to which this section 5 applies) and
will remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director
or controlling Person of such indemnified party and will survive the transfer of Registrable Securities and the termination or expiration
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
6</B> <U>Cooperation with Underwritten Offerings</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Person may participate in any underwritten registration hereunder unless such Person: (i) agrees to sell such Person&rsquo;s securities
on the basis provided in any underwriting arrangements approved by the Person or Persons entitled hereunder to approve such arrangements
(including, without limitation, pursuant to the terms of any over-allotment or &lsquo;green shoe&rsquo; option requested by the underwriters;
provided that no Holder will be required to sell more than the number of Registrable Securities such Holder has requested to include
in such registration); and (ii) completes, executes and delivers all questionnaires, powers of attorney, stock powers, custody agreements,
indemnities, underwriting agreements and other documents and agreements required under the terms of such underwriting arrangements or
as may be reasonably requested by the Company and the lead managing underwriter(s). To the extent that any such agreement is entered
into pursuant to, and consistent with, section 2, section 3 and/or this section 6, the respective rights and obligations created under
such agreement will supersede the respective rights and obligations of the Holders, the Company and the underwriters created thereby
with respect to such registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
7</B> <U>Joinder.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investors or the Company may from time to time permit any Person who acquires Common Stock (or rights to acquire Common Stock) to become
a party to this Agreement and to be entitled to and be bound by all of the rights and obligations as a Holder by obtaining a Joinder.
Upon the execution and delivery of an executed joinder to this Agreement from such Person in the form of Exhibit A attached hereto (&ldquo;<B>Joinder</B>&rdquo;)
by such Person, the Common Stock held by such Person shall be considered to have Registrable Securities, and such Person shall be deemed
the category of Holder (i.e. Investors), in each case as set forth on the signature page to such Joinder. For the avoidance of doubt,
no Person shall be considered a Holder hereunder without execution of a Joinder and no assignment shall otherwise be permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
8</B> <U>General Provisions.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Amendments and Waivers.</U> Except as otherwise provided herein, the provisions of this Agreement may be amended, modified or waived
only with the prior written consent of the Company and the Investors holding shares of Registrable Securities representing a majority
of all Registrable Securities; provided that no such amendment, modification or waiver that would treat a specific Holder or group of
Holders of Registrable Securities (i.e., Other Investors) in a manner materially and adversely different than any other Holder or group
of Holders will be effective against such Holder or group of Holders without the consent of the holders of a majority of the Registrable
Securities that are held by the group of Holders that is materially and adversely affected thereby. The failure or delay of any Person
to enforce any of the provisions of this Agreement will in no way be construed as a waiver of such provisions and will not affect the
right of such Person thereafter to enforce each and every provision of this Agreement in accordance with its terms. A waiver or consent
to or of any breach or default by any Person in the performance by that Person of his, her or its obligations under this Agreement will
not be deemed to be a consent or waiver to or of any other breach or default in the performance by that Person of the same or any other
obligations of that Person under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Remedies</U>. The parties to this Agreement will be entitled to enforce their rights under this Agreement specifically (without posting
a bond or other security), to recover damages caused by reason of any breach of any provision of this Agreement and to exercise all other
rights existing in their favor. The parties hereto agree and acknowledge that a breach of this Agreement would cause irreparable harm
and money damages would not be an adequate remedy for any such breach and that, in addition to any other rights and remedies existing
hereunder, any party will be entitled to seek specific performance and/or other injunctive relief from any court of law or equity of
competent jurisdiction (without posting any bond or other security) in order to enforce or prevent violation of the provisions of this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Severability</U>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Agreement is held to be prohibited, invalid, illegal or unenforceable in any respect
under any applicable law or regulation in any jurisdiction, such prohibition, invalidity, illegality or unenforceability will not affect
the validity, legality or enforceability of any other provision of this Agreement in such jurisdiction or in any other jurisdiction,
but this Agreement will be reformed, construed and enforced in such jurisdiction as if such prohibited, invalid, illegal or unenforceable
provision had never been contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Entire Agreement</U>. Except as otherwise provided herein, this Agreement contains the complete agreement and understanding among
the parties hereto with respect to the subject matter hereof and supersedes and preempts any prior understandings, agreements or representations
by or among the parties hereto, written or oral, which may have related to the subject matter hereof in any way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Successors and Assigns.</U> Except as otherwise provided herein, this Agreement shall bind and inure to the benefit and be enforceable
by the Company and its successors and permitted assigns and the Holders (including, specifically, the Investors) and their respective
successors and permitted assigns (whether so expressed or not).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notices. </U>Any notice, demand or other communication to be given under or by reason of the provisions of this Agreement will be
in writing and will be deemed to have been given: (i) when delivered personally to the recipient, (ii) when sent by confirmed electronic
mail or facsimile if sent during normal business hours of the recipient; but if not, then on the next Business Day, (iii) one Business
Day after it is sent to the recipient by reputable overnight courier service (charges prepaid) or (iv) four Business Days after it is
mailed to the recipient by first class mail, return receipt requested. Such notices, demands and other communications will be sent to
the Company at the address specified on the signature page hereto or any Joinder and to any Holder, or at such address or to the attention
of such other Person as the recipient party has specified by prior written notice to the sending party. Any party may change such party&rsquo;s
address for receipt of notice by giving prior written notice of the change to the sending party as provided herein. The Company&rsquo;s
address is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuraxis,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">829
S Adams St.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Versailles,
IN 47042</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Brian Carrico, CEO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Business Days.</U> If any time period for giving notice or taking action hereunder expires on a day that is not a Business Day, the
time period will automatically be extended to the Business Day immediately following such Saturday, Sunday or legal holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Governing Law.</U> All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>No Recourse.</U> Notwithstanding anything to the contrary in this Agreement, the Company and each Holder agrees and acknowledges that
no recourse under this Agreement or any documents or instruments delivered in connection with this Agreement, will be had against any
current or future director, officer, employee, general or limited partner or member of any Holder or any Affiliate or assignee thereof,
whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation or other
applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever will attach to, be imposed on or otherwise
be incurred by any current or future officer, agent or employee of any Holder or any current or future member of any Holder or any current
or future director, officer, employee, partner or member of any Holder or of any Affiliate or assignee thereof, as such for any obligation
of any Holder under this Agreement or any documents or instruments delivered in connection with this Agreement for any claim based on,
in respect of or by reason of such obligations or their creation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Descriptive Headings; Interpretation.</U> The descriptive headings of this Agreement are inserted for convenience only and do not
constitute a part of this Agreement. The use of the word &lsquo;including&rsquo; in this Agreement will be by way of example rather than
by limitation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>No Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties hereto to
express their mutual intent, and no rule of strict construction will be applied against any party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Counterparts.</U> This Agreement may be executed in multiple counterparts, any one of which need not contain the signature of more
than one party, but all such counterparts taken together will constitute one and the same agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Electronic Delivery.</U> This Agreement, the agreements referred to herein, and each other agreement or instrument entered into in
connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent executed and
delivered by means of a photographic, photostatic, facsimile or similar reproduction of such signed writing using a facsimile machine
or electronic mail will be treated in all manner and respects as an original agreement or instrument and will be considered to have the
same binding legal effect as if it were the original signed version thereof delivered in person. No party hereto or to any such agreement
or instrument will raise the use of a facsimile machine or electronic mail to deliver a signature or the fact that any signature or agreement
or instrument was transmitted or communicated through the use of a facsimile machine or electronic mail as a defense to the formation
or enforceability of a contract and each such party forever waives any such defense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Further Assurances.</U> In connection with this Agreement and the transactions contemplated hereby, each Holder agrees to execute
and deliver any additional documents and instruments and perform any additional acts that may be necessary or appropriate to effectuate
and perform the provisions of this Agreement and the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Dividends, Recapitalizations, Etc.</U> If at any time or from time to time there is any change in the capital structure of the Company
by way of a stock split, stock dividend, combination or reclassification, or through a merger, consolidation, reorganization or recapitalization,
or by any other means, appropriate adjustment will be made in the provisions hereof so that the rights and privileges granted hereby
will continue.</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>No Third-Party Beneficiaries.</U> No term or provision of this Agreement is intended to be, or shall be, for the benefit of any Person
not a party hereto, and no such other Person shall have any right or cause of action hereunder, except as otherwise expressly provided
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Current Public Information.</U> At all times after the Company has filed a registration statement with the SEC pursuant to the requirements
of either the Securities Act or the Exchange Act, the Company will file all reports required to be filed by it under the Securities Act
and the Exchange Act and will take such further action as the Investors may reasonably request, all to the extent required to enable
such Holders to sell Registrable Securities pursuant to Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Costs and Attorneys&rsquo; Fees</U>. In the event any action, suit or other proceeding is instituted concerning or arising out of
this Agreement or any transaction contemplated hereunder, the prevailing party will recover all of such party&rsquo;s costs and attorneys&rsquo;
fees incurred in each such action, suit or other proceeding, including any and all appeals or petitions therefrom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>APPENDIX
E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEURAXIS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt">Brian Carrico<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
</FONT></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt">Chief Executive Officer<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE OF HOLDERS FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">EA-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B><I>APPENDIX
E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>[SIGNATURE
PAGE OF HOLDERS]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Holder: </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;__________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Holder</I>: </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>___________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________ &nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory: __________________________</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">EA-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>APPENDIX
E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
B</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFINITIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used in this Agreement have the meanings set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
of any Person means any other Person controlled by, controlling or under common control with such Person and, in the case of an individual,
also includes any member of such individual&rsquo;s Family Group. As used in this definition, &lsquo;control&rsquo; (including, with
its correlative meanings, &lsquo;controlling&rsquo;, &lsquo;controlled by&rsquo; and &lsquo;under common control with&rsquo;) will mean
possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of
securities, by contract or otherwise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Agreement</U>&rdquo;
has the meaning set forth in the first paragraph of this document on page 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means a day that is not a Saturday or Sunday or a day on which banks in New York City are authorized or requested by law
to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Company&rsquo;s common stock, without par value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company</U>&rdquo;
has the meaning set forth in the first paragraph of this Agreement and shall include its successor(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended from time to time, or any successor federal law then in force, together
with all rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Excluded
Registration</U>&rdquo; means any registration of equity securities of the Company solely for a Company sponsored employee benefit plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Family
Group</U>&rdquo; means with respect to any individual, such individual&rsquo;s current or former spouse, their respective parents, descendants
of such parents (whether natural or adopted) and the spouses of such descendants, any trust, limited partnership, corporation or limited
liability company established solely for the benefit of such individual or such individual&rsquo;s current or former spouse, their respective
parents, descendants of such parents (whether natural or adopted) or the spouses of such descendants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FINRA</U>&rdquo;
means the Financial Industry Regulatory Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Free
Writing Prospectus</U>&rdquo; means a free-writing prospectus, as defined in Rule 405.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holdback
Period</U>&rdquo; has the meaning set forth in section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
means a holder of Registrable Securities who is a party to this Agreement (including by way of Joinder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Parties</U>&rdquo; has the meaning set forth in <U>Section 5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Investors</U>&rdquo;
has the meaning set forth in the first paragraph of this Agreement. recitals. Any decision to be made under this Agreement by the Investors
shall be made by the Investors holding a majority of the Registrable Securities held by the Investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Joinder</U>&rdquo;
has the meaning set forth in section 7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
has the meaning set forth in <U>Section 5(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">EB-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>APPENDIX
E</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Other
Investors</U>&rdquo; has the meaning set forth in section 8(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Participating
Investors</U>&rdquo; means any Investors participating in the request for a Piggyback Registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint
venture, an unincorporated organization and a governmental entity or any department, agency or political subdivision thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Piggyback
Registrations</U>&rdquo; has the meaning set forth in Section 1(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Offering</U>&rdquo; means any sale or distribution by the Company, one of its Subsidiaries and/or Holders to the public of Common Stock
or other securities convertible into or exchangeable for Common Stock pursuant to an offering registered under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Conversion Shares (assuming on such date the Notes are converted
in full without regard to any exercise limitations therein), (b) all Warrant Shares (assuming on such date the Warrants and any Default
Contingency Warrants are exercised in full without regard to any exercise limitations therein), (c) any additional shares of Common Stock
issued and issuable in connection with any anti-dilution provisions in the Notes or Warrants (if any) (assuming on such date that the
Notes and Warrants are converted or exercised in full without regard to any exercise limitations therein), and (d) any securities issued
or then issuable upon any share split, dividend or other distribution, recapitalization or similar event with respect to the foregoing;
<I>provided, however,</I> that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be
required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as:
(i) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the
Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration Statement,
(ii) such Registrable Securities have been previously sold in accordance with Rule 144, or (iii) such securities become eligible for
resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written
opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming that such
securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were
issued or are issuable, were at no time held by any Affiliate of the Company, as reasonably determined by the Company, upon the advice
of counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Expenses</U>&rdquo; has the meaning set forth in section 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo;, &ldquo;<U>Rule 158</U>&rdquo;, and &ldquo;<U>Rule 405</U>&rdquo;, mean, in each case, such rule promulgated under the
Securities Act (or any successor provision) by the SEC, as the same will be amended from time to time, or any successor rule then in
force.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Sale
Transaction</U>&rdquo; has the meaning set forth in section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended from time to time, or any successor federal law then in force, together with
all rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means, with respect to the Company, any corporation, limited liability company, partnership, association or other business entity of
which: (i) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any
contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly,
by the Company or one or more of the other Subsidiaries of the Company or a combination thereof, or (ii) if a limited liability company,
partnership, association or other business entity, a majority of the limited liability company, partnership or other similar ownership
interest thereof is at the time owned or controlled, directly or indirectly, by the Company or one or more Subsidiaries of the Company
or a combination thereof. For purposes hereof, a Person or Persons will be deemed to have a majority ownership interest in a limited
liability company, partnership, association or other business entity if such Person or Persons will be allocated a majority of limited
liability company, partnership, association or other business entity gains or losses or will be or control the managing director or general
partner of such limited liability company, partnership, association or other business entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Violation</U>&rdquo;
has the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">EB-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>13
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in this Registration Statement of Neuraxis, Inc. on Form S-1/A of our report dated June 1, 2023, with
respect to our audits of the financial statements of Neuraxis, Inc. as of December 31, 2022 and 2021 and for each of the two years in
the period ended December 31, 2022, which report appears in the Prospectus, which is part of this Registration Statement. Our report
includes an explanatory paragraph as to Neuraxis, Inc.&rsquo;s ability to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to our Firm under the heading &ldquo;Experts&rdquo; in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Rosenberg Rich Baker Berman, P.A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Somerset,
New Jersey</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
1,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2023</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>14
<FILENAME>ex99-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit 99.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><U>Neuraxis,
Inc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Charter
of the Audit Committee of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
                                            Committee Purpose</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Audit Committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board of Directors (the &ldquo;<B>Board</B>&rdquo;) of Neuraxis,
Inc. (the &ldquo;<B>Company</B>&rdquo;) is to oversee the processes of accounting and financial reporting of the Company and the audits
and financial statements of the Company. The Committee&rsquo;s primary duties and responsibilities are to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitor
                                            the integrity of the Company&rsquo;s financial reporting process and systems of internal
                                            controls regarding finance, accounting and legal compliance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitor
                                            the independence and performance of the Company&rsquo;s independent auditors and the Company&rsquo;s
                                            accounting personnel.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                            an avenue of communication among the independent auditors, management, the Company&rsquo;s
                                            accounting personnel, and the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appoint
                                            and provide oversight for the independent auditors engaged to perform the audit of the financial
                                            statements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discuss
                                            the scope of the independent auditors&rsquo; examination.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            the financial statements and the independent auditors&rsquo; report.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            areas of potential significant financial risk to the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitor
                                            compliance with legal and regulatory requirements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solicit
                                            recommendations from the independent auditors regarding internal controls and other matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Make
                                            recommendations to the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Resolve
                                            any disagreements between management and the auditors regarding financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepare
                                            the report required by Item 407(d) of Regulation S-K, as required by the rules of the Securities
                                            and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">M.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Perform
                                            other related tasks as requested by the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
committee has the authority to conduct any investigation appropriate to fulfilling its responsibilities, and it has direct access to
the independent auditors as well as anyone in the organization. The Committee has the ability to retain, at the Company&rsquo;s expense,
special legal, accounting, or other consultants or experts it deems necessary in the performance of its duties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit Committee Composition and Meetings</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall be compromised of three or more directors as determined by the Board. Each
                                            member must be independent of the management of the Company and are free of any relationship
                                            that, in the opinion of the Board, would interfere with their exercise of independent judgment
                                            as a Committee member. Further, each member of the Committee shall meet the independence
                                            and experience requirements of the listing rules of any securities exchange or association
                                            in which the Company&rsquo;s securities are traded and the rules and regulations of the SEC,
                                            including Rule 10A-3. All members of the Committee shall have a basic understanding of finance
                                            and accounting and be able to read and understand fundamental financial statements, including
                                            a company&rsquo;s balance sheet, income statement, and cash flow statement. At least one
                                            member of the Committee must have past employment experience in finance or accounting, professional
                                            certification in accounting, or any other comparable experience or background that results
                                            in the member&rsquo;s financial sophistication, including being or having been a Chief Executive
                                            Officer (&ldquo;<B>CEO</B>&rdquo;) or Chief Financial Officer (&ldquo;<B>CFO</B>&rdquo;)
                                            or other senior officer with financial oversight responsibilities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 31.5pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committee
                                            members shall be appointed by the Board after due consideration of recommendations of the
                                            Nominating and Corporate Governance Committee, and the Board may designate a Chair of the
                                            Committee. If an Audit Committee Chair is not designated or present, the members of the Committee
                                            may designate a Chair by majority vote of the Committee membership. The Board may, at any
                                            time and at its complete discretion, replace a Committee member.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committee
                                            members shall meet (either in person or telephonically) at least four times each fiscal year
                                            and more often if the Committee, at its discretion, deems this desirable. The Committee shall
                                            meet, at its discretion, with management, the Company&rsquo;s principal accounting officer,
                                            the independent auditors, and as a committee to discuss any matters that the Committee or
                                            each of these groups believes should be discussed. The Committee may request any officer
                                            or employee of the Company or the Company&rsquo;s outside counsel or independent auditors
                                            to attend a meeting of the Committee or to meet with any members of, or consultants to, the
                                            Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
                                            Committee Responsibilities and Duties</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Review
Procedures</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            the Company&rsquo;s annual audited financial statements prior to distribution. Review should
                                            include discussion with management and independent auditors of significant issues regarding
                                            accounting principles, practices, and judgments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            consultation with the management, the independent auditors, and the Company&rsquo;s principal
                                            accounting officer, consider the integrity of the Company&rsquo;s financial reporting processes
                                            and controls, including any major issues as to the adequacy of the Company&rsquo;s internal
                                            controls, and any special steps adopted in light of any identified material control deficiencies.
                                            Discuss significant financial risk exposures and the steps management has taken to monitor,
                                            control, and report such exposures. Review significant findings prepared by the independent
                                            auditors and the Company&rsquo;s principal accounting officer together with management&rsquo;s
                                            responses.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall review with the management and the independent auditors any correspondence
                                            with regulators and any published reports that raise material issues regarding the Company&rsquo;s
                                            accounting policies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Independent
Auditors</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall have the sole authority to appoint or replace the independent auditor. The
                                            Committee shall be directly responsible for the compensation and oversight of the work of
                                            the independent auditor (including resolutions of disagreements between management and the
                                            independent auditor regarding final reporting) for the purpose of preparing or issuing an
                                            audit report or related work. The independent auditor shall report directly to the Committee.
                                            The Committee shall approve in advance the provision by the independent auditors of all services
                                            to the Company whether or not related to the audit. However, neither the Committee nor any
                                            person with authority delegated from the Committee may approve an auditor providing the services
                                            that are described in Section 10A(g) of the Securities Exchange Act of 1934 (the &ldquo;<B>Exchange
                                            Act</B>&rdquo;) as &ldquo;prohibited activities.&rdquo;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall obtain, review and discuss reports from the independent auditor regarding
                                            (1) all critical accounting policies and practices to be used; (2) all alternative treatments
                                            of financial information within generally accepted accounting principles that have been discussed
                                            with management officials of the Company, ramifications of the use of these alternative disclosures
                                            and treatments, and the treatment preferred by the independent auditor and the reasons for
                                            favoring that treatment; and (3) other material written communications between the independent
                                            auditor and Company management, such as any management letter or schedule of unadjusted differences.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall assure the regular rotation of the lead audit partner as required by Section
                                            10A(j) of the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall assure that hiring policies for employees or former employees of the independent
                                            auditor are consistent with Section 10A(l) of the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall discuss with the independent auditor and then disclose the matters required
                                            to be discussed and disclosed by applicable accounting and auditing guidance, including any
                                            difficulties the independent auditor encountered in the course of the audit work, any restrictions
                                            on the scope of the independent auditor&rsquo;s activities or on access to requested information,
                                            and any significant disagreements with management.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall ascertain annually from the independent auditor whether the Company has issues
                                            under Section 10A(b) of the Exchange Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall determine the independence of the auditors and receive from the independent
                                            auditors a formal written statement delineating all relationships between the auditor and
                                            the company (consistent with PCAOB Independence Standards Board Standard 1 or any other applicable
                                            standards), and thereafter actively engaging in a dialogue with the auditor with respect
                                            to any disclosed relationships or services that may impact the objectivity and independence
                                            of the auditor and for taking, or recommending that the full Board take, appropriate action
                                            to oversee the independence of the outside auditor.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Accounting
Department and Legal Compliance</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            the personnel activities and qualifications of the Company&rsquo;s accounting personnel,
                                            as needed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            the appointment and performance of the principal accounting officer, and review financial
                                            and accounting personnel succession planning with the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            significant reports prepared by the Company&rsquo;s principal accounting officer together
                                            with management&rsquo;s response and follow-up to these reports.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            at least an annual basis, review with the Company&rsquo;s counsel any legal matters that
                                            could have a significant impact on the Company&rsquo;s financial statements, the Company&rsquo;s
                                            compliance with applicable laws and regulations, and inquiries received from regulators or
                                            governmental agencies.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
                                            procedures for the receipt, retention and treatment of complaints received by the Company
                                            regarding accounting, internal accounting controls or auditing matters and the confidential,
                                            anonymous submission by employees of the Company of concerns regarding questionable accounting
                                            or auditing matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall review the CEO and CFO&rsquo;s disclosure and certifications under Sections
                                            302 and 906 of the Sarbanes-Oxley Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                            an appropriate review of and approve all related party transactions on an ongoing basis and
                                            the Committee shall review potential conflict of interest situations where appropriate.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conduct
                                            an annual risk review with respect to the matters within the role and the responsibilities
                                            of the Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
                                            regularly to the Board on its activities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain
                                            minutes of its meetings and records relating to those meetings and the Committee&rsquo;s
                                            activities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                            authority to obtain, at the expense of the Company, advice and assistance from internal or
                                            external legal, consulting or other advisors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
                                            and delegate authority to subcommittees of one or more Committee members when desired and
                                            appropriate;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            and reassess the adequacy of this Charter annually and recommend to the Board any proposed
                                            changes to this Charter; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodically
                                            review the Committee&rsquo;s own performance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>General</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
performing their responsibilities, Committee members are entitled to rely in good faith on information, opinions, reports or statements
prepared or presented by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
                                            of more officers or employees of the Company whom the Committee member reasonably believes
                                            to be reliable and competent in the matters presented;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counsel,
                                            independent auditors, or other persons as to matters which the Committee member reasonably
                                            believes to be within the professional or expert competence of such person; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            committees of the Board as to matters within their respective designated authority which
                                            the Committee member reasonably believes to merit confidence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee has the powers and responsibilities delineated in this Charter. It is not, however, the Committee&rsquo;s responsibility to
prepare and certify the Company&rsquo;s financial statements, to guarantee the independent auditor&rsquo;s report, or to guarantee other
disclosures by the Company. These are fundamental responsibilities of management and the independent auditor. Committee members are not
full-time Company employees and are not performing the functions of auditors or accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>15
<FILENAME>ex99-5.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><U>Neuraxis,
Inc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Charter
of the Compensation Committee of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Authority
                                            and Composition</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board of Directors (the &ldquo;<B>Board</B>&rdquo;) of Neuraxis, Inc.
(the &ldquo;<B>Company</B>&rdquo;) is established pursuant to Article III of the Bylaws of the Company. Committee members are appointed
annually by the Board on the recommendation of the Nominating and Corporate Governance Committee, and may be replaced by the Board. The
Committee must consist of at least two directors, each of whom shall meet the independence requirements of the NASDAQ Corporate Governance
Rules (subject to any applicable transition periods or exceptions permitted under NASDAQ requirements) and the standards of independence
prescribed by NASDAQ and/or for purposes of any federal securities, tax or other laws relating to the Committee&rsquo;s duties and responsibilities,
including Section 162(m) of the Internal Revenue Code. Without limiting the foregoing, to be considered as independent, the Board will
consider all relevant factors, including (a) the source of compensation of the director, including any consulting, advisory or other
compensatory fee paid by, or on behalf of, the Company, and (b) whether the director is affiliated with the Company, any subsidiary of
the Company or any affiliate of a subsidiary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board shall appoint a Chairman of the Committee upon the recommendation of the Nominating and Corporate Governance Committee. The Committee
may also appoint a Secretary, who need not be a director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Charter may be amended only by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>II.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purposes
                                            of the Committee </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary purposes of the Committee are to: (i) develop recommendations for the Board with respect to the compensation of the Company&rsquo;s
Chief Executive Officer (the &ldquo;<B>CEO</B>&rdquo;) and non-employee directors; (ii) discharge the responsibilities of the Board relating
to the approval of the compensation of the Company&rsquo;s executive officers, other than the CEO; (iii) make determinations with respect
to the compensation programs and policies of the Company; (iv) review and discuss with the Company&rsquo;s management, the Compensation
Discussion and Analysis (the &ldquo;<B>CD&amp;A</B>&rdquo;) and other Committee or executive compensation disclosures to be included
in the Company&rsquo;s annual proxy statement and/or annual report on Form 10-K, and determine whether to recommend to the Board of Directors
that the CD&amp;A be included in the proxy statement and/or annual report on Form 10-K; and (v) provide the Compensation Committee Report
for inclusion in the Company&rsquo;s annual proxy statement and/or annual report on Form 10-K that complies with the rules and regulations
of the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>III.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Duties
                                            and Responsibilities of the Committee </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following activities are set forth as a guide with the understanding that the Committee may diverge from this guide as it considers appropriate,
subject to compliance with applicable NASDAQ, securities, tax and other legal and self-regulatory requirements. Although the Board may
consider other duties from time to time, the Committee, to the extent it deems necessary or appropriate, will have the following responsibilities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall annually review goals and objectives relevant to the CEO&rsquo;s compensation,
                                            evaluate the CEO&rsquo;s performance in light of those goals and objectives, determine the
                                            CEO&rsquo;s cash and equity-based compensation based on this evaluation, and recommend such
                                            goals, objectives and compensation to the Board for its approval. In determining any incentive
                                            component of the CEO&rsquo;s compensation, the Committee will consider appropriate factors,
                                            which may include the Company&rsquo;s performance and relative shareholder return, the achievement
                                            of the CEO&rsquo;s performance milestones, the value of similar incentive grants or awards
                                            to chief executive officers at comparable companies, and the grants or awards given to the
                                            CEO in past years. The CEO may not be present for such discussions and determinations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall annually review and approve the compensation of the Company&rsquo;s &ldquo;executive
                                            officers,&rdquo; (as that term is defined in the regulations promulgated by the SEC and the
                                            NASDAQ Rules) other than the CEO. In making such compensation decisions, the Committee will
                                            take into account peer group practices and other appropriate factors, such as corporate and
                                            individual performance and historical compensation practices for such officers. The Committee
                                            will solicit the recommendations of the CEO in connection with the foregoing. The Committee
                                            will also provide general oversight of the Company&rsquo;s compensation and benefits plans,
                                            policies and programs that pertain to employees other than executive officers.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall annually review and recommend to the Board for its approval, the fees and
                                            equity compensation paid to the Company&rsquo;s non-employee directors, based on appropriate
                                            factors as determined by the Committee. Such review and recommendations shall ensure that
                                            no agreements or arrangements for providing professional or consulting services to the Company
                                            or an affiliate or an individual officer of the Company or one of their affiliates are made
                                            with any director, immediate family members of a director or persons (including entities)
                                            with an existing business or personal relationship with any director, without a full review
                                            and evaluation of potential conflicts of interest.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall have the sole authority to retain and terminate any compensation consultant
                                            to be used by the Committee or the Company to assist in the evaluation of the compensation
                                            of non-employee directors, the CEO or the other executive officers, shall have sole authority
                                            to approve such compensation consultant&rsquo;s fees and other retention terms, and shall
                                            have sole authority to oversee the work of such compensation consultant. In determining whether
                                            to engage a compensation consultant, the Committee shall consider the independence factors
                                            set forth in the NASDAQ Corporate Governance Rules. Management will advise the Committee
                                            of any compensation consultant to be retained with respect to other compensation matters
                                            in advance of such retention.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall periodically review and make recommendations to the Board with respect to
                                            incentive-compensation programs and equity-based plans, and shall periodically review and
                                            make recommendations to the Board with respect to the adoption of or material changes in
                                            material employee benefit, bonus, severance and other compensation plans of the Company.
                                            As appropriate in connection with this process, the Committee shall seek appropriate input
                                            from internal or external advisors.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall determine the need for and the appropriateness of employment agreements and
                                            change in control agreements for each of the Company&rsquo;s executive officers and any other
                                            officers recommended by the CEO or the Board.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall determine and approve the options and other equity-based compensation to
                                            be granted to executive officers, other than the CEO; and shall recommend to the Board for
                                            approval options and other equity-based compensation to be granted to the CEO and non-employee
                                            directors. The Committee shall, in conjunction with the CEO, determine the issuance of options
                                            and other equity-based compensation under the Company&rsquo;s incentive compensation and
                                            other stock-based plans to all other officers and employees of the Company. The Committee
                                            may delegate the determination with respect to persons other than officers to the CEO but
                                            will approve the aggregate amount granted to all employees and all new hire grants. Any equity
                                            awards to the CEO shall be determined by the Committee and recommended to the Board for its
                                            review and approval.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Committee shall perform such duties and responsibilities as may be assigned to the Committee
                                            by the Board and/or under the terms of any compensation plan of the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
                                            regularly to the Board on its activities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain
                                            minutes of its meetings and records relating to those meetings and the Committee&rsquo;s
                                            activities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                            authority to obtain, at the expense of the Company, advice and assistance from internal or
                                            external legal, consulting or other advisors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
                                            and delegate authority to subcommittees of one or more Committee members when desired and
                                            appropriate;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            and reassess the adequacy of this Charter annually and recommend to the Board any proposed
                                            changes to this Charter; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodically
                                            review the Committee&rsquo;s own performance.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IV.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General
                                            </B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
performing their responsibilities, Committee members are entitled to rely in good faith on information, opinions, reports or statements
prepared or presented by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
                                            or more officers or employees of the Company whom the Committee member reasonably believes
                                            to be reliable and competent in the matters presented;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counsel,
                                            independent auditors, or other persons as to matters which the Committee member reasonably
                                            believes to be within the professional or expert competence of such person; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            committees of the Board as to matters within their respective designated authority which
                                            committee the Committee member reasonably believes to merit confidence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.6
<SEQUENCE>16
<FILENAME>ex99-6.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B>Exhibit 99.6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B><U>Neuraxis,
Inc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Charter
of the Nominating and Corporate Governance Committee of the Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the Nominating and Corporate Governance Committee (the &ldquo;<B>Committee</B>&rdquo;) of the Board of Directors (the &ldquo;<B>Board</B>&rdquo;)
of Neuraxis, Inc. (the &ldquo;<B>Company</B>&rdquo;) shall be as set forth in this charter (the &ldquo;<B>Charter</B>&rdquo;). The Committee
has been delegated authority by the Board to: (1) identify qualified individuals to become Board members; (2) determine the composition
of the Board and its committees; (3) monitor the self-assessment practices of the Board and its committees; and (4) develop and implement
the Company&rsquo;s corporate governance guidelines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Authority
and Responsibilities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
furtherance of these purposes, the Committee has the following authority and responsibilities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            oversee the administration of the Company&rsquo;s Code of Ethics and related policies.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            lead the search for individuals qualified to become members of the Board and to select director
                                            nominees to be presented for election by the shareholders at each annual meeting. The Committee
                                            shall select individuals as director nominees who shall have the highest personal and professional
                                            integrity, who have demonstrated exceptional ability and judgment and who shall be most effective,
                                            in conjunction with the other nominees to the Board, in collectively serving the long-term
                                            interests of the shareholders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            ensure, in cooperation with the Compensation Committee, that no agreements or arrangements
                                            are made with directors or relatives of directors for providing professional or consulting
                                            services to the Company or an affiliate or an individual officer of the Company or one of
                                            their affiliated, without appropriate review and evaluation for conflicts of interest.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            ensure that Board members do not serve on more than three other for-profit public company
                                            boards that have a class of securities registered under the Securities Exchange Act of 1934
                                            in addition to the Company&rsquo;s board. Newly appointed or elected directors shall have
                                            a grace period of nine (9) months to gain compliance with this condition.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            review the Board&rsquo;s committee structure and to recommend to the Board for its approval,
                                            directors to serve as members of each committee as well as recommendations for committee
                                            chairs. The Committee shall review and recommend committee positions, including chairs of
                                            such committees, annually and shall recommend additional committee members to fill vacancies.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            review recommendations received from shareholders for persons to be considered for nomination
                                            to the board of directors, and to designate a member of the Committee to receive such communications
                                            directly from shareholders, and to publish the name and contact information of such person
                                            in the Company&rsquo;s proxy statement for each of its annual meeting of shareholders.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            monitor compliance with the Company&rsquo;s corporate governance guidelines. The Committee
                                            shall review the guidelines at least annually, and recommend changes as necessary to the
                                            Board.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            develop and implement an annual self-evaluation of the Board, both individually and as a
                                            Board, and of its committees. The Committee shall oversee the annual self-evaluations, with
                                            a focus on the effectiveness of the directors, Board, and committees as representative of
                                            the shareholders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            review and recommend changes to procedures whereby shareholders may communicate with the
                                            Board.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            assess the independence of directors annually and report to the Board.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            recommend to the Board for its approval, the leadership structure of the Board, including
                                            whether the Board should have an executive or non-executive Chair, whether the roles of Chair
                                            and CEO should combine, and whether a Lead Director of the Board should be appointed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Actions
and Recommendations</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
carrying out its responsibilities under its charter, the Committee is required to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
                                            criteria for selection of potential directors, taking into consideration the following desired
                                            attributes: leadership, independence; interpersonal skills; financial acumen; business experiences;
                                            industry knowledge; diversity of viewpoints, and any other experiences as the Committee deems
                                            important to the effectiveness of the Board. The Committee will periodically assess the criteria
                                            to ensure it is consistent with the best practices and the goals of the Company.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identify
                                            individuals who satisfy the criteria for selection to the Board and make recommendations
                                            to the Board on new candidates for Board membership.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receive
                                            and evaluate nominations for Board membership which are recommended by existing directors,
                                            officers, or shareholders in accordance with procedures established by the Committee in accordance
                                            with the Company&rsquo;s corporate governance guidelines and applicable law.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oversee
                                            the process for conducting background checks on new candidates for Board membership, including
                                            the process of validating candidate credentials.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            any potential conflicts of interest for Board members in the event of a particular member&rsquo;s
                                            change of employment and recommend to the Board the Committee&rsquo;s belief as to whether
                                            that director should continue his or her board service or resign from the Board.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establish
                                            criteria for the evaluation of existing directors and the reelection or removal of directors
                                            based on the needs of the Company.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monitor
                                            the requirement that Board members shall not serve on more than three other for-profit public
                                            company boards in addition to the Company&rsquo;s Board. Determinations regarding the definition
                                            of &ldquo;for-profit public company board&rdquo; shall be made by the Committee.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            the qualifications, performance and independence of existing Board members and make recommendations
                                            to the Board whether they should stand for reelection.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommend
                                            to the Board the removal of a director where appropriate.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recommend
                                            to the Board a slate of nominees for the next annual meeting of shareholders.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oversee
                                            the orientation process for new directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shareholder
Recommendations</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee will consider all recommendations for nominations to the Board from any person (or group) who has (or collectively if a group
have) held more than 3% of the Company&rsquo;s voting securities for longer than one year. Shareholders desiring to submit recommendations
to the Committee should submit information regarding such recommendation in writing or by electronic mail to the person designated in
the proxy statement circulated in advance of each annual meeting of shareholders. Each proxy statement shall set forth the information
to be provided either directly in the proxy statement or by reference to the Company&rsquo;s website. When the required information has
been received, the Committee will evaluate the proposed nominee based on the criteria described above, with the principal criteria being
the needs of the Company and the qualifications of such proposed nominee to fulfill those needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report
                                            regularly to the Board on its activities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintain
                                            minutes of its meetings and records relating to those meetings and the Committee&rsquo;s
                                            activities;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                            authority to obtain, at the expense of the Company, advice and assistance from search firms
                                            and internal or external legal, consulting, or other advisors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
                                            and delegate authority to subcommittees of one or more Committee members when desired and
                                            appropriate;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Review
                                            and reassess the adequacy of this Charter annually and recommend to the Board any proposed
                                            changes to this Charter; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodically
                                            review the Committee&rsquo;s own performance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
performing their responsibilities, Committee members are entitled to rely in good faith on information, opinions, reports or statements
prepared or presented by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
                                            or more officers or employees of the Company whom the Committee member reasonably believes
                                            to be reliable and competent in the matters presented;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counsel,
                                            independent auditors, or other persons as to matters which the Committee member reasonably
                                            believes to be within the professional or expert competence of such person; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            committees of the Board as to matters within their respective designated authority which
                                            committee the Committee member reasonably believes to merit confidence.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.7
<SEQUENCE>17
<FILENAME>ex99-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.7</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Neuraxis,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>POLICY
ON INSIDER TRADING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Insider Trading Policy (&ldquo;Policy&rdquo;) sets forth the policies of Neuraxis, Inc. (the &ldquo;Company&rdquo;) on trading and causing
the trading of securities while in possession of confidential information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purpose</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors of the Company has adopted this Policy to provide guidance to the Company&rsquo;s directors, officers, and employees
about trading in the Company&rsquo;s securities and the securities of any publicly traded companies with whom the Company has a business
relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Policy is designed to (i) promote compliance with applicable securities laws in order to preserve the Company&rsquo;s reputation for
integrity and ethical conduct, (ii) provide guidelines for transactions in the securities of the Company, and (iii) provide guidelines
for the handling of confidential information about the Company and any companies with which the Company does business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Scope</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
policy applies to the following &ldquo;Covered Persons&rdquo;: (i) all directors of the Company; and (ii) all officers of the Company
and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sections
1 through 3 and Section 5 apply to the following &ldquo;Associated Person(s)&rdquo;: members of your immediate family and persons sharing
your household; it also covers venture capital funds and other entities (such as partnerships, trusts and corporations) that are affiliated
or associated with such person(s). Affiliated means directly or indirectly controlled or controlled by, or under common control with,
such person(s). Associated means (1) a corporation or organization (other than the Company or a majority-owned subsidiary of the Company)
of which such person(s) is an officer or partner or is directly or indirectly the beneficial owner of 10% or more of any class of equity
securities or (2) any trust in which such person(s) has a substantial beneficial interest or as to which such person serves as trustee
or in a similar capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                            Basic Policy&mdash;No Trading or Causing Trading While in Possession of Material Non-Public
                                            Information</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
No person associated with the Company may purchase or sell any security, whether or not issued by the Company, while in possession of
material non-public information concerning the security. (The terms &ldquo;material&rdquo; and non-public&rdquo; are defined in Section
2 below.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) No
person associated with the Company who knows of material non-public information may communicate that information to any other person
if he or she has reason to believe that the information may be improperly used in connection with securities trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Covered
Persons and Associated Persons must &ldquo;preclear&rdquo; all trading in securities of the Company in accordance with the procedures
set forth in Section 4 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) This
Policy applies to all transactions in the Company&rsquo;s equity securities, including common stock and any other type of securities
that the Company may issue, such as preferred stock, notes, bonds, convertible debentures and warrants, and exchange-traded options (including
puts and calls) and other derivative securities. This Policy applies to sales, purchases, gifts, exchanges, pledges, options, hedges,
puts, calls and short sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) This
Policy does not apply to a surrender of shares to the Company or the retention and withholding from delivery to the applicable officer,
director or employee of shares by the Company (i.e., a so-called &ldquo;net settlement&rdquo;) upon vesting of restricted stock in satisfaction
of any tax withholding obligations in a manner permitted by the applicable equity award agreement or the Company plan pursuant to which
the restricted stock was granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
                                            Law Against &ldquo;Insider Trading&rdquo;</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the principal purposes of the federal securities laws is to prohibit so-called insider trading. In recent years this has become a
major focus of the enforcement program of the Securities and Exchange Commission and of criminal prosecutions brought by United States
Attorneys.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Application
to Non-Insiders and to Securities Other Than Securities of the Company</U></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 67.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prohibitions
against &ldquo;insider trading&rdquo; apply to trades, tips, and recommendations by any person&mdash;including all persons associated
with the Company &mdash;if the information involved is &ldquo;material&rdquo; and &ldquo;non-public.&rdquo; Thus, for example, the prohibitions
would apply if you trade on the basis of material non-public information you obtain regarding the Company, its borrowers, customers,
suppliers, or other corporations with which the Company has contractual relationships or may be negotiating transactions. For compliance
purposes, you should never trade, tip, or recommend securities (or otherwise cause the purchase or sale of securities) while in possession
of information that you have reason to believe is material and non-public unless you first consult with, and obtain the advance approval
of, the Company&rsquo;s Chief Compliance Officer (the &ldquo;Compliance Officer&rdquo;). The current Compliance Officer referred to herein
is the [*] of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Materiality</U></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider
trading restrictions come into play if the information you possess is &ldquo;material.&rdquo; Materiality, however, involves a low threshold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
is generally regarded as &ldquo;material&rdquo; if it has market significance, that is, if its public dissemination is likely to affect
the market price of securities, or if it otherwise is information that a reasonable investor would want to know before making an investment
decision. Information dealing with the following subjects is reasonably likely to be found material in particular situations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20pt"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
                                            changes in the Company&rsquo;s prospects;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
                                            write-downs in assets or increases in reserves;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developments
                                            regarding significant litigation or government agency investigations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
                                            problems;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in earnings estimates or unusual gains or losses in major operation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
                                            changes in management;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in dividends;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extraordinary
                                            borrowings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
                                            or loss of a significant contract;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in debt ratings;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proposals,
                                            plans, or agreements, even if preliminary in nature, involving mergers, acquisitions, divestitures,
                                            recapitalizations, strategic alliances, licensing arrangements, or purchases or sales of
                                            substantial assets;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Public
                                            offerings; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending
                                            statistical reports (e.g., consumer price index, money supply and retail figures, or interest
                                            rate developments).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
information is not limited to historical facts but may also include projections and forecasts. With respect to a future event, such as
a merger, acquisition, or introduction of a new product, the point at which negotiations or product development are determined to be
material is determined by balancing the probability that the event will occur against the magnitude of the effect the event would have
on a company&rsquo;s operations or stock price should it occur. Thus, information concerning an event that would have a large effect
on stock price, such as a merger, may be material even if the possibility that the event will occur is small. When in doubt about whether
particular non-public information is material, exercise caution. Consult the Compliance Officer before making a decision to disclose
such information (other than to persons who need to know it) or to trade in or recommend securities to which that information relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Non-Public Information</U></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insider
trading prohibitions come into play when you possess information that is material and &ldquo;non-public.&rdquo; The fact that information
has been disclosed to a few members of the public does not make it public for insider trading purposes. To be &ldquo;public&rdquo; the
information must have been disseminated in a manner designed to reach investors generally. Even after public disclosure of information
regarding the Company, you must wait two full business days for the information to be absorbed by public investors before you can treat
the information as public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-public
information may include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
                                            available to a select group of analysts or brokers or institutional investors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Undisclosed
                                            facts that are the subject of rumors, even if the rumors are widely circulated; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
                                            that has been entrusted to the Company on a confidential basis until a public announcement
                                            of the information has been made and enough time has elapsed for the market to respond to
                                            a public announcement of the information (two full business days).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
with questions of materiality, when in doubt about whether information is non-public, call the designated Compliance Officer or assume
that the information is &ldquo;non-public&rdquo; and, therefore, treat it as confidential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Severe
                                            Penalties for Violating Insider Trading Laws</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Penalties
for trading on or communicating material non-public information are severe, both for individuals involved in such unlawful conduct and
their employers and supervisors. A person who violates the insider trading laws can be sentenced to a substantial jail term and required
to pay a penalty of several times the amount of profits gained or losses avoided.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
Congress has passed insider trading legislation that, in a significant departure from prior law, explicitly empowers the Securities and
Exchange Commission to seek substantial penalties from any person who, at the time of an insider trading violation, &ldquo;directly or
indirectly controlled the person who committed such violation.&rdquo; Such persons may be held liable for up to the greater of $1 million
or three times the amount of the profit gained or loss avoided. Thus, even for violations that result in a small or no profit, the Securities
and Exchange Commission can seek a minimum of $1 million from the Company and various management and supervisory personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the severity of the potential penalties, compliance with the policies set forth in Section 1 of this Statement is absolutely mandatory,
and noncompliance is a ground for dismissal. Exceptions to these policies, if any, may only be granted by the Compliance Officer and
must be provided before any activity contrary to the above policies takes place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preclearance
                                            of Securities Transactions</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
Covered Persons are likely to obtain material non-public information on a regular basis, the Company requires all such persons to preclear
all purchases and sales of the Company&rsquo;s securities in accordance with the following procedures:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the exemption in part &ldquo;(d)&rdquo; below, no Covered Person may, directly or indirectly,
                                            purchase or sell any security issued by the Company without first obtaining prior approval
                                            from the Compliance Officer. These procedures also apply to transactions by such person&rsquo;s
                                            spouse, other persons living in such person&rsquo;s household and minor children, and to
                                            transactions by entities over which such person exercises control.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Compliance Officer shall record the date each request is received and the date and time each
                                            request is approved or disapproved. Unless revoked, a grant of permission will normally remain
                                            valid until the close of trading two business days following the day on which it was granted.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Requests
                                            are most likely to be approved for trading that is to occur in the following &ldquo;window
                                            periods&rdquo;:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Commencing
at the close of trading on the second full business day following the date of public disclosure of the financial results for a particular
fiscal quarter or year and continuing until the eleventh business day of the third month of the next fiscal quarter. For example, if
public disclosure occurs on Monday, May 14th, trading requests would likely be approved from Thursday, May 17th through Thursday, June
14th; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Following
the wide dissemination of information on the status of the Company and current results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclearance
                                            is not required for purchases and sales of securities under a preexisting written plan, contract,
                                            instruction, or arrangement that is adopted pursuant to Securities and Exchange Commission
                                            Rule 10b5-1(c) (17 C.F.R. &sect; 240.10b5-1(c)) and approved in writing by the Compliance
                                            Officer or such other person as the Board of Directors may designate from time to time (the
                                            &ldquo;Authorizing Officer&rdquo;). Generally, Rule 10b5-1(c) trading plans are developed
                                            in consultation with individual counsel and not the responsibility of the Compliance Officer.
                                            For more information about Rule 10b5-1 trading plans, see Section 5 below.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
                                            10B5-1 Trading Plans, Section 16 and Rule 144</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
  <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule 10b5-1 Trading Plans</B></FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) <U>Overview</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
10b5-1 will protect directors, officers and employees from insider trading liability under Rule 10b5-1 for transactions under a previously
established contract, plan or instruction to trade in the Company&rsquo;s stock (a &ldquo;Trading Plan&rdquo;) entered into in good faith
and in accordance with the terms of Rule 10b5-1 and all applicable state laws and will be exempt from the trading restrictions set forth
in this Policy. The initiation of, and any modification to, any such Trading Plan will be deemed to be a transaction in the Company&rsquo;s
securities, and such initiation or modification is subject to all limitations and prohibitions relating to transactions in the Company&rsquo;s
securities. Each such Trading Plan, and any modification thereof, must be submitted to and pre-approved by the Compliance Officer, or
such other Authorizing Officer, who may impose such conditions on the implementation and operation of the Trading Plan as the Authorizing
Officer deems necessary or advisable. However, compliance of the Trading Plan to the terms of Rule 10b5-1 and the execution of transactions
pursuant to the Trading Plan are the sole responsibility of the person initiating the Trading Plan, not the Company or the Authorizing
Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
Plans do not exempt individuals from complying with Section 16 short swing profit rules or liability.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
10b5-1 presents an opportunity for insiders to establish arrangements to sell (or purchase) Company stock without the restrictions of
trading windows and black-out periods, even when there is undisclosed material information. A Trading Plan may also help reduce negative
publicity that may result when key executives sell the Company&rsquo;s stock. Rule 10b5-1 only provides an &ldquo;affirmative defense&rdquo;
in the event there is an insider trading lawsuit. It does not prevent someone from bringing a lawsuit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
director, officer or employee may enter into a Trading Plan only when he or she is not in possession of material, non-public information,
and only during a trading window period outside of the trading black-out period. Although transactions effected under a Trading Plan
will not require further pre-clearance at the time of the trade, any transaction (including the quantity and price) made pursuant to
a Trading Plan of a Section 16 reporting person must be reported to the Company promptly on the day of each trade to permit the Company&rsquo;s
Securities Counsel to assist in the preparation and filing of a required Form 4. Such reporting may be oral or in writing (including
by e-mail) and should include the identity of the reporting person, the type of transaction, the date of the transaction, the number
of shares involved and the purchase or sale price. However, the ultimate responsibility, and liability, for timely filing remains with
the Section 16 reporting person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reserves the right from time to time to suspend, discontinue or otherwise prohibit any transaction in the Company&rsquo;s securities,
even pursuant to a previously approved Trading Plan, if the Authorizing Officer or the Board of Directors, in its discretion, determines
that such suspension, discontinuation or other prohibition is in the best interests of the Company. Any Trading Plan submitted for approval
hereunder should explicitly acknowledge the Company&rsquo;s right to prohibit transactions in the Company&rsquo;s securities. Failure
to discontinue purchases and sales as directed shall constitute a violation of the terms of this Section 5 and result in a loss of the
exemption set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officers,
directors and employees may adopt Trading Plans with brokers that outline a pre-set plan for trading of the Company&rsquo;s stock, including
the exercise of options. Trades pursuant to a Trading Plan generally may occur at any time. However, the Company requires a cooling-off
period of 30 days between the establishment of a Trading Plan and commencement of any transactions under such plan. An individual may
adopt more than one Trading Plan. Please review the following description of how a Trading Plan works.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 10b5-1, an individual&rsquo;s purchase or sale of securities will not be &ldquo;on the basis of&rdquo; material, non-public information
if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in">&#9679;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
                                            before becoming aware of the information, the individual enters into a binding contract to
                                            purchase or sell the securities, provides instructions to another person to sell the securities
                                            or adopts a written plan for trading the securities (i.e., the Trading Plan).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
                                            the Trading Plan must either:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">specify
                                            the amount of securities to be purchased or sold, the price at which the securities are to
                                            be purchased or sold and the date on which the securities are to be purchased or sold;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">include
                                            a written formula or computer program for determining the amount, price and date of the transactions;
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">prohibit
                                            the individual from exercising any subsequent influence over the purchase or sale of the
                                            Company&rsquo;s stock under the Trading Plan in question.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third,
                                            the purchase or sale must occur pursuant to the Trading Plan and the individual must not
                                            enter into a corresponding hedging transaction or alter or deviate from the Trading Plan.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revocation
                                            of and Amendments to Trading Plans</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revocation
of Trading Plans should occur only in unusual circumstances. Effectiveness of any revocation or amendment of a Trading Plan will be subject
to the prior review and approval of the Authorizing Officer. Revocation is effected upon written notice to the broker. Once a Trading
Plan has been revoked, the participant should wait at least 30 days before trading outside of a Trading Plan and 180 days before establishing
a new Trading Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
person acting in good faith may amend a prior Trading Plan so long as such amendments are made outside of a quarterly trading black-out
period and at a time when the Trading Plan participant does not possess material, non-public information. Plan amendments must not take
effect for at least 30 days after the plan amendments are made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
certain circumstances, a Trading Plan <I>must </I>be revoked. This may include circumstances such as the announcement of a merger or
the occurrence of an event that would cause the transaction either to violate the law or to have an adverse effect on the Company. The
Authorizing Officer is authorized to notify the broker in such circumstances, thereby insulating the insider in the event of revocation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Discretionary
                                            Plans</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
non-discretionary Trading Plans are preferred, discretionary Trading Plans, where the discretion or control over trading is transferred
to a broker, are permitted if pre-approved by the Authorizing Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Authorizing Officer of the Company must pre-approve any Trading Plan, arrangement or trading instructions, etc., involving potential
sales or purchases of the Company&rsquo;s stock or option exercises, including but not limited to, blind trusts, discretionary accounts
with banks or brokers, or limit orders. The actual transactions effected pursuant to a pre-approved Trading Plan will not be subject
to further pre-clearance for transactions in the Company&rsquo;s stock once the Trading Plan or other arrangement has been pre-approved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reporting
                                            (if Required)</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
required, an SEC Form 144 will be filled out and filed by the individual/brokerage firm in accordance with the existing rules regarding
Form 144 filings. A footnote at the bottom of the Form 144 should indicate that the trades &ldquo;are in accordance with a Trading Plan
that complies with Rule 10b5-1 and expires <U>_____</U>.&rdquo; For Section 16 reporting persons, Form 4s should be filed before the
end of the second business day following the date that the broker, dealer or plan administrator informs the individual that a transaction
was executed, provided that the date of such notification is not later than the third business day following the trade date. A similar
footnote should be placed at the bottom of the Form 4 as outlined above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Options</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercises
of options for cash may be executed at any time. &ldquo;Cashless exercise&rdquo; option exercises through a broker are subject to trading
windows. However, the Company will permit same day sales under Trading Plans. If a broker is required to execute a cashless exercise
in accordance with a Trading Plan, then the Company must have exercise forms attached to the Trading Plan that are signed, undated and
with the number of shares to be exercised left blank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
a broker determines that the time is right to exercise the option and dispose of the shares in accordance with the Trading Plan, the
broker will notify the Company in writing and the Authorizing Officer will fill in the number of shares and the date of exercise on the
previously signed exercise form. The insider should not be involved with this part of the exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30pt"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 30pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Trades
                                            Outside of a Trading Plan</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
an open trading window, trades differing from Trading Plan instructions that are already in place are allowed as long as the Trading
Plan continues to be followed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Public
                                            Announcements</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may make a public announcement that Trading Plans are being implemented in accordance with Rule 10b5-1. It will consider in each
case whether a public announcement of a particular Trading Plan should be made. It may also make public announcements or respond to inquiries
from the media as transactions are made under a Trading Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prohibited
                                            Transactions</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transactions prohibited under <U>Section V</U> of this Policy, including among others short sales and hedging transactions, may not be
carried out through a Trading Plan or other arrangement or trading instruction involving potential sales or purchases of the Company&rsquo;s
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limitation
                                            on Liability</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company, the Compliance Officer, the Authorizing Officer or the Company&rsquo;s other employees will have any liability for any
delay in reviewing, or refusal of, a Trading Plan submitted pursuant to this <U>Section 5</U> or a request for pre-clearance submitted
pursuant to <U>Section 5</U> of this Policy. Notwithstanding any review of a Trading Plan pursuant to this <U>Section 5</U> or pre-clearance
of a transaction pursuant to <U>Section 5</U> of this Policy, none of the Company, the Compliance Officer, the Authorizing Officer or
the Company&rsquo;s other employees assumes any liability for the legality or consequences of such Trading Plan or transaction to the
person engaging in or adopting such Trading Plan or transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
                                            16: Insider Reporting Requirements, Short-Swing Profits and Short Sales</B><U>&#9;</U></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) <U>Reporting
Obligations Under Section 16(a): SEC Forms 3, 4 and 5</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the 1934 Act generally requires all officers, directors and 10% stockholders (&ldquo;insiders&rdquo;), within 10 days after
the insider becomes an officer, director or 10% stockholder, to file with the SEC an &ldquo;Initial Statement of Beneficial Ownership
of Securities&rdquo; on SEC Form 3 listing the amount of the Company&rsquo;s stock, options and warrants which the insider beneficially
owns. Following the initial filing on SEC Form 3, changes in beneficial ownership of the Company&rsquo;s stock, options and warrants
must be reported on SEC Form 4, generally within two business days after the date on which such change occurs, or in certain cases on
Form 5, within 45 days after fiscal year end. A Form 4 must be filed even if, as a result of balancing transactions, there has been no
net change in holdings. In certain situations, purchases or sales of Company stock made within six months prior to the filing of a Form
3 must be reported on Form 4. Similarly, certain purchases or sales of Company stock made within six months after an officer or director
ceases to be an insider must be reported on Form 4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) <U>Recovery
of Profits Under Section 16(b)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of preventing the unfair use of information which may have been obtained by an insider, any profits realized by any officer,
director or 10% stockholder from any &ldquo;purchase&rdquo; and &ldquo;sale&rdquo; of Company stock during a six-month period, so called
&ldquo;short-swing profits,&rdquo; may be recovered by the Company. When such a purchase and sale occurs, good faith is no defense. The
insider is liable even if compelled to sell for personal reasons, and even if the sale takes place after full disclosure and without
the use of any inside information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
liability of an insider under Section 16(b) of the 1934 Act is only to the Company itself. The Company, however, cannot waive its right
to short swing profits, and any Company stockholder can bring suit in the name of the Company. Reports of ownership filed with the SEC
on Form 3, Form 4 or Form 5 pursuant to Section 16(a) (discussed above) are readily available to the public, and certain attorneys carefully
monitor these reports for potential Section 16(b) violations. In addition, liabilities under Section 16(b) may require separate disclosure
in the Company&rsquo;s annual report to the SEC on Form 10-K or its proxy statement for its annual meeting of stockholders. No suit may
be brought more than two years after the date the profit was realized. However, if the insider fails to file a report of the transaction
under Section 16(a), as required, the two-year limitation period does not begin to run until after the transactions giving rise to the
profit have been disclosed. Failure to report transactions and late filing of reports require separate disclosure in the Company&rsquo;s
proxy statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Officers
and directors should consult the attached &ldquo;Short-Swing Profit Rule Section 16(b) Checklist&rdquo; attached hereto as &ldquo;Attachment
A&rdquo; in addition to consulting the Compliance Officer prior to engaging in any transactions involving the Company&rsquo;s securities,
including without limitation, the Company&rsquo;s stock, options or warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) <U>Short Sales Prohibited Under Section 16(c)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(c) of the 1934 Act prohibits insiders absolutely from making short sales of the Company&rsquo;s equity securities. Short sales include
sales of stock which the insider does not own at the time of sale, or sales of stock against which the insider does not deliver the shares
within 20 days after the sale. Under certain circumstances, the purchase or sale of put or call options, or the writing of such options,
can result in a violation of Section 16(c). Insiders violating Section 16(c) face criminal liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compliance Officer should be consulted if you have any questions regarding reporting obligations, short-swing profits or short sales
under Section 16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
                                            144</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
144 provides a safe harbor exemption to the registration requirements of the Securities Act of 1933, as amended, for certain resales
of &ldquo;restricted securities&rdquo; and &ldquo;control securities.&rdquo; &ldquo;Restricted securities&rdquo; are securities acquired
from an issuer, or an affiliate of an issuer, in a transaction or chain of transactions not involving a public offering. &ldquo;Control
securities&rdquo; are <I>any </I>securities owned by directors, executive officers or other &ldquo;affiliates&rdquo; of the issuer, including
stock purchased in the open market and stock received upon exercise of stock options. Sales of Company restricted and control securities
must comply with the requirements of Rule 144, which are summarized below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Holding
                                            Period</I></B>. Restricted securities must be held for at least six months before they may
                                            be sold in the market.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Current
                                            Public Information. </I></B>The Company must have filed all SEC-required reports during the
                                            last 12 months or such shorter period that the Company was required to file such reports.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Volume
                                            Limitations. </I></B>For affiliates, total sales of Company common stock for any three-month
                                            period may not exceed the <I>greater </I>of: (i) 1% of the total number of outstanding shares
                                            of Company common stock, as reflected in the most recent report or statement published by
                                            the Company, or (ii) the average weekly reported volume of such shares traded during the
                                            four calendar weeks preceding the filing of the requisite Form 144.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Method
                                            of Sale. </I></B>For affiliates, the shares must be sold either in a &ldquo;broker&rsquo;s
                                            transaction&rdquo; or in a transaction directly with a &ldquo;market maker.&rdquo; A &ldquo;broker&rsquo;s
                                            transaction&rdquo; is one in which the broker does no more than execute the sale order and
                                            receive the usual and customary commission. Neither the broker nor the selling person can
                                            solicit or arrange for the sale order. In addition, the selling person or Board member must
                                            not pay any fee or commission other than to the broker. A &ldquo;market maker&rdquo; includes
                                            a specialist permitted to act as a dealer, a dealer acting in the position of a block positioner,
                                            and a dealer who holds himself out as being willing to buy and sell Company common stock
                                            for his own account on a regular and continuous basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Notice
                                            of Proposed Sale. </I></B>For affiliates, a notice of the sale (a Form 144) may be required
                                            to be filed with the SEC at the time of the sale. Brokers generally have internal procedures
                                            for executing sales under Rule 144 and will assist you in completing the Form 144 and in
                                            complying with the other requirements of Rule 144.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are subject to Rule 144, you must instruct your broker who handles trades in Company securities to follow the brokerage firm&rsquo;s
Rule 144 compliance procedures in connection with all trades.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prohibited
                                            Activities</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Prohibitions<B>.
</B>Except for limited exceptions described below, the following activities are prohibited under this Policy:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) No
Covered Person may purchase, sell, transfer or effectuate any other transaction in Company securities while in possession of material
nonpublic information concerning the Company or its securities. This prohibition includes sales of shares received upon exercise of stock
options or upon vesting of Restricted Stock Units and Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) No Covered Person may &ldquo;tip&rdquo; or disclose material nonpublic information concerning
the Company or its securities to any outside person (including family members, affiliates, analysts, investors, members of the investment
community and news media). Should a Covered Person inadvertently disclose such information to an outsider, the Covered Person must promptly
inform the Compliance Officer regarding this disclosure. The Company will take steps necessary to preserve the confidentiality of the
information, including requiring the outsider to agree in writing to comply with the terms of this Policy and/or sign a confidentiality
agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
No Covered Person may purchase Company securities on margin, hold Company securities in a margin account, or otherwise pledge
Company securities as collateral for a loan because, in the event of a margin call or default on the loan, the broker or lender
could sell the shares at a time when the Covered Person is in possession of material nonpublic information, resulting in liability
for insider trading. In addition, pledging of securities by Covered Persons, including margin arrangements, can be perceived to
undermine the alignment of their interests and incentives with the long-term interests of other stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Short-term
and speculative trading in Company securities, as well as hedging and other derivative transactions involving Company securities, can
create the appearance of impropriety and may become the subject of an SEC investigation, particularly if the trading occurs before a
major Company announcement or is followed by unusual activity or price changes in the Company&rsquo;s stock. These types of transactions
can also result in inadvertent violations of insider trading laws and/or liability for short-swing profits under Section 16(b) of the
Securities Exchange Act of 1934.<SUP>1</SUP> Therefore, it is the Company&rsquo;s policy to prohibit the following activities, even if
you are not in possession of material nonpublic information:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            Covered Person may trade in any interest or position relating to the future price of Company
                                            securities, such as put or call options or other derivatives, or short sale of Company securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
                                            Covered Person may hedge Company securities. A &ldquo;hedge&rdquo; is a transaction designed
                                            to offset or reduce the risk of a decline in the market value of an equity security, and
                                            can include, but is not limited to, prepaid variable forward contracts, equity swaps, collars,
                                            and exchange funds.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Covered
                                            Persons may not trade in securities of the Company on an active basis, including short term
                                            speculation.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) No Covered Person may trade in securities of another company if the Covered Person is in possession
of material nonpublic information about that other company which the Covered Person learned in the course of their work for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) &ldquo;Quiet&rdquo;
Periods. The Company&rsquo;s announcement of its quarterly financial results has the potential to have a material effect on the market
for the Company&rsquo;s securities. Therefore, to avoid even the appearance of trading on the basis of material non-public information,
Covered Persons who are subject to the pre-clearance procedure set forth above may not, except as expressly permitted under this Policy,
carry out any transaction in the Company&rsquo;s securities during the period beginning on the 15th day of the last month of each quarter
(March, June, September, December) and ending on the third business day following the release of the Company&rsquo;s earnings for that
quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) Event-Specific
Quiet Periods. The Company reserves the right to close any open window period at any time if the Compliance Officer, or his or her designee,
determines, in his or her sole discretion, that there may be material non-public information with respect to the Company. If the Company
closes an open window, it will not pre- clear any transaction that is not expressly permitted by this Policy during the period that such
open window is closed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may on occasion issue interim earnings guidance or other potentially material information by means of a press release, Current
Report on Form 8-K, or other means designed to achieve widespread dissemination of the information. Covered Persons should anticipate
that trading will be prohibited while the Company is in the process of assembling the information to be released and until the information
has been released and absorbed by the market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, an event may occur that is material to the Company and is known by only a few directors, executives, or other employees.
So long as the event remains material and non-public, the persons who are aware of the event, as well as all Designated Persons, may
not trade in the Company&rsquo;s securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
existence of an event-specific quiet period will not be announced, other than to those who are aware of the event giving rise to the
quiet period. If, however, a person whose trades are subject to the pre-clearance requirements set forth above desires to effect a transaction
during an event-specific quiet period, the Compliance Officer may refuse to grant permission to carry out the transaction and will have
no obligation to disclose to the person the reason for the refusal or the reason for the event-specific quiet period. Any person who
becomes aware of the existence of an event-specific quiet period shall not disclose the existence of the quiet period to any other person.
The failure of the Compliance Officer to inform a person that they are subject to an event-specific quiet period will not relieve that
person of the obligation not to trade while aware of material non- public information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Exceptions
to Prohibited Activities. Prohibitions in trading securities under this Policy do not include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The
exercise of vested employee stock options where no Company stock is sold to fund the option exercise.<SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) The
receipt of Company stock upon vesting of Restricted Stock Units and Awards, as well as the withholding of Company stock by the Company
in payment of tax obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><SUP>1</SUP> While vested employee stock options
may be exercised at any time under this Policy, the sale of any stock acquired through such exercise is subject to this Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Company
securities purchased or sold under a Company authorized Rule 10b5-1 Trading Plan (see Section 4(d) above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Transfers
of Company stock by a Covered Person into a trust for which the Covered Person is a trustee, or from the trust back into the name of
the Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Blackout
                                            Periods Applicable to Covered Persons</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) No
Trading During Blackout Periods. No Covered Person may trade or effectuate any other transactions in Company securities during regular
blackout periods or during any special blackout periods designated by the Compliance Officer (except for the limited exceptions described
in Section 5(b) above). Remember that even during an open trading window, you may not trade in Company securities if you are in possession
of material nonpublic information concerning the Company or its securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Regular
Blackout Periods Defined. Subject to obtaining trading pre-approval from the Compliance Officer, Covered Persons may not trade in Company
securities during the period beginning on the 15<SUP>th</SUP> day of the last month of each quarter (March, June, September, December)
and ending on the third business day following the release of the Company&rsquo;s earnings for that quarter. To provide clarity, the
Compliance Officer will notify Covered Persons, in advance of each quarter end, of the date on which the blackout period begins and ends.
Trades made pursuant to an approved 10b5-1 Trading Plan (see Section 4(d) above) are exempted from this restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Special
Blackout Periods. From time to time, the Compliance Officer may determine that trading in Company securities is inappropriate during
an otherwise open trading window due to the existence of material nonpublic information. Accordingly, the Compliance Officer may prohibit
trading at any time by announcing a special blackout period. The Compliance Officer will provide notice of any modification of the trading
blackout policy or any additional prohibition on trading during the period when trading is otherwise permitted under this Policy. The
existence of a special blackout period should be considered confidential information and Covered Persons are prohibited from communicating
the existence of a special blackout period to anyone who is not a Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Hardship
Trading Exceptions. The Compliance Officer may, on a case-by-case basis, authorize trading in Company securities during a trading blackout
period due to financial or other hardship. Any person wanting to rely on this exception must first notify the Compliance Officer in writing
of the circumstance of the hardship and the amount and nature of the proposed trade. Such person will also be required to certify to
the Compliance Officer in writing no earlier than two business days prior to the proposed trade that he or she is not in possession of
material nonpublic information concerning the Company or its securities. Upon authorization from the Compliance Officer, the person may
trade, although such person will be responsible for ensuring that any such trade complies in all other respects with this Policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inquiries</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you have any questions regarding any of the provisions of this Policy, please contact the Compliance Officer at spope@emulatetx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Acknowledgment
                                            and Certification</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned does hereby acknowledge receipt of the Company&rsquo;s Policy On Insider Trading regarding trading on material non-public
information. The undersigned has read and understands (or has had explained to them by someone who understands) such Policy and agrees
to be governed by such Policy at all times in connection with the purchase and sale of securities and the confidentiality of non-public
information. The undersigned understands that if the undersigned is a Covered Person, the entire policy applies to them. The undersigned
understands that if the undersigned is not a Covered Person, Sections 1 through 3 and Section 5 applies to them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please print name)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title/Relationship to the Company</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>ATTACHMENT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SHORT-SWING
PROFIT RULE SECTION 16(B) CHECKLIST</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
ANY combination of PURCHASE AND SALE or SALE AND PURCHASE within six months of each other by an officer, director or 10% stockholder
(or any family member living in the same household or certain affiliated entities) results in a violation of Section 16(b), and the &ldquo;profit&rdquo;
must be recovered by Neuraxis, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;). It makes no difference how long the shares being sold
have been held or, for officers and directors, that you were an insider for only one of the two matching transactions. The highest priced
sale will be matched with the lowest priced purchase within the six-month period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sales</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a sale is to be made by an officer, director or 10% stockholder (or any family member living in the same household or certain affiliated
entities):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                            there been any purchases by the insider (or family members living in the same household or
                                            certain affiliated entities) within the past six months?</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                            there been any option grants or exercises not exempt under Rule 16b-3 within the past six
                                            months?</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                            any purchases (or non-exempt option exercises) anticipated or required within the next six
                                            months?</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Has
                                            a Form 4 been prepared?</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:
If a sale is to be made by an affiliate of the Company, has a Form 144 been prepared and has the broker been reminded to sell pursuant
to Rule 144?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchases
and Option Exercises</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a purchase or option exercise for Company stock is to be made:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
                                            there been any sales by the insider (or family members living in the same household or certain
                                            affiliated entities) within the past six months?</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
                                            any sales anticipated or required within the next six months (such as tax- related or year-end
                                            transactions)?</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Has
                                            a Form 4 been prepared?</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
proceeding with a purchase or sale, consider whether you are aware of material, non-public information which could affect the price of
the Company stock. All transactions in the Company&rsquo;s securities by officers and directors must be <U>pre-cleared </U>by contacting
the Company&rsquo;s Compliance Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>forms-1a_001.jpg
<TEXT>
begin 644 forms-1a_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" #@ E8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BC-% !1110 4449H **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML=OI=W_-H@OZUR6M?\%Q_P!@G2"P@\8:M?8_Y\K&'GG_ &YEK\M#_P $<_\
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M:PG=G='X=MR3[?-(17Y\;E]:-R^M;?ZG9'_*_P#P)F/_ !$'B3^:/_@*/O\
M/_!?G]IS'&LI_P"$W9__ !5.7_@OQ^TP5RVMKGT'AFS_ /BJ_/[<OK2@YZ4?
MZFY'_*__  )C_P"(A<2?S1_\!1^@B_\ !?+]I)N&\2QK]?"]K_\ %5I6/_!?
MSX_1F,W.IZ3(% W"?PR/GX[[)!^F*_.FBLWP7DK_ )E\_P#@&D?$7B*._(_^
MW?\ )GZ6VG_!P-\9ACSG\(_]MO#=W_[+-6OIW_!P)\5BZBXL/A_*O\6[2+^-
MC^)N,#\J_+NCK6,N!\I>TYKYK_Y$Z(>)6>1^*G3?RDO_ &X_770O^"_-]*N=
M4^'GA&X/_3OXA>W)Z]G#GT_R>.Q\-_\ !=?P]JCJFH? 6-U_BDTWQ<DQQW^4
MVX_G7XL;1UQ0% Z5RU. \,_@K->JO^J.ZEXGXN/\3#1?I)K\TS]W]#_X+3_L
M\W95/$'PW\86.[^*""UG5?K^^4_D#]*[GPU_P57_ &+M?*K>_$*^TEFZ)J6@
MW/\ .))%'XG%?SYV&OZ]I3;M+UN\MS_TPNG3^1K8L/BY\1],C,=OXKN''_3P
MJS'\W!->?6X#Q4?X5:+]4U^7,>IA_$[+Y?QJ$H^C4OSY3^COPG^U[^R[XVC6
M3P]\?O"<C/\ =AN-:B@E/_;.5E;]*]"M;RTOK=;RRN8YH9%W1RQ.&5AZ@CJ*
M_F?TW]H[QK:^6FHZ;872+_K&\MDD?\0VT?\ ?-=W\//VU=:\$WXU/P_J?B+P
MW=AL)<Z#JK(P![ED:-OP ->/B.$<ZH:JGS+R:?X:/\#WL+QUPWBM'5Y'_>37
MXJZ_$_HIR**_&?X.?\%A?VB?#,MK:Z=\=K77K>WD_P"0;XKLTE:X)'W6E<)<
M,/\ =DKZD^$__!;+2YHX;+XW?!R:%O))FU3PK="19'SP!;3E2BXZGSF.1TYX
M\&MA<3AI<M6#B^S33_$^GP^,PN,AST*D9KO%IK\+GWI17F_P7_:Z_9U^/X6#
MX8_%'3[R];/_ !*;AC;W@P!G$,H5V R/F4%?>O2,USG2%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 57U&TN;V'R;;4IK4[@?,MU0M]/G5AC\,U8HH Y'6OA!IO
MBCCQ+XU\63C_ *<?$USIOK_SX- ?_P!7UKE=8_8A_9L\31&'QCX.U7Q C?>3
MQ)XQU74E;IU%S=29Z=_?U->L45M'$8BG\,FO1V_(YYX3"U/C@GZI/\SQ_1_^
M"?G[#&A8-A^R%\.&9>CW7@^SG8>^9(V.?>NDTS]E?]F'10!HW[./@.TV_=^R
M^$+*/'_?,0]!^5=Y152Q>*G\523^;)C@<%3^&E%>D5_D9.C^!/ _AW;_ ,(_
MX-TJQVG*_8]/CBQSG^%1W-:VT9SBBBL'*4M6=$8QBK)6#:/2C:.M%%(H3:/2
ME  &*** #:.N*,#.:** #K1110 =>**** # SG%&!Z444 &T>E)M'I2T4 )M
M'I2[0>U%% &'XA^&'PU\7%CXK^'NAZIN^]_:&DPS9YS_ !J>]<;K/[$_[&_B
M)677/V4/AO=;L9:;P38EO^^O*R/SKTZBMH8BO3^"37HVC"IA<-6^."?JDSYX
M\2?\$GO^"=?BG<=3_93\.1;O^@:UQ9_^B)$KS[Q-_P $(/\ @G1KT;)I7PVU
MW1=WW6TSQ7=N4^GVAY1^>:^R**ZZ>;YK2^&O-?\ ;S_S."KD.25OCPU-_P#;
MD;_?8_.OQ5_P;@?LN7T4A\%_'#Q]ILC?ZO\ M%K*\1#]%@B)'_ L^]>5^+O^
M#:CQS:V\TO@/]K+2[Z;DP0ZOX3DM%/H&>.XF(^H7\*_6BBN^EQ3GU+:M?U47
M^:N>76X)X9K;X=+T<E^3M^!^&OCW_@W^_P""@?@^P-[X>M?!GBJ0-@6N@^)#
M'(??_38K=?\ QZO%_B%_P3/_ &^_AC?1Z=XF_9-\:7$DB[E?0=);5HQ]9+'S
MD4^Q(-?T9$9X(HV@=J]2CQQFE/2I",ODT_P=OP/%Q'AKDM36E4G%^J:_%7_$
M_EBU32]3T/49M'UO3KBSN[>39<6MU"T<D3?W65@"#[$5 #GI7]17CKX<_#WX
MH:"WA7XE^!-&\1:7(P:33==TN*[MV8="8Y5921]*^>/B]_P1N_X)Y_%]KR]N
MO@):^';^\4 7_@^]ET[R,=X[>-OLP/UB(/>O:P_'F#EI7HRCZ-2_/E/G<7X8
MXZ&N&KQE_B3C^7-^GR/Y_**_5SXU?\&VFC3+<:A^SM^T==6[<?9M)\9::LH/
MKNNK8*0/3$!KX[^//_!(7]OCX "XO]8^"EQXDTR$G_B;>"Y?[2C8#JWE(!<(
MHZ[GB48^AKZ/!\0Y/C;*G52?9^Z_QM?Y7/D\?PIQ!EUW5H-I=8^\OPO;YV/F
M>BGW=M<V%W)8WUM)#-#(4FAF0JR,#@J0>00>QIE>R?.AM'I6MX>\=^+_  J5
M_L+7KB%%_P"6#-NC_P"^&R/TS6316=6C1Q$.2I%279JZ_$VH8C$86HJE&;C)
M=4VG]Z/7/!G[2VRXB3Q98-;2*P*ZA8$_(V1ABO48ZY4D^@K[F_92_P""LGQF
M^&=O:VOB?71X]\+\+Y=_=9O(%Q_RSN""V1Q\DH;@8&SJ/R]Z\&M+POXMU[P;
MJ U+0+YHFW#S(SS'*/1AW'ZCM@U\?FG!N#Q$7/">Y+MO%_JOEIY'Z!D?B%C\
M))4\>O:0_F5E)?I+YV?F?TL? +]I#X2?M+>#_P#A,?A5XE6Z2/:-0T^8".ZL
M)&!(2:/)VGAL,"5;:=K,!FNZK\$_V2/VN_&'PZ\9V?Q.^%FL_P!FZYI_RZAI
M\C%H;N$D;X9%R/-A? ST*D*05958?ME^SA\>_"?[2GPDTOXK>$?W<=XA2^L6
MD#/972X$D#$8S@\@X&Y65L ,!7YEBL+7P=9TJL;26Z?]?B?LF#QF&S##QKX>
M2E&6J:_K1KJMT=U1117,=04444 %%%% !1110 4444 %%%% !1110 45XK_P
M4:\5>*/ _P"PU\3O%O@KQ)J&CZMI_A::6QU/2[Q[>XMI 5P\<D9#(WN"#7X,
M_P##=?[;O_1X_P 5/_#A:E_\?KZ3)>&ZV=4)585%'E=M4^R?ZGR/$7%V'X=Q
M,*-2DY<RO=-+JUU]#^E"BOYL$_;M_;@CD66/]L;XI[E;(W?$#4B/Q!FP?QK]
MU/\ @G#^VAHO[;_[,FD_$]IK>/Q)8XT_QEIL *BVU"-1N=5/2.52LR8+ "0I
MN+1M@SGAG%Y/0C6E)2BW9M7T[7]?ZW)X?XRP/$&)EAXP<))72;6O>UNJ[=M>
MA[W1117S9]@%%>7_ +;7B#7O"G[''Q6\4>%M;O--U+3OAWK-SI^HZ?<-#/:S
M)92LDL<B$,CJP!# @@@$5_/_ /\ #=?[;O\ T>/\5/\ PX6I?_'Z^BR7AVMG
M5*4X5%'E=M4SY/B+BS#\.UX4JE-RYE?1I=;=3^E"BOS!_P"#?/X_?'?XT>.?
MB;:?&+XU^+O%D-AI.FO8Q>)O$EU?K;,TMP&,8GD;82 ,D8S@9Z5^GU>;FF7S
MRO'2PTI*35M5YI/]3U\ES6GG66PQD(N*E?1[Z-K] HHHKSSU0HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **\-_X*'_M!R?L]_LT
M:QJVCWS0ZYKW_$HT)HV*O'+,K;Y@005,<0D=6&<.(P>M?DZ/BO\ %(?\U*\0
M?^#B?_XJJC'F%<_=0G S0#D9%?B'\/?VBOB_\._'6C^.[#Q]K%Q+I.HPW2VM
MUJTS13A&!,;@MRK#*D=P37[2?#WQQH'Q+\"Z/\0?"USYVGZUIT-Y9L<;MDB!
M@&'9AG!'8@CM1*/*"9L4445(PHHHH **** "BBB@ HHI&.!0 %@.M*#GI7\^
M?_!2[]NGXV?M2?M%>+-$U3QOJ5MX,T?7+G3M \+V]T\=HEO!*T:RR1*=LDS[
M=[,^X@MM!"JH'8?\$@?V[OC/\"_VH_!WP7OO&FHZEX'\8ZU;Z'<>'KRY>:&T
MFN'$4$]NK$B!EE=-VW 9"P()"E?LY\%XR.6_6/:+FMS<MNEKVO?>WE:_4_/:
M?B'E]3-EA/9/D<N53OUO:_+;:_6][=.A^[E%"_=HKXP_0@HHHH *,#THHH \
MK_:%_8G_ &6/VI[-K?XY?!31=:N/+"1ZMY)M[^)0<@)=0E9E7/\ "&VGH002
M*_.;]K/_ (-V/%WA^"X\5_L=?$@Z[$OS#PCXJECANR,=(;M0L4C%NBRK$%7K
M(QZ_K;1@'J*]?+\\S3+&O8U'R_RO6/W=/E9G@YKPUDV<1?UBDN;^9:2^];^C
MNO(_EX^)7PP^(OP;\8W7P^^*W@?5/#VM63 7.FZM9O!*@(RK88#*L.5895@0
M02#FL*OZ5OVH/V0/@#^V%X';P+\=/ EOJ4<:M_9VIQ?NK[39&'^LMY@-R'(!
M*\HVT!E8<5^(_P#P45_X)A?%W]@KQ/\ VPTDWB+P#J-QLT?Q7!;D>2QZ6UVH
MR(IL=#]R0#*D$.B?I>1\487-I*E47)4[='Z/]'KZZGX[Q)P7CLCBZ])^TH][
M:Q_Q+MYK3O8^8:***^J/BR]X9\1:CX2URWU[2GVS0R9*GI(O=3[$<?J.:_7#
M_@B!\:GN?'.O?#6*[=M+\0:"FL6,<A^Y/$Z(P !P&:.7YO\ KB!VK\@:_1[_
M (( 17VM?'2&6-,II/A_4C(WI&9(E'_CTP%?!\<8*G+!PQ27O)\K\T[O\&M/
M5GZ=X:YC6ACJF";]V4>9+M)-)_>GKZ(_8:BBBOR\_9@HHHH **** "BBB@ H
MHHH **** "BBB@#P7_@J'_RCZ^+/_8H3_P UK^=6OZ*O^"H?_*/KXL_]BA/_
M #6OYU:_4N _^1?5_P ?Z(_%?$W_ )&M'_!_[<PKZ;_X)2_MPW/[$_[3=GJ?
MB+4I$\$^*O+TSQA;[V\N*,M^YO=HX+0.Q;."?+>91R]>->%/V?\ QSXV^!/B
M[X_>'(/M6E^"=6TVSU^&.,E[>.]$XCN">GEB2$1GN&FC[9(XD]*^NQ%'#9AA
MZF'GJGHUV=D_OU37R/@\)B,9E>*I8JGI)>]%]U=KYIV:?S1_5!;7-O>6Z7=I
M,DD4BAXY(V#*ZD9!!'4$5)7Y^_\ !!K]ND_'#X,S?LM?$'56D\4> ;-#HLTS
M#=?:+D(@ZY+6[%8CP!Y;P8R=Q'Z!5^&YC@:V6XR>'J;Q>_=='\T?TKE.94,W
MR^GBZ6TEMV?5/T?^9Y+^WS_R8Y\8O^R8Z[_Z035_-K7])7[?/_)C?QB_[)CK
MO_I!-7\VM?H/ ?\ N=;_ !+\C\J\3O\ D88?_"_S/TY_X-J/^2@_%C_L#:5_
MZ-N:_6NOR4_X-J/^2@_%C_L#:5_Z-N:_6NOEN+O^1]5](_\ I*/MN _^27H^
ML_\ TN0452\1^)/#_@_0;SQ5XLUVSTO2]/MWN-0U'4+I(8+:%1EI))'(5% &
M2Q( %?#G[1W_  <"?LA?"6^NO#GP?T+6OB-J5LVW[3IVVQTMG#LKI]IF!D;&
M,AHX7C<$%7(.1XN#R_'9A+EP]-R]-EZO9?-GT&89MEN54^?%U5#M?=^B6K^2
M/O"BOR3UK_@Y5^(,]\9/#?[*&CVMKM&(K[Q5+<29[G<L$8Q[;>/4UU/@#_@Y
M6\*7.JVMG\5/V4]2L+%L_;-0\/\ BB.\F7T*6\T$*GG'!F'KD]*]>7">?1CS
M>Q_\FC?\_P CP8<=<+SGR^WMZQFE_P"DZ?.Q^H=%>.?LJ?M[?LN?MFZ2UU\#
M/B3!=ZE;VZRZAX<U",VVI68VH6WP/RZJ753+&7BW<!R:]CKP:U&MAZCIU8N,
MET:LSZC#XG#XNBJM&:E%[-.Z^]!117P)/_P<8?L2V]Q);/\ "[XJ;HY"K;=$
MTW&0?^PA71@\NQV8<WU>FY<MKVZ7V_(Y<?FV6Y7R_6ZJAS7M?K:U_NNC[[HK
MYS_8@_X*;_ ?]OGQ!K_AOX/>$?%VFS>';.&YOF\2V%K"KK*[*H3R+F4DY4YR
M!QZU]&5CB,-B,'6=*M%QDNC\]3?!XS"X_#JOAYJ4'>S6VFC_ !"BBO&?VV/V
MX_A/^P=\/=+^)/Q>\/>(M2L=6UI=,MX?#=I!-,LQADEW,)IHE";8F&0Q.2..
MI$T:-;$UE2I*\GLEU+Q.)H8.A*M6ERQCNWLCV:BO@$_\'&_[$0Y/PM^*G_@C
MTW_Y85]O?";XD:'\8_A9X9^+OABUNH--\5>'[/6-/AOHU6>."Y@2:-9 C,H<
M*X# ,P!S@D<UTXO+,PP$5+$4W%/:YQ8'.<KS23CA:JFUJ[=#H**^<?VW?^"G
MOP$_8(\3Z'X4^,'A'QAJ5QX@L9;NS?PWI]K,B)&X0AS/<Q$')XP",=Z\J^&O
M_!?W]C/XH?$;P_\ #/1_A]\2+.\\1:W:Z9:W>HZ/IZ6\,EQ,L2O*R7S,$!<%
MBJL0 < GBM*.3YIB,.JU.DW%ZWZ:&5?B#)<+BGAZM>*FFE9[W>WYGW'17S7^
MVY_P51_9?_8<G'A;QMJ5[X@\721AX_"?AU$DN(5:-F22Y=V6.WC)"CDF0B16
M6-UR1\@G_@YB56(3]BMF7L6^(V/_ ''5OA.'\XQU%5:-%N+V;:5_2[5_D<^.
MXJX?RVNZ.(KI26Z2E*WKRIV?D]3]4J*_/?\ 9\_X.(OV8_B)J\>@?'3X;ZY\
M/I;B<K%J4=P-6T^)=N097CCCF0EOE 6!U&02RC)'WSX7\4^&_&WAZS\6^#M>
ML]4TK4;=;C3]2T^Z2:"YB8962.1"5=2.A!(-<F.RW'9;)1Q--QOMV?HU=/[S
MNR[.,LS:#EA*JG;>VC7JG9KYHOT45YU^U=\<K/\ 9U^ ?B+XIRO']KL[,Q:3
M$^#YMY)\D*X[@.0S#^ZK'M7">D?GA_P5=^/_ /PMS]HQO .C7OF:/X(C:PC"
MME7O6(-R_3J&"1$<\PDCK7S JN[;(T+,>BJ.M27M]>ZI>S:GJ-U)/<7$S2SS
M2L6:1V.2Q)ZDDY-?67_!(W]GBU^)_P 9-2^*OBC28[G1_"MF8X8KB,-'/>7"
M,BJ0>&"Q>:Q'8M&:V^&)&[/D@'(K]&_^"-GQ_7Q'X U?]GG7;X&[\/R-J&B(
M[#+64K_O44>B3-N)_P"G@>E?%7[6/P.O/V=?V@/$?PM>&3[':7IFT::3)\VQ
ME^> [BHW,$(1B!C>C@=*B_99^.-]^SK\>/#OQ6@>8VMC>K'J\$*[FGLI/DG0
M+N4,VPEE!. ZH3THE[T06C/VSHJ'3M1L-7T^#5M*OH;JUNH5FMKFWD#QRQL,
MJZL.&4@@@C@@U-6)8445X?\ M%?MY_#3]F'QG'X,^)/P\\8LUU:K<6.I:=86
MLEK=I_%L9[E6W*WRLI4$'!QM96+2<M$3*48J[/<**^3_ /A\1^S-_P!"-XZ_
M\%EE_P#)=?17P?\ BWX*^.7P\TWXF^ +]I]-U*'<JRJ%E@<</%(H)VNK94@$
MCC()!!+E&4=6@C4C+9G3445X+^TE_P %%_@#^S!X\C^&_C.TU[5=5^R+<74/
MA^U@F%H&^XDIDFCVN5PP49.TJ3@,,R4>]4,,C%?(9_X+1_LN#_F0O'W_ (*[
M'_Y,KZ6^$/Q.L/C'\-M)^)^D^&]6TFSUJV^TV=GK<$<=QY))V2%8W=0'7#K\
MQRK*>,XIV: _(_\ X*)_\$4OVF;#X]>(OBK^S)X,C\6>%O$FJSZDNFV-]#%=
MZ7+,YDDA,4K)YD8=FV&,L=N P!&3U/\ P2M_X(U_M >$OC_H?[1'[4GAJ/PS
MI?A6Z74-%T&:\BFO+^]7_4NPB9EACC?$AW$.610%P2P^UOB__P %4?V>_@I\
M2]8^%GBKP;XRN-0T6Z\BZFT_3[1H7;:&RA>Z5B,$=5%7?@'_ ,%-/@/^T7\4
M].^$7@GPEXNM=2U-)FMYM4L+6.!1%"\K;C'<NWW4.,*><=.M?3RXLS:67_57
M;:W-;WK6MWM>W6WXZGQE/@7(Z>:?75S?%S<MURWO?M>U];7_  T/HJB@'/-9
MOC#QGX3^'_AVY\7>./$EEI.EV:AKJ_U"X6**/)P,LQ R20 .I) &2:^7/LS2
MHKX\^*O_  68^ OA6YDT_P"%?@G6O%LD<B@7DI&GVDJD DHTBM-D'C#0KR.#
MC!/GMQ_P6^UMIRUK^SC:I'QM23Q4S-^8MA_*JY9"NC]!:*^'?!G_  6W^'][
MJ#0_$+X$:QI=KL^2;1]8BOY"WH4D2  >^XGVKZL^"W[1?P7_ &AM$DUWX0^/
M;/5XX,?:K=-T=Q;9) \R&0+(@)!P2H#8."1S2<6AG;4444@"L/XE_#;P+\8/
M 6J_#+XF>&;76-!UJS:VU+3;Q,I-&?IRK @,K*0RL%92" 1N45492A)2B[-$
MRC&I%QDKIZ-/9H_G/_X*(?L5^(/V%OVC=0^%,\]S>^'[R/[?X2UBX4;KNQ=B
M KE0%\V-@8WP!DJ'"JKJ*\+K]R?^"\7[-VG_ !D_8ONOBG8V ;7/AQ>IJ=K,
MD9:1K*5DANXO9=ICF/\ U[#WK\-@<BOVOAS-)9KED:DW[\?=EZJVOS5GZW/Y
MSXNR6.1YS*E37N27-'R3Z?)IKTL!.*_9#_@WH^!%UX8^!6M?'76=/:.37[K[
M#I;2(58PQN7E<>JL3$ ?6)J_*']GKX%^-_VE_C7X;^!7P\MU?5?$FI+:PR29
M\NWCP6EN),<^7%&KR-@$[4. 3@'^DKX+_"7PC\"/A3X?^#_@.U,.D^'=+BLK
M-6QN<(.9&P "[MEV.!EF)KY[CK&QCAZ>%3U;YGZ*Z7WMO[CZOPSR^<L56QS7
MNQ7(O-MIO[DE]YU%%%%?F9^QA1110 4444 %%%% !1110 ,<#.* <C->?^(_
M'6F^-OB^/@#HK0W7]GZ6FJ^-FY86MK(S):6C888>Y=)6((93#;2JRCSHVKT
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M^)?B1I/[/6BW?^B^&X5U#6D&?FOIH_W2$$?P0,&!4D'[20>5K[]^+GQ,\/\
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MHP]05)!HE)I@D?B;\6OV<_CI\"947XL_"_5=%CDD"1WD\.^V=R"0BSH6C9L
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M51J1E:3V:?3R/H/#G 8[!XZNZ]*4$XJW-%J^OFD?F1_P<G_\EF^&7_8L7O\
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MU;XW_&+X?:5KD6L7?V/P[:ZUIL=S$D$+$2SJK[ER\N8\E0R^0V#AS7@FC?\
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MDBD4Y5E8<J0>01R#7V_^R9_P7B_:L^ \%MX5^,EM#\2M A4(KZM<F#5(E P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWY-_S^0JW;?\&Y_P0213>?&6ZD7/S"/0Y%)'L3=MC\C7Z-T5/]L9M_T$3_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>forms-1a_002.jpg
<TEXT>
begin 644 forms-1a_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,J!: # 2(  A$! Q$!_\0
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M9I/-7^X1^%1B:7/*G]3_ %IPN"/O9_%0*+H.1]AX=<<EC_GZTGF+G ./JO\
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MXX_6HFD=3RQ'U7%1!G4X(_\ 'L_UJ0H_!"_B5_\ K4N9LKE2'+-*?XL_1O\
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M>^ZIC)M'?\\5$L1QE6S]!4;^83A@WX\4[R0639-Q)R8@?^V@IAV'A4(/U_\
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MX T!P/NM^:B@%6Z.X^O-!1O[_P"8J2[(-Q/5%-*-AZQ$?1JC "G(=L_[(_\
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M<C_EG^6?Z4U78$\1G_@-/06J(O+7NC TH![%L>ZU. #T4(?;%#*4ZO\ I_\
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MP;;P#GZ9_I2/&,<G/XTSGLZGVVDT;"W'ED'WY1] 33?,B4\*I]R#_A33&V>
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M1TP?H<TY8AV!/T.*]V_X4KX;_P"?S5/^_L?_ ,11_P *6\.G_E_U7_OY%_\
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MLR/S_P :58Q_>3_OLU[N/@IX<'_+]JW_ ']C'_M.G?\ "EO#G>]U4_66,_\
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ML?\ \;I_6:8O83N> B0#G@?0C^M2QSY!QO\ Q/\ ]:O=S\$/#/:]U8?2:/\
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MZU3[L7U>?9'@PE(/* _5J<9CV4+_ +H/]:]X_P"%*>&N]YJC?66/_P"(I?\
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M6VNY#J12O<[ZBBBLBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKRK'*AB5'BW$88%>"!G/?([U7^!2*?$.J.1\PM  ?8N/\!5?XK@#XH69'>*
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MZ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYE1&6VCCC(2)CT;!8Y'L,?6NM\%>"#X1TF^TV;41?VUT^_;Y'E[<KM;^(YR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7\J/[3N?5?RJG10!<_M.Y]5_*C^T[GU7\JIT4 7/[3N?5?RH_M.Y]5_*J=%
M%S^T[GU7\J/[3N?5?RJG10!<_M.Y]5_*C^T[GU7\JIT4 7/[3N?5?RH_M.Y]
M5_*J=% %S^T[GU7\J/[3N?5?RJG10!<_M.Y]5_*C^T[GU7\JIT4 7/[3N?5?
MRH_M.Y]5_*J=% %S^T[GU7\J/[3N?5?RJG10!<_M.Y]5_*C^T[GU7_OFJ=%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >8?&#&-$W
M?=WS9^GR5B>,AX)&EI_8)7[=Y@_U6_&WOG=Q_6MSXO ,=$!'!>4?^@5VEOX1
M\/VDRS0Z1:K(IRK%-V#^->E"JJ=.#=^NWZG'*#G.25NAR>H>+]2\)^'/#:RV
MR3RW%O\ OA,2& 4+@?7#=ZN+XUU?3-#O-2\0:2EL5=$M(ERIE9@3@Y)Z 9S]
M>*SOBDH;5O#:GH99 ?\ OJ.M;XG:3=:IX:C>TC:5[:82NBC)*X() [XR/UJ$
MJ;4.9?%>_P!XVYKFL]O\C-B\?Z[I[V5SKVC10:;>$>7-$3N /<C)[<X.*]$,
ML8ZR)Z]:\,0Z%J*:?96EEK-_>R8$T#7(54;&#M^4\9SZ8%=_K/PVL=;U$WLM
M]<1.8T3:H4@;5"]2/:BM3IIJ_N[]/^".G.;3MJ8GBA6\3_$RR\/S2L+*$ LJ
M'K\GF,?J1@9K9UKX8Z3?1P?V7C39HV&YUW.&7Z%NO3FL7Q)HM[X2U[2O$&GP
MO=VUK#'#-@<C8GE\XZ97OV/X4:K\0[_Q UK8>%K6[BNVD#.[*I/TQR-O/)/I
M5VJ-1=)Z)?U<B\4Y>T6O];$GQ,BD@_X1B&68S2(SJTI&"Y'EY)'O6E?WMLOQ
M:L+5M.@:=HLBZ+OO7Y&X SM_3O69\2DG0>%TNI!+<*S"5P,!F_=Y('UJ;4O^
M2VZ;_P!<?_:;T15Z:])#;M)^J+=UXYUD>*[[0M/TF&[FC)6##%>1@DL2<8QG
MT[5<\)>,;_6-9O-&U:QCMKZV4L?*)QP0",$GU'.>:R/#P_XO'K?_ %Q?^:4:
M#_R636O^N+_^R5,H0Y6K?93&I2NG?K8F^'^LV$>CZU>_V?!806Q#R>2SMN !
M/\1//TJ >/O$]U92ZO9:! VDQOM+,Q+XSCL1^84@5F>!=/EU7PAXFL8/]=+M
M"#.,M@D#]*30O'9\,^%SHS:?/_:UN[+$DB?*2S9^89!R,GCZ5I*FG.5HW=U]
MUB%-J*N[*QU^I^+]171-.NM)T.YN+F]XV21MMA.<88CU/3IQS5/2?&>M)XJA
MT+Q!IMO;S3C*- V=N02,_,P(.,=:P_&&M:^]CH;ZFL^GV=R-UVMIE2/FZ'/?
M;S@GJ?:L?3FTJ+X@Z--I<-U%8/(JK+<YS,^2"P)]R!^%*-&+@[KO_5_^ .51
M\VC['3>'_P#DL>M?]<7_ )QUH>"_^)GXK\2ZV>5:<6T3>JK_ /6"5@1WW]F?
M$?Q3>YP8+*5U_P![Y,?KBNO^'5A]A\%VA88DN2T[>^X\?^.A:BMI!ONHK]2J
M>LK>;9U5%%%>>=84444 %%%% !1110!QWQ/_ .1)N/\ KK'_ .A5B:#\1M#T
MWPW96$XNO.A@$;;8@1G'KFMOXG_\B3<?]=8__0JM>%+"SD\&::[VD#.;4$L8
MP23CZ5VQ<%07,KZG,U+VKY7T./\ AI>/I_A;Q%>QJK/;IYJJW0E48@'\JZS1
M/%5UJG@F]UR6"%)X$F98USM.Q<C/.:Y#X<VTEYX1\2VL0S)-$8T'J3&P'\ZH
MZ%XGCT_P3J?AYK*Z?49!,JHL?"JRX);N,<D\5O5IJ<Y66MU]QG"?+&.NEF=0
M?'U__P ((->^R6WG_:O(\OYMN,=>N<U3NOB'K]E;V6IW.A0QZ5<D!&+G>_')
M'/&>2,BN>/\ R1P?]A+^E;/CH8^&7ASZ0?\ HDT*E34DN7=M"YYVO?9)ER?X
MA:UI]W97&HZ)';Z5>G,+;LR%..>N,X(."!6_XF\0:W8:C;:=HFC/=S2KN,\J
M-Y2]>,\#/&3R.U<K\31C0/#P'^?E6D\>:A/'XQMK35;B]M]",8/^BG&_@Y/N
M<X'L/K41IPERM177OT+<Y1NF^WXF_P"%_&.HZCXAN="UFQAM[V)2V8#\O&,@
M\GL<Y!K(TSQ_XEUNWN%TO0K>>X@^9V#$(J]A@L"2<'@'M61X*-E#\2@+.WGM
MK2:%_LR7&=S#:#GGUP36S\(!_H6K'_ILG\C3J4X04I<O1"A.4K*_<Z3P5XJ;
MQ5IDTTT"PW$#['5#E3D9!&>G?CVKIJ\U^$7_ ![:Q_UV3^35Z57)B(J%1J.Q
MO2DY0384445@:A1110 4444 %%%% !7'?$__ )$FX_ZZQ_\ H5=C7'?$_P#Y
M$FX_ZZQ_^A5M0_BQ]3.K\#,30?B-H>F^&[*PG%UYT, C;;$",X]<U4^&EX^G
M^%O$5[&JL]NGFJK="51B ?RKL/"EA9R>#--=[2!G-J"6,8))Q]*XSX<VTEYX
M1\2VL0S)-$8T'J3&P'\Z[&X.,[+JK_><_O)QN^C_ ".OT3Q5=:IX)O=<E@A2
M>!)F6-<[3L7(SSFLH^/K_P#X00:]]DMO/^U>1Y?S;<8Z]<YKE]"\3QZ?X)U/
MP\UE=/J,@F546/A59<$MW&.2>*B/_)'!_P!A+^E/V$5)W7VE;T%[5M:/I^)T
M-U\0]?LK>RU.YT*&/2KD@(Q<[WXY(YXSR1D5)/\ $+6M/N[*XU'1([?2KTYA
M;=F0IQSUQG!!P0*I^.ACX9>'/I!_Z)-+\31C0/#P'^?E6B,*<N5<N[:^X)2F
MKZ[69U7B;Q!K=AJ-MIVB:,]W-*NXSRHWE+UXSP,\9/([53\+^,=1U'Q#<Z%K
M-C#;WL2ELP'Y>,9!Y/8YR#6!X\U">/QC;6FJW%[;Z$8P?]%.-_!R?<YP/8?6
MJ'@HV4/Q* L[>>VM)H7^S)<9W,-H.>?7!-2J,?8W:Z7_ *_RL4ZC]I9/J:^F
M>/\ Q+K=O<+I>A6\]Q!\SL&(15[#!8$DX/ /:NF\%>*F\5:9--- L-Q ^QU0
MY4Y&01GIWX]JYOX0#_0M6/\ TV3^1H^$7_'MK'_79/Y-2K0@E-)6M;\0IRE>
M+;WN>E4445YYUA1110 4444 %%%% !1110!P7C+Q'K%IXGL='T>\M[9I8#)(
M\X7:/O=2P..%/YUJ^';G7;73[^^\17MK<VR1B2)[7# *H8O]T#/;\JR-:L?"
M&I>-WAU>:X%\(@#'*_EPD;01AN#G!]>N:I?#<*-:\0Z=;.;C1U<B/=\RD;B!
M['*_GBN]QC[+1;)7T\^C.5-^TW_'] LO'FH:UXZTZVM5DM=*FR!')&NZ8 -\
MV<<<C'![5J^*?$&L-XFLO#>@21074R>9)/(H(48)QR#V!/0]JHZZJI\8/#ZJ
MH51:@  8 &9:9J,L>F_&6TN;N01036^%D<X4?(R]?J,?C3Y8-II?9;M_6XKR
M2:;ZE[PYXIU2[LM=L-39!JFF(Y$J* &P&&<=."/3D$5+X2\6[_"(U3Q#J$:L
M;AHA(ZA<], !1]>U8&@,M[X@\:ZA =]L8)D5U^ZV2<$?@IKCM,AN+:VTS5M1
MMS<Z'%>&,QDY /!;C_.=N*T]C"7,MMORV1/M)1L_7\SW^UNH;VUCN;=]\,B[
MD;!&1Z\US=QJE[/\1[72K:=EL[>T:>Y0 ?,3D '\U-=/#)'-!'+"RM$ZAD9>
MA!'!%<;X-_XF/B;Q+K1Y5[D6L3?[*#!_3;7#32M*3Z+\SIDW=(O>/M6OM%\,
M->:?/Y,XF1=^Q6X/7@@BN9>Y^(5GHD>N'4K.[M?)6X:$1+NV$;N0$'0=<&MG
MXI?\B8__ %WC_K3)/$VCV?P\CC;4;5[C^S5B$"2JSES&!C:#GKU]*Z*>E.+4
M;W?;T,I_&[NVALZ-XILM2\,1ZU<R1VL>")M[8".."/?V^M6=*\2Z-K<K1:=J
M$4\BC)095L>N" 2*\:O[6\M/A]HWFJRVUS>RS$/G'W5"YQZ@.:Z"VLK@>-]&
MG$_A^TF4KB'36<>;'D@]B"=N>XXJI8:%FT^_X$QK2T5NWXGK5%%%>>=84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%8GBS7)/#N@RZC%"LSHZKL8X!R<5'X2\30^*-(^U*B
MQ7$;;)H@<[3V/T(_KZ5?LY<G/T)YUS<O4WZ*Y?P5XJF\4VMW+-;1P&"0( C$
MYR,]ZZBE.#A+EEN$9*2NAH10Q8* QZD#DTZBBI*"FJBIG:H7)R<#&:=7*>-/
M%L_A;[!Y-K'/]J9P=[$;=NWT_P!ZKA!SERQ)E)15V=7169X@U-]&T&\U&.-9
M'@3<$8X!Y _K47A;6I/$'AZWU*6%87E+@HIR!AB/Z4<CY>?H',N;EZFQ1114
M%!32BE@Q4%AT..13J* $95=2K ,#U!&:4# P*** $95=2K*&4]01D4!0JA5
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MT)#2Q3,ZJ1R<D1^]:QIUDK1?X_\ !,W.F]7^1W=[I=CJ-@;&[M8Y;4@#RR,
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MB?#&E'3?L_V3SV\O[/MV?=/3'%/N/!?C35H8].U77;=K!",D$LQ Z?P@L?\
M>-:OB?P-+J'AS3=(TB2")+-B<W#$;A@Y/ /))S6]+DISBW*^OR,Y\TXOW3-\
M<2R)XN\*JCLJF1,@'&?WBU1U2RN-7^+EWIJWUQ;0RQJ)6A?!V")20/3.*ZCQ
M+X4OM8U[1+ZWEMEBL&4RB1F#'# _+@'T[XIT?A:^3XD3>(C+;_8WCVA-S>9G
MRPO3&.H]:J%6,8K76S^^XI0DY/3JOR.;\,6\OASXH7.A6]U-)9-&3MD;.<H'
M!/;(SC-)H.HRV/B[QG=[F?[+'<2JC$D95R0/TKI4\+7R_$>3Q$9;?[&T>T)N
M;S,^6%Z8QU'K46C>#KFS\2:]>WKV\EGJ8D41QLV[:[9P<@8X/8T.K!W;>Z7W
MWU$H25DN[.4\/^$Y_&>BW6M7FK7/]HM*RP$O\BD ?>XSCGMC KH]>L[S3_ D
M5EJ_B46TB/M>Y6-F:9><)P<GW/MSWK,7P+XKTRVN]*TG5[;^R[HG<),AL$8.
M?E.,CC@\U=U7X<S3^$K'3+2]#75K(TA>;(20L.1WQC Q]/>JE.+FFYJU]--A
M*+47[NMCB(Y[32?$&DW'A^75$C>55DENE"K-\PSMQU&#R#ZBNNA_Y+E<?]<1
M_P"B5I-1\%^+=9FL;R_U'3GGM&'EPC<J*!@YR%ZD@=JW8_"U\OQ'E\1&6W^R
M/'M"!F\S/EA>F,=1ZTYU8-;ZV:_K048273JCKJ***\P[0HHHH **** "BBB@
M KEOB/\ \B%J?_;+_P!&I74UE>(]&_X2#0;G2_/\CS]O[S9NV[6#=,CT]:TI
M-1FF^Y$TW%I'E%D;CP7]AOQO?2]8L0)1_=<KS^()R/8D5+I^LW>C?"AWLG:.
M6XU!H?,7J@* G!['C%>CW7A2WO?!\7A^XEW>3"J)/LP5=1@,!G],]"15&P\!
M6D'A*;0+RZ:Y228S+,J>64;  (&3TQ^M=WUBG)7EO?[TKG-[*:>G8Y+7_#\_
M@[2++7M/U>[:],B";S'RLA()X'<<=#GBM"_O9-#\=:1KCNT=AJ\"B968[48@
M _3'R'\ZNQ?#>::2VBU77[F^T^U(,5L4VC'H3N/T^GI70^*?#,'B;1EL&E%N
MT;J\4@3=LQQC&1Q@D=:EUH72D[[W=NC_ ,AJG*S:5MK'#Z1J=Y<?\)1XS!=E
MC5HK-&R5!XP<>PV_F:K0^&IKSP3)XJEUF]_M0(]PK>;\H"L?E]<\>O7M7HND
M^'+33/#*Z&^)X#&R2L1M\S=G<>O'7UXKES\-+A86T^+Q'=)I+ON:UV9[YQG.
M/TZ]J(UX7=G;5=.BZ Z<K*ZO_F='X,U6XUGPG8WMT<SLK([8QN*L5S^./SKA
MO$:ZFWQ:A&CO$E_Y \LR_=_U;9S^&:]-T[3[?2M/@L;1-D$*[4']3[GK6-+X
M4\SQQ#XD^VX\N/9]G\KK\A7.[/OGI6-.I&,Y2Z-.QI.$G%+T*MA'XI2PU3_A
M()K1XOLK^4(!R&P<YX':J'PE_P"12G_Z_'_] 2NVNH/M-G/;[MOFQLF[&<9&
M,UP%I\,]1L8&M[;Q==P6[$LT<,3("3P>!)[4XSC.$HR=KVZ XRC)-*^Y!X*>
M./XA>)FA*K9KYA8C[H(D_E]ZN3EUG2-8UCQ!?ZN\@:YB,=D!'NVG/RGVP%7\
MS7IUGX(M],\,7NDZ?=O%/>KB:[=-S'L1@$<8R!SQFKOA[PO9:%HT5@4BN70E
MGF>( N2<].<=AU[5K[>FFY+?1?=U,_93:2]687PLUG[?X<:PD;,UB^T9[QMR
MOZY'X"NZKE]-\'#2?%MUK5I>A(+D$/9B'CG!X;=_>&>G?%=17+7<93<H]3>F
MI*-I= HHHK$T"BBB@"K<Z;8W;^9<V5O,X& TD2L<>F2*\T^$UA9WEIJANK2"
M<J\>TRQAL<-TS7JIZ&O._A9INH:?9:HMY9W%J[NFSSXF3/#=,@9KJIR_<S5^
MQA-?O(Z=RMJNJ^,K9[R4W>FZ):VX/D6LK1%I%&<!>&R< >E68?&FIW?PSO-:
M4QQW]M,L)<("&^9.<'CHU<M8:5J,%SJ5OJ7A>[U+5IR1%<RY,:$Y!8D_*1GG
M.?RK0TW2M37X4ZSISZ9>K=M=HZ0M;N&=<Q\@8R?NGI77*$+*]MUV_P _S,%*
M5WOLS9\.:WXLO($UW4I8%T1()))$1%#.$4\CN,D>N/:JNE^(/&VMVMUKEDUD
MMA S8M'7F0 9(4XSG'?(YKI]#TQY?AW#IEVCVSR6;Q2"12ICW C)!Z8SFN+T
M2?Q5X?TB\T*'1#.KES'>!OW48(P3NQ@CC(Y!_E6:Y9<UDKI_@6[JUV_^":.C
M>/;]/!.H:OJ!2XN8K@0P+L"@DJ",X[=3^%9__"9>*M,L[36;V\T^ZL[AAFT3
M;O0$9&<#(X]S[U2\-Z%<>(/AQJ=M:@&XCOA+&I.-Q"#(S]":BM]/GDMK/3X/
M S'45(6>>Z641N.F>H SUSG%;<E)2DK+?RVL9\T[+7H6?%LFJW?CW2;BVGAS
M<"*33F(X52<C=Q_>R>]>MV"W2Z?;+>LCW8B43,GW2^/F(]LYKSGQEINH:=KW
MAW4;/3)+J"QBC0QVRLP!1L[>Y QT)KT73[F2\TZWN9K=[:66,.\+_>C)'*G@
M=/I7)7=Z<+;&])6G*YYV_P#R7:/_ '/_ &W->FUY5KZ:QIGQ/?6K/1+R^BC1
M0OEPN5;,6T_, >F?TK>TSQCK]_J4%K-X3O+2.5MK3R+)MC]SE!_.G5IN<8R7
M1+JA4YJ+:?<R]8UCQI%-?7$E[I^C6\.6AMYWB+RCG 7ALG\N35F#QGJ5W\,K
MW6E,<>H6LJP[P@(;YDYP>.CUREAI6HP7.I6^I>%[O4M6G)$5S+DQH3D%B3\I
M&><Y_*MGP_H6I7'PQUK2'L;F"\>?S8XYHC&7 V$8W 9^X16\H4TE>VC7;;[[
M_>91E-MVOLSH+GQ%J4?PN77%E47YB1M^P8R9 IXZ=#63K7C'6;+P1H>J0SH+
MJZ8B9C&I#8SVQQTK'>Z\0WG@(^'(_#=ZI@ $LS1L,J'# *N,DYQTSP/RG\0Z
M/JDWP[\/6L6FWDEQ$S>9$D#%TZ]1C(I1IP37-;XGVVL-SDT[7V_$LZSXF\9^
M'GLM3U!K,V=TV?LD:@[!UVDXSG!Z@GI6UXJ\4ZI'KUEX?T!8A>W"AVFD&0H.
M2.OL"3P:K_$_3KV_T/3H[*SN+ETFRRPQ,Y4;>X JOXITK5M,\5:=XGTVQDO5
MCC59H8P2P(!4\#G!4]<<8J8>SDHMI7U_X!4N:-TF[:?\$U?#UYXPM]>?3==M
MUNK4KD7L2!54XR.0!D=NF<UQGA7_ (2&77M>M] DMH)'E+2SSC(4!FP!P>3D
M]NU==X?UCQ5KOB0W$UE)IVBHO,,\8RQQQAB 22>?0 56^'FG7UEK?B&2[LKB
MW2653&TL3('&Y^A(YZBB_(IW2O9:?,+<SC:^[+O@#Q-J.N+J%GJNQKJR=09%
M4#=G((('&05[>M=I7G_P]TZ^LM>\0R75G<01RR@QM+$RAQN?H2.>H_.O0*Y<
M0HJH^78VI-N&H4445@:A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 >8?&+_ (]](_WY?Y+4'Q%O[VQ3
MP\;.ZFA8P$XC<@,1LQD=ZT?BMIM_J,&EBQLKFZ*-+O$$3/MR%QG XJI\0-*U
M&];P]]EL+J?RHB)/*A9MA^3K@<=#7IT7'EIW\SBJ)WG;R,SQ;I&N>%H;+6&\
M074]U+)MD(8@*^-V!SRO!&,?AVK8\=^*-031=&MK&5H)M1A665XSM;! PH/8
M$D_E6C\4K"\U#0+2.RM)[F1;H,5AC+D#:W. *S?%WA?4=0\+Z%>6,$C7EC;(
MDD 7Y\;5Z#KD$=.O-$)QDH2G;=_\ )1<>91\C%\7^%-3\.^'(Y7UF:\@ED5;
MB%\[5?!(89)]QV-7/$-W<VGPM\.O;7$L+%E!:-RI(VMZ5%XBU/Q5XMT%+<^'
M;F".!E>9EC<M*_0;5(SCDDCGZU;\2:3J4_PUT"UAT^[DN8G7S(4A8NGRMU &
M16B;]Q5&KW\NQ+2][EO:Q-XP\2:A8>&=!L+&=X[F^MD:28-\^-JC /49)Z]>
M*1_ _BG2)[2[TC6Y+FX)S.LCE5!]\D[AVZ?_ %I?%WA74=3\,:'=V,+M>6-L
MBR08P^-J] >X(Z>]5;CQ%XW\0/:65CI5SILR,/.GV,JDXQR6& .^.:SC\"Y+
M=;WL5+XGS7Z6-CQS;ZI<FQ\[7;32=/*CSU\]E=G_ (L #YP!C S7':-JATCQ
MS86ND:Y<7]A/+'%(9 RJVYL$;6].H-:GC;1]5A\4:?J,]A-K%E%%&K*J$ABO
MW@P4<9//3'-4KBUU>\\7:/JX\+W%A8Q2Q;(8+<G:B/DE@H&#R>H%722]G9M6
M:?;_ (>Y,V^>_GY_\,5];T*X/Q,73O[3E$MS*'6XP=T0;) 'S=NG45M>+I+W
M2O$WABP34+AA'#!'(P=E\TA\%B,]\>]+XSM-5T[X@VFN6FF3WD*JC*(D+ D9
M!4D X-+XIM-5U?Q'X:U!=)NQ^ZA:=5A9A"V_)#''&/>A2YN1MJUGVWL#5N9+
M>Y+XRU?5=7\8P>%=+NGM4^42NC%2Q*[B21S@+V[\UFZM;ZW\.+^RNX=7EOK.
M9B'CDR 2,$J5)/4=".?ZZOC+0M8T_P 6P^*=&MFNB-IDC1=S @;>@Y(*\<>]
M9NI)XC^(>H65O+I$NFV,!)=Y%8 9QDY8#)P. *5-KEC:W+;7;?\ ,<[W>_-?
M0F^(&J:@/$NB-I=W+$9X(WC"N0I8N<$CH>W6L_Q5I^M>"[NPU&/7KJZFG+;V
M<D?,N#@@DY4YZ5M>--'O9/&/A]K*PN9K:W6)&DCB9E0"3N0,#BK/Q5TV^U&S
MTQ;&RN+HI)(6$$3/MX'7 XI4YI>SCI9IWV'.+?,^IZ!#)YL$<F,;U#?F*?4-
MHI6R@5@01&H(/;BIJ\Q[G:%%%%( HHHH **** "BBB@ HHHH **** "BBB@
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MHHH JZAJ5GI5FUW?W"00+P7<]_0#N?85C6'COPYJ5XMI;ZBOG.VU!)&R!CZ
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M>I/Y ?A6K1142DY.[*225D%%%%(84444 %%%% !1110 4444 %%%% !1110
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MX-T+2;J6XLK+RY)4:-CYKD;3U !-1*M"2DDK7M^!4:<DT_4\TT;_ )(_K_\
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MS[K_ )Y?^/#_ !KPJBC^R_[WX?\ !#ZY_=/=?[/NO^>7_CP_QH_L^Z_YY?\
MCP_QKPJBC^R_[WX?\$/KG]T]U_L^Z_YY?^/#_&C^S[K_ )Y?^/#_ !KPJBC^
MR_[WX?\ !#ZY_=/=?[/NO^>7_CP_QH_L^Z_YY?\ CP_QKPJBC^R_[WX?\$/K
MG]T]U_L^Z_YY?^/#_&C^S[K_ )Y?^/#_ !KPJBC^R_[WX?\ !#ZY_=/=?[/N
MO^>7_CP_QH_L^Z_YY?\ CP_QKPJBC^R_[WX?\$/KG]T]U_L^Z_YY?^/#_&C^
MS[K_ )Y?^/#_ !KPJBC^R_[WX?\ !#ZY_=/=?[/NO^>7_CP_QH_L^Z_YY?\
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M^->%44?V7_>_#_@A]<_NGNO]GW7_ #R_\>'^-']GW7_/+_QX?XUX511_9?\
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MNES<*L?EHS@#Y-BCC(!/)X_&H]#TO2O#T^J7;^(-.F2>UDBMD2<;F4\_-[\
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MH ?FC-,S1F@!^:,TS-&: 'YHS3,T9H ?FC-,S1F@!^:,TS-&: 'YHS3,T9H
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MJ?W?Q_X ?4_[QX517OM[>3PW3(DF% '&!5?^T+K_ )Z_^.C_  H_M3^[^/\
MP ^I_P!X\*HKW7^T+K_GK_XZ/\*/[0NO^>O_ (Z/\*/[4_N_C_P ^I_WCPJB
MO=?[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "C^U/[OX_P# #ZG_ 'CPJBO=?[0N
MO^>O_CH_PH_M"Z_YZ_\ CH_PH_M3^[^/_ #ZG_>/"J*]U_M"Z_YZ_P#CH_PH
M_M"Z_P">O_CH_P */[4_N_C_ , /J?\ >/"J*]U_M"Z_YZ_^.C_"C^T+K_GK
M_P".C_"C^U/[OX_\ /J?]X\*HKW7^T+K_GK_ ..C_"C^T+K_ )Z_^.C_  H_
MM3^[^/\ P ^I_P!X\*HKW7^T+K_GK_XZ/\*/[0NO^>O_ (Z/\*/[4_N_C_P
M^I_WCPJBO=?[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "C^U/[OX_P# #ZG_ 'CP
MJBO=?[0NO^>O_CH_PH_M"Z_YZ_\ CH_PH_M3^[^/_ #ZG_>/"J*]U_M"Z_YZ
M_P#CH_PJQ%>3M9SR&3YE*X.!QS1_:G]W\?\ @!]3_O'@5%>Z_P!H77_/7_QT
M?X4?VA=?\]?_ !T?X4?VI_=_'_@!]3_O'A5%>Z_VA=?\]?\ QT?X4?VA=?\
M/7_QT?X4?VI_=_'_ ( ?4_[QX517NO\ :%U_SU_\='^%']H77_/7_P ='^%'
M]J?W?Q_X ?4_[QX517NO]H77_/7_ ,='^%']H77_ #U_\='^%']J?W?Q_P"
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MC^U/[OX_\ /J?]X\*HKW7^T+K_GK_P".C_"C^T+K_GK_ ..C_"C^U/[OX_\
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M9C3L[HMWM[-J%[-=W+[YIG+N?<U7S3,T9H225D%[C\T9IF:,TQ#\T9IF:,T
M/S1FF9HS0 _-&:9FC- #\T9IF:,T /S1FF9HS0 _-&:9FC- #\T9IF:,T /S
M5W3M/EU"<(@.W/)INFZ=-J,X1 =N>37I^B:)%80+\HW8KR\;C?9_NZ>_Y?\
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M]XTRW_X^8O\ ?'\Z?>?\?<O^\: (**** "BBB@ HHHH **** "BBB@ HHHH
M:[;5)KD=0\1ZC9731;;<KGY6VGD?G77D9&*YW7=%%U&9(^''(K6E.,9>^KHB
M<6UH[,Q_^$NU#^Y;_P#?)_QH_P"$NU#^Y;_]\G_&L"6-X)#'(N&%,W5[D,/0
MFN:,58\]U:D79LZ+_A+M0_N6_P#WR?\ &C_A+M0_N6__ 'R?\:YW=1NJ_JE'
M^5"]M/N=%_PEVH?W+?\ [Y/^-'_"7:A_<M_^^3_C6%;V]Q=.4MX)9F'41H6/
MZ4DL,T$OE30R1R?W'4@_D:7U:A>W*OZ^8>UJ=S>_X2[4/[EO_P!\G_&C_A+M
M0_N6_P#WR?\ &N?D22&0QRHR..JL""/PINZCZK1_E0>VGW.B_P"$NU#^Y;_]
M\G_&C_A+M0_N6_\ WR?\:YW=1NI_5*/\J#VT^YT7_"7:A_<M_P#OD_XT?\)=
MJ']RW_[Y/^-<[NIYCE6)96C<1L<*Y4X/T-+ZK1_E0>VGW-__ (2[4/[EO_WR
M?\:/^$NU#^Y;_P#?)_QKG=U*N68*H)). !WI_5:/\J#VT^YT/_"7:A_<M_\
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M)KFZ*/J]+^5?<'M9]V=)_P )]XF_Z"?_ ) C_P#B:/\ A/O$W_03_P#($?\
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M/#/_ $!?_)J3_&C_ (1CPS_T!?\ R:D_QK1HH^L5?YG]X>RAV1G?\(QX9_Z
MO_DU)_C1_P (QX9_Z O_ )-2?XUHT4?6*O\ ,_O#V4.R,[_A&/#/_0%_\FI/
M\:/^$8\,_P#0%_\ )J3_ !K1HH^L5?YG]X>RAV1G?\(QX9_Z O\ Y-2?XT?\
M(QX9_P"@+_Y-2?XUHT4?6*O\S^\/90[(SO\ A&/#/_0%_P#)J3_&C_A&/#/_
M $!?_)J3_&M&BCZQ5_F?WA[*'9&=_P (QX9_Z O_ )-2?XT?\(QX9_Z O_DU
M)_C6C11]8J_S/[P]E#LBG<^$O#-O,8_['W8QS]ID'_LU1?\ ",>&?^@+_P"3
M4G^-;>HC%ZV/0?RJK1]8J_S/[P]E#LC._P"$8\,_] 7_ ,FI/\:/^$8\,_\
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M#EEV'[VV[=QV]<9XK=_MZWMO!XT>Q25;BYE,E[*P # ?=5<'ITST_6N?V/\
MW&_*C8_]QORJ).G*UVM-=U_F4E-;(7-&:38_]QORHV/_ '&_*K]I#NOO7^9/
M++L+FC-)L?\ N-^5&Q_[C?E1[2'=?>O\PY9=A<T9I-C_ -QORHV/_<;\J/:0
M[K[U_F'++L+FC-)L?^XWY4;'_N-^5'M(=U]Z_P PY9=A<T9I-C_W&_*C8_\
M<;\J/:0[K[U_F'++L+FC-)L?^XWY4;'_ +C?E1[2'=?>O\PY9=A<T9I-C_W&
M_*C8_P#<;\J/:0[K[U_F'++L+FC-)L?^XWY4;'_N-^5'M(=U]Z_S#EEV%S1F
MDV/_ '&_*C8_]QORH]I#NOO7^8<LNPN:,TFQ_P"XWY4;'_N-^5'M(=U]Z_S#
MEEV%S1FDV/\ W&_*C8_]QORH]I#NOO7^8<LNPN:,TFQ_[C?E1L?^XWY4>TAW
M7WK_ ##EEV%S1FDV/_<;\J-C_P!QORH]I#NOO7^8<LNPN:,TFQ_[C?E1L?\
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MQZ77^ZO\ZJ5;MO\ CTNO]U?YU4H **** "BBB@ HHHH **** "BBB@ HHHH
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M[Y7_ !H^K5OY6'M8=RQ_PC5G_<'Y4?\ "-6?]P?E5?\ X3&S_P">-Q_WRO\
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MU?YU4H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP;I^_#;\CT*-?F]V6YT5% .:*\TZ@JWJ'_'PO^X*J5;U#_CX7_<% %2BBB@
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M_P"%D)_T XO_  (/^%'_  LA/^@'%_X$'_"CZC7[?B@^LT^YU]%<A_PLA/\
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M * <7_@0?\*/^%D)_P! .+_P(/\ A1]1K]OQ0?6:?<Z^BN0_X60G_0#B_P#
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M_"R$_P"@'%_X$'_"C_A9"?\ 0#B_\"#_ (4?4:_;\4'UFGW.OHKD/^%D)_T
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M110 4444 %%%% $EO_Q\Q?[X_G3[S_C[E_WC3+?_ (^8O]\?SI]Y_P ?<O\
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M\_M_^2?X4?\ " :'_P _M_\ DG^%']H4._X!]5J'FU%>D_\ " :'_P _M_\
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M_A -#_Y_;_\ )/\ "C_A -#_ .?V_P#R3_"C^T*'?\ ^JU#S:BO2?^$ T/\
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M6[;_ (]+K_=7^=5* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@"WJ7_'Z_T'\JJ5;U+_ (_7^@_E52@ HHHH **** "BBB@"4QVD
M]D8[N)9@LJR+&W0L.F?:F22-*Y=SEC3:*=W:P6"BBBD 4444 %%%% !1110
M4444 %6X?^0=<_5?YU4JW#_R#KGZK_.@"I1110 4444 %%%% !1110 4444
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M>@_\(/%Z4?\ "#Q>E']JP_E?X!]2EW//LT9KT'_A!XO2C_A!XO2C^U8?RO\
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M^X*J5;U#_CX7_<% %2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@"W;?\ 'I=?[J_SJI5NV_X]+K_=7^=5* "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"WJ7_ !^O]!_*JE6]2_X_7^@_
ME52@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JW#_P @
MZY^J_P ZJ5;A_P"0=<_5?YT 5**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** '1_P"M3_>%37W_ !^R_4?RJ&/_ %J?[PJ:^_X_9?J/
MY4 5Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH DM_^/F+_
M 'Q_.GWG_'W+_O&F6_\ Q\Q?[X_G3[S_ (^Y?]XT 04444 %%%% !1110 44
M44 %%%% !1110 C':,U@7'BJVMIVADM[@,IP?E7_ !K>9=RD5R'B+2)"3/&,
MD=JUI>SYK5-B)\UO=W+G_"8V7_/&X_[Y7_&C_A,;+_GC<?\ ?*_XUQ!."0>"
M.U&ZO86!HM77YG$\1-';_P#"8V7_ #QN/^^5_P :/^$QLO\ GC<?]\K_ (UQ
M&ZC=3^H4?/[Q?6)G;_\ "8V7_/&X_P"^5_QH_P"$QLO^>-Q_WRO^-<1NHW4?
M4*/G]X?6)G;_ /"8V7_/&X_[Y7_&C_A,;+_GC<?]\K_C7$;J-U'U"CY_>'UB
M9V__  F-E_SQN/\ OE?\:/\ A,;+_GC<?]\K_C7$;J-U'U"CY_>'UB9V_P#P
MF-E_SQN/^^5_QH_X3&R_YXW'_?*_XUQ&ZC=1]0H^?WA]8F=O_P )C9?\\;C_
M +Y7_&C_ (3&R_YXW'_?*_XUQ&ZC=1]0H^?WA]8F=O\ \)C9?\\;C_OE?\:/
M^$QLO^>-Q_WRO^-<1NHW4?4*/G]X?6)G;_\ "8V7_/&X_P"^5_QH_P"$QLO^
M>-Q_WRO^-<1NHW4?4*/G]X?6)G;_ /"8V7_/&X_[Y7_&C_A,;+_GC<?]\K_C
M7$;J-U'U"CY_>'UB9V__  F-E_SQN/\ OE?\:/\ A,;+_GC<?]\K_C7$;J-U
M'U"CY_>'UB9V_P#PF-E_SQN/^^5_QH_X3&R_YXW'_?*_XUQ&ZC=1]0H^?WA]
M8F=O_P )C9?\\;C_ +Y7_&C_ (3&R_YXW'_?*_XUQ&ZC=1]0H^?WA]8F=O\
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M=W<QM)!:S2HGWFCC+ ?4BH,UZQX<@N4\+:5<!YK**U#R3PB+)N%Y.<=>>O\
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M_P +%T__ * TO_@1_P#6KSVBCZC0[?BP^LU.YZ%_PL73_P#H#2_^!'_UJ/\
MA8NG_P#0&E_\"/\ ZU>>T4?4:';\6'UFIW/0O^%BZ?\ ] :7_P "/_K4?\+%
MT_\ Z TO_@1_]:O/:*/J-#M^+#ZS4[GH7_"Q=/\ ^@-+_P"!'_UJ/^%BZ?\
M] :7_P "/_K5Y[11]1H=OQ8?6:G<]"_X6+I__0&E_P# C_ZU'_"Q=/\ ^@-+
M_P"!'_UJ\]HH^HT.WXL/K-3N>A?\+%T__H#2_P#@1_\ 6H_X6+I__0&E_P#
MC_ZU>>T4?4:';\6'UFIW/0O^%BZ?_P! :7_P(_\ K4?\+%T__H#2_P#@1_\
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M_A8NG_\ 0&E_\"/_ *U'_"Q=/_Z TO\ X$?_ %J\]HH^HT.WXL/K-3N>A?\
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M%KAI"65BF\!?0 <=:Y_['8Z=X0MM0>SCN)H]6,3%R1YB -\I]N!47_"66/\
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MNWI<QJ_%\D/S1FF9HS709#\T9IF:,T /S1FF9HS0 _-&:9FC- #\T9IF:,T
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MI]CB?^%;WO\ T%+#_OIO\*/^%;WO_04L/^^F_P *[:BC^T*_?\ ^JT^QQ/\
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M_:%?O^ ?5:?8XG_A6][_ -!2P_[Z;_"C_A6][_T%+#_OIO\ "NVHH_M"OW_
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M/4FDHHKS3K"BBB@ HHHH **** "BBB@ JW#_ ,@ZY^J_SJI5N'_D'7/U7^=
M%2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!T?^M3
M_>%37W_'[+]1_*H8_P#6I_O"IK[_ (_9?J/Y4 5Z*** "BBB@ HHHH ****
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M[?@._P"$'A]!1_P@\/H*;_PEVH?W+?\ [Y/^-'_"7:A_<M_^^3_C1]5Q/?\
M$/:TNWX#O^$'A]!1_P (/#Z"F_\ "7:A_<M_^^3_ (T?\)=J']RW_P"^3_C1
M]5Q/?\0]K2[?@._X0>'T%'_"#P^@IO\ PEVH?W+?_OD_XT?\)=J']RW_ .^3
M_C1]5Q/?\0]K2[?@._X0>'T%'_"#P^@IO_"7:A_<M_\ OD_XT?\ "7:A_<M_
M^^3_ (T?5<3W_$/:TNWX#O\ A!X?04?\(/#Z"F_\)=J']RW_ .^3_C1_PEVH
M?W+?_OD_XT?5<3W_ !#VM+M^ [_A!X?04?\ "#P^@IO_  EVH?W+?_OD_P"-
M'_"7:A_<M_\ OD_XT?5<3W_$/:TNWX#O^$'A]!1_P@\/H*;_ ,)=J']RW_[Y
M/^-'_"7:A_<M_P#OD_XT?5<3W_$/:TNWX#O^$'A]!1_P@\/H*;_PEVH?W+?_
M +Y/^-'_  EVH?W+?_OD_P"-'U7$]_Q#VM+M^ [_ (0>'T%'_"#P^@IO_"7:
MA_<M_P#OD_XT?\)=J']RW_[Y/^-'U7$]_P 0]K2[?@._X0>'T%'_  @\/H*;
M_P )=J']RW_[Y/\ C1_PEVH?W+?_ +Y/^-'U7$]_Q#VM+M^ [_A!X?04?\(/
M#Z"F_P#"7:A_<M_^^3_C1_PEVH?W+?\ [Y/^-'U7$]_Q#VM+M^ [_A!X?04?
M\(/#Z"F_\)=J']RW_P"^3_C1_P )=J']RW_[Y/\ C1]5Q/?\0]K2[?@._P"$
M'A]!1_P@\/H*;_PEVH?W+?\ [Y/^-'_"7:A_<M_^^3_C1]5Q/?\ $/:TNWX#
MO^$'A]!1_P (/#Z"F_\ "7:A_<M_^^3_ (T?\)=J']RW_P"^3_C1]5Q/?\0]
MK2[?@._X0>'T%'_"#P^@IO\ PEVH?W+?_OD_XT?\)=J']RW_ .^3_C1]5Q/?
M\0]K2[?@._X0>'T%'_"#P^@IO_"7:A_<M_\ OD_XT?\ "7:A_<M_^^3_ (T?
M5<3W_$/:TNWX#O\ A!X?04?\(/#Z"F_\)=J']RW_ .^3_C1_PEVH?W+?_OD_
MXT?5<3W_ !#VM+M^ [_A!X?04?\ "#P^@IO_  EVH?W+?_OD_P"-'_"7:A_<
MM_\ OD_XT?5<3W_$/:TNWX#O^$'A]!1_P@\/H*;_ ,)=J']RW_[Y/^-'_"7:
MA_<M_P#OD_XT?5<3W_$/:TNWX#O^$'A]!1_P@\7I2Q>+[T2*9(H2F?F"@@X]
MN:ZVQOX;^W66%@5/Z5A5IUZ6LF_O9I"5.>R_ Q=+\+V]B^[8,_2NC1 B@ 4Z
MBN9MO5FR5M@HHHI %6]0_P"/A?\ <%5*MZA_Q\+_ +@H J4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 6[;_CTNO]U?YU4JW;?\>E
MU_NK_.JE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!;U+_C]?Z#^55*MZE_Q^O]!_*JE !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !5N'_D'7/U7^=5*MP_\@ZY^J_SH J4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 .C_UJ?[PJ:^_X_9?J/Y5
M#'_K4_WA4U]_Q^R_4?RH KT444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!);_P#'S%_OC^=/O/\ C[E_WC3+?_CYB_WQ_.GWG_'W+_O&@""B
MBB@ HHHH **** "BBB@ HHHH **** $(R,5SNNZ*+J,R1C#CD5T=(RAA@TTV
MG= U<\FE1X)#'(N&%,W5W&NZ$EU&9(QAQSQ7#31/;RF.0885[N$Q2JKEE\7Y
MGG5J3AJMA=U&ZHMU&ZO0L<UR7=1NKMK^]B\%:=86EC:P-J,\(FGN)4W$ ]A^
M(/Y>IJC=ZKIWBBSMHKF**TUAIUC$T<>$920,M^?OT]ZYHU6_>4?=[_K;L:N"
M6E]3E]U&ZM=?#-XWB@Z%O43 \R8.W;C=N_*K%KX4,MO)=W6I6MI9"9H8IY/^
M6I!(RH].#5NK377^F2H2?0P-U&ZNUT[09=&77X+KRI@=,>6&5>588."/0\5G
M7>FZAJ&E^'+:-+9C<+*(1&I5L9&2Y/7'7CWJ%7BWIMW^5RG3:7]=['-[J-U=
M)<^#72UNGM-4M+N>T4M/!$3N4#KCUK-\,:A'IWB&TFF5&A9O+DW#("MQG\.O
MX5:J1E%RAK8GE::4M#-W4;JW-6T&2+QF^DPKA9IQY7' 1N?T&?RK;UK2!KFL
M7$=M);V6F:5&L#SR<+N'7ZGM^'O4NO%6[-7'[-ZG$;J-U;MWX4F@-E);7D%W
M9W<RPI<1=%8G'([?_6J^W@"?SI;6/5;*2^1=XM@3N*]B?3M^=-UZ2W8>SGV.
M3W4;JZ"_\)/::7<7L&I6EV;4@7$<)R4R<=>_Z=ZZ73])2[\1V?\ :?V!BFFH
M\4*1D!P=W)!ZD8Y^HJ)8B"7,M=QJG)NS/.MU&ZNE%A,GA>[A@N+*>T%^D?G*
MAWLQ"]#Z<^GK5A_ +QW?V-]9L5NW&8H23N<8].H[^O2J]O37Q/\ K[A>SD]C
MDMU&ZM?3?#-S?27IGGAL[>R8I/-,?E5@<8'J:EUCPN^E:3'J:7]O=6TLHCC:
M+/.03G]",5?M:?-RWU%R2M>QA[J-U;G@N"RNO$L$5\$9-I*(_P!UG[ UT\VH
MZK;7$L/B30HGTHJP+6\&X1CL00>/QP:SJ5N2?*E?YV^[N5&%U>YYYNHW5ISZ
M*?[".LVTXDMOM!A*8PZ>A;MTQ^8J[9>#[F\73<W4,4E_&\B(P.55><GZY'YU
MHZL$KMDJ$F[)'/[J-U='=>#GAL+JXM]4L[N6S7=<0Q-DH!UY]L'TZ&FVGA"2
M:RMI[O4K2RDNQFWAF/S/Z?3/'KUJ?;4[7N/DG>UCGMU&ZN[U[PV^M^,+NWMI
M8;<0V\;G<,#T[5D+X.,EQ,8M6LGL($#RW@;Y%)S\ON?Q[BICB*;2;=ANG)/0
MYO=1NK9U+PS+8PVUU!=P7EE<2"-9XN@8]B.U:K^ )DN6M/[7LOMA7?'!D[G'
MK[?K5.O22NV+V<WT.1W4;JZ.Z\&RV^GW4\>I6EQ/9KNN+>)LF,=^?48/Y4RT
M\)L]A;75_J=K8"ZY@28_,X]?8<C\Z/;4[7N')*]K'/[J-U6=6TRYT;49+*[
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M);_\?,7^^/YT^\_X^Y?]XTRW_P"/F+_?'\Z?>?\ 'W+_ +QH @HHHH ****
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M ._S?_$T?\*WU3_H(:7_ -_F_P#B:/K=#^9!["IV.-HKLO\ A6^J?]!#2_\
MO\W_ ,31_P *WU3_ *"&E_\ ?YO_ (FCZW0_F0>PJ=CC:*[+_A6^J?\ 00TO
M_O\ -_\ $T?\*WU3_H(:7_W^;_XFCZW0_F0>PJ=CC:*[+_A6^J?]!#2_^_S?
M_$T?\*WU3_H(:7_W^;_XFCZW0_F0>PJ=CC:*[+_A6^J?]!#2_P#O\W_Q-'_"
MM]4_Z"&E_P#?YO\ XFCZW0_F0>PJ=CC:*[+_ (5OJG_00TO_ +_-_P#$T?\
M"M]4_P"@AI?_ '^;_P")H^MT/YD'L*G8XVBNR_X5OJG_ $$-+_[_ #?_ !-'
M_"M]4_Z"&E_]_F_^)H^MT/YD'L*G8XVBNR_X5OJG_00TO_O\W_Q-'_"M]4_Z
M"&E_]_F_^)H^MT/YD'L*G8XVBNR_X5OJG_00TO\ [_-_\31_PK?5/^@AI?\
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M44 %%%,EE2&-G=@J@9))Z4 $LJ0QEW8*H&23VKS3Q/XH;4I&M+1B+4'#,/\
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M: 'YHS3,T9H ?FC-,S1F@!^:,TS-&: 'YHS3,T9H ?FC-,S1F@!^:,TS-&:
M'YHS3,T9H ?FC-,S1F@!^:,TS-&: 'YHS3,T9H ?FC-,S1F@!^:,TS-.C5Y7
M"(,L>@%)M)78TKZ(>BM(X1!ECT KN/#?AO;MGG7+'UI/#7AK8%GG7+'UKN(H
MEB0*HP!7SN,QCK/DA\/YGJX?#\GO2W"*)8D"J, 5)117FG6%6]0_X^%_W!52
MK>H?\?"_[@H J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 6[;_CTNO\ =7^=5*MVW_'I=?[J_P ZJ4 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** +>I?\?K_0?RJI5O4O^/U_H/Y54H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *MP_\@ZY^J_SJI5N'
M_D'7/U7^= %2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@!T?^M3_>%37W_'[+]1_*H8_]:G^\*FOO^/V7ZC^5 %>BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** )+?_CYB_WQ_.GWG_'W+_O&F6__
M !\Q?[X_G3[S_C[E_P!XT 04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4K,S'+$D^YI** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!0S $!B >H!ZTE%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 K,SG+,6
M/J3FDHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *4,
MP4J&(4]1GK244 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !TI68L26))/<TE% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%%  "000<$=Z4DL2222>YI** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,
MMO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+
M;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z
M,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^
MS+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_L
MRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.
M@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH
M_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO
M[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1O
MSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\
MZ/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BM
MK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T
M;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&
M_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%H
MK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV
M]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO
M1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q
M:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,
MMO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+
M;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z
M,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^
MS+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_L
MRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.
M@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH
M_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO
M[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1O
MSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\
MZ/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BM
MK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T
M;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%HK:_LRV]&
M_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV]&_.@#%H
MK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO1OSH_LRV
M]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH Q:*VO[,MO
M1OSH_LRV]&_.@#%HK:_LRV]&_.C^S+;T;\Z ,6BMK^S+;T;\Z/[,MO1OSH N
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVK_]_H__ (W1R4?YG]W_  0YJG\OXGIE%>9_\*.\,_\ /]J__?Z/_P"-T?\
M"CO#/_/]J_\ W^C_ /C=')1_F?W?\$.:I_+^)Z917F?_  H[PS_S_:O_ -_H
M_P#XW1_PH[PS_P _VK_]_H__ (W1R4?YG]W_  0YJG\OXGIE%>9_\*.\,_\
M/]J__?Z/_P"-T?\ "CO#/_/]J_\ W^C_ /C=')1_F?W?\$.:I_+^)Z917F?_
M  H[PS_S_:O_ -_H_P#XW1_PH[PS_P _VK_]_H__ (W1R4?YG]W_  0YJG\O
MXGIE%>9_\*.\,_\ /]J__?Z/_P"-T?\ "CO#/_/]J_\ W^C_ /C=')1_F?W?
M\$.:I_+^)Z917F?_  H[PS_S_:O_ -_H_P#XW1_PH[PS_P _VK_]_H__ (W1
MR4?YG]W_  0YJG\OXGIE%>9_\*.\,_\ /]J__?Z/_P"-T?\ "CO#/_/]J_\
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MVK_]_H__ (W1R4?YG]W_  0YJG\OXGIE%>9_\*.\,_\ /]J__?Z/_P"-T?\
M"CO#/_/]J_\ W^C_ /C=')1_F?W?\$.:I_+^)Z917F?_  H[PS_S_:O_ -_H
M_P#XW1_PH[PS_P _VK_]_H__ (W1R4?YG]W_  0YJG\OXGIE%>9_\*.\,_\
M/]J__?Z/_P"-T?\ "CO#/_/]J_\ W^C_ /C=')1_F?W?\$.:I_+^)Z917F?_
M  H[PS_S_:O_ -_H_P#XW1_PH[PS_P _VK_]_H__ (W1R4?YG]W_  0YJG\O
MXGIE%>9_\*.\,_\ /]J__?Z/_P"-T?\ "CO#/_/]J_\ W^C_ /C=')1_F?W?
M\$.:I_+^)Z917F?_  H[PS_S_:O_ -_H_P#XW1_PH[PS_P _VK_]_H__ (W1
MR4?YG]W_  0YJG\OXGIE%>9_\*.\,_\ /]J__?Z/_P"-T?\ "CO#/_/]J_\
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M\1+8V^X,8A(1YPR#D <-GI@\<^]=%?:K8:8@:]NHH<] QY/T'4URWC$ >(-
M & )>G_ EJ+Q#I5]%XH_M;^S3JEH5 \D9.WY<8QSWYZ8YIN3:2?0E12;:ZG6
MV&KZ?J8/V*[BF(&2JGY@/7!YK+\4^$=/\363K+$D=Z%_<W(&&4]@?5?;\JS_
M  YJ6E-K;P?V.VF:C(F I'! YP.!@GZ=J[$D $DX ZFB,G%W0Y1C-<LEH?/7
MA'1KNY\;VEEL97MI]T_^PJ'YN?T^IKZ%KG_#?A^+2Y=0U%T'VS4;AYW)ZHA8
ME4_#//OZX%=!6V(J^TE='-A*+I0L^H4445SG6%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>forms-1a_004.jpg
<TEXT>
begin 644 forms-1a_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ('!2D# 2(  A$! Q$!_\0
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MS.QP /4T[.]@'XI<57LK^TU*W%Q97$=Q"20'C8,,CKS5BDU8!1UIS4T=:<U
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MNK2'PW\7;*ZC.V#58PDRCH6Z9_E3K:67QAXYMK^&"2.RM2K;F'93D?F:B^(
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M/&":LQ"*",1PQ+&@Z*HP!245E=ED.HVL.IZ;<6,ZYBGC*-[9[USG@G2;[2]
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M[T!Q],U,*,TG)MW&DEH5[O3[*_55N[6&<+]T2(&Q3I+&TEM5MI+:)X%&!&R
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M!BS_ ._HI?\ A*- _P"@Q9_]_11[.?9_<'-'N:?S>M'S>M9G_"4:!_T&+/\
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M_P"_PIH\8^'0>-;L?^_PH]G/L_N#GCW-V3[N*A*BL@^,?#Q/_(;L?^_PI/\
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M>BBNE)+8QN%%%%,04444@"BDHH **** "BBB@ HHI*!BTE%%( HHHH ****
M"BBDS0 M&:2B@ HHHH **** "BBBD 4444 %%%&: "BDS10 M%)10 M%)10
MM%)10 M=!X'_ .1UTK_KM_0USU=#X&_Y';2O^NW]#45?X<O1ET_C1]"XI*=3
M';9CCBOG3UQ1UI]1E@%W=J3[0E #J***8@IU-IU(84V66.&)Y975(T!9F8X
M [TZO*OB;XJ+R'0K.3"#FY93U/9:UHT75GRHSJ5%3CS,Q/&_C:7Q!<M:63M'
MIL9P.QE/J?;T%<;117T%.G&G'EB>5*3F[L*2BBK)"BBB@ HHHI %)110 444
M4 %%%% !1244AA1110 4444 %%%)F@!:3-%% !1110 4444@"BBB@ HHS24
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M@ HHI* %I*** "BBB@ HHHI %%%% !129HH 6C-)10 9HHHH **** "BBB@
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M\1]4-]XC:V4_N[5=G_ N_P#GVKCJ]W!TN2DGU>IYF(GS3MV"DHHKK.<****
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M3F.V'E+]>]<K7O8.E[.DN[U/,Q$^:?H%)11748!1110 444E( HHHH ****
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MC'!SQP:HZ)K%UH&KV^IV0C-Q <IYBY7\1D5I[*5IKOM]UB.=>[Y?YFS\2/\
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M7GA^ 6_V*[;=(60E^W0Y]O2L[1]5N=$U:VU*TV&XMWWIY@RN?<5LJ<K3\_\
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M$>E2:#XPU3PYJMUJ-B+<SW082>:A9>3DX&115HRDYVZI"A4BE&_1L[OX-_\
M(W>(/^O5_P#T.O*[O_C]N/\ KJW\S6QX=\7ZGX8U"[O=/%N9;I#')YJ%A@G/
M&"*PY',DCR-C<[%CCU-:P@U4E)];$2DG!+U/:?BEI\>J^+?"=A,^R*X38S#L
M"14GC#Q6OPZU"'1- \/VD:K$K"XDCSO)]/4_C7F/B+QGJWB>ZLKF^,,<MFNV
M%K="F.G/4\\5T4'QC\1):)#<VNFW<D8PLT\)+?4X.*YO8348IJZ72YM[6+;:
M=K]3O7U#7]8^#VMW^O($FFC9HD$>S:F1VKE_ G_)'_%G^\?_ $ 5S4GQ2\33
MV]_;W4UO<PWJ%'CEB^5%(QA ",?K65I?B[4](\/7^B6PMS:7W,I="6Z8X.>*
M<:$U%K3=,'5BVGY-&#VKU+X%?\C7??\ 7K_[-7EM;GA?Q9J/A&_EO-,$!ED3
MRV\Y"PQG/8BNBM!SIN*ZF-*2C--CM2\2:XNJWB+K-^%$\@ %P^ -Q]ZQ[B[N
M;R3S+JXEG?\ O2N6/ZTR>9KBXEF?&^1R[8Z9)S4=7&*1+;9ZU\-=&TRU\'ZI
MXJN=/74KRU+"*!EW!< =O7FK7AOXB^*_$_B*TT_3K&UM;4R@S>3"3L3ODG@<
M5Y[X6\:ZSX1EE.FR1M%+_K()EW(WO[&MK4/BYXCNXO*M4L].4D%C:189OJ2>
MGTKDG1E*4FTG?:[V^1T1J145K;]37^)P(^+UAGNUM_Z$*V/&G_)=-"_W8OYM
M7FFN^,=3\1:S::K>I;"ZM0H0Q1E0VTY&[DYJ34O'&KZIXHM?$-PML+VV"B,)
M&0G&<9&??UIJC.T?)-"=2-WZIFG\7/\ DI>J?[L/_HM:Z&Z_Y-VMO^OP?^AF
MO.M?UV\\2:U/JM^(A<S!0PB7:OR@ 8&3V%6W\7:G)X03PRPM_P"STD\P$(=^
M<YZY_I5NE+D@NUB>=<TGWN8-%%%=!B%%%% !1110 4444 %;_@K_ )&[3_\
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M ./B7_?/\Z97TRV/&8444E @HHHH **** "BDHH&%%%%( HHHH *3.>E=?\
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M6M0I#(>C,J_>/T_QJI)Z<GVE;^OQ%&VO-TU/)-5UN;5O%MQK+,1)-=>:O^R
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M^'+T9=/XT>_5'+VJPX 4D#FHE42C)XKP#U2$5D^*#_Q2^H_]<36[Y ]:PO%
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M7B#Q)::9-*\4<Q(+H 2, GO]*&[*X)7=C&HKM/'O@:/PB+26VN)9X)\JS2
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M4E !1110,**** "BBB@ HI** %S2444@"BBB@ HHHH **** "BBB@ HHHS0
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M<Z9>LI\EV/WOU(_ UR%KX/O9_&O_  C3L%E60J\@' 0<EORJ/P1#-<>,]+6
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M/*X.3CI5_37^&M[J<>B1:=<L9&\M+QR0';\\C/TJUX)D5]$\<21'"D3%2/\
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M^(M'TBQ2S> V"%2[."'R ./3I7+4N*%3BMAN;9WVC_$2W_L./1O$FE+J=K$
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M0 M%-S10(=FDS244 +FC-)10 N:Z#P.?^*TTO_KM_0USU=!X'_Y'32_^NO\
M0U%3X'Z,J'Q(^@Z*,BC->">J*O!J3)]:C%.I#'T444 %-E_U$G^X?Y4ZF2_Z
MB3_</\J$!\QS_P#'Q+_OG^=,I\__ !\2_P"^?YTROID>,PH-%"JSL%4$LQP
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MOK]QQ9DYPRR<*M*4;R5O:3N[ZWY5:]K;N]MB"BC-)FO:/C1:3-)10(,T444
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M7+D\[LYS7J_Q#_?6'@ZYF'^DNP#$]<80G]:SQ:_#J[U#^V7U*:)&;S7L2O\
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M/).:M64T<4DA<X!'%5!U!KKHP:Q-636ZC^3/*Q=:$LOPU.,M5*;:OM>2M?\
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M4J*NV&D:CJAE%A9S7!A7=)Y:YVCU-4J+A8**** "BC-)0,6BDHH 7-)FBBD
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MT$TE(04444 %%%)0,6DHHH ****0!1110,**,TE "T4E% "YI,T44@#-%%%
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M'AG8VH6X\ESA9HSN0GTSVHT?P?K&NZ=)>Z? LL:2"(C=ALG';\:]4MM'DM/
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M!?\ (Z:=_P!=*YNND\!?\CIIW_72IG\+*C\2/HVBBBO#/2"L+QG_ ,B9J_\
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M1II#=Z\0](2C%*124 .HHHH *9-_Q[R_[A_E3Z9-_P >\O\ N'^5" ^8I_\
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MI5 );KFG4P^(K>UE))<T4DK]GU(P^89?A/JU.G-R5.;E)\MMU;17+FG?\?\
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M&*Y%.2:7O7BUJW?6]]MA)O\ D$1?[U-@M(EM_M%RQ"GHH[TZ;_D$1?[U.O\
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M*6DH-,D0T444@"BBDH&%%%% !2444 %%%)2 ****0!1110 44E% Q<TF:**
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MQPLJ$8'U]ZS:*YGEU!OK:][7=K^AZ4.(,=&-DXWM;FY5S-6M9O=EBTNVM7)
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M%)FD,6C-)10 9KIO '_(ZZ=_UTKF:Z7P!_R.NG?]=*F7PLJ.Z/I"DHHKQCT
MK#\9_P#(F:O_ ->S5N5A^,_^1,U?_KV:KI?&O5$S^%GSM24M)7T1Y 4444@
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M!V.*VC6A.;@MTD_OV.*K@ZM*C&O->[)M+O>.^@E%6KNU2 Q;23O'.:L26-M
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M?Q3+<[<K! >?0GC_ !J*CM!OR*@KR1[I2$?G2T5Y!WB _G2TA&:.: &T444
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MMP!S7=.$GBHSMIRO\T>)2K4UE56DY>\YQ:76R3NRK11176>2%)112 *,TE%
M"U[E\(M(-EX8EOW7$E[+D9_N+P/US7C6C:7-K.KVVGP EYG"Y]!W/Y5]/6%E
M%IVGV]G H6*",(H'H!7)BYVCRF]".MRP*6D%+7 =05C^*O\ D5-3_P"N!K8K
M(\5_\BIJ?_7 U=/XUZHF?PL^<:***^B/("BBBD E%%% PHHH- "4444@"D-+
M24  I:!10,0TE!ZT4A!24M)0,****0"4444AA24M)0 4AI:2D,*#TH%!H 2B
MBBD,*2EI* "DI:2@ H-%)2 ****0!24II*!A1124AA1110,*2BBD 49I** "
MO<?A%I)M- FOW7#7+X7_ '17CFCZ;-J^K6]C"I9Y7"_A7T]IMA%I>FV]C"/W
M<*!![^IKFQ4[0Y>YM0C>5RU1117G'6%87C/_ )$S5_\ KV:MVL+QG_R)FK_]
M>S5=+XUZHF?PL^=J***^B/("BBBD E%%% PH-%(: "BBBD 4AI:2@ %+0**!
MB&DH/6BD(*2EI*!A1112 2BBBD,*2EI* "D-+24AA0>E H- "4444AA24M)0
M 4E+24 %!HI*0!1112 *2E-)0,***2D,****!A2444@"C-)10 5[E\(=)-GX
M>FOY%PUT_P O^Z*\:TC39M7U6VL8%+23.%&*^H-,T^+2],M[&$8CA0(/?WKE
MQ4[0Y>YM0C>5^Q9)(Z<BE!)/2CIS1UY%>>=8M%%% #,T9J#GUHY]:+ 3U'-_
MQ[R_[A_E3.?4TR;/D2<_P'^5-(1\T3_\?$O^^?YU'4D__'Q+_OG^=1U]&>0P
MHHHH$)1110,*0TM(: "BBBD 4E+24 *****0QIZT444""DI:2@84444AB444
M4@ '!!J>ZN?M+*=FW:,=<U!25G*E&4U-K57M\S>&)JPHSHQ?NRM==[;!4\%W
MY$,D>S._OGI4%)14I1JQY9K3_(>&Q-7#3]I2=G9KY-6?X *#UI133UJC ***
M*!@:2@T4 %)2FDH *2EI*0!1112 2BBB@84E!HI#"DI:2D,*2BB@ HHKT3X=
M> GUBXCU74XB-/C.8XV'^N(_]E_G43FH*[*C%R=D=/\ "KPDVG6/]MWL>VYN
M5Q K#E(_7\?Y5Z52      #@ 4M>7.;G+F9VQBHJR$%**!2BH*%K&\5_\BIJ
M?_7 ULUC>*_^14U/_K@:NG\:]43/X6?.-%%%?1'D!110:0"4444#"D-+2&@
MHHHI %)2TE "BBBBD,;1110(*2EI*!A1112&)1112 *2EI* "DI:2D,44AZT
MM-[T@"BBB@8&DH-%  :2@T4 %)2TE( HHHI )1110,*2BBD,*2EI*0PI***
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M_P!_/_K4?\*Q\-_\\9_^_G_UJ[*BCZQ5_F8>RAV.-_X5AX;_ .>,_P#W\_\
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M +^?_6KM!2T>WJ?S![.'8XK_ (57X8_YX3?]_/\ ZU'_  JOPQ_SPF_[^?\
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ME#L<1_PJGPU_<N?^_O\ ]:D_X53X:_YYW/\ W]_^M7<4E/V]7^8/90['#_\
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M00#_ &$ /YU<HJ95)2W8U&*V044E+4%!1110 O6DHI>OUH **3-+0 E%+24
M5Z***H04444 %****0!1110 4444 )2444P"BBB@ HHHH **** "BBB@ I:*
M* "BBB@ HHHH **** "BBB@!:*** "BBB@ HHHH 6BBB@ HHHH *0T44 -)S
M2445(Q0,G%2J !110 M%%%  10!110 H%+110 M%%% !WHHHH 0<\TM%% !1
M110 4444 %%%% "=Z,T44 )N/H*49P2:** "BBB@ HHHH 44444 %%%% !11
M10 V1MJ5 @R:** )@.*<*** %HHHH 6@T44 %%%% !1110 "G"BB@!:*** "
MBBB@ H-%% "4444 %%%% !33110 4E%% !1110 E%%% !1110 4444 %%%%
M!1110 4444 +1110 4444 %**** %I:** "D-%% #:*** "BBB@ HHHH ***
M* "BBB@ HHHH 2DHHH 2F,,T44 1=#5F-MZT44 .HHHH **** "BBB@ HHHH
9 *!110 4444 %+110 'UHHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>forms-1a_005.jpg
<TEXT>
begin 644 forms-1a_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #B D # 2(  A$! Q$!_\0
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MQ&_Y$74/K'_Z&*RH?Q8^J+J? _0\'K9T?PKJ>NZ;?W]DL1AL5W2[WP3P3Q^
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MUUOIKMUZ>FENMST%4PT^3GG'V?NMQY?>NM9:V5KOK=IW2LK:+-&K.C1KM5^
M#V-1RPB/^/)S@C&#3A<%HRLH+\@C)HEG5XM@#'G.6.<>PHIK$0E&#V7Y>KUV
M"N\OJPJ58NTFDTMK.VJLM-7KHVDF044E%=YX8444E "TE%%( HI,TM !1FC%
M% "4O-)FC- $D'_'Q%_OK_.OJ2'_ (]XO]Q?Y5\M0'_2(O\ ?7^=?4L/_'O%
M_N+_ "KS<?\ 9^9V83J<U\1/^1%U'Z+_ .A"O Z]\^(G_(BZC]%_]"%>!5OE
M_P#"?J9XOXT2Q3O$K!<?,.<U%125UQIPC)R2U>YG.O5J0C3G*\8WLNU]7;YD
MUN5RX9@NY" 32QJL3DF1#E2.#42HSYP.@R:96$Z*G*5I;VNM/D==/&.E3IWI
MZQORN[ZO739ZEKS5\X'=QY>/TI\31+Y;;EX7!+$Y!JHJ,YPHR>M(JEF"CJ?6
ML:F#IR3CS6LM?37_ #.RAFU>$E/V:=WIOO>.B^Y??NBP"KI$1*$V#!]?PI?,
M1EV!P"T8&3ZYJI15O!I_:]-O7YZ]S&.;3CM!:I)ZO6RMWTT[>OD7%=!MC,BY
M",-W;)I-Z,GE[P"8P,]L@]*IT $G J7@H[\S[]-^_P#P"UG%2W+R*VV[VT5O
M7SW+PD16"EU;]WMR>F:@N'!5$!0[<_=Z"H6!5BI&".#3:*6$A&2J)W_I_P"9
M.)S6K5I2H2BETZW2NM-=]8K=_+L9HHHKL/)"BDI: #-)FEHR* "DYHS1FD!Z
M5\'_ /D):I_UQ3_T*O6TYE6O(_@^?^)EJG_7%/\ T*O6E.&!KQ\9_&9Z.'_A
MHEKEOB-_R(NH?6/_ -#%=37+?$;_ )$:_P#K'_Z&*RH?Q8^J-*GP/T/!J>D$
MTJ.\<,CI&,NRJ2%'N>U,K<T3Q9J&@Z7J.GVBP&&_3;(9$R1P1Q^!KZ"3=M#R
M5;J85;'A_2;35#?R7MS+!;V=L9V,2!F/(&,'ZUC=!BND\):K'I*:S,TL23/8
ME(5E4,'?<.,'@\9J9WMH.-KZB3^'+:[TE-0T"YN;Q3<K:M!+"$DWL"5Q@D'H
M:ICPMKS79M!I5SYX02%"H&%/0GTK5T?Q9>7/B+2#J5U%#96UP)=L<:QHIQ]X
MA1R:2SNH]5\/:EI;:I%:WDE^+H27,A59DP1C=['G%1>2W+M%E+3_  K?W]KJ
MH6"<7]BT:_9=F"=S8.<],#FJAT6XMX]26]M[J"XLXU<IY>0,D#YCV'/!KL+K
M4K#4K?6+"#688IGM+2W2YE8HMRT?WN>N.V34=SK>FPV5S:F\CNI+;3K:W,@S
MBX=)=S!2>H XS[5//(?+$Y&X\/:S:V*WL^FW$=LV,2,O'/3/IGWK0U7PG<:,
MEQ]K$Y9+6*X1DCRN6(!#'/ &<9]:W;V_L8+_ ,0ZR=9ANK?4K5X[>U5B9"SX
MP&7^'9_3BDOM4TX6=[<"_@G%QIMFBPAB6WQLN]2.QX-'/(.6)R,_A[6+>R2\
MFTVX2W?;M<IZ]..HSVI-0T'5=*A2:_L)K>-SM#..,^GL?:NLU.YM&UO4-<C\
M3B.WNY$>&*#+R'Y@=KH> %Q^G%,\57>G7&BW+-<V+7\MRKQG3Y7V3KSEY(SP
MI_J::F] <5J<+24M)FM#,6DS244@%S249I*!BT4E%(!:]9^$/_(*U/\ Z[K_
M .@UY+7K7P@YTK4_^NZ_^@US8S^$S?#_ ,0]&KPCQU_R.FI?]=!_(5[R!7@_
MCK_D==3_ .N@_D*YLO\ XC]#;%_ CG:2BBO7//"GF(@(!DNW.!Z5'5LE?/1F
M.%,?'..W2N7$590:MY_@MOZ['HX##4ZRES]XKM9-N[[=+:]RN89%8*4.3T]Z
M7[/-G'EMS5@2(IA^9!M8D[>W%1"4>2@+\B3)KGCB:\EI%?<_/_)?>=\\OP--
MOFFWUT<>T=/6\G]VV]FQP&0J!D$MCD<4W[/)D_(VT'!-6?.C$@.X8\TG\*B9
MPJQ*'!PY)P?>ICB*[EMOY/S_ .&+G@<%&%W*[75-:[)::^;=NW0C\B1F;8C$
M XZ4"WD:(N >&VXJP^)(F(D"CS2>3UIDLJNLI5P#O##/?BE'$UI62[KH_+?U
MOTV'/+L)3O*3;T;6L==WIZ6Z[W5KD$<+22!<$#."?2E,)X"AB22.GI5EY$5X
MCG'F,)&]O\\TU)4!0[P,%_UZ4OK-:7OJ.G;[_P!5]P_[.PD+TI3UOJ]-G9JU
MWV:^;:Z%9H9$*AD(+=/>AH6C91*I4'O5B"9$2/>W(<]>V139W'DB,&,DMG"9
M-:+$5O:*FXZ=]?/5>AA+ X14'7A.[LFD[/HG9VM>[NM""1#%(4/:F9J:[/[_
M !W50#]<5!731FYTXR>[1YF,I1I8B=.&R;7]>FWR"BDS16ISBT4E%("2#_CY
MB_WU_G7U-#_Q[Q?[B_RKY9@_X^(O]]?YU]2P_P"HB_W%_E7GX_[/S.S"]3FO
MB+_R(NH_1?\ T(5X'7OGQ$_Y$74?HO\ Z$*\#K?+_P"&_4RQ?QHEA>%5<2(6
M)'RU#1175&FHR<DWKY_EV,ZE>4Z<*;2M&^RLW=WU?7ROL36P)\T 9/EFB",^
M80R'E3@$5"&*G*D@^U!D<D$LQ(Z<UA4HS;GRM6E;O?0[:&+HPA2YXMN#?:S3
M=^NI<@0KY7R?,=W!'7BA!O,32( VXCIC(Q5,NY.2QS]:0NQ()8DCOFN>6#G)
MN3DKOU\]-]M?P.Z&;T81C!0;4;:/EL[<NKTW]UVZ:Z^=Q P2 +&"K?>..O-)
M\BK$F%V,Q!..2,U6:9C&J D!1C@]:C). ,\#I1'!RD[R=M7W\[/?=75O0<\V
MIP2C3C?2*UMVA=+2]G9WZZ_?=<,RRB2, *1MXQWZ4Z3^\ %V,/E9<8^A[U19
MV8 ,Q('3)H+NP +$@=,FE]2EIJOQ[6[]?U^\_MFFE+W6[]7RWW;5VETNDO)=
M-&KLI=3*ZH#)YF/N]!228B61E10WRYXZ$]:I^8X;(=L^N:;D\Y)YZT1P35DV
MK:=]=M-]M-/4*F<PES.$7=WM>VC?-JM+W?-K_A5O*^%3?(^W#;%(PN<9ZG%5
M[H#>A"D$KDY&,^^*AWL#D,<^N::6+')))]ZNCA94ZBFY7T\^UON,,7F=.O0=
M*,+-N_3O>_KT]/N#-&:2C-=IXX44E% "T4E%(#TCX0G&I:I_UQ3_ -"KUD/@
MUY/\(%W:CJG_ %Q3_P!"KUGR_>O(Q?\ %9Z&'_AHL5ROQ&_Y$6_^L?\ Z&*Z
MJN5^(W_(BW_UC_\ 0Q65#^+'U1I4^!^AX-1170:!?>';72-5BUC3Y+F\E3%I
M(O1#@^_'.#7OR=E<\E*YSU:&DZ+>ZW-+%9+&3#'YDADD"*JYQDDUGCIS75>"
MS;+#X@:\CDDMAIQ\Q(FVL1O7H3TI3;2NAQ5WJ9.J>'=2TBVCN;J*-K>1MBS0
MRK(F[TRIX-9.17=:'J.AW][IOAZVT^6#3I[T7%P;J8.TKJI"KP  /YUIW,-M
M="T:ZLY3*FJQ1)))8);*JD_-'@'YACVJ/:-:-%\B>J/,>#1D5Z9=02W,NKIJ
MNEP6D-IJ$*616W$?)EP4!Q\P*\GK3=8MVN)/$EOJNFP65A:3(+.1(!'L)D P
MK ?-E23WI>T#D/->,TF17JNOVEA'!K=E]BE-G;6VZWVV*1I"1C:XFSEL]^N<
MU"UW&OB>33_[.L3:V>EM<+&;=?GD\@-N8]3S2]I?H/V?F>89%3RVDD%I;W+[
M/+N-VS# G@X.1VKT33M3-U_PBAFL;!GU.62&[?[*F94#;0.G'7J*;IUK:VFF
MVMP+&WE:*RU%P)(PP8I)A2?7%#J>0<AYY:6MQ?W*6UK$TLSYVHO4X&3^E1Q1
M23S)#$C22.P5449+$]A7I6@WDMSJ'A?4O(MUO;N.[AD:.!5\S:/EX QGM7+^
M$;D0>/+:6^*P2M+(NYUV".4@A21VP2*.=ZBY=B&Y\&:U:V\LK0P.T"[IH8IU
M>6(>K(#D50AT2^N(5EB1'5K=[GB09$:'#$CM]*Z/PMHVL:;XTCN;VVGMH;1W
MDNYY00FS!W98\'/ZYK2LXH%TRVFMX5C$VA7SDA<%AYAQGUXI.;12@F><T9I!
MTHJR S11FDS0 M>N?!__ )!.J?\ 7PO_ *#7D6:]=^#W_()U3_KX7_T&N;%_
MPF;4/C/2*\%\=_\ (ZZG_P!=!_(5[U7@OCO_ )';4_\ KH/Y"L,!_$?H:XOX
M$<[24M2SM"S+Y*%1CG->E*;4U&SUOKT7KZG/"DI4I5'-)JVG5W[>G4AJ802N
MBCC'55)Y-0U< +&-9(BQP-LB&N?%U94TG&W7\%TNU\];VV.[*\-"NY*=^BTN
MEJ^K2E\KJU]VBLD+N"1@ <$L<4?9Y#(4Q@@9Y/:IP&5'4H)H]YZ'D'UIP54E
M;.XJ8B=K'D>U<T\9--VMY?AYWOKLTNFIWTLIHR4>9-:KFUM_/_=::]U:QDWO
M>.Q5>!T3<<%?4'-,=&C;:PP:LL5-HQA7 S\X)R1Z5(<">4E3T7Y@,XX]*:QD
MXWYEW\GT\WW\[HF6549V]G*UU%WW6JFW9V3?PK=*SNGW*.YMNW/R@YQ2E63:
MQXSR*DN%V7!!V\X/RC%3L/W\Y"AF11L&,UK+$)1C)+1J_P"2_-ZOL<M/+Y2G
M.$Y.\6HKY*3VWVCHK[LJ$O,6=CDCKFFL"C%6&".HJW\VQW=%5M@/3WZU)(&\
MZ9R ,8 .S)_ 5E]<Y7RI*R\_3;[SJ>4^UCSN3<F]6T]O>;;N[IZ=64%1G5F
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M_BL[Z'P(EKE?B/\ \B+?_6/_ -#%=57*_$?_ )$6_P#K'_Z&*SH?Q8^J+J?
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M\>\7^XO\J^5(#_I,7^^O\Z^JX?\ CWB_W%_E7!C?LG5ANIS7Q$_Y$74?HO\
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MTF1ZU]-CPQH/_0&L?^_(H_X1C0/^@-8_]^11]=CV#ZL^Y\QDCUI"1ZU]._\
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M - 6Q_[\BE]>CV8?59=SYHR/6D)'K7TQ_P (KX?_ .@+8_\ ?D4?\(KX?_Z
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<3I110!)%_JA3J** "BBB@ [T444 +0*** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>forms-1a_021.jpg
<TEXT>
begin 644 forms-1a_021.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %. J<# 2(  A$! Q$!_\0
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MBH$PLFT$!MPS^/-55\):0J;#',ZY8L'E)W%AM.>YXKT;R8O^>2?]\BCR8O\
MGDG_ 'R*0SSL^%=**!629OEVY,IR1\P[?[QJ>+0-/@OUO8XW$ZL6SOR&))//
MXDX^M=[Y,7_/)/\ OD4>3%_SR3_OD4[@<K175>3%_P \D_[Y%'DQ?\\D_P"^
M10(Y6BNJ\F+_ )Y)_P!\BCR8O^>2?]\B@#E:K:A86^J6$UE=H7@F7:Z@X./8
M]J[/R8O^>2?]\BCR8O\ GDG_ 'R*0SSV3PQI,C2OY#(\LBRLR/@AE7:,>@QV
M]Z;)X4T>59%>!RCR>:4W\!N>1Z<DGZUZ)Y,7_/)/^^11Y,7_ #R3_OD4P.*?
M3XI+ZVO&EG,MNA1!YGRD'KD=R<#\JMUU7DQ?\\D_[Y%'DQ?\\D_[Y%%Q'*T5
MU7DQ?\\D_P"^11Y,7_/)/^^10!RM%=5Y,7_/)/\ OD4>3%_SR3_OD4 <5>Z;
M::@]J]U%O-M+YT7.,-C'/J.>E4(O"NCPK"L=NP6)60#?G<K$L0V>O)->B>3%
M_P \D_[Y%'DQ?\\D_P"^12&>>P>&=,MIK::-)?-MO]4YDY7V_3'TJW::9!9W
MMU=QRW#27+;I!))N7/; [8]*[?R8O^>2?]\BCR8O^>2?]\BG<1RM%=5Y,7_/
M)/\ OD4>3%_SR3_OD4 <K175>3%_SR3_ +Y%'DQ?\\D_[Y% '*TCJKHR, 58
M$$'N#75^3%_SR3_OD4>3%_SR3_OD4AGG2>$M%2%8EMFVK;_9A^\.0F[=^>>]
M*?"FD,) T,C+*H60%^'QCD\=>*]$\F+_ )Y)_P!\BCR8O^>2?]\BF!PDFB6<
MMO;0.9S#;X")YQP0"" WKC Q6CG)KJO)B_YY)_WR*/)B_P">2?\ ?(HN(Y6B
MNJ\F+_GDG_?(H\F+_GDG_?(H Y6BNJ\F+_GDG_?(H\F+_GDG_?(H Y6LJ]\.
MZ7J$]Q/<VY:2X6-9"'(R$.5^GOZUW_DQ?\\D_P"^11Y,7_/)/^^10,\]D\+Z
M5*TK&*0&27SOE?&UN<E>.,Y/'O4MMH&FVJ7*1V^8[K_7QNV5<YSDCUY_*N]\
MF+_GDG_?(H\F+_GDG_?(I <98V%MIMM]GM(_+BW,^W.>6.35FNJ\F+_GDG_?
M(H\F+_GDG_?(IB.5HKJO)B_YY)_WR*/)B_YY)_WR* .5HKJO)B_YY)_WR*/)
MB_YY)_WR* .$O]'M]2OK>XN'D*0H5$2G"MD@_-ZCY1Q3+WP_IU_/<3S)();A
M521DD*Y"]/\ Z_K@>E=]Y,7_ #R3_OD4>3%_SR3_ +Y%(9YU_P (II&%'E3;
M1C*^:<,!C /J/E%:&G:;;:7;"WM@PC!R-YR?IG\*[7R8O^>2?]\BCR8O^>2?
M]\BG<#E:*ZKR8O\ GDG_ 'R*/)B_YY)_WR*!'*T5U7DQ?\\D_P"^11Y,7_/)
M/^^10!PDNAV$HF^1TDEG^T&5'VN).F0W;Z567PII,>WRHYHF7E&24@H?4'M7
MHGDQ?\\D_P"^11Y,7_/)/^^12&>>IX7T>.ZBN4M<21%"GSG VKM''T_,@&F7
MOA?3[LRLAEMY)%P/+;"KP!D+TS@ 5Z+Y,7_/)/\ OD4>3%_SR3_OD4P..M+2
M&QMEMX=VP$MEVW,22223W))-3UU7DQ?\\D_[Y%'DQ?\ /)/^^10(Y6BNJ\F+
M_GDG_?(H\F+_ )Y)_P!\B@#E:SKS1K>_U*"\N'=A"FU8@<*3N#9/KR!Q[5W?
MDQ?\\D_[Y%'DQ?\ /)/^^10,X"\\.Z;?S7,TT<@DNMOFE)"N[;T_^OZX%0MX
M4TAB,Q3;?XE\T[6^H[UZ+Y,7_/)/^^11Y,7_ #R3_OD4@.,L+&#3;06UMO\
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M!<, .GS$4ZXT6Z?7!J$?V<X=)0SDAQM0KY8P#\I)S^?% &T;F ;\SQC8</\
M./E/OZ5+7+W'AZZD&H+'%:>7<MN$<DA;YCNS("4.T\CC!'':NBM(6M[."%B"
MT<:H2!@$@8H FHHHH *"<#)HJ"\@%S93P%%<2(5VN< Y'0^U)@B7S$V;]Z[,
M9W9XI0RL2 02#@X/2N;GT34IM$T^P62"(VJID)(=K,H(!^[T!P<8YQVJU8Z=
M=Z>FJ,B1![B7S8S"<EFV@$D,  21GJ>M,#9=TC0O(ZJHZEC@4CS11LBO(BLY
MPH+ %C[>M<__ &9J=YHUI'>".>Y@EWM'=8V2C:1SMSZYZ=J4Z'=[=+ :$RV0
M">>9&.4&W/R8P<XQUX]: .@21) 2CJP!P2ISS3JR-#TR;3OM;2I;Q^?(&6.#
ME5PH'H/3IC\36O0 4444 %-$B%V0.I=?O*#R/K3JYH^'[O[9=R(]N@F6=1*I
M(D82D'YN/X,<<_E0!T2S1,H99$*DX!##!/I3ZY*+PUJ,=Q#-'+;6X24.(82?
M+C("J6 V_,2H;CC&[K76T %%%% !1110 45!%%<+<2/)<[XF^['Y8&W\>]3T
M %%%% !1110 4444 %%%03Q7#R1M#<^4JGYU\L-N_'M0!/1110 4444 %%%%
M !1110 4R:58())GSLC4LV/0#-/IDT2SP20OG9(I5L'L1BA@9EGXCT^\MVE#
MM"1@>7-A6)*AACG'0CO4XUFP:":1+A',$1EDC1@S*H&>@-59_"^F3P6L'EO'
M#;#")&VT'IR1W/ YJ:WT&PMP0J.RF-XR&;(*OMW#_P =%# 7^W=.6;RI;A86
M*HP\TA0V\$C&>_%.?6].298A=1,Q<HVUP0A 8G=Z?=-5D\,6 4AVN)6*&/>\
MF6VE=NWZ =*A7PCI[1LMT\LY)?&YL!58L=H [?.: -+^V--"!S?6^TKO!\P8
M(SC/YTLFJZ?"',MY FS;NW.!C/3\ZS6\(Z:[!F:<D(4&6&!GJ<8QFI8O#-A#
M=?: UP\GR8+REL;>G6@"PFO:4\KQB_@#+)Y>&<#+8!X]>&'YU*-6TXG OK<G
M<4XD'4=15)/#&G)&8QYQ0ILVF3@ A0?T1::GA73HHDCC$JHDGF* 1D>V<9Q[
M4 :\$\5S"LT$BR1MRK*<@U)5:PL8M-LTM8"YC3.-[9/)S_D59H **** &NP1
M&<@D*,X R?RK,77[9K-I_)N0RS"#R#'^\+G!  SCH<]:TW7?&R;F7<"-RG!'
MTK)C\.V\5BEJ+J[98VWH[2#>KYSNSCD]>3ZF@"2QUZSU&\-M;^86$0E)8 #!
M[8SG/X5;N;^WM;2:YDDS'#P^SDY],>O(JM;:):VL\,L;2D01F.)&;*IGJ1[G
M'.:@M?#EM!!>0.P>.Z.7"QJA!]01^% #Y?$-G#IRWCI,H,WD&-E 97ST.3@?
MG6J#E0?45E_V% +.2U%S=!)23*?,&9"<[B3COGGZ"M..-8HDC081 %4>@% #
MJ*** "BBB@"HNH0MJK:<%D\Y8O.)*$*5SC@]S5-O$5I'Y@DANT9)8XRK0G/S
MG"M[#@\G%6I=,274/MOGW"2^5Y0". H&0>F.O%5!X=M_LL\!N[QEGF$[L9 6
MW YZXZ<#CV% &L9$614+J';.U2>3CKBJ,&LVMQ?R6BB4,N_#LF%<J0&"GO@D
M5'=:+'=:K;W[2*'@&%!B4GWY/-.31+:.]>[CDG5V8L%#_*A8@M@=MQ S0!+I
M>J0:O9_:K<.(RQ WXS^0)Q^-7:J6.GQ6 E*/))),^^225LLQP /T %6Z "BB
MB@ JC!JL%PEXT<<Y-I(8W7RCN8@ _*.IZ\5>K/72(UDNG6ZN@;E][XDQ@[=O
M&!QQC\J (+?Q%:7$MLBPW*_:':-6:/@,,Y4G/7Y3TR*TVGB3S-TBCRUW/S]T
M>I_(UFP>'K2":"02W+>2YD"M)E6<Y^8C'7D],#VI8=#ABU.YO69'-PI5T\I1
MQ]1SWH :OB*R;3KF]*3HENJLZ.F&*L,J0,]#5BSU>WO;O[-&LHD\A9\LOR[6
M.!ANA/TJ*VT*"TB=(+F[0N I?S,M@ !1R.P''U-.LM%MK"Y2>!YALA\D(7RN
M,YSC'7.30!I4444 %%%% %2XU"&UO;6UD60R7+,J%4)4$#/)Z#I56]\06EA<
M/#<17"E1E6,>%?E1P2?5AR<#WJS>:>E[-;2O--&UNY=/+; )((YXYX)JG-X=
MMKBXFFEN;MVE" AI 0NW!&!CU&<="2: -"WOH+FT@N4?$<X!CW\$YZ#ZU7?6
M+:/4Q8$2^86"%POR!R"P4GU(&:K77ARWGMK.W1]D=H<IOC60D_4U/-HEM->_
M:R\R2<'"/A=P!4/CU .* (3XEL0TPV3D0W"VS%4S\Q.,\'(&>YQ6Q63/H%O<
MM,\EQ=&25D)<2#("MN"CCIGFM:@ HHHH *@O;N.PLIKJ57:.)"["-2S$#T Z
MU/4-U;K=VLMN[.JRJ4)0X(!]*&!5NM8@M+2"Z>*=X90&W(F=@..6].H]Z73]
M8M=3FN(K??NMVVON&.Y'\U/7FH9-!BECM8S>7@2V9611(,$J,#(QSZ_7FB#0
M;6UBND@+ W"[3OPX49)Q@]>6/7-# L7FJ06EM%-AYQ,VV)8!N+G!/'X G\*A
M?7K)9;%%+O\ ;4WQ$ 8V\<G)]QP.:B@\.V\.F16/FNHA??'+"!&R'&.P]"1^
M-3'1+;R[>'S9Q!;LK)#O^7Y<;>V>" >M %C3[^+4K)+J!9%C8L )%VL""0<@
M].15JJNGV*:=;&".2612[/F5LG+$D_J35J@ HHHH *S%UZR-Q/$WFH(5D8R,
MGR-L^_M/?&>:TZRF\/V33S2EIL2[LQ[_ )0'.7 ';=CG^E $:^);0B,M!=H6
ME6)@T6"A;&W=SWW#&,G\C6S6./#=F @::Z?$@D?=+GS",;=WTVC&,'\ZV* "
MBBB@ HHHH **@CL[>&XDGCA199/ON!RWUJ>@ HHHH **** "BBB@ HHJ":SM
M[F2.2:%'>,Y0L.5/M0!/1110 4444 %%%% !1110 5#=RM!93S+C='&S#/3(
M&:FH(R,&A@<A%XT:%<7]LJ3)#"9(D)Y9]Q)4GJN "/QJ\_BVU6=8A Y^<)(=
MX_=DNR<CKU3I[BMYHHVQN13CID4>3%NW>4F[.<[1U]: .>M_&%M.]LOV65#<
M3B) Q&<$@;L?4C([5TE,$,0;<(DSG.=HZ^M/H **** "BBB@ HHHH ****
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MOI@Y_2IZ** "BBB@ HHHH **** "H9KAHI(U6WFE#G!9,87ZY(J:B@ HHHH
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MQ,YA<G/&.0,#O52VM-2@UJ>=XIVC9I [B8$2*Q'E[5)^7:,YX'XUT)=0P4L
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M5:/RRXPJ,264<9P2<^O YIG_  CVGL_F/=W#R.?WSLZYF ((#8'0;1TQ4]%
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MGEHC1LK;L;N01QQSD^M:%94>B!#$WVV=I$G6=G95RY5=H!XX 'I6K0 4444
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MF!B0:Y+)J26DL$:,]QY:KDY\LAB'ST.=O:HXO$$LLK$I!%#&R[VD+;B'8JN
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M .=?7'AO=,LIX46YN=OGX)VQ$@D '')R.G:M"+4;:>^ELXW8S1 %AM('/O\
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M:2_?M7<44 <;H/B+6+SQ,=+U&.*'RX-S((&!9L#G.2!USS[8[UV5&!G..:*
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MJ2:M8/<S6ZW*>; "T@.0 !UYZ'&1G'2@"[168OB'2F2-A>+B1MHRK YXZC'
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MZ,!V]*=_94W]JO?B^;>4\M%,:_*N02#Z]./3/>M"">*YB$L$BR1GHRG(-24
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M;&_=\\'!.$8<_P!ZJMOX5O8;I)SJ'_+16D1&<;R !N)R3DX/'3DT =3Y4?\
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MH!'1(()-VP1MM.UL <'TH=8(HVD=8U102S$   =ZY\^';\SLZZCM5F)4 O\
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M5<HH JSZ;97)8SVL4A9@S%E') P#^7%.-C:&(1&VB,8<N%VC&XYR<?B:L44
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H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>forms-1a_014.jpg
<TEXT>
begin 644 forms-1a_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $% G # 2(  A$! Q$!_\0
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M7J$EH<I=V%_<6LM_?R'*CY4]/\*W?#__ "!H?J?YT_7/^0-<_P"Z/YTSP_\
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MLRU1114%!1110 4444 =3X=_Y L?^^_\ZU:RO#O_ "!8_P#??^=:M0,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I1UI*4
M=: //8O]6/J?YT^F1?ZL?4_SI]6)A1110 4444 %%%% !1110 4444 %%%%
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M^^34U% 7(<7/]^+_ +Y-&+G^_%_WR:FHH"Y#BY_OQ?\ ?)HQ<_WXO^^34U%
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MC<W5U*9)@I(YKHHQ@Y>_]W<YZ\JBC[B^?8U]%NY;W3EFF(+[B,@8HU;5%TR
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MY;R2N5(*A>A'M6H;NW#P)YHW7 S$!_$,9K$B\S4=9LW;39H(8[>2*1I% &2
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M2BEFQP *K1W#NPC* GVXKBQ6+=&481C=O^OO%=7L6Z*;@YY/Y5)*;=-BK/\
M.W16&,UU0FY2<>5Z?UH*4XPUD[#:*@FN1$Z1K&\DC D(OH._--^WP+GS6,1'
M4/UZ9J[HJQ9HJN][;H2/,5F&.![_ /ZZ/MUKS^_3CK1=!9EBBJYOK4!29T^8
M9'-+;7D-U_JB2,9SC'?']*+H+,GHHHH *1ONGZ4M(WW3]* .WL?^0?;_ /7-
M?Y58JO8_\@^W_P"N:_RJQ4#>X4F!G.!GZ4M% !1110 4444 %%%% !11BB@
MHHHH **** "BBB@!DT2SP20O]V12I^A&*YE;2V329=,06VGZND81)7&T.RD%
M9%/\0X!P.AKJ:CE@BN$V31)(OHZ@TF@3.3U*UT*RMI8U9+B:1%A=B=\=N,!6
MD8#A<]3W)Q7464MM+9Q?9)!)"BB-3W^48P>X--FT^VFL9+01B*)Q_P L@%(/
M8CZ5FPI?Q:M&3;N)F;;<S( (9X\</UX<=,?TI;#W-RBBBJ$%%%% !11@T4 %
M%%% !116%K5[]GU;3X)-1N+*"2.5V,"@EF4I@<JWJ:3!&[17(V/V2SLU@/B;
M4R5+'*Q#'))[Q>]%Y]DNA !XFU,>5.DOS1#^$]L1=:5QV.NHK&T&[-S)?HM]
M->112JJ23* PRH)'"KW]JV:8@HHHI@ ZUY_']S\3_,UZ .M>?Q_<_$_S-.(#
MJ***H04444 )@9S@4M%% !1110 4444 -D198VC<95@01[5':6D%C;K;VT8C
MC7H!4U%, HHHI %%%% !1110 4444 %%%'?% !1110!5O]7&C0?:/),KM\J#
M. #[UAV?BBXN[F?SU1W4#:JC:%'\S6UJEE_:&GR0#A_O(?<5YXT=S97YE1<.
M#AT;C\*SEI+4]3 4</47[Q7?7T/1+*^2\5L+M=>JU//-;1*C7CA85?=[Y]JY
MW1]4L8E:2>;RI&&-A!X_&K\]UI^J316Q9CSE6Q@'V_&JY[+W7J9XC 4IUW'E
M;IK5Z7L6;Z>V*+J'GO;KSL;;R0>V#UJE%<63SL7:Z64QL?WT>TN-N"1[XJ;5
MHF1K*X2(R16TF7C49.,=0/:EDU2WO(Y8K=))28FRVP@)QWS2ZG%ITV'6]G#-
M9J8II/L\H$@0@9SQSZ]JC@^R27%HBF8/L)0.F,A6YS^-4K>T6WCT::-'65R!
M(<GD;3P:BM7DA-A(VY6,4R*S _?+<"E<=C4N;6WLU#/-*J2R*K!0#N;=D?2K
M=M9K;.2'9LC:,]ADG^M<X%MC:V@59C?"=//W!LYSSGM4YMIO[-O;B%9#<>>Z
MYR<A-W.!0I>0->9TM,FE6"%Y6!*HNXA1DXKF2F;6[:UE39]G(>.)7Y/8\]ZN
MK9QP:CIQC1L2Q,)LDD-P.N:?,3RFU'(LL22+]UU##/I06#1DJ01CJ#7-G9#J
MF5 N6:?&TAUD0?R*BNAC@CMX#'$H5!G %-.XFK'=V/\ R#[?_KFO\JL57L?^
M0?;_ /7-?Y58I ]PHHK/NM>TBRE>*ZU*VADC^^KO@K]:0&A17-#Q:?,P; !1
M"+DKY_[P0DXW;=OXXS6K::[I-_*D5IJ-M.[C**CY+#VHN@LS0HHHI@%%9E_K
M]AIUT;>X:?S%C$K>7 [A4)(R2H.!P:LVVI6=XLCP7",D;!6;.!D@,,$]>"*=
MGN*YR-W<S0QZOJ2:K<)=VVH&*"W\T%'&5 39[Y-3S>+[V"#[4]O:&&83>3$K
MGS(S&<'S/8\_2ND_LO3!?_:OL5I]L)W^9L7>3Z^OXU#+#HMM<^8\%HLM\QA:
M0(#YAQDAC]/6KYD^@K,PM0UZ_D\0QVUA-:(L+RH?.<[' B5^<=QVJF/&%\)7
M>WM][W;(Z))EEA A#$ 9'4G^M=4=#T7R4MSIUEY>=R1F->3Z@5!JSZ';!(+Z
MTCE:;YUA2W,K-M&-VU03@#C-"E':P6?<S-:U*YO-!T2Y@$L+WEP@>**X$9(*
MME=_0#(K'BUN_CB6.6YF+0O/&R&8,1B2/:"X^]@-U]\5VHCTK5].MP8[:XLW
M :%'4;3CCA3Z4V:#1K"S+20V<5O .0%7" D=AZG%"DEI8+'/MXMU&&'[1/:V
MACF60VX1F&TI($RY].<\=*UO#MS>7$NK+>S12R17>P&$DH!L4X7/UK1:UT\Q
M[6BMMBJRX(7 #=1^-5K6?2-.N_[+M$BMY6<#RHH\ L5)'3CH*3::T0&G13?,
MCV%_,38.K;AC\ZCM;J&]M4N;=]\4F2K8QG!Q_2H&34444#&N<1L1UP:YJUUR
M:'P?IERLD4]Y<>5%NE?@,QQN?'.*Z>L]-"TB)95CTRT42KMD"Q ;AUP:::ZB
M9SLGBO50URD=O8,UE%))</N;;)L;'R?4'OT(JPGBF[:_B)@@-G)/+"(H\M<#
M8I;.WH<^E:]XNDZ/IYDFM8H[8*(=L<.[(8\*% R<D]*R]+L-'N]:FUB"YE,T
M#DM%-&(FB9ACG(#8QTSQ5WBU>PM2#6CYMWI]ZESJD$5PLK26XD,9PD98#;V.
M15>R\7:M=0PQ)9VRW$[0"%I"0H$A(^;DDXQU[UUK364MZL+O"US%'YH!P2JG
M(W9]#R*9;:9IL W6MG;(&<29C0<L.AX[TN96LT%CF'\3:X S+;Z=L\NXD&2^
M<0G#?GV]*Z^"7S[>*8#'F(&QZ9&:9]BM,8^S18PR_<'1OO#\>]3*H50J@!0,
M #L*4FGLAI"US/BJ:6WD\Z!V25-/NBC*<$',?0]JZ:N:\40&XFBB9)?+FL[B
M R);O,JLQ3&X*,X.#4/8I;E&Y2[CU.RA6"\5)#)N7^U0=V%R.<<574WI36"8
MKS-NS"/_ (F@^3]V#Z<\G-)+;1RW<$_]GZ:OD[OD&B7&&R,<\=JC%A&%OA]A
MTX_:B3SHEQ^[RH7CCVS4%'3:"[227CN2780%B>Y\I:VJQ?#XYO"J3",&)%:6
M%H]VV, D!@#C-;56B'N%%%%, '6O/X_N?B?YFO0!UKS^/[GXG^9IQ =115>]
MNTL;1YW&<<*HZL3T%6E<DL$@#)( ]335='^XRM]#FO.;_6KG4;P1^8I+-M!8
M_(OT'3'N:L)#<VB"6*?=,@+.%79T_NL, _0BMW0LM69^TOLCT"C%9&A:P-3@
MVR$&91G<!C>OKCL>QK.UN6Z_M2Z$,DP$5J)%V3A AR>2#][Z5FJ;YN5EN2M<
MZBBN?_MVX:"::!(&AMHT:0RL5>3(SP.U)+K=VSW$82* &)G@WYW-A<Y!'&?:
MCV<@YD=#16!;:M?RQVL"BU:=K?SWDD<A2/0>_KZ5&/$%Y<1N]K;0!8[;SW\Q
MCZG(&.O3BCV<@YT='145M-]HM8IL8\Q V/3(J6LR@HHHH **** "BBB@"&Z6
M=H&%M(J2]BPS^%9>KZFZZ0LMNS0EY5BFD(Y@'\1/I]?>MJN3\2R21:M!"D68
M;D*)B >><<XK.J[09UX'#/$UE37KKY:DVDW^_5)XM.EFO+1;<N1(Y/[S/ !;
MIGFB?[ _AB[U#5-3N8]=1"\5LK;1$W.$51][. #58)!9WC?9TBBB<!8I%)W-
M\A9B!_=X'6JWV1+93<VEQ'*EN$DEE$C(B,1D8_O<\?6N2&E-0<F[=>Y[,LHJ
M^T<X-:^J.RM)/-LH)-I7=&IP>W%35D>';^?4M/:YF8D%RJ@@9&/I6O7=%W5S
MP*]&5&K*G+=,*S]1T>UU'YG!27M(O7\?6M"BFTGN1"<H/FB[,Y4^%;A9,K/&
MZ#U!!JY!X><.&FG  .<)U_.MZBL_91N=L<SQ,8N,7:_DK@!@ 9)QW-%%%:'
M%%%% !1110 4444 %(WW3]*6D;[I^E ';V/_ "#[?_KFO\JL57L?^0?;_P#7
M-?Y58J!O<*Y[,#:;K$%R\R137LB%H4+,#D$' !]*Z&N>2806^H.;Z:S_ .)A
M(/,BB$A/M@@_RI,:&HZOYUZVNW41C4"2>:QC0A2?[Q7.,TY&A^P>'X[;SC;1
M7B1Q/*,&15C<!OH:='?!M/O'&N-+M0?O+VU58X\GN JY!Z&F))YMOHLGG33[
MM1!\V1=N_P"1^5'9/3VI#.BHHHJB3 O= ?4-?N+F6YN8;62T2$BWFV&0AF)#
M>V"/SK$U3PM?N\\-G:PFT9W\I=RY4>4J+][@#(//7TKNJ*I3:)LCB5\.:H8Y
M(WMH6NY(UV:@TYW08BV%0!R><^W.:JV_A74(1!)+IR7$4<R.]I),@#X0J6&!
MCJ1UY/>O0**?M&'*CA5\,:HD:1O!%-,R1"&Y,W-EM<D@=SP<<=<<UT-_;WUM
MKJ:I96JW8:V^SR1&41LN&W!@3QCG!K9HI.;>X6.-NM"U:YN/-GM;5[B98MD\
M3[19,K9;:.ISZCJ>M5[GP?<M8;8[6 SND_G9?_6$R!D!/T!^E=U13]HPY4<8
M?#,J.+MM+AN6:[FEFM6D WHPPG/3Y?2JP\)ZSY(3SD67RPHE\S[I\IEZ]>"0
M,UWE%'M)!RHX.U\,:A!&KR62S0+,K/8/*@63"%=W V\$YYZ]>M=5X>LIM.\/
MV5G.BI+$A#*K;@O). >_6M*BE*;EN-*P4445(PHHHH R_$%K<W>F*EI&)9DG
MBE"%@NX*X8C)^E86IZ/J^IW,U_)90(97B0VWF+(WEH&^;)^4G+=#GBNQHJE)
MH31Y_'X7U:&R1/L<$LQMEA=FD4E0LI; SP?E(QGCCFNE\+:==:7IDUO=J$)N
M'DC4,#A&.0..!]!6W13<VU9B2L%%%%04%%%% !FBBB@ HHHH ****  =:\_C
M^Y^)_F:] '6O/X_N?B?YFG$!U<QXQG:.") 2 $9OQ.!_4UT]<WXNM&FM8Y%&
M>&C^A/(_48_&MJ5N=7,Y_"S'TJQ23P^\AL\NQ.V9H\_-T&#G@#UK5U&U?4;
MI'Y:72H%VJ<H_&#U[^]3Z?+%)X<M4L[T02I'@#(^]W!!]Z5+H6S3ZA=PND5M
M& CL<^:_?![^@K24FY-^9*22L<YX8EDM]52)@05EV,#VSD$?F!^5=+>1?VEJ
MLT,%I:,]NJ^9-<*6R3R  *P/#4,E[J_VIUQND,Q]@,_U(_*NEFMH[C6I5MKB
MXMKH1*TC1X*NN<#(/<555^_\A07NE.ZG@BU-$U#3HII$MA(3!&6((/\ ( =Z
M2:]MHKJ2ZM;:W9V\G#E#DK(<'/X59M$LI8#>O=R*)86M=UPX!.&.3]:&TFPC
M\N)KS#.L00%URP3ICZU%TM&59E6XN-,D:VMX--5X#<E-[Q$)_M;3ZU875M):
M'S$MGVRKY*CR\>8!_".V!2KIUF)%6/47=(9#.ELKJ<'G/O44=MIMS;V=@)WC
MG@C\Z/>%) /4'L?I1[OF&I:77K%8H5MXYI 8RR)%'DA5."/;%+;ZW'+=K"$:
M02@21&-3PA[MGWSTJ$I8V2"[%R9\)]E/E[?XVZX%2GP_%_HBFYEV6H4*N!DX
M]\9'O4V@/WC7HHHK(L**P[_5+JWU&ZAC*;(DA9=Z_*-S8.X]A4LVK""[7?*H
M@6:1)<IC:%7/X_6ES(?*S7HK/76+5Y%C"RAVSM!0C.,9 ]>HI9+J5]8^P1GR
MPL'G%\9R=V *+H+,OUDZYI_VI;=Q'-*JN/.2&0JQ3T'([XHM]49+J>VN3N99
M1'&Z)\I.P-C^=,MM8#3D22;T>*(Q;4P69L]OPJ79EPE*#O'<BT;0T&G'[:LL
M<CR.55GW,B$_*"?7%9FI6<ZSS6?F7$B(Z?8[?R R2@XW,QQU'/7IBMBTUV+[
M%"]WO$C1&5V5/E50Q&3Z=*L/KEI&N6$P&&8_NSP%QD_J*GDBT=$<;B8[2?WL
MGT^Q33K46\>W:&)^7IS5JJ(O5@G2"XE5I)VS#@8^7M4%W?3P:J]NI)C%HTP"
MIDA@<?E6BLE8YIRE4DYRW>IJT5DV.LQ26MJ)W9KB2)'?8API8$CITZ&DGUE/
M-@,&6C#NLRD<\)N&*+HGE9KT5CQ:S_I7[Y66!X8I%&W)4N<<G\JV*:=Q-6"B
MBB@ HHHH **** "BBB@ I&^Z?I2TC?=/TH [>Q_Y!]O_ -<U_E5BJ]C_ ,@^
MW_ZYK_*K%0-[A7-I?0VLFH6\FHR6$YO'D#"(L2IQCJI&#7244@1SIU6$6LZ?
MV\MQ*ZX3[3;$H#[A5&0>E,2Z@GETFWBO7O;A;P2RMY;  ;&S@8PJC( %=+^
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M%7!;P@8$2@>F*<J*@PJ@#VHL%RK_ &59[<>4<85?OGHIROY&KE%%,5PHHHH
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MTV>2VB,KI+<!-JM&P 9AD*3C ..U:U<NGA"3[=;74VIM*T#Q2#,0SE%VX'/
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M2/<U:*R+?5KV2>)9M(GCBE.%?<#CZCM6O42BX[E1DI;!1114E!1110 4444
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M3_Z8_P#CW_UJ/[3_ .F/_CW_ -:BB@.5!_:?_3'_ ,>_^M1_:?\ TQ_\>_\
MK444!RH/[3_Z8_\ CW_UJ/[3_P"F/_CW_P!:BB@.5!_:?_3'_P >_P#K4?VG
M_P!,?_'O_K444!RH/[3_ .F/_CW_ -:C^T_^F/\ X]_]:BB@.5!_:?\ TQ_\
M>_\ K4?VG_TQ_P#'O_K444!RH/[3_P"F/_CW_P!:C^T_^F/_ (]_]:BB@.5!
M_:?_ $Q_\>_^M1_:?_3'_P >_P#K444!RH/[3_Z8_P#CW_UJ/[3_ .F/_CW_
M -:BB@.5!_:?_3'_ ,>_^M1_:?\ TQ_\>_\ K444!RH/[3_Z8_\ CW_UJ/[3
M_P"F/_CW_P!:BB@.5!_:?_3'_P >_P#K4?VG_P!,?_'O_K444!RH/[3_ .F/
M_CW_ -:C^T_^F/\ X]_]:BB@.5!_:?\ TQ_\>_\ K4?VG_TQ_P#'O_K444!R
MH/[3_P"F/_CW_P!:C^T_^F/_ (]_]:BB@.5!_:?_ $Q_\>_^M1_:?_3'_P >
D_P#K444!RH/[3_Z8_P#CW_UJ0ZEE2/)[?WO_ *U%% <J/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>forms-1a_025.jpg
<TEXT>
begin 644 forms-1a_025.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (T!$P# 2(  A$! Q$!_\0
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MFJ"]N])BDMH!<7S 3O \-I9RA-5U'Q2?7;:)6@EFU2[G@>W6WAU'P]97;O\
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MGU&\9(=,MKNX:ZM%U&_BBDN-2DY@M-(G6\M;;4YXD5I(W%]?L/,1"TTA>:3
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M$#:-#:7.FWD<B312"5_$RS:C$VV*(V\%REV)OL\DMG&PAC;H[71&+V4DIO\
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M*7[1-]I?AO4%<M#J$>I:A\-_^)KJ303R+]AMTG\.V.9"@N+QF*<S_P ,!?\
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M "WDZ:A;2MK+:M):I)(]A;PQO%'$'GU:"-DN$]_L_P#@FO\ M_-<V[O^Q/\
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M'J,G'6GT5_ RA"*M&$(I;*,8Q2]%&,4ODD?Z W>]W?O=W^^]_P 1NQ./E'
M''( )('T&3@4AC0G)12?< T^BJVVT"[[R_\  I?_ "0PQH0044@C!&U<$'J.
MG0]Q[4&-"""H(8%6!&0RG.00<Y!R<CW/J:?14>S@G=0@GO=0A>[=V[\M[MZM
MWU>KN]17?=_>]?777YW&&-&^\H;G/(!YZYSC.<DGKWH$: $!% /4!0,_7 ]>
M?K3Z*JR[+[E_D.[VN[=KNWW7M^ W:./;@=#@>@R#_C^'%&Q?[H]>1G^?2E+
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M!'&<=N""<@C!SWI=B\<#C..!D9X.#U&1P<'D<4ZBGRQ_EC_X"O\ (/F_O?\
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M,7O&+]8Q?YIA=]W][_S&>6F0=J\-N'RCAL8W XSN(X)SD@D'@T>6F -BX&
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M.K[?#/#KA^LH.EF4<3[;V$Z4Y5(4HTHU)8AUY?5_8^V3@O9_M[*>6$OKM/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&>I:'!KMEIDGB"'QQ->1KX/7Q+IF@VCZKJJZ;?\ KW_!,?X*_P#!0O\ ;?\
M^")]Q\.?A;^T[XT^ 'B'2/VLM0E_9W^-EU\2OB_X5U^X^!'@;1M/TOQAX$TC
MQ=\.[JS\:W7P^TWXJW/C30/#-E_PD.HV%O>>'M9\.W5K8:1X8T72$_=6Q_X(
MG?\ !*O3+^TU*T_8?^"LUU97,5U%%J]CXB\1:5,\3[_*U'0==\3WVBZQ9RD!
M;G3]6L+[3KR(O!>6EQ"[(?TX\+^%O#7@SP[H?A3PCX>T/PMX8\-:38:%X?\
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M8ZCX@N= \2>&DTSPOI6L^*?$.IG1/"UQ;77R5\-_VBO^#>O]L_\ 9\M/BO\
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M5_GY?&[X[^(?VGO^"87B;]H']K3_ (*\^._B)^T/XJ\56?@_X=?\$_O#NO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 & >HS00#U /UHHH **** "DP.N!GUQ2T4 %%%%
M6# YX'/7W^M& .@ HHH 3 ]!^5+110 4444 %%%% !1110 F >H!_"EP/044
M4 %)@#H /PI:* # ]!1110 48'H*** $P.F!CTQ1@>@_(4M% !@>E&!Z444
M! /4 _6BBB@ P/2C SG SZ]Z** "@@'J ?K110 F!Z#CIQ1@>@_(4M% !@=,
M<>E)@=,#'IBEHH *3 ]!^5+10 8 Z#%%%% !1110 48 Z "BB@ HHHH ,#&,
M#'IVHHHH **9(XC1G;[JX)Z# R!G+$  9R22,"OD+X*?M]?L>_M%?'GXX_LP
M?!;X\^#?'WQ[_9MO;[3?C9\--(37(-:\$7VD^()?">NV\EUJFD:?H_B#_A&_
M%4)\->*)?"FI:[#X9UZ6TTG7Y--O[^RM[@ ^P**1R45G*N0HSA49F/LJ@%B3
MV &2> ,U\,>(_P#@I%^QYX;TC5=?'Q1O_%NB:!^U7I_[$>O:K\,OAS\3OBM8
MZ+^T_J&CZ+K3?#+4KOX<>#O%%K:KI$/B'2](\2>,I9U\">&_%\TW@37/$MAX
MUL;_ ,/VH!]T45XY\9OV@?@Y^SU8^ -3^-'Q \/_  [L/BG\5O GP-^'UUXA
MN)H5\5_%OXFZH=(\!^!-(CMH+J:?6?$-Y%=O$S(FGZ?I^GZEJVKWUAI6GW=[
M%[)@^A_*@!**7!]#^((_F*,'I@Y/08ZXZT )11@YQ@YZXQ_G_./6EP?0_D?\
M.OMUH 2BEP3G )QU]OK1@^A_(T )17C4_P"T'\&X/V@]-_95;X@: _[0FJ_!
MW7?V@(/A7;RW=UXGMO@WX=\:>&OAW?\ C_5HK:TFL=#T.Z\:^*]+\/: =:OK
M"\\4WUMXB/AJTU:#PCXKFT7V4@CJ".W0T %%%% !1110 4444 %%%% !1110
M 4444 %%%>/_ !]^/OP>_9<^#_CKX^_'WQ[HOPQ^$'PUTN#6?&WCCQ +Y],T
M2QN]2L=%L-UMI5EJ.JZA>ZGK6IZ;H^DZ5I6GWVJ:MJVH66FZ=9W5[=002 'L
M%%>,_L__ +0GP:_:G^$7@OX]_L^^/=&^*/P?^(NEW&L>"?'/A[[6NFZ]966J
MZGH.HJEIJ5M8:OIU_I.OZ+J^A:QI.KZ=I^J:3K.EZAI>H6=O>V=S!$GA+]H7
MX,^._C-\6_V>O"/Q!\/:_P#&CX#Z7\/-:^,/P]TZYEFU[X>Z=\5]+U;7/AY)
MXA1H([:&;Q1HFBWNKVEI:7-Y=6FG-I]WJD-A;ZUH<NI 'L]%?/O[4W[4?P1_
M8N^ _CK]I?\ :.\77'@+X+?#1?#<GC;Q=;>&/%GC&71H?%OB_P /^!-#E'AS
MP/H?B3Q1J*77BCQ1HFGRG2]%O!917;ZC?FUTRTO;RWO>!/VE/@E\3?BO\4/@
M=X#^(.B>*/BM\$_#GPD\5_%[P9I7VZ;4OAQI/QWTKQ5KWPEB\63-9)I^EZYX
MRT#P7K_B*T\+2WI\3Z;X;;P[XAU[1])TCQEX3N]8 /=**^;]$_:Z_9U\2>/?
MVEOAEH/Q/T?5?&_['MIX3O\ ]I30[.PU^23X4V7CCP/J7Q'\+S:S=OI$>G:L
MVI^#]'U75C!X6O=>GL&L+C3=42QUA#IU=?\  'X^?"7]J+X0>!OCW\!_&%M\
M0?A#\2](?7? WC2RTW6](M/$&E1:C?:3-<PZ7XDTW1M?L3#J.FWMI+!JND6%
MPLD!(B9&#4 >PT4N#Z&O'_CY\>OA+^S!\'OB%\?OCMXST[X>_"+X5>&=0\7^
M//&.J0ZA=P:-HFGB.,M;Z;I-GJ.L:WJNH7MQ9Z3H?A_1+#4-=U_6M0T_1M$T
M[4-4OK6SF /7Z*_$'XL?\'&?_!'[X%_$;4_A+\7?VI-=\ _$/1(/"MQKGA?6
M_P!G']I[[?H</C+PUH7B_0_[7-E\';N'3[E_#OB/2M0U'3;F2/5-&DFGTS5[
M&RUBSO-/@_83X7_$SP)\:/AOX#^+WPN\3Z9XU^&WQ-\(^'_'?@7Q=HSS/I7B
M/PGXITNVUG0M8LC<PVUU'#?:=>03^1>6UK>VS.UO>VMM=1301@'=45R/Q!\<
M>'OAAX!\<?$OQ<^JQ>$_AWX0\3>.O$\VA^'?$'B[6HO#WA'1;[7]:DT?PIX3
MTS6_%/B?54TW3[IM/\/>&=&U?Q!K5X(=-T;3+_4;FVM9>4^!/QN^'G[27PC\
M"_'+X2WVO:K\./B1I#:]X0U/Q+X*\9_#W6=0TD7MW8)>77@_X@:#X9\7Z/%<
MS64TUC_;&AV+:AI[VNJ60N-.OK.ZG /6:*^<]._:O^!.J_M0>(OV,['QG)+^
MTCX5^#FC_'_6_AR?#?BJ-H/A'KOBYO NG^+[?Q.^ACP=>1_\)08=.N](M_$#
MZ]9K=6]_-I8TUS>+]&X)Z \<'CH?2@!**7!]#CUP<<>]<3\2_B'X3^$/PX^(
M'Q9\?ZC-HW@/X7>"?%?Q$\;:Q!IFJ:Q-I7A'P3H-_P")?$FI0Z1HMGJ&L:K+
M8:-IE[=1Z;I-A?:G?/$MK86ES=2Q0N =K17Q%^SK_P %%_V0?VKOB#I/PM^!
M'Q/U#QGXWUS]GCP/^U7I>DW'PY^)GA:"[^!'Q(U"VTOP7XV&K>+?"&AZ/!)K
M=]=1Q1>&;F_A\6VJI//?:%;6\$LJ_;O;/;U[4 %%?'W[0G[?/[(?[*OQ7^ W
MP.^/_P ;_#'PV^*O[3?B$>%O@?X.U>R\27M_XXUM_$'AGPK#:B\T/0M5TCPS
M!>>(O&&@:3I^J>--2\-Z/J-U<7XLM1GCT+7Y-+^OPQ*;PK'Y=VT#YNF=N.S8
MQ\I/!XSWH =17R?\3_VWOV9OA%XH^*O@7Q?\1UN/'GP0^$*?'CXL^!?!/ACQ
MC\3/&G@7X57&K6FC:=XDUKPI\.O#_BC7UN]:N[Q)M \,6^GS^*M=TRWOM;TG
M1;O1+&YU&/WKX9?$/PM\7_AM\/OBSX$NM0O_  1\4/!'A3XB>#;[5=#UOPSJ
M=[X5\:Z%8>)/#UWJ7AOQ+I^D^(_#]_<Z1J5G-=Z)K^EZ;K6E7#R6.J6%I>P3
MP1@';44N">@)_"D]L'/ICGUZ=>E !17C_P ?/C]\'?V7/A%XY^/7[0'C_0?A
M9\'_ (:Z,==\;^//$\TMOH^B6+WMGI5A"$MX;B^U36=<UO4M+\/^&/#FCVFH
M>(?%7B/5=+\.^'-+U77-2L-/N;_Q8^-'PP^!/PK\9?&OXS>-O#WPQ^%_P^T*
M;Q'XS\9^--031-$\.:7$T,2R:C<7*B475S=W-IIUCIMM!<ZIJ>JWEGI&F65[
MJUW;64H!ZC17R_\ #']LK]G3XP?&_P :?LX> ?'EQJOQJ^'WPM^&_P :?%G@
M>\\'^-]"N-,^&GQ:LTOO ?B1-6U[P[IN@7_]K6TL)O-(T_5+G7=!GGCM-?TS
M3+K="OU#@\\'CKP?K0 E%>"_M+?M0? +]COX/^)OCY^TO\4/#7PB^$GA!;<:
MYXP\327DD(NKUFCT_2='T?2+/4_$7BCQ#JDR&#2?#/A?1]9\0ZK*&33M,N3'
M)M^3_P!B#_@K[_P3L_X*->)_%O@;]CW]H[1_BGX[\#Z/!XD\1^![_P '?$3X
M;^+XO"\]]!I<GBG2/#OQ0\)>#M3\3^'=-U.\T[3M>U;PQ!K%IX;O=7T.W\02
M:9)KVC+?@'Z5456O;NWT^TN;Z\ECM[6SADN+JXGD2"WMK>%#)-<7-Q,R0VUM
M!&K2SW$[QPP0H\LKJB,P\F^ _P ?_A!^T[\--"^,OP&\<Z5\2OA7XIO/%%GX
M6\=Z"MV- \3?\(;XR\0^ ->O]!N+ZVM)-4T6/Q5X4UZRTO7K2*71/$5C:V^O
M>'=0U;0-3TS4[L ]BHKPG]F?]ICX'_MA_!'P3^T=^S?X[M?B9\%_B*/$A\&>
M-[/1O$WAZVUL>$?%NO>!?$7EZ/XPT7P[XCLO[,\5^&-=TB0:EHUF9Y-/>ZM/
M/L9K:ZF]WP?0_E0 E%&">Q].G0^A]#[5X#^U'^T_\$OV,?@1X]_:6_:-\77'
M@/X,?#*+P]/XV\6VWACQ7XQGT:'Q5XMT'P/HDJ^&_!&B>(O%&HI<^)?$NC6,
MQTS1KS[%#<R:A>_9]/M+NZ@ /?J*^??A%^U)\$/CE\0OC3\*/AQXNN=3^(_[
M/=[X"M?BWX.U;PQXL\*:UX7M_BGX7D\9?#?7([?Q5HFC+KWA;QMX>M[^\\.>
M+/#CZMX;U.XTC7-.M=4DU#1=3MK7Z"H **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBBBZ[K[U_F 4444KKNOO7^8'R
M7^W?^U1X4_8C_8[_ &B?VK/&(:?3/@K\,];\5:9I:6M]>/XD\:S>1HGPY\'I
M%I]O<SQOXT^(.J^&/":7<JPZ?I[:R+_5;W3],MKR^M_X8OV,OAI^WS_P2Q_:
M*_X)E?MT_M8_L5-\&/"WQ7^*'Q'^ G[;W[36F?&7P[XG^)/[2,?_  4%\7ZC
M\2? 7B+]H?X2>%;*]U?X:)^S]XP&G>(=1@NM%NKW6=3\):1X.UO4]$UC_A%=
M,M_]% C(QDCW!*G\"I!'X&F>4N$ +@(V]2LLJ$G# [V5P9%.XEDD+HS8<J75
M64NNZ^]?Y@?YZ7P*\*?%_1/A-^QU^T_K7[0_[6MY\5OC#_P<VQ_L;:O(O[3'
M[1NC>'O#/[('Q;\=>+X?C?\ !O2O">G_ !3C\(P:7\4_'/@]?%WC?QY9>'M&
M\87VJ1Z5:)K$$NA)J&H?-/@7PWX!^"OPZ\9? CX/:S\7-(^*_@O_ (.QO@7X
M0^(/@=]:^+=QXF@_9\FL/VDO!OP,FN;[628O$FH>-9O!/Q=T_P 3:I;W>K^+
M/$EWX5TR7QYG[-X6>[_TP/LT)W$JQ9H_*9VDE:1XN<1O*7,C("S%59BJL[LH
M#.Q*BWC"A!Y@4 A0)IAM4@@HI$F5CQC]VI"#:F%_=IM+KNOO7^8'^;4?&'B?
MXN_$?X0>!/VJO&_[5_Q!_P""HG@?_@XN^!__  OWX:7>M_M=>+_@-X._9FT_
MXEWUCX)N/#'A;4SJ?[+GAKP'H'C#7=7L/@8^DQ6/Q"M_"/BG5[;PHD_PZU!E
MAE\0_M+?MX7_ .VK^T9X8^(7QV\7_ W]OGP[_P %%/B8-1\.:K\0_P#@I+'X
MD\;?L+^&O %[/I/[-_@;]GSX2?L^_%O]C#0OV:M7\+ZSJ?Q-^'_[0_BSQUIG
MC?P[&DGQ4U#5M(\%26'Q=U/_ $D/(C\MHOG$; @H)I@H4[LHH\SY(\,5$:;4
M5=J*H1$5>;\9>$-%\<>#?%/@37[>:Z\-^,O#VN>%/$%E#?7EC+=:%XDT^[TK
M6;6WOK2>*\L9;C3[ZYA@NK2:&XLW=)K:2-XHRI==U]Z_S _SS/\ @DY\:]%\
M2^,?^"+%E^R7\:/VTO&_[96E:'\>O"?_  4F\-^-O&/[3VL?#/1?V2+#0?%%
MY\.6\2V/Q%U.^^ &B?#+X=>'KSPU=_ 23X.ZII=M!>ZKX;O-<T>Z^,5]X:LK
M'B$\(_M/_L_?\$4_^";G[4<OB[]HWQ#\/?VO_C;\./#_ /P4K\3_ !-^/'[3
MDWA^R_97^%GQ>^+7A;]EOX57_B?X.6OQ!^,WP$_98^(/@+QEK.F>*K[X+^"-
M8UK5M1U_P'I&EP76OZ[X7\(^(O[T/@?\!?AK_P $_/V-O#/P.^$D6NW'PM_9
MG^$FO)X2C\9:Z=<\0:A;>%K75O%ES?\ B/6K>STBVNM0U/4VO-2N_L.EZ;I]
MO)=30:9I^G:?:V-E!]0^%M0B\0>'?#WB,*%?7-"T?6 T4TK+C4]+@NPH<L#)
M&BW)6/?NRHC<DR*"K _SZ?C!\0/V@_B%_P $CO _B/X@_MOZKK/[/VH?\%2O
MB=>^ ;SQOHW_  5<\8_LR>)_V7U\">'_ !+X"_9I_:!_:*M?@'\*OV__ !/\
M*/ /Q"G\4>%/A?XZL-)\:6/CCQA>:3X;OO$OAG6/A2EY\)OE?XQ_&OXE_%#]
M@;]@K5_B#\7/B;\,O@I\*?'?[9?PU\.^!_VM?$7_  4K\0_LN_M&R:#>>#->
M^''Q)^$7[0/[-?PL\*?M"SWGAJQ\9ZWX<_9,\#_M":;K>B_#[PE\*/%>D>+/
M'LD6G>)O!'C#_3:-M"TC2X82NH1I4EE21D7HI='5MH/(7.,\XR<TOD)G.^?.
MU5S]JN1PH0#.)N3A 2QY+-(Q):64N ?YMO[=_P"U'K_QY_9V_P""?OAOXO>!
M/VS?A;\2]?\ ^"9OC/Q-\&M=_:O^.O[8OC33_%7QDT#XK?$KX4>"=8\%_#K]
ME/X ^!/%/QH_;:\7:=X.\'^.OA_\8?CKXX^'?P17X9?$'P7JOQ;\(_$"UU#P
MOJ7C;U/P;IWQJ_:;TWXW^/OBE^T%^U?J3_!'_@U^^#_[3/A71_#'Q]^/'@.W
M\3_M0_#_ .'5UXN^$?Q1\87/@+Q[X:/CCQ'X \9>'[GQ?9Z1XGL_$%MXK\>S
M1>+O$R:KK-EJ+:U_H@B)0VX%U.6)Q+* Q8("S*'"NV$7#,"1\Q4@N^X,2GJ9
M&P0PW32MA@<@C+G!!Y!&".,=!0!_ =^R_HV@VO\ P4T_8]^,WC?XJ_M):+^T
MC^U)_P &U'ACXJ_#[XQV5Y\9?V@/B7XT_;<\2?"7Q;8>*=8\,^'M>OO%-MXQ
M\6:7\&/A_P#$+XA^%_@UJ5]I'@+7_B?X6LI-'TRW\>Z_I$.H['_!N9\9?%.D
M_P#!0"X^$EMXH\>?'T_$/]GKQWK?QS^+GPS\=?MZ/X)MOB+HOB:7Q%=^,?VX
MOA'^VC\.KK1=)_:=\1:C%'X/TGX@_ #QYX:^'^A:S=:[X9L!XZ7QYJC-_>P8
M(R<D,?F#G,DA#. @61P7P\B>6ACD<,\91&C9652&FVB8*'#R!7\Q1+--*H<?
M=8+)(PW(?FC./W; /'M8 @ GHHHH **** "BBB@ HHHH ****5UW7WK_ # *
M***+KNOO7^8!7\P'_!PWXN^,_P"T+XM_8R_X)<?LR_!FY_:-^(/QM^*NB_M7
M?M#_  ;N?$VE> /!7BS]E+]F76K3Q!-X ^(_Q'\2VLFA>"/#?Q>^),-G8Z5X
M@AFDU&R\0?#J#36L+RX\1Z#I/B'^G^HF@C<LS;SNVEE$LHC;:K*,Q!Q&>'.X
M[,N5C+[C%$4+KNOO7^8'^<5XG^,W_!0O]C[]@O\ X*-?\$[[3X=^-_V,_&_P
M'_;"^%/[8Y\"? KXL^+?%?B3X1?\$UOVG_'-UJOQ'^'/[.7Q-^&<SW3^$O@M
M\5;GX6V?C35]*\10:AK7A;XL?$E?$6D06^D>,F33^([67B/X+?\ !S!\1O\
M@FQJG[5_B;X-:K\#_P#@DUKWP$^)>L7?[5UQ\3K_ .$_@3Q#IES\9I=$\;?M
M "#X]ZC\.O!/@SPQ\4=,FD\0ZC<Z=9?"+PQJ=GIDUQ\-],MW'^C"MO&H 7S
M%(91Y\Y"D($RH,A"Y4$-MP'+.S[FDD+*\$<CK(X9G0@H3)(=A!5LJ-^%.44D
MJ!G'.:+KNOO7^8'^?]_P5Y_;/^'7[=W@?_@K_P#$_P#9PN_C)J_P,N?^"8?_
M  3JT[1-2\:_#CXF_"[PW\1M?T#_ (*5W&IZCXX\#^#_ (@Z/X<UCQ!H7AQ/
M$>L^ )/&MQX:M8E\4>%OB+I&C7=YHNGMJFI_IG_P2:^&WP'^!_\ P<!?\%AO
M >GZCX]TCXD^*_@I^QYXZ^#VA>,/%GQ:\7VWC#P!XL^$?P^^(?[3FN+XE\;W
M^OV&OW'A3XM^+_A18^%H?$?B2[U_PMX;US5O#?P^M1X4L/%,.E?UG>2F<[IB
M=Q89N)VVDER2N9#M^^RX7 V$)]Q54(L$:;=OF *20OG3&/+%228S(8V.Y0X+
M*2'+.I#NY8NNZ^]?Y@?QI_$W]L[X+?\ !-?_ (*.?\' ^B_MB?\ "P?AD/VT
M_A-^SGXZ_94U"P^%GQ*\<:?\<[+PM^S#\1?AUK&F^#]6\&>$=:\/Z?>P^.=6
MM_"RZAXNUGP[X=M];L]<LM4UG3ET'4+E/PQ_:D\*?&K]F7]F;_@F79_&GXB?
M$'X4W_PZ_P"":JZ]X._99^+,W[>GP2U?0?C/<?'#XE?$/0_BA^R)\3?V5/"?
MB'X6Z1^V7!X>N_ VC:EH7[5EA:^&?AF^L> E^(6C>(QJ6BVGPM_T^_)3=O'F
M(=VXB.66-&8D$LZ(ZH[': 2RDD?*<J2"&&/! WH&8NWERRQ%G889F:-T9F(Z
MLQ)) ).0""Z[K[U_F!_G(_\ !0/]J#]L[Q3^U)J[_&CXM?&S]CF]\7_L1?L"
M^+O^">,_QA^*_P#P4$\&>,OA3X^\=_!KP%XI^-^I:#X7_8;_ &7O&_ASX^_M
M Q_&37?B;\%/C%>_M > _AI?W<U]#HVD:18:9IVA:)X1_HF_X+R'XC:__P $
M@_V>M,^((N_$.N>,?VA/^">6E?'VTCT'6=,\/>)VU3XA>"KGQ7:>,?"FK^$/
M DMGX7U3X@1:3(WAWQGX \'16NM'1+#4/!WA[68;31K/^DA88T!"!DW/YC;)
M)$+N0 7<JP+LP W%LEB,MDUX5^TW^S9\'_VO/@9\0_V</CYX,LO'_P 'OBGH
MD6A^,_"=Y>ZEI@O(K#5=,\0:%J&GZIH]S9:GHVM^'/$FC:1XD\/:WIUU!?Z/
MKFDZ??V4D<\*2(77=?>O\P/Y!?A?^QS^U=^V5_P5+_X.0?@W\"/VTK3]COX;
M?$?Q!^S7\,_CSIVJ_LH>"OVCIOC/X(^)7PI^*FB2:5HNH>-O&?@Q?A_+I/A>
M+QYX;O+[2H==?7-+^)4]^G]D:SX8\/ZS%^?/_!07PY\:_P!AS]K?Q]^Q'H_[
M1'Q'_9[^#W[/O[+O[)_P[_X)2_$GQS\7/V__  ;)8:M8^%=!N_C%\8OAYX2_
M84_9[^,O@SXU_%WQQ\9+_P"*'@GXHV?QJT#PEI^GV/BK2/!?@L0>#O#_ (.T
MCPG_ *,>C:1%I&EZ7I:W.IWL>D65II]K=ZQJE_K.J3P6-JEG#/J6JZC<7-]J
MNHS0QK)?ZGJ$]Q?:C=M+>7DTMQ(SUI^4GS8WIN;>WER219;!!8^6R9)!^8]6
M(5FRRJ077=?>O\P/X?\ XA_!SXK?';]H_P#X+T?&7XX?$3]I6\\6_LB_\$S/
MV>_B;\+?"GA;XE?%[X<_!MOVE?B/_P $HOB3H?C3QA)\(5TSX=F_\7Z=<7'B
MK_A'M*G\!^ ;[PU<>*_%EEXA\ Z=J'B&]TI/QC^ WQE^"FB:%XA\,?MY_'G]
MLWP/IWB+_@C/\'[KX :/\/?'/[5&E:)J/[54?B;XF^./@)X@\46GP;OIVO/&
MFDW=_K'B_P""R?%W2-1^"MV^O^+_ !%K\$]_+H-S>?ZC(MH5"!5($>XQCS)-
MJ%GWDHN_"_-TV@;1\JX7BOE?PA^QK\&?!'[7OQD_;9T&V\41_&SXZ?"GX:_!
MWQU<77B>\N?"S>$_A==ZK=Z%<:-H!BC?3->O_M]A::W?O?WEM/:>']-?3K'2
M[Z]\1WFN%UW7WK_,#^(^V^"/Q<_:/^.'C'7_ -LS5/VC-'^.G@+_ (-6M&^+
MGC!=.^)OQ8^%/CK7_C+X0\9:UK'P\OOC5<> ?%.@>(_&WB+3;BV\.>/?$/PX
M^(US?VVJ?$K3(+[X@>$;O7=#N=-@^/?C=^U1^V_XAF_9GO/VEOVD?BA\//"G
MB_\ X)8_LUZW^PC\<_&WQN_X*"^!Q!^T3JW@#PGH/Q5^.VB7?[#_ ,)OC5KO
MQJ_:>T;QYK?Q!\#>)+/X\6^@)J7@3Q'H7_"3:U=1^(?#.J:U_IN+#&@PH8#<
M[X\R0@/(V]W +$!V<EMWW@S.007;(L*("%,HR5)/GSEF*@ ,[M(7=MJJI9V9
MF155B5  +KNOO7^8'\:/PY^'GQA^+_\ P4)_:,^/G[3/BK]LWXP:E^Q'_P $
MIOV!OVJKWX;_  +\8?%?X.VGQ+_:^TGX'^*_%EK=6/P'OO#'PLOYOB=XMUC1
M/C';_#OX;^-/A9X+32]>\7>./#?C/X9Z3>ZEJ7ABR_$3]B?XM^(-3^-7Q4D^
M#OC;XDCX<?M'?\$O?^"D$7QV\"^)/B#^UW\<O&OB'XI>%?V=/%/Q)AM?VG?B
MS^T=\,?A%\+?B%^TYX5U_P 8V3:SK/[+'PE\'>"?#NAZOI5I;ZYXI7XG^(=8
M\5?Z=!@B)R5;H0!ODPH+[SL7=M0ENI0*2 %)*@ .\I><F1LG=AY97 ;(8%0[
ML%*L R;0-A *;2*+KNOO7^8'^=_^RC^RIXZ_;&T+XD_ #X=2^*-'^*7BG_@V
MI_8CU[X-7_AW6&\&ZN_QO^&/Q4T'XE?"32+/Q==ZGX?LO#R>(/B!X.T;P[J.
MK7NMZ=866E:AJES>W*6EM<LG[3?\&_OQH^-O_!23XW?M:?\ !5SXPR^.]$T+
M6_AY^SO^Q9\&OAOK&MSV?A'0-=^%/PU\$^-_VMO$&D>"+2:/0#I?BW]H'4K7
MQ%X(UT6D6JZ/9ZOXQ\.2R"]35[&S_HI_:0^!=I^T=\%_&7P7O/B=\;?@]:^,
MX]&BF^(_[/7Q2\0?"#XQ>&UT7Q#I/B-)/!WQ%T$SZEH$FI2Z/%H^N*MM=V^L
M^&-0UOP]>V[V6K7&/G'PG\(/A/\ \$T_V3/AU\%OV8OASIWA[X5_#KQA\'?A
MMH'A.XU*^OKB9/C)\=? ?@;QCXQU[7+G=JFN^(=_Q \3>/=7O;R9Y]4U5)(4
M:QTQ;>QL]*<'5G&G"SE)V775^EW^'X7,ZL_9TYU+7Y(\S7DK7^=MN[/XXO\
M@HS\$?VWO^"OO[87_!13]HC]EO\ 9 @_:#^#7P*T'3/V"?V6OC7XA^,G@3X(
M>*/@I\3?V8_'/@_XT?&'XI_!;POK&H1>)/'OBC5?BROB?PMX6\<:5J6A1:GX
M!\72>&$UBZE;5-#\.[OQG_;M^&W[7WQ+_9V_:M_X*5?$O]L/X1_L#?&#_@E1
M/>_ ^\_9JU7]HSP=H_AC_@J5\*OBX_A[XKWOAC3O@\T6@1_M ?#CQAX;\>ZI
M\++SXTZ++\,)]%T[X::SXHC;P\VE0S_WZ0VL+&X9U>23*0F621S(8TRJJ'4J
M0B!I&C4?ZMIKAEPT\Q>UY* L0TH+[=Q$\X)VDE>?,R ,D8'!'RG*\5!<7=)O
M1M)M=KI,_P VGXC^#OA=\$?CA_P4JUK3M>_;:\.?&#XU?\$)OAUX\^ \_P"V
M%XO^)OB']J'QOJNM> /">M?%34?BMKZW_B?2;+Q[H?A/X<6][+X2/C&RT#X>
MSZ=K_A3P3X?TMM!FT#PSZ=\/_AK\4?C%X8_;E\6>/OCC^U-H=G^RE_P;C_\
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MW%PQ4MOR4+2GR\AV&$VC;M4 *B!7>4FTK\^"P<GS9 Y8,&!,F_S#@@  M@(
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M?B=^W#^RM\)8-)\2_%N"[\7^/O'W@;X=_$6]TZ'5+A=4@\-:[H.FV6J^"_\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***:Q
M&3G&0..I+?*H]LL5&> !U.* '45XQJ?QE\-Z??W=E*FLB2TN;BUD\JPMI8S)
M;RO&^QVOXG*;D.TM&A88)53D"C_PO#PS_=UW_P %EI_\LZ]>GP]GU6$*E/*L
M5.G4A&I3G&%U.$TI0FGS:J46FGYGDSSW**<YTZF84(3ISE3G%\]XS@VI1>FZ
M::?W[-'NM%>%?\+P\,_W==_\%EI_\LZ/^%X>&?[NN_\ @LM/_EG5_P"K7$/_
M $*,7_X+_P#MB/\ 6#)?^AEA_P#R?_(]UHKPK_A>'AG^[KO_ (++3_Y9T?\
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M_P"':\>__+BNB_X3O3?^?;4/RA_^*H_X3O3?^?;4/RA_^*HY*W\K_P# %_\
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MXKHO^$[TW_GVU#\H?_BJ/^$[TW_GVU#\H?\ XJCDK?RO_P  7_R(>TH=I_\
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M&W_YYM_WV:.9^7W+_(-/Y8_?/_,X+_A3>C_]#M\9?_#N>.__ )<T?\*;T?\
MZ';XR_\ AW/'?_RYKO?^$AM_^>;?]]F@^(K8<F-^HZ.<\G'I1S/R^Y?Y!I_+
M'[Y_YG!?\*;T?_H=OC+_ .'<\=__ "YH_P"%-Z/_ -#M\9?_  [GCO\ ^7->
MB7&N6D!6/YFE(5BGSJ A7.=V ,@E1M^\<DGH:@_X2&W_ .>;?]]FCF?E]R_R
M#3^6/WS_ ,S@O^%-Z/\ ]#M\9?\ P[GCO_Y<T?\ "F]'_P"AV^,O_AW/'?\
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M16__ #S/_?7_ -:ES8OO3^[_ .U#7LOO?^1P_P#PJ6'_ **'\5__  X5]_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *AE;E4QU>,Y^DB-T^E356E_UB?[Z?\ H25,VTKK
M^:"^3G%/\&QQ5Y)/:TOPA)K\4C\_/$TK#Q7KZ80@:WJPY4<C[?<#G@_Y)/7K
ME<^@_,_X5H^)_P#D;O$/_8<U;_TX7%9]?TIEL8QR[+^56_X3\(MV]J,$MS\
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MBCF?:/\ X!'_ ""[[B8'O^9_QHP/?\S_ (TM%',^T?\ P"/^07?<3 ]_S/\
MC1@>_P"9_P :6BCF?:/_ (!'_(+ON)@>F?KS_//K6EJ8S9:.3R?)4#/.!YDA
M(Y]R3U[GI6=6EJ?_ !XZ-_UQ'_HQZ5]5I'_P"/;T*4Y1O9O5--;JSWT>GX&9
MM'O^9_QHP/?\S_C2T4^9]H_^ 1_R)NQ,#W_,_P"-&![_ )G_ !I:*.9]H_\
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M\B_+_P#L PG_ *9IG\]YE_OV)_Z_UO\ T_7/SE_X*P?'CXL_LV?L*_%SXO?
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MJJ$?:N[;FT]+V:I.TG%)-IMI-I:*5E\0/]QO]UOY&O:/!7_(L6O_ &%]5_\
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M;_2K?QWI$&H:EX=&IZP]OX<U5[RS_L[O?A%_P3*T'X2W/_!+":S^,VOZX?\
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M*IU:CI4N>,9U6U%)2;YOXB_\%0_B9\(_VG-?U+XN> /CI\+O"_@+_@FIX_\
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M .G> 1=ZE>0PR6&N7=Y+%HTV!\/_ /@DA\3OB+X(M=>_:G_; \=?$?QQ>?L
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MXQ>,YM4^%_PO^'7PXMVTFU@\0>&;SXC>.-9\*^!?%?Q[U>]CNO$7AW]G_P
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MZY_8U-X;&8I9USTZ]"K0G3S)9;1C6PM/,L4\+1Q>'JX%T,6ITOF<[I9]5Q6
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MVC@U\:6W_!3_ .)?P@^/?CW]AC6O@%\7_P!L'XG_ +(_PI^%/B#]IO\ :O\
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M90\.J3I3]_#<N)I5)8[12S2%2,</"%_J?-74:;_:[X0_%/P9\<?A7\-OC/\
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M)\$_!/Q%OOAO_P %%_CM^VWJ'[%O[27B>#P!\*_$NM?#1OV:=5;4OVJ?':>
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M\4_LJWOB&7P%XJ^#P\+W^IA_"?BCQO=I)XIU*^N9;T^$-0\5_#_Q)[?\+_\
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M7R^K/VKQ&+A4Q,J5:%*>%]K!.%XSDOO"BBBOA3ZD**** .BT'_4ZA_UTL?\
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MD@ =:B:DTDHR;<H='TG%N^FBLGJ]/O1491O?FC91FWJNL)+OW:7S/SX\3_\
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M:8;E68"TO&!.0?LLX[ ?W#GIG(-+J_1?J-II*_6_Z"44;+G_ )\KS_P&G_\
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M_"7#?_* ^NXS_G]^-7_,V/\ A)_%W_0QZO\ ^!]Q_P#'*/\ A)_%W_0QZO\
M^!]Q_P#'*Q]H[Y&>F5 S],KS_P#7'J*7:/\ (7_XFC^S\!_T X+_ ,)<-_\
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M]),]U<71(73+\@+]I>8)@C.4"L>A)&,9IU'4W9R=4U0?-T74]1  VJ< ?:N
M,^IJ;2_^0AIO_7:__P#37J%9J]7_ -X?^@+248W?NQV7V8^;_E[C;=EJ^O7T
M+?V_4_\ H*ZK_P"#34?_ )+H^WZG_P!!75?_  ::C_\ )=5J*=H_RQ_\!C_\
MB*[[O[W_ )EG[?J?_05U7_P::C_\ET?;]3_Z"NJ_^#34?_DNJU%%H_RQ_P#
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MI_\ 05U7_P &FH__ "75:BBT?Y8_^ Q_^1"[[O[W_F6?M^I_]!75?_!IJ/\
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M<?G%_P#&Z/M.K?\ 01N/SB_^-TZB@!OVG5O^@C<?G%_\;H^TZM_T$;C\XO\
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M3+*[:Z='M+749[3Z'A;$8S#9U0G@,+]=Q-3"YGA8T+T$G3QV5XW!5ZLGBO\
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M $$TY?\ 6P?]=D_K36_X^KK_ 'H__030 ZBBB@ HHHH **** "BBB@ HHHH
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M_B_5M4A\2Z;+^T''\%C\,+F+1=2M]8CU+1X?!GB?ZG_80_X)U?%O]G/XY?\
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M"*U]4U2C?IYV]4S\DS"E4^NXSW):XS$/ILY76[7<6BDY]!^9_P *.?0?F?\
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M!C'3UYSS3_,3^\*_-4K1BNJBD_57/TB7Q2_Q,?13/,3^\*/,3^\*!#Z3&?\
MZQ(_E3?,3^\*/,3^\* '8'^<_F?4^YYI:9YB?WA1YB?WA0 ^BF>8G]X4>8G]
MX4 /HIGF)_>%'F)_>% &GI?_ "$--_Z[7_\ Z:]0K-7J_P#O#_T!:TM'_>:C
MINT[A]HU <$9_P"05J'X_>XS^M96Y59LNIRQ/!!&-H'YY'U'MS6?M(^U=/7F
MLM;::)];_H,EHIGF)_>%'F)_>%:"'T4SS$_O"CS$_O"@!]%,\Q/[PH\Q/[PH
M ?13/,3^\*/,3^\* 'T4SS$_O"CS$_O"@!]:6I_\>.C?]<1_Z,>LDNA/W\#C
MH<>N?Z?YS6MJ0/V#2&Y*K$ 3V&7<\'N.V1GICM4.<5-0UO=+;3WEIK?[] ^9
MFT4SS$_O"CS$_O"M&K-KLVON ?13/,3^\*/,3^\*0#Z*9YB?WA1YB?WA0 ^B
MF>8G]X4>8G]X4 /HIGF)_>%'F)_>% #CT_%?YBM_PS_K]1_[ ?\ [D;.N=,D
M9'+@>^?3FNB\- K/J!R/FT<1J0<@N;^WDV ]-WEQNV!T&!W%98VM!83V;4N9
MW2=E;=/5W_0NG\</\:_-&]%_JU_'_P!"-24Q"FP;3@<X#<'J<YS[YIV1ZC\Q
M7SAZHM%)D>H_,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>
MH_,49'J/S% "TR3[A^J_^A"G9'J/S%,D(V'D<%3Z_P 0H LWW_'^/^O8?^A)
M45/NV#7NX9VBW"DD8&28SP3P>/UJ/(]1^8H 6BDR/4?F*,CU'YB@!:*3(]1^
M8HR/4?F* %HI,CU'YBC(]1^8H 6BDR/4?F*,CU'YB@!:CE_U;?A_Z$*?D>H_
M,4R3#(0",G'<=B#0!+%_Q[:O_P!?NF?^FRXIB?<7_=7^0IT;8M=4)!_>7MAL
M&.6$6GS1NP'7:KL!GIS]:8I 502 =J\$^PH ?129'J/S%&1ZC\Q0 M%)D>H_
M,49'J/S% "T4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "
MK_K8/^NR?UIK?\?5U_O1_P#H)IZ#=+"%()$JGJ.@SFF.0+JZR<?-'_Z": '4
M4F1ZC\Q1D>H_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1D>
MH_,4 +129'J/S%&1ZC\Q0 M%)D>H_,49'J/S% "T4F1ZC\Q1N'J#[ C)^E '
M1Z#_ *G4/^NEC_Z%+76KT'T'\JY/P^&>&^VJ<.]KM)^4$Q,Q<9/IYB?7/'2N
ML'09ZX&: %HHHH **** "BBB@ HHHH **** "BBB@!K=!^/Z@BO,O&=TMOJ5
ML39V=R[Z?(\1O(C<1Q!VVE3 66.547)5'PH<@C;DY]/KPKXE^)O#6D^*_!GA
MS5?$GAW2_$GB_3-73PAX=U+6]+L?$/BMO#UJ-3\1?\(OH=U=1:KXA7P]ILL&
MHZ^VD6EXFB6$]O>:F;6WN(9'Z<);ZQ3YDW'7F44Y/EMKHDVE;>5O=7O-I*YC
M7BYP44XIN<5'F:BI2J2C",%=I.4I.,815Y2E)1BG)I.A_:4QY&G>'2/^P!:=
MN/\ GK_+/%']HS?] WP[_P"""T_^.U0!P.AQ]!W/OCKD8X_K2EP.N1^!/MSC
M..>/KQ7OR5"\N2-H1:LO:OW5)2E%2_>Z7C&4E>UU%M72U\ZSNXI7:M>RD]&X
MI/2.TG**B]FY1LW?2Z=2F')TWP[_ .""T_\ CM U.4]--\._^""T_P#CM4MP
M/&,\]/7KR.V!@]>.W6C[N?EQQVQS^(..!VSS^%)JDG9QLVFTG5E>T4G)V]HW
M:*:;T5KJ^]B_9R4'4<>6,4VW)2CI&/,VKI)Q45*3:;7+&3O:+:O?VC-_T#?#
MO_@@M/\ X[1_:,W_ $#?#O\ X(+3_P".U1W#G@\>WU'X9QQG% 8'H#^7;L?7
M!_/MC.*&J2W5M9JSJR3O3MSJWM+WA=<RM>-]41JFTU9I)M--63;2>ME9N,DG
M?>+6C3+QU*8<G3?#O_@@M/\ X[31J<IX_L[P[_X(+3_X[6?/<06\,UQ<30V]
MO;P2W%Q<W,L=O;6]O#&TL]Q<SS-'#!;P0J\T\\KI%#$CR2.J(Q'F?AGXX_ [
MQKK5GX;\%?&KX-^,O$FH0W%QI_ASPA\5/ 'B?Q#?V]I92:C=SV&AZ'XAO]5O
M(;33X9K^[EMK21+:Q@GNIVC@@ED36-!SC*4,/7G&"4ISA'$SA"+YK2G.$)PI
MI\D[.I4II\DFFU&33]U/EE.E";ER1ISJTX5)S>BA3ISJPG4FVU%1A";YFHVN
MTGZ]_:,W_0-\._\ @@M/_CM']HS?] WP[_X(+3_X[5(G'4'\QW_'CZ'!'>F[
MQG&&SQQCUS^?0Y].^,BL^6FE=Q:5KW]I+;17_B7W:6SW1-_3:_79\UG?:SY9
M=?LR[.U_^T9O^@;X=_\ !!:?_':/[1F_Z!OAW_P06G_QVJ:Y?.U2=J/(QX 5
M(T,DCLQ("K&BL[LQ"JJEB<#-8EKXF\-ZAK.K>&]/\1^'[_Q'H-MI-[KOAZQU
MO2[S7M$L->CNIM"U#5]&M[N74=-T_7(;*[DT6_O;:&SU58'-A/<?+N%"#NU"
M345S2<9U)J,;I.4G"4XQ5VE>4HJ[2;5[CW<597DU&*LTY-N:2C%VE*[I5+<L
M7?V<[-\DFNG_ +1F_P"@;X=_\$%I_P#':/[1F_Z!OAW_ ,$%I_\ ':HDD'N>
MG]T@^H!'?KQGJ*"V.H(_+_&DO8RUBFTX\VM22?*VTI6=76+::4E=-J25VFDN
M9=T[VZ2ZVMTZW5GMJM47O[1F_P"@;X=_\$%I_P#':/[1F_Z!OAW_ ,$%I_\
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M^#)__)A?R7]?,N?VC-_T#?#O_@@M/_CM']HS?] WP[_X(+3_ ..U3HHY:?\
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MCCI0<@'ID UR6@_ZG4/^NEC_ .A2UUJ]!]!_*@!:*** "BBB@ HHHH ****
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M=>%=4BM[YM,MD\6Z/?#7+OQKJ-UK;W<S0W'@O2? /].MC\,?AMIJ01:=\.O
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M>WOXO%E[:6UA?>*+>[MM'@N+;Q%J-E:06>J:Y!(FKZC;1Q0W%^4MK06_8@$
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MF)3*5M(IS&K)YWE>9'N=7YE_\%$?V<_C]\0KS]G_ /:._9-UB>3]H/\ 9?\
MB"/$&F?#W5/%UUX3\$_%+P#XF2UTKQOX-UTZEJUGX7.IW-BGG6.KW<$<EKIL
MNI0174>HVNF$@'LWQ*_:@UW0OVP?@-^R/\.?"ND^*?$_C#PAXF^+OQPU#5M2
MO8?^%0?!G3K*:'PYXAAMM)::"Z\1^-O%-O<^%M.LM5>.VL_*2ZF>)KBW6?[-
M  & & &.'"JW09)54C49/( C3Y2"1DDG\_/V'/@!\4?!>I_'#]IK]HS3_#VC
M?M/?M1>);O5_%/AW1-0A\5:/\)?A;X9NI(/A1\'- \4VZW*:E-H^BQ6DWB2;
M3;B'19_$5UJLMM=:I##I]W+^@:]!\NW@?+N5\$@$C<ORM@Y&1]"20:%_7_#?
M\. M%%% !1110!H:7_R$--_Z[7__ *:]0K-7J_\ O#_T!:TM+_Y"&F_]=K__
M -->H5FKU?\ WA_Z M+J_1?J'1?/]!U%%%, HHHH **** "BBB@ HHHH *TM
M3_X\=&_ZXC_T8]9M:6I_\>.C?]<1_P"C'H[?/\@,VBBB@ HHHH **** "BBB
M@ HHHH 0]/Q7^8K?\,_Z_4?^P'_[D;.L ]/Q7^8K?\,_Z_4?^P'_ .Y&SHQG
M^X/Y_FBZ?QT_\:_-&]%_JU_'_P!"-25'%_JU_'_T(U)7RYZH4444 %%%% !1
M110 4444 %,D^X?JO_H0I],D^X?JO_H0H L7W_'^/^O8?^A)452WW_'^/^O8
M?^A)45 !1110 4444 %%%% !1110 5'+_JV_#_T(5)4<O^K;\/\ T(4 2Q?\
M>VK_ /7[IG_ILN*8GW%_W5_D*?%_Q[:O_P!?NF?^FRXIB?<7_=7^0H =1110
M 4444 %%%% !1110 4444 "_ZV#_ *[)_6FM_P ?5U_O1_\ H)IR_P"M@_Z[
M)_6FM_Q]77^]'_Z": '4444 %%%% !1110 4444 %%%% !1110 4444 =%H/
M^IU#_KI8_P#H4M=:O0?0?RKDM!_U.H?]=+'_ -"EKK5Z#Z#^5 "T444 %%%%
M !1110 4444 %%%% !1110 ASQ@XYZ_@3_2OY]?^"L'C!O@Y_P %&O\ @CA^
MT3XB\*?%?6/A+\'%_P""@UO\2_$_PM^%7Q*^+-SX1?XE? ?X:^#O!*:GH7PR
MT#Q#K(EU_7WFBT^(V@GFM-,US4K<?8M$U:XL_P"@EOX?]X?UKRKQQ-)%JEB(
MI9(V;30,1R.C,-[%QA"&8;0"PY& "> *]GA_&QP&9^VJ8>.)I2P69X*M1E6G
M0YZ.:97CLLJRA6IQE.G5I4\;*M1FE)*K2@W:R:\W-\-+%X'V,*JHSEB,/6C4
M]E&LHSPF)PV+I<U*;C&<75P]-23?P.=M6C^.?PCI_P"T_;^(?%?[5OPD\ ?M
M(_L_?!S]L'_@NQ^Q1XQ\*?#S_A&/&WPI\;>)/@/::9\7+;XV_$+XE>$O"FJW
M/B6Q^$OQ7U'5/#]UXQM/%]E+\/[MO#YU2$ZA;2V;6F=^R%J_[5/@_P#X*:7V
MM:YH/[6WQ@;Q)X[_ &O%\7W>OV'[8_PJ^,NDZ#X:^'?CGQ3\-1\;O _C:X^)
MO[#_ (B\"6OB#5-.\*?LM:?\*_$5S9)J^NZ'XFFGM3J'AKP[;?UX@.&9P)0[
MEB[ 2!F+,[,68#+%FDD9B226DD)R78E2'*&-A*T9X,9$A0CYN"I!!'S-P1CY
MFXY.?T:KQK5JTL;2ED^7N.+P=?!1E&<X58T9/ K#?6,2L)5Q&+G1I99@X3JJ
MIAZM62K5+Q]I&%/Y>'#T*<\-..-K\V'Q&&Q32A"%*56G4Q]2ORT824(0J/'U
M8TJ;<H4H/D=U9O\ B"^ %O\ '>ZT3]K2QTWP3^TYX=\(?'O_ ()!?MR1^-OA
MS\0;?]M/XA3>(OVH-*T35Y=)MOBM\2?CYHFB>&OBC^U+J/AM]3U;Q/J'P.^&
M7PW\$VX\10>'?".ARZSJ_B6WO_4+^[^+>A_ O]I%OV.-._X*;>"-)M/^"77@
MF;]H*P^+P_:=T?Q':_MWQ?&7X!Z3X;USX>CQMJ,^MV_Q*O/@_I7Q'TR^/[/Q
MM?AU8?#C0[#3]!M+'PW9FUMO[+]\_ W3X7) )E(!)0D@'@9,49..IC0G)12
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M4NUO[C_]\-_A1M;^X_\ WPW^% "44NUO[C_]\-_A1M;^X_\ WPW^% %_2_\
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MT>9'_P ]$_[Z7_&@!]%,\R/_ )Z)_P!]+_C1YD?_ #T3_OI?\: 'T4SS(_\
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MS^%"C?K+YR:']WW%_P S2_\ GTU'_P &Q_\ E71YFE_\^FH_^#8__*NJ(SW
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M^/'1O^N(_P#1CUE*A&4E)S=KKW4WS72W;::M^(?UL1>9I?\ SZ:C_P"#8_\
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MG_SXM_W]7_&C?9_\^+?]_5_QJ&B@";?9_P#/BW_?U?\ &C?9_P#/BW_?U?\
M&H:* )M]G_SXM_W]7_&C?9_\^+?]_5_QJ&B@";?9_P#/BW_?U?\ &C?9_P#/
MBW_?U?\ &H:* )M]G_SXM_W]7_&C?9_\^+?]_5_QJ&B@";?9_P#/BW_?U?\
M&C?9_P#/BW_?U?\ &H:* .MT&XB\BYCCA,$<3Q,1N#DM*553P2<L(R",<8'0
M$9Z,'(!]1FN1T'_4ZA_UTL?_ $*6NM7H/H/Y4 +1110 4444 %%%% !1110
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M\5_L6GWLB?R,_LV>#[;]KFV_8E_95^">@_L?_";XDZ!^P/\ \%%?V=+3XR?
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M-?[C?[K?R->S^"O^17M?^POJO_I!I]>,/]QO]UOY&O9_!7_(KVO_ &%]5_\
M2#3Z^2XU_P"1(_\ L+H_^D3/K^"/^1VO^P>I_P"E(Z=/X?\ KFO]*DJ-/X?^
MN:_TJ2OS./PP_P $?U/TJ7Q2_P 3"BBBF(#P#7@_Q"_:7^"?PJ^*_P '/@IX
M]\9C0?B1\>=2U31OACH=QI&L/::_J6D6L5W?:;/X@@L9M T*^N8KBR72XO$.
MI:6-0EN[6&P-_<7/D0>\5\A?MF_L=>!OVTOACHG@7Q9XE\0>!/$O@?QAH/Q
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M=/JVJM>W]LL[LUG8W-K9*Q2!0/1:0 *JJ. D<42CKMCAC6*)<]3LC15#,2Q
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M:??'N/ECRX$:1OFRI5 9&SM4%BM=6"FH8FG*5[+FO97W6]O+<PQ+_=+SF_\
MVT\\ #*,@'@+R,_*"<+_ +HR<#H,GCFGJ2KB525D4[ED4D2*VX/N#@A@V]5;
M<#G<JMG*@BR8]+R=NL\#I_Q)-='8$Y_T<]R>M)Y>F_\ 09_\HFN__(U>_.<9
MR<E=Q;;C=/9ZJRY;+331+R.!MW;N]?/_ ()SNF^&O#6BW%S>:+X;\.Z->7L!
MM;V\T?0M*TN[O;4S1W#6MW=6%I;SW5LUQ##.UO/))"9X8I2ADC1EV-B@Y"@'
M(.<#.0P8'/7(8!@<Y# '.1FK7EZ;_P!!G_RB:[_\C4>7IO\ T&?_ "B:[_\
M(U$JDI.\ISD[)7DZDG9))*\G)V2225[))))))*4N56BE%7O:-HJ_>T>57\[7
M\RKL3IM4#&, 8&/3 XQ0%4 *  H& !P ,DX &  "S$#L6)'))-KR]-_Z#/\
MY1-=_P#D:CR]-_Z#/_E$UW_Y&I<VSN[K;26GIII\K#U[O3;7;TUT^5BKL7&W
M:-O.%Q\HW?> '0!OX@!\W?-&Q2<E03SR1D\XSD]2#M7(/!P,]!5KR]-_Z#/_
M )1-=_\ D:CR]-_Z#/\ Y1-=_P#D:ES+3?3;26GIII\K!KW?W_\ !*VU?0#&
M<8&,9ZD>A/<CD\9Z"D"J     "H Z!3M)4#H%)1#M'&44X^5<6O+TW_H,_\
ME$UW_P"1J/+TW_H,_P#E$UW_ .1J+J]];][._P!]K_B&O?RWZ=MRKL49(4 G
MDLHPQ. ,DCDG  YSD#%,_=@%=ORD %<#:0,8! .T@8&!C  &.@J[Y>F_]!G_
M ,HFN_\ R-1Y>F_]!G_RB:[_ /(U6ZKDDI.325DO>2M:STY==%;8N$YT[N#Y
M6]&U;5:Z=^KZVU>FKO379]T+@$DE< *25522O0G:J+G&=J*/NJ,.VJ<Y&<@
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MC^&"03XNO3M(8?\ %%:KP1T/_(6^H_&GR:5X7DV_\57?+MP?^1,U4Y(((/\
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M[/\ Y^G_ ._5!:S;"_:7Y*_\LO<4 27W_'^/^O8?^A)456[Q;83+*]RV3&J
MB,="%;&/PSG]:J[[/_GZ?_OU0 E%+OL_^?I_^_5&^S_Y^G_[]4 )12[[/_GZ
M?_OU1OL_^?I_^_5 "44N^S_Y^G_[]4;[/_GZ?_OU0 E%+OL_^?I_^_5&^S_Y
M^G_[]4 )4<O^K;\/_0A4N^S_ .?I_P#OU2%K)@0;ER#_ -,OQ[4 +%_Q[:O_
M -?NF?\ ILN*8GW%_P!U?Y"K,2VPMKT_:2ZW$\$[/Y>"A@MWMTCP.,[78Y/7
M(/H1 'L@ !<O@  ?NNW:@ HI=]G_ ,_3_P#?JC?9_P#/T_\ WZH 2BEWV?\
MS]/_ -^J-]G_ ,_3_P#?J@!**7?9_P#/T_\ WZHWV?\ S]/_ -^J $HI=]G_
M ,_3_P#?JC?9_P#/T_\ WZH 2BEWV?\ S]/_ -^J-]G_ ,_3_P#?J@!%_P!;
M!_UV3^M-;_CZNO\ >C_]!-3PFS>>%?M+DF5<9CP,@''2F2?9DNKD/<MDLN,1
MYZ @_3]?PZ4 -HI=]G_S]/\ ]^J-]G_S]/\ ]^J $HI=]G_S]/\ ]^J-]G_S
M]/\ ]^J $HI=]G_S]/\ ]^J-]G_S]/\ ]^J $HI=]G_S]/\ ]^J-]G_S]/\
M]^J $HI=]G_S]/\ ]^J-]G_S]/\ ]^J $HI=]G_S]/\ ]^J-]G_S]/\ ]^J
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M*E5PV'RJ..J>UHS4H5:N&Q]2-+ZQ&O3]I5CB<+AJ%.C#"/VE/%3<ZBG"#?\
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MVK:?$30_VL/&ES\;?C#J=OXQT?X/V?B"S^+.C:7\&?"/QC\-:G_9.F^ -/\
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M#X%W<6G1?#NTUFZ2*&35-5\06]K+XN.IRK<R3:?J]M;I<R6WV:5OLM1@8/\
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M5->GPWX:U#5+.TUS7X-+A^T:M<:/IMQ-'=W]MIL3Q/?7-G%<"V616V.@F:$
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M;OAOF?46/+#1003R<_VC:+G)R<[7=<YSM9AT)%8)Z?BO\Q6_X9_U^H_]@/\
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MOAL/1K4U.G*5)24:U:C5]E6<764X0DU*H?M.G_!7#]FG3OA5^T'\3?&7A?\
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MN-3F9-'\&>!/"ZWLHNCX.^'?@ZQTO0=$BDL]/BDDDU*]>T::XB^S_:/3_/H
M!^0 '\^:3:,YQS2T %%%% !1110!H:7_ ,A#3?\ KM?_ /IKU"LU>K_[P_\
M0%K2TOG4-- Y/GWXQWS_ &7J!_'BLQ3RW^]C\D7_ #_/FINN9JZO9.UU?KTO
M?\!]/O\ T'T4450@HHHH **** "BBB@ HHHH *TM3_X\=&_ZXC_T8]9F?8G\
MOZD5IZE_QXZ-_P!<1_Z,?_#]12;2:O**?9RBGJM-&T]>FFH&;11UHI@%%%%
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M?$-[# NVQFGT]M0O+.VTZ*V_6%551M554#HJJJJ._"J HR>3@#)R3R2:7%%
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M110 +_K8/^NR?UIK?\?5U_O1_P#H)IR_ZV#_ *[)_6FM_P ?5U_O1_\ H)H
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M[.3_ *"?AW_P>04?V<G_ $$_#O\ X/(*H8'O^9_QHP/?\S_C71RR_P"?L?\
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MS_C1@>_YG_&@!VU_[H_[Z_\ K4;7_NC_ +Z_^M3<#W_,_P"-&![_ )G_ !H
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ML_@K_D5[7_L+ZK_Z0:?7C#_<;_=;^1KV?P5_R*]K_P!A?5?_ $@T^ODN-?\
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M+V5L]OX9U'3[/2H9[>[\4>,/$T-QX9L+769(K-5:"[<1EP]?:*X&0JA5W/L
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M'I^*_P Q6_X9_P!?J/\ V __ '(V=8!Z?BO\Q6_X9_U^H_\ 8#_]R-G1C/\
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M#VO2Z1XS^&VG:?K,&L^)+B37YM;R=(TK]H#]FGX+?#^P^$_C3]J[03\8O^"
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MF(V@^LKHQZ*V/^$2\6_]"]KG_@FA_P#DZC_A$O%O_0O:Y_X)H?\ Y.KO_M+
M?]!F&_\ !]+_ .6')]1QG_0-6_\  '_F8^ >HI,>R]<Y.<KZ[<$#YN V0> *
MV?\ A$O%O_0O:Y_X)H?_ ).H_P"$2\6_]"]KG_@FA_\ DZC^TL!_T&8;_P '
MTO\ Y8'U+&?] U;_ , ?^9CT5L?\(EXM_P"A>US_ ,$T/_R=1_PB7BW_ *%[
M7/\ P30__)U']I9?_P!!F&_\'TO_ )8'U'&?] U;_P  ?^9CT5L?\(EXM_Z%
M[7/_  30_P#R=1_PB7BW_H7M<_\ !-#_ /)U']I8#_H,PW_@^E_\L#ZCC/\
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MC_P9V_\ C1_9NJ?] 6X_\&=O_C0!5HJU_9NJ?] 6X_\ !G;_ .-']FZI_P!
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MY$_]U?UH\B?^ZOZT 1T5)Y$_]U?UH\B?^ZOZT 1T5)Y$_P#=7]:/(G_NK^M
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MIM-T:=K+5_8WMT28/%8I)OV^(=K:1E5D]6HKX;VU:5Y-+ST=K?VN]/26]/\
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MBES>W^L 1I T FFM_I?D%@=N0SCY"2G#$?(6RQ08^0L68K@EF)+$ F^UWO\
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M !H^UWO_ #\M_P!\C_&H:* )OM=[_P _+?\ ?(_QH^UWO_/RW_?(_P :AHH
ME-U>\XNF&1C[H]^G(YYK4U.[NQ9:.4F,9:$>80-QD.^3ELD8)R.A.,>G%8U:
M6I_\>.C?]<1_Z,>HE3A)IRBF[K5WZ+3JM@*8NKT #[2W'^R/\:/M=[_S\M_W
MR/\ &H:*L";[7>_\_+?]\C_&C[7>_P#/RW_?(_QJ&B@";[7>_P#/RW_?(_QH
M^UWO_/RW_?(_QJ&B@";[7>_\_+?]\C_&C[7>_P#/RW_?(_QJ&B@";[7>_P#/
MRW_?(_QH^UWO_/RW_?(_QJ&B@"5KN]P?]);G ^Z.YQZUO>'KBXFN;]Y)"S)H
M@P<8./[3LSSC /!/;N:YL]/Q7^8K?\,_Z_4?^P'_ .Y&SJ,;3@\$YN*<E=IZ
M]UYV_ NG\</\:_-'1B60C(?(/?'_ ->E\R7^_P#I_P#7J&+_ %:_C_Z$:DKY
MH]4=YDO]_P#3_P"O1YDO]_\ 3_Z]-HH =YDO]_\ 3_Z]'F2_W_T_^O3:* '>
M9+_?_3_Z]'F2_P!_]/\ Z]-HH =YDO\ ?_3_ .O1YDO]_P#3_P"O3:* '>9+
M_?\ T_\ KTUI95&=_0K[?Q#WHIDGW#]5_P#0A0!=OYI6O@"Y_P"/=2/08,8Z
M9]*K^9+_ '_T_P#KT^^_X_Q_U[#_ -"2HJ '>9+_ '_T_P#KT>9+_?\ T_\
MKTVB@!WF2_W_ -/_ *]'F2_W_P!/_KTVB@!WF2_W_P!/_KT>9+_?_3_Z]-HH
M =YDO]_]/_KT>9+_ '_T_P#KTVB@!WF2_P!_]/\ Z](99 ,E\ =\?_7I*CE_
MU;?A_P"A"@"U%<S?9[YMV/L\]M#@YRQN+62X)]@GEX&.#DD\"HA+(0#OQD X
MQGJ/J*(O^/;5_P#K]TS_ --EQ3$^XO\ NK_(4 2>9+_?_3_Z]'F2_P!_]/\
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MIG<?0_S6GV_WX_\ MI_Z+DI]O1FJ_P!UQ'^*/_I,CPOQ9_R-OBC_ +&+7/\
MTYSU@UO>+/\ D;?%'_8Q:Y_Z<YZP:_9LJ_Y%^7_]B_!_^FHGX=F'^^XW_L,Q
M'_I;"BBBO1.,C? VL=\@1TE>*%S'(ZQR)OM_/X^R2SQ[O(G,5Y$C%6FMYD+1
M5^$WC3XH_M^> O%O[2/[%#Z7\2OBGX]^-?C*T3]EO]IV?PG"W@_P-\./B=?&
MT\77GBS5='L-.T'P_9?";PC:R6VC67DMJW_"27]U<2RK%/HQ'[NX_P _YZ4U
M"8X_(C4PQYF;%O-<6H/VAWDG8BVFA!,T[BYFX#2SQQ/(6"[6\C,LNJ8QT'3K
MU*3IS<:BC4<%+#U)-UDM;N=E!12L][2C>QZF58VE@9XB=6G"JJE/FI*<%-+$
M0C:CITAS.4IMIKX;Q>C/*_@A\)?!GP)^$7PZ^#/@&/'A#X9>%=-\&Z-)+B2[
MO4T*&+3+W5-2G\J+[5JVKWVGMJ.J7A#M<W<F6FG\J.4^K?F2>I)))^I/)H[D
M]SMS@ #Y5"C &%'"C(4 $Y8@NS,Q7ITZ<:45&*2245IU<8J+=MKNUWW>K;=V
M>=.<ZDG*<G*3<G=W;2E)R4;MMVC>RUV6R6B****T(&O]QO\ =;^1KV?P5_R*
M]K_V%]5_](-/KQA_N-_NM_(U[/X*_P"17M?^POJO_I!I]?)<:_\ (D?_ &%T
M?_2)GU_!'_([7_8/4_\ 2D=.G\/_ %S7^E25&G\/_7-?Z5)7YG'X8?X(_J?I
M4OBE_B84444Q >AK\R/^"B_C#]JKX'S? +]I?]GRZ\<>,_AO\)/'7]G_ +2G
M[/GAS1K?5?\ A9/PU\875A:#Q1IMI9:;>^*=0UCP1+!+-#9V.KV-M%;SQZA+
M:/9P:E$?TWI@5UD26*:X@DCWA7@FDA;9(-LD1:-E8QR *'4$$[5P1B@#\Q?V
M'_AYXY^)GQ;^/?[>OQI\&^(? OB[XV2:?\+_ ($?#;Q;97>A^+?A3^S+X+E<
M:9'XDT;4H(9M*\2_$KQ#;KXP\1V,$-O?W$NH*FM18T^VCMOT[1=JJO'R@#C@
M8 P!^  'X4]V,DC2,(P[A!(Z1HCR>6J*AE=1NF<*BJ992\I555G(50$H_K^O
MZ[@%%%% !1110!H:7_R$--_Z[7__ *:]0K-7J_\ O#_T!:TM+_Y"&F_]=K__
M -->H5FKU?\ WA_Z M+J_1?J'1?/]!U%%%, HHHH **** "BBB@ HHHH *TM
M3_X\=&_ZXC_T8]9M:6I_\>.C?]<1_P"C'H[?/\@,VBBB@ HHHH **** "BBB
M@ HHHH 0]/Q7^8K?\,_Z_4?^P'_[D;.L ]/Q7^8K?\,_Z_4?^P'_ .Y&SHQG
M^X/Y_FBZ?QT_\:_-&]%_JU_'_P!"-25'%_JU_'_T(U)7RYZH4444 %%%% !1
M110 4444 %,D^X?JO_H0I],D^X?JO_H0H L7W_'^/^O8?^A)452WW_'^/^O8
M?^A)45 !1110 4444 %%%% !1110 5'+_JV_#_T(5)4<O^K;\/\ T(4 2Q?\
M>VK_ /7[IG_ILN*8GW%_W5_D*?%_Q[:O_P!?NF?^FRXIB?<7_=7^0H =1110
M 4444 %%%% !1110 4444 "_ZV#_ *[)_6FM_P ?5U_O1_\ H)IR_P"M@_Z[
M)_6FM_Q]77^]'_Z": '4444 %%%% !1110 4444 %%%% !1110 4444 =%H/
M^IU#_KI8_P#H4M=:O0?0?RKDM!_U.H?]=+'_ -"EKK5Z#Z#^5 "T444 %%%%
M !1110 4444 %%%% !1110 UNWX_^@M7R!^U9^SG\!/VE]*T7PC^T-\&?AM\
M:?">AWS>)]%T;XD^%-*\46>BZR]E<:;+?Z6=1@DGTZXN-.N+FTO#9S1)>6\@
MBN4F$<)3[ 89P/4D?^.FO,/&E[>6>J6CV=P]M(]@\C2Q+&S?._*E95DC9 5X
M5T<')# @FNO UJ^&Q5'$8:M7H5Z,G4I5L-6K8>O3FHM<T*N'JT:L;J4H22J*
M,Z<YPG&<)RB^7&TX5<.Z=6G3JTYMQG"I"%2$HWIRLXSC)?%"+35I*WNRBVV?
M"]]^QA^QMJGP9T?]G;4OV8_@-?\ P)\/:]+XKT#X377PU\+3>"="\57%Q>7%
MSXHT;2GL&&E^)+K^T=2M+O7K*2#5KO2M2U'1+F[ET6_N]/F[WP=\ OV?OAY:
M?"2P\"?!KX6>$;+X!V'C#3/@A;Z!X*\/:='\)K+XB6YM?B'#X ,%BK>&G\?0
MM*/&]UIK0W?BZ2>ZG\0SZC/>74DWOG]N:\22=8GS_P!>FE^@]+"C^V]>_P"@
MQ/\ ^ FE_P#R!7T3QN-K4W&KB<54A4G4KSA4QN,G"5;$0Y*]65.IB*L?:UH.
M4:U6SK5%.:J5IJ31YL</AXRYHT:49\L8\\</AXS486=.*J0HPGR4VH.E!S<*
M7LZ;IP@X19\XV/[-/[,NF:'X/\+Z?\ ?@G9^%_A[H/Q7\+> _#4/PT\'#P]X
M,\,_'B=KGXV^'?"^B'2#IFAZ'\6YI)#\1-)TZVM['Q<DDL.M0W<,TL;>:^#?
MV!_V%OAU8^*=-\ _LH_ 3P78^.OAQX@^$'C>V\,_#_1=&C\9_#'Q5J$.J>(_
M!7BLV,4+^(=%UF]MK7[?'J[7ES)96EGI:W*Z59VUE%]L?VWKW_08G_\  32_
M_D"C^V]>_P"@Q/\ ^ FE_P#R!6L<PS"'/[/&8RG[1\T^3,,='FFZCJ^TE;$O
MFJ^U<JGM)*4O:2<]9OF(^J8/3_9L,^5<L'+"X:<H14>2,:<JM&K*$802C!0E
M%048\JBU=_*&@?L??LB^%K<V?A[]G/X+Z59/\#]6_9GFL+?P+H;Z=/\ L]:[
MXGU#QKK/P7N=.N8)[&Z^'.J>+=5U+Q#?>&+FWEL+C4[R>X=.55>B^!G[-G[-
MO[,>D:YH/[.OP1^%/P0TGQ/?V6J>);7X8^#=#\)-XAOM-BO(-+FUVZTNUAO=
M772(=1U*+1H-0N;BVT=-3U3^S8;5M3U W/T;_;>O?]!B?_P$TO\ ^0*/[;U[
M_H,3_P#@)I?_ ,@5%3&8VK"=.IBL7*E5=)U:+Q^-="K*A*<J$JM'ZQ[*JZ#J
M5/9*K3J0@IS_ ';;4HZQIT8.$HTJ*E37+3FL/0C.FF[S49TZ5*25315+RGSQ
MC&/NI/F^-M&_8;_8G\.?&(?M">'OV6?@%H?QP_X2G5/&Y^*FE_#;PS9^,U\9
M:W+=7&K>+(]5@LHVA\1WUY?7VI3:Q#'%J U>[GUB&XBU:0WPX_X+?L>K\.OV
MLOVA?VR/B/\ %M?C'\6/C-X5T3X2^"U7X8>&/AOI/P<^ 7AKQ'=^*-(^%UB-
M'UGQ!?>.M0NM1.@CQ3XZU^YL;WQ(/"'AJ3^Q=,^RW45Y]\_VWKW_ $&)_P#P
M$TO_ .0*/[;U[_H,3_\ @)I?_P @5M_:>9?[1S8O$57BL(L!6>(Q-7%S>"56
MA7^JTZF,>*J8?#RJ8;#N=+"SP\*BH4HU(S5.+6#P."YJ4EAZ,'1K/$1]G1I4
MU.NZ=6E[6JJ<(JK-4ZU2,7/X.9NFH7DI^">'?@'^S[X13X7IX7^"_P )?#Z?
M!+PKXG\#?!Q=)\ ^%;,?"[P7XWL[&P\9^%/ AATQ&\,^'_%MEIME:^)M*TLV
M]GKL$)CU.*Y6:?S?C[QA_P $O/V1?B%\=/#GQ*\>?"GX/^+_ (2>"/V3?!?[
M*_P^_9NUOX1>&+GP+\/8/ WQ;\9?$_2/B)X.U?[;OT'5Q8>,KWP2-(TCP_IU
MS'IAU"^E\47::UJ6D2?IY_;>O?\ 08G_ / 32_\ Y H_MO7O^@Q/_P" FE__
M "!2P^9YIA:DZV&Q^-H5JE*I1E5I8[$4JWLZK3JJ%:G*G5I2J2YI3J4JE.HW
M5KOG7MZRJ55PF#K<GM,/1ER585H)T*4HJK3550FX5(UJ<N55I:3ISBW&FW&3
MIP9\XZE^S5^S7K'CGX7?$S4_@;\)+KQ]\#_"C^ _@WXH/@?P_%J'PN\"MHVI
M>'1X,\#1V]G#9>'/"D.@:SJNA6GA[3K6'2+'1;^YTNSM(+&3[..*\ ?L0_L4
M_"JV^*-E\-/V6/V?_ -E\:_">I^ ?BU8^$_ACX5T:R\?^ ];2\CUGP-XALK3
M3X[6?P7JT=]-%J?A."*WT"^CCL([K3Y4TG2EL?L/^V]>_P"@Q/\ ^ FE_P#R
M!3O[=\0?]!F?_P  ]*_^0*R6-Q\:<J,<9C84I0ITW2CF&-C25.C5E7H15)8C
MV25#$3GB:'[J3H8BI4K4G3G-VT5&BIJ<*="G.,G-3^JT93O*G[.7+4E"=2FI
MQUJ*G4I>UDHRJ.7+%1\!UGX!?L^^(F\0OKGP7^$VJ/XM^#47[.WBB6Z\!^&6
MFU[X"0/<R6_P;U.9-.26Z^&MK)=SO:>$'?\ L>U9T^SVT7D6_E>>?$#]BC]B
M[XJ^.=$^)GQ)_9;^ 'C7X@>&[;PS9:+XN\0?"_PC>ZS:6'@M[(^$--FG.FK'
MJ.E^&8M-TZRT/3-4BO=/TS2[&UT>TMH])@CLE^P3KNOG@ZQ/_P" >E?_ "!3
M?[;U[_H,3_\ @)I?_P @4H8O&4Y*5+$8FG)1Y5*&-Q:DH6G%P3>(E[CA4E3<
M?A=/EA9*,;*="A4CR5J=&NFW*3J8:A)R;<7>4I4_:-\T5._.O?;EO*2>,;N)
MF=WE5GD8N[$J6=V)+.[9W.[$Y9W+.QY9B>A]J@_YZ+^8_P :V?[;U[_H,3_^
M FE__(%']MZ]_P!!B?\ \!-+_P#D"N?WM%RK1)?%T227V-[*[?5MMZMFSLVW
M?=MZ122NV[)7T2O9+9))+1(QOM4'_/1?S'^-'VJ#_GHOYC_&MG^V]>_Z#$__
M (":7_\ (%']MZ]_T&)__ 32_P#Y IWE_*O_  +_ .T%IW?W+_,QOM4&<^8O
M0CJ.^/?VJ6WGA\V%1(I+N47GJ[@HJ]^2SJ!V]\\5JC7-?'36)_\ P#TO_P"0
M*EAUS76G@WZM.ZK+O*-::6%<Q+O"L5L0P!. 2I# 9VD'!HO+^6/_ ($__D"N
M9*E.FF_?U>GVDFEK?169\[^*QN\5^)70AD?Q!K3JP[J^HW#*?;@=_P#]6#L?
MV_+_ .RKN?$WB;7[?Q-X@MHM3D$=OK>J6T:M#: >5!?3Q1_=ME&0J<[0%'90
M.*Q/^$L\1?\ 06/_ 'YMN/\ R7_QK]9P$\R6 P/L\-@I06!PW*UCJW,X*G'E
M<HRP+M)JS:3TDY1NU&+?Y!C<-@Y8W&WQ=926+K\R5*BTI.6J3E)72ES)/=I)
MM*Y@[']OR_\ LJ-C^WY?_95O?\)9XB_Z"Q_[\VW_ ,C4'Q9XC_Z"K'Z0VW];
M<?YS78JN;-V6%P2?>>-K*/S<<!?TMU.7ZI@_^@RM_P""</\ _)&#L?V_+_[*
MC8_M^7_V5;W_  EGB/\ Z"Q'_;&V_P#D>C_A+/$?;5B3V_<VW7V_T?KZ4>TS
M?_H%P7JL?5Y?E? 7MZZV\P^J8/\ Z#*W_@G#_P#R1@[']OR_^RHV/[?E_P#9
M5O#Q9XC_ .@JW_?FU_I;T?\ "6>(O^@L?^_-M_\ (U#J9NM\+@7_ ->\=6:_
M\FP%[^FEOF'U3!_]!E;_ ,$X?_Y(P=C^WY?_ &5&Q_;\O_LJWO\ A+/$7_06
M/_?FV_\ D:@^+/$?_05;_OS:_P!;>A5,W>V%P*_Z^8ZLE_Y+@+W]=+?(/JF#
M_P"@RM_X)P__ ,D8#1R%2 !D@@#C))X ^]U)X^M>Q^#)(E\-VL;2HK_VOJP*
MY!.186.1P2,\9KSIO%GB+#$ZJ3@$E3#;9.!R.;?J?KC->Q^#O$&MOX:@E&JS
MQS2:MJ<3,MMI[;DCL[!E!\RS<_*&/0\YYS@ ?+\85<?_ &/RXBAA:<'BJ3YZ
M>(J5I749)))X>BDG?1OFZ/35/Z;A*C1I9S!T<1.I>A/FYZ=-?:CHG"36O=Z]
MM"47$"D#S%X4+U'4?C_/GVIWVJ#_ )Z+^8_QK877=?(3.L7'* \VFE^W_3A[
M_P O2E_MO7O^@Q/_ . FE_\ R!7P-IQ2C*,>:*47:?5+_!YGZ%*W-+5_$^GG
MZF-]J@_YZ+^8_P :/M4'_/1?S'^-;/\ ;>O?]!B?_P !-+_^0*/[;U[_ *#$
M_P#X":7_ /(%.\OY5_X%_P#:"T[O[E_F8WVJ#_GHOYC_ !H^U0?\]%_,?XUL
M_P!MZ]_T&)__  $TO_Y H_MO7O\ H,3_ /@)I?\ \@47E_*O_ O_ +0-.[^Y
M?YF-]J@_YZ+^8_QH^U0?\]%_,?XUL_VWKW_08G_\!-+_ /D"C^V]>_Z#$_\
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MG=_<O\S&^U0?\]%_,?XT?:H/^>B_F/\ &MG^V]>_Z#$__@)I?_R!1_;>O?\
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MSNI*VMG&2=I1E&*=\>Q_I_C3[?\ UD9[YD.??RV_^)'Y4SN/H?YK3[?[\?\
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M]D_\%#/%7BWP#XI_8Q\=?#S08O%'Q+\%?$;]K_Q5\//"<VFWVL-XF\=>'O\
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M !2\8_#[X>Z)9:/8:[X<@@L=4\66^L>(+S58;?1M-O$L+^:V^CX3Q>:8'/\
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M$/X0V'AGQ+H-OK?COX;GQ%!X<U+X91^+'\+20WDKZ[)/X:T*]\5^'?O?X?\
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M'(5UC61V1B'18+EF4+;RE/YS+_X0?M0:I\&_VC_C%\6M0_:J3]K7X._LN?\
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MBS@UV>T&I0V12XGAN=/2]6T03F*XM5,ZHWXA>.(/B@GQOUC6+!?VNT_;/?\
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M'[45O\(+W]D'X0^*]3\-_M(G]JS1Y7^)!^-GQ2\-W7BG2/"_[6]CI?Q#AO\
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MZ4:;JU(8B%&"4H87#I1@HQ53NK[_ (_Q_P!>P_\ 0DJ*I;[_ (_A_P!>P_\
M0D_STS[5\ZQ?M0_!Z7]I2+]DA=?O!\<)?ABWQ;&A_P!C:HWAX>%1J8TZ/3_^
M$SCMG\-GQK/;[O$<?@L7W]M+X.C/BFXC@TJ6UEN/(HX?$8CVOU>A6K^PP]7%
M5_8TY5?8X:@HNM7J<E^2E34X\TY:7=E=II>E5K4:+IJM5ITG6K4L/2YY*/M:
M]9S5*C3NGSU)N$^6$;NT6VE'4^A#U'US^&"/YD5^'.C_ +2'[-?P _X*'?\
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MN[6:-9(;JRNX9)8+B">,QRQW%O*\4D;HRL5<9LM_Q]77^]'_ .@FOF,TQ_\
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M%%%%<IN%%%% !1110 4444 )W'T/\UI]O]^/_MI_Z+DIG<?0_P UI]O]^/\
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M<_A30_"VJ^((M4U;QUHOB&<>#?$OA70H]6U/1O&MO=^%IUDU2$1/V>N_M$?
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MF\.K16(@XZ4ZSC^GUS\6?A=IGQ'T[X1W_P 5?AMI_P 8=3TJ+7M)^%&H>/\
MPE9_%#4]#EEOK>+6=-^'UUK,/B_4-%EETW485U.UT>;3Y#97J^>1!.%\&T+X
ML_L[?!_X%_$VU_9I;P7\4_"W[*OAWQ)J?B7X'_LW^.O OCCQ?X+2PE\1>+=:
M\&P>&K?Q7<-X>\8S_8O%U[X=\!Z[>:)J6J7VDWWAO0;..6UBLK3XH^(/[('Q
MA\0?M3_$?Q5X+\ Z9X7\*>/OC[H/Q,G^(%WK?P3^(OPE-I#\%_#?P^NOCR/"
M/C#3Q^U'\*/VN_ %SHTGA+X:WOP$\3:1\,KHP:)J=[=>'+#4_&=MJ6'^RO\
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M1V=W;+LS$LQ-'E)Z?Y_SZY]Z^=Q'%.9UZ^68MPPOUG*O9O#IRQ[PKEALNQ.
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M7@'4?!,'CCX/Z!\/_P!GWQ_X>\6>(M.E\7Z;XJ\'ZC>:9XINM)\)W%K)X?\
M&%I<C6GF&BZQI4=['+YY^TE^Q3XB\ ?##4+OX1>'/%_[7/Q4^+GQZ^!FK_'S
MXB?M-1>$?VCO'UK\.OAE8>-)_"GB?PK\'O$/CW]F?X'^(8OA;X]U?3=5T+X:
MV:Z+X7T6P\7>,O&>E>$/$>M^%_">@VO[&A%4Y QZX[^F?ICBD,:GJ,\ '/.0
M.Q]J\JGQ3F5'ZK&$*'L,-B\9C:F%48TZ6.K8[,<5FU6EC*\*<<=4PM#&XF,\
M-A?K\<+'ZKAZD\-.K!S.RIPYEU557*,E5G0PF'A66KHTL)A(8&"A2E-X:4JE
M",E4JU,+5K1]I4A2K4X3D?S16O[&'[3]Y\!_B!X9L?@#XH\/7]S^SW_P7 \-
M^$?"6LM\#O#-_:W_ .V9H'P,\2_L^>"[3P[\-/&NI?#?PIJ7C/4!XA\/ZCH'
M@:\E\'>$O%WA7Q58RZD^AP6/B37OT]_9N_91\.?LX?M4>+]3^$/P5\+_  =^
M"7B']BW]G+PA?GP'I'AOPWH'BCXX> ?BO\;Y-<E\2Z?HL\>J>)/'VD^ /%6A
MG4?'?B*TO]1U;3]8-O+XEU2Z?48$_1\11CHH XX' & !^6!C'3T[4V1%5&(
M!X_F*US'C#-LTH8K#8BGAH4,:L3]8I4)XQ4Y3Q-*A3=:<*M>I3K5Z,Z+J4*L
MX.=.=;$3A.$ZLIRC!\-9=@YX:M%UIXC!SH3H5:BP\IQ6&YN2E"I"E"K2HU5/
MEQ%*$U&I"G14HSY+$\(!AU-20%;4M(5BQ8 (=.G#MN57*[%R^=CD[=BHS,HK
M^?R^_94_;O>SO_VW_#VN0/\ 'N+]KC5/VR=*_8]UOP!X.TGQ[?>'[.PF_9QL
M_@#>_M!6_P 6KKPS:QZU^Q3I>E^&+O1V\+ZKHMQXZBTN[;4K_7M'\.>)+/\
MH#B_X]M7_P"O[3#^6F7%0I&F%;: 2%)(]0 >^:\W*<YQ.3O$_5J6$K1QGL(X
MF.+PM'%*=##_ %F^$A&LN6C0Q4L7*IC*M.V,E+"8*%"I3I4WR^CF&64,R5#V
M]7$TWAG5J8?ZK7J86=+%3>&5/%^VHR52I.C2I5J=.A./L>:KSS<DYPE_,+'^
MPA^V1?Z7\1-*T;X8ZUX6U7Q#^SC_ ,%4O!NA:EJWB/P7:6]WKOQ\_;D\$_%[
MX7>#=0>T\8@6TGQ?^%F@ZG'$]Q?6^A6=GJ%U8^+M5T*.>>"'K]4_80\>?$;6
M_A?]E_91\6:#\$9_VY/V%O'WQ)^#7Q*^''['_P ,?AY:^"OAG\,_VC].^+WQ
M ;]GCX'^(/%/@1K/3+#XA?##X;^.?%FH^)O$GB/XI'18/"]AX3G\$_#/P]KV
MM?TG%%/4 _7VX'Y#BF^5'_='.>P[_AV))'OS7U%7Q&SUR=3#8?+L%55.K"D\
M/''0I495,!CL"IJA'%THSE36)I5Z%3FI5L-B(5JM"K3E6FZGAPX.RN%.5/V^
M+G&52-23G'"2DY0Q6%Q//)3IRI\U54:U*NHPY*D*UI0FE[O\M/Q'^%?P9\!_
M&[PIX L?V5_ FN?%2#_@M!^SG?\ P^_:A\)ZA^SY>Z?X2\!V_P 4OA#XU\,?
ML]:)'9_$)OC]H6I_!O\ 9RCMO!E[^S]+\*]-^%W@/X>>'!\1M)DT[PUHOA[4
M+GV_X1_LD?$+P%\/?AEH?QJ_8!U7]J#QOK?['O\ P3B^&7@'4Y/'/P?\'Q_L
MX:_^SY\/_ VC?%?X<^(/BM?_ !#L/B)\'G\$?%+2;CXSZ;K_ ,'-!\6Z7XXU
M:UN-*L;B;6[>VMKC]WH?@I\&+;XD7?QDMOA#\+;;XOZAI[:3J'Q7MOA[X0M_
MB5?Z6]M:6+:=?>.X-'C\47EDUA86>GFVN-4DB_L^VAL-OV1!#7I(BC"A0OR@
M  9/ '09SG Z 9X' IX[CS%XK 8/ 0HUZD(4W+'U\;F.9/$UL346!]JL'5PF
M9.>!P2G@8S6$P]:C3KNO6A4IX>G4Q*Q483A2%*OB:U:OA]:U*6#C1P6'G&E0
MHQQ<8QQ5/$T8T<7B*D<;4C*O4I7I>QP\H>U=.,:?Y^?M6_L\^*_CS^TK^R'K
M.G:W\6?!G@;P!I'[5!\=?$SX,>.D^&WBSPU=>,?#WPFM_!>D'5X)FUPZ;XRO
M= UB"[L=*L+R!SI,9U.:SCBM6G_.CQ1^Q3\>/#6F>&_!^N?"SQ9\==-^&O[;
M_BCXH?%+XG:V?A]^T5XL_:T\!^/?V>]9\"?!_P#:!\1_#C]I3XC:?X,U#XC_
M  %GN/#/PQ^(7@66/0] \'3Z#>?$C]GGX?\ ]A7.AZ!8?T-^6GIVQV]<].GZ
M<=1SS08T))*@DD$D]3C@9]<#IW&*\/+^*\VR["X7!4HX26&P]"%%0<*M-N?U
MK-\76Q$JE"IA\1*K)YSB*=*+Q%2C3J4<+CHX>..H*M+T,3P]@\35K8CFK4<1
M6J*K*M1J4XM<F&P6'IT?9.'U94U4R["XB<Z6'HU9Q]M@G)X7$5E/^9;XI_L?
M?M1>(?@U\./A=:_LIWOB/PW<_LT_M+>$/ T_C#X8_LB_%+XP?"7Q/\<?C;X^
MO?"7P7OI_$GQ?\'_  2_97^&'A/P-K'P>\91?\*>^'_QKO\ P3H/AC7OA#H'
MC35X?A7X$@U_Z>^&?[/'B_1OB#-JOQF_8(UKXZ>/?B5\:OV)/B7X1^..L^)_
M@WHH^ _P[^&/P!_9W\&>)="\7>/KCXD7'Q:T;7?@5XZ\!?'KQ#J7PJ\*^&/$
M'A+XT/\ %FY\&1ZYX@\/_$;XAW%C^Y1B0C&T8]..<X')ZGIUSGWZ4"*,'(4
M^HX_3I^G6O0QG'&9X["_5*^$P4*,GBZE14*^;4:LZ^+Q%7$3JO$4\P4HISQ$
MWB84H488Z.'P\,32A[2M)9QX;PL*].M'$8EJC'#0IQJT\!6A"E2C#GHTX5,+
M+V4>:FHX>M&JZV&IU*D:;;5/E_FJ\*_L(?M&Z5\+O#?PT\'?L_WWPX'P[_9P
M_:\^#OC.#1?%O@_X:Z#\9%\1?\% /V2OC3J7A_P!K?@G5[V^M-+_ &HOV;O
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MBISY'&FX.,:5/'5I05*/-&&'BH13A3B_7M0_:J_9ITO4_&FA/^T9\!+GQ/\
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M_B#\4M=^$>E_&OX?:5XOAC^%-SX&M/$?CSP%X;E^-VC_ !H^%WA3XN> -?\
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MO"I,I_SQ'Y__ &5&4_YXC\__ +*@"/S$_O"CS$_O"I,I_P \1^?_ -E1E/\
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M\!Z!KULZ?#;X7Z/;WKM9Z-I7@SPA>K;W.C6-A#"NL7^J75V9=1=[H@'Z0 Y
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M O@MI?[0?PV\>0^--4^($'C'PUX T_1= ^(/@S6+.SOOB#87JRZ?H_Y_R_\
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M>I.I*I.C3E&G3C.4_<I3J2C4Q4'&?UE4:$'R*#<ORV_:]_80^)G[9?[4_P
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M(GU$D8']AXSQC/\ :-GQP?\ .:G&_P"XR76STZ[HNG\=/_&OS1NQ?ZM?Q_\
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MYR1^7OZ@^M'-.-I4VE----MI>=^6[V[":35FDUV:NCS8_#JU8DF^GSWQP.
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M_K4?\*XM/^?ZX_/_ .M7I5%'US$_\_7]R_S#V=/_ )]P_P# 3S7_ (5Q:?\
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M_ #_ .V5]*44?ZU\0?\ 0RK?=#_Y$/\ 5+(/^@"'_@<SYK_X9_\ ^IFD_P#
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MH^N8G_GZ_N7^8>SI_P#/N'_@)YK_ ,*XM/\ G^N/S_\ K4?\*XM/^?ZX_/\
M^M7I5%'US$_\_7]R_P P]G3_ .?</_ 3S7_A7%I_S_7'Y_\ UJ/^%<6G_/\
M7'Y__6KTJBCZYB?^?K^Y?YA[.G_S[A_X">:_\*XM/^?ZX_/_ .M1_P *XM/^
M?ZX_/_ZU>E44?7,3_P _7]R_S#V=/_GW#_P$\[M_ <=I,DL-W-(T9=E!'W2\
M<D+$D G+Q2R(2>@)*X8 B'_A75JQ9C?S@L2=JG"J,# '&2.IR>>>IKTG&?\
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M)ZD]3V_D*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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DWFD9S>8XJGS2]G&E1<87]V+:U:71OKW)****T.P**** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>forms-1a_008.jpg
<TEXT>
begin 644 forms-1a_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '4 AT# 2(  A$! Q$!_\0
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M)&* ,-M9<]O2I)7BZ2(0IZ-BE*[$#+AU;H0>E, VQY\L @>H/4U*EK*?N/\
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M<TJ31E,5G&R(;,=O6GP/(I,<H^1>23VJ=[-SAB K+_'V/UJ-R9_DP05_A/\
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MU8O%=R$"31*X'0CBH;W4S>K9PQQ_,P=\$^O_ .JLD1;@-CJV1FG3(BW$ E)
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ME5N!)W7\?0U[#:W45W )8CQG!!X*GN".QJL/). L9%JJV^I/1116YRA1110
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MVUU%#-YLDZ@#;T4?6N$D2.]ODF4+N1-NX=^<T)2WL9SM>R-&:-3I%L(R"-S
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M(W/X5WZ',8QZ5Y_X_1I)[7/0$UM'=&5KR..L-/\ ,(9OPKJ;)8K:+D#BLNT
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MPP#<@UJQ.DC@<$>]>E.H^;4\ZG%*.AY7'X7UF*!IKBYMI-Q&"P/W:DATX1N
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MGZ/!::G.MQ-&N#,&)+<^_M6O110 5SVO?\A.R_W6_I70USVO?\A.R_W6_I0
MVD-+10 E5K@[;BV?TE7^=6:JWW$2O_=8']: -+Q?%Y_@_5%STMV;\AG^E?/M
MTI%JC@$C.,_A7TAJ,7VG0[J+ /F6[#!]UKYXN8V?2Y-O0$'/TK&>DDS:G\+1
MS]Y&9;ZRPP5'7!W58UNR6]LA-;PI&JG"L&R7;OQ45Q +O3 !D2IG8P/0C_\
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MY6RM9^=^J\?PK6_0P>Z+V.,4I%+M[TGTI%HY[QW"6LM&F Z"6//X$_UK-TZ
M3V,L#<O;3.!]",_XUO>+5#^';4G[R7#X'L5'^%9VG1>5KFI0=FV/^8(_K7?!
M^[%G!47O21TGA"0-HXC'\!Q705R_@\[5N8O0Y%=1BA[@MB&Y_P"/:3_=-=)H
MW_((MO\ <%<Y<_\ 'M)_NFNCT;_D$6W^X*:%(O4444R0HHHH **** "BBB@
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MVUQ'*T3;9 C9*GT- %BN>U[_ )"EE_NM_2NAKGM>_P"0I9?[K?TH ;2&EH-
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M)TS4[Y=8N+$7#F!4W_-R0<]C5O\ X2*YL=2BBD)N(96V!3]X'US0!U?DQ?\
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M>HHK%U"_>=7BM9< ':74]^],1=O=3ALT?(:1U&=J#-84VHBYB\R64N2.(QP
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M[VQ68<#'3TH R/#[&=KW464CS6V(#UPO_P!>BP3[;K$ERW,5ID#W<_X"K6A
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MU/>/]B>U9"-WFA>>^:S]%2>'6-0B;"@N&VGKCU%:FH:=]NB +[60[E([$=*
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M"\9X_6K:WVIJ/GT^0?1@:W'\-O%\MC>>2G9&3./QJ!M!U;!(U&$^WEG_ !H
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M! \8Q>IM&KI&'[LCTKF;[">++5CCYK:0#\C4M%)ES0.=&A/KN/ZFM*LW0/\
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M>K>N 3BMN]U/3].,:WU_;6IE.V/SI53>?09/)KE&UW5$TQM-,P;6!?M;>8%
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M45L9"]J;WHHH&+0:**!"BCO110 4HHHH !2T44 +VIPHHH&+1FBBD  TM%%
M"T444 !&>#4!ZT44T =Z<***!#A3J**0PI!110!6N5!C<'H:YF>$^8<3SCV$
MAHHI@1^2W_/Q<?\ ?PTHA;/_ !\7'_?PT44@%$!_Y^+C_OX:1X6"$BXN/^_A
MHHH A"/_ ,_-Q_W\-.,3[3_I-Q_W\-%% ""-_P#GYN/^_AI?+?\ Y^;C_OZ:
M** %\I_^?FX_[^FD\I_^?FX_[^FBB@!WDMC_ (^;C_OZ:!"W_/Q<?]_#113L
M OE-_P _%Q_W\- B;_GXN/\ OX:**0!Y3_\ /S<?]_#2^4W_ #\7'_?PT44
M.$)/_+Q<?]_#3OLY_P">\_\ W\-%%( ^SG_GO/\ ]_#1]G_Z;S_]_#110 [[
M-_TWG_[^&D:VPIQ/<?\ ?PT44 0^2W_/Q<?]_#2^2W_/Q<?]_#114%AY+?\
M/Q<?]_#1Y+?\_%Q_W\-%% "^0?\ GXN/^_AH\@_\_%Q_W\-%% "_9S_SWN/^
M_AH^SG_GO<?]_#110 ?9S_SWN/\ OX:/LY_Y[W'_ '\-%% !]G/_ #WN/^_A
JH\@_\]Y_^_AHHH 46Y_Y[S_]_#6CIENJS!B\CD=-[DT44 ;M%%%(9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>forms-1a_015.jpg
<TEXT>
begin 644 forms-1a_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $+ )L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH J:GJ5MI&FSW]VY6"%=S8&2?0 =R3@ =R:DL[J.^L;>[B#".>-9%##!PPR
M,_G6=XAT!=?M8XC>7-L\+,\;0E<;BI4;@RD'&35C2M--AH%IIDT[SF&W6%I2
M=I; QGC&/:@#0HKD?!T'V#6/$VFQ37,EK:WD0A6XN'F*!H(V(#.2>I)ZUUU
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M,[5;:)%^^,,.3SS@\BNBH **** "BBB@ HHHH **** .7\-_\C;XP_Z_8/\
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M22*10R.ARK \@@]Q0!S7AO\ Y&WQA_U^P?\ I-%745R_AO\ Y&WQA_U^P?\
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M/1110!R_AO\ Y&WQA_U^P?\ I-%745R_AO\ Y&WQA_U^P?\ I-%744 %%%%
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M)+ W-O'*NS:KEHV"%BH)",0 X!.,CCBMFL?P]X<L_#=DUO9[OWFUI?F.TN%
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M<W\MM'+HLOV=1N*F??\ *0 #\WO1X5\2P:_XETY;2_DN1%HI^U## ";?'UR
M"WWOUH [ZBBB@#E_#?\ R-OC#_K]@_\ 2:*NHKE_#?\ R-OC#_K]@_\ 2:*N
MHH AO/\ CRN/^N;?RKX&/4U]\WG_ !Y7'_7-OY5\#'J: "BBB@#W[]F;[_B7
MZ6W_ +5KZ!KYI^ 7B&R\/KX@>\$I\W[.$$:Y/'F9[^]>S?\ "R="X.V[P>_E
M#C]: -'PW_Q_>(O^PH?_ $3#6_7F^A>/M'M[O7&D2Z_?:@9$ C&2OE1CU]C6
MQ_PLG0L [;O'<^4./KS0!V%%,AE$T$<J@@.H8 ]>13Z "BBB@ HHHH ****
M"BBB@#E_#?\ R-OC#_K]@_\ 2:*NHKE_#?\ R-OC#_K]@_\ 2:*NHH AO/\
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L% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>forms-1a_010.jpg
<TEXT>
begin 644 forms-1a_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #* >X# 2(  A$! Q$!_\0
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M_GXB_P"_7_UZ** #[3J'_/Q%_P!^O_KT?:=0_P"?B+_OU_\ 7HHH /M.H?\
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MM_S\0_\ ?8H^UVW_ #\0_P#?8H FHJ'[7;?\_$/_ 'V*/M=M_P _$/\ WV*
M)J*A^UVW_/Q#_P!]BC[7;?\ /Q#_ -]B@":BH?M=M_S\0_\ ?8H^UVW_ #\0
M_P#?8H FH'6HA=6Y.!<1$GMO%.>6.+'F2(F>FY@,T >37=GJDUOXCU."9X(+
M6XNUEE^T,3,. J!.@ /.:M:A9/HUGI>HWL%IY,0W3::+]RTNXJ!*A)R6']WI
M7I&^P\MX]]KLD)+KE<,3UR.]-D&F321R2BSD>+_5L^TE/IZ5'(7S'G6G7(&M
M1RV=W.=4DUV2)X!(6S;?Q;DZ #UK8U?Q7J%K>:R8+JUB%A*D"6LD>7(;'[\G
M.=HR3@>E==&=.AE>6(VB2/RSKM!;ZGO2.-,DE,L@LWE*["[;22OIGTHY7;<5
MSA9O%FNM(UG:7MC(T37/^F"#<DRQ(&!4 X!YP>HIA\7:_'+##<7NG0B<VK_:
M&A(6%)E8D$$\X(ZUWJ+ID:(B"S5$!"J-H"@]0/K5+4M,TG4_LHEEMU6WG2;:
MNS#[00%/^SS19]PNNQQ4/CS6)+8RO-91M;(K!3&?^)AF4I^[YXX&>,\FGOXC
MO[_4([&^-NUU%J<0C5$#)$K;MK!E;YCQT-=^5TLF$E;,F'_5'"_N_P#=]*1$
MTN(DQK9(2^\[0H^;U^OO1RON%UV/.+'Q7KUOINF6T5_:7=Q-YSL\VU<%7QY3
M$MP2,GUQCBMKQ1XHU32=7EAM[NRACCM(KE()8]SSL7VF-3G^5=6UOH[*5:*P
M(+[R"J<MZ_7WJLVG:7)KIU:6:"2;R%A5'VD)@DAAZ'FBSMN%T<+=>,YM475[
M5VAN+58TDA1XMA!$P4CALG'OBMO0/$>L7FNV<=W+:M9W;W4:1QQ%6C\HX!+9
MYS74B+2@S,$L@7.6.$^8^]2*VGHRLC6JE22I!48SUQ]:$GW"Z['!+XSU47DV
MGW-W:6UPUZL/VCRP\%O&VXJVX-@D[0,'&#4DGC+58;F8BYLYMLL]O]F6/YU$
M<983$Y^Z2/I@CFNT\G2/*DB\NQ\N0[G3:F&/J1WIP32UD,@6R#LFPL N2OIG
MT]J+/N%UV.)M/%7B*35-+M)&LG,UO!<R_*(Q(LAY"[CG*CTSDUZ'WJFZZ9(T
M3.+-FA_U1.TE/IZ5-]KMO^?B'_OL525A,FHJ'[7;?\_$/_?8H^UVW_/Q#_WV
M*8B:BH?M=M_S\0_]]BC[7;?\_$/_ 'V* )J*A^UVW_/Q#_WV*/M=M_S\0_\
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MU3Y=A4\8QTI<H[G-:!<V;:CJMWHT2O;92/[.DA!;!.^7!Z>@]<5D)?#4+KQ
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M1>)+B;4_)2R3[,]P]I&YDPXF5=WS+CA3R*75O#_G:7_9NGV=BL3CF6;.Z)L
M!UP.6P/44R3PY+<:Y#>D6UO]G!*W$8)FE?9M#-GCCD]\\4:AH/\ ^$CFM;'5
M)+^UC%Q8N(PENY=9G9<JJD\Y[&K6FZM-=WD,4\2(MQ9I=1;3TZ!U/T)'YU03
MP@G]F"UGU"XFDC9Y(I5_=-O92"S8^\3GJ:L:/H]Q87=L)G+Q6=DMM&[-N,C$
M@L?8#  H5PT-ZBBBJ)"L;6=9N=/G$-I:)<.EN]U-O?;MC7KCU8]JV:R=6T3^
MTY5E2[EMG,+6\A10=\3=5YZ'CK2?D-#-8\0PZ;HJ7\4?VB24#R80>6R,G/H
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M=;^&\N)Y;F5"$>-E(3+]\DKP.FVDV.QV(NK=KEK<3Q&=5W-$'&X#U(ZXJ/\
MM"R^S-<_;+?R%.UI?,&T'T)Z5Q%[IU]<27%K!9RKJ8GN9I+D(0KQNA"@/WSD
M #MBGI"AO8M072[A=)CEA$MN;<Y++$REMF,D D#I2YF.QW(GA+H@EC+.NY5#
M#+#U'M4E<-H]LMAK&B&2PN$N3!,LLGDL0BL08U9N@P.W:NYIIW$T,D_UMO\
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M<'!PHI?[-L?^?2'_ +X% %CS$_OK^='F)_?7\ZK_ -FV/_/I#_WP*/[-L?\
MGTA_[X% %CS$_OK^='F)_?7\ZK_V;8_\^D/_ 'P*/[-L?^?2'_O@4 6/,3^^
MOYT>8G]]?SJO_9MC_P ^D/\ WP*/[-L?^?2'_O@4 6/,3^^OYT>8G]]?SJO_
M &;8_P#/I#_WP*/[-L?^?2'_ +X% %CS$_OK^='F)_?7\ZK_ -FV/_/I#_WP
M*/[-L?\ GTA_[X% %CS$_OK^='F)_?7\ZK_V;8_\^D/_ 'P*;]BTWS?*^SVW
MF[=VS:,X]<>E %KS$_OK^='F)_?7\ZK_ -FV/_/I#_WP*/[-L?\ GTA_[X%
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MUH44<J#F9G_V'I__ #R?_OZW^-']AZ?_ ,\G_P"_K?XUH44<J#F9G_V'I_\
MSR?_ +^M_C1_8>G_ //)_P#OZW^-:%%'*@YF9_\ 8>G_ //)_P#OZW^-']AZ
M?_SR?_OZW^-:%%'*@YF9_P#8>G_\\G_[^M_C1_8>G_\ /)_^_K?XUH44<J#F
M9G_V'I__ #R?_OZW^-']AZ?_ ,\G_P"_K?XUH44<J#F9G_V'I_\ SR?_ +^M
M_C1_8>G_ //)_P#OZW^-:%%'*@YF9_\ 8>G_ //)_P#OZW^-']AZ?_SR?_OZ
MW^-:%%'*@YF9_P#8>G_\\G_[^M_C1_8>G_\ /)_^_K?XUH44<J#F9G_V'I__
M #R?_OZW^-']AZ?_ ,\G_P"_K?XUH44<J#F9G_V'I_\ SR?_ +^M_C1_8>G_
M //)_P#OZW^-:%%'*@YF9_\ 8>G_ //)_P#OZW^-']AZ?_SR?_OZW^-:%%'*
M@YF9_P#8>G_\\G_[^M_C1_8>G_\ /)_^_K?XUH44<J#F9G_V'I__ #R?_OZW
M^-']AZ?_ ,\G_P"_K?XUH44<J#F9G_V'I_\ SR?_ +^M_C1_8>G_ //)_P#O
MZW^-:%%'*@YF9_\ 8>G_ //)_P#OZW^-']AZ?_SR?_OZW^-:%%'*@YF9_P#8
M>G_\\G_[^M_C1_8>G_\ /)_^_K?XUH44<J#F9G_V'I__ #R?_OZW^-']AZ?_
M ,\G_P"_K?XUH44<J#F9G_V'I_\ SR?_ +^M_C1_8>G_ //)_P#OZW^-:%%'
M*@YF9_\ 8>G_ //)_P#OZW^-']AZ?_SR?_OZW^-:%%'*@YF9_P#8>G_\\G_[
M^M_C1_8>G_\ /)_^_K?XUH44<J#F9G_V'I__ #R?_OZW^-']AZ?_ ,\G_P"_
MK?XUH44<J#F9G_V'I_\ SR?_ +^M_C1_8>G_ //)_P#OZW^-:%%'*@YF9_\
M8>G_ //)_P#OZW^-']AZ?_SR?_OZW^-:%%'*@YF9_P#8>G_\\G_[^M_C1_8>
MG_\ /)_^_K?XUH44<J#F9G_V'I__ #R?_OZW^-']AZ?_ ,\G_P"_K?XUH44<
MJ#F9G_V'I_\ SR?_ +^M_C1_8>G_ //)_P#OZW^-:%%'*@YF48]'L8I4E6)M
..Z'<I,C'!_.KU%% S_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>forms-1a_016.jpg
<TEXT>
begin 644 forms-1a_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "Q 7 # 2(  A$! Q$!_\0
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M8L?+] V<$4 =G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3_ZU'_"P!_SX?^1/_K5O]6J]C+ZQ3[G;45Q/_"P!_P ^'_D3_P"M1_PL ?\
M/A_Y$_\ K4?5JW8/K%/N=M16#H'B+^VWF46_E>6 ?O9SFMZL90E!\LMS2,E)
M70M%%%(H**** "BBB@ HHHH **S=<U+^QM O]3\OS?LD#S>7G&[:,XS7B?\
MPTJG_0M-_P"!7_V- 'OU%> _\-*I_P!"TW_@5_\ 8T?\-*I_T+3?^!7_ -C0
M![]17@/_  TJG_0M-_X%?_8UVWPX^*8^(%_>6JZ4;/[-&'W>;OW9.,=!0!Z1
M1110 4444 %%%% !1110 4444 %%%% $<B[XV48R1CGI7*V?A2ZM[VRN6O45
MK?*D1(0-NXG &<<YYKJI#LC=L@$ G)Z"N3M?$U]<S:5&MN9([B1EN)HXCLXS
M@#TZ=Z .PHHHH **** "L3QA_P B9K?_ %XR_P#H!K;K$\8?\B9K?_7C+_Z
M: /ANBBB@ HHHH ]J_9P_P"1JU7_ *]!_P"A5]!ZY_R [S_KDW\J^?/V</\
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M110([/X??Z^\^@KNJX7X??Z^\^@KNJ\;%_QF>IA_X:%HHHKG-PHHHH ****
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MH$=G\/O]?>?05W5<+\/O]?>?05W5>-B_XS/4P_\ #0M%%%<YN%%%% !1110
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M":^(: "BBB@ KW#]FW_D.ZS_ ->Z?^A5X?7N'[-O_(=UG_KW3_T*@#WS7O\
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M'_?=>YSQ[GD\K[%NBJG]JV'_ #^P?]]TG]JV'_/[!_WW3YX]Q<K['?\ P_\
M]=>?05W5>:>!]>TBVENS-J=K&&"XW2 9_.NS_P"$JT#_ *#-C_W^%>1BG>J[
M'I8?^&C9HK&_X2K0/^@S8_\ ?X?XT?\ "5:!_P!!FQ_[_#_&N<W-FBL;_A*M
M _Z#-C_W^'^-'_"5:!_T&;'_ +_#_&@#9HK&_P"$JT#_ *#-C_W^'^-'_"5:
M!_T&;'_O\/\ &@#9HK&_X2K0/^@S8_\ ?X?XT?\ "5:!_P!!FQ_[_#_&@"OX
MZ_Y$+7O^O&7_ -!-?$-?9/C/Q'HEQX)UN&'5K2662SE5564$L2IX KXY\F7_
M )Y/_P!\F@!E%/\ )E_YY/\ ]\FCR9?^>3_]\F@!E>X?LV_\AW6?^O=/_0J\
M2\F7_GD__?)KV3]GZ^M-+UO5GO[B.U1X%"M,VT$Y[9H ^A=>_P"0'=_]<S7D
M=>C:UXFT*71KI$U>R9C&0 LPR:\N_M6PQ_Q^P?\ ?=>E@6E!W[G!BTW)6+=+
M5/\ M6P_Y_8/^^Z/[5L/^?V#_ONNWGCW.7E?8MUVGP^_UM]]$_K7 _VKI_\
MS^P?]]UUO@;7M(MGO#-J=K'N"XW2 9Z^M<^*DG2>IMAT_:(],HK&_P"$JT#_
M *#-C_W^%'_"5:!_T&;'_O\ #_&O(/3-FBL;_A*M _Z#-C_W^'^-'_"5:!_T
M&;'_ +_"@#9HK*M_$&C7EPD%MJEK+,_W424$GZ5JT %9UQI-G<WL=Y-%NGCQ
MM.XX..1D=\5HT4 1O&DJ%)$5U/4,,BH?[/LO^?.W_P"_0JU10!5_L^R_Y\[?
M_OT*/[/LO^?.W_[]"K5% %7^S[+_ )\[?_OT*/[/LO\ GSM_^_8JU10!7^Q6
MG_/I!_W[%'V*T_Y](/\ OV*L44 5_L5I_P ^D'_?L4?8K3_GU@_[]BI9B5AD
M8=0I(_*O,-"\7ZC!;SR7MYYA>WCDB\TB0;RQ!^[]WMP: /238VAZVD!_[9BD
M%A9CI9V__?L5Q\/CB<V]M=36B"*:U:4(I+-)(H)*CTZ9R:K3>)M3N[&UNI8A
M HE<CR7R)5\IF ]L&@#N_L5I_P ^D'_?L4?8K3_GT@_[]BN0B\6W\<BL]I&]
MH'\D88F5F$/F9QC'M6GX6UR\URWDFN;1(4PKQLC@Y##D8[$47 W/L-I_SZ0?
M]^Q1]AM/^?2#_OV*L447 K&QM#UM(#_VS%)_9]E_SYV__?H5:HH J_V?9?\
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FHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>forms-1a_017.jpg
<TEXT>
begin 644 forms-1a_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #G -<# 2(  A$! Q$!_\0
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M*T %>P_LY?\ (^7W_8/;_P!#2O'J]A_9R_Y'R^_[![?^AI0!]/4444 %%%%
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MO%: "O8?V<O^1\OO^P>W_H:5X]7J_P"S_>BS\=7>+>>X=[!PJ0@$_?0YY(H
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M?\E*D_[!\O\ Z$E>45ZO^SU_R4J3_L'R_P#H24 ?5%%%% &5K?W]+_Z_D_\
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M+_Z_D_\ 06K5H **** "OF_]I3_D8]$_Z]'_ /0Z^D*^;_VE/^1CT3_KT?\
M]#H \0HHHH ]5_9[_P"2EG_KPE_FM?55?*O[/?\ R4L_]>$O\UKZJH *R=<^
M]I?_ %_Q_P FK6K)US[VE_\ 7_'_ ":@#6HHHH **** "BBB@ HHJ-)X99)(
MXY4=XSAU5@2I]QVH SO#?_(O6?\ N'^9K5K*\-_\B]9_[A_F:U: /FK]I+_D
M;=(_Z\#_ .C&KQ6O:OVDO^1MTC_KP/\ Z,:O%: "O5_V>O\ DI4G_8/E_P#0
MDKRBO5_V>O\ DI4G_8/E_P#0DH ^J**** ,K6_OZ7_U_)_Z"U:M96M_?TO\
MZ_D_]!:M6@ HHHH *^;_ -I3_D8]$_Z]'_\ 0Z^D*^;_ -I3_D8]$_Z]'_\
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:444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>forms-1a_012.jpg
<TEXT>
begin 644 forms-1a_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $G G # 2(  A$! Q$!_\0
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M [S9/^>C_P#?1H\V3_GH_P#WT:;10 [S9/\ GH__ 'T:/-D_YZ/_ -]&FT4
M.\V3_GH__?1H\V3_ )Z/_P!]&FT4 .\V3_GH_P#WT:/-D_YZ/_WT:;10 [S9
M/^>C_P#?1JQ8R.;Z$%V(W=R:JU8L/^/Z'_>H Z6N:UN>*VN+B>9PD4:AG8]
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MBH #< C&!P<<9Q0!T((89!!'J#2U1TG3(M'T]+.%RR*2=Q &<^PJ]0(****
M"J]]]D^RE;W9Y#,JG>2 22 !^>*L56U"RCU'3[BRE9E29"I9>J^A'N#S0!GP
M6GAZY?9!';2-ACA7/9MI[_WN*D?3-$CECB>V@5Y"0H+'D@9/?TJ@W@K3BK!9
M9AEXVP<$#:I!&/<DL?<YI1X-LA*)%N9PPG,X/!^;T;^\/K0!=CT[0Y;J6UC@
M@:>$ R1AFR@/3//?%3?V'I?_ #XQ_FW^-2QV/EZM/?\ GD^=&L9BV  ;22#G
MJ3R:MT 9_P#8>E_\^,?YM_C1_8>E_P#/C'^;?XUH44 9_P#8>E_\^,?YM_C3
M)M(T>W@DFEM(DCC4L[$M@ =3UK3IKHLD;1N R,"K ]P:!F.EMX<DF\I$M6DW
M;-H<_>V[L=?[I!J:72]$@"^;;0KO947+'DMT'7O68O@?3EA\L7%R3Y/E%F(.
M3NW;CZG@+]!3G\%6$GF W$X$@0';@$;<=#V' XH NM8Z EY':-# +B0;DCW-
MEA^>.Q_*K']AZ7_SXQ_FW^-)_9;?VA:737CLEM'L2 QKMSC!;V.*T:!&?_8>
ME_\ /C'^;?XT?V'I?_/C'^;?XUH44 9_]AZ7_P ^,?YM_C1_8>E_\^,?YM_C
M6A10!D7-AH-GC[3!!$"K,"[,.%&6/7L.:6#3]"N=WD06\FT@':Q[@,._H0?Q
MJ?5=)M]8AABN"P6*991M_BQU4^Q!P:R/^$)T_8B_:+C"B1<DC/S$G@]B.GT
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M2W_YXQ_]\BIJ* (?LEO_ ,\8_P#OD4?9+?\ YXQ_]\BIJ* (?LEO_P \8_\
MOD4?9+?_ )XQ_P#?(J:B@"'[);_\\8_^^11]DM_^>,?_ 'R*FHH A^R6_P#S
MQC_[Y%'V2W_YXQ_]\BIJ* (?LEO_ ,\8_P#OD4?9+?\ YXQ_]\BIJ* (?LEO
M_P \8_\ OD4?9+?_ )XQ_P#?(J:B@"'[);_\\8_^^11]DM_^>,?_ 'R*FHH
MA^R6_P#SQC_[Y%'V2W_YXQ_]\BIJ* (?LEO_ ,\8_P#OD4?9+?\ YXQ_]\BI
MJ* (?LEO_P \8_\ OD4?9+?_ )XQ_P#?(J:B@"'[);_\\8_^^11]DM_^>,?_
M 'R*FHH A^R6_P#SQC_[Y%'V2W_YXQ_]\BIJ* (?LEO_ ,\8_P#OD4?9+?\
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M]Q].1S4:>)=2AMG\_2Y7DCC!SM(+L?8#@=OJ* ->ST*VLK]+J-G9HX! @;G
MR3GW.,#Z"M2N<'B6Z+HO]ES;FFV;0K8"X'.<8[\BF+KVKM<1J=,1=R@;27QN
M)3G.WH YS]#0'F=-17-)XEOF21VT>2,(4X8G<<XR0-O/7CZ5KZ5?2ZA:O+-
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M&J3Q_P!KK/.RF"0^2Z6K'"[ >!_&0<_4T 74T>VCNX;A&D'D1^7%'N^1!C'
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MY1/Y8">6X*;LKN5N#G@Y4<\U2G\,23F]<WJE[K#-NB+ ,"I!P6[;<#&, ]Z
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MMH6FGE2*->KNP4#\34E4]2L6OH(U241R12K*C,FY<CU&1D<^M %@W$*B,F5
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M)P&8'<,<'Y<CV^E='+;6LDJRS0PM(/E5W0$_0$TUK6RQ(K06^#AI 4'..A-
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M-!).EG%LV[U5YMK( RJV\8X^]D>N*ZKK4#VEK+O+V\+^9C?E =V.F?6IP
M!@"@ HHHH *H76H-;:K96A2/RKA9"9&DP5*C. ._?FK]0S0VTDL?G1PM)R$W
MJ"??&: .?OO$UU:7-Q%':0SK&5VM'(6R"2 " /O$@#C@$\UMG48%U!+%O,$[
MH7 \LE<#'?&.].$=E&SLJ6ZMO&X@*#O[9]Z5K&V:[%TT*F<# D[B@#(M?$37
M*W9:.WB\N,R1EYL  ,RX<X^4_+GOQ4FGZO>WMY:QF" 1RPF63:Y+(,X4].C=
MAUQGTK2-M8R"8-#;L"29<JIR<<[OP]:6 V<;"*W,"$J,)'@9';@=J +%%%%
M!56\OX;$Q"7<7E;8BJ.I^IX'XFK5-=%D0HZAE/4,,@T <\/$[@79:WB'EJ3$
M/-YXD*?/Q\O//?C-5W\7RQ"0M:1,(B8W"2G+-\WS+QRGR=??VKH_)LRTK>5
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MBX4LKX;E23P#\OICTXS4UA!JJZHD]TX^S&U$8C#Y*,-O4="Q.[G- &Q1110
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M6C\M@04=@> !C.>F /RH&.BUW392<72C#E,L" <8YSZ<CFA==TN0?N[R-F)
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M;%NC.V+EO*:5 N4P,8QVZUT/V6'^Y^M'V6'^Y^M,#-HK2^RP_P!S]:/LL/\
M<_6@1FT5I?98?[GZT?98?[GZT <[?)<&_M'A:Y$4>7E$9^5@.BX[DD_D#64D
MFNNL331SK(MSN9$4A74X^4G^%5]>=U=O]EA_N?K1]EA_N?K0,YY+^5]:DL_)
M A5,K+\V2><CICT[UGO+J8T6Y1?MYNUG<QOY(W.@DX&.F"OZ"NQ^RPXQM_6C
M[+#_ '/UI 9N0>0" ?6BM+[+#_<_6C[+#_<_6F(S:*TOLL/]S]:/LL/]S]:
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M0D\,3,KJFH*H;*<V^?W;,693\PZDXSZ<=\T =&#D9'2BD10B*HP !C@8%+0
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M\\J[.01M(P0%Y['K]*ETC3[FPN[^:ZO$N/M+JX8 @C P>,D = ,>E:?D0_\
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MN-1N[F+4%V30&%4!*,B[E.%/(!(#?-C/-=!Y$/\ SR3_ +Y%'D0_\\D_[Y%
M&#/I%Q>V=G#<_9?,MP3YH)R2%^4# &!G&?\ =]ZCMK'5=,\/O;6TJFZ,NY2"
MKX7C/4J.QZ>OXUN1R6,T\L$9@>6+[Z+@E?K4WD0_\\D_[Y% &/=VES<ZGI]U
MY,)$*[GD,VQ]V#A<#(V\\\\\>E9UYH6H3374CRV]U]J="=TC1F$#=]WJ,@$
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M /W?EQE>.<D=J (CX1'F)(;]F,:@ R1YR/E^4\\I\OW??K3O^$10_,-0F,F
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MT7 ]\4YO"4?F2/%=;0_&TQY &6(7KT&_@>H!JN/#^LI%:QK?1,+?:4:0EBI
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MX+-@ !%')N (7!;)7@D]< <#UJVVG>())R3J2QIDL=C9R<';@%> #MR,\XH
M;_PB,1E9FO9G5MN5?)Z+C'7&,\].M-_X1 !65;]UW$L6"8;)QD@YZG'7T./>
MHH]'\0Q!_*U 1>878CS-YWD  DE>>GH,5J6EIJ,%^ZSS//:-@(7D&Y1MP<C
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M^X%7=3O;[3+H7D)%Q'=A8XX,LP#!6;Y=H/7 'XYKH2 001D'J*3 XX''3VH
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ML2"99 T*J2=@!"EN,CD9X_"N@HH Y>;Q'J5O;RW$NEA8D!"L=PW'C#<C@'/
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>forms-1a_018.jpg
<TEXT>
begin 644 forms-1a_018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $N G # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@!AE
MC#;2ZY],T^O"+^SCU#Q/XPC_ +"U74[P716VFLW(6!B#C<<\<X/3M73W_B/Q
M#X7T32=.EN[#^T(K#S;A9E>:9V'1=J=!@8+&NEX?9)ZO_(Q5;>Z/4*0,&&5(
M(]J\IM?$&O:[XU\*W44D$-O=Z<\[6Q9MO!Q(<=S_ ':JZ?XUGT?PSIEMI]M;
MV\U_?W2^9())4B5'Y; RQ)STI?5Y?/\ X?\ R'[9'L-%>9I\0-=N-*T@P6%L
ME_=:DU@_G(ZQN N1(N<$ \?D:R_$OBCQ'=>$M>LYY;:"\TV_CMYIK8LHD1N1
MM[CGK[4+#S;LP=:-KGL%)N&[;D9],U3@N)+/2HIM7GMHY50>=(IVQAO;/:N
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M[*MY;FX.?W0E7?QUXSGB@"S1110 4444 %%%% !1110 4444 %%%% !1110
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MY4;CK@X([<X_&EROL%T5M!^(4&OZE96\6ES107?RK.TBG#^5YFTJ.>F>:[3
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]@-JBN<D\:Z4S;+$7.H2?W;6%F_,]!4?]J>)[_\ X\M%BLT/22]ER1_P%?\
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M_OH4>=%_ST3_ +Z% !Y2>A]>II/)3&,'ICJ:7SHO^>B?]]"CSHO^>B?]]"@
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M.JA]/;2VN(K<#9' HDQD\\MC.6KNZK2Z?9SS/--:PR2O$87=D!+1GJI/I[4
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M!F_NLVUA^!K5ZUFWV@:3J/\ Q]Z?;R-_>V ,/Q'-&@:EZ2>&$*998T#'"EF
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MA0.4&3NZ,.V*EB\)^%;%([R.VCME*!4D,S)\NT@#D_W68?0FFPZ#X2TZ8:C
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M\MMD3:9I4!MHA!JC"%T5'6/ $P484\\CY2,XZXIMEX6M;!$FM-0,,WW%EC5
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M!C &.3CN:B@\*:9YQNA?O+'LPH9P0 W3_P"M5BY\)0W-KI\!N2HLT9 PB7+
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M0Y5@&!]0:336X73%B_X_D_W&_F*O51B_X_H_]QOZ5>I#*FJ?\@B\_P"N#_\
MH)JAX0_Y%'2_^N J_JG_ ""+S_K@_P#Z":H>$/\ D4=+_P"N JOLBZFU1114
MC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME?3!]*DC\475O*5N=,=4=81&JD9,C@GMG@D?A@TW_A-\&+=IS8<C)27=C(!
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M0 4444 %07?_ ![_ / E_F*GJ"[_ ./?_@2_S% $]5K_ /X\I/P_F*LU6O\
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M'YASS77_ +[_ )]W_P"^A1^^_P"?=_\ OH4>VEY?</V:.&'@S6#=?:7U0-<
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M6D]M +>6:2X?:!'CY0.K')' _.@"W151;\'4WLGMY8R$WQRMC9(.^,'/&1U
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MQOO7;A$*EOF)RW/)YP/8"MNH:2>A2OU"BBBD,**** "BBB@"KJ/V/^SYA?\
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I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex10-18_001.jpg
<TEXT>
begin 644 ex10-18_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  T -0# 2(  A$! Q$!_\0
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M>,D $VK79\FQMP,EY#QG'H,_R% '"_%?Q<=7\06W@K3[>XO;>-UFU9+1@'9
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MG[S'W-;= !1110 5Q>I:3X]F\6175AXCT^#1!*I>T:UR^SC(S@Y/7G(KM**
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M %>0>*T_X3/XW:+X;?Y].T6'[==)V9S@@'_QP?\  C7K]>3^#V2'X]>-8;K
MNY8(G@)/6/"Y _-?RH ]8KQ_XC^,->UGQ"? ?@HD7_EF2]ND?;Y:@9V!OX>,
M9/N!75?$'Q_!X2LEL[)?MFOWG[NSLH_F8L> S =OYUY#X"\7Z;X6\-:OJ+F3
M4O&^K7#Q+:*A:0'/&[T&[)/KP* .X^ .KZGJ/AC4[74[F:=K.[\M#,Q9ER,E
M<GWJ+7?CC/HVK:@J^&);C2+*\-D]\MQC,@!. NWK@$XS6%\*/'/A[P?\/]5D
MU:]2/5Q>2R26S ^;*V!M&,>H(]JX3Q)IU]IG@S0]3U6UE,6KZE/J$\?(.T[
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,ZU?HHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex10-18_002.jpg
<TEXT>
begin 644 ex10-18_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ ,\# 2(  A$! Q$!_\0
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; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ex10-20_001.jpg
<TEXT>
begin 644 ex10-20_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G )X# 2(  A$! Q$!_\0
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@8\'^'!8/.)[J:5KFZE50JF5\9VJ.BC  ^E=-110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ex10-20_002.jpg
<TEXT>
begin 644 ex10-20_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J -L# 2(  A$! Q$!_\0
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MK(N'OKD;G)]!_=7_ &1@52\/:5JYN8M1\0-";N" V\*1/O R<NY.!RV%P,<
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M-;)<:@^$A$C (A/&]O8=<=\8J'PUH$7AW2A;"5KBZE8S7=U)]^XE/WG/]!V
M K8HH **** "BBB@#+TWP_IVE:CJ.H6T/^F:A+YES.YRS8& ,]E'858U'2=/
MU>.*/4;.&Z2&02HLJ[@KCH<>U7** #H*\FL=$NOB-XSU'5=<T]1X=M)A!8QS
MI\TXC)R0#T4MR3WP!VKUFB@#E7^&_A.3<&TE?+;@Q":01G_@.[%6=$\"^&/#
MMRUSI6BVMM.23YH3+#V!.2!]*Z&B@ ILD:31M'*BNC<%6&0?PIU% "    #
0'0"EHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>ex10-22_001.jpg
<TEXT>
begin 644 ex10-22_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  N +H# 2(  A$! Q$!_\0
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CU[>?X_M0)^OW:E3X'Z2B*H\1^(\* /\ C] _]EKU"B@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>ex10-22_002.jpg
<TEXT>
begin 644 ex10-22_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !, + # 2(  A$! Q$!_\0
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M?KEZUZ "BBB@ HHHH **** "BBB@ HHHH **,CUJM>7]II\/FW4Z1+VR>3[
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MT,%DANYEAPLSYV]6Z <;0:Z>L>S/]IZO)J'6VMMT%L>S-_&X]LC:#[&@"@-
MG_Z!FBC_ ("YJ:WTB]M)/-M[31HY.S+$^1^-=#4$-[;7$\L,4\;RPG$D8/S+
M]10!@ZQ#K_D07*K83&UF$QB5'RP (..>2 <CZ5;M;G5KVW6XMKG3)(FZ,$?\
MCSP?:MJLVYTA6G>ZLIWL[I^7:, K(?\ ;4\'Z\'WH S-<76DTQIW?3S]GD28
M81^-K ^OIFM$C7>TFG?]\/\ XU1U6XU6/2+R"[T\7"M X,UHP_NG^!N?R)JS
M9^(].>SMWGN# [QJQ\^-H^H'<C% $N->_O:;_P!\O_C1_P 3[UTT_@]6X=0L
MKC_4W=O)_N2 _P C5D'/2@#+_P")]_U#1[_/2$Z^.BZ<WXN*U"0HR2 /4TM
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9DGW/N>M %FBBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
